data_2c34_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2c34 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.635 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -26.12 105.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.424 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 89.69 6.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.921 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -74.15 98.85 3.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.622 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.479 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 6.6 p -155.34 177.32 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.479 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 3.4 p-10 -98.21 -175.24 3.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -173.76 -173.0 0.8 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 112.094 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.57 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m-70 -114.73 -167.35 1.21 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 30.6 t -94.0 135.23 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.137 0.494 . . . . 0.0 112.153 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.64 16.53 11.49 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.437 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.7 tptm -65.73 81.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.445 HG21 HD23 ' A' ' 77' ' ' LEU . 5.9 m -46.71 99.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.733 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.5 m -93.79 99.6 11.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.51 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.3 131.73 35.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.53 HG21 ' HG ' ' A' ' 26' ' ' LEU . 43.7 mt -134.67 103.97 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.731 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -86.02 95.51 9.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HG ' HG21 ' A' ' 24' ' ' ILE . 8.2 mt -92.95 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.302 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -101.6 168.52 9.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.47 -130.53 1.93 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.429 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.595 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.614 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 2.4 ttt -148.3 151.81 36.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.728 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.8 m95 -109.4 90.33 3.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.081 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.614 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 9.6 t -139.72 -166.58 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.375 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.2 mtp85 -92.23 124.21 36.13 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.797 0.332 . . . . 0.0 110.737 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.6 p -52.88 142.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.27 78.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.749 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.15 -0.65 5.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.499 . . . . 0.0 110.184 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 37' ' ' THR . 38.1 t -54.78 105.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.036 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.101 -179.566 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.5 mt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.452 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 62.4 p -53.23 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.655 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.83 -86.61 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.47 -30.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.161 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.6 mm -74.04 -73.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.278 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.588 HD21 ' HA ' ' A' ' 80' ' ' PRO . 12.1 mt -104.96 116.02 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.344 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.33 68.81 0.36 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 109.902 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 38' ' ' ARG . 14.0 t -74.17 84.67 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.993 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.0 85.41 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 76' ' ' VAL . 34.6 t -102.63 142.69 33.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.69 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -133.01 113.59 12.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.987 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.527 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.68 102.66 10.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.451 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -101.67 110.95 63.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.643 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.45 -1.043 0 C-N-CA 123.539 2.826 . . . . 0.0 111.695 179.163 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.4 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -131.37 98.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.95 106.64 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG22 HD12 ' A' ' 90' ' ' LEU . 29.7 t -110.0 120.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.445 HD23 HG21 ' A' ' 21' ' ' THR . 82.6 mt -110.13 100.97 9.79 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.765 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 105.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.048 0.452 . . . . 0.0 111.18 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -107.18 102.08 41.64 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.239 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.588 ' HA ' HD21 ' A' ' 52' ' ' LEU . 52.5 Cg_exo -51.44 97.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.681 2.254 . . . . 0.0 112.705 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.3 mtt180 -66.24 -43.26 87.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.319 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 86.9 mttt -114.85 173.74 6.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -108.97 125.07 51.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.798 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.568 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 155.04 -138.42 6.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.406 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.4 m80 -97.85 95.16 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.8 m-70 -112.07 162.18 15.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.498 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 109' ' ' HIS . 85.2 m -159.72 144.9 15.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 111.68 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 38.2 tp -101.0 92.66 5.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.026 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.4 mt-10 -75.13 88.51 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.481 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 48.2 mt -103.54 123.42 46.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG21 ' N ' ' A' ' 92' ' ' TYR . 13.1 p -126.19 158.49 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.5 t80 -102.34 91.85 4.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.327 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.567 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.5 t -122.45 167.46 13.3 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -101.07 94.89 4.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.41 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.9 Cg_exo -46.94 -28.77 7.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.252 . . . . 0.0 112.549 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -72.44 -42.62 64.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.312 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.19 -69.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.01 179.04 37.31 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.975 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.4 mt -98.4 140.84 17.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.959 0.409 . . . . 0.0 111.258 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 46.2 mtmt -140.39 159.44 63.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.194 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 30.6 Cg_endo -63.79 -36.32 51.83 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.917 2.411 . . . . 0.0 112.693 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.68 0.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.518 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -85.27 158.07 20.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.185 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 166.37 9.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.659 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.7 tpp180 -133.49 164.31 27.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.592 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.659 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 55.4 t80 -171.34 69.66 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.007 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -93.17 90.13 6.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.731 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 28.2 tp -70.59 89.96 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.326 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 36.8 m-70 -72.97 135.93 45.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.963 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 86.4 mt -140.1 103.97 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.541 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.5 t-20 -79.26 65.43 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.568 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -43.49 116.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.521 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.968 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.648 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 112.01 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.565 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -25.15 107.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.776 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 108' ' ' LEU . 77.0 tttt -106.78 97.24 7.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.732 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 m95 -85.17 106.08 16.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.586 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.485 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 2.9 p -152.94 -178.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 112.454 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -103.56 -179.74 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.797 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.412 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.8 t -177.67 -171.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.793 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.6 m-70 -122.25 173.13 7.8 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.041 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG12 HH21 ' A' ' 83' ' ' ARG . 8.9 p -67.36 138.66 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.282 0.563 . . . . 0.0 112.163 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 62.05 11.65 32.98 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.872 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 18.9 tptt -60.04 83.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.236 0.518 . . . . 0.0 109.828 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.439 HG21 HD23 ' A' ' 77' ' ' LEU . 2.5 m -57.41 99.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.447 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -96.99 100.67 12.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.3 tt0 -83.24 133.86 34.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.984 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.405 HD13 HD23 ' A' ' 108' ' ' LEU . 39.3 mt -139.79 105.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.03 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -88.98 113.92 25.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.138 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.501 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 14.5 mt -109.48 147.36 33.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.274 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -100.68 161.19 13.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.895 0.379 . . . . 0.0 110.621 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.18 -155.14 25.62 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.456 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.89 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.488 ' HE3' ' HB ' ' A' ' 37' ' ' THR . 8.0 ttt -108.98 151.54 26.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.432 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.3 m95 -109.54 103.07 11.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.619 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.488 ' HB ' ' HE3' ' A' ' 35' ' ' MET . 15.1 t -146.9 -174.05 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -77.38 138.22 39.18 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.219 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 91' ' ' VAL . 98.0 t -54.1 134.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.586 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -33.63 1.52 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.581 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 39' ' ' VAL . 12.4 m-85 -87.55 25.13 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.651 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG22 HG22 ' A' ' 93' ' ' THR . 25.3 t -79.63 107.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.985 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.684 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.2 mt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -51.04 177.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -154.16 -95.64 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 111.751 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.88 -31.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.119 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.5 mm -72.12 -70.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.579 HD21 ' HA ' ' A' ' 80' ' ' PRO . 16.2 mt -105.79 116.27 31.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.222 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -68.32 72.94 0.21 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG12 ' CZ ' ' A' ' 38' ' ' ARG . 3.8 t -76.44 84.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.304 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -81.51 82.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' HB3' HD11 ' A' ' 47' ' ' LEU . 11.1 t -108.71 147.9 31.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.426 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -138.87 125.4 20.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.488 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.33 97.08 7.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.925 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 116.05 65.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.443 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 C-N-CA 123.231 2.621 . . . . 0.0 111.586 179.305 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 3.4 pt . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.05 0.453 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.501 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -143.38 103.68 4.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.027 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.77 126.53 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.49 HG12 HD22 ' A' ' 88' ' ' LEU . 18.2 t -122.28 122.37 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.593 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 79.8 mt -109.94 96.4 6.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.851 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.35 105.38 16.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.239 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.4 mtmt -108.65 100.87 40.95 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HA ' HD21 ' A' ' 52' ' ' LEU . 72.2 Cg_exo -48.18 96.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.733 2.289 . . . . 0.0 112.992 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 4.8 mtt180 -63.41 -37.01 85.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.652 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -116.44 -173.85 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.466 HH21 HG12 ' A' ' 18' ' ' VAL . 97.5 mtt180 -132.77 119.22 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.86 -100.59 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.33 100.98 7.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.426 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -118.33 161.12 20.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.536 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -160.64 150.66 17.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.886 0.374 . . . . 0.0 111.76 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 20.6 tp -132.26 82.52 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.662 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.725 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -86.64 105.76 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 28.2 mt -89.81 167.09 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.769 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.439 ' HB ' HG23 ' A' ' 39' ' ' VAL . 3.6 p -155.2 147.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.918 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 7.7 t80 -97.88 82.62 3.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.564 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.473 ' HB ' HG21 ' A' ' 99' ' ' ILE . 9.9 t -121.99 158.24 29.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 27.1 mtp180 -101.17 101.15 15.31 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.326 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 93' ' ' THR . 78.1 Cg_exo -46.99 -39.45 25.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.752 2.301 . . . . 0.0 113.257 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 9.38 0.99 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.73 4.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 0.0 111.348 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.95 -171.74 51.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.797 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.473 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -112.15 150.14 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 111.86 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -135.42 164.17 45.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.81 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -19.79 13.0 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.543 2.162 . . . . 0.0 111.651 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.2 pt-20 -76.75 -0.11 22.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.7 m120 -82.21 149.41 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.44 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.9 171.5 1.19 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.2 tpp180 -136.9 159.5 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.664 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 36.0 t80 -162.21 72.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.874 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 22.7 m -85.51 151.33 24.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.866 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.4 tp -140.7 87.74 2.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.36 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.732 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 13.6 m-70 -74.69 144.11 43.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 85.5 mt -144.66 102.75 3.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.296 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -80.6 61.3 4.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -38.64 140.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.86 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.045 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 111.913 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' H ' HD21 ' A' ' 10' ' ' ASN . 8.6 m-20 -25.67 103.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.924 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 55.5 tptt -94.26 90.26 6.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.414 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.19 103.34 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.476 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 4.7 p -155.42 177.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.088 0.47 . . . . 0.0 111.83 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.476 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -100.07 -178.17 3.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.765 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.8 t -175.59 -174.75 0.72 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.119 0.485 . . . . 0.0 112.08 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.611 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.9 m80 -115.51 -170.02 1.69 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.22 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.56 139.46 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.239 0.542 . . . . 0.0 112.308 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.11 22.29 9.54 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.69 81.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.446 HG21 HD23 ' A' ' 77' ' ' LEU . 3.0 m -51.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.864 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -91.6 101.6 14.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.958 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -84.81 129.73 34.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.39 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.4 mt -139.66 98.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.87 106.32 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 11.3 mt -98.86 143.78 28.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.075 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -94.08 166.57 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.025 0.44 . . . . 0.0 110.806 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.81 -137.01 3.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.078 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.424 0.154 . . . . 0.0 110.615 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.019 0.437 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 20.9 ttm -143.87 148.81 35.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.175 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 4.6 m95 -106.1 78.47 1.31 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.987 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 42' ' ' VAL . 12.0 t -125.73 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.4 mtp85 -88.61 156.42 19.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 89' ' ' GLU . 47.4 t -74.39 130.21 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.05 12.23 79.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.525 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -135.25 -1.55 2.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.088 0.471 . . . . 0.0 110.578 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.609 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.7 t -53.85 117.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.02 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.873 -179.609 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.211 0.529 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.6 p -52.32 179.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.745 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.25 -90.98 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.7 pt-20 -130.12 -28.82 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.181 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.1 mm -76.85 -73.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.335 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 80' ' ' PRO . 12.0 mt -103.94 115.52 30.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.539 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -71.02 69.38 0.48 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.502 HG23 ' HD2' ' A' ' 38' ' ' ARG . 10.8 t -75.92 88.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.091 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 39.4 t -86.27 90.11 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 52.0 t -95.38 144.64 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.94 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 75.7 mttt -130.56 92.63 3.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.887 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 58' ' ' TYR . 3.3 t80 -57.7 -17.8 17.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.321 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.9 m 31.57 78.09 0.31 Allowed Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.971 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 124.182 3.255 . . . . 0.0 113.298 -179.162 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.6 pt . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -150.26 82.14 1.37 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.609 0.242 . . . . 0.0 110.782 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 93.3 t -79.91 91.9 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.062 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG22 HD12 ' A' ' 90' ' ' LEU . 40.4 t -90.05 118.67 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 HG21 ' A' ' 21' ' ' THR . 79.1 mt -110.53 95.12 5.37 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -90.6 104.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -178.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.0 mtmm -110.16 93.9 16.72 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.086 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HA ' HD21 ' A' ' 52' ' ' LEU . 4.1 Cg_endo -48.6 100.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.594 2.196 . . . . 0.0 112.549 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.517 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.0 mtt180 -64.63 -32.67 74.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.998 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 55.8 mttm -120.91 -175.38 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.634 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.51 117.45 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.05 -107.56 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.251 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.452 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.0 m80 -116.48 91.6 3.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.452 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -111.78 157.69 20.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.576 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 109' ' ' HIS . 47.0 m -159.47 146.04 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.1 tp -112.86 92.38 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.552 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.7 mt-10 -78.44 94.95 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.197 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 67.7 mt -101.8 135.03 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -140.11 154.26 23.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 0.0 112.09 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.11 94.13 6.65 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.959 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.555 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 7.6 t -129.72 157.13 43.02 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 79.3 mtp180 -91.64 99.93 2.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.859 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.6 Cg_exo -37.93 -56.49 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.261 2.641 . . . . 0.0 113.732 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 8.2 p90 -78.15 23.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.7 mm-40 -149.9 0.87 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.38 50.44 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.498 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.2 mt -104.84 158.65 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.431 . . . . 0.0 111.933 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 13.1 mttt -135.26 165.99 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.883 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.11 -41.03 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.886 2.39 . . . . 0.0 111.974 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.47 -26.73 68.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -49.27 148.33 2.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.304 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.76 160.67 1.3 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.1 tpp180 -133.54 161.21 35.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.54 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.647 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.5 t80 -171.33 65.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 89' ' ' GLU . 9.0 m -87.35 94.66 9.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.39 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 36.2 tp -74.91 92.56 2.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.617 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.4 m-70 -77.55 138.48 39.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.3 mt -143.35 103.09 4.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.429 HD21 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.54 66.09 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -44.76 113.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.762 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.924 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.648 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 121.018 0.437 . . . . 0.0 112.041 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.82 102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.447 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -97.23 93.09 6.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.107 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -82.01 99.93 9.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.1 m -149.82 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 112.271 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.78 -163.71 1.06 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.133 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 112' ' ' VAL . 1.9 t 178.24 -175.04 0.17 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 59.0 m80 -120.73 -164.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.432 HG21 ' HG2' ' A' ' 83' ' ' ARG . 24.2 t -95.76 115.45 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 111.442 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 67.99 10.7 59.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.108 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.8 tptm -60.11 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.418 HG21 HD23 ' A' ' 77' ' ' LEU . 6.9 m -45.6 103.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.702 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.9 m -91.26 94.75 9.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.571 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -80.11 128.41 33.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.69 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -136.18 104.55 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.56 96.97 8.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.423 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 7.8 mt -91.12 140.89 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.196 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -98.98 165.31 11.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.51 -132.72 2.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.32 0.105 . . . . 0.0 110.767 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 121.047 0.451 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 10.1 ttm -149.09 149.25 30.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.802 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.49 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.5 m95 -103.23 85.31 2.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.894 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.5 t -137.23 165.46 26.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.596 HH11 HD22 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -61.37 132.89 54.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.905 0.383 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 41' ' ' PHE . 3.8 p -55.07 147.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.486 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.74 -8.03 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.278 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.514 ' H ' ' C ' ' A' ' 39' ' ' VAL . 21.8 m-85 -117.7 33.37 5.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 109.943 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 93' ' ' THR . 13.0 t -97.55 87.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.582 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 56' ' ' CYS . 14.5 mt . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 3.2 t -45.55 168.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.961 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.479 ' H ' ' HG ' ' A' ' 48' ' ' SER . 11.4 m-20 -157.53 -159.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.961 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 9.4 pt-20 -74.69 -29.82 61.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.854 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 13.9 mm -80.38 -74.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.325 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 80' ' ' PRO . 19.7 mt -104.42 109.28 21.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.527 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -68.43 75.59 0.26 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.601 ' N ' ' HB2' ' A' ' 48' ' ' SER . 1.7 t -82.58 91.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 23.3 t -92.88 95.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.784 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 47' ' ' LEU . 41.0 t -111.9 148.61 33.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.438 0.637 . . . . 0.0 112.151 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -126.17 110.28 13.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.559 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.517 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.87 102.81 11.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.566 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -104.67 116.51 60.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.449 -1.129 0 C-N-CA 123.042 2.495 . . . . 0.0 112.25 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -132.74 98.07 4.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.063 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 80.5 t -84.37 103.42 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.951 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 HH22 ' A' ' 38' ' ' ARG . 33.0 t -102.3 123.28 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 77' ' ' LEU . 64.9 mt -112.68 93.45 4.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.538 HG23 HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -91.85 107.14 18.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.116 0.484 . . . . 0.0 111.102 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 45.9 mtmt -108.96 95.15 16.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.462 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 52' ' ' LEU . 9.7 Cg_endo -53.06 102.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.153 1.902 . . . . 0.0 111.965 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.406 HH11 ' HA ' ' A' ' 50' ' ' GLU . 17.2 mtt180 -64.82 -45.33 86.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.52 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.572 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 58.8 mttm -106.32 173.56 6.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.432 ' HG2' HG21 ' A' ' 18' ' ' VAL . 59.4 mtp180 -109.42 142.64 40.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.558 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.03 -150.97 20.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -87.47 92.18 9.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.572 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.7 m-70 -108.77 156.18 19.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.436 HG21 ' N ' ' A' ' 88' ' ' LEU . 90.5 m -160.34 151.33 18.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.116 0.484 . . . . 0.0 111.851 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.596 HD22 HH11 ' A' ' 38' ' ' ARG . 13.8 tp -128.71 142.73 50.92 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 6.1 mt-10 -123.56 86.73 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.216 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.461 HD22 HH12 ' A' ' 38' ' ' ARG . 7.0 mp -75.5 125.77 29.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.073 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.435 HG21 ' N ' ' A' ' 92' ' ' TYR . 12.8 p -122.29 156.45 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.76 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -102.51 95.91 6.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.465 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.527 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 3.5 t -125.35 169.97 11.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -101.6 93.86 3.79 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.118 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -44.29 -27.76 2.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.777 2.318 . . . . 0.0 112.74 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.71 -46.22 59.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.472 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.82 -67.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.93 0.395 . . . . 0.0 111.262 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.41 172.48 27.73 Favored Glycine 0 CA--C 1.507 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.99 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.486 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.2 mt -86.15 139.31 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.932 0.396 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HB3' ' HZ2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -128.5 164.53 37.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.253 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 103' ' ' ASN . 11.5 Cg_exo -71.65 -35.19 8.14 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.038 2.492 . . . . 0.0 112.205 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.81 11.99 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.211 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.499 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -88.1 150.36 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.41 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.2 tt0 -54.43 162.36 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.584 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.648 ' HB3' HD21 ' A' ' 10' ' ' ASN . 15.0 tpp180 -131.93 163.9 27.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.273 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.604 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.9 t80 -174.3 71.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.036 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.5 m -84.4 101.67 12.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.504 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 78' ' ' VAL . 59.4 tp -79.05 89.46 4.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 4.6 m-70 -76.77 137.11 39.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.563 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.4 HD23 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -145.28 104.42 3.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.453 HD21 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.68 73.74 7.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.558 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -51.86 123.98 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.455 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.981 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -30.11 106.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.189 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HD3' HD12 ' A' ' 108' ' ' LEU . 53.5 tttp -95.27 101.08 12.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.987 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.619 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.0 m95 -84.18 102.11 12.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.318 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 110' ' ' LEU . 34.6 m -147.47 -168.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.733 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.55 -179.32 3.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.482 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.419 ' HB ' HD23 ' A' ' 110' ' ' LEU . 3.1 t -175.22 -172.66 0.6 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.3 m80 -115.98 -163.74 0.92 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.268 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 38.4 t -93.27 137.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.115 0.483 . . . . 0.0 112.083 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.07 15.03 9.1 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.492 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptm -64.08 82.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.466 HG21 HD23 ' A' ' 77' ' ' LEU . 5.1 m -47.82 98.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.579 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -91.63 99.83 12.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.532 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.66 130.28 35.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.459 HG21 ' HG ' ' A' ' 26' ' ' LEU . 46.7 mt -134.29 104.85 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.873 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -85.94 96.54 9.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 20.4 mt -91.73 145.18 24.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.442 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.93 163.13 12.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.546 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.16 -141.31 5.03 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.558 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.1 t30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.557 0.218 . . . . 0.0 110.575 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.035 0.445 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.7 ttm -149.16 151.68 34.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.478 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -106.37 86.98 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.113 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -132.02 -167.4 1.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.101 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 24.7 mtp85 -88.54 150.25 23.18 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.57 131.91 33.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.617 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.61 6.33 89.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.576 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.81 -0.76 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.2 t -55.08 103.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.022 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.228 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.233 -179.645 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.72 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.1 mt . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.191 0.519 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.599 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 48.3 t -57.0 -179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.208 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.599 ' H ' ' HG ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -163.14 -88.6 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.41 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.17 -37.61 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.4 HD11 ' HD2' ' A' ' 82' ' ' LYS . 21.5 mm -62.89 -77.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.38 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 78' ' ' VAL . 69.6 mt -111.23 125.52 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 72.37 0.23 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 38' ' ' ARG . 3.1 t -75.8 85.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.76 84.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' HD11 ' A' ' 47' ' ' LEU . 33.8 t -99.53 148.15 24.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.324 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -138.15 111.18 7.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.304 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.457 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -76.42 102.67 6.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.281 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -100.56 109.44 57.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.076 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 0 N--CA 1.446 -1.299 0 C-N-CA 123.582 2.854 . . . . 0.0 111.132 178.84 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.3 pt . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -136.66 100.13 4.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.5 t -85.21 103.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 90' ' ' LEU . 26.6 t -106.01 119.29 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.211 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD23 HG21 ' A' ' 21' ' ' THR . 75.3 mt -109.37 98.98 8.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.824 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.73 104.01 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.953 0.406 . . . . 0.0 111.256 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -102.87 101.67 22.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 77.5 Cg_exo -47.03 98.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.802 2.335 . . . . 0.0 113.299 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -74.47 -36.21 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.354 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' A' ' 51' ' ' ILE . 66.8 mttm -112.38 172.0 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.641 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.3 121.82 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.556 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 139.9 -149.77 21.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.576 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.02 98.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -132.97 156.44 47.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 88' ' ' LEU . 90.6 m -158.92 155.63 28.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.022 0.439 . . . . 0.0 112.111 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 28.8 tp -104.51 94.1 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.888 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.6 mt-10 -73.43 96.51 2.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.186 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.0 mt -112.15 135.46 52.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.2 p -142.49 154.71 18.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 111.765 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.35 88.89 4.27 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.498 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 3.9 t -117.74 172.6 7.26 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -102.91 93.1 4.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.305 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.8 Cg_exo -43.59 -35.62 6.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.743 2.295 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -71.9 -39.61 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.303 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.73 -72.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.397 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 178.0 36.43 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.973 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.493 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.5 mt -90.91 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 13.8 mttt -134.54 162.28 58.63 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.151 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 46.5 Cg_endo -69.22 -40.9 5.52 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.686 2.258 . . . . 0.0 112.16 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.66 -25.76 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -53.18 149.58 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.348 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -56.08 161.12 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.9 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.673 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.2 tpp180 -132.35 163.54 28.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.992 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.673 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.0 t80 -172.78 71.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 109.424 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.09 90.29 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.156 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.8 tp -70.85 90.59 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 29.2 m-70 -72.0 145.91 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.592 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 14' ' ' VAL . 94.7 mt -146.54 115.94 7.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.665 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.1 t30 -83.96 51.1 1.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.556 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.7 t -36.05 121.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.825 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.036 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.586 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.945 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -54.06 100.33 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.5 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -92.65 93.34 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -76.83 102.98 6.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.74 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG22 HD21 ' A' ' 110' ' ' LEU . 17.5 m -150.14 -172.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.067 0.46 . . . . 0.0 112.126 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.75 179.43 4.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.591 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.7 t -175.37 -175.07 0.78 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.018 0.437 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.458 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 62.3 m-70 -118.76 -171.9 2.18 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.271 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.28 125.95 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 111.789 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 66.37 18.5 67.57 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.571 -0.741 . . . . 0.0 113.393 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -59.61 85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.495 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -55.86 98.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.348 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -96.09 103.37 15.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.634 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.93 131.14 35.25 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 HD23 ' A' ' 108' ' ' LEU . 46.8 mt -137.21 105.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.953 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.68 99.85 12.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.254 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.484 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.1 mt -96.11 149.08 22.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.604 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.27 162.21 13.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 179.17 -144.11 6.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.337 0.113 . . . . 0.0 110.761 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 78.9 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.155 0.502 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.6 ttm -144.02 149.79 37.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.505 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.0 m95 -102.77 82.8 2.17 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -128.48 -171.2 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.25 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.4 mtp85 -86.28 144.05 27.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.013 0.435 . . . . 0.0 111.09 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.83 144.53 12.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.067 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.81 72.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.116 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' A' ' 42' ' ' VAL . 53.8 m-85 -138.24 -37.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.726 0.263 . . . . 0.0 111.43 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 37' ' ' THR . 9.8 p -18.11 118.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.767 0.667 . . . . 0.0 112.439 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.359 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.018 -179.432 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 1.9 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.008 0.432 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.47 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.2 p -49.0 176.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.847 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -77.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.37 -36.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.361 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 24.5 mm -72.22 -79.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.453 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.5 HD23 HG11 ' A' ' 78' ' ' VAL . 11.0 mt -99.23 114.52 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.517 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.72 68.9 0.27 Allowed 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG23 ' HD2' ' A' ' 38' ' ' ARG . 16.4 t -74.0 84.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.862 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.95 85.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 76' ' ' VAL . 31.8 t -102.26 144.28 30.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.612 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -130.2 107.46 9.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.055 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -80.2 108.73 14.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.3 m -113.05 117.28 46.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.201 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 N--CA 1.447 -1.213 0 C-N-CA 123.381 2.721 . . . . 0.0 111.566 179.301 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.7 pt . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.6 m-85 -135.26 99.48 4.26 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 57.9 t -84.99 101.89 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.729 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.474 HG22 HD12 ' A' ' 90' ' ' LEU . 40.0 t -105.9 121.02 57.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.495 HD23 HG21 ' A' ' 21' ' ' THR . 78.8 mt -111.37 99.54 8.31 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.11 106.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 111.359 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.4 mtmm -111.69 92.85 18.13 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HA ' HD21 ' A' ' 52' ' ' LEU . 8.1 Cg_endo -51.26 101.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.648 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 18.9 mtt180 -64.17 -29.85 70.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.397 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 75.9 mttt -127.36 -177.23 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.321 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 21.3 ptt180 -120.31 139.96 51.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.57 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.5 -118.82 0.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.691 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -116.65 30.66 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.006 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -46.83 152.06 0.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.568 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 109' ' ' HIS . 78.2 m -158.24 142.58 15.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.5 tp -93.19 90.53 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.538 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 41.8 mt-10 -72.57 96.21 1.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.699 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.574 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 28.0 mt -111.36 137.97 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.471 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -146.47 157.16 11.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.487 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.2 t80 -95.8 91.28 5.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' HG21 ' A' ' 99' ' ' ILE . 2.4 t -121.73 150.87 41.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.6 mtp180 -87.42 100.53 1.71 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.485 ' HG3' ' HE1' ' A' ' 35' ' ' MET . 5.5 Cg_endo -51.44 -30.33 34.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.384 2.056 . . . . 0.0 112.039 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.36 -32.05 66.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.271 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -108.75 -78.6 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.282 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.48 -178.73 45.28 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.321 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.482 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -94.36 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -144.79 154.99 56.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.85 -47.13 4.04 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.897 2.398 . . . . 0.0 112.632 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.89 -14.75 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.759 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.9 m120 -68.56 159.23 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 111.445 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 5.0 tt0 -56.49 157.03 5.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.615 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.5 tpp180 -130.93 163.16 28.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.615 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 59.6 t80 -175.32 73.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.534 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -96.11 88.78 4.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.353 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.5 tp -69.5 90.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.432 . . . . 0.0 110.523 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.0 m-70 -73.03 143.75 47.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 14' ' ' VAL . 87.2 mt -144.39 111.83 6.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -83.41 59.53 5.11 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.57 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -38.54 133.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.629 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.94 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.888 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 2.1 p30 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -128.21 -112.55 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.877 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HG2' HG11 ' A' ' 14' ' ' VAL . 32.7 ttpt -162.03 151.03 15.52 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.886 0.374 . . . . 0.0 111.001 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.737 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.0 m0 -106.07 115.79 30.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' HG2' ' A' ' 12' ' ' LYS . 19.6 m -148.7 -173.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.566 ' HA ' ' N ' ' A' ' 111' ' ' ASN . 3.3 p-10 -101.85 -171.54 1.99 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.706 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.5 t -175.32 178.89 1.6 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 74.9 m80 -109.73 -144.37 0.39 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -106.02 132.23 53.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.163 0.506 . . . . 0.0 111.586 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 59.76 18.66 46.77 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.328 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tptt -61.35 83.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.6 m -55.48 102.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 78' ' ' VAL . 93.3 m -105.69 97.39 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.346 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' NE2' ' A' ' 25' ' ' HIS . 28.6 tt0 -72.79 122.09 20.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.299 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 HD23 ' A' ' 108' ' ' LEU . 34.3 mm -117.33 101.0 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.252 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.43 ' NE2' ' HG2' ' A' ' 23' ' ' GLU . 2.4 m80 -89.94 115.68 27.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.377 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 51.5 mt -111.83 147.49 35.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.309 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -100.99 162.36 12.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.593 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.75 -132.79 2.46 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.347 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.353 0.121 . . . . 0.0 110.783 179.869 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 121.066 0.46 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.5 ttm -99.98 153.22 19.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.5 m95 -101.95 88.76 3.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.152 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -133.04 -169.05 2.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.396 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.557 ' NH2' ' HA ' ' A' ' 48' ' ' SER . 6.6 mtp85 -82.28 142.72 31.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.384 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 89' ' ' GLU . 60.2 t -53.86 145.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.122 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.21 6.89 3.4 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.845 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -127.86 29.22 5.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.527 0.68 . . . . 0.0 110.707 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.618 ' HA ' HG23 ' A' ' 37' ' ' THR . 7.4 p -65.45 133.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.999 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.923 0.392 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.557 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . 67.2 p -63.67 -162.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.848 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.42 -73.36 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.14 -24.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.937 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.7 mm -70.19 -66.93 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.113 0.482 . . . . 0.0 111.559 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.539 HD21 HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.98 105.86 12.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.964 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -59.06 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.759 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 52' ' ' LEU . 40.7 t -95.3 92.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.828 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.3 t -84.36 77.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.503 0.668 . . . . 0.0 109.2 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 76' ' ' VAL . 13.0 t -92.19 134.81 34.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.283 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 75' ' ' VAL . 43.0 mtmt -129.64 119.47 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.512 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 1.1 t80 -84.29 98.78 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.123 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -91.22 108.7 30.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.291 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 61.0 Cg_endo . . . . . 0 N--CA 1.447 -1.256 0 C-N-CA 123.713 2.942 . . . . 0.0 111.465 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 5.9 pt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -139.93 100.0 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.284 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 57' ' ' LYS . 10.4 p -92.25 133.13 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 109.856 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' SG ' ' A' ' 56' ' ' CYS . 43.6 t -132.93 99.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 77' ' ' LEU . 2.1 mm? -83.09 103.8 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.33 112.66 28.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.947 0.403 . . . . 0.0 110.797 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.8 mtmm -118.25 101.63 51.17 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.05 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HG2' ' N ' ' A' ' 19' ' ' GLY . 4.6 Cg_endo -49.17 101.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.477 2.118 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.536 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 3.8 mtt180 -74.89 -42.47 57.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.498 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 67.2 mttm -113.71 160.03 19.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.013 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -96.19 129.15 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.51 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.53 -119.24 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.456 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -121.14 99.47 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -111.18 164.79 12.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 m -161.78 152.98 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.668 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.7 tp -119.4 77.79 1.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.959 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.53 ' HB3' HG21 ' A' ' 107' ' ' THR . 0.2 OUTLIER -81.53 107.76 14.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.823 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 38' ' ' ARG . 96.2 mt -101.78 154.86 18.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.362 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 158.92 9.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.23 0.538 . . . . 0.0 112.04 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -94.34 68.9 3.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.558 HG22 ' HB ' ' A' ' 42' ' ' VAL . 1.1 t -84.73 167.27 16.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.82 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -109.35 92.67 11.92 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.718 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.92 -33.71 26.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.635 2.223 . . . . 0.0 112.541 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -69.41 -31.36 69.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.11 -81.28 0.61 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.58 -172.07 40.09 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.32 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.513 HG12 ' OG1' ' A' ' 93' ' ' THR . 4.9 mt -102.99 116.55 46.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.658 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.0 170.54 5.43 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.58 -35.53 16.95 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.514 2.143 . . . . 0.0 112.175 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.45 -19.24 22.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.435 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.77 132.54 52.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 111.325 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -53.55 161.06 1.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.713 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.613 ' HG2' HD21 ' A' ' 10' ' ' ASN . 4.4 tpt180 -126.47 153.12 45.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.242 0.544 . . . . 0.0 112.171 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.888 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 42.5 t80 -165.1 83.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.049 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 89' ' ' GLU . 1.4 m -95.81 111.46 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.7 tp -98.0 94.13 6.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.958 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 37.0 m-70 -77.27 141.16 40.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 0.0 111.033 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 73.7 mt -144.17 77.91 1.56 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.298 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.566 ' N ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 t30 -57.17 89.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 17' ' ' HIS . 5.5 t -57.9 133.49 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.724 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.972 179.692 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.672 HD21 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.131 0.491 . . . . 0.0 112.026 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.486 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -47.75 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.083 -179.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD3' HD11 ' A' ' 108' ' ' LEU . 53.4 tttp -102.47 98.7 8.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.763 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.676 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.3 m95 -87.55 104.32 16.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.265 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 110' ' ' LEU . 30.7 m -146.45 -171.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 112.055 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 -176.04 2.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.585 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.41 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.6 t -175.83 -177.04 0.9 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.138 0.494 . . . . 0.0 112.164 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.8 m80 -115.1 -167.7 1.28 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.805 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG22 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -84.55 128.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.169 0.509 . . . . 0.0 111.905 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.63 20.63 59.55 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.483 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.2 tptp -59.03 84.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.026 0.413 . . . . 0.0 109.975 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.483 HG23 HD23 ' A' ' 77' ' ' LEU . 3.9 m -55.72 93.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.353 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -94.59 101.91 13.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.69 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.0 tt0 -82.43 133.46 35.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.577 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.466 HD13 HD23 ' A' ' 108' ' ' LEU . 41.4 mt -135.5 101.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.158 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -84.72 107.87 17.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.3 mt -100.89 144.86 29.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.273 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.9 164.01 13.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.93 0.395 . . . . 0.0 110.334 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.61 -139.84 5.78 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.291 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.329 -0.319 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.84 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.28 151.97 32.56 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.062 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 3.8 m95 -110.38 88.97 2.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.87 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.568 HG22 ' HA ' ' A' ' 42' ' ' VAL . 5.9 t -136.67 -168.7 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.927 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HD2' HG23 ' A' ' 54' ' ' VAL . 10.2 mtp85 -81.17 140.26 35.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.784 0.326 . . . . 0.0 111.102 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 89' ' ' GLU . 20.3 t -54.39 144.44 5.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.53 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.18 -0.97 5.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.864 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 39' ' ' VAL . 26.9 m-85 -128.66 54.12 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.568 0.699 . . . . 0.0 110.504 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.568 ' HA ' HG22 ' A' ' 37' ' ' THR . 26.2 t -107.69 121.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.653 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -177.631 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.535 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 36.9 mt . . . . . 0 CA--C 1.519 -0.245 0 CA-C-O 121.449 0.642 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.532 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 36.9 t -47.23 174.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.532 ' H ' ' HG ' ' A' ' 48' ' ' SER . 7.8 m-20 -157.02 -83.13 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.91 -31.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.135 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.3 mm -73.97 -79.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.509 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 8.0 mt -99.93 115.84 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.678 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -68.78 70.27 0.19 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.541 HG23 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -75.41 83.71 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.251 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.72 84.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 76' ' ' VAL . 21.1 t -99.29 127.11 45.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.439 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -109.37 107.32 17.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.597 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.467 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -81.66 103.99 11.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.42 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -102.45 119.31 56.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.007 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.452 -0.942 0 C-N-CA 123.163 2.575 . . . . 0.0 113.134 -179.183 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -138.37 109.68 6.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.136 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 75' ' ' VAL . 5.0 p -103.58 111.51 33.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 56' ' ' CYS . 28.1 t -104.97 124.04 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.482 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 HD23 HG23 ' A' ' 21' ' ' THR . 83.7 mt -109.65 100.96 9.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.75 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.1 mtmt -114.27 94.14 34.04 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.354 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.48 105.43 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.495 2.13 . . . . 0.0 112.577 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 17.5 mtt180 -69.62 -35.85 75.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -117.64 -177.39 3.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.872 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HE ' HG22 ' A' ' 18' ' ' VAL . 85.9 mtt180 -121.3 142.21 50.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.8 -107.37 0.5 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.417 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.8 m80 -125.96 94.68 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.528 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -109.96 162.6 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.163 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.2 m -159.92 149.62 18.16 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HB2' HG13 ' A' ' 78' ' ' VAL . 27.1 tp -119.47 80.19 1.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -77.71 106.85 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.968 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 38' ' ' ARG . 73.1 mt -102.96 154.0 19.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.099 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.43 152.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.833 0.349 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.3 t80 -102.67 92.09 4.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 99' ' ' ILE . 8.1 t -131.42 162.54 29.94 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.5 mtp180 -94.96 95.36 1.53 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.613 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HB3' HG11 ' A' ' 42' ' ' VAL . 1.3 Cg_endo -45.45 -34.07 10.17 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.094 2.529 . . . . 0.0 112.967 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -72.39 -36.78 68.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.019 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.58 6.32 39.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.675 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.4 -168.35 42.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.923 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.547 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.7 mt -117.14 154.49 18.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.27 0.557 . . . . 0.0 112.343 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.26 163.55 49.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.549 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.53 -17.47 16.28 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.569 2.179 . . . . 0.0 111.665 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.3 pt-20 -78.79 -6.73 56.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.46 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -69.65 151.11 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.51 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.99 166.31 3.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.672 ' HB3' HD21 ' A' ' 10' ' ' ASN . 16.6 tpp180 -130.46 163.69 26.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.602 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 46.7 t80 -172.97 68.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.5 m -89.64 103.27 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.884 -178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 34.7 tp -86.53 90.24 8.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 14.0 m-70 -74.45 145.9 43.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 14' ' ' VAL . 86.4 mt -146.81 104.93 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.176 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -79.58 70.62 6.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -47.55 117.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.683 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 2.4 p-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -43.44 103.41 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.488 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HB3' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.2 57.13 0.95 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.555 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.62 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.5 m0 -78.48 122.83 26.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.921 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 5.7 p -174.76 160.95 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.549 0.69 . . . . 0.0 112.099 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 m-20 -61.77 176.06 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.059 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' HB ' HD23 ' A' ' 110' ' ' LEU . 4.1 t -174.31 -172.75 0.71 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.04 0.448 . . . . 0.0 111.63 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.0 m80 -117.38 -169.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.439 HG21 ' HG2' ' A' ' 83' ' ' ARG . 40.8 t -90.29 129.27 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.687 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 58.34 15.14 22.38 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.26 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.3 tptp -62.96 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.2 m -44.02 103.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.5 m -94.35 95.12 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.568 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 39.2 tt0 -81.76 131.83 35.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.831 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.438 HD11 ' OH ' ' A' ' 106' ' ' TYR . 41.2 mt -139.3 102.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.5 102.16 11.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 11.5 mt -95.11 145.22 25.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.652 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 mptt -99.58 161.45 13.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.335 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.82 -147.01 7.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.559 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.0 t30 . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 120.39 0.138 . . . . 0.0 110.742 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.3 ttm -147.14 151.08 36.2 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.476 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.3 m95 -104.2 82.79 1.99 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 42' ' ' VAL . 9.8 t -127.97 161.6 28.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.364 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HD3' HD13 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -54.71 139.88 37.65 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.776 0.322 . . . . 0.0 111.408 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG23 ' HB ' ' A' ' 91' ' ' VAL . 42.3 t -51.14 140.88 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.268 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.38 5.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.432 ' HB3' HD21 ' A' ' 47' ' ' LEU . 23.2 m-30 -117.25 47.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.207 0.527 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.587 ' HB ' HG23 ' A' ' 93' ' ' THR . 7.3 p -93.44 128.76 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.859 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.066 -178.746 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.577 HD12 HH21 ' A' ' 38' ' ' ARG . 15.6 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 92.3 p -51.89 175.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.294 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -157.26 -99.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 111.388 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.28 -32.46 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.8 mm -73.52 -72.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.618 ' HB3' HG11 ' A' ' 78' ' ' VAL . 85.1 mt -106.15 116.98 32.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.217 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.64 73.32 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' HD3' ' A' ' 38' ' ' ARG . 1.3 t -78.9 90.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -92.65 90.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.56 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 9.2 t -114.99 145.88 41.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.287 0.565 . . . . 0.0 111.604 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -126.61 125.2 41.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.143 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.548 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -85.59 103.87 14.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.15 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 27.4 m -105.8 128.46 26.4 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 29.7 Cg_endo . . . . . 0 N--CA 1.449 -1.147 0 C-N-CA 123.499 2.799 . . . . 0.0 111.737 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 pt . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.491 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -139.27 98.01 3.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.775 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 75' ' ' VAL . 11.3 p -89.12 113.25 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-O 121.343 0.592 . . . . 0.0 110.661 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 HH22 ' A' ' 38' ' ' ARG . 20.7 t -107.06 126.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.764 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HA ' HD21 ' A' ' 77' ' ' LEU . 70.0 mt -113.62 90.68 3.41 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -90.85 105.21 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.074 0.464 . . . . 0.0 111.057 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 46.5 mtmt -106.01 96.27 12.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD22 ' A' ' 52' ' ' LEU . 7.4 Cg_endo -50.67 103.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.283 1.989 . . . . 0.0 112.503 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.1 mtt180 -67.69 -35.39 78.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 53.0 mttm -117.43 178.99 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.831 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG2' HG21 ' A' ' 18' ' ' VAL . 67.3 mtp180 -117.65 146.55 43.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.466 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.45 -149.59 21.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.782 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -91.26 28.3 1.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.752 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 72.3 m-70 -47.54 157.6 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.478 HG21 ' HA ' ' A' ' 109' ' ' HIS . 54.4 m -157.31 148.22 21.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.922 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.605 HD13 ' HD3' ' A' ' 38' ' ' ARG . 17.4 tp -107.99 165.78 11.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.75 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.555 ' HB3' HG22 ' A' ' 39' ' ' VAL . 34.5 mt-10 -151.68 121.24 6.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 9.7 mp -116.81 161.83 18.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.289 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 39' ' ' VAL . 13.3 p -158.65 155.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.117 0.484 . . . . 0.0 112.047 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.7 t80 -100.12 86.86 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.587 HG23 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -109.82 171.46 7.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -105.54 93.25 6.84 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 93' ' ' THR . 88.9 Cg_exo -49.17 -29.2 16.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.536 2.158 . . . . 0.0 112.339 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.38 -34.69 63.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.213 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -110.24 -76.88 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.249 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.47 -174.76 47.02 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.242 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.465 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -96.44 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 0.0 111.013 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.8 mttt -136.11 157.01 76.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.65 -47.38 11.43 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.735 2.29 . . . . 0.0 112.739 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.06 -12.71 8.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.85 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.516 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -64.26 149.94 46.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.927 0.394 . . . . 0.0 111.357 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.71 164.03 2.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.702 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 12.1 tpp180 -137.77 162.13 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.702 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -164.41 83.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.304 0.573 . . . . 0.0 110.08 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.421 HG22 ' HG2' ' A' ' 89' ' ' GLU . 25.8 m -88.82 133.76 34.16 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 37.5 tp -118.59 80.98 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.8 m-70 -66.46 145.42 55.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.876 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.7 mt -143.58 108.34 4.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.579 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 60.9 t30 -82.8 50.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.466 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -37.7 112.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.67 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.848 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.96 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.25 98.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.804 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HD3' HD11 ' A' ' 108' ' ' LEU . 75.5 tttt -100.96 94.55 6.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.034 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m95 -84.64 103.32 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.05 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 110' ' ' LEU . 29.6 m -148.21 -171.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.133 0.492 . . . . 0.0 112.104 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -109.32 178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.819 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.4 t -176.39 -172.67 0.48 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.95 0.405 . . . . 0.0 111.692 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.567 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 66.6 m80 -122.23 179.9 4.39 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.59 136.23 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.339 0.59 . . . . 0.0 112.221 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 58.24 15.16 21.73 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.862 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.4 tptt -58.72 85.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.327 0.563 . . . . 0.0 110.015 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.442 HG21 HD23 ' A' ' 77' ' ' LEU . 3.6 m -56.67 102.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.332 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 m -102.16 101.42 11.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.4 tt0 -81.6 135.02 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 108' ' ' LEU . 42.0 mt -136.41 104.95 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -86.24 97.87 10.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.8 mt -91.02 145.69 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 5.7 mptt -91.4 159.71 15.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.35 -154.39 25.48 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.009 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.4 0.143 . . . . 0.0 110.987 179.72 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.446 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 2.1 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.937 0.399 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.523 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.3 ttt -133.89 149.76 51.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 23.2 m95 -100.87 110.56 22.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.154 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.626 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -154.99 -172.39 4.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.819 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.663 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 mtp85 -89.08 153.66 20.8 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.807 0.337 . . . . 0.0 111.044 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 51.6 t -67.11 132.88 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.977 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.46 15.43 81.44 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.851 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -135.75 -5.56 2.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.626 ' HA ' HG23 ' A' ' 37' ' ' THR . 4.3 p -43.47 124.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.489 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 72.2 p -50.95 177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.016 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -156.43 -89.83 0.04 OUTLIER 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.399 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -127.14 -35.25 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.7 mm -70.53 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.231 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.53 HD23 HG13 ' A' ' 78' ' ' VAL . 8.4 mt -101.35 116.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.451 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -71.16 66.98 0.43 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.513 HG23 ' HD2' ' A' ' 38' ' ' ARG . 19.2 t -71.23 81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.822 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.7 t -75.69 78.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' HG23 ' A' ' 76' ' ' VAL . 15.2 t -94.63 139.71 30.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.366 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -131.36 107.53 9.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.747 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.523 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -72.6 109.58 6.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.289 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.58 ' HG1' HG13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -94.18 112.8 58.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.429 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 N--CA 1.456 -0.696 0 C-N-CA 123.105 2.537 . . . . 0.0 113.714 -179.344 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.58 HG13 ' HG1' ' A' ' 59' ' ' THR . 9.9 pt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.483 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -133.02 99.8 4.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.466 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.79 108.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.192 0.52 . . . . 0.0 110.724 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 43.0 t -104.84 126.33 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.825 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 82.1 mt -110.66 98.44 7.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.761 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.47 107.87 19.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.005 0.431 . . . . 0.0 111.275 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 44.8 mtmt -112.65 95.13 31.37 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.22 101.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.1 . . . . 0.0 112.848 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.498 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -65.77 -31.06 71.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.872 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.549 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 57.8 mttm -119.01 176.97 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.632 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -120.71 126.06 49.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.968 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.439 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 149.63 -109.21 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.236 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -111.98 113.55 25.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.549 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 2.7 m80 -135.77 156.48 48.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.591 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.418 HG21 HG21 ' A' ' 107' ' ' THR . 28.9 m -158.75 148.68 19.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.534 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.64 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 41.2 tp -108.58 90.23 3.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 39.3 mt-10 -71.8 97.29 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.104 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.64 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -111.46 125.28 53.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.75 172.24 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.488 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 1.7 t80 -109.69 86.36 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.014 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.468 ' HB ' HG21 ' A' ' 99' ' ' ILE . 3.6 t -117.61 158.01 25.39 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 79.8 mtp180 -100.49 98.9 8.72 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.84 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -43.39 -38.02 8.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 112.845 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.88 -40.35 92.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.618 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -102.38 -75.58 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.04 -173.58 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.272 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.468 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -99.94 143.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 0.0 111.34 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -135.59 169.49 13.55 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.16 -37.87 17.34 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.643 2.229 . . . . 0.0 112.067 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.57 -17.21 53.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.169 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.61 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.96 135.06 56.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.75 158.37 2.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.579 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 6.3 tpp180 -119.24 160.16 22.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.433 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.579 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 49.7 t80 -173.28 68.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.975 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.72 97.63 10.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.328 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 19.5 tp -78.85 93.28 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.2 m-70 -76.66 142.71 40.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 14' ' ' VAL . 89.9 mt -146.64 110.94 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.302 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 44.0 t30 -83.44 65.7 8.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.439 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -42.4 136.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.991 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.579 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 111.772 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -59.32 97.71 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.304 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.508 ' HD3' HD12 ' A' ' 108' ' ' LEU . 20.0 ptmt -93.69 74.69 4.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.663 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -50.22 103.89 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.834 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.541 HG22 HD21 ' A' ' 110' ' ' LEU . 34.7 m -146.82 -174.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 112.436 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.95 -178.1 3.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.808 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.407 HG22 HG12 ' A' ' 112' ' ' VAL . 1.8 t -177.31 -173.39 0.44 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.983 0.421 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 47.9 m-70 -124.12 -177.22 3.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.979 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.94 137.79 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 112.174 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.33 14.01 11.7 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.659 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 20.5 tptt -57.82 85.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.193 0.497 . . . . 0.0 109.927 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.478 HG21 HD23 ' A' ' 77' ' ' LEU . 3.8 m -57.27 92.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.291 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -88.36 103.2 15.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.613 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.2 129.66 34.76 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.491 HG21 ' HG ' ' A' ' 26' ' ' LEU . 42.1 mt -133.84 107.69 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.645 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -87.83 91.64 8.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.368 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 24' ' ' ILE . 15.5 mt -86.24 145.13 27.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.488 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HZ3' ' HB2' ' A' ' 27' ' ' LYS . 7.9 mtmp? -99.53 163.65 12.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.22 -141.24 5.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.6 t30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.548 0.214 . . . . 0.0 110.564 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.097 0.475 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.0 ttm -150.61 151.05 31.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.087 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.4 m95 -106.62 88.14 2.69 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 42' ' ' VAL . 11.5 t -134.56 -168.57 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.722 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -74.99 157.5 34.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.67 0.271 . . . . 0.0 110.722 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 89' ' ' GLU . 98.9 t -79.56 134.81 26.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.749 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 -10.44 5.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.822 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 39' ' ' VAL . 16.8 m-30 -106.08 7.91 32.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.143 0.497 . . . . 0.0 110.284 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 93' ' ' THR . 14.4 t -62.16 106.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.749 -179.412 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 6.8 mt . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.47 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 40.6 p -49.54 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.779 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.2 -89.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.35 -30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.279 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.7 mm -75.32 -79.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 80' ' ' PRO . 8.2 mt -102.52 113.42 26.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.572 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -69.81 71.14 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.825 0.345 . . . . 0.0 110.249 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG12 ' HD3' ' A' ' 38' ' ' ARG . 2.1 t -72.78 87.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG11 ' HE3' ' A' ' 57' ' ' LYS . 20.4 t -86.78 86.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 5.6 t -111.82 134.19 53.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.896 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HE3' HG11 ' A' ' 55' ' ' VAL . 32.1 mmtp -113.91 112.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.511 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -70.95 117.5 12.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.847 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.2 114.05 62.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.631 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 112.926 -179.435 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.141 0.496 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -133.73 102.8 5.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.708 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 74.3 t -87.57 107.1 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.777 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 21.8 t -108.95 119.6 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 21' ' ' THR . 72.4 mt -112.2 95.38 5.42 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -90.8 108.76 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.021 0.439 . . . . 0.0 111.282 -178.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.0 mtmm -110.45 92.27 13.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HA ' HD21 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.63 102.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.524 2.149 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.3 mtt180 -64.1 -34.76 78.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 55.7 mttm -116.06 -175.81 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.83 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -122.8 146.46 47.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 133.19 -136.79 8.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.492 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.88 95.32 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.963 0.411 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.8 m-70 -113.14 164.37 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.613 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 88' ' ' LEU . 88.3 m -159.8 150.24 18.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.586 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.649 HD13 HH11 ' A' ' 38' ' ' ARG . 34.6 tp -120.28 94.53 4.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.608 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HB3' HG22 ' A' ' 39' ' ' VAL . 41.7 mt-10 -73.88 105.54 5.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.802 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 26.5 mt -111.39 129.64 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 92' ' ' TYR . 9.9 p -133.66 158.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.161 0.505 . . . . 0.0 112.092 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -102.37 92.11 4.55 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.979 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.518 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.6 t -123.02 170.36 10.23 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -102.11 94.81 4.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.9 Cg_exo -45.21 -38.17 14.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.721 2.28 . . . . 0.0 112.729 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -37.7 88.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -101.57 -80.71 0.49 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.413 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.04 178.39 44.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.495 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.8 mt -94.39 153.08 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 0.0 111.557 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.7 mttt -140.41 162.65 48.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.2 Cg_endo -70.95 -39.77 3.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.712 2.275 . . . . 0.0 111.998 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.5 -27.47 69.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.784 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -52.5 153.72 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 160.35 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.6 tpp180 -129.87 163.9 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.206 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.624 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.7 t80 -176.49 71.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 0.0 109.111 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 89' ' ' GLU . 1.9 m -85.83 95.98 9.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.341 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 48.2 tp -72.88 86.28 1.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -75.74 139.6 41.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.541 HD21 HG22 ' A' ' 14' ' ' VAL . 94.6 mt -145.49 102.52 3.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.621 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -79.26 73.0 5.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.451 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -48.4 137.82 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.729 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.969 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -34.63 100.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.778 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -89.84 100.25 13.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.472 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.644 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -82.05 105.08 12.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 3.1 p -154.84 -178.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.077 0.465 . . . . 0.0 111.718 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -100.67 -176.12 3.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.604 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.41 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.1 t -174.12 -174.4 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.183 0.516 . . . . 0.0 112.195 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.7 m-70 -114.96 -168.93 1.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.113 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.79 128.77 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 111.897 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.65 15.86 27.75 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.505 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.61 84.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.426 HG21 HD23 ' A' ' 77' ' ' LEU . 4.9 m -47.8 101.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.981 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -96.03 99.62 11.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.97 131.6 35.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.311 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.472 HD12 HD23 ' A' ' 108' ' ' LEU . 43.7 mt -138.67 103.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.764 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -85.58 107.02 17.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.346 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.54 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 6.4 mt -104.34 143.93 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.137 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 4.6 mtpm? -96.79 162.94 13.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.977 0.418 . . . . 0.0 110.591 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.62 -158.76 29.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.311 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.694 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.455 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 17.7 ttm -117.7 152.84 34.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.896 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.4 m95 -111.44 89.99 3.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.186 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.564 HG22 ' HA ' ' A' ' 42' ' ' VAL . 15.0 t -134.24 -165.88 1.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.07 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.651 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.8 mtp85 -90.66 155.01 19.15 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.958 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 89' ' ' GLU . 37.8 t -74.5 133.01 32.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.49 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.75 89.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -130.68 -1.18 4.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 0.0 110.477 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 37' ' ' THR . 21.0 t -54.13 118.74 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.067 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.982 -179.49 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.651 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.15 0.5 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.475 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 64.4 p -53.47 -179.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.59 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -157.2 -90.81 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.63 -30.37 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -74.99 -79.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.214 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.532 HD23 HG13 ' A' ' 78' ' ' VAL . 7.1 mt -100.21 113.62 26.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.71 68.32 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.068 0.461 . . . . 0.0 109.928 177.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG23 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -72.7 84.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.768 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 29.3 t -80.14 80.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.591 0.71 . . . . 0.0 109.19 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' A' ' 76' ' ' VAL . 17.4 t -97.17 124.23 41.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.212 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -114.82 105.96 13.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.456 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -70.37 97.95 1.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 m -95.47 125.42 49.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.133 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 22.1 Cg_endo . . . . . 0 N--CA 1.448 -1.201 0 C-N-CA 123.196 2.597 . . . . 0.0 111.571 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.9 m-85 -138.99 101.08 4.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.348 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.46 100.2 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 120.876 0.369 . . . . 0.0 110.814 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 90' ' ' LEU . 26.3 t -100.96 118.95 48.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.138 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 77' ' ' LEU . 79.4 mt -110.35 97.52 6.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.629 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.532 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.81 106.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.9 mtmm -111.75 92.99 18.66 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.211 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 52' ' ' LEU . 8.3 Cg_endo -51.76 102.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.388 2.059 . . . . 0.0 112.606 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.5 mtt180 -63.93 -36.37 83.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.822 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 79.2 mttt -119.45 178.01 4.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -119.82 140.36 50.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.963 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.544 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.45 -113.57 0.71 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.359 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.458 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.9 m80 -115.99 93.2 4.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.816 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.458 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.1 m-70 -113.63 162.27 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.6 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 109' ' ' HIS . 60.0 m -159.31 149.92 19.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 111.723 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 22.6 tp -115.66 93.47 4.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.388 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.8 mt-10 -78.42 92.62 4.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.191 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.3 mt -103.22 123.72 47.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.431 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.9 p -126.66 155.59 37.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.946 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.1 t80 -97.89 82.88 3.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.472 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.561 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.6 t -118.79 158.75 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.455 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 58.5 mtp180 -97.45 98.21 4.78 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.512 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 93' ' ' THR . 93.8 Cg_exo -44.04 -38.44 10.44 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.884 2.39 . . . . 0.0 112.735 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.3 93.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -97.26 -74.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.44 179.7 39.36 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.088 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.463 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.7 mt -94.23 146.25 6.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.587 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 43.6 mtmt -140.28 162.9 47.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.215 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 42.4 Cg_endo -68.02 -38.76 12.13 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.777 2.318 . . . . 0.0 112.089 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.7 -28.22 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.826 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.55 HD22 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -55.22 149.37 12.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.05 166.17 2.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.644 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.6 tpp180 -132.7 164.11 27.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.44 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.644 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.3 t80 -174.47 64.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.635 0.731 . . . . 0.0 109.184 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 89' ' ' GLU . 9.3 m -87.61 92.22 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.228 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 27.5 tp -73.46 93.55 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.644 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.2 m-70 -77.31 140.71 40.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 92.3 mt -143.78 104.08 4.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.39 68.33 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.544 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -45.02 118.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.369 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.963 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.623 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.106 0.479 . . . . 0.0 112.137 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.2 99.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.713 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 53.6 tptt -95.09 92.13 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.244 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.669 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m95 -75.84 105.68 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.743 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 9.9 p -156.93 173.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.239 0.542 . . . . 0.0 111.888 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 m-20 -93.64 -173.59 3.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -175.57 -175.96 0.84 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.153 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.578 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 4.5 m-70 -115.24 -163.77 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.715 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.13 132.37 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 111.985 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.55 20.05 22.08 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.507 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptm -63.3 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.488 HG21 HD23 ' A' ' 77' ' ' LEU . 4.1 m -51.43 99.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.517 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -98.58 101.02 12.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.722 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HG3' HG21 ' A' ' 75' ' ' VAL . 33.4 tt0 -76.79 133.92 39.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.452 HG21 ' HG ' ' A' ' 26' ' ' LEU . 23.2 mt -131.48 94.97 2.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.262 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -84.82 78.27 9.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.026 0.441 . . . . 0.0 110.024 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 24' ' ' ILE . 89.8 mt -68.98 160.15 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.325 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -113.63 164.24 13.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.07 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.08 -145.95 11.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.771 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.9 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.367 0.127 . . . . 0.0 110.782 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.138 0.494 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.629 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 4.6 ttt -147.98 151.9 36.57 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.851 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -107.6 96.7 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.131 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.629 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 11.9 t -147.39 -166.42 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 54' ' ' VAL . 5.1 mtp180 -84.84 155.7 21.64 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.849 0.357 . . . . 0.0 111.253 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 89' ' ' GLU . 43.2 t -74.35 132.8 32.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.439 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.44 89.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.261 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.418 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 64.9 m-85 -127.6 3.98 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.098 0.475 . . . . 0.0 110.419 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.607 ' HA ' HG23 ' A' ' 37' ' ' THR . 3.6 p -45.22 133.1 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.071 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.302 -179.771 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 45.6 p -48.87 -179.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.384 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -156.55 -85.45 0.05 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.89 -30.5 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.585 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -73.74 -76.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.55 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.518 HD23 HG13 ' A' ' 78' ' ' VAL . 8.9 mt -102.85 115.65 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.324 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.18 70.91 0.24 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.21 0.528 . . . . 0.0 109.699 177.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.507 HG23 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -76.63 83.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.312 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -82.01 86.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 76' ' ' VAL . 31.5 t -96.18 150.95 19.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.792 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' HB2' HG11 ' A' ' 75' ' ' VAL . 55.1 mttm -139.77 114.4 9.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.973 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -94.68 105.52 17.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.945 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.6 m -107.39 108.52 61.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.446 -1.265 0 C-N-CA 123.47 2.78 . . . . 0.0 111.71 179.76 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 121.876 0.846 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 1.9 m-85 -130.27 76.2 1.71 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.564 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 23' ' ' GLU . 2.3 p -84.5 110.27 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.001 -177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.445 HG23 ' SG ' ' A' ' 56' ' ' CYS . 90.3 t -106.81 122.06 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.3 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 21' ' ' THR . 81.8 mt -105.36 102.49 11.96 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.905 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.15 108.51 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.951 0.405 . . . . 0.0 111.091 -178.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -113.9 93.78 30.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.493 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.9 Cg_endo -47.99 102.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.567 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.545 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.9 mtt180 -69.16 -36.72 77.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.293 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 87.7 mttt -117.15 170.58 8.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -107.22 123.82 48.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.56 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.77 -128.79 2.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.537 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -106.86 95.58 5.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.377 . . . . 0.0 110.962 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -109.65 161.53 15.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.402 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 109' ' ' HIS . 53.0 m -158.17 148.93 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 111.732 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.583 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.9 tp -115.77 90.39 3.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.571 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.526 ' HB3' HG22 ' A' ' 39' ' ' VAL . 43.5 mt-10 -75.57 94.19 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.583 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.1 mt -101.91 125.33 48.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 92' ' ' TYR . 9.5 p -131.12 158.08 43.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.715 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.6 t80 -97.1 86.44 3.96 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.522 HG22 ' HB ' ' A' ' 42' ' ' VAL . 5.0 t -110.86 167.11 10.49 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 61.5 mtp180 -102.52 97.68 9.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.393 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.0 Cg_exo -51.44 -31.78 40.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.544 2.163 . . . . 0.0 112.635 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.14 10.12 11.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.2 mm-40 -148.41 -79.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.85 40.92 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.463 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.6 mt -94.87 155.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.894 0.378 . . . . 0.0 111.267 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.3 mtmt -143.76 161.4 46.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.944 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.4 Cg_endo -72.08 -39.7 2.96 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.31 -27.02 69.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.0 m120 -55.97 155.03 6.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.25 161.95 2.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.623 ' HB3' HD21 ' A' ' 10' ' ' ASN . 17.3 tpp180 -131.66 164.28 26.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.746 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.586 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 50.0 t80 -177.58 65.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.345 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 89' ' ' GLU . 10.4 m -87.25 94.12 9.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.7 tp -74.93 93.8 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.669 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.2 m-70 -77.11 138.65 39.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 110.706 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 96.2 mt -142.29 98.06 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -76.08 78.17 2.92 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.56 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.4 t -51.77 123.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.474 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.657 HD21 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.009 0.433 . . . . 0.0 111.919 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 4.1 m-20 -55.22 97.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' HD3' HD11 ' A' ' 108' ' ' LEU . 54.5 tttp -99.63 95.27 6.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.85 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.646 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.54 102.36 12.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.166 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG13 ' HZ1' ' A' ' 12' ' ' LYS . 35.2 m -147.34 -170.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.041 0.448 . . . . 0.0 111.809 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.99 -176.19 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.303 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.2 t -173.83 -175.65 1.1 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 112.293 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 17.5 m80 -116.56 -163.06 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.017 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.56 129.06 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.808 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.67 14.52 36.64 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.287 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -64.08 83.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.451 HG21 HD23 ' A' ' 77' ' ' LEU . 5.1 m -47.2 102.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.809 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.3 m -96.16 100.19 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.389 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.34 131.45 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.033 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mt -136.0 104.46 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.78 100.94 12.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.8 mt -95.52 147.72 23.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.466 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -101.94 162.01 13.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.54 -147.49 9.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 t30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.39 0.138 . . . . 0.0 110.754 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.465 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 65.9 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.059 0.457 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ttm -150.94 152.94 34.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.902 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 9.1 m95 -107.25 87.24 2.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -131.85 -166.55 1.74 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.175 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 22.0 mtp85 -90.24 148.14 23.1 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.217 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.07 136.29 26.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.544 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.31 1.7 88.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.405 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -128.24 -1.62 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 37' ' ' THR . 21.6 t -55.21 107.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.057 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.959 -179.551 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.691 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.3 mt . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.135 0.493 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.6 t -51.43 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.69 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -157.58 -91.34 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -130.88 -32.64 1.63 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.157 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.9 mm -70.46 -76.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.304 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -104.34 114.48 28.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -66.36 72.99 0.08 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.437 ' N ' ' HB2' ' A' ' 48' ' ' SER . 10.9 t -79.44 85.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.164 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.0 t -81.12 83.3 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.418 ' SG ' HG23 ' A' ' 76' ' ' VAL . 36.8 t -98.33 139.87 33.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.369 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -133.28 110.0 9.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.441 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -76.77 101.44 5.84 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.2 m -97.87 109.22 50.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.059 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.446 -1.282 0 C-N-CA 123.593 2.862 . . . . 0.0 111.266 178.758 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.063 0.458 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -135.32 100.42 4.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.69 104.32 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.926 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.509 HG22 HD12 ' A' ' 90' ' ' LEU . 37.2 t -107.09 120.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.289 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 HD23 HG21 ' A' ' 21' ' ' THR . 80.0 mt -110.38 100.38 9.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.826 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.13 107.26 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.146 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.0 mtmm -109.5 103.58 53.19 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.392 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 52' ' ' LEU . 50.8 Cg_exo -51.59 101.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.204 . . . . 0.0 112.605 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.55 HH11 ' HA ' ' A' ' 50' ' ' GLU . 11.8 mtt180 -71.91 -37.1 70.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.828 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' H ' ' HE1' ' A' ' 86' ' ' HIS . 57.1 mttm -120.39 173.45 7.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -110.05 137.43 47.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.652 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.54 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 141.63 -118.8 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.742 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -110.15 100.38 9.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.0 111.268 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 11.5 m-70 -119.43 156.45 30.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 109' ' ' HIS . 58.1 m -159.63 147.93 17.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.605 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 33.2 tp -104.67 90.12 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.368 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 42.9 mt-10 -72.43 95.15 1.73 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.894 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.605 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 35.8 mt -109.9 133.96 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.45 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.3 p -140.41 153.93 22.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.843 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.5 t80 -97.83 84.57 3.37 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.543 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 4.4 t -116.4 167.83 10.69 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 77.8 mtp180 -100.38 94.53 3.46 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 93' ' ' THR . 77.7 Cg_exo -43.45 -24.63 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.802 2.334 . . . . 0.0 113.371 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -79.47 -62.21 1.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 94' ' ' ARG . 1.6 pp20? -72.23 -39.1 68.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.674 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.8 -165.14 24.64 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.481 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -112.98 132.9 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 111.748 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.431 ' HE3' ' CD ' ' A' ' 97' ' ' GLU . 5.8 mttt -120.57 156.26 55.97 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.8 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.53 -47.42 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.918 2.412 . . . . 0.0 112.73 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -53.75 -17.7 2.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.832 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 11.3 m120 -63.76 157.22 24.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -57.51 159.22 5.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.244 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.657 ' HB3' HD21 ' A' ' 10' ' ' ASN . 13.5 tpp180 -129.68 164.34 24.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.029 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.594 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.0 t80 -174.85 72.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.05 96.02 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.397 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 20.6 tp -76.46 93.3 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.7 m-70 -77.55 144.87 37.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 14' ' ' VAL . 75.1 mt -145.67 113.37 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.23 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.39 65.29 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -46.06 129.01 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.443 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.937 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.641 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.568 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.6 OUTLIER -32.36 99.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.207 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' HD3' HD12 ' A' ' 108' ' ' LEU . 19.8 ptmt -93.88 73.57 4.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -49.62 104.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 110' ' ' LEU . 28.2 m -146.62 -175.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 112.503 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -110.83 179.68 3.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.641 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.439 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.8 t -177.08 -173.12 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 112.023 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 64.1 m80 -119.15 -167.47 1.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.038 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 25.9 t -84.46 139.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 112.182 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.4 13.15 10.1 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.731 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.1 tptt -59.92 82.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.461 HG21 HD23 ' A' ' 77' ' ' LEU . 3.7 m -54.39 98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.381 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -94.96 101.24 13.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.4 tt0 -84.18 130.15 34.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.55 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.484 HD12 HD23 ' A' ' 108' ' ' LEU . 46.9 mt -136.47 101.07 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.205 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -81.69 109.82 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.5 mt -104.63 152.35 22.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -108.48 159.57 16.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.979 0.418 . . . . 0.0 110.443 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.537 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 178.81 -39.14 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.172 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.77 -0.215 . . . . 0.0 110.951 179.79 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.453 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 121.114 0.483 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.59 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 3.3 ttt -118.88 151.21 38.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.966 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -108.39 89.88 3.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 42' ' ' VAL . 14.5 t -135.58 -167.05 1.95 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.413 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.693 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.0 mtp85 -89.97 147.23 23.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.703 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 42.5 t -63.92 132.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.697 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.31 14.23 79.12 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.809 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -136.44 0.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.734 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.599 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.3 p -45.28 123.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.175 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.536 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.8 mt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HB ' ' A' ' 54' ' ' VAL . 88.6 p -52.64 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.495 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.78 -86.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.183 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.61 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.97 -34.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 52' ' ' LEU . 37.9 mm -61.52 -62.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.748 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 80' ' ' PRO . 38.6 mt -126.79 134.46 50.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.947 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -74.07 67.05 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 4.0 t -73.82 82.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.059 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -80.6 81.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.51 0.672 . . . . 0.0 109.215 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 76' ' ' VAL . 24.4 t -91.8 135.35 33.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.873 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -127.52 105.14 8.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -81.62 111.92 18.36 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -103.27 100.35 17.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.806 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 39.6 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 C-N-CA 123.799 3.0 . . . . 0.0 113.401 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.4 pt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.174 0.511 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HH ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -142.71 97.73 3.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.172 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 75' ' ' VAL . 3.1 p -92.67 104.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 110.662 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.448 HG23 ' SG ' ' A' ' 56' ' ' CYS . 23.3 t -99.68 127.16 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.586 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 21' ' ' THR . 85.9 mt -111.71 98.7 7.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.851 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.626 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.95 105.11 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -104.46 98.81 15.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.592 ' HA ' HD23 ' A' ' 52' ' ' LEU . 93.2 Cg_exo -43.05 100.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.066 2.511 . . . . 0.0 113.105 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.61 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.5 mtt180 -76.56 -29.73 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.118 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 79.5 mttt -122.4 154.88 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -96.66 124.62 40.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.031 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.541 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.35 -159.53 24.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.591 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -67.12 117.77 9.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.433 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 88.8 m-70 -145.43 170.04 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 88' ' ' LEU . 51.4 m -161.28 159.65 28.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.119 0.485 . . . . 0.0 112.202 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.626 HD21 HG22 ' A' ' 78' ' ' VAL . 10.1 tp -119.13 93.29 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.467 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.67 95.95 1.94 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 49.7 mt -107.98 115.89 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 92' ' ' TYR . 10.6 p -120.16 157.17 22.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.1 t80 -95.98 79.8 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.22 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.609 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 6.3 t -108.45 150.61 27.18 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.453 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 17.2 mtp180 -92.03 102.65 6.59 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.821 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 93' ' ' THR . 50.2 Cg_exo -55.25 -30.86 73.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.597 2.198 . . . . 0.0 112.437 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -65.04 -25.14 67.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.464 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -122.65 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.282 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.65 -173.73 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.373 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.1 mt -97.26 139.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 111.127 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -132.65 166.84 26.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.22 -41.2 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.822 2.348 . . . . 0.0 112.334 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.91 -18.01 41.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.529 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -60.85 148.19 40.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 168.3 2.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.0 tpp180 -131.75 164.18 26.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.445 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 45.2 t80 -171.81 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.507 -0.769 . . . . 0.0 108.955 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -86.7 91.98 8.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.574 -179.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.2 tp -70.69 90.99 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.075 0.464 . . . . 0.0 110.277 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 31.6 m-70 -77.38 139.96 39.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.693 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.492 HD22 HD13 ' A' ' 108' ' ' LEU . 97.6 mt -144.06 108.82 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -84.09 61.29 6.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.541 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.8 t -40.55 140.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.942 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.999 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.621 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.1 p-10 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 22.1 m-20 -38.45 98.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.539 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -98.38 87.9 3.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.644 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.8 m95 -78.72 98.27 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.752 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.556 HG22 HD21 ' A' ' 110' ' ' LEU . 30.4 m -147.3 -172.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 111.961 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.76 -178.55 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.798 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.492 ' HG1' ' H ' ' A' ' 17' ' ' HIS . 2.0 t -174.74 -174.06 0.78 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.06 0.457 . . . . 0.0 111.927 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 56.6 m80 -116.04 -173.72 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.012 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.81 135.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.249 0.547 . . . . 0.0 112.05 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 60.26 14.18 32.09 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.883 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.574 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.0 tptm -58.13 84.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.24 0.52 . . . . 0.0 109.902 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.497 HG21 HD23 ' A' ' 77' ' ' LEU . 3.0 m -56.54 100.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -96.81 103.72 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.546 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 77' ' ' LEU . 38.2 tt0 -75.9 117.01 17.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.046 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.66 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 67.5 mt -114.15 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.301 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.402 ' CD2' HG21 ' A' ' 75' ' ' VAL . 10.2 m170 -100.93 104.29 15.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.415 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 36.3 mt -96.08 163.08 13.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.308 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -101.88 163.56 12.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.096 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.29 -146.31 16.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.516 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.517 0.199 . . . . 0.0 111.2 179.992 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.439 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 81.2 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.242 0.544 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.54 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.2 ttm -146.86 154.26 41.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.661 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 3.4 m95 -110.92 91.8 3.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -134.73 -163.8 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.083 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -83.23 150.52 26.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.627 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG22 ' HG3' ' A' ' 89' ' ' GLU . 11.1 t -73.44 129.7 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.359 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.89 80.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -136.2 4.14 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.543 ' HA ' HG23 ' A' ' 37' ' ' THR . 7.2 p -49.17 133.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.253 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.83 179.748 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.9 mt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.417 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 54.1 p -54.18 -171.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.863 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -165.89 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 12.5 pt-20 -137.87 -34.62 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.486 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.8 mm -70.58 -77.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.502 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 80' ' ' PRO . 11.3 mt -101.46 119.49 38.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.404 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.95 70.36 0.35 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.094 0.473 . . . . 0.0 109.887 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.585 HG23 HG12 ' A' ' 78' ' ' VAL . 19.8 t -72.58 84.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.896 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.8 t -81.04 91.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 54.0 t -90.25 130.27 36.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.113 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 54.8 mttm -124.98 80.25 1.86 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.842 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.54 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -64.73 119.59 10.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.617 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.5 m -100.43 100.62 12.52 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 40.5 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 C-N-CA 123.839 3.026 . . . . 0.0 113.753 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 11.6 m-85 41.75 87.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -88.39 131.71 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 38.2 t -137.49 97.61 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.525 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 21' ' ' THR . 79.2 mt -92.37 102.52 15.0 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.79 109.14 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 111.3 -178.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -113.21 92.78 23.25 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.08 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.1 Cg_endo -46.97 102.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 112.619 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 19.9 mtt180 -66.37 -33.49 75.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.792 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 52.5 mttm -119.08 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -123.13 143.92 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.62 -117.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.587 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.9 m80 -112.72 94.33 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.103 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.461 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -112.51 161.26 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.425 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.9 m -159.22 140.4 12.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.956 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.672 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -112.51 82.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.52 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 13.2 pt-20 -80.43 128.06 33.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.149 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 88' ' ' LEU . 45.7 mt -122.64 162.51 21.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.917 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -156.08 150.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 111.587 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -93.6 85.91 5.03 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.569 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 4.3 t -118.53 161.84 19.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 72.9 mtp180 -99.01 97.95 5.74 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -47.83 -32.62 17.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.767 2.311 . . . . 0.0 113.378 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.06 11.64 17.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -151.38 1.36 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.26 -175.96 49.96 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.305 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -104.17 154.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.909 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.532 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.6 mmtt -132.47 168.72 16.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.62 -49.77 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.28 2.653 . . . . 0.0 112.702 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.06 -13.51 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.623 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -59.91 144.43 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.414 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -55.5 163.35 1.29 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.9 tpt180 -130.55 161.29 31.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.624 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 43.3 t80 -171.99 75.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.263 0.554 . . . . 0.0 109.643 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.722 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.9 m -97.71 102.38 14.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.833 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.7 tp -84.05 90.22 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 8.8 m-70 -74.33 142.92 45.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 0.0 110.109 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.556 HD21 HG22 ' A' ' 14' ' ' VAL . 88.8 mt -146.39 99.8 3.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.859 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t30 -75.91 73.27 2.82 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.4 148.08 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.726 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.527 ' H ' HD21 ' A' ' 10' ' ' ASN . 13.2 m-20 -32.11 101.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.795 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -95.35 90.89 5.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.29 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.661 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -78.26 103.15 8.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.761 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.48 HG22 HD21 ' A' ' 110' ' ' LEU . 20.9 m -149.93 -172.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 2.9 p-10 -112.88 -177.77 3.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.36 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.558 HG21 HG21 ' A' ' 112' ' ' VAL . 1.5 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.105 0.478 . . . . 0.0 112.255 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m80 -113.52 -167.77 1.25 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -89.64 138.07 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 112.294 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.28 17.95 19.67 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.738 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.74 81.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.495 HG23 HD21 ' A' ' 77' ' ' LEU . 9.2 m -48.21 97.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.5 m -93.09 101.43 13.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.722 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HA ' HD22 ' A' ' 77' ' ' LEU . 34.6 tt0 -75.51 119.22 19.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.72 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.29 93.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.407 ' CD2' HG21 ' A' ' 75' ' ' VAL . 10.3 m170 -86.68 104.17 15.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 52.7 mt -95.53 160.96 14.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.23 163.43 12.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.82 -160.63 27.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.68 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.93 0.395 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 19.9 ttm -113.66 152.32 30.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.433 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.512 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 8.0 m95 -109.36 87.12 2.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -134.78 -165.07 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.625 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.7 mtp85 -90.34 156.78 18.01 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 89' ' ' GLU . 39.6 t -76.12 132.02 33.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.521 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.95 88.98 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.407 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -131.92 -0.41 3.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 110.414 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HA ' HG23 ' A' ' 37' ' ' THR . 12.7 t -55.58 119.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.002 -179.557 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.424 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.0 p -51.26 179.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.925 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.78 -87.03 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.189 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -131.81 -30.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.2 mm -72.96 -76.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.509 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.524 HD21 ' HA ' ' A' ' 80' ' ' PRO . 9.6 mt -102.91 116.65 32.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.511 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -69.58 69.87 0.28 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 109.848 178.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.534 HG23 ' HD2' ' A' ' 38' ' ' ARG . 24.7 t -73.53 85.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.725 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.5 t -77.34 85.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.395 0.617 . . . . 0.0 109.41 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.24 136.09 52.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.134 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.655 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 68.0 mttm -135.72 50.68 2.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.654 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -52.59 116.6 2.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.815 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.42 ' N ' ' HD1' ' A' ' 58' ' ' TYR . 29.4 m -97.32 101.88 11.11 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.405 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 45.5 Cg_endo . . . . . 0 N--CA 1.445 -1.378 0 C-N-CA 124.469 3.446 . . . . 0.0 111.799 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 7.9 m-85 39.58 90.41 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.117 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 99.2 t -92.73 95.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.681 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.29 108.86 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.731 0.3 . . . . 0.0 111.773 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 23' ' ' GLU . 40.3 mt -95.6 110.81 22.86 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.95 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.501 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -101.7 104.52 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.888 0.375 . . . . 0.0 110.965 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.1 mtmt -107.79 101.36 40.05 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.339 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.524 ' HA ' HD21 ' A' ' 52' ' ' LEU . 54.0 Cg_exo -51.52 97.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.664 2.243 . . . . 0.0 112.74 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.567 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -62.89 -36.75 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 58.6 mttm -117.25 -172.62 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.569 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -133.31 125.71 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.831 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.527 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.32 -98.61 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.016 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.414 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 49.4 t-80 -122.09 105.57 10.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.74 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.479 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.7 m80 -124.41 159.98 29.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.429 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 52' ' ' LEU . 32.4 m -159.59 148.7 18.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.704 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.7 tp -120.46 91.52 3.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.53 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.51 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.4 mt-10 -75.86 88.63 2.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.24 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.624 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.3 mt -98.45 122.84 42.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 93' ' ' THR . 9.2 p -125.77 154.54 34.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.675 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' MET . 9.7 t80 -96.51 82.41 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.212 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 91' ' ' VAL . 6.2 t -121.48 151.93 39.7 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 57.5 mtp180 -88.79 102.04 3.55 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.26 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.505 ' HB3' HG11 ' A' ' 42' ' ' VAL . 9.3 Cg_endo -52.99 -33.44 62.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.753 2.302 . . . . 0.0 112.429 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -64.52 -32.72 74.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.19 -72.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.24 38.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.996 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.6 mt -96.44 143.68 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.7 mtmt -137.93 163.06 50.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.146 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.3 Cg_endo -67.92 -38.76 12.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.762 2.308 . . . . 0.0 112.032 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.69 -28.99 69.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -54.74 147.49 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.024 179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 165.91 1.95 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.9 tpp180 -131.75 164.1 26.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.071 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.647 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 t80 -176.06 66.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.452 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 89' ' ' GLU . 18.2 m -90.07 97.46 11.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.061 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.3 tp -77.98 93.86 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.266 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.661 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.2 m-70 -77.63 144.0 37.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 14' ' ' VAL . 79.1 mt -144.64 104.56 4.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.627 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.9 t30 -81.03 61.53 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 16' ' ' THR . 2.1 t -43.33 131.18 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.569 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.929 179.851 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -44.89 102.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.752 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HG3' HG23 ' A' ' 14' ' ' VAL . 22.7 tptm -98.79 90.95 4.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.301 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.1 m95 -82.13 101.36 10.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.498 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 110' ' ' LEU . 11.3 m -152.7 -175.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.407 0.622 . . . . 0.0 112.411 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -97.07 -174.29 2.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.286 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -175.6 -175.69 0.8 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.188 0.518 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.563 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 38.8 m80 -114.12 -161.51 0.77 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.694 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.88 131.84 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 0.0 111.767 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 14.29 14.44 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.485 -0.779 . . . . 0.0 113.351 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.563 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.2 84.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.442 HG23 HD23 ' A' ' 77' ' ' LEU . 6.8 m -46.22 98.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.718 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 m -92.94 98.38 11.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.411 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -80.22 133.92 36.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.034 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG21 ' HG ' ' A' ' 26' ' ' LEU . 40.7 mt -135.97 106.63 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.732 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -88.78 91.26 8.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.689 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.6 mt -88.27 144.62 26.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.269 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.79 165.66 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.78 -134.15 2.78 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.505 0.193 . . . . 0.0 110.61 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 70.1 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.004 0.431 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.668 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 13.3 ttm -146.95 148.95 32.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.408 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -103.24 80.02 1.79 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.749 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.403 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 12.1 t -124.68 -164.74 1.3 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.344 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 5.9 mtp85 -87.19 135.82 33.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.045 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 89' ' ' GLU . 39.3 t -50.27 152.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.25 1.1 18.98 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.456 ' HE2' HH21 ' A' ' 38' ' ' ARG . 24.8 m-85 -127.07 43.72 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.473 0.654 . . . . 0.0 110.536 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 93' ' ' THR . 2.4 p -80.0 98.19 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.061 179.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.7 mt . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.19 0.519 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -50.13 173.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.762 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.65 -87.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.16 -31.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.261 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 mm -73.59 -73.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.417 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' A' ' 80' ' ' PRO . 53.3 mt -105.5 118.31 36.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.414 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.29 69.57 0.38 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.252 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.504 HG23 ' HD2' ' A' ' 38' ' ' ARG . 12.4 t -76.19 86.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.178 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.8 t -82.79 87.4 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.407 ' SG ' HG23 ' A' ' 76' ' ' VAL . 40.2 t -101.63 130.56 47.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.726 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -121.27 110.26 15.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.937 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.48 110.63 17.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.556 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -115.09 110.67 45.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.653 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 N--CA 1.451 -1.029 0 C-N-CA 123.328 2.685 . . . . 0.0 112.21 179.181 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.0 pt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -126.35 102.4 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.088 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -88.97 106.03 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.988 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.407 HG23 ' SG ' ' A' ' 56' ' ' CYS . 41.6 t -107.89 122.13 61.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.12 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' HD21 ' A' ' 77' ' ' LEU . 82.9 mt -112.03 102.61 10.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.811 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -96.42 106.82 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -178.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -110.78 94.53 20.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.691 ' HA ' HD22 ' A' ' 52' ' ' LEU . 2.6 Cg_endo -48.29 107.24 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.16 . . . . 0.0 112.506 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.497 HH11 ' HA ' ' A' ' 50' ' ' GLU . 12.8 mtt180 -73.31 -43.67 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.149 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 88.2 mttt -108.87 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -110.09 146.91 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.773 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.95 -125.69 4.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.385 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 56.9 t-80 -110.63 106.06 15.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.2 m-70 -117.29 164.77 14.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 109' ' ' HIS . 67.7 m -159.59 145.32 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.967 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 13.5 tp -111.81 91.91 3.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.493 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.1 mt-10 -75.57 104.24 6.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 66.2 mt -112.97 132.28 55.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.5 p -138.09 155.48 29.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -93.42 76.39 4.48 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.599 ' HA ' HD21 ' A' ' 103' ' ' ASN . 5.6 t -105.71 155.11 19.58 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 28.1 mtp180 -86.24 104.18 5.12 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.475 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.0 Cg_endo -55.98 -30.08 76.44 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.756 2.304 . . . . 0.0 112.181 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.6 -25.78 61.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.836 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.5 -88.32 0.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.729 0.3 . . . . 0.0 111.655 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.53 -166.12 28.94 Favored Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.562 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.504 HG12 ' HG1' ' A' ' 93' ' ' THR . 3.0 mt -103.17 145.11 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.834 0.35 . . . . 0.0 111.231 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -134.57 168.73 16.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.608 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.12 -38.96 11.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.725 2.283 . . . . 0.0 112.47 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.7 -1.8 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.439 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.599 HD21 ' HA ' ' A' ' 93' ' ' THR . 3.3 m120 -76.18 141.26 41.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.746 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 91' ' ' VAL . 5.1 tt0 -58.16 162.04 3.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.0 tpt180 -130.2 160.01 35.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.251 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.603 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.6 t80 -175.24 72.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.461 0.648 . . . . 0.0 109.472 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 89' ' ' GLU . 8.1 m -91.5 96.62 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.15 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.0 tp -75.97 91.73 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.9 m-70 -77.05 137.13 38.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.491 HD21 HG21 ' A' ' 14' ' ' VAL . 94.0 mt -143.73 112.7 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.375 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.444 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.1 t30 -86.7 85.51 7.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 17' ' ' HIS . 14.8 t -55.5 124.35 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.324 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.643 ' HZ3' ' HB3' ' A' ' 113' ' ' LYS . 3.2 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.821 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 107' ' ' THR . 25.5 t70 -144.34 -128.82 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.62 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 50.8 tptt -160.24 172.16 17.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.752 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 4.5 m0 -120.46 123.99 44.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.746 0.418 . . . . 0.0 110.334 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.672 HG21 ' HB2' ' A' ' 109' ' ' HIS . 2.3 m -150.68 159.21 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.673 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -50.4 168.2 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.313 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 HG21 ' HA ' ' A' ' 112' ' ' VAL . 3.1 t -174.19 -173.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.426 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.566 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 26.2 m80 -109.23 -168.58 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.625 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.83 138.45 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.151 0.501 . . . . 0.0 111.891 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.61 17.48 20.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.294 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.2 tptp -66.07 80.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.484 HG21 HD23 ' A' ' 77' ' ' LEU . 5.1 m -44.46 101.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.625 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 m -98.97 102.62 14.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.754 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.2 127.56 32.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.584 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG21 ' HG ' ' A' ' 26' ' ' LEU . 48.1 mt -130.9 105.23 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.907 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -87.19 96.36 10.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HG ' HG21 ' A' ' 24' ' ' ILE . 20.7 mt -91.12 145.6 24.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -100.46 162.99 12.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.68 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.76 -138.95 4.02 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.373 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--N 1.33 -0.282 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.815 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.79 150.05 29.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.7 m95 -103.04 82.9 2.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.673 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 42' ' ' VAL . 10.0 t -124.88 -174.73 3.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.643 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.3 mtp85 -83.12 150.63 26.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 89' ' ' GLU . 41.5 t -64.47 127.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.83 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.95 18.46 67.51 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.064 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -138.02 0.86 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 110.652 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 37' ' ' THR . 5.6 p -47.05 125.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.257 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.859 179.778 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.692 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.7 mt . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.16 0.505 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 35.3 t -51.05 173.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.766 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -159.04 -85.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.256 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.07 -33.98 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.431 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.9 mm -67.42 -78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 80' ' ' PRO . 96.4 mt -106.42 119.3 38.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.94 72.29 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 38' ' ' ARG . 7.6 t -80.81 86.18 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.498 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.52 85.7 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.454 ' SG ' HG23 ' A' ' 76' ' ' VAL . 33.8 t -101.91 149.34 24.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.741 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -139.64 112.99 8.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.879 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.27 107.69 11.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.488 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.6 m -103.05 107.01 53.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.923 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 N--CA 1.445 -1.343 0 C-N-CA 123.647 2.898 . . . . 0.0 111.312 179.079 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -133.52 100.86 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.071 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -85.11 107.53 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 110.558 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 ' SG ' ' A' ' 56' ' ' CYS . 40.3 t -112.71 120.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 21' ' ' THR . 73.2 mt -108.58 99.84 9.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -96.55 108.55 21.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.457 . . . . 0.0 111.698 -178.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 31.7 mtmm -110.16 98.41 35.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD22 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.62 109.03 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.368 2.046 . . . . 0.0 112.778 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.4 mtt180 -81.06 -36.4 30.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.086 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -108.68 173.63 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.169 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.418 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 63.9 mtp180 -110.76 148.19 32.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.905 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.13 -164.52 13.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -70.5 102.0 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.687 0.28 . . . . 0.0 110.714 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.43 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 99.2 m-70 -128.04 149.95 50.15 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.483 0.659 . . . . 0.0 111.33 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.544 HG22 ' HB ' ' A' ' 107' ' ' THR . 40.3 m -150.95 146.81 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.483 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 78' ' ' VAL . 20.9 tp -91.16 106.79 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.5 mt-10 -80.82 109.11 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.022 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 55.6 mt -119.03 143.2 47.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.067 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.57 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.398 0.618 . . . . 0.0 112.411 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.0 t80 -104.23 85.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.48 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 2.2 t -114.58 165.66 12.54 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.457 ' H ' ' HG1' ' A' ' 93' ' ' THR . 71.3 mtp180 -102.95 93.59 4.56 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 93' ' ' THR . 91.7 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.632 2.221 . . . . 0.0 112.627 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.89 -40.21 63.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.24 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -103.22 -68.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.92 -178.99 37.56 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.035 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.491 HG21 ' HB ' ' A' ' 93' ' ' THR . 7.9 mt -90.75 144.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.999 0.428 . . . . 0.0 111.249 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HG3' HD22 ' A' ' 103' ' ' ASN . 1.5 mttp -132.61 166.57 28.03 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.39 -40.78 29.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.853 2.369 . . . . 0.0 112.377 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.45 -13.01 35.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.553 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.82 134.77 56.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 111.45 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.74 164.67 2.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.072 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 2.1 ttp180 -139.79 158.48 44.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 0.0 111.649 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.821 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 47.4 t80 -162.65 103.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.009 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.619 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.7 OUTLIER -102.41 109.42 21.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.51 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 110' ' ' LEU . 25.9 tp -72.5 126.12 29.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.183 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 2.8 p80 -65.66 65.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.387 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.537 HD12 HD21 ' A' ' 108' ' ' LEU . 80.2 mt -102.07 53.93 0.8 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 30.1 t30 -71.09 76.52 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.4 t -53.84 150.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.763 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.451 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.236 0.541 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.425 ' HA ' ' N ' ' A' ' 107' ' ' THR . 1.2 p30 -54.86 104.07 0.11 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.286 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HD3' HD12 ' A' ' 108' ' ' LEU . 22.0 ptmt -101.79 119.69 39.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.028 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.749 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -103.71 111.94 24.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -148.31 -176.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.663 0.744 . . . . 0.0 112.882 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -93.8 -173.0 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.429 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -172.8 -174.54 1.13 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.416 0.627 . . . . 0.0 112.651 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.597 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 30.0 m80 -120.44 -148.52 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.382 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.7 t -108.93 128.13 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.589 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.13 20.18 19.62 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.262 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptp -65.95 84.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -47.17 102.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.851 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.3 m -98.98 93.62 6.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.11 127.95 33.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.156 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 108' ' ' LEU . 38.2 mt -133.67 105.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.077 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.2 107.36 18.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 34.7 mt -103.16 149.05 25.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -101.14 161.46 13.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.251 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.04 -150.9 13.66 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.564 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.418 0.151 . . . . 0.0 110.63 179.945 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 44.6 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.086 0.47 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.553 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.4 ttm -150.71 152.32 33.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 42.7 m95 -100.06 90.7 4.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.693 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 42' ' ' VAL . 9.6 t -136.92 -178.49 5.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.325 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.8 mtp85 -83.46 160.1 21.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.972 0.415 . . . . 0.0 111.618 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 89' ' ' GLU . 59.0 t -70.68 141.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.918 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.7 2.99 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.079 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -124.7 -3.11 7.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.597 0.237 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.595 ' HA ' HG22 ' A' ' 37' ' ' THR . 2.1 p -34.81 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.282 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.409 -179.677 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.0 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.846 0.355 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.3 p -46.34 171.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.233 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.41 -85.23 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.3 pt-20 -129.37 -34.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.389 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -68.89 -76.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.241 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -105.0 118.47 36.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.81 66.31 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.153 0.502 . . . . 0.0 109.753 177.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG23 ' HD2' ' A' ' 38' ' ' ARG . 18.2 t -76.91 83.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.563 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 25.4 t -77.29 80.69 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.21 139.51 30.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.553 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -133.15 105.46 7.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.961 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.553 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.33 115.28 22.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.792 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 m -117.08 119.98 34.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.713 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 C-N-CA 123.23 2.62 . . . . 0.0 112.03 -179.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -138.48 98.65 3.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.405 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' A' ' 77' ' ' LEU . 90.9 t -87.59 106.12 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.26 110.88 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 77' ' ' LEU . 2.4 mm? -95.71 105.59 17.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.855 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.522 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.37 105.53 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.048 0.452 . . . . 0.0 111.212 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.8 mtmm -110.75 103.23 54.18 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.156 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HA ' HD21 ' A' ' 52' ' ' LEU . 10.6 Cg_endo -55.1 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 15.0 mtt180 -81.15 -56.01 4.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.608 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -98.69 161.06 13.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.42 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -94.54 141.34 28.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.577 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.74 -116.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.579 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -129.57 99.98 5.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -108.04 164.78 11.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -157.74 149.91 22.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.9 tp -123.11 87.35 2.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.252 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -86.98 93.96 9.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.057 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 77.1 mt -91.41 99.22 12.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.028 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -92.94 150.82 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.121 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.3 t80 -90.28 76.96 6.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.513 HG22 ' HB ' ' A' ' 42' ' ' VAL . 3.0 t -98.48 172.46 7.51 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 69.1 mtp180 -104.42 95.61 8.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.458 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 93' ' ' THR . 66.5 Cg_exo -44.04 -27.58 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 112.651 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -37.19 20.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.391 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 13.9 mm-40 -103.65 -91.64 0.36 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 0.0 111.719 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.42 -178.76 39.84 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.281 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.441 HG21 ' HB ' ' A' ' 93' ' ' THR . 11.7 mt -85.24 -77.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER 71.54 156.3 0.16 Allowed Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.966 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 37.8 Cg_endo -66.3 -35.01 33.51 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.795 2.33 . . . . 0.0 112.8 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 7.9 pt-20 -54.17 -17.94 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.524 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.544 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -86.67 140.16 30.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 111.467 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -64.91 -176.21 0.25 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.55 179.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.641 ' HB3' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -165.23 -164.47 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.552 0.692 . . . . 0.0 111.875 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 45.0 t80 -165.27 69.28 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.015 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -70.4 88.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.612 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.7 tp -83.59 92.03 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.653 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.9 m-70 -77.79 145.06 36.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' HG23 ' A' ' 16' ' ' THR . 90.4 mt -144.36 92.77 2.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.269 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.452 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -64.68 85.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 17' ' ' HIS . 4.7 t -62.76 115.01 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.664 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.936 179.702 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.624 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.492 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.542 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -33.24 104.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.921 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.98 96.75 10.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.124 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -79.68 100.76 8.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG22 HD21 ' A' ' 110' ' ' LEU . 27.4 m -146.7 -171.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.0 0.428 . . . . 0.0 112.113 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.02 -177.13 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.768 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.4 t -175.25 -175.81 0.87 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.218 0.533 . . . . 0.0 112.185 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.567 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 7.4 m80 -117.93 -165.35 1.09 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.954 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.44 132.77 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.19 0.519 . . . . 0.0 112.067 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.18 19.63 8.16 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.51 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.2 tptt -63.06 85.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.465 HG23 HD23 ' A' ' 77' ' ' LEU . 6.3 m -49.76 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.471 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -94.73 99.81 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.489 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HA ' HD21 ' A' ' 77' ' ' LEU . 30.7 tt0 -76.2 132.84 40.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.838 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -132.97 99.62 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.105 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -84.03 98.25 9.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.493 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 38.0 mt -93.37 148.29 22.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.581 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -101.91 162.26 13.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.97 -143.87 7.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.417 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.458 0.17 . . . . 0.0 110.82 179.821 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.3 ttm -152.1 152.46 32.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.019 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.8 m95 -107.07 85.27 2.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.742 178.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 42' ' ' VAL . 15.2 t -130.35 -163.61 1.33 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.7 mtp85 -91.25 139.58 30.61 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 111.269 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 t -53.99 133.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.056 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 -39.05 1.85 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.603 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 47' ' ' LEU . 55.2 m-85 -82.15 3.25 27.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.141 0.496 . . . . 0.0 110.62 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.579 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.3 t -53.29 110.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.223 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 -179.734 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 12.0 mt . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.843 0.354 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.478 ' OG ' ' HA ' ' A' ' 53' ' ' GLU . 41.9 t -59.24 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.5 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.475 ' H ' ' HG ' ' A' ' 48' ' ' SER . 7.9 m-20 -147.99 -83.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.386 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.07 -28.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.602 -179.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.3 mm -76.11 -86.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.69 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.702 HD21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.19 106.0 18.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.45 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 1.1 tm-20 -58.08 146.46 33.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 38' ' ' ARG . 46.3 t -145.6 90.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.2 t -77.04 85.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.21 129.67 37.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.808 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.677 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 50.9 mtpt -130.71 68.48 1.47 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.442 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -65.22 103.86 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.353 178.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 m -105.61 114.31 63.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.45 -1.083 0 C-N-CA 123.287 2.658 . . . . 0.0 111.912 179.667 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.3 pt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.6 OUTLIER -134.12 98.43 4.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 87.7 t -85.81 100.0 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.797 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.5 t -103.54 116.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.039 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 91.3 mt -103.11 108.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.86 108.89 23.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.003 0.43 . . . . 0.0 111.519 -178.924 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 46.7 mtmt -114.11 95.95 40.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.469 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.41 106.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.253 1.969 . . . . 0.0 112.219 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 73.2 mtt180 -69.81 -30.22 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 85.4 mttt -123.53 -176.98 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -117.4 144.73 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.91 -129.26 4.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.388 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.412 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.7 m80 -105.92 91.73 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.921 0.391 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -107.75 164.21 12.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.388 179.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.486 ' N ' HD11 ' A' ' 52' ' ' LEU . 71.0 m -160.26 157.25 27.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 111.784 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 78' ' ' VAL . 51.7 tp -118.96 87.66 2.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.284 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.3 mt-10 -69.46 95.89 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.804 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.65 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 51.9 mt -108.51 127.28 53.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.466 HG21 ' N ' ' A' ' 92' ' ' TYR . 11.0 p -133.18 157.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.739 -178.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.4 t80 -99.13 88.82 4.05 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.239 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.9 t -121.41 169.37 10.69 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -101.49 95.94 5.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.951 178.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 93' ' ' THR . 96.0 Cg_exo -44.26 -30.69 3.74 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.662 2.241 . . . . 0.0 112.607 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.65 -40.61 63.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -97.05 -76.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.98 173.11 31.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.195 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.474 HG21 ' HB ' ' A' ' 93' ' ' THR . 2.7 mt -86.03 151.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.847 0.356 . . . . 0.0 111.256 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.528 ' HE3' HD22 ' A' ' 103' ' ' ASN . 40.6 mtmt -145.09 166.22 18.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.42 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.74 -46.47 11.11 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.029 2.486 . . . . 0.0 112.009 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.16 -29.77 65.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.053 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.564 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -53.78 146.07 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.73 164.32 4.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.66 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.4 tpp180 -131.61 163.0 29.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.297 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.66 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.1 t80 -174.26 71.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.177 177.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.01 90.96 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.383 -178.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.1 tp -72.18 93.71 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 24.5 m-70 -78.97 145.29 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.528 HD21 HG22 ' A' ' 14' ' ' VAL . 75.0 mt -145.89 110.04 4.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.474 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.03 69.29 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.34 117.93 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.64 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.946 179.725 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.008 0.432 . . . . 0.0 111.466 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 6.1 p-10 -85.94 98.37 10.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.711 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HD3' HD11 ' A' ' 108' ' ' LEU . 51.4 tttp -111.41 76.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.702 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 5.5 m0 -86.91 108.9 18.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.679 -178.026 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.94 -171.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.532 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.4 p-10 -97.84 177.46 5.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.08 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -173.92 -174.66 0.96 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.012 0.434 . . . . 0.0 111.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 60.7 m80 -122.94 -173.98 2.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.919 179.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 83' ' ' ARG . 22.5 t -72.49 134.58 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.166 0.508 . . . . 0.0 112.309 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.19 15.87 12.2 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.944 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.0 tptt -58.13 86.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.279 0.539 . . . . 0.0 109.944 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.486 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -57.43 101.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.519 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -98.5 100.8 12.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HA ' HD21 ' A' ' 77' ' ' LEU . 32.3 tt0 -72.42 131.83 43.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.71 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 42.6 mt -128.18 87.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.298 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CD2' HG21 ' A' ' 75' ' ' VAL . 8.8 m170 -86.99 106.95 18.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 19.1 mt -101.31 174.12 6.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 111.575 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -119.55 160.94 21.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.767 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.62 -163.59 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.954 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.4 t30 . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 179.887 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 2.1 m-85 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.514 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 14.5 ttm -114.79 151.02 34.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.653 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 66.6 m95 -105.89 99.57 9.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.034 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 42' ' ' VAL . 5.9 t -147.78 -176.58 5.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.658 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.9 mtp85 -82.88 157.12 23.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.024 0.44 . . . . 0.0 111.404 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 89' ' ' GLU . 19.7 t -57.97 130.85 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.595 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -41.75 1.83 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.146 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -70.21 -4.61 22.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 0.0 111.037 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 37' ' ' THR . 21.9 t -49.71 121.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.276 -179.805 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.7 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.098 0.475 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.492 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 83.2 p -52.99 179.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.702 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.07 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.89 -42.5 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.126 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.538 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.2 mm -62.55 -76.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 80' ' ' PRO . 8.7 mt -103.98 118.57 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.495 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -72.65 65.01 0.66 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.124 0.488 . . . . 0.0 109.77 177.646 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' HD2' ' A' ' 38' ' ' ARG . 12.0 t -71.08 84.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.58 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.5 t -80.05 85.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 18.6 t -103.82 123.49 47.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.86 -178.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -116.94 106.81 13.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.683 178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -74.17 103.62 4.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.482 179.853 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.2 m -100.35 112.58 64.55 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 123.279 2.652 . . . . 0.0 111.506 179.487 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 121.108 0.48 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.653 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.6 m-85 50.25 90.17 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.386 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 72.8 t -97.94 107.21 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.777 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 11.9 t -112.99 109.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.821 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 21' ' ' THR . 72.3 mt -102.64 99.38 9.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.042 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.3 105.69 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 0.0 111.192 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 7.8 mtmp? -109.19 94.57 15.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.9 Cg_endo -49.75 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.686 2.258 . . . . 0.0 112.855 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 11.8 mtt180 -74.56 -35.33 63.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.915 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 51' ' ' ILE . 4.2 mptp? -108.03 150.28 27.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.15 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG2' HG21 ' A' ' 18' ' ' VAL . 49.7 mtm180 -94.28 129.69 40.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.532 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 148.53 -116.91 0.84 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -130.77 120.04 23.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -131.57 -178.7 4.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.683 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 53.4 m -158.25 156.28 30.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.705 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.504 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.2 tp -133.04 85.7 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.617 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -84.76 88.25 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.089 0.471 . . . . 0.0 111.105 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 HG13 ' A' ' 76' ' ' VAL . 88.7 mt -83.47 103.05 12.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -84.21 145.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.075 0.464 . . . . 0.0 111.98 -178.719 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 35' ' ' MET . 13.5 t80 -95.18 76.22 3.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.49 HG22 HG12 ' A' ' 99' ' ' ILE . 8.0 t -117.4 155.92 28.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 71.6 mtp180 -92.33 103.56 8.82 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.71 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 10.1 Cg_endo -51.51 -37.45 62.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.865 2.377 . . . . 0.0 112.776 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -78.91 12.87 1.95 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.477 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -147.26 3.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.259 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.93 179.18 49.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.831 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 93' ' ' THR . 4.2 mt -105.37 156.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.047 0.451 . . . . 0.0 111.716 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mtmt -139.05 162.84 50.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.0 Cg_endo -72.18 -37.11 4.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.711 2.274 . . . . 0.0 112.212 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.21 -25.94 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.05 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.483 HD22 ' HE3' ' A' ' 100' ' ' LYS . 13.7 m120 -58.48 136.77 57.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.45 -175.13 0.15 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.2 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -163.26 -159.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 179.712 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 80.9 t80 -165.59 72.81 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.614 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 1.2 m -69.78 105.81 2.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.366 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 12' ' ' LYS . 18.2 tp -106.71 94.49 5.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.727 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.702 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.5 m-70 -76.65 153.58 35.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.276 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 16' ' ' THR . 96.4 mt -146.92 99.74 3.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.693 -178.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.8 t30 -74.79 68.56 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.532 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.3 t -50.19 122.07 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.436 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 16' ' ' THR . 31.9 mmmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.832 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 3.9 p30 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 107' ' ' THR . 22.9 t70 -136.36 -119.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.612 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 22.2 tptm -158.02 171.87 19.46 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.416 0.15 . . . . 0.0 110.662 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 7.3 m0 -124.39 121.7 35.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.657 0.383 . . . . 0.0 110.749 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 109' ' ' HIS . 2.9 m -152.5 -171.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.655 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 2.6 p-10 -80.49 175.75 10.38 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.397 0.436 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 110' ' ' LEU . 2.5 t -172.01 -173.66 1.16 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.503 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 78.5 m80 -108.37 -177.99 3.48 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.485 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.02 136.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.119 0.485 . . . . 0.0 111.765 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.78 10.75 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.388 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.4 tptm -63.96 82.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 HD23 ' A' ' 77' ' ' LEU . 9.6 m -39.49 99.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.678 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.5 m -92.75 96.88 10.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.7 tt0 -80.62 132.17 35.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.38 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 108' ' ' LEU . 38.9 mt -134.21 104.55 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -86.97 98.73 11.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 12.9 mt -91.69 145.7 24.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.378 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -95.32 161.78 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.93 -139.35 5.28 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.516 0.198 . . . . 0.0 110.54 179.847 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.051 0.453 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.569 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 1.5 ttt -149.35 147.93 28.9 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.118 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.422 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 2.8 m95 -105.07 86.58 2.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.74 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.569 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 14.6 t -130.46 -171.97 2.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.558 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -71.58 144.92 49.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.761 0.315 . . . . 0.0 110.807 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 91' ' ' VAL . 77.4 t -60.73 137.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.956 0.407 . . . . 0.0 111.413 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.31 -1.72 8.51 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.058 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.31 40.14 2.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 110.766 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' A' ' 93' ' ' THR . 7.6 p -82.18 128.27 38.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.099 179.643 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.558 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 29.8 mt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.352 0.596 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 78.9 p -51.98 176.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.089 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -153.75 -90.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -131.26 -31.93 1.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.4 mm -71.22 -73.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.389 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.551 ' HB3' HG11 ' A' ' 78' ' ' VAL . 28.1 mt -111.58 123.46 50.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.7 73.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.917 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 ' HD3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -77.79 92.85 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.5 t -96.96 86.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.382 177.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.527 ' HB3' HD13 ' A' ' 47' ' ' LEU . 2.7 t -107.08 142.19 37.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -119.37 115.67 24.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.403 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.554 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.78 100.6 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 116.16 65.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.084 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 C-N-CA 123.277 2.651 . . . . 0.0 113.2 -179.141 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.3 pt . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.191 0.52 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.458 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.57 106.26 6.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.852 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.77 117.96 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.212 0.53 . . . . 0.0 110.548 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 78' ' ' VAL . 23.5 t -113.39 126.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.874 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 63.1 mt -111.4 90.93 3.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -93.07 108.86 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.178 0.513 . . . . 0.0 111.645 -178.226 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.2 mtmt -107.25 95.81 14.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -47.03 108.23 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.591 2.194 . . . . 0.0 112.592 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 21.9 mtt180 -76.14 -33.93 59.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -116.27 171.43 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.033 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 68.5 mtp180 -110.1 146.56 35.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.845 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.58 -170.42 21.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.5 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -70.98 104.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 110.576 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.414 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 96.8 m-70 -130.09 142.48 50.6 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.782 0.801 . . . . 0.0 111.676 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 96.2 m -138.24 127.32 24.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 78' ' ' VAL . 15.6 tp -93.81 99.72 12.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.113 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.469 ' HB3' HG22 ' A' ' 39' ' ' VAL . 35.1 mt-10 -76.69 124.6 27.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.436 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.475 HD22 ' NH1' ' A' ' 38' ' ' ARG . 28.0 mt -115.56 165.83 12.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.528 ' HB ' HG23 ' A' ' 39' ' ' VAL . 13.6 p -156.14 154.38 6.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.2 t80 -103.34 86.88 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.635 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 42' ' ' VAL . 2.8 t -115.83 167.0 11.34 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -103.07 94.36 5.41 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 93' ' ' THR . 90.3 Cg_exo -46.8 -29.91 8.66 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.572 2.181 . . . . 0.0 112.565 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -73.19 -37.04 66.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -106.61 -74.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 111.327 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.91 -174.68 44.73 Favored Glycine 0 CA--C 1.508 -0.345 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.296 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.458 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -96.91 145.56 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.871 0.367 . . . . 0.0 111.153 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -130.76 166.74 25.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.633 -179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.14 -44.78 4.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.893 2.395 . . . . 0.0 112.34 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.06 -14.92 27.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.472 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -58.58 139.96 55.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -179.786 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 174.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.141 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -155.0 158.62 39.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.554 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.832 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 24.3 t80 -152.96 108.53 3.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.49 178.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.587 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.8 OUTLIER -98.15 130.88 44.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.621 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 14.0 mt -89.92 126.43 35.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.337 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.693 ' HB2' HG21 ' A' ' 14' ' ' VAL . 1.7 p80 -72.0 57.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.609 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.438 ' HB3' HG23 ' A' ' 16' ' ' THR . 52.6 mt -103.98 80.31 1.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 17.8 t30 -94.35 59.11 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.1 t -33.41 130.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.695 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 14.6 mmmm . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.995 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.204 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -53.24 99.97 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.841 -178.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -89.61 91.63 8.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.472 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.647 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -73.75 99.81 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.512 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.486 HG22 HD21 ' A' ' 110' ' ' LEU . 29.3 m -149.69 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.987 -178.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.2 p-10 -111.88 -175.14 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.508 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.42 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.2 t -174.47 -177.22 1.18 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.104 0.478 . . . . 0.0 112.075 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.607 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 72.9 m80 -111.96 -159.64 0.69 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.841 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.6 128.01 49.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 0.0 111.929 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 71.73 7.51 65.59 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.674 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -56.75 85.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.293 0.547 . . . . 0.0 109.734 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.478 HG21 HD23 ' A' ' 77' ' ' LEU . 3.5 m -58.19 93.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.293 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -85.83 99.71 11.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.72 129.62 34.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.735 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.479 HD12 HD23 ' A' ' 108' ' ' LEU . 46.0 mt -134.61 107.35 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.926 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -88.76 96.84 10.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.28 178.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.0 mt -91.43 148.22 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.418 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -102.56 161.07 14.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 176.86 -145.81 7.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.51 0.195 . . . . 0.0 110.984 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 121.166 0.507 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 5.5 ttm -155.85 152.12 27.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.435 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 8.0 m95 -106.92 85.38 2.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.544 HG22 ' HA ' ' A' ' 42' ' ' VAL . 11.3 t -129.9 -165.47 1.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.377 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.658 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.2 mtp85 -89.2 151.51 22.12 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.861 0.362 . . . . 0.0 110.977 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 89' ' ' GLU . 21.8 t -72.14 133.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.497 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.56 3.51 90.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.3 -0.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 110.462 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.3 t -55.27 109.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.141 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.172 -179.751 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.658 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.216 0.531 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.408 ' HG ' ' HA ' ' A' ' 53' ' ' GLU . 33.4 t -50.39 175.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.565 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -155.75 -86.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.81 -34.04 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.0 mm -70.33 -76.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.364 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -101.19 112.23 24.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.501 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 3.0 tt0 -66.01 78.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 109.832 178.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 t -86.51 90.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.325 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.31 86.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.0 t -101.43 124.97 47.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.652 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -115.79 109.45 17.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.553 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -79.77 121.02 24.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.309 -179.784 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 118.96 31.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 123.164 2.576 . . . . 0.0 112.856 -179.312 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.8 pt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.06 0.457 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' HH ' ' HA2' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -136.01 105.81 6.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.979 179.989 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -90.27 104.57 15.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.01 120.16 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.927 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 21' ' ' THR . 78.3 mt -111.2 99.9 8.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.892 178.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.581 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.74 102.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.053 0.454 . . . . 0.0 110.994 -179.085 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 38.2 mtmt -104.18 104.0 41.54 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HA ' HD21 ' A' ' 52' ' ' LEU . 50.2 Cg_exo -51.43 98.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.406 2.071 . . . . 0.0 112.446 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 7.4 mtt180 -69.82 -41.72 74.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 89.5 mttt -115.54 165.43 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -100.87 119.22 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.592 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.38 -150.45 21.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.363 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.436 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 55.4 t-80 -86.84 101.74 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.11 0.481 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 2.0 m-70 -117.12 165.82 12.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 109' ' ' HIS . 57.6 m -159.84 148.64 17.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 111.945 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 11.6 tp -114.52 93.33 4.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.245 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.51 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.0 mt-10 -77.12 98.23 4.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.045 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 51.1 mt -107.69 130.33 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.68 156.05 37.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.965 -178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.3 t80 -99.88 86.73 3.34 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.104 178.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.524 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 4.5 t -120.35 169.34 10.38 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.11 94.85 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.4 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.6 Cg_exo -42.22 -35.61 3.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.839 2.36 . . . . 0.0 112.755 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -68.52 -44.04 75.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.564 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.77 -79.31 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.81 177.18 40.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.105 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.508 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -92.11 151.31 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.934 0.397 . . . . 0.0 111.292 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.599 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 10.0 mttm -141.43 163.15 43.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.125 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 38.8 Cg_endo -67.6 -40.18 10.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.264 . . . . 0.0 112.133 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.05 -28.09 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -55.36 148.75 14.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.003 179.704 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.92 160.7 3.36 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.589 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpt180 -130.18 162.9 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.219 -179.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.589 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -176.53 69.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.453 0.644 . . . . 0.0 109.677 177.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 12.4 m -91.52 91.33 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.517 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 41.0 tp -71.45 94.36 1.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.524 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -78.22 143.31 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.661 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.486 HD21 HG22 ' A' ' 14' ' ' VAL . 85.2 mt -145.85 104.64 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.807 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.449 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 45.6 t30 -78.42 68.91 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.5 t -48.75 127.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.65 -178.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.976 179.988 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.614 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 111.541 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 107' ' ' THR . 1.2 m-20 -47.65 104.52 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.284 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -97.24 92.72 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.141 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.642 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.09 104.02 12.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 4.5 m -150.95 -173.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 112.136 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.41 176.7 5.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.819 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.2 t -175.49 -177.1 0.96 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.9 m-70 -120.82 -166.16 1.3 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.968 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG23 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -87.19 136.59 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 112.111 -179.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.59 12.16 32.32 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.628 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tptt -59.79 83.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.182 0.491 . . . . 0.0 109.782 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.469 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -54.93 98.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.424 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 100.0 m -96.2 101.18 12.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.6 tt0 -82.44 132.7 35.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.799 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.422 HD13 HD23 ' A' ' 108' ' ' LEU . 45.6 mt -134.97 101.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.961 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -83.67 98.91 9.9 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 14.5 mt -92.61 148.73 21.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -102.9 159.93 15.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.844 0.354 . . . . 0.0 110.399 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 -161.64 34.18 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.715 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 25.0 ttm -108.53 151.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.306 179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -109.88 85.03 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.653 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -132.65 -166.95 1.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -93.04 122.52 35.5 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.5 p -53.16 138.78 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.178 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.47 -4.59 77.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.743 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 48.8 m-85 -130.78 3.14 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.286 0.565 . . . . 0.0 110.037 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 37' ' ' THR . 18.2 t -52.12 119.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.095 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.004 -179.447 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.8 mt . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.874 0.369 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 40.8 t -49.28 179.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.142 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -152.55 -88.84 0.06 Allowed 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -136.11 -31.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.397 -179.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.1 mm -73.21 -72.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.438 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 80' ' ' PRO . 11.1 mt -105.13 114.37 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.472 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.13 72.1 0.1 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.795 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' N ' ' HB2' ' A' ' 48' ' ' SER . 10.9 t -76.39 84.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.324 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.7 t -80.2 81.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 76' ' ' VAL . 36.3 t -94.81 146.84 23.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.315 -178.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -138.82 113.18 8.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.36 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.491 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.85 104.86 15.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.274 179.373 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.8 m -101.83 109.63 60.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.618 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.079 0 C-N-CA 123.533 2.822 . . . . 0.0 111.652 179.316 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.78 95.38 3.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.941 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 75' ' ' VAL . 10.6 p -87.97 111.81 22.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.536 0.684 . . . . 0.0 110.602 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 90' ' ' LEU . 38.7 t -108.88 122.91 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.53 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.469 HD23 HG21 ' A' ' 21' ' ' THR . 81.3 mt -108.46 99.23 8.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.808 178.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.49 106.2 17.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.999 0.428 . . . . 0.0 111.145 -178.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -108.1 102.15 44.79 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.344 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HA ' HD21 ' A' ' 52' ' ' LEU . 70.0 Cg_exo -49.93 98.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.747 2.298 . . . . 0.0 112.81 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.56 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -67.57 -37.25 82.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 56.6 mttm -120.99 -178.81 3.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.489 ' HE ' HG23 ' A' ' 18' ' ' VAL . 95.7 mtt180 -115.17 124.86 52.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.491 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.78 -142.8 9.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.576 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.454 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 61.9 m80 -87.34 91.65 8.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -111.65 154.5 24.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.412 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 109' ' ' HIS . 62.9 m -158.55 146.23 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.932 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.623 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 39.6 tp -96.72 92.24 6.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.072 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.77 94.19 1.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.166 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.623 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 40.0 mt -111.53 127.41 55.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.466 HG21 ' N ' ' A' ' 92' ' ' TYR . 11.8 p -128.95 158.57 41.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.511 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -99.17 83.33 2.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.429 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.48 HG22 HG22 ' A' ' 42' ' ' VAL . 10.0 t -117.5 150.83 38.28 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 41.5 mtp180 -91.49 104.49 10.16 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 178.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.9 Cg_exo -39.79 -31.99 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.055 2.503 . . . . 0.0 113.168 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.414 ' HD2' ' HG3' ' A' ' 97' ' ' GLU . 6.7 t80 -77.02 -60.08 2.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.414 ' HG3' ' HD2' ' A' ' 96' ' ' PHE . 36.9 mt-10 -67.91 -64.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.894 0.378 . . . . 0.0 111.301 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.3 -179.78 20.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.813 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.472 HG21 ' HB ' ' A' ' 93' ' ' THR . 2.5 mt -93.86 148.07 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.918 0.389 . . . . 0.0 111.472 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 26.2 mtmm -147.82 162.64 30.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.115 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.8 Cg_endo -67.75 -37.1 16.91 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.797 2.331 . . . . 0.0 112.012 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.06 -29.34 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.2 m120 -58.21 154.36 13.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 164.41 4.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.245 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.7 tpp180 -132.24 165.95 22.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.663 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.0 t80 -174.57 74.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.297 177.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.93 94.29 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.418 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.3 tp -72.86 93.17 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.016 0.436 . . . . 0.0 110.656 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 40.8 m-70 -75.19 146.02 41.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.668 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 16' ' ' THR . 97.4 mt -145.69 120.21 9.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.568 -178.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -86.31 63.07 7.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.491 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -44.74 122.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.729 -178.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.093 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.644 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.054 0.455 . . . . 0.0 111.267 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -32.44 108.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.705 179.906 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -87.17 93.7 9.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.5 m95 -75.74 98.52 4.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 HD21 ' A' ' 110' ' ' LEU . 28.4 m -149.42 -172.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 112.245 -178.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.438 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -112.37 179.0 4.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.455 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.455 HG21 HG21 ' A' ' 112' ' ' VAL . 1.8 t -177.88 -172.77 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 112.046 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.8 m-70 -117.62 -171.15 2.0 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 10.1 p -83.44 142.51 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.79 18.67 8.64 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.669 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptm -65.49 80.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.455 HG21 HD23 ' A' ' 77' ' ' LEU . 4.6 m -50.5 97.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.422 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.3 m -94.67 104.63 16.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.827 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.2 tt0 -86.91 129.72 34.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.803 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD23 ' A' ' 108' ' ' LEU . 47.1 mt -132.48 104.63 7.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.64 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -85.03 96.36 9.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.0 mt -89.27 145.91 25.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.398 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -97.66 161.99 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.847 0.356 . . . . 0.0 110.399 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.16 -137.13 4.11 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.499 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.1 t30 . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.889 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -151.71 151.79 31.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.931 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.433 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -108.39 87.08 2.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.347 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -130.39 -170.98 2.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.832 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.658 HH21 HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -76.27 137.89 40.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.518 HG23 ' HB ' ' A' ' 91' ' ' VAL . 49.0 t -57.1 136.32 20.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.387 -179.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.11 -13.81 1.8 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.776 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' VAL . 14.6 m-30 -105.62 22.08 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.341 0.591 . . . . 0.0 110.49 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 93' ' ' THR . 12.7 t -76.16 107.13 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.148 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.286 -179.854 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.658 HD12 HH21 ' A' ' 38' ' ' ARG . 22.6 mt . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -50.42 173.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.979 178.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -150.46 -95.73 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.618 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.09 -33.11 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.9 mm -73.38 -72.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.19 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 78' ' ' VAL . 77.2 mt -107.6 117.86 35.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.322 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -70.36 73.03 0.49 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.712 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG12 ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -76.38 91.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 22.4 t -93.34 87.97 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.328 177.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB3' HD11 ' A' ' 47' ' ' LEU . 8.1 t -110.0 144.83 37.98 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.935 -178.46 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -122.9 115.89 22.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.647 178.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.465 ' HD1' ' C ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -85.14 105.85 16.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.449 179.466 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 4.3 m -103.0 126.28 32.88 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.45 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 2.6 Cg_endo . . . . . 0 N--CA 1.457 -0.655 0 C-N-CA 123.01 2.473 . . . . 0.0 113.178 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 121.195 0.521 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -136.2 98.68 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.81 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 75' ' ' VAL . 5.5 p -90.21 111.34 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.298 0.571 . . . . 0.0 110.625 -179.266 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 HH22 ' A' ' 38' ' ' ARG . 46.2 t -107.18 124.55 63.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.923 -178.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 71.5 mt -111.63 92.95 4.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 177.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -91.73 110.72 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.223 -178.775 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.642 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 7.7 mtmp? -107.84 101.96 43.08 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.226 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 71.4 Cg_exo -48.22 99.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.707 2.271 . . . . 0.0 113.066 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.442 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.1 mtt180 -69.34 -31.44 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -121.25 170.69 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.767 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -115.66 128.45 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 135.65 -152.92 21.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.183 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -65.9 106.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.498 . . . . 0.0 110.639 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -138.04 160.59 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.619 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 109' ' ' HIS . 87.0 m -160.17 148.27 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 111.774 -179.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.619 HD22 HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -110.03 101.55 10.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.878 179.194 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 39' ' ' VAL . 40.1 mt-10 -79.35 115.75 19.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 ' NH1' ' A' ' 38' ' ' ARG . 29.4 mt -121.84 151.49 40.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HB ' HG23 ' A' ' 39' ' ' VAL . 7.2 p -154.26 153.6 8.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.094 0.473 . . . . 0.0 111.899 -178.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.2 t80 -100.7 91.97 4.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.996 178.459 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.573 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.5 t -126.69 166.1 18.0 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -177.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.502 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.7 mtp180 -98.63 97.52 4.92 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.643 178.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.5 Cg_exo -46.14 -40.74 21.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.8 2.333 . . . . 0.0 113.415 -179.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.47 17.34 3.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.1 mm-40 -150.57 0.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.29 -178.96 50.69 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.264 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.485 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 6.8 mt -108.7 151.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.075 0.464 . . . . 0.0 112.031 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.546 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 16.2 mttt -128.39 166.78 22.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.767 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.65 -40.91 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.858 2.372 . . . . 0.0 112.146 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.16 -24.77 67.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.199 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -49.38 148.75 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 179.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -61.77 166.11 4.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.433 -179.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.696 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.3 tpp180 -134.78 163.73 29.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.386 -178.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.696 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 30.8 t80 -172.31 80.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.223 177.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.46 93.68 6.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.654 -178.882 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 47.7 tp -66.77 83.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 25.9 m-70 -69.89 136.16 50.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.47 HD21 HG22 ' A' ' 14' ' ' VAL . 94.6 mt -143.41 109.82 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.474 -178.058 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.438 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 60.7 t30 -85.24 54.05 2.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.577 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -35.74 135.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.863 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.9 mmpt? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.656 HD21 ' HB3' ' A' ' 105' ' ' ARG . 1.1 p-10 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 14.8 m-20 -48.49 97.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.126 -178.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HD3' HD11 ' A' ' 108' ' ' LEU . 52.9 tttp -100.84 92.04 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.679 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.632 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -80.69 104.69 11.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.59 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 3.8 p -151.29 -179.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.988 0.423 . . . . 0.0 111.694 -179.03 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -99.45 -179.14 4.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.417 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.1 t -174.54 -173.45 0.75 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.152 0.501 . . . . 0.0 112.111 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 19.4 m80 -115.4 -170.31 1.74 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.09 132.39 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 112.054 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.11 11.97 34.9 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.39 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -64.81 82.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.457 HG21 HD23 ' A' ' 77' ' ' LEU . 6.1 m -47.16 99.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.568 -178.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -93.82 96.22 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' HD21 ' A' ' 77' ' ' LEU . 33.8 tt0 -73.99 132.34 42.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.718 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.4 102.0 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.249 -179.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -85.64 99.64 11.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 35.5 mt -94.29 147.6 23.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.752 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -99.81 164.75 11.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.73 -134.21 3.14 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.536 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.3 t30 . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 179.925 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.085 0.469 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.553 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.4 ttm -147.82 154.09 40.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.816 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.418 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 4.6 m95 -110.42 88.15 2.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.922 178.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.597 HG23 ' HA ' ' A' ' 42' ' ' VAL . 14.4 t -133.54 -163.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.8 mtp85 -90.18 158.38 17.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.812 0.339 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 89' ' ' GLU . 21.9 t -77.23 132.03 33.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.656 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.47 9.3 86.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -134.02 -1.75 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.206 0.527 . . . . 0.0 110.538 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.597 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.3 t -51.71 116.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.115 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.235 -179.743 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 22.8 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.466 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 55.6 p -62.1 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.572 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -151.73 -82.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.96 -30.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.371 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.1 mm -74.25 -85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.491 -179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.99 108.76 21.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.43 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 10.5 tt0 -61.62 140.89 58.09 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG23 ' HD2' ' A' ' 38' ' ' ARG . 59.2 t -141.06 89.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.87 0.367 . . . . 0.0 111.753 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.9 t -73.7 94.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -72.16 115.07 10.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.125 -178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 99.4 mttt -121.37 43.92 2.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -66.13 106.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.543 178.726 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -101.37 117.39 62.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.327 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.452 -0.918 0 C-N-CA 123.17 2.58 . . . . 0.0 112.402 -179.499 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 11.8 pt . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -124.97 103.41 8.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.961 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 84.9 t -92.98 100.17 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.063 0.459 . . . . 0.0 110.547 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.76 118.9 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.135 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 81.5 mt -103.82 105.59 15.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.754 178.511 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.667 HG13 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.72 100.99 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.032 0.444 . . . . 0.0 110.992 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -105.53 102.57 38.53 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.449 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 37.3 Cg_exo -55.96 98.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.241 1.961 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.676 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 70.3 mtt180 -62.26 -34.63 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -124.29 179.69 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -118.28 144.11 46.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.34 -111.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.556 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.417 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.1 m80 -116.25 96.66 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 111.031 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.502 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.33 163.26 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.512 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.489 HG21 ' N ' ' A' ' 88' ' ' LEU . 30.1 m -160.08 157.93 29.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 111.712 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.622 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.0 tp -126.14 89.09 2.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 39' ' ' VAL . 43.2 mt-10 -73.85 93.9 2.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.123 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 56.3 mt -103.38 134.27 47.03 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 92' ' ' TYR . 8.3 p -139.52 154.86 25.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 111.83 -178.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.9 t80 -97.85 90.37 4.92 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' HG21 ' A' ' 99' ' ' ILE . 5.8 t -120.02 173.02 7.33 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -103.22 95.05 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.861 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 93' ' ' THR . 89.1 Cg_exo -46.8 -30.5 9.44 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.626 2.218 . . . . 0.0 112.682 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.67 -37.24 62.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.22 -79.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.35 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.4 178.48 43.4 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.18 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.5 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.1 mt -95.45 154.66 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.454 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.7 mttt -140.72 161.65 53.18 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -71.15 -39.01 4.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.93 -28.07 69.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -54.72 152.27 7.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.215 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -52.89 156.14 2.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HB3' HD21 ' A' ' 10' ' ' ASN . 15.9 tpp180 -127.71 164.94 21.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.528 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.598 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 54.2 t80 -176.64 64.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 109.52 177.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 89' ' ' GLU . 11.1 m -87.12 92.9 9.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.866 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.4 tp -74.75 95.63 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.301 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.632 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.3 m-70 -79.72 144.02 34.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.773 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 79.6 mt -144.44 106.55 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.352 -178.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -82.79 65.65 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -42.73 136.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.568 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.637 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.932 0.396 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 7.5 p-10 -54.7 100.02 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -115.09 60.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.718 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.627 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m0 -78.25 119.24 21.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.401 -177.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.9 -174.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.429 0.633 . . . . 0.0 112.317 -178.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.07 177.16 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.58 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -176.31 176.36 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.111 0.481 . . . . 0.0 112.265 179.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.536 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 31.6 m-70 -114.52 -153.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.683 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.3 128.8 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 111.797 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 64.37 13.36 54.3 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.33 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.7 tptm -57.27 86.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.445 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -56.86 97.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.033 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -87.92 104.88 17.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.448 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 41.1 tt0 -89.26 129.24 35.85 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.181 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.41 HD12 ' OH ' ' A' ' 106' ' ' TYR . 25.0 mt -141.41 109.85 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -85.38 113.22 21.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.272 179.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mp -104.96 162.28 13.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.4 mptt -119.42 158.6 25.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.448 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . -174.92 -141.19 3.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 120.426 0.155 . . . . 0.0 111.052 179.989 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.019 0.437 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 9.5 ttm -146.53 146.38 30.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.174 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -97.36 80.63 2.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 178.882 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 42' ' ' VAL . 14.9 t -121.94 -170.5 2.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 -179.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.697 ' HE ' ' HB2' ' A' ' 47' ' ' LEU . 1.9 ttm-85 -81.84 137.58 35.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.527 HG23 ' HB ' ' A' ' 91' ' ' VAL . 71.6 t -54.38 140.18 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.841 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.12 4.47 4.67 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.642 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -123.4 25.65 8.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.546 ' HB ' HG23 ' A' ' 93' ' ' THR . 6.4 p -67.82 130.68 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.994 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.945 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.697 ' HB2' ' HE ' ' A' ' 38' ' ' ARG . 12.3 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.59 0.233 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 83.1 p -58.82 -171.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 179.112 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.02 -92.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.439 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.609 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -129.89 -33.32 1.8 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.561 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 52' ' ' LEU . 37.8 mm -63.94 -64.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.522 ' HB3' HG11 ' A' ' 78' ' ' VAL . 81.7 mt -122.39 124.21 43.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -71.73 68.89 0.64 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.45 178.482 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -78.86 132.45 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.169 0.509 . . . . 0.0 110.992 -179.661 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.1 t -131.78 85.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.18 179.601 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.554 ' H ' HH22 ' A' ' 38' ' ' ARG . 10.4 t -99.19 111.86 24.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.538 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -95.99 112.66 24.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.36 108.3 14.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.212 179.392 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 26.5 m -120.69 128.42 25.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 3.0 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 123.428 2.752 . . . . 0.0 111.179 178.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.5 pt . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 4.3 m-85 -141.35 103.14 4.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.639 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 63.4 t -86.25 93.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 56' ' ' CYS . 21.3 t -88.58 124.59 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.796 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 77.1 mt -120.12 93.34 4.02 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.589 HG12 HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.18 103.97 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.943 0.402 . . . . 0.0 110.915 -179.148 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.7 mtmt -101.93 98.25 9.65 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.439 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.7 Cg_endo -46.42 106.7 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.758 2.305 . . . . 0.0 112.721 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.609 HH11 ' HA ' ' A' ' 50' ' ' GLU . 9.1 mtt180 -79.44 -48.62 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 62.3 mttm -102.91 156.52 17.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -95.32 123.5 38.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.539 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.21 -153.72 25.14 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.493 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -90.33 104.13 16.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 15.6 m-70 -122.28 179.2 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 94.8 m -160.12 155.26 24.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.086 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.493 ' HB2' HG13 ' A' ' 78' ' ' VAL . 1.5 tm? -131.46 93.4 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -104.61 121.37 43.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.98 -179.799 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.444 ' CD2' ' HG3' ' A' ' 38' ' ' ARG . 39.2 mt -99.0 171.84 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.478 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HB ' HG23 ' A' ' 39' ' ' VAL . 7.1 p -160.34 151.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.107 0.48 . . . . 0.0 112.272 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.57 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -94.4 85.19 4.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.146 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.546 HG23 ' HB ' ' A' ' 42' ' ' VAL . 3.7 t -107.7 172.1 7.02 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -104.57 94.04 6.71 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.8 Cg_exo -49.6 -30.89 23.08 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.408 2.072 . . . . 0.0 112.382 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -74.6 -35.35 62.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -107.95 -77.89 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.319 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.95 -173.72 46.52 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.127 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.452 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.3 mt -96.68 148.72 5.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 4.4 mttt -133.75 174.03 5.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.41 -38.16 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.405 2.07 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.51 -10.05 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.762 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.528 ' N ' HD21 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -64.45 161.84 16.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -179.927 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.1 tp10 -74.01 167.79 20.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.943 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.7 tpp180 -142.77 158.83 43.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.6 t80 -158.72 81.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.533 177.027 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 2.6 m -76.59 157.76 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.506 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.535 HD22 HG23 ' A' ' 78' ' ' VAL . 33.7 tp -156.51 82.69 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.256 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.7 m-70 -67.82 156.28 37.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.398 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' A' ' 16' ' ' THR . 96.1 mt -147.92 106.4 3.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.034 -178.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.62 61.88 3.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.539 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 3.3 t -45.16 121.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.603 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.978 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.2 p-10 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.6 p-10 -50.83 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.664 -179.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -104.89 93.51 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.45 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.654 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -84.39 105.88 15.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.593 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.483 HG22 HD21 ' A' ' 110' ' ' LEU . 29.5 m -147.44 -174.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.259 0.552 . . . . 0.0 112.285 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.93 179.69 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.1 t -177.39 -175.76 0.57 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.054 0.454 . . . . 0.0 111.891 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 49.1 m-70 -117.81 -167.11 1.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 179.118 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 33.7 t -86.66 135.84 24.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 111.94 -179.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 63.33 11.53 40.69 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.476 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.0 tptt -59.79 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.1 0.45 . . . . 0.0 109.812 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.481 HG21 HD23 ' A' ' 77' ' ' LEU . 3.8 m -55.61 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.368 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 m -94.48 98.66 11.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.527 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -75.45 133.51 41.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mt -134.02 101.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -87.19 110.22 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 33.7 mt -108.18 148.48 29.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.352 -179.229 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -99.5 160.66 14.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.986 0.422 . . . . 0.0 110.605 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.95 -128.63 1.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.374 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.537 0.208 . . . . 0.0 111.146 179.953 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.957 0.408 . . . . 0.0 110.872 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -136.87 154.71 50.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.174 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 8.3 m95 -112.47 98.23 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.94 178.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 42' ' ' VAL . 14.6 t -142.56 -165.79 2.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.822 -179.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.645 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.8 mtp85 -88.54 156.57 19.0 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.8 t -72.83 131.17 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.935 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 13.96 82.02 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.858 179.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -134.88 -4.31 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.725 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.6 t -49.52 124.39 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.123 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.17 -179.685 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.5 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.181 0.515 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.5 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 24.4 p -50.78 177.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.127 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -153.3 -81.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.19 -33.23 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 22.8 mm -69.28 -81.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.676 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 6.7 mt -97.15 117.59 31.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.615 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 23.5 tt0 -68.68 84.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.514 HG23 ' HD2' ' A' ' 38' ' ' ARG . 39.0 t -88.95 91.66 3.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.511 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.6 t -79.68 86.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.4 t -68.95 135.22 50.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.006 -178.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 8.9 mtpm? -138.25 54.09 1.79 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.84 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -52.52 112.37 0.81 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.511 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.43 ' OG1' HG13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.36 104.16 28.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.537 -179.548 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 27.1 Cg_endo . . . . . 0 N--CA 1.451 -0.976 0 C-N-CA 123.765 2.977 . . . . 0.0 113.039 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.9 pt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -136.44 107.32 6.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.279 -179.482 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -94.36 100.99 12.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.945 0.403 . . . . 0.0 110.737 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.26 118.2 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.028 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 89.0 mt -104.1 106.92 17.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.44 104.99 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.272 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 39.3 mtmt -108.75 100.45 39.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.46 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 81.8 Cg_exo -46.41 96.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.586 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 10.4 mtt180 -69.04 -33.81 74.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.173 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 65.9 mttm -118.95 -178.45 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 -179.722 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -119.52 120.83 37.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.795 179.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.7 -121.35 1.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.608 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.36 113.89 26.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 111.102 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.584 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 5.6 m80 -136.14 150.72 49.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m -161.19 152.6 19.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 112.063 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 53.8 tp -121.87 71.79 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.073 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 3.1 pt-20 -70.71 105.38 3.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.624 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -107.18 154.67 20.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.34 160.22 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.695 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -103.88 89.16 3.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.562 178.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.545 ' HG1' ' H ' ' A' ' 94' ' ' ARG . 9.1 t -120.25 169.12 10.56 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.545 ' H ' ' HG1' ' A' ' 93' ' ' THR . 77.2 mtp180 -101.49 95.91 5.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.948 178.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 5.6 Cg_endo -47.18 -33.46 15.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -68.46 -35.61 77.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.497 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -103.82 -80.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.359 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.65 46.25 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.095 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.475 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -97.21 149.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.027 0.441 . . . . 0.0 111.669 -179.08 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.8 mttt -135.18 162.91 54.76 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.0 Cg_endo -64.74 -35.23 47.03 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.607 2.205 . . . . 0.0 111.743 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.75 -24.45 66.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.1 m-80 -48.67 136.43 13.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 11.0 tt0 -51.86 155.44 1.76 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.582 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 4.3 tpp180 -119.96 159.15 25.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.534 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.9 t80 -172.47 69.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 16.5 m -91.43 101.97 14.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.465 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.2 tp -87.97 94.48 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.185 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.654 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 15.3 m-70 -77.55 147.87 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.677 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.483 HD21 HG22 ' A' ' 14' ' ' VAL . 94.9 mt -146.19 108.44 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.547 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 39.4 t30 -84.35 69.68 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 17' ' ' HIS . 2.9 t -45.71 143.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.852 -178.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.927 0.394 . . . . 0.0 111.867 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 8.8 m-20 -48.18 96.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.618 -179.297 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HD3' HD12 ' A' ' 108' ' ' LEU . 20.8 ptmt -101.06 68.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.554 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.705 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -49.85 104.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.137 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.489 HG22 HD21 ' A' ' 110' ' ' LEU . 35.4 m -146.87 -176.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.3 p-10 -103.38 -171.33 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.466 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -174.41 -174.74 0.89 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.3 0.571 . . . . 0.0 112.379 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 28.7 m80 -113.85 -156.58 0.6 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.647 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.445 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 42.3 t -105.26 125.56 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.468 . . . . 0.0 111.585 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.9 12.7 43.95 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.061 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptp -63.64 83.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.135 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.441 HG21 HD23 ' A' ' 77' ' ' LEU . 5.3 m -47.87 103.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.829 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -97.48 100.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.536 179.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HG3' HG21 ' A' ' 75' ' ' VAL . 35.4 tt0 -83.47 131.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.286 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 108' ' ' LEU . 36.1 mt -136.09 100.0 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.522 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.432 ' ND1' HD13 ' A' ' 73' ' ' ILE . 10.8 m170 -84.08 82.05 8.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 178.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 75.0 mt -72.24 158.54 35.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.285 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -116.16 164.76 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.103 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.42 -149.57 11.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.724 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.559 0.219 . . . . 0.0 110.849 -179.95 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 93' ' ' THR . 79.8 m-85 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 121.02 0.438 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.559 ' HE2' ' H ' ' A' ' 43' ' ' GLY . 8.5 ttp -113.58 154.8 26.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.423 179.388 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -105.22 107.03 17.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.867 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -156.65 -166.27 2.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.485 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 mtp85 -84.25 161.94 20.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.184 -179.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 89' ' ' GLU . 48.6 t -76.36 138.69 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.813 -179.418 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.13 79.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.605 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -135.03 -2.59 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.635 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.594 ' HB ' HG23 ' A' ' 93' ' ' THR . 2.3 p -40.29 108.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.287 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.559 ' H ' ' HE2' ' A' ' 35' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.9 mt . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.461 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.6 p -50.93 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.742 179.038 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.96 -88.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.587 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -131.02 -32.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.056 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -71.64 -73.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.324 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 80' ' ' PRO . 14.8 mt -107.5 118.97 38.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.442 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.64 69.22 0.42 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 HG23 ' HD2' ' A' ' 38' ' ' ARG . 11.8 t -76.56 83.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.316 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 14.9 t -83.61 87.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.413 ' SG ' HG23 ' A' ' 76' ' ' VAL . 39.9 t -95.38 150.57 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.489 -178.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB2' HG11 ' A' ' 75' ' ' VAL . 58.5 mttm -139.02 118.13 12.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.456 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 1.5 t80 -96.57 101.64 13.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.128 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.7 m -107.87 90.23 6.21 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 96.7 Cg_endo . . . . . 0 N--CA 1.459 -0.543 0 C-N-CA 122.987 2.458 . . . . 0.0 111.818 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm . . . . . 0 CA--C 1.513 -0.457 0 CA-C-O 121.954 0.883 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -129.87 67.57 1.46 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.506 178.463 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.487 HG21 ' HG3' ' A' ' 23' ' ' GLU . 2.2 p -81.04 107.31 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.476 -178.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.413 HG23 ' SG ' ' A' ' 56' ' ' CYS . 96.6 t -102.02 125.98 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.46 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 HG21 ' A' ' 21' ' ' THR . 76.6 mt -109.3 96.9 6.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.77 178.408 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.553 HG22 HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -93.73 106.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.04 0.448 . . . . 0.0 111.044 -178.904 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -107.87 105.07 55.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.985 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HA ' HD21 ' A' ' 52' ' ' LEU . 47.8 Cg_exo -53.05 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.49 2.127 . . . . 0.0 112.45 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.587 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.6 mtt180 -69.87 -49.14 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.459 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -107.62 161.05 15.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -98.15 113.79 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.733 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.93 -129.25 1.9 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.578 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.401 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.7 m80 -106.62 99.09 8.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.462 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -111.04 162.69 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.673 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.7 m -159.63 148.87 18.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.044 0.449 . . . . 0.0 112.052 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 25.7 tp -121.61 79.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.757 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -77.07 100.19 5.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.178 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.9 mt -98.68 140.75 32.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.116 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.98 164.49 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.808 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -99.11 84.18 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 42' ' ' VAL . 7.6 t -95.5 -175.67 3.54 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.831 -177.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 55.7 mtp180 -117.91 101.17 52.08 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.297 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 84.4 Cg_exo -39.92 -34.93 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.054 2.503 . . . . 0.0 113.399 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.438 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -88.74 -47.23 8.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.414 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -83.92 -86.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.884 0.374 . . . . 0.0 111.803 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 172.82 -174.06 45.68 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.246 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.465 HG12 ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -93.68 154.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.502 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 10.6 mttm -145.44 166.46 17.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.506 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.2 Cg_exo -59.62 -44.88 28.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.857 2.371 . . . . 0.0 111.864 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.51 -26.74 67.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.307 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.554 ' N ' HD21 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -49.56 135.47 18.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 9.3 tt0 -49.42 152.53 1.28 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.24 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 7.4 tpp180 -117.63 159.2 23.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.167 0.508 . . . . 0.0 111.71 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.493 ' H ' ' HG3' ' A' ' 105' ' ' ARG . 41.5 t80 -175.55 62.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.532 177.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 9.1 m -84.26 98.12 9.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.726 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 18.6 tp -80.57 92.41 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.862 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.705 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -79.59 140.94 36.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.341 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 108' ' ' LEU . 89.3 mt -144.01 99.83 3.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.58 -178.322 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 7.9 t30 -73.16 77.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.565 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 6.1 t -51.5 120.55 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.418 -178.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.887 -179.97 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.241 . . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -149.56 -140.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.517 ' C ' ' HB3' ' A' ' 109' ' ' HIS . 22.1 ptmt -132.63 -173.94 3.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.451 -179.12 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 16.7 m0 -136.63 117.48 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 179.214 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.52 ' N ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 p -158.35 158.57 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.547 0.689 . . . . 0.0 112.077 -178.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 p30 -44.98 165.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.925 -178.454 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 110' ' ' LEU . 3.1 t -173.02 -167.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.391 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.549 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 57.2 m80 -111.99 179.34 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -94.03 147.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.208 0.528 . . . . 0.0 112.195 -178.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.19 21.63 5.96 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.849 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.8 tptt -75.18 73.53 2.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 109.658 179.38 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.436 HG23 HD21 ' A' ' 77' ' ' LEU . 11.6 m -40.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.809 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.6 m -104.52 103.84 13.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.581 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' HG3' HG21 ' A' ' 75' ' ' VAL . 28.0 tt0 -82.58 121.7 27.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.42 ' O ' HD23 ' A' ' 26' ' ' LEU . 56.7 mt -126.99 99.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.514 ' HB3' HD13 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.36 109.61 20.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.61 178.639 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 2.6 mm? -91.05 167.56 12.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -107.46 167.66 9.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.965 179.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.6 -148.82 18.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.579 -179.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.331 0.11 . . . . 0.0 110.871 -179.966 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 87.9 m-85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.19 0.519 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.0 ttm -123.8 150.29 44.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -105.66 81.82 1.72 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 178.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -124.01 -160.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.699 -179.292 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 1.8 ttp85 -95.24 114.12 25.87 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG12 HH11 ' A' ' 105' ' ' ARG . 0.9 OUTLIER -48.14 134.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 111.514 -179.283 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.16 3.19 76.29 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.917 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.37 0.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.971 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HA ' HG23 ' A' ' 37' ' ' THR . 9.3 p -49.48 136.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.195 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.696 179.971 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.0 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.101 0.477 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.475 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 22.7 t -48.69 172.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.472 178.683 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.475 ' H ' ' HG ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -152.46 -78.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.74 -34.44 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.469 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -69.97 -78.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 -179.306 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' A' ' 80' ' ' PRO . 60.2 mt -98.54 117.2 32.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.385 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.684 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 25.9 tt0 -67.93 84.26 0.22 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.58 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG23 ' HD2' ' A' ' 38' ' ' ARG . 19.8 t -92.22 94.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -91.48 82.13 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' HG23 ' A' ' 76' ' ' VAL . 22.2 t -99.61 155.21 17.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.622 -178.367 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -143.41 123.86 13.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -89.36 109.34 20.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.398 179.741 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 m -97.72 105.04 24.11 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.574 -179.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 44.1 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 C-N-CA 123.849 3.033 . . . . 0.0 112.464 179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' A' ' 25' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.6 0.714 . . . . 0.0 111.429 . . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 29.1 m-85 -144.52 79.79 1.62 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.56 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' ' 23' ' ' GLU . 2.8 p -85.05 106.52 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.268 0.556 . . . . 0.0 110.755 -178.994 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG23 ' SG ' ' A' ' 56' ' ' CYS . 20.4 t -107.83 116.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.583 -178.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 21' ' ' THR . 29.1 mt -100.46 100.96 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 114.19 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.252 0.549 . . . . 0.0 111.17 -178.947 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.7 mtmm -119.44 92.41 45.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.416 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HA ' HD22 ' A' ' 52' ' ' LEU . 5.4 Cg_endo -47.46 112.87 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.487 2.125 . . . . 0.0 112.905 -178.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.1 mtt180 -80.51 -39.82 27.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.861 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' O ' HG22 ' A' ' 112' ' ' VAL . 66.3 mttm -108.28 176.38 5.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 112' ' ' VAL . 93.8 mtt180 -113.62 149.82 34.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 112' ' ' VAL . . . 124.01 -160.56 18.56 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.726 179.8 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.471 ' HA ' HD21 ' A' ' 111' ' ' ASN . 65.7 m80 -71.43 98.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 110.752 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -129.91 154.07 47.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 0.0 111.331 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.531 HG23 ' HE1' ' A' ' 13' ' ' TRP . 37.5 m -159.87 138.9 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 78' ' ' VAL . 32.0 tp -74.53 111.18 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.292 179.531 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 44.5 mt-10 -87.6 96.75 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.732 -179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 36.3 mt -101.14 170.01 8.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.449 178.796 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 13.3 p -166.56 153.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -104.56 84.27 2.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.475 HG23 HG11 ' A' ' 91' ' ' VAL . 5.6 t -124.55 149.23 47.2 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.12 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 74.7 mtp180 -85.81 101.65 2.01 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.965 178.495 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 8.6 Cg_endo -52.28 -38.24 72.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.721 2.281 . . . . 0.0 112.685 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.14 10.89 3.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.74 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 20.7 mm-40 -147.88 1.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.41 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.84 -174.75 54.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.114 -179.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.473 HG21 ' HB ' ' A' ' 93' ' ' THR . 7.2 mt -106.45 148.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.002 0.429 . . . . 0.0 111.635 -179.326 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 9.9 mttt -131.63 157.93 76.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.565 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.39 -43.98 50.53 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.75 2.3 . . . . 0.0 112.744 -179.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.76 -14.09 49.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.074 -179.365 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.589 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -62.02 137.7 58.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 -179.632 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' VAL . 5.9 tt0 -60.37 -179.46 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -162.97 162.35 26.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.214 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.576 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 26.3 t80 -151.53 114.94 4.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.042 0.449 . . . . 0.0 110.177 178.151 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.554 HG22 ' NE ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -104.37 132.12 50.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.043 -178.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 110' ' ' LEU . 26.5 tp -101.62 110.45 22.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.527 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 8.6 p80 -55.32 71.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.868 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 108' ' ' LEU . 21.1 mt -112.72 70.72 0.72 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.839 0.745 . . . . 0.0 112.937 -178.896 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 2.2 t-20 -82.31 60.21 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.757 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 84' ' ' GLY . 0.2 OUTLIER -40.71 141.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.615 -178.07 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.044 179.719 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.941 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -36.72 103.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.804 -179.581 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.67 100.54 13.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.492 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.4 m95 -82.86 105.44 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.696 -179.521 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 4.7 p -153.37 176.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.146 0.498 . . . . 0.0 111.838 -179.118 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -94.39 -176.69 4.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.601 179.67 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.419 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.7 t -174.1 -175.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 112.093 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.0 m-70 -116.68 -163.25 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.005 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.06 126.7 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.795 -179.598 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.44 10.55 29.96 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.09 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.1 tptm -63.27 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.502 ' OG1' ' HE3' ' A' ' 79' ' ' LYS . 5.0 m -46.55 98.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.907 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -90.89 94.8 9.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.031 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.9 tt0 -83.77 128.3 34.44 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.282 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.535 HG21 ' HG ' ' A' ' 26' ' ' LEU . 55.5 mt -133.57 103.42 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.048 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -87.89 119.11 27.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.535 ' HG ' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -118.64 151.66 37.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -178.554 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -125.59 157.9 35.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 163.85 -43.22 0.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.436 -1.364 . . . . 0.0 114.195 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 121.067 0.461 . . . . 0.0 110.009 -177.656 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 60.2 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.75 0.309 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 15.9 ttm -161.31 150.55 16.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.062 0.458 . . . . 0.0 111.053 -179.606 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -106.49 84.72 2.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.042 178.102 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.602 HG23 ' HA ' ' A' ' 42' ' ' VAL . 6.4 t -136.63 -165.85 1.8 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.329 -178.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -86.69 155.68 20.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.906 0.384 . . . . 0.0 111.636 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 89' ' ' GLU . 43.6 t -72.82 132.4 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.84 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.43 85.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.625 179.618 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -132.53 -4.61 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 0.0 110.503 -179.903 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.602 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.7 t -53.65 111.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.039 179.314 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.954 -179.471 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 18.8 mt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.506 ' HB3' HG22 ' A' ' 54' ' ' VAL . 76.9 p -67.53 -168.6 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -151.19 -86.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.16 -31.33 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.274 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -72.3 -83.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.475 -179.495 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.686 HD21 HG11 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -99.95 107.03 18.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.65 179.767 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 35.5 tt0 -60.43 142.89 54.44 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.276 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -144.66 85.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.304 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.2 t -86.06 83.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.425 0.631 . . . . 0.0 109.353 178.12 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 76' ' ' VAL . 9.2 t -102.18 133.51 46.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.447 -178.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -116.12 120.84 40.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.303 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CZ ' ' HE1' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -90.88 95.37 10.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.245 179.512 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -95.61 108.1 37.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.721 -179.122 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 56.5 Cg_endo . . . . . 0 N--CA 1.447 -1.24 0 C-N-CA 123.582 2.854 . . . . 0.0 111.283 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.08 0.466 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 9.7 m-85 -145.04 95.42 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.892 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.97 126.29 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.257 0.551 . . . . 0.0 110.655 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -123.06 122.76 66.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.18 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 79.4 mt -105.33 94.25 5.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.134 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.686 HG11 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -92.63 101.57 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.099 0.475 . . . . 0.0 110.756 -179.186 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HE3' ' OG1' ' A' ' 21' ' ' THR . 11.2 mttt -102.11 102.62 25.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.454 -179.326 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' HD22 ' A' ' 52' ' ' LEU . 41.5 Cg_exo -56.12 95.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.132 1.888 . . . . 0.0 112.157 179.388 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 68.9 mtt180 -67.43 -28.15 67.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 65.5 mttm -128.89 173.35 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.436 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -113.46 137.91 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.587 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.56 -136.7 6.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.183 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.458 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 62.0 m80 -99.32 91.68 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 110.742 179.853 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.548 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.7 m-70 -111.28 164.48 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.592 -179.899 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.48 HG21 ' N ' ' A' ' 88' ' ' LEU . 32.4 m -158.75 157.99 32.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 0.0 111.823 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.8 tp -124.02 88.49 2.92 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB3' HG22 ' A' ' 39' ' ' VAL . 39.4 mt-10 -74.25 101.28 3.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.246 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.496 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 75.9 mt -107.38 139.2 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.323 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.93 166.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.149 0.499 . . . . 0.0 112.087 -179.248 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -106.16 84.26 2.02 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.178 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.507 ' HB ' HG21 ' A' ' 99' ' ' ILE . 7.5 t -126.66 159.86 32.43 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -176.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.0 mtp180 -93.23 100.76 4.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.537 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 93' ' ' THR . 82.7 Cg_exo -34.14 -42.96 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.485 2.79 . . . . 0.0 113.972 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.42 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -80.6 -52.94 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.038 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -70.56 4.98 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.83 -169.26 54.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.931 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.507 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -115.03 155.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.267 0.556 . . . . 0.0 112.256 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 49.5 mtmt -147.0 158.75 44.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.349 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 20.3 Cg_endo -60.86 -34.65 90.97 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.735 2.29 . . . . 0.0 112.684 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.18 -11.88 4.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.838 -179.704 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -71.04 140.51 50.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 111.441 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -55.45 161.99 1.74 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.608 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.5 tpp180 -122.94 160.61 25.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.608 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 42.2 t80 -173.63 66.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.887 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 8.7 m -87.01 92.02 8.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.333 -178.881 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 69.6 tp -72.26 94.46 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.185 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.5 m-70 -78.56 142.74 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.076 0.465 . . . . 0.0 110.709 179.443 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 93.6 mt -142.69 109.18 5.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -178.038 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -81.73 66.95 7.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.587 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.41 110.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.357 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.934 -179.89 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 107' ' ' THR . 6.4 m-20 -151.82 -146.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.401 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -133.89 -170.23 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.701 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 12.5 m0 -130.86 123.95 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.806 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 109' ' ' HIS . 16.4 m -147.88 154.5 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -178.607 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.4 p-10 -51.02 168.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.83 -179.404 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 t -171.36 -168.96 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.803 -179.5 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.1 m80 -104.03 -175.98 2.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.767 0.318 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -96.89 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.142 0.496 . . . . 0.0 111.897 -179.27 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.25 15.5 5.54 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.416 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -66.39 79.2 0.1 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.023 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.47 HG21 HD23 ' A' ' 77' ' ' LEU . 4.4 m -44.06 101.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.751 -178.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -96.25 101.84 13.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.621 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -80.71 130.06 34.87 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.659 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.496 HG21 ' HG ' ' A' ' 26' ' ' LEU . 46.2 mt -132.86 105.61 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.873 -179.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -89.23 96.04 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HG ' HG21 ' A' ' 24' ' ' ILE . 14.7 mt -90.29 146.01 24.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.303 -179.046 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -100.57 161.31 13.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.44 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.56 -145.02 8.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.441 -179.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.999 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.154 0.502 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.63 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 2.0 ttt -147.88 154.03 39.88 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.739 -179.091 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.463 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.5 m95 -110.19 93.28 4.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.196 178.921 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.63 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 15.1 t -137.25 -168.46 2.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.0 mtp85 -87.62 140.34 29.62 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.549 HG23 ' HB ' ' A' ' 91' ' ' VAL . 13.2 t -60.96 130.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.778 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.65 75.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -137.66 0.73 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 110.432 -179.797 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 37' ' ' THR . 21.5 t -54.39 111.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.147 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.04 -179.694 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.4 mt . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.112 0.482 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.455 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.0 p -52.66 175.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.691 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.12 -85.43 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.77 -31.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.299 -179.315 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.5 mm -70.2 -72.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.359 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 80' ' ' PRO . 92.0 mt -111.5 121.47 45.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 68.0 0.37 Allowed 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 38' ' ' ARG . 5.8 t -75.62 86.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.42 -178.536 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.0 87.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 76' ' ' VAL . 30.5 t -105.44 141.24 37.28 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.992 -178.1 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -130.84 115.81 17.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.744 179.033 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.529 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -83.54 113.96 21.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.736 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.6 m -112.72 111.56 51.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 N--CA 1.451 -0.998 0 C-N-CA 123.522 2.815 . . . . 0.0 112.109 179.563 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.1 pt . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -130.94 100.48 5.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.183 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 110.746 -179.467 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 88' ' ' LEU . 22.0 t -119.38 120.39 63.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.549 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.47 HD23 HG21 ' A' ' 21' ' ' THR . 72.4 mt -109.58 97.61 7.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.729 178.203 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -93.98 105.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.987 0.422 . . . . 0.0 111.24 -178.721 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -105.78 103.3 43.23 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.035 -179.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' HG23 ' A' ' 112' ' ' VAL . 73.1 Cg_exo -48.41 99.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.738 2.292 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -76.85 -33.76 57.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.767 178.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.76 161.14 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 96.3 mtt180 -103.64 124.53 49.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 146.78 -167.95 28.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -63.49 100.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -135.91 161.01 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.24 0.543 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.525 HG23 ' HE1' ' A' ' 13' ' ' TRP . 47.0 m -165.24 146.27 7.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.52 -179.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 42.2 tp -78.68 105.28 9.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.949 178.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.0 97.33 9.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.418 179.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 25.5 mt -104.22 169.93 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 9.1 p -165.88 150.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.036 -179.017 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.1 t80 -101.28 91.69 4.62 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.37 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.528 ' HG1' ' H ' ' A' ' 94' ' ' ARG . 1.7 t -126.53 164.93 20.11 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.45 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' H ' ' HG1' ' A' ' 93' ' ' THR . 58.4 mtp180 -101.38 91.85 2.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.536 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 93' ' ' THR . 58.7 Cg_exo -39.69 -35.43 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.0 2.467 . . . . 0.0 113.014 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.77 85.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.97 -88.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -163.95 -179.28 38.13 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.053 -179.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 22.2 mt -93.26 -60.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.528 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 34.7 mtmt 69.15 159.59 0.15 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 83.7 Cg_endo -76.71 -34.77 2.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 123.137 2.558 . . . . 0.0 112.388 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.63 -35.77 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -54.91 151.7 8.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.96 0.41 . . . . 0.0 111.611 -179.786 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 91' ' ' VAL . 3.8 tt0 -65.35 178.23 0.97 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -159.25 164.36 35.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.097 -179.482 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.603 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 23.4 t80 -147.01 113.93 6.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.992 0.425 . . . . 0.0 109.973 178.318 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.563 HG22 ' HE ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -103.72 128.65 51.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.308 -178.604 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.555 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 33.2 tp -98.87 108.27 20.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 4.5 p80 -50.4 72.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.747 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.555 ' HG ' ' HG ' ' A' ' 108' ' ' LEU . 94.5 mt -110.22 64.37 0.61 Allowed 'General case' 0 C--N 1.342 0.251 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 42.4 t30 -79.58 51.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -28.36 136.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.462 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.66 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.545 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.4 OUTLIER -25.26 105.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.658 -179.251 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HD3' HD11 ' A' ' 108' ' ' LEU . 75.4 tttt -101.39 98.36 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.648 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.8 m95 -85.52 103.2 14.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.416 -178.64 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.504 HG21 HD21 ' A' ' 110' ' ' LEU . 26.9 m -149.14 -167.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.671 -179.389 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -108.08 -168.99 1.44 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 179.805 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 15' ' ' ASP . 1.5 t 174.24 -173.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.606 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.7 m80 -120.65 -176.27 3.2 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.099 179.126 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.7 137.67 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.25 0.548 . . . . 0.0 111.999 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.09 16.86 34.91 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.598 179.501 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.2 tptm -57.7 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.091 0.445 . . . . 0.0 110.042 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.468 HG21 HD23 ' A' ' 77' ' ' LEU . 2.9 m -57.2 94.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.25 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -95.57 105.92 17.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.002 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.8 tt0 -85.81 124.98 32.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.851 179.497 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 74' ' ' TYR . 51.7 mt -126.46 101.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.014 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.468 ' ND1' HD13 ' A' ' 73' ' ' ILE . 13.9 m170 -86.57 109.95 19.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 18.8 mt -99.14 176.51 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.98 0.419 . . . . 0.0 111.098 -179.173 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -119.98 169.87 9.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.131 179.26 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.34 -159.07 31.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.717 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 t30 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.402 0.144 . . . . 0.0 110.81 179.824 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.989 0.423 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 14.0 ttm -109.47 149.89 28.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.604 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . 4.2 m95 -108.82 83.78 1.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.708 178.29 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 42' ' ' VAL . 14.1 t -125.51 -168.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.561 ' NH1' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -83.61 134.5 34.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.906 0.384 . . . . 0.0 111.512 -178.941 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 41' ' ' PHE . 33.6 t -52.57 136.58 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.8 -23.52 1.06 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.51 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 39' ' ' VAL . 11.7 m-30 -100.19 21.08 13.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 110.159 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 37' ' ' THR . 20.1 t -76.34 106.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.725 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.032 -179.638 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 56' ' ' CYS . 20.6 mt . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 80.6 p -50.55 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.42 178.485 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.09 -96.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.368 179.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -127.24 -32.76 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -73.67 -75.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 80' ' ' PRO . 14.6 mt -103.28 115.58 30.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.315 179.498 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -69.44 71.45 0.3 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.768 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 HG12 ' NE ' ' A' ' 38' ' ' ARG . 2.1 t -74.3 87.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.324 -178.805 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.2 t -88.33 86.62 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.488 178.127 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' HB3' HD11 ' A' ' 47' ' ' LEU . 29.6 t -110.41 153.82 24.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.743 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -136.9 118.13 14.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.273 179.34 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.422 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -80.34 94.77 6.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -99.58 104.48 27.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.356 -179.369 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.449 -1.128 0 C-N-CA 123.289 2.659 . . . . 0.0 111.847 -179.559 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.468 HD13 ' ND1' ' A' ' 25' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.514 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 23.9 m-85 47.31 75.94 0.12 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.326 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 75' ' ' VAL . 4.9 p -92.04 101.44 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.179 0.514 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG23 HH22 ' A' ' 38' ' ' ARG . 17.3 t -99.67 117.29 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' HA ' HD21 ' A' ' 77' ' ' LEU . 64.4 mt -107.38 94.58 5.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.105 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -90.98 112.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.023 0.439 . . . . 0.0 111.297 -178.809 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.6 mtmt -113.15 94.25 29.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.2 Cg_endo -47.58 103.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.579 2.186 . . . . 0.0 112.669 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.459 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.7 mtt180 -67.46 -33.68 75.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.541 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 82.0 mttt -119.29 -176.06 3.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.53 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -127.8 121.59 30.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 154.54 -106.98 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -105.58 99.74 9.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.6 m80 -128.67 150.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.47 ' HG1' ' HA ' ' A' ' 109' ' ' HIS . 91.4 m -158.17 147.72 19.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.96 0.409 . . . . 0.0 111.935 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.9 tp -98.31 84.82 3.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.568 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 46.4 mt-10 -69.64 99.11 1.26 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 21.6 mt -110.57 151.77 27.22 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.937 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 39' ' ' VAL . 3.6 p -154.79 146.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.632 -178.606 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' MET . 12.4 t80 -95.67 78.04 3.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.4 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 99' ' ' ILE . 5.4 t -118.45 159.65 23.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -98.43 98.17 5.55 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.605 178.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.3 Cg_exo -40.78 -34.51 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.079 2.519 . . . . 0.0 113.105 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -68.93 -62.95 1.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.003 -179.416 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.73 4.53 9.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.304 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.03 -164.74 37.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.081 -179.562 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.516 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 7.6 mt -113.04 121.02 64.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.976 -179.198 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -107.76 162.74 18.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.36 -37.47 17.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.663 2.242 . . . . 0.0 112.393 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.4 -17.59 8.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.743 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.75 142.29 56.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 111.473 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.42 173.55 1.18 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.599 179.429 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.703 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.8 tpp180 -135.89 163.07 31.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.265 -179.211 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.703 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 13.4 t80 -169.76 74.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 177.152 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -95.94 93.3 6.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.729 -178.851 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.3 tp -76.73 88.65 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 110.24 179.291 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.648 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.0 m-70 -72.38 144.06 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 14' ' ' VAL . 64.5 mt -146.37 113.31 6.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.123 -178.35 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.3 t30 -83.34 55.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.491 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.456 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -35.64 126.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.743 -178.871 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.928 179.952 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.132 0.491 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.55 103.52 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.698 -179.284 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 90.48 7.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.889 179.198 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.633 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.7 m95 -73.67 99.12 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.715 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 10.9 p -156.49 169.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 m-20 -85.75 -173.25 4.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -175.51 -172.06 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.244 0.545 . . . . 0.0 112.375 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.9 m80 -118.11 -160.12 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.709 178.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.409 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.1 t -101.16 132.64 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 111.764 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.404 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.4 17.85 13.31 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.203 179.758 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.1 tptt -63.89 84.07 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.151 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 HD23 ' A' ' 77' ' ' LEU . 6.1 m -47.84 101.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.674 -178.957 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 m -97.51 100.77 12.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.562 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.82 134.0 36.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' A' ' 26' ' ' LEU . 40.2 mt -138.34 104.38 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.964 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -84.18 96.58 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' A' ' 24' ' ' ILE . 13.6 mt -95.88 148.01 23.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 -178.583 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.623 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 5.7 mtpm? -113.54 162.12 16.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.149 179.175 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.29 -23.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.545 -179.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.463 0.173 . . . . 0.0 111.016 179.926 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.015 0.436 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.561 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.7 ttt -141.32 148.69 40.15 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.081 -179.814 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -104.56 83.5 2.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.849 178.916 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.558 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 14.6 t -127.43 -168.91 1.95 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.23 -179.261 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 1.9 mtp180 -85.63 135.85 33.62 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.31 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 91' ' ' VAL . 40.9 t -48.63 150.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.068 -179.254 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.81 1.3 4.83 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.595 179.745 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 39' ' ' VAL . 23.2 m-85 -125.91 32.48 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.449 0.642 . . . . 0.0 110.614 -179.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' A' ' 93' ' ' THR . 2.1 p -60.26 100.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.994 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.678 179.893 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.9 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.902 0.382 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.421 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.5 p -46.66 172.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.255 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -154.19 -84.82 0.07 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.416 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -130.65 -33.33 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.399 -179.202 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -70.5 -78.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.437 -179.53 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -103.16 116.01 31.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.452 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.66 69.83 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.673 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 78' ' ' VAL . 20.6 t -76.62 84.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG11 ' HE2' ' A' ' 57' ' ' LYS . 21.0 t -79.41 86.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.284 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.91 142.14 31.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.434 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE2' HG11 ' A' ' 55' ' ' VAL . 72.4 mmtt -133.41 108.96 9.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.072 179.402 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -78.76 100.63 7.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.259 179.564 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.2 m -93.57 108.2 32.33 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.831 -179.056 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 77.5 Cg_endo . . . . . 0 N--CA 1.444 -1.416 0 C-N-CA 124.109 3.206 . . . . 0.0 111.434 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.159 0.504 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -134.56 97.16 3.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.226 -179.779 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.54 102.98 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.501 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 90' ' ' LEU . 40.2 t -105.55 124.06 60.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD23 HG23 ' A' ' 21' ' ' THR . 85.9 mt -113.17 102.95 10.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.669 178.13 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.49 110.4 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.438 . . . . 0.0 111.428 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.6 mtmt -115.32 96.04 44.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.0 Cg_endo -50.99 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.38 2.054 . . . . 0.0 112.403 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 13.6 mtt180 -74.22 -38.11 63.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.536 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 62.1 mttm -111.4 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.142 -179.069 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -112.01 144.2 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.68 -119.74 2.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -110.58 117.42 33.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 3.1 m80 -132.85 159.06 40.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -159.39 142.41 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.3 tp -99.36 92.14 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.7 mt-10 -72.51 99.35 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 33.8 mt -113.72 128.87 56.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.316 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 39' ' ' VAL . 10.7 p -134.55 158.25 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.799 -178.713 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -97.15 82.38 3.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.977 178.605 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.582 HG23 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -101.77 177.07 5.01 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.458 ' HB2' ' H ' ' A' ' 98' ' ' GLY . 61.4 mtp180 -110.25 94.05 17.37 Favored Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.022 179.544 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 81.3 Cg_exo -50.81 -29.2 25.59 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.52 2.146 . . . . 0.0 112.441 179.431 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -79.89 -31.14 40.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.459 -179.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.26 -77.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.932 0.396 . . . . 0.0 111.361 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 174.22 -173.94 46.2 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.007 -179.331 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.411 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.3 mt -93.1 149.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.855 0.359 . . . . 0.0 111.026 -179.471 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.469 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -138.95 168.18 16.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.978 -179.264 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.61 -28.06 4.58 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 112.156 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -78.44 11.62 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.675 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -93.4 150.11 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.342 -179.419 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 163.88 8.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.4 tpp180 -130.96 164.11 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.649 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.637 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.9 t80 -174.4 76.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 109.558 177.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.75 88.78 5.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.389 -179.18 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 22.1 tp -67.6 90.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 0.0 110.472 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -73.4 133.91 43.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.662 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.2 mt -141.4 102.86 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.273 -178.191 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -78.64 85.76 4.66 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 17' ' ' HIS . 18.3 t -55.11 112.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.284 -179.062 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.009 179.877 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.622 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.732 . . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' H ' HD21 ' A' ' 10' ' ' ASN . 7.8 m-20 -30.17 104.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.617 -179.672 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -93.11 89.86 6.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.548 179.489 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.04 101.22 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 110' ' ' LEU . 22.8 m -149.29 -175.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.237 0.541 . . . . 0.0 112.167 -178.849 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.4 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.53 -173.71 2.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.295 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.3 t -174.45 -175.75 1.0 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.226 0.536 . . . . 0.0 112.187 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.8 m80 -116.82 -162.24 0.84 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.882 179.23 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.53 122.52 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.069 0.462 . . . . 0.0 111.634 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.2 10.69 35.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.14 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptp -62.81 84.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.061 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.453 HG21 HD23 ' A' ' 77' ' ' LEU . 7.7 m -45.39 100.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.807 -178.7 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 m -91.64 102.96 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.28 179.389 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 41.6 tt0 -86.43 132.18 34.01 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.339 -179.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.433 HD13 HD23 ' A' ' 108' ' ' LEU . 37.3 mt -139.2 104.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.413 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -79.62 95.76 5.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.777 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 28.8 mt -88.75 143.95 26.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.444 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 166.08 11.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.873 0.368 . . . . 0.0 110.627 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.89 -150.99 13.04 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 -179.947 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 93' ' ' THR . 87.9 m-85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.116 0.484 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.504 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 7.1 ttm -147.51 148.89 31.68 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.009 -179.615 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -93.67 81.48 4.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.218 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.424 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 1.7 t -125.4 146.83 49.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.527 -177.766 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HD3' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -53.39 177.34 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.981 0.419 . . . . 0.0 110.623 179.428 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 89' ' ' GLU . 42.8 t -81.78 102.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.522 -179.773 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.5 -12.92 56.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.527 179.236 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.594 ' CD1' ' C ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -73.92 -42.01 61.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 117.45 0.625 . . . . 0.0 110.599 -179.741 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.519 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.0 p -26.7 90.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.138 0.494 . . . . 0.0 111.06 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . . . . . . 0 CA--C 1.522 0.518 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -178.478 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 56' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.277 0.56 . . . . 0.0 110.125 . . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.565 ' HB3' HG21 ' A' ' 54' ' ' VAL . 81.1 p -64.19 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.781 -179.734 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.51 -80.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.71 -31.29 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.513 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.3 mm -74.35 -86.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.622 -179.465 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.658 HD21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -97.86 109.1 21.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.267 179.803 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.597 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 1.3 tm-20 -62.24 147.46 47.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.052 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 48' ' ' SER . 11.5 t -146.36 133.84 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.594 -179.548 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.6 t -137.87 86.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 178.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.499 ' SG ' HG23 ' A' ' 76' ' ' VAL . 42.0 t -93.94 97.58 10.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.784 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.605 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 81.7 mttt -72.65 73.71 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.35 178.844 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.53 ' HD1' ' C ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -64.24 103.71 0.66 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.473 179.8 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -108.37 125.04 32.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.436 178.658 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.452 -0.936 0 C-N-CA 123.031 2.487 . . . . 0.0 113.047 -178.716 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -136.31 100.71 4.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.094 -179.989 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 62.1 t -79.43 89.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 120.811 0.338 . . . . 0.0 110.893 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 88' ' ' LEU . 21.5 t -83.41 121.31 36.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 77.3 mt -117.02 98.29 6.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.081 178.304 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.658 HG11 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.12 110.69 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.827 -179.127 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 42.9 mtmt -110.97 102.58 53.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.959 -178.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 45.4 Cg_exo -54.77 100.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.353 2.036 . . . . 0.0 112.315 179.343 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.0 mtt180 -69.77 -42.26 74.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.545 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 66.3 mttm -112.24 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -117.62 142.83 46.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.749 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.1 -135.28 7.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.485 179.906 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.417 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.8 m80 -101.33 91.16 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 -179.989 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.8 OUTLIER -107.43 163.98 12.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.202 179.761 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.496 HG21 ' N ' ' A' ' 88' ' ' LEU . 85.6 m -160.89 155.09 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.14 0.495 . . . . 0.0 112.156 -179.574 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.534 HD22 HG12 ' A' ' 76' ' ' VAL . 14.9 tp -125.64 96.26 4.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.832 178.961 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HA ' HG21 ' A' ' 107' ' ' THR . 5.5 mt-10 -84.36 99.38 10.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.868 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 33.4 mt -95.88 129.26 43.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.364 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.465 HG12 HG22 ' A' ' 99' ' ' ILE . 11.2 p -130.83 157.19 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.064 0.459 . . . . 0.0 112.097 -178.58 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -100.93 95.02 6.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.595 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.56 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.0 t -117.2 167.65 11.01 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.73 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.481 ' H ' ' HG1' ' A' ' 93' ' ' THR . 77.1 mtp180 -103.2 93.67 4.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.796 178.507 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -48.91 -29.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.867 2.378 . . . . 0.0 112.961 -179.617 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -77.77 10.37 2.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -150.55 -72.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.09 0.472 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.66 175.34 36.78 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.539 -179.518 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.474 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.9 mt -94.24 150.79 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.08 0.467 . . . . 0.0 111.604 -179.123 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -137.53 166.88 23.24 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.3 -48.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.344 2.696 . . . . 0.0 112.498 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.37 -18.15 10.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.683 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.8 m120 -62.56 162.86 9.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.784 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 161.26 5.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpp180 -135.05 164.28 27.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.57 -178.605 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.647 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.4 t80 -174.29 67.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.248 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 89' ' ' GLU . 12.4 m -87.34 97.81 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.559 -178.828 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.526 HD21 HG22 ' A' ' 78' ' ' VAL . 63.2 tp -76.56 88.06 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 12.7 m-70 -73.81 142.94 46.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 179.424 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.413 HD23 ' HB ' ' A' ' 16' ' ' THR . 91.2 mt -143.71 108.6 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.692 -178.056 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.4 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.8 t-20 -81.48 72.23 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 17' ' ' HIS . 1.6 t -53.09 122.84 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.667 -178.235 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.071 179.757 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.81 100.42 12.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.148 0.499 . . . . 0.0 111.636 -179.178 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' O ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -109.67 61.72 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.497 179.132 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.664 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 m0 -78.73 112.55 15.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -178.008 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 34.8 m -150.24 -166.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 -178.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.42 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.5 OUTLIER -96.05 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.696 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 112' ' ' VAL . 2.7 t 177.82 -174.51 0.15 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.143 0.497 . . . . 0.0 112.059 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.556 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 67.7 m-70 -118.55 -160.98 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.761 179.212 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.7 121.86 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 111.34 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 64.45 16.98 61.46 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.062 179.84 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -58.09 91.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 HD23 ' A' ' 77' ' ' LEU . 6.9 m -56.73 101.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.482 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 m -100.81 99.21 9.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.663 179.642 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 38.1 tt0 -78.66 137.12 37.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.789 179.731 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.92 102.57 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -83.49 112.9 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.695 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 37.4 mt -108.62 154.28 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -178.315 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -110.89 155.68 22.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.98 179.333 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.578 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 176.26 -19.3 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.505 -179.229 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.1 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.517 0.199 . . . . 0.0 110.598 -179.918 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 16.5 ttm -123.88 150.89 44.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.3 m95 -109.24 84.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.769 178.545 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 42' ' ' VAL . 7.0 t -132.38 -164.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 -179.124 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 19.0 mtp85 -92.75 121.69 34.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 0.0 110.474 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.3 p -51.9 140.07 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.67 -6.76 81.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.714 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -128.31 1.16 5.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.285 0.564 . . . . 0.0 110.187 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 37' ' ' THR . 15.4 t -56.08 119.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.064 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.913 -179.482 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.0 mt . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.9 p -52.89 -178.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.765 178.828 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -158.39 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.207 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.535 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -129.98 -29.02 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 11.6 mm -74.77 -76.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.283 -179.61 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.579 HD23 HG11 ' A' ' 78' ' ' VAL . 4.3 mt -102.4 115.27 30.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.299 179.154 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.38 69.52 0.24 Allowed 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.091 0.472 . . . . 0.0 109.94 178.062 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' N ' ' HB3' ' A' ' 48' ' ' SER . 18.4 t -74.32 81.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.018 -179.18 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -78.01 81.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.018 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.472 ' SG ' HG23 ' A' ' 76' ' ' VAL . 15.2 t -97.38 136.21 38.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.478 -178.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -126.7 113.75 17.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.858 179.189 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.489 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.32 107.19 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.732 179.826 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -99.11 109.33 53.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.702 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.453 -0.896 0 C-N-CA 123.336 2.691 . . . . 0.0 112.183 179.846 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.4 pt . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.578 ' HH ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -140.29 110.99 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.058 -179.619 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -103.48 113.8 41.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.55 . . . . 0.0 110.477 -179.672 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG23 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -109.02 125.77 66.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.499 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.429 HD23 HG23 ' A' ' 21' ' ' THR . 86.3 mt -110.05 101.36 10.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.021 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.579 HG11 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.0 111.11 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.976 0.417 . . . . 0.0 111.233 -178.786 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.9 mtmt -115.6 96.81 47.28 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.499 -179.435 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.447 ' HA ' HD21 ' A' ' 52' ' ' LEU . 5.5 Cg_endo -50.31 104.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.476 2.117 . . . . 0.0 112.656 179.752 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.535 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.4 mtt180 -71.24 -42.16 69.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.298 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -107.77 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -114.67 123.41 49.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.6 -101.78 0.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.488 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -143.72 91.58 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.546 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.3 m-70 -100.0 173.71 6.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 109' ' ' HIS . 53.8 m -160.53 150.51 17.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.781 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.597 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 36.4 tp -113.93 88.75 2.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 43.8 mt-10 -75.51 93.82 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.071 -179.634 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.597 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 62.8 mt -104.16 131.05 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.935 178.654 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 93' ' ' THR . 14.8 p -133.93 153.47 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.722 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.3 t80 -96.88 89.66 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.476 HG23 HG11 ' A' ' 91' ' ' VAL . 7.2 t -130.4 151.7 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.479 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.568 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.5 mtp180 -86.99 101.59 2.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.713 178.362 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HB3' HG11 ' A' ' 42' ' ' VAL . 1.6 Cg_endo -47.44 -36.63 24.14 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.871 2.381 . . . . 0.0 113.117 -179.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -87.72 18.9 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 17.3 mm-40 -149.75 1.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.433 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.69 178.66 51.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.122 -179.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.475 HG21 ' HB ' ' A' ' 93' ' ' THR . 7.5 mt -105.72 154.29 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.472 . . . . 0.0 111.872 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.607 ' HE3' HD22 ' A' ' 103' ' ' ASN . 42.8 mtmt -137.78 163.04 50.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.885 -179.574 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.1 Cg_endo -70.76 -38.41 5.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.782 2.322 . . . . 0.0 112.347 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.77 -24.59 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.607 HD22 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -54.73 148.1 13.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.398 -179.999 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.6 tt0 -56.31 163.28 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.584 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.3 tpp180 -132.59 163.59 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 65.1 t80 -174.03 74.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.239 177.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -95.09 106.81 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 -178.863 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.1 tp -93.02 91.4 7.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.664 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.1 m-70 -74.91 151.48 38.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.423 179.704 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.41 HD23 ' HB ' ' A' ' 16' ' ' THR . 95.5 mt -148.58 116.97 6.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -178.538 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.68 68.07 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.565 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -49.26 119.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.469 -178.684 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.999 179.995 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.509 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 4.2 p-10 -37.63 97.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.894 -179.5 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -107.26 93.53 4.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.436 179.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.651 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.2 m95 -88.96 105.03 17.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.12 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 110' ' ' LEU . 7.3 m -151.41 -175.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.997 -179.621 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 -176.33 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.417 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 17' ' ' HIS . 0.9 OUTLIER -174.82 -178.06 1.22 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 112.177 -179.807 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.8 m80 -114.14 -167.25 1.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.06 135.41 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.261 0.553 . . . . 0.0 112.046 -179.299 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.1 14.82 11.86 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.546 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptp -65.58 81.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 HG21 HD23 ' A' ' 77' ' ' LEU . 5.5 m -47.34 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.76 -178.785 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.8 m -94.97 98.13 10.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 179.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.74 132.85 37.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.988 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.459 HD13 HD23 ' A' ' 108' ' ' LEU . 39.5 mt -137.53 104.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.999 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.23 98.75 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.311 178.214 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 23.9 mt -94.31 145.12 24.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.613 -179.058 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 4.4 mptt -98.73 162.3 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.543 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.41 -141.72 6.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.267 -179.341 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.403 0.144 . . . . 0.0 110.873 179.855 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 121.103 0.477 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 6.0 ttm -146.7 153.17 39.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.166 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 m95 -105.53 94.92 5.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.843 178.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.58 HG23 ' HA ' ' A' ' 42' ' ' VAL . 9.2 t -140.83 -170.33 3.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.627 -178.938 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 9.9 mtp85 -86.62 157.07 19.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 89' ' ' GLU . 52.6 t -72.7 132.05 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.943 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.07 4.99 79.62 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.481 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.437 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 60.1 m-85 -127.17 -2.04 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.132 0.491 . . . . 0.0 110.45 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.58 ' HA ' HG23 ' A' ' 37' ' ' THR . 22.4 t -49.07 112.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.262 179.178 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.217 -179.734 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.3 mt . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 20.9 p -54.98 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.95 179.553 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -156.53 -86.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.329 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -132.12 -31.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.434 -179.132 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.5 mm -73.0 -78.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 7.1 mt -102.68 114.23 28.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.499 179.375 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.55 70.63 0.18 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.066 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' HD2' ' A' ' 38' ' ' ARG . 14.0 t -75.1 83.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.911 -179.1 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.0 t -78.42 82.67 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.39 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.0 t -94.56 139.51 31.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.277 -178.605 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -132.45 108.1 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.162 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -79.43 112.64 16.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.368 179.636 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 m -113.15 111.14 50.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.975 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 N--CA 1.446 -1.283 0 C-N-CA 123.735 2.956 . . . . 0.0 111.264 178.828 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.126 0.489 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -134.47 99.94 4.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.078 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.35 102.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.866 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 88' ' ' LEU . 40.8 t -104.74 119.85 54.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.202 -179.385 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 78.3 mt -109.69 98.15 7.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.208 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.33 103.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.038 0.447 . . . . 0.0 111.216 -178.706 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 7.1 mtmp? -106.15 104.41 49.63 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.267 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 51.1 Cg_exo -54.31 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.475 2.117 . . . . 0.0 112.567 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.572 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -64.5 -41.84 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.407 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 90.2 mttt -113.15 173.08 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -113.2 106.92 15.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.566 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 171.19 -123.82 1.07 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.47 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.413 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -103.56 98.32 8.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.564 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.15 158.43 22.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.725 179.998 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 88' ' ' LEU . 33.8 m -159.99 151.9 20.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 111.562 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.57 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 45.7 tp -117.05 91.18 3.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HB3' HG22 ' A' ' 39' ' ' VAL . 39.1 mt-10 -76.4 97.74 4.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.105 179.948 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.57 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.6 mt -108.5 133.54 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.918 178.521 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 167.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.135 0.493 . . . . 0.0 111.681 -179.379 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.9 t80 -106.4 89.09 2.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.728 178.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.497 ' HB ' HG21 ' A' ' 99' ' ' ILE . 5.7 t -118.29 170.08 9.19 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.59 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -102.56 95.1 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.0 Cg_exo -42.08 -36.87 4.18 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -40.77 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.963 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.8 -78.55 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.86 178.24 39.19 Favored Glycine 0 CA--C 1.508 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.497 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -93.22 153.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.935 0.397 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 39.0 mtmt -145.47 163.44 31.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.067 -179.07 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 19.2 Cg_endo -60.92 -37.84 74.08 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.718 2.279 . . . . 0.0 112.034 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.78 -23.86 67.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.6 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -51.7 136.02 27.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.146 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.6 tt0 -51.93 156.56 1.47 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 8.8 tpp180 -118.93 158.33 25.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.187 0.518 . . . . 0.0 112.057 -178.54 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.558 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 34.3 t80 -171.74 64.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.772 177.319 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 m -91.08 98.96 12.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.994 -179.278 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 35.0 tp -83.39 94.56 7.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.651 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 26.8 m-70 -79.24 141.41 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 14' ' ' VAL . 91.5 mt -145.17 105.66 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.482 -178.293 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 10.7 m120 -78.13 74.13 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.221 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.566 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -55.4 117.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 34.1 mmtp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.915 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 78.7 p -142.14 110.23 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.64 0.257 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 61.4 m80 59.34 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm -75.52 173.93 10.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.08 -25.91 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.05 88.23 0.13 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.254 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.5 121.22 7.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.492 2.128 . . . . 0.0 112.22 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HG ' ' H ' ' A' ' 7' ' ' VAL . 45.5 tp -75.02 147.27 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 m -86.74 12.03 11.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.145 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.574 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 4.9 t -110.67 6.57 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 110.906 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HE3' ' H ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -157.4 127.57 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.525 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -115.03 114.54 25.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.307 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.635 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -127.09 -89.26 0.55 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -26.12 105.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.424 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 89.69 6.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.921 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -74.15 98.85 3.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.622 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.479 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 6.6 p -155.34 177.32 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.479 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 3.4 p-10 -98.21 -175.24 3.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -173.76 -173.0 0.8 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 112.094 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.57 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m-70 -114.73 -167.35 1.21 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 30.6 t -94.0 135.23 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.137 0.494 . . . . 0.0 112.153 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.64 16.53 11.49 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.437 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.7 tptm -65.73 81.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.445 HG21 HD23 ' A' ' 77' ' ' LEU . 5.9 m -46.71 99.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.733 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.5 m -93.79 99.6 11.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.51 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.3 131.73 35.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.53 HG21 ' HG ' ' A' ' 26' ' ' LEU . 43.7 mt -134.67 103.97 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.731 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -86.02 95.51 9.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HG ' HG21 ' A' ' 24' ' ' ILE . 8.2 mt -92.95 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.302 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -101.6 168.52 9.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.47 -130.53 1.93 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.429 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -174.99 90.35 0.3 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.595 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HG3' ' HH ' ' A' ' 58' ' ' TYR . 74.0 Cg_exo -49.2 -18.94 2.29 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.695 2.263 . . . . 0.0 113.069 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -97.5 25.36 5.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.1 t -103.65 -34.03 8.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.206 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.55 -43.72 1.19 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.746 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -89.61 -176.78 5.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.118 0.485 . . . . 0.0 111.406 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.614 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 2.4 ttt -148.3 151.81 36.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.728 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.8 m95 -109.4 90.33 3.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.081 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.614 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 9.6 t -139.72 -166.58 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.375 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.2 mtp85 -92.23 124.21 36.13 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.797 0.332 . . . . 0.0 110.737 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.6 p -52.88 142.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.27 78.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.749 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.15 -0.65 5.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.499 . . . . 0.0 110.184 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 37' ' ' THR . 38.1 t -54.78 105.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.036 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.1 -30.04 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.101 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.601 ' HZ2' ' HB3' ' A' ' 44' ' ' LYS . 8.3 mtpm? -66.9 175.08 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.361 . . . . 0.0 110.993 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.88 -40.79 15.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.31 131.66 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.337 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.5 mt -84.41 -51.94 6.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.012 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.452 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 62.4 p -53.23 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.655 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.83 -86.61 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.47 -30.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.161 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.6 mm -74.04 -73.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.278 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.588 HD21 ' HA ' ' A' ' 80' ' ' PRO . 12.1 mt -104.96 116.02 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.344 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.33 68.81 0.36 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 109.902 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 38' ' ' ARG . 14.0 t -74.17 84.67 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.993 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.0 85.41 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 76' ' ' VAL . 34.6 t -102.63 142.69 33.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.69 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -133.01 113.59 12.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.987 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.554 ' HH ' ' HG3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -81.68 102.66 10.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.451 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.429 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 10.7 m -101.67 110.95 63.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.643 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB2' HG23 ' A' ' 70' ' ' VAL . 63.8 Cg_endo -99.88 41.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.539 2.826 . . . . 0.0 111.695 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.474 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -41.27 140.67 1.18 Allowed Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.779 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' HG23 ' A' ' 61' ' ' THR . 23.8 Cg_exo -63.55 -176.59 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 112.386 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -67.61 -172.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -63.26 -71.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.038 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 60.6 m -101.98 -48.36 0.18 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.896 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 12.6 Cg_exo -71.33 -161.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.842 2.361 . . . . 0.0 112.326 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.2 mtt -143.11 15.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.23 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 p -87.23 27.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.979 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.29 84.15 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.545 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 60' ' ' PRO . 14.5 p -82.41 50.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.507 0.67 . . . . 0.0 110.652 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.78 130.17 9.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.95 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -127.63 -119.67 2.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.167 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.4 pt -144.67 -166.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.483 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -131.37 98.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.95 106.64 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG22 HD12 ' A' ' 90' ' ' LEU . 29.7 t -110.0 120.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.445 HD23 HG21 ' A' ' 21' ' ' THR . 82.6 mt -110.13 100.97 9.79 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.765 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 105.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.048 0.452 . . . . 0.0 111.18 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -107.18 102.08 41.64 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.239 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.588 ' HA ' HD21 ' A' ' 52' ' ' LEU . 52.5 Cg_exo -51.44 97.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.681 2.254 . . . . 0.0 112.705 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.3 mtt180 -66.24 -43.26 87.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.319 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 86.9 mttt -114.85 173.74 6.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -108.97 125.07 51.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.798 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.568 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 155.04 -138.42 6.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.406 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.4 m80 -97.85 95.16 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.8 m-70 -112.07 162.18 15.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.498 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 109' ' ' HIS . 85.2 m -159.72 144.9 15.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 111.68 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 38.2 tp -101.0 92.66 5.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.026 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.4 mt-10 -75.13 88.51 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.481 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.594 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 48.2 mt -103.54 123.42 46.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG21 ' N ' ' A' ' 92' ' ' TYR . 13.1 p -126.19 158.49 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.5 t80 -102.34 91.85 4.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.327 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.567 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.5 t -122.45 167.46 13.3 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -101.07 94.89 4.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.41 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.9 Cg_exo -46.94 -28.77 7.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.252 . . . . 0.0 112.549 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -72.44 -42.62 64.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.312 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.19 -69.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.01 179.04 37.31 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.975 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.4 mt -98.4 140.84 17.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.959 0.409 . . . . 0.0 111.258 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 46.2 mtmt -140.39 159.44 63.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.194 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 30.6 Cg_endo -63.79 -36.32 51.83 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.917 2.411 . . . . 0.0 112.693 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.68 0.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.518 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -85.27 158.07 20.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.185 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 166.37 9.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.659 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.7 tpp180 -133.49 164.31 27.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.592 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.659 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 55.4 t80 -171.34 69.66 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.007 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -93.17 90.13 6.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.731 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 28.2 tp -70.59 89.96 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.326 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 36.8 m-70 -72.97 135.93 45.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.963 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 86.4 mt -140.1 103.97 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.541 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.5 t-20 -79.26 65.43 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.568 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -43.49 116.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.521 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.968 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -140.18 145.05 36.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -115.8 115.36 26.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm -133.82 -25.25 1.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ILE . 9.5 mt 58.96 14.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.04 152.06 77.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.003 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.89 144.99 64.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.529 2.153 . . . . 0.0 112.28 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.6 tp -125.02 -63.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.808 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.3 t -83.13 171.1 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.26 100.3 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -156.52 127.55 6.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.61 113.16 23.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.463 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.648 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -126.94 -86.57 0.59 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.565 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -25.15 107.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.776 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 108' ' ' LEU . 77.0 tttt -106.78 97.24 7.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.732 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 m95 -85.17 106.08 16.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.586 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.485 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 2.9 p -152.94 -178.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 112.454 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -103.56 -179.74 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.797 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.412 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.8 t -177.67 -171.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.793 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.6 m-70 -122.25 173.13 7.8 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.041 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG12 HH21 ' A' ' 83' ' ' ARG . 8.9 p -67.36 138.66 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.282 0.563 . . . . 0.0 112.163 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 62.05 11.65 32.98 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.872 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 18.9 tptt -60.04 83.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.236 0.518 . . . . 0.0 109.828 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.439 HG21 HD23 ' A' ' 77' ' ' LEU . 2.5 m -57.41 99.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.447 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -96.99 100.67 12.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.3 tt0 -83.24 133.86 34.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.984 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.405 HD13 HD23 ' A' ' 108' ' ' LEU . 39.3 mt -139.79 105.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.03 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -88.98 113.92 25.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.138 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.501 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 14.5 mt -109.48 147.36 33.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.274 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -100.68 161.19 13.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.895 0.379 . . . . 0.0 110.621 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.18 -155.14 25.62 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.456 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.616 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.6 t30 -172.04 118.95 0.43 Allowed Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HD3' ' HH ' ' A' ' 58' ' ' TYR . 37.0 Cg_endo -67.26 -64.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.478 2.118 . . . . 0.0 113.506 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.458 ' HB ' ' HA3' ' A' ' 69' ' ' GLY . 5.3 t -53.23 -22.91 7.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 29' ' ' ASN . 40.4 m -86.11 -67.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 111.203 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 -117.66 4.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.929 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 -111.42 -171.45 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.488 ' HE3' ' HB ' ' A' ' 37' ' ' THR . 8.0 ttt -108.98 151.54 26.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.432 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.3 m95 -109.54 103.07 11.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.619 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.488 ' HB ' ' HE3' ' A' ' 35' ' ' MET . 15.1 t -146.9 -174.05 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -77.38 138.22 39.18 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.219 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 HG23 ' HB ' ' A' ' 91' ' ' VAL . 98.0 t -54.1 134.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.586 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -33.63 1.52 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.581 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 39' ' ' VAL . 12.4 m-85 -87.55 25.13 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.651 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG22 HG22 ' A' ' 93' ' ' THR . 25.3 t -79.63 107.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.985 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.62 -19.71 25.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -65.86 170.17 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.976 0.417 . . . . 0.0 111.131 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.15 -24.18 30.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.173 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.02 138.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.2 mt -88.83 -53.43 4.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.681 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -51.04 177.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -154.16 -95.64 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 111.751 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.88 -31.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.119 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.5 mm -72.12 -70.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.579 HD21 ' HA ' ' A' ' 80' ' ' PRO . 16.2 mt -105.79 116.27 31.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.222 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -68.32 72.94 0.21 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG12 ' CZ ' ' A' ' 38' ' ' ARG . 3.8 t -76.44 84.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.304 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -81.51 82.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' HB3' HD11 ' A' ' 47' ' ' LEU . 11.1 t -108.71 147.9 31.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.426 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -138.87 125.4 20.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.516 ' HH ' ' HD3' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -81.33 97.08 7.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.925 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 116.05 65.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.443 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' HB2' HG13 ' A' ' 70' ' ' VAL . 87.1 Cg_endo -98.93 -160.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.231 2.621 . . . . 0.0 111.586 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.652 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -94.46 141.27 23.25 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.881 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.504 ' HD2' HG23 ' A' ' 61' ' ' THR . 38.3 Cg_exo -60.21 120.67 8.58 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -91.99 152.81 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -91.17 -28.86 17.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.618 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 65.8 m -156.94 -50.13 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.752 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 8.4 Cg_exo -73.42 -164.84 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 112.239 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 24.7 ttt -157.17 19.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.595 . . . . 0.0 110.089 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.46 116.49 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.084 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.458 ' HA3' ' HB ' ' A' ' 31' ' ' THR . . . 94.33 74.32 1.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.387 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.652 ' HB ' ' H ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -101.49 -111.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.274 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . 122.35 77.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.634 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -118.72 -130.07 4.1 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.171 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 3.4 pt -131.47 -165.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.05 0.453 . . . . 0.0 110.763 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.501 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -143.38 103.68 4.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.027 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.77 126.53 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.49 HG12 HD22 ' A' ' 88' ' ' LEU . 18.2 t -122.28 122.37 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.593 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 79.8 mt -109.94 96.4 6.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.851 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.35 105.38 16.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.239 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.4 mtmt -108.65 100.87 40.95 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HA ' HD21 ' A' ' 52' ' ' LEU . 72.2 Cg_exo -48.18 96.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.733 2.289 . . . . 0.0 112.992 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 4.8 mtt180 -63.41 -37.01 85.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.652 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -116.44 -173.85 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.466 HH21 HG12 ' A' ' 18' ' ' VAL . 97.5 mtt180 -132.77 119.22 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.86 -100.59 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.33 100.98 7.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.426 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -118.33 161.12 20.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.536 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -160.64 150.66 17.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.886 0.374 . . . . 0.0 111.76 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 20.6 tp -132.26 82.52 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.662 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.725 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -86.64 105.76 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 28.2 mt -89.81 167.09 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.769 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.439 ' HB ' HG23 ' A' ' 39' ' ' VAL . 3.6 p -155.2 147.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.918 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 7.7 t80 -97.88 82.62 3.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.564 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.473 ' HB ' HG21 ' A' ' 99' ' ' ILE . 9.9 t -121.99 158.24 29.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 27.1 mtp180 -101.17 101.15 15.31 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.326 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 93' ' ' THR . 78.1 Cg_exo -46.99 -39.45 25.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.752 2.301 . . . . 0.0 113.257 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 9.38 0.99 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.73 4.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 0.0 111.348 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.95 -171.74 51.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.797 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.473 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -112.15 150.14 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 111.86 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -135.42 164.17 45.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.81 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -19.79 13.0 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.543 2.162 . . . . 0.0 111.651 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.2 pt-20 -76.75 -0.11 22.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.7 m120 -82.21 149.41 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.44 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.9 171.5 1.19 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.2 tpp180 -136.9 159.5 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.664 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 36.0 t80 -162.21 72.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.874 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 22.7 m -85.51 151.33 24.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.866 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.4 tp -140.7 87.74 2.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.36 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.732 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 13.6 m-70 -74.69 144.11 43.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 85.5 mt -144.66 102.75 3.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.296 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -80.6 61.3 4.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -38.64 140.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.86 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.045 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.1 p -145.03 151.74 39.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -90.69 144.64 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -132.69 -177.15 4.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.32 -34.72 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.001 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.02 90.9 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.237 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.9 3.06 5.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.424 2.082 . . . . 0.0 112.376 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.419 ' N ' HD13 ' A' ' 5' ' ' LEU . 7.2 mp -62.06 -28.35 69.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.532 ' HB3' ' HZ3' ' A' ' 8' ' ' LYS . 47.7 t -76.25 171.97 13.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.84 134.1 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.382 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.532 ' HZ3' ' HB3' ' A' ' 6' ' ' SER . 13.9 mptt -107.88 26.84 9.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.025 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -38.39 118.38 0.71 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -114.3 -84.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.913 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' H ' HD21 ' A' ' 10' ' ' ASN . 8.6 m-20 -25.67 103.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.924 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 55.5 tptt -94.26 90.26 6.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.414 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.19 103.34 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 4.7 p -155.42 177.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.088 0.47 . . . . 0.0 111.83 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.476 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -100.07 -178.17 3.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.765 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.8 t -175.59 -174.75 0.72 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.119 0.485 . . . . 0.0 112.08 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.611 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.9 m80 -115.51 -170.02 1.69 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.22 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.56 139.46 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.239 0.542 . . . . 0.0 112.308 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.11 22.29 9.54 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.69 81.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.446 HG21 HD23 ' A' ' 77' ' ' LEU . 3.0 m -51.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.864 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -91.6 101.6 14.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.958 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -84.81 129.73 34.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.39 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.4 mt -139.66 98.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.87 106.32 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 11.3 mt -98.86 143.78 28.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.075 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -94.08 166.57 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.025 0.44 . . . . 0.0 110.806 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.81 -137.01 3.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.078 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.412 ' HB3' HG22 ' A' ' 32' ' ' THR . 63.3 t30 -176.97 99.23 0.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.424 0.154 . . . . 0.0 110.615 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 17.9 Cg_endo -60.02 -6.22 4.67 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.636 2.224 . . . . 0.0 113.099 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 p -96.89 12.11 33.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.588 0.232 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 29' ' ' ASN . 60.3 p -102.0 -66.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.137 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.97 -55.46 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.95 169.86 10.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 111.06 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 20.9 ttm -143.87 148.81 35.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.175 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 4.6 m95 -106.1 78.47 1.31 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.987 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 42' ' ' VAL . 12.0 t -125.73 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.4 mtp85 -88.61 156.42 19.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 89' ' ' GLU . 47.4 t -74.39 130.21 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.05 12.23 79.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.525 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.501 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 61.8 m-85 -135.25 -1.55 2.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.088 0.471 . . . . 0.0 110.578 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.609 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.7 t -53.85 117.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.02 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.36 -28.81 13.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.873 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 95.6 mttt -69.16 172.83 6.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -78.24 -62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.87 142.94 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.194 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt -94.64 -51.2 4.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.85 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.6 p -52.32 179.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.745 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.25 -90.98 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.7 pt-20 -130.12 -28.82 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.181 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.1 mm -76.85 -73.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.335 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 80' ' ' PRO . 12.0 mt -103.94 115.52 30.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.539 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -71.02 69.38 0.48 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.502 HG23 ' HD2' ' A' ' 38' ' ' ARG . 10.8 t -75.92 88.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.091 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 39.4 t -86.27 90.11 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 52.0 t -95.38 144.64 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.94 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 75.7 mttt -130.56 92.63 3.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.887 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 58' ' ' TYR . 3.3 t80 -57.7 -17.8 17.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.321 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.448 HG23 HG11 ' A' ' 70' ' ' VAL . 29.9 m 31.57 78.09 0.31 Allowed Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.971 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -102.36 7.03 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 124.182 3.255 . . . . 0.0 113.298 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.473 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.44 136.91 85.63 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.473 ' HD2' HG23 ' A' ' 61' ' ' THR . 88.7 Cg_endo -78.22 122.27 5.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.505 2.136 . . . . 0.0 112.464 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 55.9 m -79.57 142.59 35.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.939 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 m -109.68 -39.64 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.709 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 26.6 m -155.3 -53.46 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.601 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 40.1 Cg_endo -99.45 -149.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.86 3.04 . . . . 0.0 112.144 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.414 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 65.9 mtt 59.17 97.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.015 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.82 135.35 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 39.29 11.87 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG11 HG23 ' A' ' 59' ' ' THR . 72.8 t -140.37 81.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.449 . . . . 0.0 110.818 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.39 13.95 1.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.099 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.31 68.38 0.8 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.249 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.6 pt -114.43 -152.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -150.26 82.14 1.37 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.609 0.242 . . . . 0.0 110.782 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 93.3 t -79.91 91.9 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.062 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG22 HD12 ' A' ' 90' ' ' LEU . 40.4 t -90.05 118.67 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD23 HG21 ' A' ' 21' ' ' THR . 79.1 mt -110.53 95.12 5.37 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -90.6 104.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -178.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.0 mtmm -110.16 93.9 16.72 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.086 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HA ' HD21 ' A' ' 52' ' ' LEU . 4.1 Cg_endo -48.6 100.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.594 2.196 . . . . 0.0 112.549 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.517 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.0 mtt180 -64.63 -32.67 74.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.998 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 55.8 mttm -120.91 -175.38 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.634 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.51 117.45 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.05 -107.56 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.251 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.452 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.0 m80 -116.48 91.6 3.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.452 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -111.78 157.69 20.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.576 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 109' ' ' HIS . 47.0 m -159.47 146.04 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.1 tp -112.86 92.38 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.552 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.7 mt-10 -78.44 94.95 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.197 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 67.7 mt -101.8 135.03 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -140.11 154.26 23.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 0.0 112.09 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.11 94.13 6.65 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.959 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.555 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 7.6 t -129.72 157.13 43.02 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 79.3 mtp180 -91.64 99.93 2.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.859 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.6 Cg_exo -37.93 -56.49 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.261 2.641 . . . . 0.0 113.732 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 8.2 p90 -78.15 23.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.7 mm-40 -149.9 0.87 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.38 50.44 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.498 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.2 mt -104.84 158.65 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.431 . . . . 0.0 111.933 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 13.1 mttt -135.26 165.99 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.883 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.11 -41.03 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.886 2.39 . . . . 0.0 111.974 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.47 -26.73 68.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -49.27 148.33 2.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.304 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.76 160.67 1.3 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.1 tpp180 -133.54 161.21 35.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.54 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.647 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.5 t80 -171.33 65.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 89' ' ' GLU . 9.0 m -87.35 94.66 9.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.39 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 36.2 tp -74.91 92.56 2.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.617 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.4 m-70 -77.55 138.48 39.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.3 mt -143.35 103.09 4.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.429 HD21 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.54 66.09 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -44.76 113.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.762 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.924 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.8 p -92.75 -24.13 18.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -126.77 161.58 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm -79.13 -175.52 4.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 pt -76.18 -5.3 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.18 145.81 51.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.86 165.0 12.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.531 2.154 . . . . 0.0 112.142 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 tp -166.88 -43.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -125.8 -155.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.559 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.4 m -55.03 171.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.063 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -164.62 131.26 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.665 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.44 123.56 22.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.648 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -123.87 -93.97 0.5 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.018 0.437 . . . . 0.0 112.041 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.82 102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.447 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -97.23 93.09 6.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.107 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -82.01 99.93 9.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.1 m -149.82 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 112.271 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.78 -163.71 1.06 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.133 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 112' ' ' VAL . 1.9 t 178.24 -175.04 0.17 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 59.0 m80 -120.73 -164.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.432 HG21 ' HG2' ' A' ' 83' ' ' ARG . 24.2 t -95.76 115.45 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 111.442 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 67.99 10.7 59.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.108 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.8 tptm -60.11 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.418 HG21 HD23 ' A' ' 77' ' ' LEU . 6.9 m -45.6 103.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.702 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.9 m -91.26 94.75 9.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.571 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -80.11 128.41 33.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.69 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -136.18 104.55 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.56 96.97 8.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.423 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 7.8 mt -91.12 140.89 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.196 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -98.98 165.31 11.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.51 -132.72 2.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' O ' HG21 ' A' ' 32' ' ' THR . 60.6 t30 -174.24 95.42 0.31 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.32 0.105 . . . . 0.0 110.767 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 12.1 Cg_endo -55.91 -13.66 9.36 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -101.62 21.82 13.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.404 HG21 ' O ' ' A' ' 29' ' ' ASN . 6.2 t -100.13 -31.68 11.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 134.86 -39.27 1.71 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -93.33 -175.43 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 0.0 111.371 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 10.1 ttm -149.09 149.25 30.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.802 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.49 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.5 m95 -103.23 85.31 2.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.894 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.5 t -137.23 165.46 26.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.596 HH11 HD22 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -61.37 132.89 54.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.905 0.383 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 41' ' ' PHE . 3.8 p -55.07 147.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.486 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.74 -8.03 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.278 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.693 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 21.8 m-85 -117.7 33.37 5.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 109.943 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 93' ' ' THR . 13.0 t -97.55 87.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.582 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.21 7.37 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -66.77 -160.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.537 -0.831 . . . . 0.0 111.722 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 5.8 m-20 -106.94 -41.12 5.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.639 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 t -152.8 118.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.963 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.574 HD22 ' HZ3' ' A' ' 44' ' ' LYS . 14.5 mt -55.0 -59.25 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.331 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 3.2 t -45.55 168.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.961 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.479 ' H ' ' HG ' ' A' ' 48' ' ' SER . 11.4 m-20 -157.53 -159.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.961 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 9.4 pt-20 -74.69 -29.82 61.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.854 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 13.9 mm -80.38 -74.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.325 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 80' ' ' PRO . 19.7 mt -104.42 109.28 21.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.527 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -68.43 75.59 0.26 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.601 ' N ' ' HB2' ' A' ' 48' ' ' SER . 1.7 t -82.58 91.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 23.3 t -92.88 95.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.784 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 47' ' ' LEU . 41.0 t -111.9 148.61 33.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.438 0.637 . . . . 0.0 112.151 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -126.17 110.28 13.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.559 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.517 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.87 102.81 11.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.566 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.424 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 30.8 m -104.67 116.51 60.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 30' ' ' PRO . 68.8 Cg_endo -98.0 12.3 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.042 2.495 . . . . 0.0 112.25 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.41 ' CG2' ' HD2' ' A' ' 62' ' ' PRO . 4.4 m -62.19 136.24 95.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' CG2' ' A' ' 61' ' ' THR . 11.3 Cg_endo -54.16 152.74 23.69 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.757 2.305 . . . . 0.0 112.368 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.6 m -72.57 -173.59 1.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.5 m -64.07 -42.84 96.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.1 p -85.53 155.04 59.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.302 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.21 -156.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.74 2.293 . . . . 0.0 112.141 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.4 mmm 61.17 17.61 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.73 110.71 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.92 100.87 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.337 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t 47.75 83.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 111.264 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.34 109.55 0.49 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.36 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -115.14 -125.56 4.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.821 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt -149.81 -165.19 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -132.74 98.07 4.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.063 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 80.5 t -84.37 103.42 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.951 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 HH22 ' A' ' 38' ' ' ARG . 33.0 t -102.3 123.28 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 77' ' ' LEU . 64.9 mt -112.68 93.45 4.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.538 HG23 HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -91.85 107.14 18.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.116 0.484 . . . . 0.0 111.102 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLY . 45.9 mtmt -108.96 95.15 16.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.462 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 52' ' ' LEU . 9.7 Cg_endo -53.06 102.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.153 1.902 . . . . 0.0 111.965 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.406 HH11 ' HA ' ' A' ' 50' ' ' GLU . 17.2 mtt180 -64.82 -45.33 86.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.52 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.572 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 58.8 mttm -106.32 173.56 6.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.041 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.432 ' HG2' HG21 ' A' ' 18' ' ' VAL . 59.4 mtp180 -109.42 142.64 40.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.558 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.03 -150.97 20.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -87.47 92.18 9.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.572 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.7 m-70 -108.77 156.18 19.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.436 HG21 ' N ' ' A' ' 88' ' ' LEU . 90.5 m -160.34 151.33 18.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.116 0.484 . . . . 0.0 111.851 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.596 HD22 HH11 ' A' ' 38' ' ' ARG . 13.8 tp -128.71 142.73 50.92 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 6.1 mt-10 -123.56 86.73 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.216 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.461 HD22 HH12 ' A' ' 38' ' ' ARG . 7.0 mp -75.5 125.77 29.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.073 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.435 HG21 ' N ' ' A' ' 92' ' ' TYR . 12.8 p -122.29 156.45 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.76 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -102.51 95.91 6.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.465 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.527 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 3.5 t -125.35 169.97 11.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -101.6 93.86 3.79 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.118 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -44.29 -27.76 2.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.777 2.318 . . . . 0.0 112.74 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.71 -46.22 59.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.472 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.82 -67.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.93 0.395 . . . . 0.0 111.262 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.41 172.48 27.73 Favored Glycine 0 CA--C 1.507 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.99 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.486 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.2 mt -86.15 139.31 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.932 0.396 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HB3' ' HZ2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -128.5 164.53 37.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.253 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 103' ' ' ASN . 11.5 Cg_exo -71.65 -35.19 8.14 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.038 2.492 . . . . 0.0 112.205 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.81 11.99 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.211 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.499 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -88.1 150.36 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.41 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.2 tt0 -54.43 162.36 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.584 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.648 ' HB3' HD21 ' A' ' 10' ' ' ASN . 15.0 tpp180 -131.93 163.9 27.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.273 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.604 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.9 t80 -174.3 71.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.036 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.5 m -84.4 101.67 12.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.504 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 78' ' ' VAL . 59.4 tp -79.05 89.46 4.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 4.6 m-70 -76.77 137.11 39.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.563 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.4 HD23 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -145.28 104.42 3.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.453 HD21 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.68 73.74 7.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.558 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -51.86 123.98 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.455 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.981 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.8 m -140.46 140.23 35.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.717 0.294 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -118.67 117.22 28.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp 58.29 -171.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 2' ' ' ILE . 3.8 mp -87.65 -40.81 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.85 89.37 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.83 126.49 21.91 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.522 2.148 . . . . 0.0 112.336 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.35 -64.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.4 m -152.0 -14.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.43 132.17 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -142.69 -161.5 1.26 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -122.4 108.34 13.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 110.32 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -129.19 -87.33 0.54 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.127 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -30.11 106.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.189 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HD3' HD12 ' A' ' 108' ' ' LEU . 53.5 tttp -95.27 101.08 12.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.987 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.619 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.0 m95 -84.18 102.11 12.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.318 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 110' ' ' LEU . 34.6 m -147.47 -168.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.733 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.55 -179.32 3.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.482 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 ' HB ' HD23 ' A' ' 110' ' ' LEU . 3.1 t -175.22 -172.66 0.6 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.3 m80 -115.98 -163.74 0.92 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.268 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 38.4 t -93.27 137.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.115 0.483 . . . . 0.0 112.083 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.07 15.03 9.1 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.492 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptm -64.08 82.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.466 HG21 HD23 ' A' ' 77' ' ' LEU . 5.1 m -47.82 98.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.579 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.5 m -91.63 99.83 12.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.532 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.66 130.28 35.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.459 HG21 ' HG ' ' A' ' 26' ' ' LEU . 46.7 mt -134.29 104.85 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.873 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -85.94 96.54 9.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 20.4 mt -91.73 145.18 24.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.442 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.93 163.13 12.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.546 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.16 -141.31 5.03 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.558 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB3' HG21 ' A' ' 32' ' ' THR . 59.1 t30 -174.6 94.39 0.3 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.557 0.218 . . . . 0.0 110.575 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HD2' ' HA3' ' A' ' 71' ' ' GLY . 50.9 Cg_exo -53.86 -15.84 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 113.28 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.57 HG22 ' HA3' ' A' ' 69' ' ' GLY . 69.4 p -86.41 13.28 8.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 29' ' ' ASN . 47.5 p -95.5 -58.61 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.75 -29.37 0.67 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -97.48 -176.4 3.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 0.0 111.062 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.7 ttm -149.16 151.68 34.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -106.37 86.98 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.113 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -132.02 -167.4 1.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.101 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 24.7 mtp85 -88.54 150.25 23.18 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.0 t -69.57 131.91 33.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.617 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.61 6.33 89.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.576 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -130.81 -0.76 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.505 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.541 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.2 t -55.08 103.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.022 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.92 -28.96 10.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.233 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 44' ' ' LYS . 8.7 mtpm? -63.68 172.11 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 111.108 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.61 -55.87 6.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.66 142.36 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.598 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.72 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.1 mt -87.64 -46.46 9.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.811 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.599 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 48.3 t -57.0 -179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.208 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.599 ' H ' ' HG ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -163.14 -88.6 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.41 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.17 -37.61 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.4 HD11 ' HD2' ' A' ' 82' ' ' LYS . 21.5 mm -62.89 -77.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.38 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 78' ' ' VAL . 69.6 mt -111.23 125.52 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 72.37 0.23 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 38' ' ' ARG . 3.1 t -75.8 85.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.76 84.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' HD11 ' A' ' 47' ' ' LEU . 33.8 t -99.53 148.15 24.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.324 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -138.15 111.18 7.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.304 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.457 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -76.42 102.67 6.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.281 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -100.56 109.44 57.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.076 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -100.45 96.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.582 2.854 . . . . 0.0 111.132 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -75.86 141.06 71.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.36 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 61' ' ' THR . 23.9 Cg_exo -63.88 -178.95 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.742 2.294 . . . . 0.0 112.171 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.9 t -150.54 165.44 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.4 p -55.74 -27.07 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.526 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 64.2 p -61.44 161.18 20.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.894 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 47.5 Cg_endo -65.96 -152.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.536 2.158 . . . . 0.0 112.081 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.4 mtm -53.85 -16.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.21 100.1 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' HA3' HG22 ' A' ' 31' ' ' THR . . . 140.42 106.87 0.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.639 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 70' ' ' VAL . 4.3 p -151.22 86.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.288 0.566 . . . . 0.0 110.868 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . -96.28 132.78 11.18 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.006 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -142.66 -136.4 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.099 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.3 pt -146.68 -166.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 110.978 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -136.66 100.13 4.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.5 t -85.21 103.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 90' ' ' LEU . 26.6 t -106.01 119.29 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.211 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD23 HG21 ' A' ' 21' ' ' THR . 75.3 mt -109.37 98.98 8.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.824 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.73 104.01 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.953 0.406 . . . . 0.0 111.256 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -102.87 101.67 22.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 77.5 Cg_exo -47.03 98.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.802 2.335 . . . . 0.0 113.299 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -74.47 -36.21 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.354 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.4 ' HD2' HD11 ' A' ' 51' ' ' ILE . 66.8 mttm -112.38 172.0 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.641 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.3 121.82 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.556 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 139.9 -149.77 21.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.576 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.02 98.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -132.97 156.44 47.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.48 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 88' ' ' LEU . 90.6 m -158.92 155.63 28.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.022 0.439 . . . . 0.0 112.111 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 28.8 tp -104.51 94.1 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.888 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.6 mt-10 -73.43 96.51 2.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.186 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.0 mt -112.15 135.46 52.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.449 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.2 p -142.49 154.71 18.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 111.765 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.35 88.89 4.27 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.498 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 3.9 t -117.74 172.6 7.26 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -102.91 93.1 4.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.305 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.8 Cg_exo -43.59 -35.62 6.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.743 2.295 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -71.9 -39.61 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.303 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.73 -72.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.397 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 178.0 36.43 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.973 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.493 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.5 mt -90.91 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.578 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 13.8 mttt -134.54 162.28 58.63 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.151 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 46.5 Cg_endo -69.22 -40.9 5.52 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.686 2.258 . . . . 0.0 112.16 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.66 -25.76 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -53.18 149.58 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.348 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -56.08 161.12 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.9 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.673 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.2 tpp180 -132.35 163.54 28.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.992 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.673 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.0 t80 -172.78 71.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 109.424 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.09 90.29 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.156 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.8 tp -70.85 90.59 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.619 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 29.2 m-70 -72.0 145.91 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.592 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 14' ' ' VAL . 94.7 mt -146.54 115.94 7.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.665 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.1 t30 -83.96 51.1 1.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.556 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.7 t -36.05 121.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.825 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.036 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.7 p -98.54 122.12 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -146.18 132.36 19.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -131.91 134.33 45.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 pt -93.72 16.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.07 111.98 3.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.22 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.91 130.02 19.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.448 2.099 . . . . 0.0 112.308 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -134.49 -174.1 3.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -61.08 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.33 143.93 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -172.48 133.49 0.63 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.432 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.38 120.67 11.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.586 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -125.06 -94.76 0.47 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.945 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -54.06 100.33 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.5 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -92.65 93.34 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.635 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -76.83 102.98 6.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.74 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG22 HD21 ' A' ' 110' ' ' LEU . 17.5 m -150.14 -172.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.067 0.46 . . . . 0.0 112.126 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.75 179.43 4.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.591 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.7 t -175.37 -175.07 0.78 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.018 0.437 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.458 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 62.3 m-70 -118.76 -171.9 2.18 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.271 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.28 125.95 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 111.789 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 66.37 18.5 67.57 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.571 -0.741 . . . . 0.0 113.393 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -59.61 85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.495 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -55.86 98.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.348 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -96.09 103.37 15.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.634 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -81.93 131.14 35.25 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.803 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 HD23 ' A' ' 108' ' ' LEU . 46.8 mt -137.21 105.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.953 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.68 99.85 12.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.254 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.1 mt -96.11 149.08 22.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.604 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.27 162.21 13.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 179.17 -144.11 6.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -174.28 93.74 0.32 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.337 0.113 . . . . 0.0 110.761 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HB3' ' OH ' ' A' ' 58' ' ' TYR . 12.4 Cg_endo -56.58 -21.02 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.738 2.292 . . . . 0.0 112.905 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.2 p -73.64 1.86 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.1 p -90.83 -52.66 4.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.96 -38.64 0.84 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.746 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 78.9 m-85 -85.37 176.74 8.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.31 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.6 ttm -144.02 149.79 37.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.505 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.0 m95 -102.77 82.8 2.17 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -128.48 -171.2 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.25 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.4 mtp85 -86.28 144.05 27.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.013 0.435 . . . . 0.0 111.09 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.83 144.53 12.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.067 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.81 72.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.116 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' A' ' 42' ' ' VAL . 53.8 m-85 -138.24 -37.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.726 0.263 . . . . 0.0 111.43 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.573 ' HA ' HG22 ' A' ' 37' ' ' THR . 9.8 p -18.11 118.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.767 0.667 . . . . 0.0 112.439 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.72 61.56 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.018 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.671 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -89.02 -164.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.237 0.541 . . . . 0.0 111.794 -179.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.69 -32.67 5.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.561 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.91 122.72 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.701 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 1.9 mt -68.92 -56.57 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.373 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.47 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.2 p -49.0 176.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.847 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -77.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.37 -36.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.361 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 24.5 mm -72.22 -79.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.453 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.5 HD23 HG11 ' A' ' 78' ' ' VAL . 11.0 mt -99.23 114.52 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.517 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.72 68.9 0.27 Allowed 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG23 ' HD2' ' A' ' 38' ' ' ARG . 16.4 t -74.0 84.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.862 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.95 85.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.451 ' SG ' HG23 ' A' ' 76' ' ' VAL . 31.8 t -102.26 144.28 30.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.612 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -130.2 107.46 9.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.055 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -80.2 108.73 14.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 26.3 m -113.05 117.28 46.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.201 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HB2' HG13 ' A' ' 70' ' ' VAL . 62.9 Cg_endo -99.88 47.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.381 2.721 . . . . 0.0 111.566 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.417 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -45.76 154.91 0.52 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.698 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' HG23 ' A' ' 61' ' ' THR . 57.5 Cg_exo -52.51 123.17 12.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.607 2.205 . . . . 0.0 112.505 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 t -66.98 173.98 3.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -83.15 17.23 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.4 p -57.41 155.49 19.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.67 10.38 2.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.717 2.278 . . . . 0.0 112.794 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.478 ' HG3' HG22 ' A' ' 68' ' ' VAL . 50.8 tpp -172.44 -90.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.403 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.478 HG22 ' HG3' ' A' ' 67' ' ' MET . 51.4 t -91.14 126.21 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.68 131.79 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.52 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 60' ' ' PRO . 47.6 t -136.23 77.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.32 114.19 0.94 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.572 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -110.62 -120.97 4.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.501 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.7 pt -145.69 -164.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.005 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.6 m-85 -135.26 99.48 4.26 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 57.9 t -84.99 101.89 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.729 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.474 HG22 HD12 ' A' ' 90' ' ' LEU . 40.0 t -105.9 121.02 57.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.495 HD23 HG21 ' A' ' 21' ' ' THR . 78.8 mt -111.37 99.54 8.31 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.11 106.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 111.359 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.4 mtmm -111.69 92.85 18.13 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HA ' HD21 ' A' ' 52' ' ' LEU . 8.1 Cg_endo -51.26 101.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.648 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 18.9 mtt180 -64.17 -29.85 70.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.397 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 75.9 mttt -127.36 -177.23 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.321 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 21.3 ptt180 -120.31 139.96 51.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.57 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.5 -118.82 0.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.691 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -116.65 30.66 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.006 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -46.83 152.06 0.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.568 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 109' ' ' HIS . 78.2 m -158.24 142.58 15.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.5 tp -93.19 90.53 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.538 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 41.8 mt-10 -72.57 96.21 1.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.699 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.574 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 28.0 mt -111.36 137.97 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -146.47 157.16 11.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.487 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.2 t80 -95.8 91.28 5.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' HG21 ' A' ' 99' ' ' ILE . 2.4 t -121.73 150.87 41.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.6 mtp180 -87.42 100.53 1.71 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.485 ' HG3' ' HE1' ' A' ' 35' ' ' MET . 5.5 Cg_endo -51.44 -30.33 34.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.384 2.056 . . . . 0.0 112.039 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.36 -32.05 66.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.271 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -108.75 -78.6 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.282 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.48 -178.73 45.28 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.321 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.482 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -94.36 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -144.79 154.99 56.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.85 -47.13 4.04 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.897 2.398 . . . . 0.0 112.632 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.89 -14.75 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.759 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.9 m120 -68.56 159.23 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 111.445 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 5.0 tt0 -56.49 157.03 5.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.615 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.5 tpp180 -130.93 163.16 28.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.615 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 59.6 t80 -175.32 73.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.534 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -96.11 88.78 4.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.353 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.5 tp -69.5 90.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.432 . . . . 0.0 110.523 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.0 m-70 -73.03 143.75 47.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.536 HD21 HG22 ' A' ' 14' ' ' VAL . 87.2 mt -144.39 111.83 6.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -83.41 59.53 5.11 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.57 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -38.54 133.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.629 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.94 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.5 p -98.08 114.71 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -97.96 118.56 34.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp -132.2 176.64 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 2' ' ' ILE . 4.0 mp -96.09 -29.61 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.71 153.74 15.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.7 137.78 67.25 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.539 2.159 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.48 178.19 4.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.1 p -104.97 6.8 33.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.71 16.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.562 ' HZ2' ' HB3' ' A' ' 8' ' ' LYS . 4.4 mtpm? -86.96 -43.08 12.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.264 0.554 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.53 134.72 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.014 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.888 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 2.1 p30 -102.0 -91.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.841 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -128.21 -112.55 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.877 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.455 ' HG2' HG11 ' A' ' 14' ' ' VAL . 32.7 ttpt -162.03 151.03 15.52 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.886 0.374 . . . . 0.0 111.001 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.737 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.0 m0 -106.07 115.79 30.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 ' HG2' ' A' ' 12' ' ' LYS . 19.6 m -148.7 -173.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.566 ' HA ' ' N ' ' A' ' 111' ' ' ASN . 3.3 p-10 -101.85 -171.54 1.99 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.706 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.5 t -175.32 178.89 1.6 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 74.9 m80 -109.73 -144.37 0.39 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -106.02 132.23 53.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.163 0.506 . . . . 0.0 111.586 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 59.76 18.66 46.77 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.328 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tptt -61.35 83.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' GLY . 4.6 m -55.48 102.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 ' O ' HG22 ' A' ' 78' ' ' VAL . 93.3 m -105.69 97.39 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.346 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' NE2' ' A' ' 25' ' ' HIS . 28.6 tt0 -72.79 122.09 20.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.299 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 HD23 ' A' ' 108' ' ' LEU . 34.3 mm -117.33 101.0 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.252 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.43 ' NE2' ' HG2' ' A' ' 23' ' ' GLU . 2.4 m80 -89.94 115.68 27.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.377 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 51.5 mt -111.83 147.49 35.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.309 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -100.99 162.36 12.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.593 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.75 -132.79 2.46 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.347 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' HB3' HG21 ' A' ' 32' ' ' THR . 44.5 t30 -176.26 97.85 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.353 0.121 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HG3' ' HH ' ' A' ' 58' ' ' TYR . 54.1 Cg_exo -53.14 -18.11 9.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.443 2.095 . . . . 0.0 112.508 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.1 m -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.479 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 29' ' ' ASN . 75.4 p -53.27 -64.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.428 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.07 -53.06 0.41 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.784 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -80.07 140.99 36.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 111.26 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.5 ttm -99.98 153.22 19.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.413 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.5 m95 -101.95 88.76 3.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.152 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -133.04 -169.05 2.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.396 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.557 ' NH2' ' HA ' ' A' ' 48' ' ' SER . 6.6 mtp85 -82.28 142.72 31.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.384 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 89' ' ' GLU . 60.2 t -53.86 145.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.122 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.21 6.89 3.4 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.845 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' HA ' ' HZ2' ' A' ' 44' ' ' LYS . 25.5 m-85 -127.86 29.22 5.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.527 0.68 . . . . 0.0 110.707 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.618 ' HA ' HG23 ' A' ' 37' ' ' THR . 7.4 p -65.45 133.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.999 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.21 -21.82 26.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HZ2' ' HA ' ' A' ' 41' ' ' PHE . 61.5 mttp -70.74 172.35 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 -54.64 2.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.427 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.49 -35.93 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.6 mt 72.8 -58.26 0.6 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.557 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . 67.2 p -63.67 -162.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.848 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.42 -73.36 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.14 -24.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.937 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.7 mm -70.19 -66.93 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.113 0.482 . . . . 0.0 111.559 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.539 HD21 HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.98 105.86 12.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.964 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -59.06 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.759 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 52' ' ' LEU . 40.7 t -95.3 92.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.828 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.3 t -84.36 77.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.503 0.668 . . . . 0.0 109.2 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.488 ' SG ' HG23 ' A' ' 76' ' ' VAL . 13.0 t -92.19 134.81 34.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.283 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 75' ' ' VAL . 43.0 mtmt -129.64 119.47 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' HH ' ' HG3' ' A' ' 30' ' ' PRO . 1.1 t80 -84.29 98.78 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.123 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.432 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 26.6 m -91.22 108.7 30.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.291 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.581 ' HB2' HG12 ' A' ' 70' ' ' VAL . 61.0 Cg_endo -102.47 93.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.713 2.942 . . . . 0.0 111.465 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.467 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -75.24 138.34 71.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 61' ' ' THR . 25.9 Cg_exo -62.05 113.76 2.02 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.679 2.253 . . . . 0.0 112.256 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -103.22 -174.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.3 p -72.82 -6.86 47.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.8 p -63.75 156.23 73.28 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 67' ' ' MET . 72.5 Cg_endo -73.68 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.546 2.164 . . . . 0.0 112.109 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.4 ' H ' ' HB2' ' A' ' 66' ' ' PRO . 56.3 ttp -65.71 -14.31 61.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.976 0.417 . . . . 0.0 110.814 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.77 108.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.01 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.4 164.99 38.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.542 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 60' ' ' PRO . 14.9 t -126.89 -104.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.626 0.251 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . 141.76 87.37 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.978 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -146.48 -138.68 3.21 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 5.9 pt -139.74 -164.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 110.934 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -139.93 100.0 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.284 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 57' ' ' LYS . 10.4 p -92.25 133.13 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 109.856 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' SG ' ' A' ' 56' ' ' CYS . 43.6 t -132.93 99.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 77' ' ' LEU . 2.1 mm? -83.09 103.8 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.33 112.66 28.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.947 0.403 . . . . 0.0 110.797 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.8 mtmm -118.25 101.63 51.17 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.05 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HG2' ' N ' ' A' ' 19' ' ' GLY . 4.6 Cg_endo -49.17 101.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.477 2.118 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.536 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 3.8 mtt180 -74.89 -42.47 57.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.498 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 67.2 mttm -113.71 160.03 19.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.013 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -96.19 129.15 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.51 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.53 -119.24 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.456 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -121.14 99.47 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -111.18 164.79 12.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 m -161.78 152.98 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.668 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.7 tp -119.4 77.79 1.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.959 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.53 ' HB3' HG21 ' A' ' 107' ' ' THR . 0.2 OUTLIER -81.53 107.76 14.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.823 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 38' ' ' ARG . 96.2 mt -101.78 154.86 18.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.362 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.89 158.92 9.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.23 0.538 . . . . 0.0 112.04 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -94.34 68.9 3.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.558 HG22 ' HB ' ' A' ' 42' ' ' VAL . 1.1 t -84.73 167.27 16.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.82 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -109.35 92.67 11.92 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.718 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.92 -33.71 26.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.635 2.223 . . . . 0.0 112.541 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -69.41 -31.36 69.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.11 -81.28 0.61 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.58 -172.07 40.09 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.32 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.513 HG12 ' OG1' ' A' ' 93' ' ' THR . 4.9 mt -102.99 116.55 46.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.658 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.0 170.54 5.43 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.58 -35.53 16.95 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.514 2.143 . . . . 0.0 112.175 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.45 -19.24 22.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.435 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.77 132.54 52.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 111.325 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG3' ' HZ3' ' A' ' 8' ' ' LYS . 11.2 tt0 -53.55 161.06 1.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.713 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.613 ' HG2' HD21 ' A' ' 10' ' ' ASN . 4.4 tpt180 -126.47 153.12 45.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.242 0.544 . . . . 0.0 112.171 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.888 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 42.5 t80 -165.1 83.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.049 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 89' ' ' GLU . 1.4 m -95.81 111.46 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.7 tp -98.0 94.13 6.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.958 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.737 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 37.0 m-70 -77.27 141.16 40.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 0.0 111.033 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.45 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 73.7 mt -144.17 77.91 1.56 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.298 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.566 ' N ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 t30 -57.17 89.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 17' ' ' HIS . 5.5 t -57.9 133.49 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.724 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.972 179.692 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -143.8 127.33 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -89.12 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt -135.44 159.31 41.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.74 -30.64 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.93 129.09 36.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -80.76 20.84 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.532 2.155 . . . . 0.0 112.436 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.36 -60.65 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.9 m -63.89 -71.67 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.038 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.32 -176.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -170.49 132.76 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.526 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.1 120.99 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.672 HD21 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -127.7 -92.32 0.48 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.131 0.491 . . . . 0.0 112.026 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.486 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -47.75 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.083 -179.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HD3' HD11 ' A' ' 108' ' ' LEU . 53.4 tttp -102.47 98.7 8.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.763 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.676 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.3 m95 -87.55 104.32 16.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.265 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 110' ' ' LEU . 30.7 m -146.45 -171.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 112.055 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.25 -176.04 2.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.585 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.41 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.6 t -175.83 -177.04 0.9 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.138 0.494 . . . . 0.0 112.164 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.8 m80 -115.1 -167.7 1.28 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.805 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG22 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -84.55 128.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.169 0.509 . . . . 0.0 111.905 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.63 20.63 59.55 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.483 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.2 tptp -59.03 84.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.026 0.413 . . . . 0.0 109.975 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.483 HG23 HD23 ' A' ' 77' ' ' LEU . 3.9 m -55.72 93.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.353 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.2 m -94.59 101.91 13.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.69 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.0 tt0 -82.43 133.46 35.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.577 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.466 HD13 HD23 ' A' ' 108' ' ' LEU . 41.4 mt -135.5 101.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.158 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -84.72 107.87 17.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.3 mt -100.89 144.86 29.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.273 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.9 164.01 13.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.93 0.395 . . . . 0.0 110.334 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.61 -139.84 5.78 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.291 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -175.4 88.51 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 67.8 Cg_exo -52.32 -16.99 5.62 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.713 2.275 . . . . 0.0 113.123 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -82.06 11.0 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.471 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.9 p -100.58 -63.27 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.077 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.14 -45.15 0.33 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.769 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -72.32 178.57 3.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.068 0.461 . . . . 0.0 111.212 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.28 151.97 32.56 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.062 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 3.8 m95 -110.38 88.97 2.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.87 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.568 HG22 ' HA ' ' A' ' 42' ' ' VAL . 5.9 t -136.67 -168.7 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.927 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.541 ' HD2' HG23 ' A' ' 54' ' ' VAL . 10.2 mtp85 -81.17 140.26 35.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.784 0.326 . . . . 0.0 111.102 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 89' ' ' GLU . 20.3 t -54.39 144.44 5.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.53 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.18 -0.97 5.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.864 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.719 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 26.9 m-85 -128.66 54.12 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.568 0.699 . . . . 0.0 110.504 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.568 ' HA ' HG22 ' A' ' 37' ' ' THR . 26.2 t -107.69 121.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.653 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 4.16 85.85 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.719 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -67.99 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.308 -0.946 . . . . 0.0 111.555 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.48 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 3.9 m-20 -107.95 -47.06 3.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.657 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.634 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.5 p -144.38 127.92 12.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.724 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.6 HD21 ' HD3' ' A' ' 44' ' ' LYS . 36.9 mt -68.77 -63.49 1.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.795 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.532 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 36.9 t -47.23 174.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' H ' ' HG ' ' A' ' 48' ' ' SER . 7.8 m-20 -157.02 -83.13 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.862 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.91 -31.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.135 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.3 mm -73.97 -79.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.509 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 8.0 mt -99.93 115.84 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.678 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -68.78 70.27 0.19 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.541 HG23 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -75.41 83.71 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.251 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.72 84.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 76' ' ' VAL . 21.1 t -99.29 127.11 45.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.439 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -109.37 107.32 17.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.597 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.467 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -81.66 103.99 11.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.42 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.493 HG23 HG13 ' A' ' 70' ' ' VAL . 1.2 m -102.45 119.31 56.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.007 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 83.7 Cg_endo -94.78 -168.98 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.163 2.575 . . . . 0.0 113.134 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 158.58 78.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.281 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.597 ' HG3' ' H ' ' A' ' 70' ' ' VAL . 32.5 Cg_exo -58.68 126.54 21.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.673 2.248 . . . . 0.0 112.465 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 55.4 m -88.74 -168.87 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.857 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -62.25 -15.82 49.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.024 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.3 p -60.27 155.77 44.42 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.51 10.08 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.41 65.86 6.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.719 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.82 136.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.346 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.23 65.55 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.418 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' H ' ' HG3' ' A' ' 62' ' ' PRO . 60.2 t -85.27 -88.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.251 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 59' ' ' THR . . . -144.73 -101.26 0.33 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.092 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.29 18.42 12.07 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt -140.48 -162.45 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 111.156 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -138.37 109.68 6.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.136 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 75' ' ' VAL . 5.0 p -103.58 111.51 33.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 56' ' ' CYS . 28.1 t -104.97 124.04 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.482 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 HD23 HG23 ' A' ' 21' ' ' THR . 83.7 mt -109.65 100.96 9.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.75 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.1 mtmt -114.27 94.14 34.04 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.354 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.48 105.43 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.495 2.13 . . . . 0.0 112.577 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 17.5 mtt180 -69.62 -35.85 75.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -117.64 -177.39 3.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.872 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HE ' HG22 ' A' ' 18' ' ' VAL . 85.9 mtt180 -121.3 142.21 50.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.8 -107.37 0.5 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.417 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.8 m80 -125.96 94.68 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.528 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -109.96 162.6 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.163 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.2 m -159.92 149.62 18.16 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HB2' HG13 ' A' ' 78' ' ' VAL . 27.1 tp -119.47 80.19 1.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -77.71 106.85 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.968 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 38' ' ' ARG . 73.1 mt -102.96 154.0 19.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.099 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.43 152.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.833 0.349 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.3 t80 -102.67 92.09 4.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 99' ' ' ILE . 8.1 t -131.42 162.54 29.94 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.5 mtp180 -94.96 95.36 1.53 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.613 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HB3' HG11 ' A' ' 42' ' ' VAL . 1.3 Cg_endo -45.45 -34.07 10.17 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.094 2.529 . . . . 0.0 112.967 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -72.39 -36.78 68.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.019 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.58 6.32 39.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.675 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.4 -168.35 42.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.923 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.547 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.7 mt -117.14 154.49 18.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.27 0.557 . . . . 0.0 112.343 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.26 163.55 49.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.549 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.53 -17.47 16.28 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.569 2.179 . . . . 0.0 111.665 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.3 pt-20 -78.79 -6.73 56.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.46 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -69.65 151.11 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.51 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.99 166.31 3.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.672 ' HB3' HD21 ' A' ' 10' ' ' ASN . 16.6 tpp180 -130.46 163.69 26.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.602 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 46.7 t80 -172.97 68.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.5 m -89.64 103.27 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.884 -178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 34.7 tp -86.53 90.24 8.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 14.0 m-70 -74.45 145.9 43.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 14' ' ' VAL . 86.4 mt -146.81 104.93 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.176 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -79.58 70.62 6.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -47.55 117.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.6 p -88.11 -51.87 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -107.07 -38.41 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.953 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm -141.74 173.3 11.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.0 pt -81.23 -33.03 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.184 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.88 88.12 0.13 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.266 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.34 4.83 4.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.572 2.181 . . . . 0.0 112.438 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.63 119.82 14.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m 59.15 -175.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 9' ' ' ASP . 24.1 t -91.98 148.62 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -119.9 -7.5 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.503 ' H ' HG13 ' A' ' 7' ' ' VAL . 18.4 t70 -42.02 117.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.341 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.683 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 2.4 p-10 -122.74 -73.47 0.65 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -43.44 103.41 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.488 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HB3' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.2 57.13 0.95 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.555 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.62 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.5 m0 -78.48 122.83 26.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.921 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 5.7 p -174.76 160.95 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.549 0.69 . . . . 0.0 112.099 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 m-20 -61.77 176.06 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.059 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' HB ' HD23 ' A' ' 110' ' ' LEU . 4.1 t -174.31 -172.75 0.71 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.04 0.448 . . . . 0.0 111.63 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.0 m80 -117.38 -169.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.439 HG21 ' HG2' ' A' ' 83' ' ' ARG . 40.8 t -90.29 129.27 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.687 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 58.34 15.14 22.38 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.26 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.3 tptp -62.96 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.2 m -44.02 103.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.5 m -94.35 95.12 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.568 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 39.2 tt0 -81.76 131.83 35.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.831 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.438 HD11 ' OH ' ' A' ' 106' ' ' TYR . 41.2 mt -139.3 102.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.5 102.16 11.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 11.5 mt -95.11 145.22 25.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.652 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 4.5 mptt -99.58 161.45 13.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.335 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.82 -147.01 7.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.559 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -174.56 93.75 0.3 Allowed Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.39 0.138 . . . . 0.0 110.742 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HD2' ' HA3' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -55.66 -29.43 70.68 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.716 2.277 . . . . 0.0 112.991 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.3 p -59.97 -17.1 35.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.5 p -70.56 -51.29 29.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.834 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.47 1.86 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.798 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.55 -179.01 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.3 ttm -147.14 151.08 36.2 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.476 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.3 m95 -104.2 82.79 1.99 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 42' ' ' VAL . 9.8 t -127.97 161.6 28.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.364 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HD3' HD13 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -54.71 139.88 37.65 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.776 0.322 . . . . 0.0 111.408 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG23 ' HB ' ' A' ' 91' ' ' VAL . 42.3 t -51.14 140.88 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.268 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.38 5.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.715 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 23.2 m-30 -117.25 47.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.207 0.527 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.587 ' HB ' HG23 ' A' ' 93' ' ' THR . 7.3 p -93.44 128.76 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.859 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.29 15.73 46.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.066 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.06 -164.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.234 0.613 . . . . 0.0 111.686 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.73 -43.7 3.78 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.178 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.581 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.2 t -147.0 115.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.171 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.594 HD21 ' HD3' ' A' ' 44' ' ' LYS . 15.6 mt -57.76 -61.19 2.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 46' ' ' VAL . 92.3 p -51.89 175.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.294 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -157.26 -99.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 111.388 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.28 -32.46 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.8 mm -73.52 -72.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.618 ' HB3' HG11 ' A' ' 78' ' ' VAL . 85.1 mt -106.15 116.98 32.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.217 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.64 73.32 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG12 ' HD3' ' A' ' 38' ' ' ARG . 1.3 t -78.9 90.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -92.65 90.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.56 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 9.2 t -114.99 145.88 41.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.287 0.565 . . . . 0.0 111.604 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -126.61 125.2 41.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.143 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -85.59 103.87 14.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.15 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 27.4 m -105.8 128.46 26.4 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.631 ' HB3' ' H ' ' A' ' 70' ' ' VAL . 29.7 Cg_endo -98.68 -152.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.499 2.799 . . . . 0.0 111.737 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.482 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -79.23 142.08 58.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.591 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 61' ' ' THR . 36.3 Cg_exo -61.16 96.73 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.48 2.12 . . . . 0.0 112.161 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.523 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 47.5 m -109.43 -167.44 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -116.75 -46.99 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.619 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 61.3 m -99.65 -49.55 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 14.4 Cg_exo -70.11 151.32 67.01 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.773 2.316 . . . . 0.0 112.257 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 67' ' ' MET . 47.5 ttp -157.01 19.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.364 0.602 . . . . 0.0 109.982 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -135.7 104.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.051 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.61 84.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.406 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.631 ' H ' ' HB3' ' A' ' 60' ' ' PRO . 1.9 t -125.45 -23.07 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.941 0.4 . . . . 0.0 111.298 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.554 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . 125.45 84.69 0.57 Allowed Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.885 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -145.9 -129.27 2.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.285 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 pt -135.08 -167.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.058 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.491 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -139.27 98.01 3.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.775 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 75' ' ' VAL . 11.3 p -89.12 113.25 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-O 121.343 0.592 . . . . 0.0 110.661 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 HH22 ' A' ' 38' ' ' ARG . 20.7 t -107.06 126.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.764 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.501 ' HA ' HD21 ' A' ' 77' ' ' LEU . 70.0 mt -113.62 90.68 3.41 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -90.85 105.21 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.074 0.464 . . . . 0.0 111.057 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 46.5 mtmt -106.01 96.27 12.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD22 ' A' ' 52' ' ' LEU . 7.4 Cg_endo -50.67 103.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.283 1.989 . . . . 0.0 112.503 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.1 mtt180 -67.69 -35.39 78.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 53.0 mttm -117.43 178.99 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.831 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG2' HG21 ' A' ' 18' ' ' VAL . 67.3 mtp180 -117.65 146.55 43.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.466 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.45 -149.59 21.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.782 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -91.26 28.3 1.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.752 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 72.3 m-70 -47.54 157.6 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.478 HG21 ' HA ' ' A' ' 109' ' ' HIS . 54.4 m -157.31 148.22 21.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.922 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.605 HD13 ' HD3' ' A' ' 38' ' ' ARG . 17.4 tp -107.99 165.78 11.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.75 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.555 ' HB3' HG22 ' A' ' 39' ' ' VAL . 34.5 mt-10 -151.68 121.24 6.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 9.7 mp -116.81 161.83 18.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.289 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HB ' HG23 ' A' ' 39' ' ' VAL . 13.3 p -158.65 155.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.117 0.484 . . . . 0.0 112.047 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.7 t80 -100.12 86.86 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.587 HG23 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -109.82 171.46 7.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -105.54 93.25 6.84 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 93' ' ' THR . 88.9 Cg_exo -49.17 -29.2 16.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.536 2.158 . . . . 0.0 112.339 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.38 -34.69 63.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.213 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -110.24 -76.88 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.249 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.47 -174.76 47.02 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.242 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.465 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -96.44 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 0.0 111.013 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.8 mttt -136.11 157.01 76.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.65 -47.38 11.43 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.735 2.29 . . . . 0.0 112.739 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.06 -12.71 8.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.85 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.516 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -64.26 149.94 46.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.927 0.394 . . . . 0.0 111.357 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.71 164.03 2.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.702 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 12.1 tpp180 -137.77 162.13 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.702 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -164.41 83.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.304 0.573 . . . . 0.0 110.08 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.421 HG22 ' HG2' ' A' ' 89' ' ' GLU . 25.8 m -88.82 133.76 34.16 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 37.5 tp -118.59 80.98 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.8 m-70 -66.46 145.42 55.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.876 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.7 mt -143.58 108.34 4.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.579 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 60.9 t30 -82.8 50.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.466 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -37.7 112.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.67 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.848 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.2 m -144.91 170.34 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -94.29 -9.49 35.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' C ' ' H ' ' A' ' 3' ' ' ALA . 68.2 mtm -93.04 -11.19 33.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 1' ' ' MET . 61.4 mt 74.33 -36.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.66 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 1' ' ' MET . . . 57.51 92.48 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.52 111.24 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.0 tp -140.08 -48.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -93.94 164.7 12.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 p -65.21 148.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.097 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -98.51 34.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.0 110.388 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -35.26 120.58 0.54 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.038 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -122.39 -87.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.96 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.25 98.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.804 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.517 ' HD3' HD11 ' A' ' 108' ' ' LEU . 75.5 tttt -100.96 94.55 6.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.034 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m95 -84.64 103.32 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.05 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.547 HG21 HD21 ' A' ' 110' ' ' LEU . 29.6 m -148.21 -171.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.133 0.492 . . . . 0.0 112.104 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -109.32 178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.819 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.4 t -176.39 -172.67 0.48 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.95 0.405 . . . . 0.0 111.692 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.567 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 66.6 m80 -122.23 179.9 4.39 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.59 136.23 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.339 0.59 . . . . 0.0 112.221 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 58.24 15.16 21.73 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.862 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.4 tptt -58.72 85.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.327 0.563 . . . . 0.0 110.015 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.442 HG21 HD23 ' A' ' 77' ' ' LEU . 3.6 m -56.67 102.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.332 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 m -102.16 101.42 11.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.4 tt0 -81.6 135.02 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 108' ' ' LEU . 42.0 mt -136.41 104.95 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -86.24 97.87 10.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.8 mt -91.02 145.69 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 5.7 mptt -91.4 159.71 15.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.35 -154.39 25.48 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.009 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 5.9 t30 -172.04 132.19 0.74 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.4 0.143 . . . . 0.0 110.987 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 29' ' ' ASN . 29.9 Cg_exo -62.82 -53.87 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.611 2.207 . . . . 0.0 112.672 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.407 ' HG1' HD22 ' A' ' 29' ' ' ASN . 66.5 p -83.53 51.24 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.676 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -135.01 -64.07 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.202 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.43 -106.67 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.777 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.446 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 2.1 m-85 -88.73 -166.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.007 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.523 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.3 ttt -133.89 149.76 51.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 23.2 m95 -100.87 110.56 22.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.154 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.626 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -154.99 -172.39 4.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.819 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.663 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 mtp85 -89.08 153.66 20.8 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.807 0.337 . . . . 0.0 111.044 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 51.6 t -67.11 132.88 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.977 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.46 15.43 81.44 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.851 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.473 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 59.8 m-85 -135.75 -5.56 2.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.626 ' HA ' HG23 ' A' ' 37' ' ' THR . 4.3 p -43.47 124.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.74 -38.5 3.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 54.8 mtpt -60.44 170.47 1.36 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.839 0.352 . . . . 0.0 111.245 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -80.33 -61.69 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.784 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.89 143.94 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.87 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt -101.82 -48.75 4.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.248 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.489 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 72.2 p -50.95 177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.016 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -156.43 -89.83 0.04 OUTLIER 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.399 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -127.14 -35.25 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.7 mm -70.53 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.231 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD23 HG13 ' A' ' 78' ' ' VAL . 8.4 mt -101.35 116.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.451 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -71.16 66.98 0.43 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.513 HG23 ' HD2' ' A' ' 38' ' ' ARG . 19.2 t -71.23 81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.822 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.7 t -75.69 78.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' SG ' HG23 ' A' ' 76' ' ' VAL . 15.2 t -94.63 139.71 30.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.366 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -131.36 107.53 9.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.747 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.523 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -72.6 109.58 6.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.289 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.58 ' HG1' HG13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -94.18 112.8 58.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.429 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.43 ' CG ' ' H ' ' A' ' 61' ' ' THR . 84.0 Cg_endo -94.23 -68.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.105 2.537 . . . . 0.0 113.714 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.506 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -131.04 142.02 44.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.831 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 61' ' ' THR . 48.3 Cg_exo -56.13 134.96 67.4 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.578 2.185 . . . . 0.0 112.475 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -95.94 -177.3 3.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 t -86.63 10.22 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.5 p -60.52 155.68 47.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.89 14.32 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -127.99 84.79 2.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.29 136.72 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.055 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.06 40.84 1.13 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.36 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.6 83.22 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 110.809 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' C ' ' A' ' 61' ' ' THR . . . 149.78 97.54 0.17 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.193 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 59' ' ' THR . . . 149.14 2.73 0.32 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.825 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.58 HG13 ' HG1' ' A' ' 59' ' ' THR . 9.9 pt -150.92 -162.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 111.112 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.483 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -133.02 99.8 4.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.466 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.79 108.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.192 0.52 . . . . 0.0 110.724 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 43.0 t -104.84 126.33 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.825 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 82.1 mt -110.66 98.44 7.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.761 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.47 107.87 19.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.005 0.431 . . . . 0.0 111.275 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 44.8 mtmt -112.65 95.13 31.37 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.22 101.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.1 . . . . 0.0 112.848 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.498 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -65.77 -31.06 71.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.872 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.549 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 57.8 mttm -119.01 176.97 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.632 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -120.71 126.06 49.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.968 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.439 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 149.63 -109.21 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.236 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -111.98 113.55 25.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.549 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 2.7 m80 -135.77 156.48 48.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.591 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.418 HG21 HG21 ' A' ' 107' ' ' THR . 28.9 m -158.75 148.68 19.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.534 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.64 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 41.2 tp -108.58 90.23 3.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 39.3 mt-10 -71.8 97.29 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.104 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.64 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -111.46 125.28 53.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.75 172.24 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.488 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 1.7 t80 -109.69 86.36 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.014 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.468 ' HB ' HG21 ' A' ' 99' ' ' ILE . 3.6 t -117.61 158.01 25.39 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 79.8 mtp180 -100.49 98.9 8.72 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.84 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -43.39 -38.02 8.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 112.845 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.88 -40.35 92.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.618 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -102.38 -75.58 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.04 -173.58 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.272 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.468 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -99.94 143.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 0.0 111.34 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -135.59 169.49 13.55 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.16 -37.87 17.34 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.643 2.229 . . . . 0.0 112.067 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.57 -17.21 53.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.169 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.61 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.96 135.06 56.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.75 158.37 2.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.579 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 6.3 tpp180 -119.24 160.16 22.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.433 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.579 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 49.7 t80 -173.28 68.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.975 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.72 97.63 10.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.328 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 19.5 tp -78.85 93.28 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.2 m-70 -76.66 142.71 40.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.547 HD21 HG21 ' A' ' 14' ' ' VAL . 89.9 mt -146.64 110.94 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.302 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 44.0 t30 -83.44 65.7 8.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.439 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -42.4 136.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.991 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.8 m -137.48 -62.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -70.27 113.75 7.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp -103.1 131.03 50.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.5 pt -85.64 -11.44 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.42 149.49 15.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.23 154.97 31.51 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.581 2.188 . . . . 0.0 112.257 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.3 tp -157.22 -59.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.41 -11.02 1.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.49 125.13 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -143.91 120.77 11.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.021 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.94 121.79 15.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.445 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.579 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.7 OUTLIER -124.01 -93.92 0.5 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 111.772 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -59.32 97.71 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.304 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.508 ' HD3' HD12 ' A' ' 108' ' ' LEU . 20.0 ptmt -93.69 74.69 4.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.663 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -50.22 103.89 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.834 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.541 HG22 HD21 ' A' ' 110' ' ' LEU . 34.7 m -146.82 -174.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 112.436 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.95 -178.1 3.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.808 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.407 HG22 HG12 ' A' ' 112' ' ' VAL . 1.8 t -177.31 -173.39 0.44 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.983 0.421 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 47.9 m-70 -124.12 -177.22 3.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.979 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.94 137.79 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 112.174 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.33 14.01 11.7 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.659 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 20.5 tptt -57.82 85.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.193 0.497 . . . . 0.0 109.927 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.478 HG21 HD23 ' A' ' 77' ' ' LEU . 3.8 m -57.27 92.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.291 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -88.36 103.2 15.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.613 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.2 129.66 34.76 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.491 HG21 ' HG ' ' A' ' 26' ' ' LEU . 42.1 mt -133.84 107.69 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.645 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -87.83 91.64 8.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.368 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.491 ' HG ' HG21 ' A' ' 24' ' ' ILE . 15.5 mt -86.24 145.13 27.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.488 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HZ3' ' HB2' ' A' ' 27' ' ' LYS . 7.9 mtmp? -99.53 163.65 12.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.22 -141.24 5.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.405 ' HB3' HG21 ' A' ' 32' ' ' THR . 62.6 t30 -174.3 92.8 0.32 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.548 0.214 . . . . 0.0 110.564 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 51.0 Cg_exo -53.86 -17.7 11.12 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.742 2.295 . . . . 0.0 113.12 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.5 p -82.84 12.77 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.405 HG21 ' HB3' ' A' ' 29' ' ' ASN . 56.8 p -96.55 -64.18 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.208 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.27 -26.38 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.705 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -98.68 -176.0 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.219 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.0 ttm -150.61 151.05 31.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.087 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.4 m95 -106.62 88.14 2.69 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 42' ' ' VAL . 11.5 t -134.56 -168.57 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.722 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -74.99 157.5 34.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.67 0.271 . . . . 0.0 110.722 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 89' ' ' GLU . 98.9 t -79.56 134.81 26.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.749 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 -10.44 5.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.822 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 39' ' ' VAL . 16.8 m-30 -106.08 7.91 32.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.143 0.497 . . . . 0.0 110.284 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.477 HG22 HG22 ' A' ' 93' ' ' THR . 14.4 t -62.16 106.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.08 -19.21 10.18 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.749 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -70.99 178.23 3.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.753 0.311 . . . . 0.0 110.724 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.64 -51.02 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.34 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.56 -30.18 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.77 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 6.8 mt 70.42 -72.85 0.1 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.47 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 40.6 p -49.54 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.779 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.2 -89.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.35 -30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.279 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.7 mm -75.32 -79.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 80' ' ' PRO . 8.2 mt -102.52 113.42 26.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.572 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -69.81 71.14 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.825 0.345 . . . . 0.0 110.249 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG12 ' HD3' ' A' ' 38' ' ' ARG . 2.1 t -72.78 87.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG11 ' HE3' ' A' ' 57' ' ' LYS . 20.4 t -86.78 86.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 5.6 t -111.82 134.19 53.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.896 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HE3' HG11 ' A' ' 55' ' ' VAL . 32.1 mmtp -113.91 112.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.511 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -70.95 117.5 12.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.847 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.2 114.05 62.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.631 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.515 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 97.9 Cg_endo -93.29 169.42 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 112.926 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.514 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.67 146.8 73.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.514 ' HD2' HG23 ' A' ' 61' ' ' THR . 32.0 Cg_exo -60.27 136.39 68.07 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.561 2.174 . . . . 0.0 112.413 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.9 t -126.64 -92.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.2 m -70.16 -22.26 62.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.612 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 53.1 p -82.96 159.42 62.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 70.0 Cg_endo -71.31 -155.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.554 2.169 . . . . 0.0 112.039 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -108.14 74.54 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.969 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.51 38.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.65 94.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.367 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 t -115.05 2.09 8.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 111.074 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.4 -140.54 15.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.948 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 115.89 15.32 7.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -151.86 -165.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.141 0.496 . . . . 0.0 111.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -133.73 102.8 5.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.708 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 74.3 t -87.57 107.1 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.777 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 56' ' ' CYS . 21.8 t -108.95 119.6 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 21' ' ' THR . 72.4 mt -112.2 95.38 5.42 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.548 HG23 HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -90.8 108.76 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.021 0.439 . . . . 0.0 111.282 -178.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.0 mtmm -110.45 92.27 13.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.417 ' HA ' HD21 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.63 102.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.524 2.149 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.3 mtt180 -64.1 -34.76 78.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 55.7 mttm -116.06 -175.81 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.83 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -122.8 146.46 47.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 133.19 -136.79 8.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.492 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.88 95.32 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.963 0.411 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.8 m-70 -113.14 164.37 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.613 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 88' ' ' LEU . 88.3 m -159.8 150.24 18.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.586 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.649 HD13 HH11 ' A' ' 38' ' ' ARG . 34.6 tp -120.28 94.53 4.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.608 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HB3' HG22 ' A' ' 39' ' ' VAL . 41.7 mt-10 -73.88 105.54 5.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.802 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 26.5 mt -111.39 129.64 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 92' ' ' TYR . 9.9 p -133.66 158.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.161 0.505 . . . . 0.0 112.092 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -102.37 92.11 4.55 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.979 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.518 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.6 t -123.02 170.36 10.23 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -102.11 94.81 4.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.9 Cg_exo -45.21 -38.17 14.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.721 2.28 . . . . 0.0 112.729 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -37.7 88.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -101.57 -80.71 0.49 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.413 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.04 178.39 44.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.495 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.8 mt -94.39 153.08 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 0.0 111.557 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.7 mttt -140.41 162.65 48.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.2 Cg_endo -70.95 -39.77 3.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.712 2.275 . . . . 0.0 111.998 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.5 -27.47 69.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.784 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -52.5 153.72 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 160.35 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.6 tpp180 -129.87 163.9 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.206 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.624 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.7 t80 -176.49 71.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 0.0 109.111 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 89' ' ' GLU . 1.9 m -85.83 95.98 9.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.341 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 48.2 tp -72.88 86.28 1.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -75.74 139.6 41.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.541 HD21 HG22 ' A' ' 14' ' ' VAL . 94.6 mt -145.49 102.52 3.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.621 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -79.26 73.0 5.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.451 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -48.4 137.82 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.729 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.969 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.6 m -93.45 -34.52 13.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -69.93 -46.22 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.35 157.87 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.7 mt -83.16 -34.94 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.38 88.92 0.11 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.85 115.34 2.45 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.526 2.15 . . . . 0.0 112.304 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -135.78 -64.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -113.6 -36.19 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.17 131.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.037 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -174.27 135.62 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.14 118.52 22.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.521 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.623 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -119.36 -87.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.98 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -34.63 100.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.778 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -89.84 100.25 13.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.472 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.644 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -82.05 105.08 12.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' CG2' ' H ' ' A' ' 15' ' ' ASP . 3.1 p -154.84 -178.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.077 0.465 . . . . 0.0 111.718 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -100.67 -176.12 3.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.604 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.41 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.1 t -174.12 -174.4 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.183 0.516 . . . . 0.0 112.195 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.7 m-70 -114.96 -168.93 1.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.113 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.79 128.77 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 111.897 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.65 15.86 27.75 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.505 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.61 84.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.426 HG21 HD23 ' A' ' 77' ' ' LEU . 4.9 m -47.8 101.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.981 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -96.03 99.62 11.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.97 131.6 35.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.311 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.472 HD12 HD23 ' A' ' 108' ' ' LEU . 43.7 mt -138.67 103.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.764 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -85.58 107.02 17.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.346 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 6.4 mt -104.34 143.93 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.137 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 4.6 mtpm? -96.79 162.94 13.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.977 0.418 . . . . 0.0 110.591 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.62 -158.76 29.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.311 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 3.9 t30 -172.33 135.39 0.82 Allowed Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.694 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD3' ' HH ' ' A' ' 58' ' ' TYR . 96.7 Cg_endo -80.35 -48.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.573 2.182 . . . . 0.0 113.086 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -71.19 2.37 4.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 29' ' ' ASN . 52.8 m -112.11 -54.93 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.11 -108.63 1.29 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.956 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -113.51 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.555 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 17.7 ttm -117.7 152.84 34.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.896 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.4 m95 -111.44 89.99 3.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.186 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.564 HG22 ' HA ' ' A' ' 42' ' ' VAL . 15.0 t -134.24 -165.88 1.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.07 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.651 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.8 mtp85 -90.66 155.01 19.15 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.958 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 89' ' ' GLU . 37.8 t -74.5 133.01 32.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.49 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.75 89.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 58.7 m-85 -130.68 -1.18 4.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 0.0 110.477 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 37' ' ' THR . 21.0 t -54.13 118.74 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.067 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.02 -28.15 15.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.982 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.0 mttm -69.35 172.44 7.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.53 -62.45 1.62 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -107.22 141.89 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.651 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt -92.76 -51.92 4.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.475 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 64.4 p -53.47 -179.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.59 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -157.2 -90.81 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.478 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.63 -30.37 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -74.99 -79.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.214 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.532 HD23 HG13 ' A' ' 78' ' ' VAL . 7.1 mt -100.21 113.62 26.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.71 68.32 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.068 0.461 . . . . 0.0 109.928 177.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG23 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -72.7 84.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.768 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 29.3 t -80.14 80.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.591 0.71 . . . . 0.0 109.19 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' A' ' 76' ' ' VAL . 17.4 t -97.17 124.23 41.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.212 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -114.82 105.96 13.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.456 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -70.37 97.95 1.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 m -95.47 125.42 49.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.133 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.564 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 22.1 Cg_endo -97.44 -157.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.196 2.597 . . . . 0.0 111.571 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 m -157.26 135.43 7.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.31 103.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.88 2.386 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.7 m -118.89 -171.48 2.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 t -75.15 -4.63 39.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 67.9 p -65.62 156.71 81.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.044 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 72.1 Cg_endo -73.83 -156.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.521 2.147 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.4 mmt -76.78 -6.26 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.77 109.44 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.75 134.41 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.349 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -122.91 -89.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.18 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' H ' ' HB ' ' A' ' 70' ' ' VAL . . . 137.55 115.69 1.41 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.231 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -156.28 -126.47 0.96 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.932 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt -123.68 -165.09 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.9 m-85 -138.99 101.08 4.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.348 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.46 100.2 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 120.876 0.369 . . . . 0.0 110.814 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 90' ' ' LEU . 26.3 t -100.96 118.95 48.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.138 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 77' ' ' LEU . 79.4 mt -110.35 97.52 6.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.629 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.532 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.81 106.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.9 mtmm -111.75 92.99 18.66 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.211 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 52' ' ' LEU . 8.3 Cg_endo -51.76 102.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.388 2.059 . . . . 0.0 112.606 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.5 mtt180 -63.93 -36.37 83.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.822 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 79.2 mttt -119.45 178.01 4.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -119.82 140.36 50.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.963 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.544 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.45 -113.57 0.71 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.359 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.458 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.9 m80 -115.99 93.2 4.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.816 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.458 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.1 m-70 -113.63 162.27 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.6 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 109' ' ' HIS . 60.0 m -159.31 149.92 19.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 111.723 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 22.6 tp -115.66 93.47 4.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.388 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.8 mt-10 -78.42 92.62 4.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.191 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.3 mt -103.22 123.72 47.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.431 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.9 p -126.66 155.59 37.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.946 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.1 t80 -97.89 82.88 3.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.472 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.561 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.6 t -118.79 158.75 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.455 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 58.5 mtp180 -97.45 98.21 4.78 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.512 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 93' ' ' THR . 93.8 Cg_exo -44.04 -38.44 10.44 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.884 2.39 . . . . 0.0 112.735 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.3 93.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -97.26 -74.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.44 179.7 39.36 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.088 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.463 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.7 mt -94.23 146.25 6.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.587 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 43.6 mtmt -140.28 162.9 47.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.215 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 42.4 Cg_endo -68.02 -38.76 12.13 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.777 2.318 . . . . 0.0 112.089 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.7 -28.22 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.826 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.55 HD22 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -55.22 149.37 12.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.05 166.17 2.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.644 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.6 tpp180 -132.7 164.11 27.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.44 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.644 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.3 t80 -174.47 64.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.635 0.731 . . . . 0.0 109.184 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 89' ' ' GLU . 9.3 m -87.61 92.22 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.228 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 27.5 tp -73.46 93.55 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.644 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.2 m-70 -77.31 140.71 40.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 92.3 mt -143.78 104.08 4.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.39 68.33 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.544 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -45.02 118.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.369 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.963 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.4 m -142.71 -3.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -142.52 108.14 5.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.44 151.7 29.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.7 pt -84.03 -1.16 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.12 153.09 53.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.56 -38.09 20.17 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.425 2.083 . . . . 0.0 112.228 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp 59.95 28.37 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.802 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 m 61.66 16.52 7.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.27 119.91 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -174.7 134.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.169 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -55.87 118.96 5.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.069 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.623 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -123.7 -95.1 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.106 0.479 . . . . 0.0 112.137 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.2 99.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.713 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 53.6 tptt -95.09 92.13 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.244 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.669 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m95 -75.84 105.68 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.743 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 9.9 p -156.93 173.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.239 0.542 . . . . 0.0 111.888 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 m-20 -93.64 -173.59 3.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -175.57 -175.96 0.84 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.153 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.578 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 4.5 m-70 -115.24 -163.77 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.715 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.13 132.37 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 111.985 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.55 20.05 22.08 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.507 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptm -63.3 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.488 HG21 HD23 ' A' ' 77' ' ' LEU . 4.1 m -51.43 99.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.517 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -98.58 101.02 12.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.722 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HG3' HG21 ' A' ' 75' ' ' VAL . 33.4 tt0 -76.79 133.92 39.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.452 HG21 ' HG ' ' A' ' 26' ' ' LEU . 23.2 mt -131.48 94.97 2.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.262 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -84.82 78.27 9.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.026 0.441 . . . . 0.0 110.024 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 24' ' ' ILE . 89.8 mt -68.98 160.15 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.325 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -113.63 164.24 13.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.07 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.08 -145.95 11.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.771 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.417 HD22 ' HB ' ' A' ' 31' ' ' THR . 42.9 t30 -170.66 105.47 0.42 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.367 0.127 . . . . 0.0 110.782 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HD2' ' HA3' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -58.93 -24.03 70.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.478 2.119 . . . . 0.0 112.279 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.417 ' HB ' HD22 ' A' ' 29' ' ' ASN . 22.4 m -60.11 -27.65 67.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.23 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.9 p -59.35 -36.16 75.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.996 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.69 -14.45 6.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.74 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.78 -175.26 2.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.138 0.494 . . . . 0.0 111.315 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.629 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 4.6 ttt -147.98 151.9 36.57 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.851 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -107.6 96.7 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.131 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.629 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 11.9 t -147.39 -166.42 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 54' ' ' VAL . 5.1 mtp180 -84.84 155.7 21.64 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.849 0.357 . . . . 0.0 111.253 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 89' ' ' GLU . 43.2 t -74.35 132.8 32.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.439 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.44 89.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.261 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.418 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 64.9 m-85 -127.6 3.98 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.098 0.475 . . . . 0.0 110.419 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.607 ' HA ' HG23 ' A' ' 37' ' ' THR . 3.6 p -45.22 133.1 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.071 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.71 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.302 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.41 -168.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.75 -46.57 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.225 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.86 -46.95 39.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.744 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 mt 71.83 -60.42 0.52 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 123.401 0.438 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 45.6 p -48.87 -179.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.384 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -156.55 -85.45 0.05 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.89 -30.5 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.585 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -73.74 -76.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.55 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.518 HD23 HG13 ' A' ' 78' ' ' VAL . 8.9 mt -102.85 115.65 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.324 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.18 70.91 0.24 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.21 0.528 . . . . 0.0 109.699 177.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.507 HG23 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -76.63 83.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.312 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.1 t -82.01 86.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 76' ' ' VAL . 31.5 t -96.18 150.95 19.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.792 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' HB2' HG11 ' A' ' 75' ' ' VAL . 55.1 mttm -139.77 114.4 9.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.973 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -94.68 105.52 17.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.945 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.6 m -107.39 108.52 61.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -98.62 92.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.47 2.78 . . . . 0.0 111.71 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 p -86.4 149.87 50.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.627 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.56 177.63 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.726 2.284 . . . . 0.0 112.203 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.1 p -106.13 -22.76 12.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.6 t 56.38 12.04 0.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 35.8 p -121.78 163.23 32.37 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 61.0 Cg_endo -69.12 11.89 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.591 2.194 . . . . 0.0 112.337 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.497 ' H ' ' C ' ' A' ' 65' ' ' THR . 50.9 ttm -117.97 85.56 2.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.104 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.4 t -38.86 126.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.795 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . 177.58 101.77 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.229 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.99 28.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . -56.96 112.94 3.9 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.219 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.14 -127.39 3.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.747 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm -127.34 154.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.876 0.846 . . . . 0.0 111.706 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 1.9 m-85 -130.27 76.2 1.71 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.564 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 23' ' ' GLU . 2.3 p -84.5 110.27 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.001 -177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.445 HG23 ' SG ' ' A' ' 56' ' ' CYS . 90.3 t -106.81 122.06 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.3 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 21' ' ' THR . 81.8 mt -105.36 102.49 11.96 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.905 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.15 108.51 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.951 0.405 . . . . 0.0 111.091 -178.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -113.9 93.78 30.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.493 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.9 Cg_endo -47.99 102.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.567 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.545 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.9 mtt180 -69.16 -36.72 77.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.293 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 87.7 mttt -117.15 170.58 8.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -107.22 123.82 48.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.56 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.77 -128.79 2.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.537 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -106.86 95.58 5.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.377 . . . . 0.0 110.962 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -109.65 161.53 15.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.402 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 109' ' ' HIS . 53.0 m -158.17 148.93 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 111.732 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.583 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.9 tp -115.77 90.39 3.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.571 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.526 ' HB3' HG22 ' A' ' 39' ' ' VAL . 43.5 mt-10 -75.57 94.19 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.583 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.1 mt -101.91 125.33 48.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.483 HG21 ' N ' ' A' ' 92' ' ' TYR . 9.5 p -131.12 158.08 43.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.715 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.6 t80 -97.1 86.44 3.96 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.522 HG22 ' HB ' ' A' ' 42' ' ' VAL . 5.0 t -110.86 167.11 10.49 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.412 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 61.5 mtp180 -102.52 97.68 9.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.393 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.0 Cg_exo -51.44 -31.78 40.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.544 2.163 . . . . 0.0 112.635 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.14 10.12 11.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.2 mm-40 -148.41 -79.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.85 40.92 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.463 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.6 mt -94.87 155.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.894 0.378 . . . . 0.0 111.267 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.3 mtmt -143.76 161.4 46.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.944 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.4 Cg_endo -72.08 -39.7 2.96 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.31 -27.02 69.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.0 m120 -55.97 155.03 6.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.25 161.95 2.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.623 ' HB3' HD21 ' A' ' 10' ' ' ASN . 17.3 tpp180 -131.66 164.28 26.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.746 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.586 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 50.0 t80 -177.58 65.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.345 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 89' ' ' GLU . 10.4 m -87.25 94.12 9.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.7 tp -74.93 93.8 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.669 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.2 m-70 -77.11 138.65 39.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 110.706 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 96.2 mt -142.29 98.06 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -76.08 78.17 2.92 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.56 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.4 t -51.77 123.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.474 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 t -148.37 -43.78 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.777 0.322 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -86.6 118.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.85 174.97 5.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.9 pt -114.05 4.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.96 116.23 12.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.02 110.62 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.456 2.104 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.17 -3.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -147.7 -14.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.5 -10.49 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.145 0.498 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -111.99 0.01 15.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t70 52.64 95.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.051 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.657 HD21 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -131.15 -92.2 0.42 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.919 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 4.1 m-20 -55.22 97.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' HD3' HD11 ' A' ' 108' ' ' LEU . 54.5 tttp -99.63 95.27 6.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.85 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.646 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.54 102.36 12.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.166 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG13 ' HZ1' ' A' ' 12' ' ' LYS . 35.2 m -147.34 -170.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.041 0.448 . . . . 0.0 111.809 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.99 -176.19 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.303 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.2 t -173.83 -175.65 1.1 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 112.293 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 17.5 m80 -116.56 -163.06 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.017 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.56 129.06 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.808 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.67 14.52 36.64 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.287 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -64.08 83.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.451 HG21 HD23 ' A' ' 77' ' ' LEU . 5.1 m -47.2 102.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.809 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.3 m -96.16 100.19 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.389 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -81.34 131.45 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.033 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.9 mt -136.0 104.46 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.78 100.94 12.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.8 mt -95.52 147.72 23.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.466 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -101.94 162.01 13.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.54 -147.49 9.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -174.78 101.87 0.27 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.39 0.138 . . . . 0.0 110.754 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.52 -22.06 49.22 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.491 2.127 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 m -62.61 -30.63 71.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.5 p -62.26 -53.87 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.11 -39.75 0.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.783 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 65.9 m-85 -81.35 -177.46 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.059 0.457 . . . . 0.0 111.375 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.541 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ttm -150.94 152.94 34.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.902 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 9.1 m95 -107.25 87.24 2.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -131.85 -166.55 1.74 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.175 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 22.0 mtp85 -90.24 148.14 23.1 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.217 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 t -68.07 136.29 26.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.544 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.31 1.7 88.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.405 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.461 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 61.5 m-85 -128.24 -1.62 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.535 ' HA ' HG22 ' A' ' 37' ' ' THR . 21.6 t -55.21 107.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.057 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.96 -29.04 8.33 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.959 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 98.0 mttt -68.08 174.92 3.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.982 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.12 -38.93 17.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.14 132.47 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.691 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.3 mt -85.62 -51.68 6.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.996 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.6 t -51.43 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.69 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -157.58 -91.34 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -130.88 -32.64 1.63 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.157 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.9 mm -70.46 -76.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.304 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -104.34 114.48 28.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -66.36 72.99 0.08 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' N ' ' HB2' ' A' ' 48' ' ' SER . 10.9 t -79.44 85.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.164 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.0 t -81.12 83.3 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.418 ' SG ' HG23 ' A' ' 76' ' ' VAL . 36.8 t -98.33 139.87 33.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.369 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -133.28 110.0 9.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.441 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -76.77 101.44 5.84 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.424 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 23.2 m -97.87 109.22 50.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.059 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.525 ' HB2' HG13 ' A' ' 70' ' ' VAL . 74.2 Cg_endo -100.8 97.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.593 2.862 . . . . 0.0 111.266 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.416 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -76.26 140.07 68.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.479 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.442 ' HA ' HG21 ' A' ' 70' ' ' VAL . 20.7 Cg_exo -65.73 -179.04 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.753 2.302 . . . . 0.0 112.158 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.4 t -84.81 -177.59 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -80.92 -64.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 62.6 m -103.05 -48.47 0.17 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.916 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 16.1 Cg_exo -69.24 -157.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.845 2.363 . . . . 0.0 112.282 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -154.62 17.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.72 118.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.02 -67.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.408 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' A' ' 60' ' ' PRO . 98.6 t 53.56 90.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.54 133.37 10.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.528 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -136.03 -128.9 2.78 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -142.96 -165.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.063 0.458 . . . . 0.0 110.991 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -135.32 100.42 4.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.69 104.32 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.926 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.509 HG22 HD12 ' A' ' 90' ' ' LEU . 37.2 t -107.09 120.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.289 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 HD23 HG21 ' A' ' 21' ' ' THR . 80.0 mt -110.38 100.38 9.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.826 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.13 107.26 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.146 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.0 mtmm -109.5 103.58 53.19 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.392 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 52' ' ' LEU . 50.8 Cg_exo -51.59 101.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.204 . . . . 0.0 112.605 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.55 HH11 ' HA ' ' A' ' 50' ' ' GLU . 11.8 mtt180 -71.91 -37.1 70.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.828 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' H ' ' HE1' ' A' ' 86' ' ' HIS . 57.1 mttm -120.39 173.45 7.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -110.05 137.43 47.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.652 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.54 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 141.63 -118.8 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.742 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -110.15 100.38 9.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.0 111.268 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 11.5 m-70 -119.43 156.45 30.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 109' ' ' HIS . 58.1 m -159.63 147.93 17.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.605 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 33.2 tp -104.67 90.12 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.368 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 42.9 mt-10 -72.43 95.15 1.73 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.894 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.605 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 35.8 mt -109.9 133.96 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.45 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.3 p -140.41 153.93 22.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.843 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.5 t80 -97.83 84.57 3.37 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.543 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 4.4 t -116.4 167.83 10.69 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 77.8 mtp180 -100.38 94.53 3.46 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 93' ' ' THR . 77.7 Cg_exo -43.45 -24.63 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.802 2.334 . . . . 0.0 113.371 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -79.47 -62.21 1.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' A' ' 94' ' ' ARG . 1.6 pp20? -72.23 -39.1 68.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.674 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.8 -165.14 24.64 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.481 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -112.98 132.9 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 111.748 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.431 ' HE3' ' CD ' ' A' ' 97' ' ' GLU . 5.8 mttt -120.57 156.26 55.97 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.8 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.53 -47.42 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.918 2.412 . . . . 0.0 112.73 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -53.75 -17.7 2.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.832 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 11.3 m120 -63.76 157.22 24.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -57.51 159.22 5.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.244 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.657 ' HB3' HD21 ' A' ' 10' ' ' ASN . 13.5 tpp180 -129.68 164.34 24.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.029 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.594 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.0 t80 -174.85 72.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.05 96.02 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.397 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 20.6 tp -76.46 93.3 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.646 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.7 m-70 -77.55 144.87 37.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.453 HD21 HG21 ' A' ' 14' ' ' VAL . 75.1 mt -145.67 113.37 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.23 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.39 65.29 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -46.06 129.01 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.443 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.937 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.8 p -146.41 -9.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -147.36 122.49 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.06 136.52 52.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -81.53 -17.51 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.552 ' HB1' ' HD3' ' A' ' 4' ' ' PRO . . . -166.47 -49.94 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.897 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.552 ' HD3' ' HB1' ' A' ' 3' ' ' ALA . 72.9 Cg_exo -49.55 120.82 6.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.535 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.6 tp -86.61 -67.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.9 t -87.5 174.05 8.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.752 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.598 HG21 ' H ' ' A' ' 9' ' ' ASP . 14.9 p -83.56 138.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 4.5 mptp? -106.23 28.36 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.598 ' H ' HG21 ' A' ' 7' ' ' VAL . 18.4 t70 -35.5 121.78 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.809 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.641 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -118.46 -89.13 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.568 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.6 OUTLIER -32.36 99.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.207 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' HD3' HD12 ' A' ' 108' ' ' LEU . 19.8 ptmt -93.88 73.57 4.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -49.62 104.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 110' ' ' LEU . 28.2 m -146.62 -175.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 112.503 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -110.83 179.68 3.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.641 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.439 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.8 t -177.08 -173.12 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 112.023 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 64.1 m80 -119.15 -167.47 1.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.038 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 25.9 t -84.46 139.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 112.182 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.4 13.15 10.1 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.731 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.1 tptt -59.92 82.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.461 HG21 HD23 ' A' ' 77' ' ' LEU . 3.7 m -54.39 98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.381 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -94.96 101.24 13.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.4 tt0 -84.18 130.15 34.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.55 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.484 HD12 HD23 ' A' ' 108' ' ' LEU . 46.9 mt -136.47 101.07 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.205 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -81.69 109.82 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.5 mt -104.63 152.35 22.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -108.48 159.57 16.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.979 0.418 . . . . 0.0 110.443 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.537 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 178.81 -39.14 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.172 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t30 65.38 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.77 -0.215 . . . . 0.0 110.951 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 178.33 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.585 2.19 . . . . 0.0 112.681 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p 47.43 25.11 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.798 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.9 m -117.94 -60.15 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.95 -103.86 0.57 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.671 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.453 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -105.83 -166.45 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.59 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 3.3 ttt -118.88 151.21 38.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.966 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -108.39 89.88 3.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 42' ' ' VAL . 14.5 t -135.58 -167.05 1.95 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.413 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.693 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.0 mtp85 -89.97 147.23 23.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.703 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 42.5 t -63.92 132.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.697 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.31 14.23 79.12 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.809 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.476 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 63.2 m-85 -136.44 0.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.734 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.599 ' HA ' HG22 ' A' ' 37' ' ' THR . 5.3 p -45.28 123.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.175 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -39.19 2.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.536 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 94.1 mttt -60.32 165.96 3.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.02 -45.5 12.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.782 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.36 135.49 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.8 mt -100.32 -50.19 4.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.14 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HB ' ' A' ' 54' ' ' VAL . 88.6 p -52.64 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.495 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.78 -86.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.183 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.61 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.97 -34.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 52' ' ' LEU . 37.9 mm -61.52 -62.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.748 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 80' ' ' PRO . 38.6 mt -126.79 134.46 50.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.947 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -74.07 67.05 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 4.0 t -73.82 82.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.059 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 t -80.6 81.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.51 0.672 . . . . 0.0 109.215 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 76' ' ' VAL . 24.4 t -91.8 135.35 33.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.873 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -127.52 105.14 8.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -81.62 111.92 18.36 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.518 HG23 HG21 ' A' ' 70' ' ' VAL . 2.6 m -103.27 100.35 17.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.806 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HA ' ' HA3' ' A' ' 72' ' ' GLY . 39.6 Cg_endo -102.15 9.87 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.799 3.0 . . . . 0.0 113.401 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -85.27 137.31 37.08 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.349 -178.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 61' ' ' THR . 92.6 Cg_endo -86.26 -178.89 2.94 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.793 2.329 . . . . 0.0 112.269 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 66' ' ' PRO . 8.0 t -163.35 -172.41 2.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.802 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -104.07 -58.54 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.623 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 58.5 m -106.19 -49.72 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.03 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 15.7 Cg_exo -69.08 122.16 9.01 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.758 2.306 . . . . 0.0 112.298 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 94.6 mmm -145.05 19.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.117 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -107.72 28.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.087 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.52 -29.29 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.518 HG21 HG23 ' A' ' 59' ' ' THR . 3.5 p -137.67 82.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.305 0.574 . . . . 0.0 110.995 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.77 16.5 0.72 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.083 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 60' ' ' PRO . . . 104.12 29.67 5.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.526 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.4 pt -101.29 -168.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.174 0.511 . . . . 0.0 111.349 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HH ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -142.71 97.73 3.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.172 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 75' ' ' VAL . 3.1 p -92.67 104.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 110.662 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.448 HG23 ' SG ' ' A' ' 56' ' ' CYS . 23.3 t -99.68 127.16 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.586 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 21' ' ' THR . 85.9 mt -111.71 98.7 7.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.851 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.626 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.95 105.11 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -104.46 98.81 15.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.592 ' HA ' HD23 ' A' ' 52' ' ' LEU . 93.2 Cg_exo -43.05 100.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.066 2.511 . . . . 0.0 113.105 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.61 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.5 mtt180 -76.56 -29.73 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.118 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 79.5 mttt -122.4 154.88 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -96.66 124.62 40.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.031 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.541 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.35 -159.53 24.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.591 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -67.12 117.77 9.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.433 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 88.8 m-70 -145.43 170.04 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 88' ' ' LEU . 51.4 m -161.28 159.65 28.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.119 0.485 . . . . 0.0 112.202 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.626 HD21 HG22 ' A' ' 78' ' ' VAL . 10.1 tp -119.13 93.29 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.467 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.67 95.95 1.94 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 49.7 mt -107.98 115.89 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 92' ' ' TYR . 10.6 p -120.16 157.17 22.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.1 t80 -95.98 79.8 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.22 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.609 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 6.3 t -108.45 150.61 27.18 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 17.2 mtp180 -92.03 102.65 6.59 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.821 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 93' ' ' THR . 50.2 Cg_exo -55.25 -30.86 73.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.597 2.198 . . . . 0.0 112.437 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -65.04 -25.14 67.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.464 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -122.65 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.282 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.65 -173.73 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.373 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.464 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.1 mt -97.26 139.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 111.127 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -132.65 166.84 26.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.22 -41.2 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.822 2.348 . . . . 0.0 112.334 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.91 -18.01 41.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.529 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -60.85 148.19 40.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 168.3 2.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.0 tpp180 -131.75 164.18 26.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.445 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 45.2 t80 -171.81 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.507 -0.769 . . . . 0.0 108.955 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -86.7 91.98 8.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.574 -179.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.2 tp -70.69 90.99 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.075 0.464 . . . . 0.0 110.277 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 31.6 m-70 -77.38 139.96 39.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.693 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.492 HD22 HD13 ' A' ' 108' ' ' LEU . 97.6 mt -144.06 108.82 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -84.09 61.29 6.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.541 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.8 t -40.55 140.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.942 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.999 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.3 t -103.51 -63.66 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 110.996 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 62.17 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp 58.63 -173.09 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.09 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -114.4 -28.52 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.036 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.65 149.96 68.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.163 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -66.13 -0.9 4.56 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.677 2.251 . . . . 0.0 112.412 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.16 -31.84 63.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.013 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -89.21 143.48 26.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.49 135.33 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.12 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.631 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -108.09 -3.91 18.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -36.63 120.74 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.367 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.621 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.1 p-10 -126.0 -94.1 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 22.1 m-20 -38.45 98.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.539 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -98.38 87.9 3.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.644 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.8 m95 -78.72 98.27 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.752 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG22 HD21 ' A' ' 110' ' ' LEU . 30.4 m -147.3 -172.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 111.961 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.76 -178.55 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.798 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.492 ' HG1' ' H ' ' A' ' 17' ' ' HIS . 2.0 t -174.74 -174.06 0.78 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.06 0.457 . . . . 0.0 111.927 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 56.6 m80 -116.04 -173.72 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.012 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.81 135.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.249 0.547 . . . . 0.0 112.05 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 60.26 14.18 32.09 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.883 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.574 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.0 tptm -58.13 84.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.24 0.52 . . . . 0.0 109.902 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.497 HG21 HD23 ' A' ' 77' ' ' LEU . 3.0 m -56.54 100.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -96.81 103.72 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.546 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 77' ' ' LEU . 38.2 tt0 -75.9 117.01 17.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.046 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.66 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 67.5 mt -114.15 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.301 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.402 ' CD2' HG21 ' A' ' 75' ' ' VAL . 10.2 m170 -100.93 104.29 15.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.415 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 36.3 mt -96.08 163.08 13.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.308 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -101.88 163.56 12.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.096 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.29 -146.31 16.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.516 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 32' ' ' THR . 8.0 p-10 -172.93 142.26 1.04 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.517 0.199 . . . . 0.0 111.2 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 83.4 Cg_endo -82.3 -3.3 11.46 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.553 2.169 . . . . 0.0 112.285 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.4 p -82.16 -41.44 20.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.696 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 29' ' ' ASN . 1.7 t -54.65 -43.4 72.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.317 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.55 -63.31 0.48 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.16 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.439 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 81.2 m-85 -60.64 175.85 0.43 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.242 0.544 . . . . 0.0 111.68 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.54 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.2 ttm -146.86 154.26 41.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.661 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 3.4 m95 -110.92 91.8 3.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -134.73 -163.8 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.083 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -83.23 150.52 26.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.627 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG22 ' HG3' ' A' ' 89' ' ' GLU . 11.1 t -73.44 129.7 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.359 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.89 80.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 91.6 m-85 -136.2 4.14 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.543 ' HA ' HG23 ' A' ' 37' ' ' THR . 7.2 p -49.17 133.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.253 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.67 -34.8 2.91 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.83 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 57.4 mttp -59.75 164.0 4.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.54 -37.84 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.38 128.47 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.12 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.9 mt -89.41 -50.49 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.113 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.417 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 54.1 p -54.18 -171.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.863 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -165.89 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 12.5 pt-20 -137.87 -34.62 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.486 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.8 mm -70.58 -77.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.502 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 80' ' ' PRO . 11.3 mt -101.46 119.49 38.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.404 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.95 70.36 0.35 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.094 0.473 . . . . 0.0 109.887 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.585 HG23 HG12 ' A' ' 78' ' ' VAL . 19.8 t -72.58 84.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.896 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.8 t -81.04 91.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 54.0 t -90.25 130.27 36.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.113 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 54.8 mttm -124.98 80.25 1.86 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.842 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.54 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -64.73 119.59 10.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.617 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.5 m -100.43 100.62 12.52 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 40.5 Cg_endo -102.7 -3.99 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.839 3.026 . . . . 0.0 113.753 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.462 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -63.72 140.72 97.86 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.029 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 61' ' ' THR . 31.7 Cg_exo -59.53 177.99 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.517 2.144 . . . . 0.0 112.37 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.8 t -129.1 170.53 13.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -66.95 -39.0 87.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.631 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 72.1 m -156.42 -50.26 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.791 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 8.2 Cg_exo -73.51 -157.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.862 2.375 . . . . 0.0 112.133 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.3 mtt -142.14 19.16 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.64 148.96 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.18 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.61 -44.52 3.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.602 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 70' ' ' VAL . 5.6 p -153.44 91.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 111.134 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.35 41.77 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.415 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.2 42.46 0.51 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -87.23 -25.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.089 -0.556 . . . . 0.0 112.456 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 11.6 m-85 41.75 87.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -88.39 131.71 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 38.2 t -137.49 97.61 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.525 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 21' ' ' THR . 79.2 mt -92.37 102.52 15.0 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.672 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.79 109.14 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 111.3 -178.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -113.21 92.78 23.25 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.08 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.454 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.1 Cg_endo -46.97 102.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 112.619 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 19.9 mtt180 -66.37 -33.49 75.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.792 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 52.5 mttm -119.08 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -123.13 143.92 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.62 -117.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.587 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.9 m80 -112.72 94.33 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.103 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.461 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -112.51 161.26 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.425 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.9 m -159.22 140.4 12.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.956 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.672 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -112.51 82.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.52 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 13.2 pt-20 -80.43 128.06 33.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.149 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 88' ' ' LEU . 45.7 mt -122.64 162.51 21.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.917 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -156.08 150.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 111.587 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -93.6 85.91 5.03 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.569 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 4.3 t -118.53 161.84 19.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 72.9 mtp180 -99.01 97.95 5.74 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -47.83 -32.62 17.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.767 2.311 . . . . 0.0 113.378 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.06 11.64 17.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -151.38 1.36 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.26 -175.96 49.96 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.305 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -104.17 154.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.909 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.532 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.6 mmtt -132.47 168.72 16.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.62 -49.77 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.28 2.653 . . . . 0.0 112.702 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.06 -13.51 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.623 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -59.91 144.43 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.414 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -55.5 163.35 1.29 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.9 tpt180 -130.55 161.29 31.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.624 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 43.3 t80 -171.99 75.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.263 0.554 . . . . 0.0 109.643 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.722 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.9 m -97.71 102.38 14.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.833 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.7 tp -84.05 90.22 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 8.8 m-70 -74.33 142.92 45.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 0.0 110.109 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.556 HD21 HG22 ' A' ' 14' ' ' VAL . 88.8 mt -146.39 99.8 3.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.859 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t30 -75.91 73.27 2.82 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.4 148.08 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.726 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.1 t -91.71 117.84 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -131.46 12.36 4.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt -64.03 153.92 35.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.14 -18.44 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.83 150.71 17.72 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 57.8 Cg_endo -71.03 148.66 57.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.526 2.151 . . . . 0.0 112.348 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -138.13 -64.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -149.52 -70.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 m -81.33 120.21 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.35 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 4' ' ' PRO . 72.9 mmtt -153.24 129.99 10.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.15 124.14 27.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -121.09 -84.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.964 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.527 ' H ' HD21 ' A' ' 10' ' ' ASN . 13.2 m-20 -32.11 101.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.795 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -95.35 90.89 5.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.29 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.661 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -78.26 103.15 8.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.761 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.48 HG22 HD21 ' A' ' 110' ' ' LEU . 20.9 m -149.93 -172.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 2.9 p-10 -112.88 -177.77 3.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.36 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.558 HG21 HG21 ' A' ' 112' ' ' VAL . 1.5 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.105 0.478 . . . . 0.0 112.255 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m80 -113.52 -167.77 1.25 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -89.64 138.07 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 112.294 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.28 17.95 19.67 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.738 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.74 81.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.495 HG23 HD21 ' A' ' 77' ' ' LEU . 9.2 m -48.21 97.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.5 m -93.09 101.43 13.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.722 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HA ' HD22 ' A' ' 77' ' ' LEU . 34.6 tt0 -75.51 119.22 19.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.72 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.29 93.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.407 ' CD2' HG21 ' A' ' 75' ' ' VAL . 10.3 m170 -86.68 104.17 15.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 52.7 mt -95.53 160.96 14.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.23 163.43 12.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.82 -160.63 27.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.68 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' OD1' ' HD2' ' A' ' 30' ' ' PRO . 65.6 t30 -168.95 126.53 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD2' ' OD1' ' A' ' 29' ' ' ASN . 78.4 Cg_exo -50.88 -58.63 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.695 2.263 . . . . 0.0 113.078 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.5 t -82.24 50.91 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.3 m -141.89 -68.47 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.492 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.83 -117.9 2.0 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.246 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 -93.89 -172.66 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.186 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 19.9 ttm -113.66 152.32 30.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.433 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.512 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 8.0 m95 -109.36 87.12 2.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -134.78 -165.07 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.625 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.7 mtp85 -90.34 156.78 18.01 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 89' ' ' GLU . 39.6 t -76.12 132.02 33.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.521 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.95 88.98 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.407 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.51 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 57.6 m-85 -131.92 -0.41 3.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 110.414 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HA ' HG23 ' A' ' 37' ' ' THR . 12.7 t -55.58 119.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.07 -27.05 20.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 65.8 mttm -69.51 172.15 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.66 -62.52 1.5 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.7 141.38 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.143 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt -91.99 -51.99 4.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.927 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.424 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.0 p -51.26 179.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.925 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.78 -87.03 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.189 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -131.81 -30.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.2 mm -72.96 -76.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.509 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.524 HD21 ' HA ' ' A' ' 80' ' ' PRO . 9.6 mt -102.91 116.65 32.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.511 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -69.58 69.87 0.28 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 109.848 178.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.534 HG23 ' HD2' ' A' ' 38' ' ' ARG . 24.7 t -73.53 85.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.725 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.5 t -77.34 85.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.395 0.617 . . . . 0.0 109.41 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.24 136.09 52.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.134 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.655 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 68.0 mttm -135.72 50.68 2.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.654 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -52.59 116.6 2.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.815 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.42 ' N ' ' HD1' ' A' ' 58' ' ' TYR . 29.4 m -97.32 101.88 11.11 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.405 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 45.5 Cg_endo -106.74 27.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.469 3.446 . . . . 0.0 111.799 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.3 t -107.87 148.18 36.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 23.4 Cg_exo -64.69 146.34 88.47 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.836 2.358 . . . . 0.0 112.426 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.1 t -79.97 -164.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.515 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.9 m -51.69 -65.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 p -104.01 153.91 38.51 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.241 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.72 15.24 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.814 2.342 . . . . 0.0 112.485 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.8 mtp -79.64 -7.16 58.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.4 29.22 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.98 -121.26 10.73 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.626 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 41.7 t -88.07 -104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.427 ' N ' HG11 ' A' ' 70' ' ' VAL . . . -156.67 -68.37 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.89 44.57 88.66 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.604 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -89.77 -22.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 7.9 m-85 39.58 90.41 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.117 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 99.2 t -92.73 95.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.681 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.29 108.86 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.731 0.3 . . . . 0.0 111.773 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 23' ' ' GLU . 40.3 mt -95.6 110.81 22.86 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.95 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.501 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -101.7 104.52 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.888 0.375 . . . . 0.0 110.965 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.1 mtmt -107.79 101.36 40.05 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.339 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.524 ' HA ' HD21 ' A' ' 52' ' ' LEU . 54.0 Cg_exo -51.52 97.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.664 2.243 . . . . 0.0 112.74 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.567 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -62.89 -36.75 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 58.6 mttm -117.25 -172.62 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.569 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -133.31 125.71 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.831 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.527 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.32 -98.61 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.016 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.414 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 49.4 t-80 -122.09 105.57 10.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.74 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.479 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.7 m80 -124.41 159.98 29.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.429 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 52' ' ' LEU . 32.4 m -159.59 148.7 18.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.704 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.7 tp -120.46 91.52 3.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.53 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.51 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.4 mt-10 -75.86 88.63 2.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.24 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.624 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.3 mt -98.45 122.84 42.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 93' ' ' THR . 9.2 p -125.77 154.54 34.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.675 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' MET . 9.7 t80 -96.51 82.41 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.212 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 91' ' ' VAL . 6.2 t -121.48 151.93 39.7 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 57.5 mtp180 -88.79 102.04 3.55 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.26 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.505 ' HB3' HG11 ' A' ' 42' ' ' VAL . 9.3 Cg_endo -52.99 -33.44 62.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.753 2.302 . . . . 0.0 112.429 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -64.52 -32.72 74.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.19 -72.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.24 38.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.996 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.6 mt -96.44 143.68 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.7 mtmt -137.93 163.06 50.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.146 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.3 Cg_endo -67.92 -38.76 12.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.762 2.308 . . . . 0.0 112.032 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.69 -28.99 69.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.53 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -54.74 147.49 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.024 179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 165.91 1.95 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.9 tpp180 -131.75 164.1 26.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.071 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.647 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 39.1 t80 -176.06 66.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.452 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 89' ' ' GLU . 18.2 m -90.07 97.46 11.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.061 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.3 tp -77.98 93.86 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.266 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.661 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.2 m-70 -77.63 144.0 37.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 14' ' ' VAL . 79.1 mt -144.64 104.56 4.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.627 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.9 t30 -81.03 61.53 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.558 HG21 HG21 ' A' ' 16' ' ' THR . 2.1 t -43.33 131.18 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.569 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.929 179.851 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -87.92 135.37 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -147.85 168.51 22.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt -131.42 -173.32 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.0 tt -129.89 -26.9 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.562 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . . . -63.09 -48.97 83.06 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.687 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 3' ' ' ALA . 48.4 Cg_exo -56.25 106.59 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.231 1.954 . . . . 0.0 112.326 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.87 -46.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -140.17 -16.61 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.95 -171.7 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -167.46 131.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.59 122.37 18.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.0 OUTLIER -128.12 -93.03 0.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 112.056 -179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -44.89 102.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.752 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HG3' HG23 ' A' ' 14' ' ' VAL . 22.7 tptm -98.79 90.95 4.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.301 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.1 m95 -82.13 101.36 10.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.498 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 110' ' ' LEU . 11.3 m -152.7 -175.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.407 0.622 . . . . 0.0 112.411 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -97.07 -174.29 2.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.286 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -175.6 -175.69 0.8 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.188 0.518 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.563 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 38.8 m80 -114.12 -161.51 0.77 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.694 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.88 131.84 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 0.0 111.767 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 14.29 14.44 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.485 -0.779 . . . . 0.0 113.351 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.563 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.2 84.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.442 HG23 HD23 ' A' ' 77' ' ' LEU . 6.8 m -46.22 98.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.718 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 m -92.94 98.38 11.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.411 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -80.22 133.92 36.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.034 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG21 ' HG ' ' A' ' 26' ' ' LEU . 40.7 mt -135.97 106.63 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.732 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -88.78 91.26 8.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.689 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.6 mt -88.27 144.62 26.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.269 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -101.79 165.66 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.78 -134.15 2.78 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.412 ' HB3' HG21 ' A' ' 32' ' ' THR . 59.5 t30 -175.72 90.46 0.28 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.505 0.193 . . . . 0.0 110.61 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HB3' ' OH ' ' A' ' 58' ' ' TYR . 11.4 Cg_endo -55.49 -22.78 36.18 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.953 2.435 . . . . 0.0 113.458 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.0 t -78.89 13.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 29' ' ' ASN . 68.5 p -98.96 -60.26 1.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.332 . . . . 0.0 111.039 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 -41.95 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.751 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 70.1 m-85 -82.96 177.75 8.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.668 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 13.3 ttm -146.95 148.95 32.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.408 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -103.24 80.02 1.79 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.749 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.403 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 12.1 t -124.68 -164.74 1.3 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.344 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 5.9 mtp85 -87.19 135.82 33.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.045 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 89' ' ' GLU . 39.3 t -50.27 152.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.25 1.1 18.98 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.456 ' HE2' HH21 ' A' ' 38' ' ' ARG . 24.8 m-85 -127.07 43.72 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.473 0.654 . . . . 0.0 110.536 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 93' ' ' THR . 2.4 p -80.0 98.19 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.45 -19.38 22.03 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.061 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -72.87 173.41 9.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.365 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.1 -62.81 1.4 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.03 146.16 7.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.666 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.7 mt -105.52 -52.94 2.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -50.13 173.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.762 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.65 -87.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.16 -31.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.261 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 mm -73.59 -73.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.417 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.691 HD22 ' HA ' ' A' ' 80' ' ' PRO . 53.3 mt -105.5 118.31 36.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.414 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.29 69.57 0.38 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.252 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.504 HG23 ' HD2' ' A' ' 38' ' ' ARG . 12.4 t -76.19 86.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.178 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.8 t -82.79 87.4 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.407 ' SG ' HG23 ' A' ' 76' ' ' VAL . 40.2 t -101.63 130.56 47.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.726 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -121.27 110.26 15.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.937 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.48 110.63 17.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.556 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 3.3 m -115.09 110.67 45.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.653 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 27.1 Cg_endo -100.73 14.06 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.328 2.685 . . . . 0.0 112.21 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 85.2 m -79.49 -50.55 1.29 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 80.2 Cg_exo -40.07 98.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.864 3.043 . . . . 0.0 112.938 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -68.58 127.06 31.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -123.45 -22.91 4.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -60.94 156.0 50.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.72 9.43 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.457 2.105 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.9 mtm -144.14 -98.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.83 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -143.26 142.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.958 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.6 -177.05 46.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 60' ' ' PRO . 21.8 t -127.64 73.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.35 101.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.309 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.623 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -101.03 -123.01 5.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.495 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.0 pt -144.69 -168.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -126.35 102.4 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.088 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -88.97 106.03 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.988 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.407 HG23 ' SG ' ' A' ' 56' ' ' CYS . 41.6 t -107.89 122.13 61.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.12 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' HD21 ' A' ' 77' ' ' LEU . 82.9 mt -112.03 102.61 10.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.811 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -96.42 106.82 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -178.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -110.78 94.53 20.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.691 ' HA ' HD22 ' A' ' 52' ' ' LEU . 2.6 Cg_endo -48.29 107.24 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.16 . . . . 0.0 112.506 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.497 HH11 ' HA ' ' A' ' 50' ' ' GLU . 12.8 mtt180 -73.31 -43.67 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.149 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 88.2 mttt -108.87 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -110.09 146.91 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.773 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.95 -125.69 4.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.385 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 56.9 t-80 -110.63 106.06 15.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.2 m-70 -117.29 164.77 14.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 109' ' ' HIS . 67.7 m -159.59 145.32 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.967 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 13.5 tp -111.81 91.91 3.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.493 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.1 mt-10 -75.57 104.24 6.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 66.2 mt -112.97 132.28 55.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 92' ' ' TYR . 7.5 p -138.09 155.48 29.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -93.42 76.39 4.48 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.599 ' HA ' HD21 ' A' ' 103' ' ' ASN . 5.6 t -105.71 155.11 19.58 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 34' ' ' TYR . 28.1 mtp180 -86.24 104.18 5.12 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.475 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.0 Cg_endo -55.98 -30.08 76.44 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.756 2.304 . . . . 0.0 112.181 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.6 -25.78 61.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.836 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.5 -88.32 0.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.729 0.3 . . . . 0.0 111.655 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.53 -166.12 28.94 Favored Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.562 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.504 HG12 ' HG1' ' A' ' 93' ' ' THR . 3.0 mt -103.17 145.11 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.834 0.35 . . . . 0.0 111.231 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -134.57 168.73 16.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.608 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.12 -38.96 11.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.725 2.283 . . . . 0.0 112.47 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.7 -1.8 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.439 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.599 HD21 ' HA ' ' A' ' 93' ' ' THR . 3.3 m120 -76.18 141.26 41.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.746 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 91' ' ' VAL . 5.1 tt0 -58.16 162.04 3.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.0 tpt180 -130.2 160.01 35.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.251 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.603 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.6 t80 -175.24 72.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.461 0.648 . . . . 0.0 109.472 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.425 HG21 ' HA ' ' A' ' 89' ' ' GLU . 8.1 m -91.5 96.62 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.15 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.0 tp -75.97 91.73 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.9 m-70 -77.05 137.13 38.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.491 HD21 HG21 ' A' ' 14' ' ' VAL . 94.0 mt -143.73 112.7 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.375 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.444 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.1 t30 -86.7 85.51 7.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 17' ' ' HIS . 14.8 t -55.5 124.35 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.324 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.643 ' HZ3' ' HB3' ' A' ' 113' ' ' LYS . 3.2 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.0 m -130.39 7.01 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -63.44 -30.2 71.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.85 165.41 25.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.7 pt -101.24 -7.2 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 74.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 152.9 31.07 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.63 2.22 . . . . 0.0 112.215 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 5' ' ' LEU . 3.6 mm? -104.26 -68.65 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -81.91 175.07 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.598 HG11 ' H ' ' A' ' 9' ' ' ASP . 16.7 t -79.17 147.99 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 2.9 mppt? -99.42 18.75 17.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.598 ' H ' HG11 ' A' ' 7' ' ' VAL . 17.0 t70 -37.25 133.06 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.821 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER -86.6 -86.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.015 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 107' ' ' THR . 25.5 t70 -144.34 -128.82 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.62 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 50.8 tptt -160.24 172.16 17.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.752 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 4.5 m0 -120.46 123.99 44.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.746 0.418 . . . . 0.0 110.334 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.672 HG21 ' HB2' ' A' ' 109' ' ' HIS . 2.3 m -150.68 159.21 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.673 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -50.4 168.2 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.313 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 HG21 ' HA ' ' A' ' 112' ' ' VAL . 3.1 t -174.19 -173.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.426 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.566 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 26.2 m80 -109.23 -168.58 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.625 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.83 138.45 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.151 0.501 . . . . 0.0 111.891 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.61 17.48 20.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.294 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.2 tptp -66.07 80.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.484 HG21 HD23 ' A' ' 77' ' ' LEU . 5.1 m -44.46 101.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.625 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 m -98.97 102.62 14.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.754 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.2 127.56 32.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.584 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG21 ' HG ' ' A' ' 26' ' ' LEU . 48.1 mt -130.9 105.23 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.907 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -87.19 96.36 10.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HG ' HG21 ' A' ' 24' ' ' ILE . 20.7 mt -91.12 145.6 24.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -100.46 162.99 12.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.68 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.76 -138.95 4.02 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.373 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.478 ' HB3' HG22 ' A' ' 32' ' ' THR . 4.2 t30 -174.93 91.85 0.3 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.552 ' HD2' ' HA3' ' A' ' 71' ' ' GLY . 69.8 Cg_exo -51.6 -30.76 37.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.431 ' HB ' HD22 ' A' ' 29' ' ' ASN . 0.5 OUTLIER -57.4 -30.05 64.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.838 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 29' ' ' ASN . 73.6 p -59.43 -65.9 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.728 0.299 . . . . 0.0 111.243 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.12 -38.23 0.53 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.691 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -77.51 -178.96 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.79 150.05 29.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.7 m95 -103.04 82.9 2.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.673 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.613 HG23 ' HA ' ' A' ' 42' ' ' VAL . 10.0 t -124.88 -174.73 3.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.643 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.3 mtp85 -83.12 150.63 26.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 89' ' ' GLU . 41.5 t -64.47 127.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.83 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.95 18.46 67.51 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.064 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 62.4 m-85 -138.02 0.86 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 110.652 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 37' ' ' THR . 5.6 p -47.05 125.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.257 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.67 -35.69 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.859 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 61.7 mttp -60.48 170.18 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.54 -62.15 1.76 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.848 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.83 144.2 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.692 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.7 mt -102.52 -49.18 3.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.44 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 35.3 t -51.05 173.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.766 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -159.04 -85.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.256 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.07 -33.98 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.431 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.9 mm -67.42 -78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.544 HD22 ' HA ' ' A' ' 80' ' ' PRO . 96.4 mt -106.42 119.3 38.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.94 72.29 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 38' ' ' ARG . 7.6 t -80.81 86.18 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.498 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.52 85.7 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.454 ' SG ' HG23 ' A' ' 76' ' ' VAL . 33.8 t -101.91 149.34 24.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.741 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -139.64 112.99 8.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.879 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.27 107.69 11.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.488 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.6 m -103.05 107.01 53.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.923 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -101.08 92.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 123.647 2.898 . . . . 0.0 111.312 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.449 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -75.62 140.22 71.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.233 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.449 ' HD2' HG23 ' A' ' 61' ' ' THR . 24.1 Cg_exo -63.65 179.78 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.21 . . . . 0.0 112.276 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -136.12 -17.4 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.763 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t 179.68 -52.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.569 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -120.13 155.21 55.93 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.11 12.41 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 112.44 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.2 mtt -113.61 -79.28 0.58 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.07 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.97 138.12 23.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.45 86.33 1.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.82 81.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 110.777 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.552 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . -100.3 129.13 9.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.881 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -143.12 -138.51 3.43 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.009 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -145.58 -167.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 111.12 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -133.52 100.86 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.071 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -85.11 107.53 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 110.558 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 ' SG ' ' A' ' 56' ' ' CYS . 40.3 t -112.71 120.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 21' ' ' THR . 73.2 mt -108.58 99.84 9.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -96.55 108.55 21.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.457 . . . . 0.0 111.698 -178.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 31.7 mtmm -110.16 98.41 35.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD22 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.62 109.03 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.368 2.046 . . . . 0.0 112.778 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.4 mtt180 -81.06 -36.4 30.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.086 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -108.68 173.63 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.169 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.418 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 63.9 mtp180 -110.76 148.19 32.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.905 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.13 -164.52 13.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -70.5 102.0 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.687 0.28 . . . . 0.0 110.714 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.43 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 99.2 m-70 -128.04 149.95 50.15 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.483 0.659 . . . . 0.0 111.33 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.544 HG22 ' HB ' ' A' ' 107' ' ' THR . 40.3 m -150.95 146.81 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.483 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.567 ' HB2' HG13 ' A' ' 78' ' ' VAL . 20.9 tp -91.16 106.79 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.5 mt-10 -80.82 109.11 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.022 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 55.6 mt -119.03 143.2 47.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.067 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 161.57 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.398 0.618 . . . . 0.0 112.411 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.0 t80 -104.23 85.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.48 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 2.2 t -114.58 165.66 12.54 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' H ' ' HG1' ' A' ' 93' ' ' THR . 71.3 mtp180 -102.95 93.59 4.56 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 93' ' ' THR . 91.7 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.632 2.221 . . . . 0.0 112.627 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.89 -40.21 63.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.24 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -103.22 -68.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.92 -178.99 37.56 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.035 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.491 HG21 ' HB ' ' A' ' 93' ' ' THR . 7.9 mt -90.75 144.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.999 0.428 . . . . 0.0 111.249 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.523 ' HG3' HD22 ' A' ' 103' ' ' ASN . 1.5 mttp -132.61 166.57 28.03 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.39 -40.78 29.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.853 2.369 . . . . 0.0 112.377 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.45 -13.01 35.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.553 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.82 134.77 56.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 111.45 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.74 164.67 2.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.072 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 2.1 ttp180 -139.79 158.48 44.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 0.0 111.649 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.821 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 47.4 t80 -162.65 103.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.009 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.619 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.7 OUTLIER -102.41 109.42 21.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.51 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 110' ' ' LEU . 25.9 tp -72.5 126.12 29.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.183 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 2.8 p80 -65.66 65.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.387 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.537 HD12 HD21 ' A' ' 108' ' ' LEU . 80.2 mt -102.07 53.93 0.8 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 30.1 t30 -71.09 76.52 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.4 t -53.84 150.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.763 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.451 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.1 p -143.77 157.25 44.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -150.95 154.26 36.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -71.76 171.22 12.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 pt -91.99 17.0 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.201 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.2 109.04 1.23 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.93 146.22 25.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 112.476 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.418 ' N ' HD13 ' A' ' 5' ' ' LEU . 7.5 mp -95.46 -13.62 24.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.4 m -135.32 -178.93 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 t -107.39 94.99 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 89.91 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.293 0.568 . . . . 0.0 110.649 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.54 27.93 4.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.822 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.84 -63.23 1.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.236 0.541 . . . . 0.0 111.08 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' HA ' ' N ' ' A' ' 107' ' ' THR . 1.2 p30 -54.86 104.07 0.11 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.286 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HD3' HD12 ' A' ' 108' ' ' LEU . 22.0 ptmt -101.79 119.69 39.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.028 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.749 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -103.71 111.94 24.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -148.31 -176.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.663 0.744 . . . . 0.0 112.882 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -93.8 -173.0 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.429 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -172.8 -174.54 1.13 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.416 0.627 . . . . 0.0 112.651 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 30.0 m80 -120.44 -148.52 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.382 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.7 t -108.93 128.13 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.589 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.13 20.18 19.62 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.262 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptp -65.95 84.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.4 m -47.17 102.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.851 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.3 m -98.98 93.62 6.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.11 127.95 33.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.156 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 108' ' ' LEU . 38.2 mt -133.67 105.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.077 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.2 107.36 18.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 34.7 mt -103.16 149.05 25.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -101.14 161.46 13.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.251 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.04 -150.9 13.66 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.564 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.8 t30 -173.81 106.41 0.3 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.418 0.151 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 19.5 Cg_endo -58.6 -23.38 64.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.46 2.106 . . . . 0.0 112.326 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.407 ' HB ' HD22 ' A' ' 29' ' ' ASN . 18.6 m -63.06 -24.9 68.12 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.403 HG21 ' HB3' ' A' ' 29' ' ' ASN . 66.2 p -61.32 -56.05 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.205 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.79 -6.27 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.927 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 44.6 m-85 -123.85 -176.18 3.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 0.0 111.24 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.553 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.4 ttm -150.71 152.32 33.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 42.7 m95 -100.06 90.7 4.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.693 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 42' ' ' VAL . 9.6 t -136.92 -178.49 5.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.325 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.8 mtp85 -83.46 160.1 21.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.972 0.415 . . . . 0.0 111.618 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 89' ' ' GLU . 59.0 t -70.68 141.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.918 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.7 2.99 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.079 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -124.7 -3.11 7.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.597 0.237 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.595 ' HA ' HG22 ' A' ' 37' ' ' THR . 2.1 p -34.81 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 129.45 -46.33 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.409 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -62.55 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 -50.98 1.26 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.434 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.68 -50.46 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.717 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.0 mt 71.81 -61.01 0.5 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.844 0.457 . . . . 0.0 111.178 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.3 p -46.34 171.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.233 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.41 -85.23 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.545 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.3 pt-20 -129.37 -34.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.389 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -68.89 -76.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.241 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -105.0 118.47 36.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.81 66.31 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.153 0.502 . . . . 0.0 109.753 177.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.493 HG23 ' HD2' ' A' ' 38' ' ' ARG . 18.2 t -76.91 83.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.563 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 25.4 t -77.29 80.69 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.21 139.51 30.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.553 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -133.15 105.46 7.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.961 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.553 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.33 115.28 22.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.792 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 m -117.08 119.98 34.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.713 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.647 ' HB2' HG11 ' A' ' 70' ' ' VAL . 63.6 Cg_endo -98.36 41.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.23 2.62 . . . . 0.0 112.03 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.467 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -39.47 139.99 0.82 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.416 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 61' ' ' THR . 80.9 Cg_exo -47.96 130.27 19.46 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 112.663 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -69.47 172.82 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.983 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -102.16 12.54 36.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 p -57.61 155.0 22.53 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.192 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.23 11.52 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.738 2.292 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -133.38 -118.89 0.19 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.773 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.28 122.61 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.06 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.35 23.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.559 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.647 HG11 ' HB2' ' A' ' 60' ' ' PRO . 42.8 t -132.16 75.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.391 . . . . 0.0 110.621 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.08 116.8 1.53 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.661 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.585 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -106.49 -117.73 4.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.273 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -141.72 -164.22 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.948 0.404 . . . . 0.0 110.875 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -138.48 98.65 3.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.405 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG11 ' CD2' ' A' ' 77' ' ' LEU . 90.9 t -87.59 106.12 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.26 110.88 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 77' ' ' LEU . 2.4 mm? -95.71 105.59 17.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.855 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.522 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.37 105.53 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.048 0.452 . . . . 0.0 111.212 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.8 mtmm -110.75 103.23 54.18 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.156 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HA ' HD21 ' A' ' 52' ' ' LEU . 10.6 Cg_endo -55.1 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 15.0 mtt180 -81.15 -56.01 4.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.608 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -98.69 161.06 13.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.42 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -94.54 141.34 28.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.577 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.74 -116.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.579 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -129.57 99.98 5.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -108.04 164.78 11.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -157.74 149.91 22.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.9 tp -123.11 87.35 2.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.252 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -86.98 93.96 9.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.057 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 77.1 mt -91.41 99.22 12.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.028 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -92.94 150.82 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.121 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.3 t80 -90.28 76.96 6.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.513 HG22 ' HB ' ' A' ' 42' ' ' VAL . 3.0 t -98.48 172.46 7.51 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 69.1 mtp180 -104.42 95.61 8.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.458 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 93' ' ' THR . 66.5 Cg_exo -44.04 -27.58 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 112.651 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -37.19 20.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.391 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 13.9 mm-40 -103.65 -91.64 0.36 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 0.0 111.719 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.42 -178.76 39.84 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.281 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.441 HG21 ' HB ' ' A' ' 93' ' ' THR . 11.7 mt -85.24 -77.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER 71.54 156.3 0.16 Allowed Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.966 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 37.8 Cg_endo -66.3 -35.01 33.51 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.795 2.33 . . . . 0.0 112.8 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 7.9 pt-20 -54.17 -17.94 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.524 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.544 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -86.67 140.16 30.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 111.467 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -64.91 -176.21 0.25 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.55 179.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.641 ' HB3' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -165.23 -164.47 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.552 0.692 . . . . 0.0 111.875 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 45.0 t80 -165.27 69.28 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.015 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -70.4 88.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.612 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.7 tp -83.59 92.03 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.653 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.9 m-70 -77.79 145.06 36.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HB3' HG23 ' A' ' 16' ' ' THR . 90.4 mt -144.36 92.77 2.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.269 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.452 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -64.68 85.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 17' ' ' HIS . 4.7 t -62.76 115.01 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.664 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.936 179.702 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -147.89 -32.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -131.17 150.94 51.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp -89.07 -3.69 58.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 2' ' ' ILE . 11.7 mm 60.44 11.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -98.58 145.08 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 35.5 Cg_exo -60.05 111.43 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.457 2.104 . . . . 0.0 112.245 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.97 -167.3 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.7 p -58.87 -25.19 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.05 142.67 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -176.05 139.08 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.192 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.02 107.04 9.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.624 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -120.19 -83.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.492 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.542 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -33.24 104.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.921 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.98 96.75 10.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.124 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.639 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -79.68 100.76 8.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG22 HD21 ' A' ' 110' ' ' LEU . 27.4 m -146.7 -171.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.0 0.428 . . . . 0.0 112.113 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.02 -177.13 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.768 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.4 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.4 t -175.25 -175.81 0.87 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.218 0.533 . . . . 0.0 112.185 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.567 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 7.4 m80 -117.93 -165.35 1.09 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.954 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.44 132.77 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.19 0.519 . . . . 0.0 112.067 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.18 19.63 8.16 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.51 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.2 tptt -63.06 85.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.465 HG23 HD23 ' A' ' 77' ' ' LEU . 6.3 m -49.76 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.471 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -94.73 99.81 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.489 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HA ' HD21 ' A' ' 77' ' ' LEU . 30.7 tt0 -76.2 132.84 40.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.838 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.1 mt -132.97 99.62 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.105 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -84.03 98.25 9.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.493 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 38.0 mt -93.37 148.29 22.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.581 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -101.91 162.26 13.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.97 -143.87 7.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.417 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' HB3' HG22 ' A' ' 32' ' ' THR . 47.0 t30 -174.16 95.05 0.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.458 0.17 . . . . 0.0 110.82 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 76.1 Cg_exo -49.91 -24.84 11.1 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.586 2.191 . . . . 0.0 112.532 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -62.08 -36.14 80.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.553 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.404 HG22 ' HB3' ' A' ' 29' ' ' ASN . 82.0 p -54.92 -60.37 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.326 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.35 -32.23 1.03 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -82.56 -176.29 6.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.55 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.3 ttm -152.1 152.46 32.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.019 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.425 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.8 m95 -107.07 85.27 2.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.742 178.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 42' ' ' VAL . 15.2 t -130.35 -163.61 1.33 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.7 mtp85 -91.25 139.58 30.61 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 111.269 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 t -53.99 133.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.056 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 -39.05 1.85 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.603 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 47' ' ' LEU . 55.2 m-85 -82.15 3.25 27.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.141 0.496 . . . . 0.0 110.62 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.579 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.3 t -53.29 110.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.223 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.94 -14.96 10.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HB2' HD22 ' A' ' 47' ' ' LEU . 92.3 mttt -82.84 -163.28 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.803 0.335 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -114.51 -57.26 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.204 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.36 -36.85 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.598 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 12.0 mt 76.13 -44.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.508 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.478 ' OG ' ' HA ' ' A' ' 53' ' ' GLU . 41.9 t -59.24 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.5 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.475 ' H ' ' HG ' ' A' ' 48' ' ' SER . 7.9 m-20 -147.99 -83.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.386 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.07 -28.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.602 -179.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.3 mm -76.11 -86.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.69 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.702 HD21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.19 106.0 18.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.45 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 1.1 tm-20 -58.08 146.46 33.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG23 ' HD2' ' A' ' 38' ' ' ARG . 46.3 t -145.6 90.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.2 t -77.04 85.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.162 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.21 129.67 37.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.808 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.677 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 50.9 mtpt -130.71 68.48 1.47 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.467 ' OH ' ' HG3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -65.22 103.86 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.353 178.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 m -105.61 114.31 63.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HB2' HG11 ' A' ' 70' ' ' VAL . 61.1 Cg_endo -97.84 42.04 0.1 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.287 2.658 . . . . 0.0 111.912 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.489 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -37.98 139.79 0.6 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.522 -179.249 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.489 ' HD2' HG23 ' A' ' 61' ' ' THR . 76.9 Cg_exo -50.09 143.88 23.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.652 2.234 . . . . 0.0 112.609 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.4 t -91.66 172.67 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 m -94.3 19.21 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.2 p -57.76 154.82 24.82 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.27 11.49 1.5 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.787 2.325 . . . . 0.0 112.523 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 14.4 ptp -147.84 -117.31 0.06 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.815 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.68 123.99 59.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.6 132.84 4.94 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.562 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 60' ' ' PRO . 23.6 t -139.57 77.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 110.611 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' HA3' ' HG2' ' A' ' 30' ' ' PRO . . . -143.94 125.25 2.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.015 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.457 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -122.91 -113.64 2.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.304 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.3 pt -142.26 -164.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 110.737 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.6 OUTLIER -134.12 98.43 4.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 87.7 t -85.81 100.0 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.797 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.5 t -103.54 116.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.039 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 91.3 mt -103.11 108.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.702 HG11 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.86 108.89 23.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.003 0.43 . . . . 0.0 111.519 -178.924 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 46.7 mtmt -114.11 95.95 40.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.469 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.41 106.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.253 1.969 . . . . 0.0 112.219 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 73.2 mtt180 -69.81 -30.22 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 85.4 mttt -123.53 -176.98 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -117.4 144.73 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.447 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.91 -129.26 4.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.388 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.412 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.7 m80 -105.92 91.73 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.921 0.391 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -107.75 164.21 12.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.388 179.776 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.486 ' N ' HD11 ' A' ' 52' ' ' LEU . 71.0 m -160.26 157.25 27.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 111.784 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 78' ' ' VAL . 51.7 tp -118.96 87.66 2.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.284 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.3 mt-10 -69.46 95.89 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.804 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.65 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 51.9 mt -108.51 127.28 53.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.466 HG21 ' N ' ' A' ' 92' ' ' TYR . 11.0 p -133.18 157.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.739 -178.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.4 t80 -99.13 88.82 4.05 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.239 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.508 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.9 t -121.41 169.37 10.69 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -101.49 95.94 5.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.951 178.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 93' ' ' THR . 96.0 Cg_exo -44.26 -30.69 3.74 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.662 2.241 . . . . 0.0 112.607 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.65 -40.61 63.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -97.05 -76.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.98 173.11 31.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.195 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.474 HG21 ' HB ' ' A' ' 93' ' ' THR . 2.7 mt -86.03 151.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.847 0.356 . . . . 0.0 111.256 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.528 ' HE3' HD22 ' A' ' 103' ' ' ASN . 40.6 mtmt -145.09 166.22 18.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.42 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.74 -46.47 11.11 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.029 2.486 . . . . 0.0 112.009 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.16 -29.77 65.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.053 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.564 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -53.78 146.07 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.73 164.32 4.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.66 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.4 tpp180 -131.61 163.0 29.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.297 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.66 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.1 t80 -174.26 71.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.177 177.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.516 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.01 90.96 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.383 -178.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.1 tp -72.18 93.71 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 24.5 m-70 -78.97 145.29 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.528 HD21 HG22 ' A' ' 14' ' ' VAL . 75.0 mt -145.89 110.04 4.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.474 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.03 69.29 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.34 117.93 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.64 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.946 179.725 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.7 p -103.99 118.44 36.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.2 m80 59.5 99.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.39 157.1 18.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt -89.45 -27.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.77 129.23 89.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.019 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.13 133.0 52.54 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.525 2.15 . . . . 0.0 112.265 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.8 tp -146.72 -55.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -122.51 -36.7 2.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.82 131.18 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -174.53 135.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.25 95.74 1.04 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.629 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -122.04 -28.56 4.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.466 -179.547 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 6.1 p-10 -85.94 98.37 10.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.711 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HD3' HD11 ' A' ' 108' ' ' LEU . 51.4 tttp -111.41 76.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.702 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 5.5 m0 -86.91 108.9 18.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.679 -178.026 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.94 -171.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.532 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.4 p-10 -97.84 177.46 5.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.08 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -173.92 -174.66 0.96 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.012 0.434 . . . . 0.0 111.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 60.7 m80 -122.94 -173.98 2.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.919 179.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 83' ' ' ARG . 22.5 t -72.49 134.58 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.166 0.508 . . . . 0.0 112.309 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.19 15.87 12.2 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.944 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.0 tptt -58.13 86.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.279 0.539 . . . . 0.0 109.944 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.486 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -57.43 101.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.519 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -98.5 100.8 12.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HA ' HD21 ' A' ' 77' ' ' LEU . 32.3 tt0 -72.42 131.83 43.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.71 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 42.6 mt -128.18 87.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.298 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.41 ' CD2' HG21 ' A' ' 75' ' ' VAL . 8.8 m170 -86.99 106.95 18.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 19.1 mt -101.31 174.12 6.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 111.575 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -119.55 160.94 21.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.767 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.62 -163.59 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.954 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 53.4 t30 -162.74 121.3 1.33 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD3' ' HH ' ' A' ' 58' ' ' TYR . 40.1 Cg_endo -66.68 -30.95 41.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 112.564 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.454 ' HG1' HD22 ' A' ' 29' ' ' ASN . 73.9 p -83.54 17.36 2.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.295 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.6 m -136.04 -67.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.512 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.09 -118.66 4.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.131 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 2.1 m-85 -114.57 -169.25 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.514 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 14.5 ttm -114.79 151.02 34.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.653 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 66.6 m95 -105.89 99.57 9.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.034 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 42' ' ' VAL . 5.9 t -147.78 -176.58 5.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.658 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.656 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.9 mtp85 -82.88 157.12 23.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.024 0.44 . . . . 0.0 111.404 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 89' ' ' GLU . 19.7 t -57.97 130.85 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.595 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -41.75 1.83 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.146 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 57.9 m-85 -70.21 -4.61 22.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 0.0 111.037 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.59 HG23 HG22 ' A' ' 37' ' ' THR . 21.9 t -49.71 121.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -32.93 5.83 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.276 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 29.0 mtpp -64.72 171.68 3.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.25 -62.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.662 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -104.46 142.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.7 mt -99.07 -50.24 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.492 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 83.2 p -52.99 179.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.702 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.07 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.89 -42.5 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.126 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.538 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.2 mm -62.55 -76.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 80' ' ' PRO . 8.7 mt -103.98 118.57 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.495 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -72.65 65.01 0.66 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.124 0.488 . . . . 0.0 109.77 177.646 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' HD2' ' A' ' 38' ' ' ARG . 12.0 t -71.08 84.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.58 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.5 t -80.05 85.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 18.6 t -103.82 123.49 47.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.86 -178.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -116.94 106.81 13.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.683 178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -74.17 103.62 4.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.482 179.853 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.404 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 20.2 m -100.35 112.58 64.55 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -82.18 88.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.279 2.652 . . . . 0.0 111.506 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 148.83 72.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.277 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.96 151.05 87.16 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.716 2.277 . . . . 0.0 112.258 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -79.98 179.93 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.781 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -56.4 -58.41 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.4 p -94.06 155.24 40.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.77 -155.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.682 2.255 . . . . 0.0 112.207 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.6 ttp 72.15 -68.54 0.22 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.244 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.0 153.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.36 111.09 2.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.718 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.11 79.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 29' ' ' ASN . . . -63.31 -168.97 1.14 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.987 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -146.11 148.57 20.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.829 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -89.13 -20.36 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.108 0.48 . . . . 0.0 111.38 179.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.653 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.6 m-85 50.25 90.17 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.386 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 72.8 t -97.94 107.21 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.777 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 11.9 t -112.99 109.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.821 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 21' ' ' THR . 72.3 mt -102.64 99.38 9.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.042 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG13 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.3 105.69 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 0.0 111.192 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.649 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 7.8 mtmp? -109.19 94.57 15.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.9 Cg_endo -49.75 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.686 2.258 . . . . 0.0 112.855 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 11.8 mtt180 -74.56 -35.33 63.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.915 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 51' ' ' ILE . 4.2 mptp? -108.03 150.28 27.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.15 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HG2' HG21 ' A' ' 18' ' ' VAL . 49.7 mtm180 -94.28 129.69 40.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.532 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 148.53 -116.91 0.84 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -130.77 120.04 23.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -131.57 -178.7 4.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.683 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 53.4 m -158.25 156.28 30.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.705 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.504 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.2 tp -133.04 85.7 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.617 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -84.76 88.25 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.089 0.471 . . . . 0.0 111.105 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 HG13 ' A' ' 76' ' ' VAL . 88.7 mt -83.47 103.05 12.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -84.21 145.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.075 0.464 . . . . 0.0 111.98 -178.719 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 35' ' ' MET . 13.5 t80 -95.18 76.22 3.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.49 HG22 HG12 ' A' ' 99' ' ' ILE . 8.0 t -117.4 155.92 28.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 71.6 mtp180 -92.33 103.56 8.82 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.71 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 10.1 Cg_endo -51.51 -37.45 62.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.865 2.377 . . . . 0.0 112.776 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -78.91 12.87 1.95 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.477 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -147.26 3.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.259 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.93 179.18 49.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.831 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.49 HG12 HG22 ' A' ' 93' ' ' THR . 4.2 mt -105.37 156.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.047 0.451 . . . . 0.0 111.716 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mtmt -139.05 162.84 50.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.0 Cg_endo -72.18 -37.11 4.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.711 2.274 . . . . 0.0 112.212 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.21 -25.94 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.05 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.483 HD22 ' HE3' ' A' ' 100' ' ' LYS . 13.7 m120 -58.48 136.77 57.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.45 -175.13 0.15 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.2 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -163.26 -159.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 179.712 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 80.9 t80 -165.59 72.81 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.614 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 1.2 m -69.78 105.81 2.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.366 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 12' ' ' LYS . 18.2 tp -106.71 94.49 5.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.727 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.702 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.5 m-70 -76.65 153.58 35.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.276 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 16' ' ' THR . 96.4 mt -146.92 99.74 3.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.693 -178.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.532 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.8 t30 -74.79 68.56 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.532 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.3 t -50.19 122.07 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.436 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 16' ' ' THR . 31.9 mmmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -106.84 124.15 49.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -83.47 -28.43 28.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp -82.45 174.82 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.9 tp -100.17 -31.68 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.63 99.13 4.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.4 3.09 5.01 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.433 2.089 . . . . 0.0 112.459 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 5' ' ' LEU . 7.4 mp -67.32 -20.09 65.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.0 p -88.41 170.32 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.14 158.72 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.507 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 3.1 mppt? -101.99 9.48 40.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.552 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -42.13 147.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.731 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.832 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 3.9 p30 -89.76 -91.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 111.753 -179.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 107' ' ' THR . 22.9 t70 -136.36 -119.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.612 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 22.2 tptm -158.02 171.87 19.46 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.416 0.15 . . . . 0.0 110.662 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 7.3 m0 -124.39 121.7 35.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.657 0.383 . . . . 0.0 110.749 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 109' ' ' HIS . 2.9 m -152.5 -171.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.655 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 2.6 p-10 -80.49 175.75 10.38 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.397 0.436 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 110' ' ' LEU . 2.5 t -172.01 -173.66 1.16 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.503 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 78.5 m80 -108.37 -177.99 3.48 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.485 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.02 136.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.119 0.485 . . . . 0.0 111.765 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.78 10.75 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.388 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.4 tptm -63.96 82.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 HD23 ' A' ' 77' ' ' LEU . 9.6 m -39.49 99.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.678 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.5 m -92.75 96.88 10.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.7 tt0 -80.62 132.17 35.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.38 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 108' ' ' LEU . 38.9 mt -134.21 104.55 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -86.97 98.73 11.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 12.9 mt -91.69 145.7 24.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.378 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -95.32 161.78 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.93 -139.35 5.28 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -174.99 90.62 0.3 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.516 0.198 . . . . 0.0 110.54 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.64 -16.32 7.89 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.712 2.275 . . . . 0.0 113.106 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.0 p -83.65 12.5 5.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 111.482 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 p -97.1 -63.65 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.256 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.56 -38.71 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.694 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.07 -178.13 6.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 111.24 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.569 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 1.5 ttt -149.35 147.93 28.9 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.118 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.422 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 2.8 m95 -105.07 86.58 2.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.74 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.569 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 14.6 t -130.46 -171.97 2.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.558 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -71.58 144.92 49.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.761 0.315 . . . . 0.0 110.807 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 91' ' ' VAL . 77.4 t -60.73 137.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.956 0.407 . . . . 0.0 111.413 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.31 -1.72 8.51 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.058 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.518 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 21.5 m-30 -115.31 40.14 2.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 110.766 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' A' ' 93' ' ' THR . 7.6 p -82.18 128.27 38.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.26 -10.4 6.15 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.099 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 64.0 mttm -64.89 172.51 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.84 -65.22 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.67 133.7 48.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.859 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.558 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 29.8 mt -82.83 -62.05 1.71 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.437 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 78.9 p -51.98 176.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.089 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -153.75 -90.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -131.26 -31.93 1.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.4 mm -71.22 -73.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.389 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.551 ' HB3' HG11 ' A' ' 78' ' ' VAL . 28.1 mt -111.58 123.46 50.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.7 73.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.917 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.555 HG12 ' HD3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -77.79 92.85 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.5 t -96.96 86.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.382 177.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.527 ' HB3' HD13 ' A' ' 47' ' ' LEU . 2.7 t -107.08 142.19 37.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -119.37 115.67 24.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.403 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.554 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.78 100.6 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.403 HG21 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.22 116.16 65.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.084 179.515 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -95.51 -169.49 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.277 2.651 . . . . 0.0 113.2 -179.141 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -59.18 137.12 88.34 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.05 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 70' ' ' VAL . 7.7 Cg_endo -48.56 155.67 2.18 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.22 2.614 . . . . 0.0 112.65 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -85.19 -167.9 2.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.771 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -73.91 -0.6 16.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -70.28 154.46 94.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.277 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.52 13.77 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.798 2.332 . . . . 0.0 112.634 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.7 mmm -62.08 -24.72 67.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t 50.43 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.876 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.444 ' HA3' ' HG3' ' A' ' 62' ' ' PRO . . . 76.96 94.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.6 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 62' ' ' PRO . 26.2 t -135.37 69.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 111.049 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 59' ' ' THR . . . 112.11 -139.88 15.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.152 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.0 15.01 40.54 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.3 pt -148.07 -165.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.191 0.52 . . . . 0.0 111.167 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.458 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.57 106.26 6.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.852 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.77 117.96 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.212 0.53 . . . . 0.0 110.548 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 78' ' ' VAL . 23.5 t -113.39 126.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.874 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 63.1 mt -111.4 90.93 3.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -93.07 108.86 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.178 0.513 . . . . 0.0 111.645 -178.226 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.2 mtmt -107.25 95.81 14.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -47.03 108.23 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.591 2.194 . . . . 0.0 112.592 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 21.9 mtt180 -76.14 -33.93 59.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -116.27 171.43 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.033 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 68.5 mtp180 -110.1 146.56 35.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.845 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.58 -170.42 21.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.5 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -70.98 104.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 110.576 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.414 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 96.8 m-70 -130.09 142.48 50.6 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.782 0.801 . . . . 0.0 111.676 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 96.2 m -138.24 127.32 24.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 78' ' ' VAL . 15.6 tp -93.81 99.72 12.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.113 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.469 ' HB3' HG22 ' A' ' 39' ' ' VAL . 35.1 mt-10 -76.69 124.6 27.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.436 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.475 HD22 ' NH1' ' A' ' 38' ' ' ARG . 28.0 mt -115.56 165.83 12.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.528 ' HB ' HG23 ' A' ' 39' ' ' VAL . 13.6 p -156.14 154.38 6.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.2 t80 -103.34 86.88 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.635 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 42' ' ' VAL . 2.8 t -115.83 167.0 11.34 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -103.07 94.36 5.41 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 93' ' ' THR . 90.3 Cg_exo -46.8 -29.91 8.66 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.572 2.181 . . . . 0.0 112.565 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -73.19 -37.04 66.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -106.61 -74.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 111.327 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.91 -174.68 44.73 Favored Glycine 0 CA--C 1.508 -0.345 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.296 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.458 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -96.91 145.56 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.871 0.367 . . . . 0.0 111.153 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -130.76 166.74 25.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.633 -179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.14 -44.78 4.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.893 2.395 . . . . 0.0 112.34 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.06 -14.92 27.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.472 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -58.58 139.96 55.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -179.786 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 174.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.141 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.712 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -155.0 158.62 39.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.554 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.832 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 24.3 t80 -152.96 108.53 3.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.49 178.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.587 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.8 OUTLIER -98.15 130.88 44.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.621 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 14.0 mt -89.92 126.43 35.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.337 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.693 ' HB2' HG21 ' A' ' 14' ' ' VAL . 1.7 p80 -72.0 57.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.609 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.438 ' HB3' HG23 ' A' ' 16' ' ' THR . 52.6 mt -103.98 80.31 1.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 17.8 t30 -94.35 59.11 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.1 t -33.41 130.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.695 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 14.6 mmmm . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.995 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -141.71 -13.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 61.94 -83.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.078 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' HE3' ' HA ' ' A' ' 3' ' ' ALA . 21.4 ptm -68.5 147.18 52.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.6 pt -85.48 2.38 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.484 ' HA ' ' HE3' ' A' ' 1' ' ' MET . . . 64.59 149.66 0.11 Allowed Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.311 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 -5.22 16.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.452 2.101 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.98 -65.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.5 p -82.93 135.15 35.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.664 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.9 t 65.79 145.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -170.35 132.27 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.49 121.92 16.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.241 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER -122.03 -94.54 0.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.14 0.495 . . . . 0.0 112.204 -179.178 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -53.24 99.97 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.841 -178.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -89.61 91.63 8.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.472 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.647 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -73.75 99.81 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.512 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.486 HG22 HD21 ' A' ' 110' ' ' LEU . 29.3 m -149.69 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.987 -178.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.2 p-10 -111.88 -175.14 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.508 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.42 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.2 t -174.47 -177.22 1.18 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.104 0.478 . . . . 0.0 112.075 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.607 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 72.9 m80 -111.96 -159.64 0.69 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.841 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.6 128.01 49.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 0.0 111.929 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 71.73 7.51 65.59 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.674 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -56.75 85.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.293 0.547 . . . . 0.0 109.734 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.478 HG21 HD23 ' A' ' 77' ' ' LEU . 3.5 m -58.19 93.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.293 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -85.83 99.71 11.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -82.72 129.62 34.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.735 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.479 HD12 HD23 ' A' ' 108' ' ' LEU . 46.0 mt -134.61 107.35 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.926 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -88.76 96.84 10.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.28 178.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.0 mt -91.43 148.22 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.418 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -102.56 161.07 14.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 176.86 -145.81 7.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.487 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -176.35 93.8 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.51 0.195 . . . . 0.0 110.984 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -9.43 12.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.444 2.096 . . . . 0.0 112.308 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -60.9 -22.69 64.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -82.67 -63.37 1.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.156 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.45 -25.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.003 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -80.11 178.19 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.166 0.507 . . . . 0.0 111.399 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 5.5 ttm -155.85 152.12 27.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.435 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 8.0 m95 -106.92 85.38 2.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.544 HG22 ' HA ' ' A' ' 42' ' ' VAL . 11.3 t -129.9 -165.47 1.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.377 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.658 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.2 mtp85 -89.2 151.51 22.12 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.861 0.362 . . . . 0.0 110.977 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 89' ' ' GLU . 21.8 t -72.14 133.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.497 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.56 3.51 90.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -129.3 -0.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 110.462 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.3 t -55.27 109.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.141 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.08 -28.04 12.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.172 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.67 172.11 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.42 -25.54 31.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.836 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.58 141.76 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.206 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.658 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt -93.11 -53.63 4.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.7 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.408 ' HG ' ' HA ' ' A' ' 53' ' ' GLU . 33.4 t -50.39 175.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.565 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -155.75 -86.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.81 -34.04 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.0 mm -70.33 -76.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.364 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -101.19 112.23 24.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.501 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 3.0 tt0 -66.01 78.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 109.832 178.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 t -86.51 90.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.325 -178.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.9 t -86.31 86.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.0 t -101.43 124.97 47.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.652 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -115.79 109.45 17.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.553 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -79.77 121.02 24.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.309 -179.784 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 118.96 31.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.15 158.42 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.164 2.576 . . . . 0.0 112.856 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.508 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -82.17 143.16 48.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 -179.878 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 61' ' ' THR . 39.1 Cg_exo -61.2 157.3 40.57 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.519 2.146 . . . . 0.0 112.224 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.561 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t -111.69 -164.75 0.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -103.09 -62.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.491 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.631 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 63.8 m -67.68 -49.99 37.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.771 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.631 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 9.6 Cg_exo -72.75 -160.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.795 2.33 . . . . 0.0 112.102 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.5 mtm -145.68 18.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.2 p -95.44 142.34 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.08 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.37 136.84 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.308 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 70' ' ' VAL . 10.0 p -155.12 14.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.208 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.87 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.918 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.87 6.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.296 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.8 pt -143.45 -164.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.06 0.457 . . . . 0.0 110.953 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' HH ' ' HA2' ' A' ' 28' ' ' GLY . 1.0 OUTLIER -136.01 105.81 6.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.979 179.989 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -90.27 104.57 15.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.01 120.16 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.927 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 21' ' ' THR . 78.3 mt -111.2 99.9 8.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.892 178.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.581 HG22 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.74 102.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.053 0.454 . . . . 0.0 110.994 -179.085 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 38.2 mtmt -104.18 104.0 41.54 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HA ' HD21 ' A' ' 52' ' ' LEU . 50.2 Cg_exo -51.43 98.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.406 2.071 . . . . 0.0 112.446 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 7.4 mtt180 -69.82 -41.72 74.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 89.5 mttt -115.54 165.43 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.092 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -100.87 119.22 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.592 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.38 -150.45 21.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.363 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.436 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 55.4 t-80 -86.84 101.74 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.11 0.481 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 2.0 m-70 -117.12 165.82 12.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 109' ' ' HIS . 57.6 m -159.84 148.64 17.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 111.945 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 11.6 tp -114.52 93.33 4.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.245 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.51 ' HB3' HG22 ' A' ' 39' ' ' VAL . 44.0 mt-10 -77.12 98.23 4.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.045 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 51.1 mt -107.69 130.33 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.68 156.05 37.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.965 -178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.3 t80 -99.88 86.73 3.34 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.104 178.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.524 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 4.5 t -120.35 169.34 10.38 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.11 94.85 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.4 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.6 Cg_exo -42.22 -35.61 3.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.839 2.36 . . . . 0.0 112.755 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -68.52 -44.04 75.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.564 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.77 -79.31 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.81 177.18 40.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.105 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.508 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -92.11 151.31 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.934 0.397 . . . . 0.0 111.292 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.599 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 10.0 mttm -141.43 163.15 43.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.125 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 38.8 Cg_endo -67.6 -40.18 10.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.264 . . . . 0.0 112.133 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.05 -28.09 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -55.36 148.75 14.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.003 179.704 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.92 160.7 3.36 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.589 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpt180 -130.18 162.9 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.219 -179.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.589 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -176.53 69.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.453 0.644 . . . . 0.0 109.677 177.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 12.4 m -91.52 91.33 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.517 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 41.0 tp -71.45 94.36 1.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.524 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -78.22 143.31 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.661 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD21 HG22 ' A' ' 14' ' ' VAL . 85.2 mt -145.85 104.64 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.807 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.449 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 45.6 t30 -78.42 68.91 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.592 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.5 t -48.75 127.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.65 -178.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.976 179.988 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.0 p -93.49 -45.69 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -158.17 176.16 12.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.26 154.69 33.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -96.96 14.12 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 4' ' ' PRO . . . -57.2 -50.73 86.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.628 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 3' ' ' ALA . 63.8 Cg_endo -73.45 172.53 15.5 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.149 1.899 . . . . 0.0 112.31 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.75 -65.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.524 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -153.36 -38.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.13 140.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.196 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 2.2 mppt? -103.17 36.53 2.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.145 0.498 . . . . 0.0 110.517 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -35.3 116.78 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.614 HD21 ' HB3' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -123.31 -90.74 0.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.541 -179.305 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 107' ' ' THR . 1.2 m-20 -47.65 104.52 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.284 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -97.24 92.72 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.141 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.642 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.09 104.02 12.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 4.5 m -150.95 -173.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 112.136 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.41 176.7 5.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.819 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' HD23 ' A' ' 110' ' ' LEU . 1.2 t -175.49 -177.1 0.96 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.9 m-70 -120.82 -166.16 1.3 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.968 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG23 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -87.19 136.59 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 112.111 -179.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.59 12.16 32.32 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.628 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tptt -59.79 83.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.182 0.491 . . . . 0.0 109.782 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.469 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -54.93 98.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.424 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 100.0 m -96.2 101.18 12.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.6 tt0 -82.44 132.7 35.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.799 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.422 HD13 HD23 ' A' ' 108' ' ' LEU . 45.6 mt -134.97 101.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.961 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -83.67 98.91 9.9 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 14.5 mt -92.61 148.73 21.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -102.9 159.93 15.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.844 0.354 . . . . 0.0 110.399 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 -161.64 34.18 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -169.83 120.02 0.57 Allowed Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HB3' ' HH ' ' A' ' 58' ' ' TYR . 58.4 Cg_endo -71.17 -29.9 16.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.428 2.085 . . . . 0.0 112.493 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -82.52 15.69 2.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.319 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.4 m -136.04 -60.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.483 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.58 -119.63 3.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.208 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -112.24 -168.25 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 -179.203 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 25.0 ttm -108.53 151.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.306 179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -109.88 85.03 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.653 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -132.65 -166.95 1.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -93.04 122.52 35.5 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.5 p -53.16 138.78 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.178 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.47 -4.59 77.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.743 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.582 ' HA ' ' HZ2' ' A' ' 44' ' ' LYS . 48.8 m-85 -130.78 3.14 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.286 0.565 . . . . 0.0 110.037 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 37' ' ' THR . 18.2 t -52.12 119.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.095 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.5 -23.09 18.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.004 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HZ2' ' HA ' ' A' ' 41' ' ' PHE . 61.4 mttp -74.59 -159.58 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.643 0.259 . . . . 0.0 110.748 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.24 -55.9 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.43 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 16.6 t -84.45 -40.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.051 -179.103 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.8 mt 75.95 -42.73 0.46 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.465 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 40.8 t -49.28 179.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.142 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -152.55 -88.84 0.06 Allowed 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -136.11 -31.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.397 -179.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.1 mm -73.21 -72.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.438 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 80' ' ' PRO . 11.1 mt -105.13 114.37 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.472 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.13 72.1 0.1 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.795 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' N ' ' HB2' ' A' ' 48' ' ' SER . 10.9 t -76.39 84.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.324 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.7 t -80.2 81.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 76' ' ' VAL . 36.3 t -94.81 146.84 23.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.315 -178.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -138.82 113.18 8.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.36 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.491 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.85 104.86 15.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.274 179.373 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.8 m -101.83 109.63 60.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.618 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.658 ' HB2' HG21 ' A' ' 70' ' ' VAL . 60.5 Cg_endo -99.4 99.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.533 2.822 . . . . 0.0 111.652 179.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.26 134.76 24.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.695 0.283 . . . . 0.0 111.365 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.51 163.11 37.99 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.825 2.35 . . . . 0.0 112.483 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.43 ' N ' HG13 ' A' ' 68' ' ' VAL . 50.6 m -81.07 -165.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.525 179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -103.05 0.05 31.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.446 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.3 p -100.73 153.81 37.52 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 0.0 111.553 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.99 32.86 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.004 2.469 . . . . 0.0 112.612 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.6 mtt -143.22 35.16 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 63' ' ' SER . 13.8 p -130.44 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.39 -179.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.95 -94.66 1.68 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 60' ' ' PRO . 7.1 p -157.79 87.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.138 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.71 114.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.867 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.481 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -105.6 -113.46 3.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.244 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt -140.27 -167.82 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 111.104 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.78 95.38 3.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.941 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 75' ' ' VAL . 10.6 p -87.97 111.81 22.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.536 0.684 . . . . 0.0 110.602 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 90' ' ' LEU . 38.7 t -108.88 122.91 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.53 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.469 HD23 HG21 ' A' ' 21' ' ' THR . 81.3 mt -108.46 99.23 8.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.808 178.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.49 106.2 17.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.999 0.428 . . . . 0.0 111.145 -178.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -108.1 102.15 44.79 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.344 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' HA ' HD21 ' A' ' 52' ' ' LEU . 70.0 Cg_exo -49.93 98.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.747 2.298 . . . . 0.0 112.81 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.56 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -67.57 -37.25 82.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 56.6 mttm -120.99 -178.81 3.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.489 ' HE ' HG23 ' A' ' 18' ' ' VAL . 95.7 mtt180 -115.17 124.86 52.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.78 -142.8 9.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.576 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.454 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 61.9 m80 -87.34 91.65 8.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -111.65 154.5 24.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.412 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 109' ' ' HIS . 62.9 m -158.55 146.23 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.932 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.623 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 39.6 tp -96.72 92.24 6.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.072 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.77 94.19 1.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.166 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.623 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 40.0 mt -111.53 127.41 55.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.466 HG21 ' N ' ' A' ' 92' ' ' TYR . 11.8 p -128.95 158.57 41.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.511 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -99.17 83.33 2.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.429 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.48 HG22 HG22 ' A' ' 42' ' ' VAL . 10.0 t -117.5 150.83 38.28 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 41.5 mtp180 -91.49 104.49 10.16 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 178.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.9 Cg_exo -39.79 -31.99 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.055 2.503 . . . . 0.0 113.168 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.414 ' HD2' ' HG3' ' A' ' 97' ' ' GLU . 6.7 t80 -77.02 -60.08 2.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.414 ' HG3' ' HD2' ' A' ' 96' ' ' PHE . 36.9 mt-10 -67.91 -64.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.894 0.378 . . . . 0.0 111.301 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.3 -179.78 20.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.813 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.472 HG21 ' HB ' ' A' ' 93' ' ' THR . 2.5 mt -93.86 148.07 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.918 0.389 . . . . 0.0 111.472 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 26.2 mtmm -147.82 162.64 30.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.115 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.8 Cg_endo -67.75 -37.1 16.91 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.797 2.331 . . . . 0.0 112.012 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.06 -29.34 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.2 m120 -58.21 154.36 13.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 164.41 4.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.245 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.7 tpp180 -132.24 165.95 22.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.663 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.0 t80 -174.57 74.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.297 177.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.93 94.29 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.418 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.3 tp -72.86 93.17 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.016 0.436 . . . . 0.0 110.656 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 40.8 m-70 -75.19 146.02 41.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.668 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 16' ' ' THR . 97.4 mt -145.69 120.21 9.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.568 -178.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -86.31 63.07 7.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.491 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -44.74 122.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.729 -178.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.093 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -88.22 -28.4 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.52 119.48 38.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 3' ' ' ALA . 1.9 mpt? -85.76 -71.04 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.6 mt 73.12 -29.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.635 ' H ' ' HD2' ' A' ' 4' ' ' PRO . . . -124.76 -54.47 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.635 ' HD2' ' H ' ' A' ' 3' ' ' ALA . 73.1 Cg_endo -76.14 100.8 1.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.005 1.803 . . . . 0.0 112.332 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tt -172.01 -63.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.461 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -142.02 -20.02 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.744 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.5 m -103.51 151.62 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -150.9 136.8 18.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.778 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.99 104.57 11.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.834 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.644 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -115.86 -82.01 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.267 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -32.44 108.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.705 179.906 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -87.17 93.7 9.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.5 m95 -75.74 98.52 4.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 HD21 ' A' ' 110' ' ' LEU . 28.4 m -149.42 -172.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 112.245 -178.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.438 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -112.37 179.0 4.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.455 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.455 HG21 HG21 ' A' ' 112' ' ' VAL . 1.8 t -177.88 -172.77 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 112.046 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.8 m-70 -117.62 -171.15 2.0 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 10.1 p -83.44 142.51 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.79 18.67 8.64 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.669 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptm -65.49 80.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.455 HG21 HD23 ' A' ' 77' ' ' LEU . 4.6 m -50.5 97.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.422 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.3 m -94.67 104.63 16.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.827 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.2 tt0 -86.91 129.72 34.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.803 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 HD13 HD23 ' A' ' 108' ' ' LEU . 47.1 mt -132.48 104.63 7.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.64 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -85.03 96.36 9.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.0 mt -89.27 145.91 25.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.398 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -97.66 161.99 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.847 0.356 . . . . 0.0 110.399 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.16 -137.13 4.11 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.499 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' O ' HG21 ' A' ' 32' ' ' THR . 61.1 t30 -175.12 101.95 0.26 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 20.5 Cg_endo -60.63 -6.57 5.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.796 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -106.53 15.0 26.42 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.657 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.522 HG23 ' HH ' ' A' ' 92' ' ' TYR . 5.9 t -98.28 -31.2 12.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.745 0.307 . . . . 0.0 111.086 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.74 -43.06 1.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.748 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -86.91 -178.88 6.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.082 0.468 . . . . 0.0 111.428 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -151.71 151.79 31.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.931 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.433 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -108.39 87.08 2.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.347 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -130.39 -170.98 2.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.832 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.658 HH21 HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -76.27 137.89 40.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.518 HG23 ' HB ' ' A' ' 91' ' ' VAL . 49.0 t -57.1 136.32 20.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.387 -179.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.11 -13.81 1.8 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.776 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' VAL . 14.6 m-30 -105.62 22.08 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.341 0.591 . . . . 0.0 110.49 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 93' ' ' THR . 12.7 t -76.16 107.13 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.148 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.13 -16.28 57.22 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 48.4 mtpt -65.07 172.89 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -75.43 -66.1 0.81 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.494 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.77 131.2 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 0.0 110.823 179.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.658 HD12 HH21 ' A' ' 38' ' ' ARG . 22.6 mt -73.7 -65.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.165 179.353 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -50.42 173.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.979 178.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -150.46 -95.73 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.618 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.09 -33.11 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.9 mm -73.38 -72.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.19 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 78' ' ' VAL . 77.2 mt -107.6 117.86 35.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.322 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -70.36 73.03 0.49 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.712 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG12 ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -76.38 91.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 22.4 t -93.34 87.97 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.328 177.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HB3' HD11 ' A' ' 47' ' ' LEU . 8.1 t -110.0 144.83 37.98 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.935 -178.46 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -122.9 115.89 22.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.647 178.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.465 ' HD1' ' C ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -85.14 105.85 16.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.449 179.466 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.509 HG23 HG13 ' A' ' 70' ' ' VAL . 4.3 m -103.0 126.28 32.88 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.45 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.537 ' HA ' ' HG3' ' A' ' 30' ' ' PRO . 2.6 Cg_endo -84.33 166.17 12.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.01 2.473 . . . . 0.0 113.178 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.6 t -53.42 149.67 14.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.646 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.557 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 21.0 Cg_exo -66.75 179.16 2.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.031 2.487 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.0 m -64.81 176.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.06 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -70.92 -34.6 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.7 p -84.75 154.62 61.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.35 14.97 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.832 2.355 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.8 mtp -94.11 -79.35 0.42 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.016 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.59 120.41 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 62' ' ' PRO . . . -113.92 137.99 14.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 59' ' ' THR . 45.0 t -119.43 -95.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.203 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.424 ' HA2' ' CG2' ' A' ' 59' ' ' THR . . . -156.23 -101.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.127 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.75 20.61 8.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt -138.94 -166.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.195 0.521 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -136.2 98.68 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.81 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 75' ' ' VAL . 5.5 p -90.21 111.34 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.298 0.571 . . . . 0.0 110.625 -179.266 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 HH22 ' A' ' 38' ' ' ARG . 46.2 t -107.18 124.55 63.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.923 -178.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 71.5 mt -111.63 92.95 4.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 177.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -91.73 110.72 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.223 -178.775 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.642 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 7.7 mtmp? -107.84 101.96 43.08 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.226 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 71.4 Cg_exo -48.22 99.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.707 2.271 . . . . 0.0 113.066 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.442 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.1 mtt180 -69.34 -31.44 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -121.25 170.69 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.767 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -115.66 128.45 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 135.65 -152.92 21.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.183 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -65.9 106.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.498 . . . . 0.0 110.639 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -138.04 160.59 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.619 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 109' ' ' HIS . 87.0 m -160.17 148.27 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 111.774 -179.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.619 HD22 HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -110.03 101.55 10.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.878 179.194 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 39' ' ' VAL . 40.1 mt-10 -79.35 115.75 19.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 ' NH1' ' A' ' 38' ' ' ARG . 29.4 mt -121.84 151.49 40.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.518 ' HB ' HG23 ' A' ' 39' ' ' VAL . 7.2 p -154.26 153.6 8.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.094 0.473 . . . . 0.0 111.899 -178.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.2 t80 -100.7 91.97 4.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.996 178.459 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.573 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 8.5 t -126.69 166.1 18.0 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -177.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.502 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.7 mtp180 -98.63 97.52 4.92 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.643 178.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.5 Cg_exo -46.14 -40.74 21.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.8 2.333 . . . . 0.0 113.415 -179.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.47 17.34 3.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.1 mm-40 -150.57 0.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.29 -178.96 50.69 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.264 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.485 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 6.8 mt -108.7 151.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.075 0.464 . . . . 0.0 112.031 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.546 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 16.2 mttt -128.39 166.78 22.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.767 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.65 -40.91 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.858 2.372 . . . . 0.0 112.146 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.16 -24.77 67.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.199 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -49.38 148.75 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 179.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -61.77 166.11 4.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.433 -179.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.696 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.3 tpp180 -134.78 163.73 29.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.386 -178.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.696 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 30.8 t80 -172.31 80.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.223 177.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.46 93.68 6.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.654 -178.882 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 47.7 tp -66.77 83.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.595 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 25.9 m-70 -69.89 136.16 50.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.47 HD21 HG22 ' A' ' 14' ' ' VAL . 94.6 mt -143.41 109.82 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.474 -178.058 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.438 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 60.7 t30 -85.24 54.05 2.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.577 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -35.74 135.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.863 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.9 mmpt? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 t -137.83 124.41 20.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -80.86 158.24 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt -134.29 167.01 21.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 2' ' ' ILE . 4.3 mp -98.3 -20.54 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.62 148.6 0.11 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.281 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.88 159.65 17.22 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.55 2.167 . . . . 0.0 112.379 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.9 tp 57.86 93.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.983 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -168.99 -37.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 7' ' ' VAL . 9.9 p -142.13 17.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' HZ1' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -159.22 150.21 19.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.191 0.52 . . . . 0.0 110.057 179.941 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.38 117.68 30.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.431 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.656 HD21 ' HB3' ' A' ' 105' ' ' ARG . 1.1 p-10 -126.94 -95.84 0.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.316 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 14.8 m-20 -48.49 97.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.126 -178.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HD3' HD11 ' A' ' 108' ' ' LEU . 52.9 tttp -100.84 92.04 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.679 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.632 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -80.69 104.69 11.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.59 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 3.8 p -151.29 -179.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.988 0.423 . . . . 0.0 111.694 -179.03 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.0 OUTLIER -99.45 -179.14 4.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.417 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.1 t -174.54 -173.45 0.75 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.152 0.501 . . . . 0.0 112.111 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 19.4 m80 -115.4 -170.31 1.74 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.09 132.39 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 112.054 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.11 11.97 34.9 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.39 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -64.81 82.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.457 HG21 HD23 ' A' ' 77' ' ' LEU . 6.1 m -47.16 99.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.568 -178.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -93.82 96.22 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' HD21 ' A' ' 77' ' ' LEU . 33.8 tt0 -73.99 132.34 42.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.718 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.4 102.0 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.249 -179.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -85.64 99.64 11.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 35.5 mt -94.29 147.6 23.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.752 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -99.81 164.75 11.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.73 -134.21 3.14 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.536 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 32' ' ' THR . 52.3 t30 -173.85 89.33 0.35 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 85.1 Cg_exo -48.41 -18.31 1.34 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.706 2.271 . . . . 0.0 113.181 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.6 p -104.62 30.35 5.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 29' ' ' ASN . 6.1 t -108.87 -35.04 6.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.05 -34.06 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.805 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -99.71 -179.33 4.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 111.477 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.553 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.4 ttm -147.82 154.09 40.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.816 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.418 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 4.6 m95 -110.42 88.15 2.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.922 178.524 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.597 HG23 ' HA ' ' A' ' 42' ' ' VAL . 14.4 t -133.54 -163.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.8 mtp85 -90.18 158.38 17.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.812 0.339 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 89' ' ' GLU . 21.9 t -77.23 132.03 33.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.656 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.47 9.3 86.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 63.1 m-85 -134.02 -1.75 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.206 0.527 . . . . 0.0 110.538 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.597 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.3 t -51.71 116.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.115 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.38 -31.15 8.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.235 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.7 mttm -66.13 171.45 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 0.0 111.1 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.29 -63.05 1.41 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.629 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.96 141.03 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.75 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.624 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 22.8 mt -92.57 -52.67 4.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.297 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.466 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 55.6 p -62.1 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.572 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -151.73 -82.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.96 -30.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.371 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.556 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.1 mm -74.25 -85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.491 -179.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.667 HD21 HG13 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.99 108.76 21.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.43 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 10.5 tt0 -61.62 140.89 58.09 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG23 ' HD2' ' A' ' 38' ' ' ARG . 59.2 t -141.06 89.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.87 0.367 . . . . 0.0 111.753 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.9 t -73.7 94.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -72.16 115.07 10.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.125 -178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 99.4 mttt -121.37 43.92 2.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -66.13 106.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.543 178.726 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -101.37 117.39 62.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.327 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 84.7 Cg_endo -95.07 -159.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.17 2.58 . . . . 0.0 112.402 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.461 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -48.9 141.6 10.16 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HG2' HG11 ' A' ' 68' ' ' VAL . 18.0 Cg_exo -66.36 179.85 1.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.819 2.346 . . . . 0.0 112.452 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.4 p -93.28 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.728 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -72.42 -1.61 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -58.17 155.34 26.12 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.74 13.16 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.782 2.321 . . . . 0.0 112.527 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.5 ptm -122.28 81.3 1.82 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.466 HG11 ' HG2' ' A' ' 62' ' ' PRO . 93.8 t -78.59 102.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.097 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.38 42.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.607 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.14 -6.92 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 111.222 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.1 -106.28 0.2 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.144 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.44 62.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.12 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 11.8 pt -131.06 -167.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 0.0 111.418 -179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -124.97 103.41 8.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.961 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 84.9 t -92.98 100.17 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.063 0.459 . . . . 0.0 110.547 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.76 118.9 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.135 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 81.5 mt -103.82 105.59 15.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.754 178.511 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.667 HG13 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.72 100.99 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.032 0.444 . . . . 0.0 110.992 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -105.53 102.57 38.53 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.449 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 37.3 Cg_exo -55.96 98.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.241 1.961 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.676 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 70.3 mtt180 -62.26 -34.63 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -124.29 179.69 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -118.28 144.11 46.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.34 -111.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.556 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.417 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.1 m80 -116.25 96.66 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 111.031 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.502 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.33 163.26 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.512 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.489 HG21 ' N ' ' A' ' 88' ' ' LEU . 30.1 m -160.08 157.93 29.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 111.712 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.622 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.0 tp -126.14 89.09 2.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 39' ' ' VAL . 43.2 mt-10 -73.85 93.9 2.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.123 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.622 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 56.3 mt -103.38 134.27 47.03 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 92' ' ' TYR . 8.3 p -139.52 154.86 25.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 111.83 -178.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.9 t80 -97.85 90.37 4.92 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.5 ' HB ' HG21 ' A' ' 99' ' ' ILE . 5.8 t -120.02 173.02 7.33 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -103.22 95.05 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.861 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 93' ' ' THR . 89.1 Cg_exo -46.8 -30.5 9.44 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.626 2.218 . . . . 0.0 112.682 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.67 -37.24 62.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.22 -79.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.35 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.4 178.48 43.4 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.18 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.5 HG21 ' HB ' ' A' ' 93' ' ' THR . 4.1 mt -95.45 154.66 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.454 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.7 mttt -140.72 161.65 53.18 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -71.15 -39.01 4.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.93 -28.07 69.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -54.72 152.27 7.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.215 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -52.89 156.14 2.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HB3' HD21 ' A' ' 10' ' ' ASN . 15.9 tpp180 -127.71 164.94 21.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.528 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.598 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 54.2 t80 -176.64 64.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 109.52 177.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 89' ' ' GLU . 11.1 m -87.12 92.9 9.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.866 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.4 tp -74.75 95.63 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.301 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.632 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.3 m-70 -79.72 144.02 34.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.773 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 79.6 mt -144.44 106.55 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.352 -178.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -82.79 65.65 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -42.73 136.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.568 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -147.83 165.14 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -96.12 128.64 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -86.38 124.03 32.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 pt -90.19 6.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.22 83.69 32.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.49 20.31 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.9 tp -56.4 -63.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.015 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -143.66 -27.81 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.046 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.8 101.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -176.7 134.76 0.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.358 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.46 123.58 19.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.637 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -125.69 -59.0 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.859 -179.402 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 7.5 p-10 -54.7 100.02 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -115.09 60.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.718 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.627 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.9 m0 -78.25 119.24 21.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.401 -177.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.9 -174.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.429 0.633 . . . . 0.0 112.317 -178.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.07 177.16 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.58 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -176.31 176.36 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.111 0.481 . . . . 0.0 112.265 179.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.536 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 31.6 m-70 -114.52 -153.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.683 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.3 128.8 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 111.797 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 64.37 13.36 54.3 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.33 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.7 tptm -57.27 86.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.445 HG21 HD23 ' A' ' 77' ' ' LEU . 3.3 m -56.86 97.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.033 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -87.92 104.88 17.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.448 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 41.1 tt0 -89.26 129.24 35.85 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.181 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.41 HD12 ' OH ' ' A' ' 106' ' ' TYR . 25.0 mt -141.41 109.85 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -85.38 113.22 21.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.272 179.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mp -104.96 162.28 13.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.4 mptt -119.42 158.6 25.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.448 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . -174.92 -141.19 3.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 60.1 t30 -172.01 104.54 0.36 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.426 0.155 . . . . 0.0 111.052 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.73 -34.33 98.89 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.69 2.26 . . . . 0.0 112.649 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.1 p -76.38 13.15 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.657 -179.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 64.5 m -95.16 -33.36 12.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.23 -32.86 3.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.866 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -100.18 -176.01 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.019 0.437 . . . . 0.0 111.296 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 9.5 ttm -146.53 146.38 30.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.174 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -97.36 80.63 2.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 178.882 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 42' ' ' VAL . 14.9 t -121.94 -170.5 2.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 -179.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.697 ' HE ' ' HB2' ' A' ' 47' ' ' LEU . 1.9 ttm-85 -81.84 137.58 35.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.527 HG23 ' HB ' ' A' ' 91' ' ' VAL . 71.6 t -54.38 140.18 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.841 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.12 4.47 4.67 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.642 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.511 ' HA ' ' HZ2' ' A' ' 44' ' ' LYS . 23.0 m-85 -123.4 25.65 8.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.847 -179.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.546 ' HB ' HG23 ' A' ' 93' ' ' THR . 6.4 p -67.82 130.68 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.994 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.57 -29.98 10.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HB2' HD22 ' A' ' 47' ' ' LEU . 63.7 mttp -62.03 170.06 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.44 -59.52 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.866 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.8 -30.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.801 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.697 ' HB2' ' HE ' ' A' ' 38' ' ' ARG . 12.3 mt 76.11 -48.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.554 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 83.1 p -58.82 -171.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 179.112 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.02 -92.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.439 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.609 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -129.89 -33.32 1.8 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.561 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 HG23 ' HG ' ' A' ' 52' ' ' LEU . 37.8 mm -63.94 -64.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.522 ' HB3' HG11 ' A' ' 78' ' ' VAL . 81.7 mt -122.39 124.21 43.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -71.73 68.89 0.64 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.45 178.482 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -78.86 132.45 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.169 0.509 . . . . 0.0 110.992 -179.661 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.1 t -131.78 85.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.18 179.601 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.554 ' H ' HH22 ' A' ' 38' ' ' ARG . 10.4 t -99.19 111.86 24.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.538 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -95.99 112.66 24.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.36 108.3 14.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.212 179.392 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.505 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 26.5 m -120.69 128.42 25.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 3.0 Cg_endo -87.71 -149.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.428 2.752 . . . . 0.0 111.179 178.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.503 ' H ' HG21 ' A' ' 70' ' ' VAL . 2.7 m -118.95 133.24 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 111.206 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 161.72 9.36 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.052 2.501 . . . . 0.0 112.072 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 t -163.53 160.0 22.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.924 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.9 p -138.9 -1.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.645 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 90.3 m -161.12 -50.9 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.645 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 13.4 Cg_exo -70.83 157.99 56.79 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.722 2.282 . . . . 0.0 112.326 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.4 mtt -147.19 15.81 1.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.4 p -110.55 24.62 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.075 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.37 92.22 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.51 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG21 ' H ' ' A' ' 61' ' ' THR . 3.5 p -139.91 80.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.238 0.542 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.68 108.77 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -93.24 -121.57 3.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.07 -179.7 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.5 pt -147.5 -165.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.347 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 4.3 m-85 -141.35 103.14 4.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.639 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 63.4 t -86.25 93.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 56' ' ' CYS . 21.3 t -88.58 124.59 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.796 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 77.1 mt -120.12 93.34 4.02 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.589 HG12 HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.18 103.97 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.943 0.402 . . . . 0.0 110.915 -179.148 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.7 mtmt -101.93 98.25 9.65 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.439 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.7 Cg_endo -46.42 106.7 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.758 2.305 . . . . 0.0 112.721 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.609 HH11 ' HA ' ' A' ' 50' ' ' GLU . 9.1 mtt180 -79.44 -48.62 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 62.3 mttm -102.91 156.52 17.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -95.32 123.5 38.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.539 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.21 -153.72 25.14 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.493 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -90.33 104.13 16.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 15.6 m-70 -122.28 179.2 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 94.8 m -160.12 155.26 24.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.086 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.493 ' HB2' HG13 ' A' ' 78' ' ' VAL . 1.5 tm? -131.46 93.4 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -104.61 121.37 43.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.98 -179.799 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.444 ' CD2' ' HG3' ' A' ' 38' ' ' ARG . 39.2 mt -99.0 171.84 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.478 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HB ' HG23 ' A' ' 39' ' ' VAL . 7.1 p -160.34 151.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.107 0.48 . . . . 0.0 112.272 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.57 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -94.4 85.19 4.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.146 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.546 HG23 ' HB ' ' A' ' 42' ' ' VAL . 3.7 t -107.7 172.1 7.02 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -104.57 94.04 6.71 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.8 Cg_exo -49.6 -30.89 23.08 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.408 2.072 . . . . 0.0 112.382 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -74.6 -35.35 62.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -107.95 -77.89 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.319 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.95 -173.72 46.52 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.127 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.452 HG21 ' HB ' ' A' ' 93' ' ' THR . 5.3 mt -96.68 148.72 5.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 4.4 mttt -133.75 174.03 5.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.41 -38.16 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.405 2.07 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.51 -10.05 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.762 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.528 ' N ' HD21 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -64.45 161.84 16.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -179.927 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.1 tp10 -74.01 167.79 20.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.943 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.7 tpp180 -142.77 158.83 43.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.6 t80 -158.72 81.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.533 177.027 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 2.6 m -76.59 157.76 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.506 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.535 HD22 HG23 ' A' ' 78' ' ' VAL . 33.7 tp -156.51 82.69 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.256 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.7 m-70 -67.82 156.28 37.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.398 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.404 ' HB3' HG23 ' A' ' 16' ' ' THR . 96.1 mt -147.92 106.4 3.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.034 -178.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -79.62 61.88 3.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.539 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 3.3 t -45.16 121.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.603 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.978 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.6 m -95.15 119.92 34.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -81.76 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -132.78 -165.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.779 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.75 -30.79 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.602 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -69.16 -50.78 19.63 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.757 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 27.2 Cg_exo -62.53 162.93 22.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.204 1.936 . . . . 0.0 112.229 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 5' ' ' LEU . 2.5 pt? -153.6 -38.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.4 m -158.76 -74.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.36 -170.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -137.37 113.6 9.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.91 120.07 8.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.651 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.2 p-10 -129.46 -92.71 0.44 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.967 -179.312 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.6 p-10 -50.83 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.664 -179.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -104.89 93.51 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.45 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.654 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -84.39 105.88 15.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.593 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.483 HG22 HD21 ' A' ' 110' ' ' LEU . 29.5 m -147.44 -174.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.259 0.552 . . . . 0.0 112.285 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.93 179.69 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.416 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.1 t -177.39 -175.76 0.57 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.054 0.454 . . . . 0.0 111.891 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 49.1 m-70 -117.81 -167.11 1.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 179.118 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 33.7 t -86.66 135.84 24.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 111.94 -179.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 63.33 11.53 40.69 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.476 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.0 tptt -59.79 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.1 0.45 . . . . 0.0 109.812 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.481 HG21 HD23 ' A' ' 77' ' ' LEU . 3.8 m -55.61 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.368 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 m -94.48 98.66 11.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.527 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -75.45 133.51 41.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.2 mt -134.02 101.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -87.19 110.22 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 33.7 mt -108.18 148.48 29.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.352 -179.229 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -99.5 160.66 14.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.986 0.422 . . . . 0.0 110.605 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.95 -128.63 1.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.374 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.558 HD21 ' HB ' ' A' ' 32' ' ' THR . 1.9 p-10 -175.77 90.41 0.28 Allowed Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.537 0.208 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 31.3 Cg_endo -63.5 163.64 23.33 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 p 44.69 28.02 0.3 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.753 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.558 ' HB ' HD21 ' A' ' 29' ' ' ASN . 53.2 m -134.73 -72.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' H ' HD21 ' A' ' 29' ' ' ASN . . . -108.5 -112.74 3.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.821 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -96.39 -166.54 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.957 0.408 . . . . 0.0 110.872 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -136.87 154.71 50.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.174 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.41 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 8.3 m95 -112.47 98.23 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.94 178.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 42' ' ' VAL . 14.6 t -142.56 -165.79 2.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.822 -179.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.645 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.8 mtp85 -88.54 156.57 19.0 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.8 t -72.83 131.17 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.935 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 13.96 82.02 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.858 179.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.518 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 58.0 m-85 -134.88 -4.31 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.725 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.6 t -49.52 124.39 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.123 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.36 -32.81 5.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.17 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 93.4 mttt -64.31 169.8 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.02 -61.7 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.602 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.97 142.0 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.5 mt -95.96 -50.46 4.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.119 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.5 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 24.4 p -50.78 177.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.127 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -153.3 -81.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.19 -33.23 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 22.8 mm -69.28 -81.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.676 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 6.7 mt -97.15 117.59 31.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.615 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 23.5 tt0 -68.68 84.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.514 HG23 ' HD2' ' A' ' 38' ' ' ARG . 39.0 t -88.95 91.66 3.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.511 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.6 t -79.68 86.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.4 t -68.95 135.22 50.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.006 -178.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 8.9 mtpm? -138.25 54.09 1.79 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.84 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.495 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -52.52 112.37 0.81 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.511 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.46 HG23 HG21 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -100.36 104.16 28.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.537 -179.548 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 30' ' ' PRO . 27.1 Cg_endo -103.1 4.55 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.765 2.977 . . . . 0.0 113.039 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -121.68 138.33 28.33 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.413 -178.729 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 61' ' ' THR . 83.9 Cg_endo -79.59 171.33 15.91 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.612 2.208 . . . . 0.0 112.253 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.1 t -165.8 169.2 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.5 p -115.54 9.93 15.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.0 p -62.39 155.49 66.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.88 13.48 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.817 2.345 . . . . 0.0 112.482 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.0 mtt -115.79 80.84 1.5 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -53.85 124.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.21 35.37 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.266 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 59' ' ' THR . 2.6 p -157.31 91.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.155 0.503 . . . . 0.0 110.955 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.07 50.82 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.238 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' ' 30' ' ' PRO . . . 103.76 16.99 18.03 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.324 179.211 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.9 pt -111.28 -168.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 111.369 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -136.44 107.32 6.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.279 -179.482 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -94.36 100.99 12.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.945 0.403 . . . . 0.0 110.737 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.26 118.2 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.028 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 89.0 mt -104.1 106.92 17.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.44 104.99 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.272 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 39.3 mtmt -108.75 100.45 39.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.46 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 81.8 Cg_exo -46.41 96.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.586 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 10.4 mtt180 -69.04 -33.81 74.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.173 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 65.9 mttm -118.95 -178.45 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 -179.722 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -119.52 120.83 37.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.795 179.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.7 -121.35 1.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.608 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.36 113.89 26.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 111.102 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.584 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 5.6 m80 -136.14 150.72 49.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.7 m -161.19 152.6 19.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 112.063 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 53.8 tp -121.87 71.79 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.073 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 3.1 pt-20 -70.71 105.38 3.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.624 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.6 mt -107.18 154.67 20.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.09 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.34 160.22 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.695 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -103.88 89.16 3.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.562 178.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.545 ' HG1' ' H ' ' A' ' 94' ' ' ARG . 9.1 t -120.25 169.12 10.56 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.545 ' H ' ' HG1' ' A' ' 93' ' ' THR . 77.2 mtp180 -101.49 95.91 5.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.948 178.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 5.6 Cg_endo -47.18 -33.46 15.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -68.46 -35.61 77.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.497 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -103.82 -80.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.359 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.65 46.25 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.095 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.475 HG21 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -97.21 149.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.027 0.441 . . . . 0.0 111.669 -179.08 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.8 mttt -135.18 162.91 54.76 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.0 Cg_endo -64.74 -35.23 47.03 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.607 2.205 . . . . 0.0 111.743 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.75 -24.45 66.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.1 m-80 -48.67 136.43 13.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 11.0 tt0 -51.86 155.44 1.76 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.582 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 4.3 tpp180 -119.96 159.15 25.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.534 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.9 t80 -172.47 69.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 16.5 m -91.43 101.97 14.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.465 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.2 tp -87.97 94.48 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.185 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.654 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 15.3 m-70 -77.55 147.87 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.677 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.483 HD21 HG22 ' A' ' 14' ' ' VAL . 94.9 mt -146.19 108.44 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.547 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 39.4 t30 -84.35 69.68 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 17' ' ' HIS . 2.9 t -45.71 143.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.852 -178.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.1 m -140.32 115.99 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.322 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -96.58 130.23 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm -110.26 164.09 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.8 tt -96.76 -30.72 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.015 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.11 151.11 18.42 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.23 128.41 13.78 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.476 2.117 . . . . 0.0 112.288 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.2 tp -124.03 -29.71 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.798 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -131.13 -58.32 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 p -164.55 130.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.564 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.09 -20.27 17.45 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.684 179.976 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 50.66 104.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -132.21 -80.47 0.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.867 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 8.8 m-20 -48.18 96.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.618 -179.297 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HD3' HD12 ' A' ' 108' ' ' LEU . 20.8 ptmt -101.06 68.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.554 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.705 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -49.85 104.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.137 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.489 HG22 HD21 ' A' ' 110' ' ' LEU . 35.4 m -146.87 -176.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.3 p-10 -103.38 -171.33 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.466 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -174.41 -174.74 0.89 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.3 0.571 . . . . 0.0 112.379 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 28.7 m80 -113.85 -156.58 0.6 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.647 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.445 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 42.3 t -105.26 125.56 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.468 . . . . 0.0 111.585 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.9 12.7 43.95 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.061 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptp -63.64 83.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.135 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.441 HG21 HD23 ' A' ' 77' ' ' LEU . 5.3 m -47.87 103.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.829 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 m -97.48 100.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.536 179.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HG3' HG21 ' A' ' 75' ' ' VAL . 35.4 tt0 -83.47 131.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.286 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD12 HD23 ' A' ' 108' ' ' LEU . 36.1 mt -136.09 100.0 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.522 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.432 ' ND1' HD13 ' A' ' 73' ' ' ILE . 10.8 m170 -84.08 82.05 8.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 178.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 75.0 mt -72.24 158.54 35.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.285 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -116.16 164.76 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.103 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.42 -149.57 11.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.724 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.602 HD22 ' HB ' ' A' ' 31' ' ' THR . 8.5 t30 -171.22 84.48 0.5 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.559 0.219 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HD2' ' HA3' ' A' ' 71' ' ' GLY . 27.5 Cg_endo -61.84 -10.37 17.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.582 2.188 . . . . 0.0 112.693 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.602 ' HB ' HD22 ' A' ' 29' ' ' ASN . 0.8 OUTLIER -52.88 -22.71 5.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.851 0.357 . . . . 0.0 110.889 179.709 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.5 p -77.44 -45.13 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.768 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.44 27.09 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.112 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 93' ' ' THR . 79.8 m-85 -140.27 143.86 36.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.02 0.438 . . . . 0.0 111.507 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.559 ' HE2' ' H ' ' A' ' 43' ' ' GLY . 8.5 ttp -113.58 154.8 26.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.423 179.388 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -105.22 107.03 17.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.867 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -156.65 -166.27 2.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.485 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.595 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 mtp85 -84.25 161.94 20.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.184 -179.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 89' ' ' GLU . 48.6 t -76.36 138.69 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.813 -179.418 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.13 79.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.605 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -135.03 -2.59 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.635 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.594 ' HB ' HG23 ' A' ' 93' ' ' THR . 2.3 p -40.29 108.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.287 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.559 ' H ' ' HE2' ' A' ' 35' ' ' MET . . . 106.68 -44.45 1.47 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -56.4 164.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 0.0 111.053 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.84 -46.77 9.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.07 136.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.9 mt -102.19 -50.55 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.973 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.461 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.6 p -50.93 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.742 179.038 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.96 -88.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.587 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -131.02 -32.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.056 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -71.64 -73.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.324 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 80' ' ' PRO . 14.8 mt -107.5 118.97 38.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.442 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.64 69.22 0.42 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 HG23 ' HD2' ' A' ' 38' ' ' ARG . 11.8 t -76.56 83.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.316 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 14.9 t -83.61 87.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.413 ' SG ' HG23 ' A' ' 76' ' ' VAL . 39.9 t -95.38 150.57 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.489 -178.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB2' HG11 ' A' ' 75' ' ' VAL . 58.5 mttm -139.02 118.13 12.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.456 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 1.5 t80 -96.57 101.64 13.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.128 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.5 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 27.7 m -107.87 90.23 6.21 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.373 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 96.7 Cg_endo -83.42 -174.75 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.987 2.458 . . . . 0.0 111.818 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.455 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.23 140.52 65.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.867 179.539 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.455 ' HD2' HG23 ' A' ' 61' ' ' THR . 25.4 Cg_exo -62.81 121.77 9.81 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.505 2.137 . . . . 0.0 112.214 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.507 ' HG ' ' HD2' ' A' ' 66' ' ' PRO . 22.7 t -113.35 -179.55 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.3 t -70.83 -67.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 58.6 m -99.89 -48.69 0.21 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 14.3 Cg_exo -70.28 156.09 62.74 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.739 2.293 . . . . 0.0 112.443 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.2 mmt -148.71 15.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.045 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.94 134.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.3 50.79 61.64 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -113.36 8.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.962 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.54 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . 84.79 111.93 0.67 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.217 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 60' ' ' PRO . . . -171.78 -120.8 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.165 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm -114.33 153.43 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.954 0.883 . . . . 0.0 111.784 -179.36 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -129.87 67.57 1.46 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.506 178.463 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.487 HG21 ' HG3' ' A' ' 23' ' ' GLU . 2.2 p -81.04 107.31 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.476 -178.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.413 HG23 ' SG ' ' A' ' 56' ' ' CYS . 96.6 t -102.02 125.98 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.46 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 HG21 ' A' ' 21' ' ' THR . 76.6 mt -109.3 96.9 6.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.77 178.408 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.553 HG22 HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -93.73 106.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.04 0.448 . . . . 0.0 111.044 -178.904 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -107.87 105.07 55.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.985 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HA ' HD21 ' A' ' 52' ' ' LEU . 47.8 Cg_exo -53.05 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.49 2.127 . . . . 0.0 112.45 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.587 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.6 mtt180 -69.87 -49.14 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.459 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -107.62 161.05 15.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -98.15 113.79 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.733 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.93 -129.25 1.9 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.578 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.401 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.7 m80 -106.62 99.09 8.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.462 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -111.04 162.69 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.673 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 99.7 m -159.63 148.87 18.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.044 0.449 . . . . 0.0 112.052 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 25.7 tp -121.61 79.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.757 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -77.07 100.19 5.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.178 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.453 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.9 mt -98.68 140.75 32.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.116 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.98 164.49 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.808 -179.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -99.11 84.18 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 42' ' ' VAL . 7.6 t -95.5 -175.67 3.54 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.831 -177.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 55.7 mtp180 -117.91 101.17 52.08 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.297 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 84.4 Cg_exo -39.92 -34.93 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.054 2.503 . . . . 0.0 113.399 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.438 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -88.74 -47.23 8.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.414 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -83.92 -86.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.884 0.374 . . . . 0.0 111.803 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 172.82 -174.06 45.68 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.246 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.465 HG12 ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -93.68 154.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.502 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 10.6 mttm -145.44 166.46 17.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.506 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.2 Cg_exo -59.62 -44.88 28.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.857 2.371 . . . . 0.0 111.864 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.51 -26.74 67.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.307 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.554 ' N ' HD21 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -49.56 135.47 18.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 9.3 tt0 -49.42 152.53 1.28 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.24 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 7.4 tpp180 -117.63 159.2 23.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.167 0.508 . . . . 0.0 111.71 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.493 ' H ' ' HG3' ' A' ' 105' ' ' ARG . 41.5 t80 -175.55 62.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.532 177.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 9.1 m -84.26 98.12 9.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.726 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 18.6 tp -80.57 92.41 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.862 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.705 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -79.59 140.94 36.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.341 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 108' ' ' LEU . 89.3 mt -144.01 99.83 3.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.58 -178.322 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 7.9 t30 -73.16 77.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.565 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 6.1 t -51.5 120.55 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.418 -178.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.887 -179.97 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.4 m -137.46 -38.27 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt -83.48 -172.61 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.773 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -144.21 -22.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.88 111.37 12.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.206 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.15 176.25 10.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.427 2.085 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -154.5 -70.4 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 78.4 p -165.72 -58.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.8 p -98.56 150.76 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -133.41 110.72 10.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.991 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.72 126.84 29.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.605 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -115.96 -16.46 11.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.241 -179.413 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -149.56 -140.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.517 ' C ' ' HB3' ' A' ' 109' ' ' HIS . 22.1 ptmt -132.63 -173.94 3.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.451 -179.12 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 16.7 m0 -136.63 117.48 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 179.214 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.52 ' N ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 p -158.35 158.57 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.547 0.689 . . . . 0.0 112.077 -178.688 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 p30 -44.98 165.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.925 -178.454 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 110' ' ' LEU . 3.1 t -173.02 -167.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.391 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.549 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 57.2 m80 -111.99 179.34 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -94.03 147.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.208 0.528 . . . . 0.0 112.195 -178.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.19 21.63 5.96 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.849 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.8 tptt -75.18 73.53 2.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 109.658 179.38 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.436 HG23 HD21 ' A' ' 77' ' ' LEU . 11.6 m -40.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.809 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.6 m -104.52 103.84 13.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.581 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' HG3' HG21 ' A' ' 75' ' ' VAL . 28.0 tt0 -82.58 121.7 27.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.42 ' O ' HD23 ' A' ' 26' ' ' LEU . 56.7 mt -126.99 99.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.514 ' HB3' HD13 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.36 109.61 20.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.61 178.639 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 2.6 mm? -91.05 167.56 12.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -107.46 167.66 9.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.965 179.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.6 -148.82 18.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.579 -179.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 49.0 t30 -171.64 116.02 0.42 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.331 0.11 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.51 -46.55 26.66 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.39 2.06 . . . . 0.0 112.404 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -57.81 -29.32 64.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.435 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 52.4 m -59.54 -55.25 36.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.19 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.64 -83.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.143 179.752 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 87.9 m-85 -55.46 158.86 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.19 0.519 . . . . 0.0 111.635 -179.256 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.0 ttm -123.8 150.29 44.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -105.66 81.82 1.72 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 178.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -124.01 -160.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.699 -179.292 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 1.8 ttp85 -95.24 114.12 25.87 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG12 HH11 ' A' ' 105' ' ' ARG . 0.9 OUTLIER -48.14 134.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 111.514 -179.283 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.16 3.19 76.29 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.917 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 55.7 m-85 -139.37 0.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.971 -179.633 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HA ' HG23 ' A' ' 37' ' ' THR . 9.3 p -49.48 136.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.195 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.99 -34.69 2.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.0 mttm -62.36 168.46 3.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.35 -61.59 1.77 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.588 179.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.44 140.56 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.743 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.0 mt -89.76 -52.08 5.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.924 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.475 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 22.7 t -48.69 172.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.472 178.683 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.475 ' H ' ' HG ' ' A' ' 48' ' ' SER . 1.0 OUTLIER -152.46 -78.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.74 -34.44 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.469 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -69.97 -78.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 -179.306 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' A' ' 80' ' ' PRO . 60.2 mt -98.54 117.2 32.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.385 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.684 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 25.9 tt0 -67.93 84.26 0.22 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.58 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG23 ' HD2' ' A' ' 38' ' ' ARG . 19.8 t -92.22 94.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -91.48 82.13 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' SG ' HG23 ' A' ' 76' ' ' VAL . 22.2 t -99.61 155.21 17.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.622 -178.367 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -143.41 123.86 13.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -89.36 109.34 20.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.398 179.741 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 m -97.72 105.04 24.11 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.574 -179.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 44.1 Cg_endo -101.5 -162.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.849 3.033 . . . . 0.0 112.464 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.503 HG22 ' HD2' ' A' ' 62' ' ' PRO . 22.8 m 58.12 138.61 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.172 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' A' ' 61' ' ' THR . 20.2 Cg_endo -59.63 178.5 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.144 2.563 . . . . 0.0 112.211 179.59 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.1 p -69.09 114.72 7.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -100.27 -30.32 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.029 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 62.8 m -155.89 -50.25 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 7.0 Cg_exo -74.56 -171.77 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.802 2.334 . . . . 0.0 112.21 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.3 ptm -160.08 20.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.457 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.67 27.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.943 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.1 84.1 1.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.516 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.53 86.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.062 0.458 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.88 39.51 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.328 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.95 29.94 1.18 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -86.0 162.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.6 0.714 . . . . 0.0 111.429 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 29.1 m-85 -144.52 79.79 1.62 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.56 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' ' 23' ' ' GLU . 2.8 p -85.05 106.52 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.268 0.556 . . . . 0.0 110.755 -178.994 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG23 ' SG ' ' A' ' 56' ' ' CYS . 20.4 t -107.83 116.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.583 -178.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 21' ' ' THR . 29.1 mt -100.46 100.96 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 114.19 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.252 0.549 . . . . 0.0 111.17 -178.947 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.7 mtmm -119.44 92.41 45.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.416 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.63 ' HA ' HD22 ' A' ' 52' ' ' LEU . 5.4 Cg_endo -47.46 112.87 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.487 2.125 . . . . 0.0 112.905 -178.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.1 mtt180 -80.51 -39.82 27.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.861 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' O ' HG22 ' A' ' 112' ' ' VAL . 66.3 mttm -108.28 176.38 5.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 112' ' ' VAL . 93.8 mtt180 -113.62 149.82 34.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.072 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' HG21 ' A' ' 112' ' ' VAL . . . 124.01 -160.56 18.56 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.726 179.8 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.471 ' HA ' HD21 ' A' ' 111' ' ' ASN . 65.7 m80 -71.43 98.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 110.752 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -129.91 154.07 47.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 0.0 111.331 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.531 HG23 ' HE1' ' A' ' 13' ' ' TRP . 37.5 m -159.87 138.9 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 78' ' ' VAL . 32.0 tp -74.53 111.18 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.292 179.531 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 44.5 mt-10 -87.6 96.75 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.732 -179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 36.3 mt -101.14 170.01 8.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.449 178.796 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 13.3 p -166.56 153.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -104.56 84.27 2.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.475 HG23 HG11 ' A' ' 91' ' ' VAL . 5.6 t -124.55 149.23 47.2 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.12 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 74.7 mtp180 -85.81 101.65 2.01 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.965 178.495 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 8.6 Cg_endo -52.28 -38.24 72.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.721 2.281 . . . . 0.0 112.685 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.14 10.89 3.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.74 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 20.7 mm-40 -147.88 1.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.41 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.84 -174.75 54.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.114 -179.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.473 HG21 ' HB ' ' A' ' 93' ' ' THR . 7.2 mt -106.45 148.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.002 0.429 . . . . 0.0 111.635 -179.326 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 9.9 mttt -131.63 157.93 76.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.565 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 52.2 Cg_exo -56.39 -43.98 50.53 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.75 2.3 . . . . 0.0 112.744 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.76 -14.09 49.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.074 -179.365 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.589 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -62.02 137.7 58.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 -179.632 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' O ' HG22 ' A' ' 91' ' ' VAL . 5.9 tt0 -60.37 -179.46 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -162.97 162.35 26.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.214 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.576 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 26.3 t80 -151.53 114.94 4.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.042 0.449 . . . . 0.0 110.177 178.151 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.554 HG22 ' NE ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -104.37 132.12 50.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.043 -178.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 110' ' ' LEU . 26.5 tp -101.62 110.45 22.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.527 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 8.6 p80 -55.32 71.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.868 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 108' ' ' LEU . 21.1 mt -112.72 70.72 0.72 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.839 0.745 . . . . 0.0 112.937 -178.896 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 2.2 t-20 -82.31 60.21 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.757 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 84' ' ' GLY . 0.2 OUTLIER -40.71 141.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.615 -178.07 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.044 179.719 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' -1' ' ' SER . . . . . 0.541 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 48.1 t -140.96 3.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 62.9 m80 58.74 26.22 14.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.847 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.541 ' HG3' ' HB3' ' A' ' -1' ' ' SER . 69.3 mtm -60.88 167.97 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.944 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 8' ' ' LYS . 40.1 pt -76.5 -28.42 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.06 90.4 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.214 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.14 110.69 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.558 2.172 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.7 tp -166.9 -33.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 m -136.43 -49.26 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.43 105.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 111.23 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -110.37 -12.93 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.701 179.875 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 54.28 106.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.678 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -137.62 -86.71 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.941 -179.667 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -36.72 103.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.804 -179.581 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.67 100.54 13.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.492 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.638 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.4 m95 -82.86 105.44 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.696 -179.521 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 4.7 p -153.37 176.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.146 0.498 . . . . 0.0 111.838 -179.118 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -94.39 -176.69 4.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.601 179.67 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 ' HB ' HD23 ' A' ' 110' ' ' LEU . 2.7 t -174.1 -175.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 112.093 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.0 m-70 -116.68 -163.25 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.005 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.06 126.7 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.795 -179.598 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.44 10.55 29.96 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.09 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.1 tptm -63.27 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.502 ' OG1' ' HE3' ' A' ' 79' ' ' LYS . 5.0 m -46.55 98.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.907 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -90.89 94.8 9.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.031 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.9 tt0 -83.77 128.3 34.44 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.282 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.535 HG21 ' HG ' ' A' ' 26' ' ' LEU . 55.5 mt -133.57 103.42 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.048 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -87.89 119.11 27.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.535 ' HG ' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -118.64 151.66 37.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -178.554 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -125.59 157.9 35.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 163.85 -43.22 0.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.436 -1.364 . . . . 0.0 114.195 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER 48.86 103.91 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 121.067 0.461 . . . . 0.0 110.009 -177.656 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.642 ' C ' ' H ' ' A' ' 32' ' ' THR . 56.2 Cg_endo -68.1 -151.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.654 1.569 . . . . 0.0 111.277 -179.45 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 43.4 p -74.02 23.4 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.785 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.642 ' H ' ' C ' ' A' ' 30' ' ' PRO . 12.0 p 63.19 23.84 14.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.152 -179.372 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.26 -34.12 0.33 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.711 179.329 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB2' ' CB ' ' A' ' 30' ' ' PRO . 60.2 m-85 -75.23 -166.78 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.75 0.309 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 15.9 ttm -161.31 150.55 16.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.062 0.458 . . . . 0.0 111.053 -179.606 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -106.49 84.72 2.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.042 178.102 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.602 HG23 ' HA ' ' A' ' 42' ' ' VAL . 6.4 t -136.63 -165.85 1.8 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.329 -178.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -86.69 155.68 20.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.906 0.384 . . . . 0.0 111.636 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 89' ' ' GLU . 43.6 t -72.82 132.4 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.84 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.43 85.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.625 179.618 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.518 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 60.4 m-85 -132.53 -4.61 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.602 ' HA ' HG23 ' A' ' 37' ' ' THR . 21.7 t -53.65 111.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.039 179.314 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.09 -28.86 13.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.954 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 98.0 mttt -68.69 174.24 4.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.09 -64.14 1.2 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.769 179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.6 p -99.25 142.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.809 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 18.8 mt -92.21 -51.71 5.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.282 -179.958 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.506 ' HB3' HG22 ' A' ' 54' ' ' VAL . 76.9 p -67.53 -168.6 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -151.19 -86.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.16 -31.33 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.274 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -72.3 -83.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.475 -179.495 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD21 HG11 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -99.95 107.03 18.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.65 179.767 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 35.5 tt0 -60.43 142.89 54.44 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.276 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG23 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -144.66 85.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.304 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.2 t -86.06 83.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.425 0.631 . . . . 0.0 109.353 178.12 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 76' ' ' VAL . 9.2 t -102.18 133.51 46.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.447 -178.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -116.12 120.84 40.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.303 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.466 ' CZ ' ' HE1' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -90.88 95.37 10.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.245 179.512 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.468 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 32.4 m -95.61 108.1 37.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.721 -179.122 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.586 ' HB2' HG21 ' A' ' 70' ' ' VAL . 56.5 Cg_endo -101.24 82.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.582 2.854 . . . . 0.0 111.283 179.154 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.493 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -53.87 139.15 52.96 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.596 -179.039 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 61' ' ' THR . 87.5 Cg_endo -90.44 154.05 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.204 2.603 . . . . 0.0 112.458 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 p -100.82 -169.91 1.78 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -112.4 -73.04 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.639 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 68.0 m -156.94 -51.58 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.595 179.795 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 1.7 Cg_endo -86.25 36.39 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.089 2.526 . . . . 0.0 111.85 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 45.0 ttp -177.06 31.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.269 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -41.03 137.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.03 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.18 124.77 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.151 -179.692 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.586 HG21 ' HB2' ' A' ' 60' ' ' PRO . 8.7 p -81.4 24.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.228 0.537 . . . . 0.0 110.979 -179.766 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.96 130.38 44.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.991 -179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -134.08 -130.65 3.04 Favored Glycine 0 N--CA 1.453 -0.18 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.54 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.29 -169.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.08 0.466 . . . . 0.0 110.789 179.033 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 9.7 m-85 -145.04 95.42 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.892 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.97 126.29 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.257 0.551 . . . . 0.0 110.655 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -123.06 122.76 66.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.18 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 79.4 mt -105.33 94.25 5.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.134 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.686 HG11 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -92.63 101.57 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.099 0.475 . . . . 0.0 110.756 -179.186 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HE3' ' OG1' ' A' ' 21' ' ' THR . 11.2 mttt -102.11 102.62 25.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.454 -179.326 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HA ' HD22 ' A' ' 52' ' ' LEU . 41.5 Cg_exo -56.12 95.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.132 1.888 . . . . 0.0 112.157 179.388 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 68.9 mtt180 -67.43 -28.15 67.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 65.5 mttm -128.89 173.35 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.436 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -113.46 137.91 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.587 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.56 -136.7 6.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.183 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.458 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 62.0 m80 -99.32 91.68 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 110.742 179.853 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.548 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.7 m-70 -111.28 164.48 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.592 -179.899 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.48 HG21 ' N ' ' A' ' 88' ' ' LEU . 32.4 m -158.75 157.99 32.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 0.0 111.823 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.8 tp -124.02 88.49 2.92 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.528 ' HB3' HG22 ' A' ' 39' ' ' VAL . 39.4 mt-10 -74.25 101.28 3.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.246 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.496 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 75.9 mt -107.38 139.2 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.323 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.93 166.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.149 0.499 . . . . 0.0 112.087 -179.248 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -106.16 84.26 2.02 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.178 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.507 ' HB ' HG21 ' A' ' 99' ' ' ILE . 7.5 t -126.66 159.86 32.43 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -176.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.588 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.0 mtp180 -93.23 100.76 4.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.537 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 93' ' ' THR . 82.7 Cg_exo -34.14 -42.96 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.485 2.79 . . . . 0.0 113.972 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.42 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -80.6 -52.94 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.038 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -70.56 4.98 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.83 -169.26 54.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.931 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.507 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -115.03 155.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.267 0.556 . . . . 0.0 112.256 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 49.5 mtmt -147.0 158.75 44.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.349 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 20.3 Cg_endo -60.86 -34.65 90.97 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.735 2.29 . . . . 0.0 112.684 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.18 -11.88 4.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.838 -179.704 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -71.04 140.51 50.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 111.441 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -55.45 161.99 1.74 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.608 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.5 tpp180 -122.94 160.61 25.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.608 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 42.2 t80 -173.63 66.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.887 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 8.7 m -87.01 92.02 8.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.333 -178.881 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 69.6 tp -72.26 94.46 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.185 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.638 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.5 m-70 -78.56 142.74 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.076 0.465 . . . . 0.0 110.709 179.443 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 93.6 mt -142.69 109.18 5.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -178.038 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -81.73 66.95 7.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.587 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.41 110.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.357 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.934 -179.89 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.417 -0.273 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.2 m -95.34 146.31 24.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -98.37 21.02 11.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt 61.41 -179.89 0.11 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.1 pt -138.1 26.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.151 -179.904 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.547 ' HB1' ' HD3' ' A' ' 4' ' ' PRO . . . -53.17 -49.32 88.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.678 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HD3' ' HB1' ' A' ' 3' ' ' ALA . 49.6 Cg_exo -56.01 152.52 36.43 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.153 1.902 . . . . 0.0 112.167 179.799 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 tp -149.04 -68.13 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.087 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.3 t -127.09 5.1 6.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.7 152.84 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.041 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -129.82 107.8 9.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 109.96 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.81 130.14 42.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -104.68 -21.55 13.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.892 -179.833 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 107' ' ' THR . 6.4 m-20 -151.82 -146.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.401 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -133.89 -170.23 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.701 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 12.5 m0 -130.86 123.95 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.806 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 109' ' ' HIS . 16.4 m -147.88 154.5 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -178.607 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.4 p-10 -51.02 168.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.83 -179.404 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 t -171.36 -168.96 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.803 -179.5 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.1 m80 -104.03 -175.98 2.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.767 0.318 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -96.89 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.142 0.496 . . . . 0.0 111.897 -179.27 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.25 15.5 5.54 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.416 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.546 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -66.39 79.2 0.1 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.023 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.47 HG21 HD23 ' A' ' 77' ' ' LEU . 4.4 m -44.06 101.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.751 -178.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -96.25 101.84 13.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.621 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -80.71 130.06 34.87 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.659 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.496 HG21 ' HG ' ' A' ' 26' ' ' LEU . 46.2 mt -132.86 105.61 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.873 -179.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -89.23 96.04 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HG ' HG21 ' A' ' 24' ' ' ILE . 14.7 mt -90.29 146.01 24.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.303 -179.046 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -100.57 161.31 13.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.44 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.56 -145.02 8.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.441 -179.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.472 HD22 ' HB ' ' A' ' 31' ' ' THR . 5.5 t30 -175.02 96.94 0.28 Allowed Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 11.4 Cg_endo -55.03 -31.13 73.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.68 2.253 . . . . 0.0 112.847 -179.552 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.472 ' HB ' HD22 ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.8 -21.74 20.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.544 -179.818 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 29' ' ' ASN . 71.5 p -66.0 -59.86 3.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.933 179.867 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.79 -33.31 0.52 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.849 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.99 -179.13 5.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.154 0.502 . . . . 0.0 111.493 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.63 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 2.0 ttt -147.88 154.03 39.88 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.739 -179.091 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.463 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.5 m95 -110.19 93.28 4.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.196 178.921 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.63 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 15.1 t -137.25 -168.46 2.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.684 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.0 mtp85 -87.62 140.34 29.62 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG23 ' HB ' ' A' ' 91' ' ' VAL . 13.2 t -60.96 130.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.778 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.65 75.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -137.66 0.73 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 110.432 -179.797 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 37' ' ' THR . 21.5 t -54.39 111.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.147 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.32 -31.77 7.58 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.04 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -68.89 173.98 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.121 179.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.42 -63.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.679 179.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.01 142.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.4 mt -96.03 -51.05 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.455 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.0 p -52.66 175.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.691 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.12 -85.43 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.77 -31.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.299 -179.315 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.5 mm -70.2 -72.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.359 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 80' ' ' PRO . 92.0 mt -111.5 121.47 45.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 68.0 0.37 Allowed 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 HG23 ' HD2' ' A' ' 38' ' ' ARG . 5.8 t -75.62 86.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.42 -178.536 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.0 87.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 76' ' ' VAL . 30.5 t -105.44 141.24 37.28 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.992 -178.1 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -130.84 115.81 17.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.744 179.033 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.529 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -83.54 113.96 21.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.736 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 13.6 m -112.72 111.56 51.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.539 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HB2' HG13 ' A' ' 70' ' ' VAL . 66.8 Cg_endo -99.52 40.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.522 2.815 . . . . 0.0 112.109 179.563 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -42.01 140.37 1.53 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.557 -179.192 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 61' ' ' THR . 26.7 Cg_exo -62.25 -177.36 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.69 2.26 . . . . 0.0 112.368 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -70.69 -170.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 179.908 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -73.83 -67.87 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.567 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 61.5 m -92.87 -48.47 0.3 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.883 -179.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.567 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 12.4 Cg_exo -71.3 -173.97 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.786 2.324 . . . . 0.0 112.303 -179.661 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -138.08 15.16 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.52 150.28 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.274 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.21 -52.25 1.09 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.578 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.565 HG13 ' HB2' ' A' ' 60' ' ' PRO . 89.2 t 52.04 86.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.985 0.421 . . . . 0.0 111.027 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.06 124.77 1.76 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.868 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -120.78 -117.37 2.55 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.378 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.1 pt -139.03 -166.38 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.104 0.478 . . . . 0.0 110.984 179.749 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -130.94 100.48 5.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.183 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 110.746 -179.467 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 88' ' ' LEU . 22.0 t -119.38 120.39 63.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.549 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.47 HD23 HG21 ' A' ' 21' ' ' THR . 72.4 mt -109.58 97.61 7.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.729 178.203 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -93.98 105.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.987 0.422 . . . . 0.0 111.24 -178.721 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -105.78 103.3 43.23 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.035 -179.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' HG23 ' A' ' 112' ' ' VAL . 73.1 Cg_exo -48.41 99.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.738 2.292 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -76.85 -33.76 57.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.767 178.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.76 161.14 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 96.3 mtt180 -103.64 124.53 49.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 146.78 -167.95 28.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -63.49 100.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -135.91 161.01 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.24 0.543 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.525 HG23 ' HE1' ' A' ' 13' ' ' TRP . 47.0 m -165.24 146.27 7.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.52 -179.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 42.2 tp -78.68 105.28 9.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.949 178.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.0 97.33 9.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.418 179.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 25.5 mt -104.22 169.93 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 9.1 p -165.88 150.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.036 -179.017 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.1 t80 -101.28 91.69 4.62 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.37 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.528 ' HG1' ' H ' ' A' ' 94' ' ' ARG . 1.7 t -126.53 164.93 20.11 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.45 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' H ' ' HG1' ' A' ' 93' ' ' THR . 58.4 mtp180 -101.38 91.85 2.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.536 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 93' ' ' THR . 58.7 Cg_exo -39.69 -35.43 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.0 2.467 . . . . 0.0 113.014 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.77 85.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.97 -88.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -163.95 -179.28 38.13 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.053 -179.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 22.2 mt -93.26 -60.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.528 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 34.7 mtmt 69.15 159.59 0.15 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 83.7 Cg_endo -76.71 -34.77 2.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 123.137 2.558 . . . . 0.0 112.388 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.63 -35.77 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -54.91 151.7 8.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.96 0.41 . . . . 0.0 111.611 -179.786 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 91' ' ' VAL . 3.8 tt0 -65.35 178.23 0.97 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -159.25 164.36 35.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.097 -179.482 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.603 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 23.4 t80 -147.01 113.93 6.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.992 0.425 . . . . 0.0 109.973 178.318 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.563 HG22 ' HE ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -103.72 128.65 51.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.308 -178.604 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.555 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 33.2 tp -98.87 108.27 20.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 4.5 p80 -50.4 72.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.747 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.555 ' HG ' ' HG ' ' A' ' 108' ' ' LEU . 94.5 mt -110.22 64.37 0.61 Allowed 'General case' 0 C--N 1.342 0.251 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 42.4 t30 -79.58 51.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -28.36 136.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.462 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -145.84 147.36 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.949 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -131.6 167.61 19.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -96.23 -178.51 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 tp -69.81 -36.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.599 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . . . -169.31 -50.49 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.826 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 3' ' ' ALA . 32.4 Cg_exo -58.45 148.2 81.84 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.18 1.92 . . . . 0.0 112.315 179.975 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 5' ' ' LEU . 7.4 mp -102.07 -52.84 3.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.863 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.7 m -143.33 -77.55 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.44 116.81 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.09 126.82 4.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.565 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.88 115.8 24.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -179.995 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.66 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -130.39 -88.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.316 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.545 ' H ' HD21 ' A' ' 10' ' ' ASN . 0.4 OUTLIER -25.26 105.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.658 -179.251 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HD3' HD11 ' A' ' 108' ' ' LEU . 75.4 tttt -101.39 98.36 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.648 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.8 m95 -85.52 103.2 14.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.416 -178.64 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG21 HD21 ' A' ' 110' ' ' LEU . 26.9 m -149.14 -167.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.671 -179.389 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -108.08 -168.99 1.44 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 179.805 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 15' ' ' ASP . 1.5 t 174.24 -173.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.606 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.7 m80 -120.65 -176.27 3.2 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.099 179.126 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.7 137.67 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.25 0.548 . . . . 0.0 111.999 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.09 16.86 34.91 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.598 179.501 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.2 tptm -57.7 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.091 0.445 . . . . 0.0 110.042 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.468 HG21 HD23 ' A' ' 77' ' ' LEU . 2.9 m -57.2 94.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.25 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -95.57 105.92 17.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.002 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.8 tt0 -85.81 124.98 32.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.851 179.497 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 74' ' ' TYR . 51.7 mt -126.46 101.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.014 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.468 ' ND1' HD13 ' A' ' 73' ' ' ILE . 13.9 m170 -86.57 109.95 19.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 18.8 mt -99.14 176.51 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.98 0.419 . . . . 0.0 111.098 -179.173 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -119.98 169.87 9.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.131 179.26 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.34 -159.07 31.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.717 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.583 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 5.4 t30 -171.64 102.53 0.38 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.402 0.144 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.09 177.66 2.35 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.423 2.082 . . . . 0.0 112.206 -179.995 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.8 p 50.42 20.14 0.64 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.431 -179.693 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.565 ' HB ' HD21 ' A' ' 29' ' ' ASN . 34.2 m -144.4 -69.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.22 -118.49 3.89 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.515 -179.883 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.46 -175.74 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.915 -179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 14.0 ttm -109.47 149.89 28.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.604 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . 4.2 m95 -108.82 83.78 1.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.708 178.29 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.502 HG22 ' HA ' ' A' ' 42' ' ' VAL . 14.1 t -125.51 -168.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.561 ' NH1' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -83.61 134.5 34.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.906 0.384 . . . . 0.0 111.512 -178.941 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.486 ' C ' ' H ' ' A' ' 41' ' ' PHE . 33.6 t -52.57 136.58 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.8 -23.52 1.06 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.51 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 39' ' ' VAL . 11.7 m-30 -100.19 21.08 13.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 110.159 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' HA ' HG22 ' A' ' 37' ' ' THR . 20.1 t -76.34 106.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.725 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.01 -20.26 26.61 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.032 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -66.15 170.41 5.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.372 . . . . 0.0 111.144 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.5 -31.13 18.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.43 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.52 121.76 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 56' ' ' CYS . 20.6 mt -74.35 -59.47 2.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.699 179.474 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 80.6 p -50.55 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.42 178.485 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.09 -96.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.368 179.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -127.24 -32.76 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -73.67 -75.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 80' ' ' PRO . 14.6 mt -103.28 115.58 30.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.315 179.498 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -69.44 71.45 0.3 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.768 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 HG12 ' NE ' ' A' ' 38' ' ' ARG . 2.1 t -74.3 87.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.324 -178.805 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.2 t -88.33 86.62 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.488 178.127 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' HB3' HD11 ' A' ' 47' ' ' LEU . 29.6 t -110.41 153.82 24.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.743 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -136.9 118.13 14.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.273 179.34 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.422 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -80.34 94.77 6.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.54 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 21.5 m -99.58 104.48 27.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.356 -179.369 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.72 ' HB2' HG12 ' A' ' 70' ' ' VAL . 69.0 Cg_endo -97.17 30.99 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.289 2.659 . . . . 0.0 111.847 -179.559 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.6 p -65.64 145.38 99.05 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.303 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.421 ' HA ' ' H ' ' A' ' 70' ' ' VAL . 92.3 Cg_endo -80.14 155.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.605 2.203 . . . . 0.0 112.492 -179.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.5 p -96.55 -174.54 3.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -136.9 -0.01 2.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.617 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 60.3 m -99.14 -49.94 0.21 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.771 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.617 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 3.1 Cg_exo -77.75 -151.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.028 2.486 . . . . 0.0 112.085 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 mtt -129.52 17.66 5.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.962 179.859 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -108.63 153.83 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.081 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.3 128.03 5.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.72 HG12 ' HB2' ' A' ' 60' ' ' PRO . 70.4 t 59.26 96.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-O 120.984 0.421 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 29' ' ' ASN . . . -122.43 -42.32 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.36 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . 107.01 120.82 4.64 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.718 179.627 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.468 HD13 ' ND1' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -89.2 -24.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 0.0 112.056 179.786 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 23.9 m-85 47.31 75.94 0.12 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.326 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 75' ' ' VAL . 4.9 p -92.04 101.44 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.179 0.514 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG23 HH22 ' A' ' 38' ' ' ARG . 17.3 t -99.67 117.29 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' HA ' HD21 ' A' ' 77' ' ' LEU . 64.4 mt -107.38 94.58 5.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.105 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -90.98 112.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.023 0.439 . . . . 0.0 111.297 -178.809 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.6 mtmt -113.15 94.25 29.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.523 ' HA ' HD21 ' A' ' 52' ' ' LEU . 2.2 Cg_endo -47.58 103.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.579 2.186 . . . . 0.0 112.669 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.459 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.7 mtt180 -67.46 -33.68 75.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.541 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 82.0 mttt -119.29 -176.06 3.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.53 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -127.8 121.59 30.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 154.54 -106.98 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -105.58 99.74 9.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.6 m80 -128.67 150.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.47 ' HG1' ' HA ' ' A' ' 109' ' ' HIS . 91.4 m -158.17 147.72 19.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.96 0.409 . . . . 0.0 111.935 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.9 tp -98.31 84.82 3.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.568 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 46.4 mt-10 -69.64 99.11 1.26 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 21.6 mt -110.57 151.77 27.22 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.937 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 39' ' ' VAL . 3.6 p -154.79 146.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.632 -178.606 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' MET . 12.4 t80 -95.67 78.04 3.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.4 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 99' ' ' ILE . 5.4 t -118.45 159.65 23.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -98.43 98.17 5.55 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.605 178.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.3 Cg_exo -40.78 -34.51 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.079 2.519 . . . . 0.0 113.105 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -68.93 -62.95 1.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.003 -179.416 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.73 4.53 9.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.304 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.03 -164.74 37.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.081 -179.562 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.516 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 7.6 mt -113.04 121.02 64.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.976 -179.198 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -107.76 162.74 18.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.36 -37.47 17.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.663 2.242 . . . . 0.0 112.393 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.4 -17.59 8.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.743 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.75 142.29 56.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 111.473 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.42 173.55 1.18 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.599 179.429 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.703 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.8 tpp180 -135.89 163.07 31.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.265 -179.211 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.703 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 13.4 t80 -169.76 74.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 177.152 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -95.94 93.3 6.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.729 -178.851 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.3 tp -76.73 88.65 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 110.24 179.291 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.648 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.0 m-70 -72.38 144.06 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 14' ' ' VAL . 64.5 mt -146.37 113.31 6.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.123 -178.35 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 9.3 t30 -83.34 55.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.491 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.456 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -35.64 126.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.743 -178.871 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.928 179.952 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 51.2 m -137.57 -14.57 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -132.51 132.65 42.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm 57.88 -168.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.68 -61.83 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.567 ' H ' ' HD2' ' A' ' 4' ' ' PRO . . . -168.71 -52.1 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.75 -179.9 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 3' ' ' ALA . 49.0 Cg_endo -68.53 100.13 0.66 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.105 1.87 . . . . 0.0 112.332 -179.748 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -171.45 91.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.789 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.8 t 59.57 13.61 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.176 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.99 94.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.057 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -179.99 152.35 0.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.796 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 112.56 19.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.531 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.569 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -132.09 -94.0 0.36 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.132 0.491 . . . . 0.0 111.952 -179.45 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.55 103.52 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.698 -179.284 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 90.48 7.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.889 179.198 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.633 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.7 m95 -73.67 99.12 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.715 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 10.9 p -156.49 169.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 1.1 m-20 -85.75 -173.25 4.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -175.51 -172.06 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.244 0.545 . . . . 0.0 112.375 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.9 m80 -118.11 -160.12 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.709 178.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.409 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.1 t -101.16 132.64 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 111.764 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.4 17.85 13.31 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.203 179.758 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.1 tptt -63.89 84.07 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.151 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 HD23 ' A' ' 77' ' ' LEU . 6.1 m -47.84 101.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.674 -178.957 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 m -97.51 100.77 12.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.562 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.82 134.0 36.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' A' ' 26' ' ' LEU . 40.2 mt -138.34 104.38 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.964 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -84.18 96.58 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' A' ' 24' ' ' ILE . 13.6 mt -95.88 148.01 23.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 -178.583 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.623 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 5.7 mtpm? -113.54 162.12 16.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.149 179.175 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.29 -23.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.545 -179.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.464 HD22 ' HB ' ' A' ' 31' ' ' THR . 41.1 t30 64.34 104.62 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.463 0.173 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HG2' ' HB ' ' A' ' 70' ' ' VAL . 11.2 Cg_endo -55.24 -27.09 55.09 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.527 2.151 . . . . 0.0 112.478 179.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.464 ' HB ' HD22 ' A' ' 29' ' ' ASN . 6.7 m -57.69 -24.52 57.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.489 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.2 p -60.46 -62.56 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 156.88 -50.7 0.43 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.75 179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -77.23 -176.31 4.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.235 -179.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.561 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.7 ttt -141.32 148.69 40.15 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.081 -179.814 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -104.56 83.5 2.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.849 178.916 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.558 ' HB ' ' HE1' ' A' ' 35' ' ' MET . 14.6 t -127.43 -168.91 1.95 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.23 -179.261 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.578 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 1.9 mtp180 -85.63 135.85 33.62 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.31 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 91' ' ' VAL . 40.9 t -48.63 150.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.068 -179.254 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.81 1.3 4.83 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.595 179.745 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 39' ' ' VAL . 23.2 m-85 -125.91 32.48 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.449 0.642 . . . . 0.0 110.614 -179.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' A' ' 93' ' ' THR . 2.1 p -60.26 100.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.994 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.36 -26.56 6.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.678 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.53 -179.75 1.45 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.865 0.364 . . . . 0.0 111.229 -179.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.59 -51.74 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.842 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -68.94 -45.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.268 -179.744 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.9 mt 71.09 -63.0 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.029 179.601 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.421 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.5 p -46.66 172.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.255 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -154.19 -84.82 0.07 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.416 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -130.65 -33.33 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.399 -179.202 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -70.5 -78.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.437 -179.53 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -103.16 116.01 31.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.452 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.66 69.83 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.673 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 HG21 HG12 ' A' ' 78' ' ' VAL . 20.6 t -76.62 84.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG11 ' HE2' ' A' ' 57' ' ' LYS . 21.0 t -79.41 86.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.284 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.91 142.14 31.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.434 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE2' HG11 ' A' ' 55' ' ' VAL . 72.4 mmtt -133.41 108.96 9.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.072 179.402 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -78.76 100.63 7.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.259 179.564 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.2 m -93.57 108.2 32.33 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.831 -179.056 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HB2' HG13 ' A' ' 70' ' ' VAL . 77.5 Cg_endo -104.18 85.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.109 3.206 . . . . 0.0 111.434 179.285 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -49.12 132.44 15.96 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.53 -179.191 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.28 153.89 15.84 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.062 2.508 . . . . 0.0 112.343 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -68.75 116.89 9.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.032 -179.947 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.0 p -79.76 -20.14 46.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.7 p -81.65 156.52 70.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.973 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.39 12.31 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.681 2.254 . . . . 0.0 112.533 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 64.6 mtt -124.27 -105.17 0.36 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.6 t -143.5 142.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.42 87.73 0.06 OUTLIER Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 179.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 60' ' ' PRO . 57.3 t -58.85 -89.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.959 179.854 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.81 99.46 0.42 Allowed Glycine 0 C--N 1.322 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.057 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.416 ' H ' ' HD2' ' A' ' 30' ' ' PRO . . . -147.74 -150.36 5.18 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.921 179.506 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt -141.52 -167.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.159 0.504 . . . . 0.0 111.338 179.405 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -134.56 97.16 3.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.226 -179.779 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.54 102.98 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.501 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 90' ' ' LEU . 40.2 t -105.55 124.06 60.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD23 HG23 ' A' ' 21' ' ' THR . 85.9 mt -113.17 102.95 10.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.669 178.13 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.49 110.4 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.438 . . . . 0.0 111.428 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.6 mtmt -115.32 96.04 44.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HA ' HD21 ' A' ' 52' ' ' LEU . 6.0 Cg_endo -50.99 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.38 2.054 . . . . 0.0 112.403 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 13.6 mtt180 -74.22 -38.11 63.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.536 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 62.1 mttm -111.4 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.142 -179.069 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -112.01 144.2 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.68 -119.74 2.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -110.58 117.42 33.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 3.1 m80 -132.85 159.06 40.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 59.3 m -159.39 142.41 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.3 tp -99.36 92.14 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.7 mt-10 -72.51 99.35 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 33.8 mt -113.72 128.87 56.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.316 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 39' ' ' VAL . 10.7 p -134.55 158.25 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.799 -178.713 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -97.15 82.38 3.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.977 178.605 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.582 HG23 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -101.77 177.07 5.01 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' HB2' ' H ' ' A' ' 98' ' ' GLY . 61.4 mtp180 -110.25 94.05 17.37 Favored Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.022 179.544 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 81.3 Cg_exo -50.81 -29.2 25.59 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.52 2.146 . . . . 0.0 112.441 179.431 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -79.89 -31.14 40.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.459 -179.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.26 -77.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.932 0.396 . . . . 0.0 111.361 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 174.22 -173.94 46.2 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.007 -179.331 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.411 HG21 ' HB ' ' A' ' 93' ' ' THR . 3.3 mt -93.1 149.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.855 0.359 . . . . 0.0 111.026 -179.471 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.469 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -138.95 168.18 16.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.978 -179.264 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.61 -28.06 4.58 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 112.156 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -78.44 11.62 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.675 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -93.4 150.11 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.342 -179.419 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 163.88 8.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.4 tpp180 -130.96 164.11 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.649 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.637 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.9 t80 -174.4 76.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 109.558 177.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.75 88.78 5.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.389 -179.18 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.648 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 22.1 tp -67.6 90.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 0.0 110.472 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.633 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -73.4 133.91 43.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.662 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.2 mt -141.4 102.86 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.273 -178.191 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -78.64 85.76 4.66 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 17' ' ' HIS . 18.3 t -55.11 112.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.284 -179.062 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.009 179.877 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -143.47 124.82 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -152.64 -55.86 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -89.97 -29.97 18.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.5 tt 42.35 28.08 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.588 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 4' ' ' PRO . . . -82.41 -50.3 0.8 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.624 -179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 3' ' ' ALA . 59.0 Cg_endo -71.82 -10.5 26.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.061 1.841 . . . . 0.0 112.322 -179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.9 tp -88.34 -48.37 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.785 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.0 p -141.25 156.31 45.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.806 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.1 t 65.77 138.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.304 179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -172.4 135.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.325 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.83 115.27 22.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.622 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -123.21 -81.06 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' H ' HD21 ' A' ' 10' ' ' ASN . 7.8 m-20 -30.17 104.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.617 -179.672 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -93.11 89.86 6.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.548 179.489 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.04 101.22 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 110' ' ' LEU . 22.8 m -149.29 -175.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.237 0.541 . . . . 0.0 112.167 -178.849 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.4 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.53 -173.71 2.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.295 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 17' ' ' HIS . 1.3 t -174.45 -175.75 1.0 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.226 0.536 . . . . 0.0 112.187 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.8 m80 -116.82 -162.24 0.84 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.882 179.23 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.53 122.52 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.069 0.462 . . . . 0.0 111.634 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.2 10.69 35.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.14 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptp -62.81 84.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.061 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.453 HG21 HD23 ' A' ' 77' ' ' LEU . 7.7 m -45.39 100.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.807 -178.7 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 m -91.64 102.96 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.28 179.389 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 41.6 tt0 -86.43 132.18 34.01 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.339 -179.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.433 HD13 HD23 ' A' ' 108' ' ' LEU . 37.3 mt -139.2 104.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.413 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -79.62 95.76 5.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.777 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 28.8 mt -88.75 143.95 26.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.444 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 166.08 11.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.873 0.368 . . . . 0.0 110.627 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.89 -150.99 13.04 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -175.86 96.16 0.26 Allowed Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.23 -16.52 17.64 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.764 2.31 . . . . 0.0 113.132 -179.599 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.2 p -82.96 9.15 10.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.675 0.274 . . . . 0.0 111.433 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.5 p -97.84 -60.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.052 179.754 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.48 -27.55 0.32 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.92 179.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 93' ' ' THR . 87.9 m-85 -102.61 175.0 5.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.633 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.504 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 7.1 ttm -147.51 148.89 31.68 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.009 -179.615 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -93.67 81.48 4.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.218 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.424 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 1.7 t -125.4 146.83 49.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.527 -177.766 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HD3' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -53.39 177.34 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.981 0.419 . . . . 0.0 110.623 179.428 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 89' ' ' GLU . 42.8 t -81.78 102.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.522 -179.773 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.5 -12.92 56.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.527 179.236 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.594 ' CD1' ' C ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -73.92 -42.01 61.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 117.45 0.625 . . . . 0.0 110.599 -179.741 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.519 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.0 p -26.7 90.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.138 0.494 . . . . 0.0 111.06 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . 89.75 49.92 3.25 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -178.478 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.662 ' HD2' ' N ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -112.07 -163.33 0.84 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.594 0.712 . . . . 0.0 112.299 -178.548 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.662 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 6.1 m-20 -115.67 -32.82 5.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.995 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.1 t -155.31 118.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.737 178.7 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -51.31 -62.7 1.46 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.125 -179.847 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.565 ' HB3' HG21 ' A' ' 54' ' ' VAL . 81.1 p -64.19 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.781 -179.734 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.51 -80.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.71 -31.29 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.513 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.3 mm -74.35 -86.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.622 -179.465 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.658 HD21 HG11 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -97.86 109.1 21.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.267 179.803 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.597 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 1.3 tm-20 -62.24 147.46 47.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.052 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 48' ' ' SER . 11.5 t -146.36 133.84 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.594 -179.548 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.6 t -137.87 86.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 178.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.499 ' SG ' HG23 ' A' ' 76' ' ' VAL . 42.0 t -93.94 97.58 10.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.784 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.605 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 81.7 mttt -72.65 73.71 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.35 178.844 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.53 ' HD1' ' C ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -64.24 103.71 0.66 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.473 179.8 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.475 HG21 ' HA2' ' A' ' 71' ' ' GLY . 1.4 m -108.37 125.04 32.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.436 178.658 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -94.0 -167.02 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.031 2.487 . . . . 0.0 113.047 -178.716 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -59.48 135.17 88.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.221 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 70' ' ' VAL . 10.9 Cg_endo -53.34 163.27 2.55 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.068 2.512 . . . . 0.0 112.427 179.638 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.5 m -85.17 -166.12 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.2 p -77.16 11.49 1.83 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 72.4 p -56.72 156.54 12.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 92.3 Cg_endo -75.25 12.89 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.723 2.282 . . . . 0.0 112.426 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 65' ' ' THR . 58.2 ttp -131.83 86.14 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.731 179.879 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.95 122.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 62' ' ' PRO . . . 123.3 68.31 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.449 179.993 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 62' ' ' PRO . 86.3 t -108.5 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.065 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.475 ' HA2' HG21 ' A' ' 59' ' ' THR . . . -164.15 -131.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.993 -179.712 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.36 15.47 29.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.508 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt -147.1 -168.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.548 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -136.31 100.71 4.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.094 -179.989 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 62.1 t -79.43 89.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 120.811 0.338 . . . . 0.0 110.893 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 88' ' ' LEU . 21.5 t -83.41 121.31 36.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.588 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 77.3 mt -117.02 98.29 6.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.081 178.304 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.658 HG11 HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.12 110.69 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.827 -179.127 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 42.9 mtmt -110.97 102.58 53.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.959 -178.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 45.4 Cg_exo -54.77 100.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.353 2.036 . . . . 0.0 112.315 179.343 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.0 mtt180 -69.77 -42.26 74.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.545 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 66.3 mttm -112.24 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -117.62 142.83 46.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.749 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.1 -135.28 7.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.485 179.906 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.417 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.8 m80 -101.33 91.16 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 -179.989 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.545 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.8 OUTLIER -107.43 163.98 12.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.202 179.761 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.496 HG21 ' N ' ' A' ' 88' ' ' LEU . 85.6 m -160.89 155.09 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.14 0.495 . . . . 0.0 112.156 -179.574 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.534 HD22 HG12 ' A' ' 76' ' ' VAL . 14.9 tp -125.64 96.26 4.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.832 178.961 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' HA ' HG21 ' A' ' 107' ' ' THR . 5.5 mt-10 -84.36 99.38 10.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.868 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 33.4 mt -95.88 129.26 43.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.364 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.465 HG12 HG22 ' A' ' 99' ' ' ILE . 11.2 p -130.83 157.19 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.064 0.459 . . . . 0.0 112.097 -178.58 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -100.93 95.02 6.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.595 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.56 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 5.0 t -117.2 167.65 11.01 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.73 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.481 ' H ' ' HG1' ' A' ' 93' ' ' THR . 77.1 mtp180 -103.2 93.67 4.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.796 178.507 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -48.91 -29.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.867 2.378 . . . . 0.0 112.961 -179.617 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -77.77 10.37 2.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -150.55 -72.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.09 0.472 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.66 175.34 36.78 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.539 -179.518 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.474 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.9 mt -94.24 150.79 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.08 0.467 . . . . 0.0 111.604 -179.123 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -137.53 166.88 23.24 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.3 -48.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.344 2.696 . . . . 0.0 112.498 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.37 -18.15 10.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.683 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.8 m120 -62.56 162.86 9.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.784 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 161.26 5.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.647 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpp180 -135.05 164.28 27.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.57 -178.605 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.647 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.4 t80 -174.29 67.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.248 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 89' ' ' GLU . 12.4 m -87.34 97.81 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.559 -178.828 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.526 HD21 HG22 ' A' ' 78' ' ' VAL . 63.2 tp -76.56 88.06 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 12.7 m-70 -73.81 142.94 46.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 179.424 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.413 HD23 ' HB ' ' A' ' 16' ' ' THR . 91.2 mt -143.71 108.6 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.692 -178.056 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.4 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.8 t-20 -81.48 72.23 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 17' ' ' HIS . 1.6 t -53.09 122.84 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.667 -178.235 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.071 179.757 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.7 m -77.31 124.93 28.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -90.44 -32.03 16.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtm -121.53 144.66 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.022 179.929 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -114.69 12.0 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.564 ' HB1' ' HD3' ' A' ' 4' ' ' PRO . . . -60.39 -49.35 90.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.657 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' HD3' ' HB1' ' A' ' 3' ' ' ALA . 51.6 Cg_exo -54.76 149.37 41.34 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.126 1.884 . . . . 0.0 112.25 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 5' ' ' LEU . 3.7 mm? 59.11 17.1 5.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -142.07 -26.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 p -160.27 148.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -171.26 134.59 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.571 -179.873 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.24 122.38 24.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.375 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.7 OUTLIER -125.56 -14.73 6.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.991 -179.303 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.81 100.42 12.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.148 0.499 . . . . 0.0 111.636 -179.178 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' O ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -109.67 61.72 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.497 179.132 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.664 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 m0 -78.73 112.55 15.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -178.008 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 34.8 m -150.24 -166.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 -178.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.42 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.5 OUTLIER -96.05 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.696 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 112' ' ' VAL . 2.7 t 177.82 -174.51 0.15 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.143 0.497 . . . . 0.0 112.059 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.556 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 67.7 m-70 -118.55 -160.98 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.761 179.212 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.7 121.86 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 111.34 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 64.45 16.98 61.46 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.062 179.84 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -58.09 91.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 HD23 ' A' ' 77' ' ' LEU . 6.9 m -56.73 101.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.482 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.8 m -100.81 99.21 9.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.663 179.642 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 38.1 tt0 -78.66 137.12 37.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.789 179.731 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.92 102.57 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -83.49 112.9 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.695 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 37.4 mt -108.62 154.28 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -178.315 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -110.89 155.68 22.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.98 179.333 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.578 ' HA2' ' HH ' ' A' ' 74' ' ' TYR . . . 176.26 -19.3 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.505 -179.229 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' O ' HG21 ' A' ' 32' ' ' THR . 61.1 t30 62.46 91.52 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.517 0.199 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 73.4 Cg_exo -49.45 -19.98 3.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.939 2.426 . . . . 0.0 113.277 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.1 p -85.19 22.89 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.543 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.487 HG23 ' HH ' ' A' ' 92' ' ' TYR . 10.7 t -110.7 -37.12 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.699 0.285 . . . . 0.0 111.222 179.915 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.3 -72.37 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.943 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -59.48 160.34 7.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.151 0.5 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 16.5 ttm -123.88 150.89 44.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.3 m95 -109.24 84.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.769 178.545 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 42' ' ' VAL . 7.0 t -132.38 -164.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 -179.124 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 19.0 mtp85 -92.75 121.69 34.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 0.0 110.474 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.3 p -51.9 140.07 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.67 -6.76 81.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.714 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 52.0 m-85 -128.31 1.16 5.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.285 0.564 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 37' ' ' THR . 15.4 t -56.08 119.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.064 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.24 -25.84 25.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.913 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 28.3 mtpp -71.28 173.09 8.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 179.77 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 -61.86 1.81 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.755 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.68 141.19 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.0 mt -90.03 -53.22 4.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.757 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.435 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.9 p -52.89 -178.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.765 178.828 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -158.39 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.207 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.535 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -129.98 -29.02 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 11.6 mm -74.77 -76.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.283 -179.61 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.579 HD23 HG11 ' A' ' 78' ' ' VAL . 4.3 mt -102.4 115.27 30.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.299 179.154 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.38 69.52 0.24 Allowed 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.091 0.472 . . . . 0.0 109.94 178.062 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' N ' ' HB3' ' A' ' 48' ' ' SER . 18.4 t -74.32 81.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.018 -179.18 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.0 t -78.01 81.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.018 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.472 ' SG ' HG23 ' A' ' 76' ' ' VAL . 15.2 t -97.38 136.21 38.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.478 -178.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -126.7 113.75 17.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.858 179.189 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.489 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.32 107.19 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.732 179.826 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.559 HG21 ' HA2' ' A' ' 71' ' ' GLY . 6.4 m -99.11 109.33 53.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 61.1 Cg_endo -98.34 -166.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.336 2.691 . . . . 0.0 112.183 179.846 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.479 HG22 HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -150.68 135.07 9.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.913 179.26 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.437 ' HD2' HG21 ' A' ' 61' ' ' THR . 65.7 Cg_endo -89.58 52.74 1.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.038 2.492 . . . . 0.0 111.904 179.548 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 t -164.32 176.63 8.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.041 -179.228 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.8 m -96.59 -1.51 46.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.54 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 74.4 p -63.66 158.44 59.79 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.113 179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 65.0 Cg_endo -70.98 -154.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.547 2.165 . . . . 0.0 112.06 179.966 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.4 mtm -60.26 -13.0 10.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 -179.873 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.87 105.91 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.34 -122.35 1.02 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.598 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 61' ' ' THR . 7.9 p -113.06 21.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.515 . . . . 0.0 110.835 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.559 ' HA2' HG21 ' A' ' 59' ' ' THR . . . 146.38 -139.96 8.44 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.635 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.24 15.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.868 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.4 pt -136.37 -164.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 179.811 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.578 ' HH ' ' HA2' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -140.29 110.99 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.058 -179.619 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -103.48 113.8 41.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.55 . . . . 0.0 110.477 -179.672 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG23 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -109.02 125.77 66.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.499 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.429 HD23 HG23 ' A' ' 21' ' ' THR . 86.3 mt -110.05 101.36 10.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.021 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.579 HG11 HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.0 111.11 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.976 0.417 . . . . 0.0 111.233 -178.786 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.9 mtmt -115.6 96.81 47.28 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.499 -179.435 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.447 ' HA ' HD21 ' A' ' 52' ' ' LEU . 5.5 Cg_endo -50.31 104.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.476 2.117 . . . . 0.0 112.656 179.752 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.535 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.4 mtt180 -71.24 -42.16 69.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.298 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -107.77 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -114.67 123.41 49.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.565 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.6 -101.78 0.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.488 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -143.72 91.58 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.546 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.3 m-70 -100.0 173.71 6.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 109' ' ' HIS . 53.8 m -160.53 150.51 17.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.781 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.597 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 36.4 tp -113.93 88.75 2.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 43.8 mt-10 -75.51 93.82 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.071 -179.634 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.597 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 62.8 mt -104.16 131.05 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.935 178.654 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 93' ' ' THR . 14.8 p -133.93 153.47 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.722 -178.963 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.3 t80 -96.88 89.66 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.476 HG23 HG11 ' A' ' 91' ' ' VAL . 7.2 t -130.4 151.7 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.479 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.568 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.5 mtp180 -86.99 101.59 2.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.713 178.362 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HB3' HG11 ' A' ' 42' ' ' VAL . 1.6 Cg_endo -47.44 -36.63 24.14 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.871 2.381 . . . . 0.0 113.117 -179.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -87.72 18.9 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 17.3 mm-40 -149.75 1.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.433 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.69 178.66 51.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.122 -179.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.475 HG21 ' HB ' ' A' ' 93' ' ' THR . 7.5 mt -105.72 154.29 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.472 . . . . 0.0 111.872 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.607 ' HE3' HD22 ' A' ' 103' ' ' ASN . 42.8 mtmt -137.78 163.04 50.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.885 -179.574 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.1 Cg_endo -70.76 -38.41 5.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.782 2.322 . . . . 0.0 112.347 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.77 -24.59 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.607 HD22 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -54.73 148.1 13.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.398 -179.999 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.6 tt0 -56.31 163.28 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.584 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.3 tpp180 -132.59 163.59 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.628 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 65.1 t80 -174.03 74.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.239 177.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -95.09 106.81 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 -178.863 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.1 tp -93.02 91.4 7.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.664 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.1 m-70 -74.91 151.48 38.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.423 179.704 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.41 HD23 ' HB ' ' A' ' 16' ' ' THR . 95.5 mt -148.58 116.97 6.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -178.538 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -86.68 68.07 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.565 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -49.26 119.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.469 -178.684 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.999 179.995 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.9 p -144.44 168.86 19.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -94.28 -2.37 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mmm 58.23 -171.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.3 pt -74.01 -32.64 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.12 151.0 7.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.009 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.85 152.22 63.49 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.255 179.992 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.2 mt -70.53 159.33 34.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.6 m -100.64 0.71 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -89.44 13.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HG3' ' H ' ' A' ' 9' ' ' ASP . 5.6 ptmm? -124.16 -62.7 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' H ' ' HG3' ' A' ' 8' ' ' LYS . 6.3 t70 50.96 99.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.274 -179.822 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -129.58 -74.09 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.855 -179.308 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.509 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 4.2 p-10 -37.63 97.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.894 -179.5 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -107.26 93.53 4.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.436 179.78 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.651 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.2 m95 -88.96 105.03 17.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.12 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 110' ' ' LEU . 7.3 m -151.41 -175.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.997 -179.621 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.95 -176.33 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.417 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 17' ' ' HIS . 0.9 OUTLIER -174.82 -178.06 1.22 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 112.177 -179.807 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.8 m80 -114.14 -167.25 1.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.06 135.41 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.261 0.553 . . . . 0.0 112.046 -179.299 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.1 14.82 11.86 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.546 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptp -65.58 81.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 HG21 HD23 ' A' ' 77' ' ' LEU . 5.5 m -47.34 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.76 -178.785 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.8 m -94.97 98.13 10.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 179.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.74 132.85 37.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.988 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.459 HD13 HD23 ' A' ' 108' ' ' LEU . 39.5 mt -137.53 104.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.999 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.23 98.75 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.311 178.214 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 23.9 mt -94.31 145.12 24.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.613 -179.058 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 4.4 mptt -98.73 162.3 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.543 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.41 -141.72 6.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.267 -179.341 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.472 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 62.3 t30 -172.46 101.11 0.35 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.403 0.144 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.57 ' HD2' ' HA3' ' A' ' 71' ' ' GLY . 47.6 Cg_exo -56.85 -36.83 99.05 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.614 2.209 . . . . 0.0 112.416 179.93 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.7 p -65.61 -21.9 66.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 39.6 m -63.99 -49.65 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.43 -70.25 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.904 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -62.52 -179.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.477 . . . . 0.0 111.46 -179.539 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 6.0 ttm -146.7 153.17 39.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.166 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 m95 -105.53 94.92 5.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.843 178.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.58 HG23 ' HA ' ' A' ' 42' ' ' VAL . 9.2 t -140.83 -170.33 3.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.627 -178.938 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 9.9 mtp85 -86.62 157.07 19.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' A' ' 89' ' ' GLU . 52.6 t -72.7 132.05 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.943 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.07 4.99 79.62 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.481 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.437 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 60.1 m-85 -127.17 -2.04 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.132 0.491 . . . . 0.0 110.45 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.58 ' HA ' HG23 ' A' ' 37' ' ' THR . 22.4 t -49.07 112.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.262 179.178 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.87 -17.71 13.02 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.217 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HB2' HD22 ' A' ' 47' ' ' LEU . 28.7 mtpp -79.92 -159.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -120.11 -56.03 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 16.9 t -86.35 -39.18 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.799 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.3 mt 76.01 -43.66 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.298 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 20.9 p -54.98 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.95 179.553 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -156.53 -86.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.329 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.572 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -132.12 -31.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.434 -179.132 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.5 mm -73.0 -78.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 7.1 mt -102.68 114.23 28.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.499 179.375 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.55 70.63 0.18 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.066 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' HD2' ' A' ' 38' ' ' ARG . 14.0 t -75.1 83.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.911 -179.1 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.0 t -78.42 82.67 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.39 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.0 t -94.56 139.51 31.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.277 -178.605 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -132.45 108.1 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.162 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -79.43 112.64 16.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.368 179.636 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.449 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 24.1 m -113.15 111.14 50.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.975 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -101.42 99.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.735 2.956 . . . . 0.0 111.264 178.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -123.31 136.93 27.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.347 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 9.0 Cg_endo -50.13 132.6 33.74 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.973 2.448 . . . . 0.0 112.298 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.527 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 26.1 t -69.35 -177.3 1.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.747 179.841 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.0 p -94.9 -9.08 35.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.194 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 p -98.3 151.64 37.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.656 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.78 33.17 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.103 2.535 . . . . 0.0 112.653 179.716 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.6 ttp -130.0 -2.25 4.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.692 -179.575 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 74.7 t -127.83 131.57 69.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.16 -179.719 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.82 -56.81 2.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 54.3 t -143.34 82.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.924 0.392 . . . . 0.0 110.625 179.868 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.57 ' HA3' ' HD2' ' A' ' 30' ' ' PRO . . . -116.37 102.93 1.1 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.867 -179.844 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -105.83 -131.12 6.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.034 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt -147.36 -166.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.126 0.489 . . . . 0.0 111.095 179.597 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -134.47 99.94 4.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.078 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.35 102.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.866 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 88' ' ' LEU . 40.8 t -104.74 119.85 54.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.202 -179.385 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 78.3 mt -109.69 98.15 7.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.208 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.33 103.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.038 0.447 . . . . 0.0 111.216 -178.706 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.625 ' HB2' ' HZ3' ' A' ' 79' ' ' LYS . 7.1 mtmp? -106.15 104.41 49.63 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.267 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.491 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 51.1 Cg_exo -54.31 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.475 2.117 . . . . 0.0 112.567 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.572 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -64.5 -41.84 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.407 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 90.2 mttt -113.15 173.08 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -113.2 106.92 15.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.566 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 171.19 -123.82 1.07 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.47 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.413 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -103.56 98.32 8.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.564 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.15 158.43 22.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.725 179.998 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 88' ' ' LEU . 33.8 m -159.99 151.9 20.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 111.562 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.57 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 45.7 tp -117.05 91.18 3.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' HB3' HG22 ' A' ' 39' ' ' VAL . 39.1 mt-10 -76.4 97.74 4.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.105 179.948 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.57 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.6 mt -108.5 133.54 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.918 178.521 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.36 167.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.135 0.493 . . . . 0.0 111.681 -179.379 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.9 t80 -106.4 89.09 2.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.728 178.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.497 ' HB ' HG21 ' A' ' 99' ' ' ILE . 5.7 t -118.29 170.08 9.19 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.59 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -102.56 95.1 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.0 Cg_exo -42.08 -36.87 4.18 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -40.77 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.963 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.8 -78.55 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.86 178.24 39.19 Favored Glycine 0 CA--C 1.508 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.497 HG21 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -93.22 153.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.935 0.397 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 39.0 mtmt -145.47 163.44 31.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.067 -179.07 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 19.2 Cg_endo -60.92 -37.84 74.08 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.718 2.279 . . . . 0.0 112.034 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.78 -23.86 67.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.6 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -51.7 136.02 27.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.146 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.6 tt0 -51.93 156.56 1.47 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.558 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 8.8 tpp180 -118.93 158.33 25.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.187 0.518 . . . . 0.0 112.057 -178.54 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.558 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 34.3 t80 -171.74 64.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.772 177.319 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 m -91.08 98.96 12.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.994 -179.278 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 35.0 tp -83.39 94.56 7.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.651 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 26.8 m-70 -79.24 141.41 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 14' ' ' VAL . 91.5 mt -145.17 105.66 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.482 -178.293 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 10.7 m120 -78.13 74.13 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.221 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.566 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -55.4 117.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 34.1 mmtp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.915 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.648 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -26.12 105.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.424 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 89.69 6.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.921 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.656 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -74.15 98.85 3.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.622 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 15' ' ' ASP . 6.6 p -155.34 177.32 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.765 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.4 p-10 -98.21 -175.24 3.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -173.76 -173.0 0.8 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 112.094 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m-70 -114.73 -167.35 1.21 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 30.6 t -94.0 135.23 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.137 0.494 . . . . 0.0 112.153 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.64 16.53 11.49 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.437 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.7 tptm -65.73 81.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.75 HG22 HD22 ' A' ' 77' ' ' LEU . 5.9 m -46.71 99.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.733 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 78' ' ' VAL . 83.5 m -93.79 99.6 11.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.0 tt0 -80.3 131.73 35.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.879 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.59 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.7 mt -134.67 103.97 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.731 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -86.02 95.51 9.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 24' ' ' ILE . 8.2 mt -92.95 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.302 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -101.6 168.52 9.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.47 -130.53 1.93 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.429 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.595 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 2.4 ttt -148.3 151.81 36.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.728 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.8 m95 -109.4 90.33 3.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.081 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.545 ' CG2' HG22 ' A' ' 42' ' ' VAL . 9.6 t -139.72 -166.58 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.375 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.2 mtp85 -92.23 124.21 36.13 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.797 0.332 . . . . 0.0 110.737 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.6 p -52.88 142.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.27 78.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.749 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 50.0 m-85 -128.15 -0.65 5.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.499 . . . . 0.0 110.184 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 93' ' ' THR . 38.1 t -54.78 105.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.036 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.101 -179.566 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.744 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.5 mt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 62.4 p -53.23 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.655 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.83 -86.61 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.47 -30.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.161 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.6 mm -74.04 -73.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.278 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.1 mt -104.96 116.02 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.344 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -70.33 68.81 0.36 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 109.902 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 78' ' ' VAL . 14.0 t -74.17 84.67 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.993 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.0 85.41 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' SG ' HG22 ' A' ' 76' ' ' VAL . 34.6 t -102.63 142.69 33.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.69 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -133.01 113.59 12.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.987 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.68 102.66 10.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.451 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -101.67 110.95 63.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.643 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.45 -1.043 0 C-N-CA 123.539 2.826 . . . . 0.0 111.695 179.163 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.4 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -131.37 98.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.95 106.64 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 88' ' ' LEU . 29.7 t -110.0 120.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.75 HD22 HG22 ' A' ' 21' ' ' THR . 82.6 mt -110.13 100.97 9.79 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.765 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 105.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.048 0.452 . . . . 0.0 111.18 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -107.18 102.08 41.64 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.239 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 52.5 Cg_exo -51.44 97.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.681 2.254 . . . . 0.0 112.705 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.3 mtt180 -66.24 -43.26 87.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.319 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -114.85 173.74 6.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -108.97 125.07 51.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.798 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.588 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 155.04 -138.42 6.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.4 m80 -97.85 95.16 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.446 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.8 m-70 -112.07 162.18 15.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.498 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 107' ' ' THR . 85.2 m -159.72 144.9 15.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 111.68 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 38.2 tp -101.0 92.66 5.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.026 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.4 mt-10 -75.13 88.51 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.481 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 48.2 mt -103.54 123.42 46.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 92' ' ' TYR . 13.1 p -126.19 158.49 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.5 t80 -102.34 91.85 4.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.327 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.926 HG21 HG21 ' A' ' 42' ' ' VAL . 5.5 t -122.45 167.46 13.3 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -101.07 94.89 4.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.41 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.9 Cg_exo -46.94 -28.77 7.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.252 . . . . 0.0 112.549 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -72.44 -42.62 64.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.312 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.19 -69.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.01 179.04 37.31 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.975 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.844 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.4 mt -98.4 140.84 17.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.959 0.409 . . . . 0.0 111.258 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 46.2 mtmt -140.39 159.44 63.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.194 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 30.6 Cg_endo -63.79 -36.32 51.83 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.917 2.411 . . . . 0.0 112.693 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.68 0.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.518 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.622 HD21 ' HA ' ' A' ' 93' ' ' THR . 6.6 m-20 -85.27 158.07 20.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.185 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 166.37 9.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.7 tpp180 -133.49 164.31 27.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.592 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.656 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 55.4 t80 -171.34 69.66 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.007 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -93.17 90.13 6.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.731 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 28.2 tp -70.59 89.96 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.326 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 36.8 m-70 -72.97 135.93 45.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.963 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.499 HD22 ' HB ' ' A' ' 16' ' ' THR . 86.4 mt -140.1 103.97 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.541 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.485 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.5 t-20 -79.26 65.43 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.588 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -43.49 116.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.521 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.968 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 112.01 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -25.15 107.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.776 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.505 ' HD3' HD13 ' A' ' 108' ' ' LEU . 77.0 tttt -106.78 97.24 7.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.766 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 m95 -85.17 106.08 16.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.586 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 15' ' ' ASP . 2.9 p -152.94 -178.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 112.454 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.793 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -103.56 -179.74 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.797 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.503 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.67 -171.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.793 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.6 m-70 -122.25 173.13 7.8 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.041 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.9 p -67.36 138.66 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.282 0.563 . . . . 0.0 112.163 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 62.05 11.65 32.98 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.872 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 18.9 tptt -60.04 83.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.236 0.518 . . . . 0.0 109.828 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 2.5 m -57.41 99.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.447 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -96.99 100.67 12.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.3 tt0 -83.24 133.86 34.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.984 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 HD22 ' A' ' 108' ' ' LEU . 39.3 mt -139.79 105.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.03 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -88.98 113.92 25.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.138 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 14.5 mt -109.48 147.36 33.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.274 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -100.68 161.19 13.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.895 0.379 . . . . 0.0 110.621 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.18 -155.14 25.62 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.456 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.89 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.446 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.0 ttt -108.98 151.54 26.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.3 m95 -109.54 103.07 11.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.619 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 42' ' ' VAL . 15.1 t -146.9 -174.05 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.717 ' NH1' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -77.38 138.22 39.18 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.219 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 89' ' ' GLU . 98.0 t -54.1 134.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.586 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -33.63 1.52 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.581 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -87.55 25.13 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.873 HG21 HG21 ' A' ' 93' ' ' THR . 25.3 t -79.63 107.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.985 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.684 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.2 mt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -51.04 177.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -154.16 -95.64 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 111.751 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.88 -31.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.119 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.5 mm -72.12 -70.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 80' ' ' PRO . 16.2 mt -105.79 116.27 31.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.222 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -68.32 72.94 0.21 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.554 HG11 ' NE ' ' A' ' 38' ' ' ARG . 3.8 t -76.44 84.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.304 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -81.51 82.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.548 ' HB3' HD12 ' A' ' 47' ' ' LEU . 11.1 t -108.71 147.9 31.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.426 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -138.87 125.4 20.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.485 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.33 97.08 7.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.925 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 25.9 m -90.29 116.05 65.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.443 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 87.1 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 C-N-CA 123.231 2.621 . . . . 0.0 111.586 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 3.4 pt . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.05 0.453 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.515 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -143.38 103.68 4.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.027 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.77 126.53 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 88' ' ' LEU . 18.2 t -122.28 122.37 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.593 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 79.8 mt -109.94 96.4 6.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.851 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.568 ' CG2' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.35 105.38 16.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.239 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.4 mtmt -108.65 100.87 40.95 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.67 ' HA ' HD23 ' A' ' 52' ' ' LEU . 72.2 Cg_exo -48.18 96.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.733 2.289 . . . . 0.0 112.992 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 4.8 mtt180 -63.41 -37.01 85.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.652 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -116.44 -173.85 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.486 HH21 HG11 ' A' ' 18' ' ' VAL . 97.5 mtt180 -132.77 119.22 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.86 -100.59 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.33 100.98 7.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -118.33 161.12 20.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.536 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -160.64 150.66 17.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.886 0.374 . . . . 0.0 111.76 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 76' ' ' VAL . 20.6 tp -132.26 82.52 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.662 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -86.64 105.76 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.717 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.2 mt -89.81 167.09 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.769 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -155.2 147.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.918 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.7 t80 -97.88 82.62 3.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.564 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.873 HG21 HG21 ' A' ' 42' ' ' VAL . 9.9 t -121.99 158.24 29.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 27.1 mtp180 -101.17 101.15 15.31 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.326 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 93' ' ' THR . 78.1 Cg_exo -46.99 -39.45 25.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.752 2.301 . . . . 0.0 113.257 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 9.38 0.99 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.73 4.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 0.0 111.348 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.95 -171.74 51.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.797 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -112.15 150.14 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 111.86 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -135.42 164.17 45.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.81 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -19.79 13.0 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.543 2.162 . . . . 0.0 111.651 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.2 pt-20 -76.75 -0.11 22.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.7 m120 -82.21 149.41 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.44 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.9 171.5 1.19 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.2 tpp180 -136.9 159.5 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 36.0 t80 -162.21 72.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.874 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.745 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 22.7 m -85.51 151.33 24.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.866 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.4 tp -140.7 87.74 2.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.36 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.766 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 13.6 m-70 -74.69 144.11 43.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.503 HD22 ' HB ' ' A' ' 16' ' ' THR . 85.5 mt -144.66 102.75 3.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.296 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -80.6 61.3 4.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -38.64 140.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.86 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.045 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.637 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 111.913 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' ASN . 8.6 m-20 -25.67 103.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.924 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 55.5 tptt -94.26 90.26 6.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.414 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.19 103.34 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -155.42 177.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.088 0.47 . . . . 0.0 111.83 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.773 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -100.07 -178.17 3.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.765 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.495 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -175.59 -174.75 0.72 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.119 0.485 . . . . 0.0 112.08 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.9 m80 -115.51 -170.02 1.69 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.22 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.56 139.46 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.239 0.542 . . . . 0.0 112.308 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.11 22.29 9.54 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.69 81.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.692 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -51.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.864 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.426 ' HB ' HG23 ' A' ' 78' ' ' VAL . 73.3 m -91.6 101.6 14.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.958 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.3 tt0 -84.81 129.73 34.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.4 mt -139.66 98.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.87 106.32 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 11.3 mt -98.86 143.78 28.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.075 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -94.08 166.57 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.025 0.44 . . . . 0.0 110.806 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.81 -137.01 3.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.078 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.424 0.154 . . . . 0.0 110.615 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.019 0.437 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 20.9 ttm -143.87 148.81 35.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.175 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 4.6 m95 -106.1 78.47 1.31 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.987 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 42' ' ' VAL . 12.0 t -125.73 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.4 mtp85 -88.61 156.42 19.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 47.4 t -74.39 130.21 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.05 12.23 79.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.525 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 61.8 m-85 -135.25 -1.55 2.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.088 0.471 . . . . 0.0 110.578 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 18.7 t -53.85 117.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.02 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.873 -179.609 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.211 0.529 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.6 p -52.32 179.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.745 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.25 -90.98 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.7 pt-20 -130.12 -28.82 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.181 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.1 mm -76.85 -73.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.335 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.0 mt -103.94 115.52 30.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.539 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -71.02 69.38 0.48 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 78' ' ' VAL . 10.8 t -75.92 88.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.091 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 39.4 t -86.27 90.11 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 52.0 t -95.38 144.64 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.94 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 75.7 mttt -130.56 92.63 3.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.887 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.3 t80 -57.7 -17.8 17.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.321 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.9 m 31.57 78.09 0.31 Allowed Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.971 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 124.182 3.255 . . . . 0.0 113.298 -179.162 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.6 pt . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -150.26 82.14 1.37 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.609 0.242 . . . . 0.0 110.782 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 93.3 t -79.91 91.9 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.062 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 88' ' ' LEU . 40.4 t -90.05 118.67 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 21' ' ' THR . 79.1 mt -110.53 95.12 5.37 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.6 104.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.0 mtmm -110.16 93.9 16.72 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.086 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 4.1 Cg_endo -48.6 100.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.594 2.196 . . . . 0.0 112.549 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.549 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.0 mtt180 -64.63 -32.67 74.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.998 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -120.91 -175.38 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.634 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.51 117.45 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.05 -107.56 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.251 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.491 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.0 m80 -116.48 91.6 3.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER -111.78 157.69 20.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.576 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 109' ' ' HIS . 47.0 m -159.47 146.04 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.1 tp -112.86 92.38 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.7 mt-10 -78.44 94.95 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.197 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 67.7 mt -101.8 135.03 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.7 p -140.11 154.26 23.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 0.0 112.09 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.11 94.13 6.65 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.959 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 7.6 t -129.72 157.13 43.02 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 79.3 mtp180 -91.64 99.93 2.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.859 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.6 Cg_exo -37.93 -56.49 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.261 2.641 . . . . 0.0 113.732 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.466 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 8.2 p90 -78.15 23.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.7 mm-40 -149.9 0.87 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.38 50.44 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.2 mt -104.84 158.65 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.431 . . . . 0.0 111.933 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.406 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.1 mttt -135.26 165.99 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.883 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.11 -41.03 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.886 2.39 . . . . 0.0 111.974 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.47 -26.73 68.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.465 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.6 m-20 -49.27 148.33 2.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.304 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 3.8 tt0 -53.76 160.67 1.3 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.639 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.1 tpp180 -133.54 161.21 35.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.54 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.639 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.5 t80 -171.33 65.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.0 m -87.35 94.66 9.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.39 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 36.2 tp -74.91 92.56 2.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.4 m-70 -77.55 138.48 39.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 16' ' ' THR . 84.3 mt -143.35 103.09 4.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.54 66.09 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -44.76 113.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.762 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.924 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.899 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 121.018 0.437 . . . . 0.0 112.041 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 2.2 m-20 -48.82 102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.447 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.425 ' HE2' HG21 ' A' ' 14' ' ' VAL . 75.5 tttt -97.23 93.09 6.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -82.01 99.93 9.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 12' ' ' LYS . 34.1 m -149.82 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 112.271 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.78 -163.71 1.06 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.133 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t 178.24 -175.04 0.17 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 59.0 m80 -120.73 -164.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 83' ' ' ARG . 24.2 t -95.76 115.45 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 111.442 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 67.99 10.7 59.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.108 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.8 tptm -60.11 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.729 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -45.6 103.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.702 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.9 m -91.26 94.75 9.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.571 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HA ' HD23 ' A' ' 77' ' ' LEU . 42.3 tt0 -80.11 128.41 33.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.69 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -136.18 104.55 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.56 96.97 8.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.423 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.523 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 7.8 mt -91.12 140.89 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.196 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 73' ' ' ILE . 54.6 mttm -98.98 165.31 11.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.51 -132.72 2.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.32 0.105 . . . . 0.0 110.767 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 121.047 0.451 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 10.1 ttm -149.09 149.25 30.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.802 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.5 m95 -103.23 85.31 2.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.894 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.538 HG23 HG22 ' A' ' 42' ' ' VAL . 14.5 t -137.23 165.46 26.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.696 HH11 HD11 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -61.37 132.89 54.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.905 0.383 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 89' ' ' GLU . 3.8 p -55.07 147.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.486 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.74 -8.03 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.278 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 39' ' ' VAL . 21.8 m-85 -117.7 33.37 5.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 109.943 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 93' ' ' THR . 13.0 t -97.55 87.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.582 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.891 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 56' ' ' CYS . 14.5 mt . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 3.2 t -45.55 168.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.961 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 11.4 m-20 -157.53 -159.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.961 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 9.4 pt-20 -74.69 -29.82 61.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.854 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 13.9 mm -80.38 -74.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.325 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 80' ' ' PRO . 19.7 mt -104.42 109.28 21.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.527 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.43 75.59 0.26 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 78' ' ' VAL . 1.7 t -82.58 91.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 23.3 t -92.88 95.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.784 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HB3' HD12 ' A' ' 47' ' ' LEU . 41.0 t -111.9 148.61 33.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.438 0.637 . . . . 0.0 112.151 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -126.17 110.28 13.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.559 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.87 102.81 11.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.566 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -104.67 116.51 60.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.449 -1.129 0 C-N-CA 123.042 2.495 . . . . 0.0 112.25 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -132.74 98.07 4.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.063 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 80.5 t -84.37 103.42 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.951 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 HH22 ' A' ' 38' ' ' ARG . 33.0 t -102.3 123.28 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.729 HD22 HG22 ' A' ' 21' ' ' THR . 64.9 mt -112.68 93.45 4.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG13 HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.85 107.14 18.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.116 0.484 . . . . 0.0 111.102 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -108.96 95.15 16.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.462 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HA ' HD23 ' A' ' 52' ' ' LEU . 9.7 Cg_endo -53.06 102.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.153 1.902 . . . . 0.0 111.965 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.437 HH11 ' HA ' ' A' ' 50' ' ' GLU . 17.2 mtt180 -64.82 -45.33 86.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.52 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -106.32 173.56 6.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.041 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 18' ' ' VAL . 59.4 mtp180 -109.42 142.64 40.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.03 -150.97 20.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -87.47 92.18 9.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 112' ' ' VAL . 1.7 m-70 -108.77 156.18 19.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 109' ' ' HIS . 90.5 m -160.34 151.33 18.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.116 0.484 . . . . 0.0 111.851 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.678 HD21 ' HD3' ' A' ' 38' ' ' ARG . 13.8 tp -128.71 142.73 50.92 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 6.1 mt-10 -123.56 86.73 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.216 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.696 HD11 HH11 ' A' ' 38' ' ' ARG . 7.0 mp -75.5 125.77 29.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.073 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 92' ' ' TYR . 12.8 p -122.29 156.45 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.76 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -102.51 95.91 6.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.465 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 42' ' ' VAL . 3.5 t -125.35 169.97 11.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -101.6 93.86 3.79 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.118 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -44.29 -27.76 2.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.777 2.318 . . . . 0.0 112.74 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.71 -46.22 59.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.472 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.82 -67.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.93 0.395 . . . . 0.0 111.262 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.41 172.48 27.73 Favored Glycine 0 CA--C 1.507 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.99 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.804 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.2 mt -86.15 139.31 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.932 0.396 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -128.5 164.53 37.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.253 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.65 -35.19 8.14 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.038 2.492 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.81 11.99 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.211 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.9 m-20 -88.1 150.36 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.41 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.2 tt0 -54.43 162.36 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.584 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 15.0 tpp180 -131.93 163.9 27.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.273 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.9 t80 -174.3 71.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.036 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.5 m -84.4 101.67 12.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.504 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 78' ' ' VAL . 59.4 tp -79.05 89.46 4.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 4.6 m-70 -76.77 137.11 39.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.563 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -145.28 104.42 3.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 32.3 t-20 -80.68 73.74 7.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -51.86 123.98 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.455 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.981 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.644 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER -30.11 106.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.189 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 14' ' ' VAL . 53.5 tttp -95.27 101.08 12.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.987 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.0 m95 -84.18 102.11 12.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.318 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 12' ' ' LYS . 34.6 m -147.47 -168.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.733 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.55 -179.32 3.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.482 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.486 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.22 -172.66 0.6 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.621 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.3 m80 -115.98 -163.74 0.92 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.268 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 38.4 t -93.27 137.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.115 0.483 . . . . 0.0 112.083 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.07 15.03 9.1 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.492 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptm -64.08 82.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.82 98.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.579 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 78' ' ' VAL . 86.5 m -91.63 99.83 12.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.532 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.3 tt0 -81.66 130.28 35.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.7 mt -134.29 104.85 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.873 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -85.94 96.54 9.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.4 mt -91.73 145.18 24.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.442 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.93 163.13 12.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.546 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.16 -141.31 5.03 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.558 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.1 t30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.557 0.218 . . . . 0.0 110.575 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 42.9 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.035 0.445 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.7 ttm -149.16 151.68 34.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -106.37 86.98 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.113 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -132.02 -167.4 1.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.101 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 24.7 mtp85 -88.54 150.25 23.18 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.0 t -69.57 131.91 33.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.617 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.61 6.33 89.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.576 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.9 m-85 -130.81 -0.76 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.505 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.942 HG21 HG21 ' A' ' 93' ' ' THR . 14.2 t -55.08 103.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.022 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.228 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.233 -179.645 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.1 mt . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.191 0.519 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 48.3 t -57.0 -179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.208 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.14 -88.6 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.41 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.17 -37.61 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.89 -77.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.38 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 54' ' ' VAL . 69.6 mt -111.23 125.52 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 72.37 0.23 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 3.1 t -75.8 85.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.76 84.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.503 ' HB3' HD12 ' A' ' 47' ' ' LEU . 33.8 t -99.53 148.15 24.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.324 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -138.15 111.18 7.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.304 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.452 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -76.42 102.67 6.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.281 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 22.9 m -100.56 109.44 57.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.076 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 75.5 Cg_endo . . . . . 0 N--CA 1.446 -1.299 0 C-N-CA 123.582 2.854 . . . . 0.0 111.132 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.3 pt . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -136.66 100.13 4.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.5 t -85.21 103.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.6 t -106.01 119.29 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.211 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 75.3 mt -109.37 98.98 8.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.824 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.73 104.01 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.953 0.406 . . . . 0.0 111.256 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -102.87 101.67 22.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 77.5 Cg_exo -47.03 98.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.802 2.335 . . . . 0.0 113.299 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -74.47 -36.21 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.354 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.38 172.0 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.641 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.3 121.82 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 139.9 -149.77 21.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.576 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.02 98.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.4 ' HB3' HD21 ' A' ' 52' ' ' LEU . 19.4 m-70 -132.97 156.44 47.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.48 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.544 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 90.6 m -158.92 155.63 28.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.022 0.439 . . . . 0.0 112.111 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 28.8 tp -104.51 94.1 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.888 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.589 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.6 mt-10 -73.43 96.51 2.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.186 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.0 mt -112.15 135.46 52.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.2 p -142.49 154.71 18.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 111.765 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.35 88.89 4.27 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.942 HG21 HG21 ' A' ' 42' ' ' VAL . 3.9 t -117.74 172.6 7.26 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -102.91 93.1 4.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.305 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.8 Cg_exo -43.59 -35.62 6.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.743 2.295 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -71.9 -39.61 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.303 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.73 -72.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.397 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 178.0 36.43 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.973 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.5 mt -90.91 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 13.8 mttt -134.54 162.28 58.63 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.151 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 46.5 Cg_endo -69.22 -40.9 5.52 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.686 2.258 . . . . 0.0 112.16 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.66 -25.76 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.618 HD21 ' HA ' ' A' ' 93' ' ' THR . 9.0 m-20 -53.18 149.58 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.348 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.2 tt0 -56.08 161.12 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.2 tpp180 -132.35 163.54 28.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.992 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.663 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.0 t80 -172.78 71.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 109.424 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.09 90.29 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.156 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.8 tp -70.85 90.59 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 29.2 m-70 -72.0 145.91 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.592 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.7 mt -146.54 115.94 7.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.665 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.517 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.1 t30 -83.96 51.1 1.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.577 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.7 t -36.05 121.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.825 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.036 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.893 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.945 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -54.06 100.33 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.5 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -92.65 93.34 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -76.83 102.98 6.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.74 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG23 HD23 ' A' ' 110' ' ' LEU . 17.5 m -150.14 -172.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.067 0.46 . . . . 0.0 112.126 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -107.75 179.43 4.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.591 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.5 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.7 t -175.37 -175.07 0.78 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.018 0.437 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.485 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 62.3 m-70 -118.76 -171.9 2.18 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.271 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.28 125.95 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 111.789 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 66.37 18.5 67.57 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.571 -0.741 . . . . 0.0 113.393 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -59.61 85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.74 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -55.86 98.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.348 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -96.09 103.37 15.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.634 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HA ' HD23 ' A' ' 77' ' ' LEU . 40.1 tt0 -81.93 131.14 35.25 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.803 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 108' ' ' LEU . 46.8 mt -137.21 105.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.953 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.68 99.85 12.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.254 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.1 mt -96.11 149.08 22.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.604 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.27 162.21 13.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.17 -144.11 6.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.337 0.113 . . . . 0.0 110.761 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 78.9 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.155 0.502 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.6 ttm -144.02 149.79 37.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.0 m95 -102.77 82.8 2.17 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -128.48 -171.2 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.25 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.704 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.4 mtp85 -86.28 144.05 27.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.013 0.435 . . . . 0.0 111.09 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.83 144.53 12.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.067 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.81 72.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.116 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' A' ' 42' ' ' VAL . 53.8 m-85 -138.24 -37.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.726 0.263 . . . . 0.0 111.43 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.8 p -18.11 118.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.767 0.667 . . . . 0.0 112.439 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.359 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.018 -179.432 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 1.9 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.008 0.432 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.499 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.2 p -49.0 176.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.847 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -77.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.37 -36.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.361 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 24.5 mm -72.22 -79.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.453 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD22 HG12 ' A' ' 78' ' ' VAL . 11.0 mt -99.23 114.52 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.517 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.72 68.9 0.27 Allowed 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 78' ' ' VAL . 16.4 t -74.0 84.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.862 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.95 85.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.8 t -102.26 144.28 30.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.612 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -130.2 107.46 9.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.055 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -80.2 108.73 14.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 26.3 m -113.05 117.28 46.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.201 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 62.9 Cg_endo . . . . . 0 N--CA 1.447 -1.213 0 C-N-CA 123.381 2.721 . . . . 0.0 111.566 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.7 pt . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.6 m-85 -135.26 99.48 4.26 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 57.9 t -84.99 101.89 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.729 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' SG ' ' A' ' 56' ' ' CYS . 40.0 t -105.9 121.02 57.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 21' ' ' THR . 78.8 mt -111.37 99.54 8.31 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.11 106.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 111.359 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.4 mtmm -111.69 92.85 18.13 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.601 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.1 Cg_endo -51.26 101.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.648 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 18.9 mtt180 -64.17 -29.85 70.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.397 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -127.36 -177.23 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.321 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 21.3 ptt180 -120.31 139.96 51.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.5 -118.82 0.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.691 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -116.65 30.66 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.006 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -46.83 152.06 0.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.568 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 78.2 m -158.24 142.58 15.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.5 tp -93.19 90.53 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.538 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.8 mt-10 -72.57 96.21 1.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.699 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 28.0 mt -111.36 137.97 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -146.47 157.16 11.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.487 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.2 t80 -95.8 91.28 5.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.4 t -121.73 150.87 41.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 77.6 mtp180 -87.42 100.53 1.71 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 5.5 Cg_endo -51.44 -30.33 34.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.384 2.056 . . . . 0.0 112.039 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.36 -32.05 66.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.271 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -108.75 -78.6 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.282 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.48 -178.73 45.28 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.321 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -94.36 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -144.79 154.99 56.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.85 -47.13 4.04 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.897 2.398 . . . . 0.0 112.632 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.89 -14.75 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.759 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.9 m120 -68.56 159.23 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 111.445 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 5.0 tt0 -56.49 157.03 5.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.5 tpp180 -130.93 163.16 28.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.613 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 59.6 t80 -175.32 73.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.534 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.615 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -96.11 88.78 4.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.353 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.5 tp -69.5 90.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.432 . . . . 0.0 110.523 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.0 m-70 -73.03 143.75 47.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.56 HD23 HG23 ' A' ' 14' ' ' VAL . 87.2 mt -144.39 111.83 6.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.6 t30 -83.41 59.53 5.11 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -38.54 133.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.629 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.94 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.895 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 2.1 p30 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -128.21 -112.55 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.877 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG2' HG13 ' A' ' 14' ' ' VAL . 32.7 ttpt -162.03 151.03 15.52 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.886 0.374 . . . . 0.0 111.001 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.773 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.0 m0 -106.07 115.79 30.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 12' ' ' LYS . 19.6 m -148.7 -173.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.586 ' HA ' ' N ' ' A' ' 111' ' ' ASN . 3.3 p-10 -101.85 -171.54 1.99 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.706 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.5 t -175.32 178.89 1.6 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.663 ' O ' HG13 ' A' ' 112' ' ' VAL . 74.9 m80 -109.73 -144.37 0.39 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -106.02 132.23 53.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.163 0.506 . . . . 0.0 111.586 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.76 18.66 46.77 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.328 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tptt -61.35 83.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.648 HG22 HD12 ' A' ' 77' ' ' LEU . 4.6 m -55.48 102.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 78' ' ' VAL . 93.3 m -105.69 97.39 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.346 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 25' ' ' HIS . 28.6 tt0 -72.79 122.09 20.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.299 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.3 mm -117.33 101.0 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 23' ' ' GLU . 2.4 m80 -89.94 115.68 27.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.377 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 51.5 mt -111.83 147.49 35.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.309 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -100.99 162.36 12.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.593 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.75 -132.79 2.46 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.347 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.353 0.121 . . . . 0.0 110.783 179.869 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 121.066 0.46 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.5 ttm -99.98 153.22 19.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.5 m95 -101.95 88.76 3.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.152 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -133.04 -169.05 2.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.396 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH2' ' HA ' ' A' ' 48' ' ' SER . 6.6 mtp85 -82.28 142.72 31.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.384 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 89' ' ' GLU . 60.2 t -53.86 145.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.122 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.21 6.89 3.4 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.845 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -127.86 29.22 5.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.527 0.68 . . . . 0.0 110.707 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.641 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.4 p -65.45 133.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.999 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.923 0.392 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.56 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . 67.2 p -63.67 -162.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.848 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.42 -73.36 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HE2' ' A' ' 82' ' ' LYS . 12.7 pt-20 -142.14 -24.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.937 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -70.19 -66.93 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.113 0.482 . . . . 0.0 111.559 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -116.98 105.86 12.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.964 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -59.06 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.759 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 52' ' ' LEU . 40.7 t -95.3 92.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.828 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.3 t -84.36 77.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.503 0.668 . . . . 0.0 109.2 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 76' ' ' VAL . 13.0 t -92.19 134.81 34.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.283 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 75' ' ' VAL . 43.0 mtmt -129.64 119.47 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 1.1 t80 -84.29 98.78 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.123 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -91.22 108.7 30.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.291 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 61.0 Cg_endo . . . . . 0 N--CA 1.447 -1.256 0 C-N-CA 123.713 2.942 . . . . 0.0 111.465 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 5.9 pt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -139.93 100.0 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.284 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 57' ' ' LYS . 10.4 p -92.25 133.13 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 109.856 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 56' ' ' CYS . 43.6 t -132.93 99.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 21' ' ' THR . 2.1 mm? -83.09 103.8 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.624 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.33 112.66 28.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.947 0.403 . . . . 0.0 110.797 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.8 mtmm -118.25 101.63 51.17 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.05 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 112' ' ' VAL . 4.6 Cg_endo -49.17 101.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.477 2.118 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 3.8 mtt180 -74.89 -42.47 57.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.498 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 67.2 mttm -113.71 160.03 19.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.013 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -96.19 129.15 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.538 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.53 -119.24 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.456 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -121.14 99.47 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.501 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -111.18 164.79 12.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 m -161.78 152.98 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.668 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.7 tp -119.4 77.79 1.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.959 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -81.53 107.76 14.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.823 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 38' ' ' ARG . 96.2 mt -101.78 154.86 18.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.362 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -146.89 158.92 9.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.23 0.538 . . . . 0.0 112.04 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -94.34 68.9 3.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.702 ' HB ' HG23 ' A' ' 99' ' ' ILE . 1.1 t -84.73 167.27 16.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.82 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -109.35 92.67 11.92 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.718 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.92 -33.71 26.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.635 2.223 . . . . 0.0 112.541 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -69.41 -31.36 69.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.11 -81.28 0.61 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.58 -172.07 40.09 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.32 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.702 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.9 mt -102.99 116.55 46.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.658 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.0 170.54 5.43 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.58 -35.53 16.95 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.514 2.143 . . . . 0.0 112.175 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.45 -19.24 22.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.435 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.77 132.54 52.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 111.325 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -53.55 161.06 1.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.713 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.666 ' HG2' HD22 ' A' ' 10' ' ' ASN . 4.4 tpt180 -126.47 153.12 45.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.242 0.544 . . . . 0.0 112.171 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.895 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 42.5 t80 -165.1 83.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.049 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 89' ' ' GLU . 1.4 m -95.81 111.46 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.7 tp -98.0 94.13 6.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.958 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 37.0 m-70 -77.27 141.16 40.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 0.0 111.033 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 73.7 mt -144.17 77.91 1.56 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.298 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.586 ' N ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 t30 -57.17 89.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 17' ' ' HIS . 5.5 t -57.9 133.49 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.724 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.972 179.692 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.876 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.131 0.491 . . . . 0.0 112.026 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.486 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -47.75 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.083 -179.161 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD3' HD13 ' A' ' 108' ' ' LEU . 53.4 tttp -102.47 98.7 8.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.763 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.71 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.3 m95 -87.55 104.32 16.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.265 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 HD23 ' A' ' 110' ' ' LEU . 30.7 m -146.45 -171.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 112.055 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.25 -176.04 2.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.585 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.6 t -175.83 -177.04 0.9 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.138 0.494 . . . . 0.0 112.164 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.8 m80 -115.1 -167.7 1.28 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.805 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -84.55 128.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.169 0.509 . . . . 0.0 111.905 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.63 20.63 59.55 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.483 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.2 tptp -59.03 84.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.026 0.413 . . . . 0.0 109.975 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.758 HG22 HD22 ' A' ' 77' ' ' LEU . 3.9 m -55.72 93.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.353 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 52.2 m -94.59 101.91 13.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.0 tt0 -82.43 133.46 35.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.577 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.572 HD11 HD22 ' A' ' 108' ' ' LEU . 41.4 mt -135.5 101.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.158 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -84.72 107.87 17.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.3 mt -100.89 144.86 29.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.273 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.9 164.01 13.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.93 0.395 . . . . 0.0 110.334 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.61 -139.84 5.78 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.291 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.329 -0.319 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.84 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 90.2 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.28 151.97 32.56 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.062 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.47 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 3.8 m95 -110.38 88.97 2.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.87 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 42' ' ' VAL . 5.9 t -136.67 -168.7 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.927 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 54' ' ' VAL . 10.2 mtp85 -81.17 140.26 35.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.784 0.326 . . . . 0.0 111.102 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 89' ' ' GLU . 20.3 t -54.39 144.44 5.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.53 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.18 -0.97 5.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.864 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -128.66 54.12 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.568 0.699 . . . . 0.0 110.504 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 93' ' ' THR . 26.2 t -107.69 121.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.653 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -177.631 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 56' ' ' CYS . 36.9 mt . . . . . 0 CA--C 1.519 -0.245 0 CA-C-O 121.449 0.642 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 53' ' ' GLU . 36.9 t -47.23 174.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.02 -83.13 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.91 -31.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.135 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.3 mm -73.97 -79.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.509 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -99.93 115.84 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.678 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.78 70.27 0.19 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.603 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -75.41 83.71 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.251 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.72 84.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HB3' HD12 ' A' ' 47' ' ' LEU . 21.1 t -99.29 127.11 45.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.439 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 75' ' ' VAL . 41.2 mttm -109.37 107.32 17.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.597 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -81.66 103.99 11.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.42 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 m -102.45 119.31 56.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.007 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 83.7 Cg_endo . . . . . 0 N--CA 1.452 -0.942 0 C-N-CA 123.163 2.575 . . . . 0.0 113.134 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.47 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -138.37 109.68 6.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.136 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 57' ' ' LYS . 5.0 p -103.58 111.51 33.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' SG ' ' A' ' 56' ' ' CYS . 28.1 t -104.97 124.04 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.482 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.758 HD22 HG22 ' A' ' 21' ' ' THR . 83.7 mt -109.65 100.96 9.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -94.75 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.1 mtmt -114.27 94.14 34.04 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.354 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.605 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.48 105.43 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.495 2.13 . . . . 0.0 112.577 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 17.5 mtt180 -69.62 -35.85 75.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -117.64 -177.39 3.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.872 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HE ' HG21 ' A' ' 18' ' ' VAL . 85.9 mtt180 -121.3 142.21 50.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.8 -107.37 0.5 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.456 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.8 m80 -125.96 94.68 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -109.96 162.6 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.163 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.2 m -159.92 149.62 18.16 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.582 ' HB2' HG11 ' A' ' 78' ' ' VAL . 27.1 tp -119.47 80.19 1.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -77.71 106.85 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.968 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 38' ' ' ARG . 73.1 mt -102.96 154.0 19.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.099 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.43 152.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.833 0.349 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.3 t80 -102.67 92.09 4.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.849 HG21 HG21 ' A' ' 42' ' ' VAL . 8.1 t -131.42 162.54 29.94 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.5 mtp180 -94.96 95.36 1.53 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.613 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 42' ' ' VAL . 1.3 Cg_endo -45.45 -34.07 10.17 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.094 2.529 . . . . 0.0 112.967 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -72.39 -36.78 68.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.019 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.58 6.32 39.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.675 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.4 -168.35 42.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.923 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.686 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.7 mt -117.14 154.49 18.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.27 0.557 . . . . 0.0 112.343 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.6 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.26 163.55 49.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.549 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.53 -17.47 16.28 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.569 2.179 . . . . 0.0 111.665 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.3 pt-20 -78.79 -6.73 56.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.46 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 100' ' ' LYS . 12.4 m120 -69.65 151.11 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.51 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -60.99 166.31 3.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.605 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 16.6 tpp180 -130.46 163.69 26.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.597 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 46.7 t80 -172.97 68.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.5 m -89.64 103.27 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.884 -178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 24' ' ' ILE . 34.7 tp -86.53 90.24 8.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 14.0 m-70 -74.45 145.9 43.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 14' ' ' VAL . 86.4 mt -146.81 104.93 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.176 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 46.7 t30 -79.58 70.62 6.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -47.55 117.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.898 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.401 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 6.9 p-10 -43.44 103.41 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.488 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB3' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.2 57.13 0.95 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.555 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.5 m0 -78.48 122.83 26.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.921 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 5.7 p -174.76 160.95 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.549 0.69 . . . . 0.0 112.099 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -61.77 176.06 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.059 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 110' ' ' LEU . 4.1 t -174.31 -172.75 0.71 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.04 0.448 . . . . 0.0 111.63 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.0 m80 -117.38 -169.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 83' ' ' ARG . 40.8 t -90.29 129.27 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.687 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 58.34 15.14 22.38 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.26 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.3 tptp -62.96 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.682 HG22 HD22 ' A' ' 77' ' ' LEU . 7.2 m -44.02 103.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.852 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.5 m -94.35 95.12 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.568 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 39.2 tt0 -81.76 131.83 35.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.831 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.451 HD13 ' OH ' ' A' ' 106' ' ' TYR . 41.2 mt -139.3 102.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.5 102.16 11.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 11.5 mt -95.11 145.22 25.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.652 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.5 mptt -99.58 161.45 13.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.335 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.82 -147.01 7.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.559 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.0 t30 . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 120.39 0.138 . . . . 0.0 110.742 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.3 ttm -147.14 151.08 36.2 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.3 m95 -104.2 82.79 1.99 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.8 t -127.97 161.6 28.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.364 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.711 ' NH1' HD11 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -54.71 139.88 37.65 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.776 0.322 . . . . 0.0 111.408 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 91' ' ' VAL . 42.3 t -51.14 140.88 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.268 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.38 5.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 47' ' ' LEU . 23.2 m-30 -117.25 47.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.207 0.527 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.617 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.3 p -93.44 128.76 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.859 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.066 -178.746 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.6 HD13 HH21 ' A' ' 38' ' ' ARG . 15.6 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 92.3 p -51.89 175.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.294 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -157.26 -99.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 111.388 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.9 pt-20 -127.28 -32.46 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.8 mm -73.52 -72.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' A' ' 78' ' ' VAL . 85.1 mt -106.15 116.98 32.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.217 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.64 73.32 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG13 HG13 ' A' ' 78' ' ' VAL . 1.3 t -78.9 90.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -92.65 90.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.56 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 9.2 t -114.99 145.88 41.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.287 0.565 . . . . 0.0 111.604 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -126.61 125.2 41.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.143 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -85.59 103.87 14.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.15 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 27.4 m -105.8 128.46 26.4 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 29.7 Cg_endo . . . . . 0 N--CA 1.449 -1.147 0 C-N-CA 123.499 2.799 . . . . 0.0 111.737 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 pt . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -139.27 98.01 3.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.775 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.3 p -89.12 113.25 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-O 121.343 0.592 . . . . 0.0 110.661 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG22 HH22 ' A' ' 38' ' ' ARG . 20.7 t -107.06 126.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.764 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 HG22 ' A' ' 21' ' ' THR . 70.0 mt -113.62 90.68 3.41 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.648 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -90.85 105.21 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.074 0.464 . . . . 0.0 111.057 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 46.5 mtmt -106.01 96.27 12.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 52' ' ' LEU . 7.4 Cg_endo -50.67 103.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.283 1.989 . . . . 0.0 112.503 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.1 mtt180 -67.69 -35.39 78.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 53.0 mttm -117.43 178.99 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.831 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 18' ' ' VAL . 67.3 mtp180 -117.65 146.55 43.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.45 -149.59 21.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.782 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -91.26 28.3 1.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.752 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.436 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 72.3 m-70 -47.54 157.6 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 109' ' ' HIS . 54.4 m -157.31 148.22 21.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.922 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 38' ' ' ARG . 17.4 tp -107.99 165.78 11.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.75 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.558 ' C ' HD12 ' A' ' 90' ' ' LEU . 34.5 mt-10 -151.68 121.24 6.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.711 HD11 ' NH1' ' A' ' 38' ' ' ARG . 9.7 mp -116.81 161.83 18.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.289 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.3 p -158.65 155.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.117 0.484 . . . . 0.0 112.047 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.7 t80 -100.12 86.86 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.706 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.9 t -109.82 171.46 7.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -105.54 93.25 6.84 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 88.9 Cg_exo -49.17 -29.2 16.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.536 2.158 . . . . 0.0 112.339 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.38 -34.69 63.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.213 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -110.24 -76.88 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.249 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.47 -174.76 47.02 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.242 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -96.44 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 0.0 111.013 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 6.8 mttt -136.11 157.01 76.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.65 -47.38 11.43 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.735 2.29 . . . . 0.0 112.739 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.06 -12.71 8.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.85 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.617 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.8 m-20 -64.26 149.94 46.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.927 0.394 . . . . 0.0 111.357 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.71 164.03 2.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.703 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 12.1 tpp180 -137.77 162.13 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.703 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -164.41 83.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.304 0.573 . . . . 0.0 110.08 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 89' ' ' GLU . 25.8 m -88.82 133.76 34.16 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 37.5 tp -118.59 80.98 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.8 m-70 -66.46 145.42 55.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.876 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.7 mt -143.58 108.34 4.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.579 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 60.9 t30 -82.8 50.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.479 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -37.7 112.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.67 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.848 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.746 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.96 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.25 98.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.804 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.516 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.5 tttt -100.96 94.55 6.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.034 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.685 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m95 -84.64 103.32 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.05 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 110' ' ' LEU . 29.6 m -148.21 -171.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.133 0.492 . . . . 0.0 112.104 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -109.32 178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.819 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.441 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.4 t -176.39 -172.67 0.48 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.95 0.405 . . . . 0.0 111.692 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 66.6 m80 -122.23 179.9 4.39 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.59 136.23 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.339 0.59 . . . . 0.0 112.221 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 58.24 15.16 21.73 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.862 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.4 tptt -58.72 85.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.327 0.563 . . . . 0.0 110.015 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.711 HG22 HD22 ' A' ' 77' ' ' LEU . 3.6 m -56.67 102.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.332 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 m -102.16 101.42 11.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.4 tt0 -81.6 135.02 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 108' ' ' LEU . 42.0 mt -136.41 104.95 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -86.24 97.87 10.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.8 mt -91.02 145.69 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 5.7 mptt -91.4 159.71 15.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.35 -154.39 25.48 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.009 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.4 0.143 . . . . 0.0 110.987 179.72 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.1 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.937 0.399 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.506 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.3 ttt -133.89 149.76 51.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.508 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 23.2 m95 -100.87 110.56 22.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.154 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.663 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -154.99 -172.39 4.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.819 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 mtp85 -89.08 153.66 20.8 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.807 0.337 . . . . 0.0 111.044 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 89' ' ' GLU . 51.6 t -67.11 132.88 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.977 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.46 15.43 81.44 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.851 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 59.8 m-85 -135.75 -5.56 2.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 37' ' ' THR . 4.3 p -43.47 124.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.517 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 72.2 p -50.95 177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.016 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -156.43 -89.83 0.04 OUTLIER 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.399 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -127.14 -35.25 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.7 mm -70.53 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.231 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.4 mt -101.35 116.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.451 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -71.16 66.98 0.43 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG21 ' HD2' ' A' ' 38' ' ' ARG . 19.2 t -71.23 81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.822 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.7 t -75.69 78.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -94.63 139.71 30.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.366 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -131.36 107.53 9.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.747 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -72.6 109.58 6.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.289 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' HG13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -94.18 112.8 58.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.429 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 N--CA 1.456 -0.696 0 C-N-CA 123.105 2.537 . . . . 0.0 113.714 -179.344 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.9 pt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -133.02 99.8 4.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.466 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.4 p -94.79 108.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.192 0.52 . . . . 0.0 110.724 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 43.0 t -104.84 126.33 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.825 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.711 HD22 HG22 ' A' ' 21' ' ' THR . 82.1 mt -110.66 98.44 7.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.761 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.584 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.47 107.87 19.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.005 0.431 . . . . 0.0 111.275 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 44.8 mtmt -112.65 95.13 31.37 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.22 101.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.1 . . . . 0.0 112.848 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.528 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -65.77 -31.06 71.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.872 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -119.01 176.97 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.632 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -120.71 126.06 49.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.968 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 149.63 -109.21 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.236 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -111.98 113.55 25.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -135.77 156.48 48.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.591 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.557 ' CG2' HG22 ' A' ' 107' ' ' THR . 28.9 m -158.75 148.68 19.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.534 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 41.2 tp -108.58 90.23 3.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.72 ' HA ' HG23 ' A' ' 107' ' ' THR . 39.3 mt-10 -71.8 97.29 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.104 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -111.46 125.28 53.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.489 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -126.75 172.24 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.488 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 1.7 t80 -109.69 86.36 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.014 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.6 t -117.61 158.01 25.39 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' TYR . 79.8 mtp180 -100.49 98.9 8.72 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.84 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -43.39 -38.02 8.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 112.845 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.88 -40.35 92.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.618 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -102.38 -75.58 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.04 -173.58 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.272 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -99.94 143.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 0.0 111.34 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -135.59 169.49 13.55 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.16 -37.87 17.34 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.643 2.229 . . . . 0.0 112.067 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.57 -17.21 53.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.169 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.623 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.96 135.06 56.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -54.75 158.37 2.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 6.3 tpp180 -119.24 160.16 22.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.433 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 49.7 t80 -173.28 68.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.975 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.72 97.63 10.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.328 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 19.5 tp -78.85 93.28 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.685 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.2 m-70 -76.66 142.71 40.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 14' ' ' VAL . 89.9 mt -146.64 110.94 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.302 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 44.0 t30 -83.44 65.7 8.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -42.4 136.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.991 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.908 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 111.772 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -59.32 97.71 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.304 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.0 ptmt -93.69 74.69 4.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.701 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -50.22 103.89 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.834 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.617 HG23 HD23 ' A' ' 110' ' ' LEU . 34.7 m -146.82 -174.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 112.436 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -108.95 -178.1 3.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.808 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.556 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.31 -173.39 0.44 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.983 0.421 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.599 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 47.9 m-70 -124.12 -177.22 3.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.979 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.94 137.79 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 112.174 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.33 14.01 11.7 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.659 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.599 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 20.5 tptt -57.82 85.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.193 0.497 . . . . 0.0 109.927 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.77 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -57.27 92.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.291 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -88.36 103.2 15.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.613 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.5 tt0 -85.2 129.66 34.76 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.553 HG22 ' HG ' ' A' ' 26' ' ' LEU . 42.1 mt -133.84 107.69 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.645 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -87.83 91.64 8.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.368 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 24' ' ' ILE . 15.5 mt -86.24 145.13 27.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.488 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -99.53 163.65 12.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.22 -141.24 5.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.6 t30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.548 0.214 . . . . 0.0 110.564 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 36.0 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.097 0.475 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.0 ttm -150.61 151.05 31.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.087 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.485 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.4 m95 -106.62 88.14 2.69 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.5 t -134.56 -168.57 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -74.99 157.5 34.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.67 0.271 . . . . 0.0 110.722 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 98.9 t -79.56 134.81 26.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.749 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 -10.44 5.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.822 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 39' ' ' VAL . 16.8 m-30 -106.08 7.91 32.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.143 0.497 . . . . 0.0 110.284 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.904 HG21 HG21 ' A' ' 93' ' ' THR . 14.4 t -62.16 106.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.749 -179.412 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.746 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 6.8 mt . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 40.6 p -49.54 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.779 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.2 -89.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -130.35 -30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.279 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.7 mm -75.32 -79.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.2 mt -102.52 113.42 26.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.572 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -69.81 71.14 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.825 0.345 . . . . 0.0 110.249 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.656 HG11 ' HD3' ' A' ' 38' ' ' ARG . 2.1 t -72.78 87.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG12 ' HE3' ' A' ' 57' ' ' LYS . 20.4 t -86.78 86.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 76' ' ' VAL . 5.6 t -111.82 134.19 53.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.896 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' HG12 ' A' ' 55' ' ' VAL . 32.1 mmtp -113.91 112.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.507 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -70.95 117.5 12.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.847 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.2 114.05 62.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.631 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 112.926 -179.435 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.141 0.496 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -133.73 102.8 5.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.708 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 74.3 t -87.57 107.1 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.777 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.547 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.8 t -108.95 119.6 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.77 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -112.2 95.38 5.42 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.587 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -90.8 108.76 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.021 0.439 . . . . 0.0 111.282 -178.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.0 mtmm -110.45 92.27 13.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.63 102.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.524 2.149 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.3 mtt180 -64.1 -34.76 78.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -116.06 -175.81 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.83 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -122.8 146.46 47.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.461 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 133.19 -136.79 8.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.492 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.88 95.32 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.963 0.411 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.14 164.37 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.613 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 109' ' ' HIS . 88.3 m -159.8 150.24 18.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.586 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 HH11 ' A' ' 38' ' ' ARG . 34.6 tp -120.28 94.53 4.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.608 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.7 mt-10 -73.88 105.54 5.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.802 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 26.5 mt -111.39 129.64 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.9 p -133.66 158.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.161 0.505 . . . . 0.0 112.092 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -102.37 92.11 4.55 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.979 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.904 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -123.02 170.36 10.23 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -102.11 94.81 4.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.9 Cg_exo -45.21 -38.17 14.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.721 2.28 . . . . 0.0 112.729 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -37.7 88.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -101.57 -80.71 0.49 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.413 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.04 178.39 44.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.732 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.8 mt -94.39 153.08 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 0.0 111.557 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.7 mttt -140.41 162.65 48.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.2 Cg_endo -70.95 -39.77 3.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.712 2.275 . . . . 0.0 111.998 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.5 -27.47 69.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.784 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.5 HD21 ' HA ' ' A' ' 93' ' ' THR . 8.1 m-20 -52.5 153.72 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -59.66 160.35 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.6 tpp180 -129.87 163.9 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.206 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.7 t80 -176.49 71.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 0.0 109.111 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 89' ' ' GLU . 1.9 m -85.83 95.98 9.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.341 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 48.2 tp -72.88 86.28 1.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -75.74 139.6 41.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 14' ' ' VAL . 94.6 mt -145.49 102.52 3.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.621 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 37.5 t30 -79.26 73.0 5.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 HG23 ' A' ' 16' ' ' THR . 1.7 t -48.4 137.82 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.729 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.969 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -34.63 100.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.778 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.5 tttt -89.84 100.25 13.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.472 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.674 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -82.05 105.08 12.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.79 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.1 p -154.84 -178.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.077 0.465 . . . . 0.0 111.718 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.79 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -100.67 -176.12 3.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.604 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.496 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.12 -174.4 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.183 0.516 . . . . 0.0 112.195 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.7 m-70 -114.96 -168.93 1.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.113 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.79 128.77 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 111.897 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.65 15.86 27.75 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.505 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.61 84.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.712 HG22 HD22 ' A' ' 77' ' ' LEU . 4.9 m -47.8 101.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.981 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 78' ' ' VAL . 51.9 m -96.03 99.62 11.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.9 tt0 -81.97 131.6 35.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.311 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 108' ' ' LEU . 43.7 mt -138.67 103.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.764 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -85.58 107.02 17.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.346 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.545 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 6.4 mt -104.34 143.93 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.137 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -96.79 162.94 13.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.977 0.418 . . . . 0.0 110.591 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.62 -158.76 29.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.311 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.694 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 17.7 ttm -117.7 152.84 34.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.896 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.4 m95 -111.44 89.99 3.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.186 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.0 t -134.24 -165.88 1.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.07 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.8 mtp85 -90.66 155.01 19.15 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.958 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 37.8 t -74.5 133.01 32.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.49 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.75 89.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.7 m-85 -130.68 -1.18 4.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 0.0 110.477 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 93' ' ' THR . 21.0 t -54.13 118.74 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.067 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.982 -179.49 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.15 0.5 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 64.4 p -53.47 -179.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.59 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -157.2 -90.81 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.63 -30.37 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -74.99 -79.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.214 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.626 HD22 HG12 ' A' ' 78' ' ' VAL . 7.1 mt -100.21 113.62 26.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.71 68.32 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.068 0.461 . . . . 0.0 109.928 177.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -72.7 84.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.768 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 29.3 t -80.14 80.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.591 0.71 . . . . 0.0 109.19 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' HG22 ' A' ' 76' ' ' VAL . 17.4 t -97.17 124.23 41.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.212 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -114.82 105.96 13.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -70.37 97.95 1.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 m -95.47 125.42 49.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.133 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 22.1 Cg_endo . . . . . 0 N--CA 1.448 -1.201 0 C-N-CA 123.196 2.597 . . . . 0.0 111.571 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.9 m-85 -138.99 101.08 4.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.348 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.46 100.2 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 120.876 0.369 . . . . 0.0 110.814 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.3 t -100.96 118.95 48.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.138 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -110.35 97.52 6.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.629 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.626 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.81 106.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.9 mtmm -111.75 92.99 18.66 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.211 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.3 Cg_endo -51.76 102.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.388 2.059 . . . . 0.0 112.606 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.5 mtt180 -63.93 -36.37 83.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.822 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 79.2 mttt -119.45 178.01 4.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -119.82 140.36 50.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.963 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.551 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.45 -113.57 0.71 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.359 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -115.99 93.2 4.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.816 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.1 m-70 -113.63 162.27 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.6 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 109' ' ' HIS . 60.0 m -159.31 149.92 19.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 111.723 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 22.6 tp -115.66 93.47 4.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.388 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.8 mt-10 -78.42 92.62 4.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.191 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 59.3 mt -103.22 123.72 47.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.9 p -126.66 155.59 37.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.946 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.1 t80 -97.89 82.88 3.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.472 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.882 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -118.79 158.75 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 58.5 mtp180 -97.45 98.21 4.78 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.512 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 93' ' ' THR . 93.8 Cg_exo -44.04 -38.44 10.44 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.884 2.39 . . . . 0.0 112.735 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.3 93.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -97.26 -74.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.44 179.7 39.36 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.088 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.651 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.7 mt -94.23 146.25 6.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 43.6 mtmt -140.28 162.9 47.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.215 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 42.4 Cg_endo -68.02 -38.76 12.13 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.777 2.318 . . . . 0.0 112.089 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.7 -28.22 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.826 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.6 HD21 ' HA ' ' A' ' 93' ' ' THR . 6.9 m-20 -55.22 149.37 12.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.05 166.17 2.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.6 tpp180 -132.7 164.11 27.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.44 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.638 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 51.3 t80 -174.47 64.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.635 0.731 . . . . 0.0 109.184 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.3 m -87.61 92.22 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.228 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 27.5 tp -73.46 93.55 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.2 m-70 -77.31 140.71 40.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 16' ' ' THR . 92.3 mt -143.78 104.08 4.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.39 68.33 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.551 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -45.02 118.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.369 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.963 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.886 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.106 0.479 . . . . 0.0 112.137 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.2 99.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.713 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 53.6 tptt -95.09 92.13 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.244 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m95 -75.84 105.68 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.743 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.678 HG22 ' H ' ' A' ' 15' ' ' ASP . 9.9 p -156.93 173.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.239 0.542 . . . . 0.0 111.888 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.678 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -93.64 -173.59 3.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.57 -175.96 0.84 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.153 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 4.5 m-70 -115.24 -163.77 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.715 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.13 132.37 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 111.985 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.55 20.05 22.08 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.507 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptm -63.3 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.782 HG22 HD22 ' A' ' 77' ' ' LEU . 4.1 m -51.43 99.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.517 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HB ' HG23 ' A' ' 78' ' ' VAL . 38.2 m -98.58 101.02 12.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.722 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HG3' HG23 ' A' ' 75' ' ' VAL . 33.4 tt0 -76.79 133.92 39.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.505 HG22 ' HG ' ' A' ' 26' ' ' LEU . 23.2 mt -131.48 94.97 2.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.262 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 6.5 m170 -84.82 78.27 9.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.026 0.441 . . . . 0.0 110.024 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HG ' HG22 ' A' ' 24' ' ' ILE . 89.8 mt -68.98 160.15 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.325 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -113.63 164.24 13.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.07 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.08 -145.95 11.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.771 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.9 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.367 0.127 . . . . 0.0 110.782 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.138 0.494 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 4.6 ttt -147.98 151.9 36.57 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.851 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -107.6 96.7 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.131 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -147.39 -166.42 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.647 HH11 HG21 ' A' ' 54' ' ' VAL . 5.1 mtp180 -84.84 155.7 21.64 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.849 0.357 . . . . 0.0 111.253 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 43.2 t -74.35 132.8 32.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.439 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.44 89.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.261 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 64.9 m-85 -127.6 3.98 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.098 0.475 . . . . 0.0 110.419 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 37' ' ' THR . 3.6 p -45.22 133.1 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.071 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.302 -179.771 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 45.6 p -48.87 -179.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.384 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -156.55 -85.45 0.05 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.89 -30.5 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.585 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -73.74 -76.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.55 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.9 mt -102.85 115.65 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.324 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.18 70.91 0.24 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.21 0.528 . . . . 0.0 109.699 177.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HH11 ' A' ' 38' ' ' ARG . 21.7 t -76.63 83.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.312 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 t -82.01 86.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.488 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.5 t -96.18 150.95 19.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.792 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' HG13 ' A' ' 75' ' ' VAL . 55.1 mttm -139.77 114.4 9.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.973 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.516 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -94.68 105.52 17.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.945 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.6 m -107.39 108.52 61.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.446 -1.265 0 C-N-CA 123.47 2.78 . . . . 0.0 111.71 179.76 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 121.876 0.846 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 1.9 m-85 -130.27 76.2 1.71 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.564 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.3 p -84.5 110.27 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.001 -177.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 56' ' ' CYS . 90.3 t -106.81 122.06 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.3 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 21' ' ' THR . 81.8 mt -105.36 102.49 11.96 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.905 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.15 108.51 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.951 0.405 . . . . 0.0 111.091 -178.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -113.9 93.78 30.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.9 Cg_endo -47.99 102.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.567 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.9 mtt180 -69.16 -36.72 77.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.293 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -117.15 170.58 8.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -107.22 123.82 48.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.593 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.77 -128.79 2.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.537 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.432 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -106.86 95.58 5.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.377 . . . . 0.0 110.962 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.433 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -109.65 161.53 15.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.402 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.0 m -158.17 148.93 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 111.732 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 24.9 tp -115.77 90.39 3.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.571 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.5 mt-10 -75.57 94.19 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.1 mt -101.91 125.33 48.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.5 p -131.12 158.08 43.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.715 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.6 t80 -97.1 86.44 3.96 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -110.86 167.11 10.49 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 61.5 mtp180 -102.52 97.68 9.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.393 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.0 Cg_exo -51.44 -31.78 40.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.544 2.163 . . . . 0.0 112.635 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.14 10.12 11.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.2 mm-40 -148.41 -79.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.85 40.92 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 mt -94.87 155.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.894 0.378 . . . . 0.0 111.267 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.579 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.3 mtmt -143.76 161.4 46.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.944 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.4 Cg_endo -72.08 -39.7 2.96 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.31 -27.02 69.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.0 m120 -55.97 155.03 6.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -56.25 161.95 2.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.042 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.58 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.3 tpp180 -131.66 164.28 26.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.746 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 50.0 t80 -177.58 65.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.345 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 10.4 m -87.25 94.12 9.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.7 tp -74.93 93.8 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.703 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.2 m-70 -77.11 138.65 39.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 110.706 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 96.2 mt -142.29 98.06 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -76.08 78.17 2.92 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.593 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.4 t -51.77 123.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.474 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.903 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.009 0.433 . . . . 0.0 111.919 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 4.1 m-20 -55.22 97.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' A' ' 14' ' ' VAL . 54.5 tttp -99.63 95.27 6.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.85 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.54 102.36 12.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.166 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.534 HG21 ' HE3' ' A' ' 12' ' ' LYS . 35.2 m -147.34 -170.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.041 0.448 . . . . 0.0 111.809 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -103.99 -176.19 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.303 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -173.83 -175.65 1.1 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 112.293 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 17.5 m80 -116.56 -163.06 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.017 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 44.4 t -98.56 129.06 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.808 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.67 14.52 36.64 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.287 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -64.08 83.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.2 102.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.809 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 98.3 m -96.16 100.19 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.389 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.0 tt0 -81.34 131.45 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.033 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.9 mt -136.0 104.46 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.78 100.94 12.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.8 mt -95.52 147.72 23.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.466 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -101.94 162.01 13.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.54 -147.49 9.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 t30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.39 0.138 . . . . 0.0 110.754 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 65.9 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.059 0.457 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ttm -150.94 152.94 34.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.902 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 9.1 m95 -107.25 87.24 2.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -131.85 -166.55 1.74 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.175 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 22.0 mtp85 -90.24 148.14 23.1 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.217 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 17.4 t -68.07 136.29 26.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.544 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.31 1.7 88.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.405 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.418 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 61.5 m-85 -128.24 -1.62 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -55.21 107.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.057 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.959 -179.551 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.3 mt . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.135 0.493 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.6 t -51.43 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.69 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -157.58 -91.34 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -130.88 -32.64 1.63 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.157 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.9 mm -70.46 -76.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.304 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -104.34 114.48 28.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -66.36 72.99 0.08 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 HG13 ' A' ' 78' ' ' VAL . 10.9 t -79.44 85.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.164 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.0 t -81.12 83.3 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.8 t -98.33 139.87 33.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.369 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -133.28 110.0 9.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -76.77 101.44 5.84 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 23.2 m -97.87 109.22 50.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.059 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 74.2 Cg_endo . . . . . 0 N--CA 1.446 -1.282 0 C-N-CA 123.593 2.862 . . . . 0.0 111.266 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.063 0.458 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -135.32 100.42 4.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.69 104.32 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.926 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HD11 ' A' ' 90' ' ' LEU . 37.2 t -107.09 120.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.289 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 80.0 mt -110.38 100.38 9.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.826 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.13 107.26 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.146 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.0 mtmm -109.5 103.58 53.19 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.392 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.8 Cg_exo -51.59 101.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.204 . . . . 0.0 112.605 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.581 HH11 ' HA ' ' A' ' 50' ' ' GLU . 11.8 mtt180 -71.91 -37.1 70.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.828 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.518 ' H ' ' HE1' ' A' ' 86' ' ' HIS . 57.1 mttm -120.39 173.45 7.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -110.05 137.43 47.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.652 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 141.63 -118.8 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.742 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -110.15 100.38 9.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.0 111.268 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.518 ' HE1' ' H ' ' A' ' 82' ' ' LYS . 11.5 m-70 -119.43 156.45 30.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 107' ' ' THR . 58.1 m -159.63 147.93 17.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.2 tp -104.67 90.12 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.368 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.768 ' HA ' HG23 ' A' ' 107' ' ' THR . 42.9 mt-10 -72.43 95.15 1.73 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.894 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 35.8 mt -109.9 133.96 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.3 p -140.41 153.93 22.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.843 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.5 t80 -97.83 84.57 3.37 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.4 t -116.4 167.83 10.69 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 77.8 mtp180 -100.38 94.53 3.46 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 93' ' ' THR . 77.7 Cg_exo -43.45 -24.63 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.802 2.334 . . . . 0.0 113.371 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -79.47 -62.21 1.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 94' ' ' ARG . 1.6 pp20? -72.23 -39.1 68.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.674 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.8 -165.14 24.64 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -112.98 132.9 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 111.748 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE3' ' CD ' ' A' ' 97' ' ' GLU . 5.8 mttt -120.57 156.26 55.97 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.8 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.53 -47.42 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.918 2.412 . . . . 0.0 112.73 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -53.75 -17.7 2.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.832 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 11.3 m120 -63.76 157.22 24.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -57.51 159.22 5.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.244 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.6 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 13.5 tpp180 -129.68 164.34 24.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.029 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.593 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.0 t80 -174.85 72.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.768 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.05 96.02 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.397 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 20.6 tp -76.46 93.3 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.7 m-70 -77.55 144.87 37.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 75.1 mt -145.67 113.37 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.23 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.4 t30 -83.39 65.29 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -46.06 129.01 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.443 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.937 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -32.36 99.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.207 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' HD13 ' A' ' 108' ' ' LEU . 19.8 ptmt -93.88 73.57 4.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -49.62 104.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG23 HD23 ' A' ' 110' ' ' LEU . 28.2 m -146.62 -175.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 112.503 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -110.83 179.68 3.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.641 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.519 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.8 t -177.08 -173.12 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 112.023 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 64.1 m80 -119.15 -167.47 1.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.038 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 25.9 t -84.46 139.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 112.182 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.4 13.15 10.1 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.731 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.1 tptt -59.92 82.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.737 HG22 HD22 ' A' ' 77' ' ' LEU . 3.7 m -54.39 98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.381 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -94.96 101.24 13.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.4 tt0 -84.18 130.15 34.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.55 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 108' ' ' LEU . 46.9 mt -136.47 101.07 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.205 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -81.69 109.82 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.5 mt -104.63 152.35 22.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -108.48 159.57 16.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.979 0.418 . . . . 0.0 110.443 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.81 -39.14 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.172 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.77 -0.215 . . . . 0.0 110.951 179.79 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 121.114 0.483 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.526 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 3.3 ttt -118.88 151.21 38.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.966 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -108.39 89.88 3.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.5 t -135.58 -167.05 1.95 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.413 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.715 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.0 mtp85 -89.97 147.23 23.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.703 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 42.5 t -63.92 132.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.697 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.31 14.23 79.12 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.809 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.423 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 63.2 m-85 -136.44 0.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.734 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.605 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.3 p -45.28 123.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.175 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.536 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.715 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.8 mt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 54' ' ' VAL . 88.6 p -52.64 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.495 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.78 -86.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.183 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.64 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.97 -34.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.9 mm -61.52 -62.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.748 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 80' ' ' PRO . 38.6 mt -126.79 134.46 50.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.947 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.434 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -74.07 67.05 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 ' NH1' ' A' ' 38' ' ' ARG . 4.0 t -73.82 82.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.059 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 27.2 t -80.6 81.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.51 0.672 . . . . 0.0 109.215 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' HG22 ' A' ' 76' ' ' VAL . 24.4 t -91.8 135.35 33.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.873 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -127.52 105.14 8.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.526 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -81.62 111.92 18.36 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -103.27 100.35 17.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.806 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 39.6 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 C-N-CA 123.799 3.0 . . . . 0.0 113.401 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.4 pt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.174 0.511 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -142.71 97.73 3.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.172 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.67 104.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 110.662 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.461 HG22 ' SG ' ' A' ' 56' ' ' CYS . 23.3 t -99.68 127.16 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.586 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -111.71 98.7 7.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.851 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.95 105.11 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -104.46 98.81 15.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.619 ' HA ' HD22 ' A' ' 52' ' ' LEU . 93.2 Cg_exo -43.05 100.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.066 2.511 . . . . 0.0 113.105 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.64 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.5 mtt180 -76.56 -29.73 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.118 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 79.5 mttt -122.4 154.88 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -96.66 124.62 40.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.031 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.569 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.35 -159.53 24.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.591 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -67.12 117.77 9.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.454 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 88.8 m-70 -145.43 170.04 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 88' ' ' LEU . 51.4 m -161.28 159.65 28.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.119 0.485 . . . . 0.0 112.202 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.666 HD22 HG21 ' A' ' 78' ' ' VAL . 10.1 tp -119.13 93.29 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.467 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.67 95.95 1.94 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 49.7 mt -107.98 115.89 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 92' ' ' TYR . 10.6 p -120.16 157.17 22.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.1 t80 -95.98 79.8 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.22 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.63 ' HA ' HD21 ' A' ' 103' ' ' ASN . 6.3 t -108.45 150.61 27.18 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 17.2 mtp180 -92.03 102.65 6.59 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.821 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 93' ' ' THR . 50.2 Cg_exo -55.25 -30.86 73.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.597 2.198 . . . . 0.0 112.437 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -65.04 -25.14 67.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.464 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -122.65 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.282 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.65 -173.73 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.373 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.597 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.1 mt -97.26 139.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 111.127 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -132.65 166.84 26.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.22 -41.2 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.822 2.348 . . . . 0.0 112.334 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.91 -18.01 41.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.63 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.6 m-20 -60.85 148.19 40.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 168.3 2.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.0 tpp180 -131.75 164.18 26.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.445 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.661 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 45.2 t80 -171.81 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.507 -0.769 . . . . 0.0 108.955 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -86.7 91.98 8.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.574 -179.057 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.2 tp -70.69 90.99 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.075 0.464 . . . . 0.0 110.277 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 31.6 m-70 -77.38 139.96 39.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.693 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -144.06 108.82 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.8 t30 -84.09 61.29 6.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.569 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.8 t -40.55 140.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.942 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.999 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.818 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.483 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 22.1 m-20 -38.45 98.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.539 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -98.38 87.9 3.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.644 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.8 m95 -78.72 98.27 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.752 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 110' ' ' LEU . 30.4 m -147.3 -172.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 111.961 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.76 -178.55 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.798 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -174.74 -174.06 0.78 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.06 0.457 . . . . 0.0 111.927 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.597 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 56.6 m80 -116.04 -173.72 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.012 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.81 135.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.249 0.547 . . . . 0.0 112.05 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 60.26 14.18 32.09 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.883 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.0 tptm -58.13 84.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.24 0.52 . . . . 0.0 109.902 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.794 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -56.54 100.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.427 HG21 HD21 ' A' ' 108' ' ' LEU . 88.6 m -96.81 103.72 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.546 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.652 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.2 tt0 -75.9 117.01 17.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.046 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.698 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 67.5 mt -114.15 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.301 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.436 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.2 m170 -100.93 104.29 15.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.415 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 36.3 mt -96.08 163.08 13.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.308 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -101.88 163.56 12.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.096 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.29 -146.31 16.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.516 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.517 0.199 . . . . 0.0 111.2 179.992 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.461 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 81.2 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.242 0.544 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.536 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.2 ttm -146.86 154.26 41.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.661 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.545 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 3.4 m95 -110.92 91.8 3.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -134.73 -163.8 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.083 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.68 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -83.23 150.52 26.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.627 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -73.44 129.7 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.359 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.89 80.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -136.2 4.14 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.2 p -49.17 133.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.253 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.83 179.748 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.9 mt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 54.1 p -54.18 -171.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.863 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.89 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.87 -34.62 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.486 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.8 mm -70.58 -77.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.502 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.3 mt -101.46 119.49 38.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.404 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.95 70.36 0.35 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.094 0.473 . . . . 0.0 109.887 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -72.58 84.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.896 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.8 t -81.04 91.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 54.0 t -90.25 130.27 36.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.113 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 54.8 mttm -124.98 80.25 1.86 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.842 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.536 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -64.73 119.59 10.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.617 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.5 m -100.43 100.62 12.52 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 40.5 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 C-N-CA 123.839 3.026 . . . . 0.0 113.753 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 11.6 m-85 41.75 87.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -88.39 131.71 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 38.2 t -137.49 97.61 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.525 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.794 HD22 HG22 ' A' ' 21' ' ' THR . 79.2 mt -92.37 102.52 15.0 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.79 109.14 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 111.3 -178.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -113.21 92.78 23.25 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.08 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.603 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.1 Cg_endo -46.97 102.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 112.619 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 19.9 mtt180 -66.37 -33.49 75.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.792 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -119.08 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -123.13 143.92 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.62 -117.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.587 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.465 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.9 m80 -112.72 94.33 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.103 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.9 OUTLIER -112.51 161.26 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.425 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.9 m -159.22 140.4 12.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.956 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.777 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -112.51 82.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.52 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 13.2 pt-20 -80.43 128.06 33.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.149 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 45.7 mt -122.64 162.51 21.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.917 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -156.08 150.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 111.587 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -93.6 85.91 5.03 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.793 ' HB ' HG23 ' A' ' 99' ' ' ILE . 4.3 t -118.53 161.84 19.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 72.9 mtp180 -99.01 97.95 5.74 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -47.83 -32.62 17.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.767 2.311 . . . . 0.0 113.378 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.06 11.64 17.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -151.38 1.36 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.26 -175.96 49.96 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.305 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -104.17 154.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.909 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -132.47 168.72 16.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.62 -49.77 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.28 2.653 . . . . 0.0 112.702 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.06 -13.51 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.623 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 7.9 m-20 -59.91 144.43 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.414 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 6.2 tt0 -55.5 163.35 1.29 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.625 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.9 tpt180 -130.55 161.29 31.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.646 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 43.3 t80 -171.99 75.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.263 0.554 . . . . 0.0 109.643 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.9 m -97.71 102.38 14.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.833 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.7 tp -84.05 90.22 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 8.8 m-70 -74.33 142.92 45.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 0.0 110.109 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 14' ' ' VAL . 88.8 mt -146.39 99.8 3.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.859 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t30 -75.91 73.27 2.82 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 112' ' ' VAL . 2.6 t -48.4 148.08 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.726 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ASN . 13.2 m-20 -32.11 101.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.795 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -95.35 90.89 5.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.29 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.694 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -78.26 103.15 8.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.761 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 110' ' ' LEU . 20.9 m -149.93 -172.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 2.9 p-10 -112.88 -177.77 3.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.36 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.557 HG22 HG22 ' A' ' 112' ' ' VAL . 1.5 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.105 0.478 . . . . 0.0 112.255 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.619 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m80 -113.52 -167.77 1.25 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -89.64 138.07 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 112.294 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.28 17.95 19.67 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.738 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.74 81.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.777 HG22 HD22 ' A' ' 77' ' ' LEU . 9.2 m -48.21 97.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 78' ' ' VAL . 53.5 m -93.09 101.43 13.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.722 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HA ' HD23 ' A' ' 77' ' ' LEU . 34.6 tt0 -75.51 119.22 19.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.72 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.29 93.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.3 m170 -86.68 104.17 15.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 52.7 mt -95.53 160.96 14.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.23 163.43 12.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.82 -160.63 27.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.68 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.93 0.395 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 19.9 ttm -113.66 152.32 30.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.433 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.538 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 8.0 m95 -109.36 87.12 2.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.607 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -134.78 -165.07 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.7 mtp85 -90.34 156.78 18.01 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 39.6 t -76.12 132.02 33.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.521 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.95 88.98 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.407 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 57.6 m-85 -131.92 -0.41 3.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 110.414 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -55.58 119.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.002 -179.557 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.0 p -51.26 179.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.925 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.78 -87.03 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.189 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.599 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -131.81 -30.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.2 mm -72.96 -76.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.509 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 9.6 mt -102.91 116.65 32.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.511 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -69.58 69.87 0.28 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 109.848 178.062 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG22 HG13 ' A' ' 78' ' ' VAL . 24.7 t -73.53 85.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.725 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.5 t -77.34 85.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.395 0.617 . . . . 0.0 109.41 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.24 136.09 52.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.134 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 68.0 mttm -135.72 50.68 2.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.654 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -52.59 116.6 2.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.815 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.426 ' N ' ' HD1' ' A' ' 58' ' ' TYR . 29.4 m -97.32 101.88 11.11 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.405 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 45.5 Cg_endo . . . . . 0 N--CA 1.445 -1.378 0 C-N-CA 124.469 3.446 . . . . 0.0 111.799 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 7.9 m-85 39.58 90.41 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.117 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 99.2 t -92.73 95.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.681 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.29 108.86 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.731 0.3 . . . . 0.0 111.773 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.777 HD22 HG22 ' A' ' 21' ' ' THR . 40.3 mt -95.6 110.81 22.86 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.95 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -101.7 104.52 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.888 0.375 . . . . 0.0 110.965 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.1 mtmt -107.79 101.36 40.05 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.339 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 54.0 Cg_exo -51.52 97.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.664 2.243 . . . . 0.0 112.74 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.599 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -62.89 -36.75 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -117.25 -172.62 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.569 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -133.31 125.71 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.831 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.32 -98.61 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.016 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.446 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 49.4 t-80 -122.09 105.57 10.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.74 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.7 m80 -124.41 159.98 29.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.429 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 52' ' ' LEU . 32.4 m -159.59 148.7 18.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.704 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.7 tp -120.46 91.52 3.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.53 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.4 mt-10 -75.86 88.63 2.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.24 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.3 mt -98.45 122.84 42.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.77 154.54 34.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.675 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' MET . 9.7 t80 -96.51 82.41 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.212 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 6.2 t -121.48 151.93 39.7 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 57.5 mtp180 -88.79 102.04 3.55 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.26 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 9.3 Cg_endo -52.99 -33.44 62.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.753 2.302 . . . . 0.0 112.429 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -64.52 -32.72 74.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.19 -72.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.24 38.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.996 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.6 mt -96.44 143.68 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.7 mtmt -137.93 163.06 50.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.146 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.3 Cg_endo -67.92 -38.76 12.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.762 2.308 . . . . 0.0 112.032 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.69 -28.99 69.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.538 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.3 m-20 -54.74 147.49 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.024 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -58.46 165.91 1.95 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.9 tpp180 -131.75 164.1 26.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.071 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 39.1 t80 -176.06 66.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.452 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 89' ' ' GLU . 18.2 m -90.07 97.46 11.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.061 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.3 tp -77.98 93.86 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.266 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.2 m-70 -77.63 144.0 37.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 14' ' ' VAL . 79.1 mt -144.64 104.56 4.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.627 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.9 t30 -81.03 61.53 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 16' ' ' THR . 2.1 t -43.33 131.18 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.569 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.929 179.851 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.825 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 15.4 m-20 -44.89 102.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.752 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.494 ' HE2' HG11 ' A' ' 14' ' ' VAL . 22.7 tptm -98.79 90.95 4.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.301 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.1 m95 -82.13 101.36 10.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.498 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 HD23 ' A' ' 110' ' ' LEU . 11.3 m -152.7 -175.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.407 0.622 . . . . 0.0 112.411 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -97.07 -174.29 2.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.286 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.464 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t -175.6 -175.69 0.8 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.188 0.518 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 38.8 m80 -114.12 -161.51 0.77 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.694 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.88 131.84 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 0.0 111.767 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 14.29 14.44 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.485 -0.779 . . . . 0.0 113.351 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.2 84.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.748 HG22 HD22 ' A' ' 77' ' ' LEU . 6.8 m -46.22 98.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.718 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.2 m -92.94 98.38 11.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.2 tt0 -80.22 133.92 36.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.034 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.538 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.7 mt -135.97 106.63 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.732 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -88.78 91.26 8.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.689 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.538 ' HG ' HG22 ' A' ' 24' ' ' ILE . 16.6 mt -88.27 144.62 26.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.269 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 73' ' ' ILE . 44.8 mttp -101.79 165.66 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.78 -134.15 2.78 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.505 0.193 . . . . 0.0 110.61 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 70.1 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.004 0.431 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.727 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 13.3 ttm -146.95 148.95 32.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.408 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.494 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -103.24 80.02 1.79 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.749 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.404 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 12.1 t -124.68 -164.74 1.3 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.344 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 5.9 mtp85 -87.19 135.82 33.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.045 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 91' ' ' VAL . 39.3 t -50.27 152.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.25 1.1 18.98 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HE2' HH21 ' A' ' 38' ' ' ARG . 24.8 m-85 -127.07 43.72 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.473 0.654 . . . . 0.0 110.536 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.4 p -80.0 98.19 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.061 179.593 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.7 mt . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.19 0.519 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.42 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.5 p -50.13 173.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.762 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.65 -87.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.16 -31.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.261 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 mm -73.59 -73.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.417 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 80' ' ' PRO . 53.3 mt -105.5 118.31 36.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.414 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.29 69.57 0.38 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.252 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 78' ' ' VAL . 12.4 t -76.19 86.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.178 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.8 t -82.79 87.4 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.427 ' SG ' HG22 ' A' ' 76' ' ' VAL . 40.2 t -101.63 130.56 47.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.726 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -121.27 110.26 15.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.937 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.48 110.63 17.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.556 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -115.09 110.67 45.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.653 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 N--CA 1.451 -1.029 0 C-N-CA 123.328 2.685 . . . . 0.0 112.21 179.181 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.0 pt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -126.35 102.4 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.088 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -88.97 106.03 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.988 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.6 t -107.89 122.13 61.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.12 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 21' ' ' THR . 82.9 mt -112.03 102.61 10.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.811 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.42 106.82 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -178.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -110.78 94.53 20.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.6 Cg_endo -48.29 107.24 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.16 . . . . 0.0 112.506 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.531 HH11 ' HA ' ' A' ' 50' ' ' GLU . 12.8 mtt180 -73.31 -43.67 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.149 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -108.87 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -110.09 146.91 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.773 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.95 -125.69 4.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.385 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.468 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 56.9 t-80 -110.63 106.06 15.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.468 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.2 m-70 -117.29 164.77 14.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' HD12 ' A' ' 52' ' ' LEU . 67.7 m -159.59 145.32 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.967 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.642 HD22 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -111.81 91.91 3.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.493 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.1 mt-10 -75.57 104.24 6.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 66.2 mt -112.97 132.28 55.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.5 p -138.09 155.48 29.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -93.42 76.39 4.48 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.664 ' HA ' HD22 ' A' ' 103' ' ' ASN . 5.6 t -105.71 155.11 19.58 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 28.1 mtp180 -86.24 104.18 5.12 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.475 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.0 Cg_endo -55.98 -30.08 76.44 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.756 2.304 . . . . 0.0 112.181 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.6 -25.78 61.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.836 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.5 -88.32 0.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.729 0.3 . . . . 0.0 111.655 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.53 -166.12 28.94 Favored Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.562 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.546 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.0 mt -103.17 145.11 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.834 0.35 . . . . 0.0 111.231 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -134.57 168.73 16.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.608 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.12 -38.96 11.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.725 2.283 . . . . 0.0 112.47 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.7 -1.8 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.439 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.664 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.3 m120 -76.18 141.26 41.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.746 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.1 tt0 -58.16 162.04 3.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.599 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.0 tpt180 -130.2 160.01 35.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.251 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.6 t80 -175.24 72.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.461 0.648 . . . . 0.0 109.472 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 89' ' ' GLU . 8.1 m -91.5 96.62 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.15 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.0 tp -75.97 91.73 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.9 m-70 -77.05 137.13 38.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.507 HD23 HG23 ' A' ' 14' ' ' VAL . 94.0 mt -143.73 112.7 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.375 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.1 t30 -86.7 85.51 7.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 17' ' ' HIS . 14.8 t -55.5 124.35 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.324 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 113' ' ' LYS . 3.2 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 107' ' ' THR . 25.5 t70 -144.34 -128.82 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.594 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 50.8 tptt -160.24 172.16 17.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 4.5 m0 -120.46 123.99 44.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.746 0.418 . . . . 0.0 110.334 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.3 m -150.68 159.21 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.673 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -50.4 168.2 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.313 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -174.19 -173.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.426 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 26.2 m80 -109.23 -168.58 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.625 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.83 138.45 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.151 0.501 . . . . 0.0 111.891 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.61 17.48 20.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.294 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.2 tptp -66.07 80.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -44.46 101.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.625 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 m -98.97 102.62 14.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.754 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.7 tt0 -80.2 127.56 32.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.584 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.529 HG22 ' HG ' ' A' ' 26' ' ' LEU . 48.1 mt -130.9 105.23 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.907 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -87.19 96.36 10.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.7 mt -91.12 145.6 24.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -100.46 162.99 12.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.68 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.76 -138.95 4.02 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.373 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--N 1.33 -0.282 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.815 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 88.3 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.79 150.05 29.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.7 m95 -103.04 82.9 2.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.673 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 42' ' ' VAL . 10.0 t -124.88 -174.73 3.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.643 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.3 mtp85 -83.12 150.63 26.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' VAL . 41.5 t -64.47 127.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.83 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.95 18.46 67.51 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.064 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.426 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 62.4 m-85 -138.02 0.86 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 110.652 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.656 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.6 p -47.05 125.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.257 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.859 179.778 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.7 mt . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.16 0.505 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 35.3 t -51.05 173.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.766 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -159.04 -85.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.256 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.07 -33.98 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.431 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.9 mm -67.42 -78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' O ' HG23 ' A' ' 54' ' ' VAL . 96.4 mt -106.42 119.3 38.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.94 72.29 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 HG13 ' A' ' 78' ' ' VAL . 7.6 t -80.81 86.18 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.498 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.52 85.7 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 76' ' ' VAL . 33.8 t -101.91 149.34 24.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.741 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -139.64 112.99 8.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.879 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.27 107.69 11.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.488 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.6 m -103.05 107.01 53.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.923 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 N--CA 1.445 -1.343 0 C-N-CA 123.647 2.898 . . . . 0.0 111.312 179.079 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -133.52 100.86 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.071 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -85.11 107.53 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 110.558 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.573 HG11 HD21 ' A' ' 88' ' ' LEU . 40.3 t -112.71 120.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 73.2 mt -108.58 99.84 9.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.55 108.55 21.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.457 . . . . 0.0 111.698 -178.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 31.7 mtmm -110.16 98.41 35.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.62 109.03 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.368 2.046 . . . . 0.0 112.778 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.4 mtt180 -81.06 -36.4 30.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.086 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -108.68 173.63 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.169 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 63.9 mtp180 -110.76 148.19 32.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.905 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.13 -164.52 13.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -70.5 102.0 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.687 0.28 . . . . 0.0 110.714 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.454 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 99.2 m-70 -128.04 149.95 50.15 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.483 0.659 . . . . 0.0 111.33 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.546 HG21 ' HB ' ' A' ' 107' ' ' THR . 40.3 m -150.95 146.81 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.483 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.604 ' HB2' HG11 ' A' ' 78' ' ' VAL . 20.9 tp -91.16 106.79 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.5 mt-10 -80.82 109.11 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.022 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 55.6 mt -119.03 143.2 47.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.067 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.19 161.57 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.398 0.618 . . . . 0.0 112.411 -179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.0 t80 -104.23 85.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.48 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.2 t -114.58 165.66 12.54 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 71.3 mtp180 -102.95 93.59 4.56 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 93' ' ' THR . 91.7 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.632 2.221 . . . . 0.0 112.627 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.89 -40.21 63.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.24 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -103.22 -68.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.92 -178.99 37.56 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.035 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.9 mt -90.75 144.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.999 0.428 . . . . 0.0 111.249 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG3' HD21 ' A' ' 103' ' ' ASN . 1.5 mttp -132.61 166.57 28.03 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.39 -40.78 29.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.853 2.369 . . . . 0.0 112.377 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.45 -13.01 35.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.553 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.612 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.82 134.77 56.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 111.45 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.74 164.67 2.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.072 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 2.1 ttp180 -139.79 158.48 44.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 0.0 111.649 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.848 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 47.4 t80 -162.65 103.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.009 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.656 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.7 OUTLIER -102.41 109.42 21.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.51 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 110' ' ' LEU . 25.9 tp -72.5 126.12 29.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.183 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 2.8 p80 -65.66 65.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.387 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.61 HD11 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -102.07 53.93 0.8 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 30.1 t30 -71.09 76.52 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.4 t -53.84 150.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.763 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.236 0.541 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HA ' ' N ' ' A' ' 107' ' ' THR . 1.2 p30 -54.86 104.07 0.11 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.286 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 108' ' ' LEU . 22.0 ptmt -101.79 119.69 39.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.028 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.79 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -103.71 111.94 24.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -148.31 -176.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.663 0.744 . . . . 0.0 112.882 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -93.8 -173.0 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.429 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -172.8 -174.54 1.13 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.416 0.627 . . . . 0.0 112.651 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 30.0 m80 -120.44 -148.52 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.382 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.7 t -108.93 128.13 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.589 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.13 20.18 19.62 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.262 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptp -65.95 84.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.672 HG22 HD12 ' A' ' 77' ' ' LEU . 6.4 m -47.17 102.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.851 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.3 m -98.98 93.62 6.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HA ' HD13 ' A' ' 77' ' ' LEU . 38.3 tt0 -78.11 127.95 33.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.156 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 38.2 mt -133.67 105.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.077 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.2 107.36 18.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 34.7 mt -103.16 149.05 25.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -101.14 161.46 13.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.251 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.04 -150.9 13.66 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.564 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.418 0.151 . . . . 0.0 110.63 179.945 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 44.6 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.086 0.47 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.552 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.4 ttm -150.71 152.32 33.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.543 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 42.7 m95 -100.06 90.7 4.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.693 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.6 t -136.92 -178.49 5.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.325 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HD2' HG21 ' A' ' 54' ' ' VAL . 14.8 mtp85 -83.46 160.1 21.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.972 0.415 . . . . 0.0 111.618 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 89' ' ' GLU . 59.0 t -70.68 141.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.918 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.7 2.99 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.079 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -124.7 -3.11 7.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.597 0.237 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HG21 ' A' ' 37' ' ' THR . 2.1 p -34.81 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.282 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.409 -179.677 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.0 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.846 0.355 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.3 p -46.34 171.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.233 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.41 -85.23 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.3 pt-20 -129.37 -34.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.389 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.574 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -68.89 -76.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.241 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -105.0 118.47 36.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.81 66.31 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.153 0.502 . . . . 0.0 109.753 177.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG22 HG13 ' A' ' 78' ' ' VAL . 18.2 t -76.91 83.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.563 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 25.4 t -77.29 80.69 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.21 139.51 30.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.553 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -133.15 105.46 7.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.961 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.33 115.28 22.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.792 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 m -117.08 119.98 34.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.713 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 C-N-CA 123.23 2.62 . . . . 0.0 112.03 -179.912 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -138.48 98.65 3.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.405 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 77' ' ' LEU . 90.9 t -87.59 106.12 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.26 110.88 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 21' ' ' THR . 2.4 mm? -95.71 105.59 17.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.855 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -99.37 105.53 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.048 0.452 . . . . 0.0 111.212 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.8 mtmm -110.75 103.23 54.18 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.156 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 10.6 Cg_endo -55.1 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 15.0 mtt180 -81.15 -56.01 4.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.608 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -98.69 161.06 13.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.42 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -94.54 141.34 28.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.577 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.74 -116.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.579 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -129.57 99.98 5.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -108.04 164.78 11.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -157.74 149.91 22.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 78' ' ' VAL . 14.9 tp -123.11 87.35 2.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.252 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -86.98 93.96 9.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.057 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 77.1 mt -91.41 99.22 12.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.028 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -92.94 150.82 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.121 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.3 t80 -90.28 76.96 6.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.0 t -98.48 172.46 7.51 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 69.1 mtp180 -104.42 95.61 8.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.458 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HA ' HG22 ' A' ' 42' ' ' VAL . 66.5 Cg_exo -44.04 -27.58 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 112.651 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -37.19 20.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.391 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 13.9 mm-40 -103.65 -91.64 0.36 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 0.0 111.719 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.42 -178.76 39.84 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.281 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 93' ' ' THR . 11.7 mt -85.24 -77.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER 71.54 156.3 0.16 Allowed Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.966 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 37.8 Cg_endo -66.3 -35.01 33.51 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.795 2.33 . . . . 0.0 112.8 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' HD22 ' A' ' 103' ' ' ASN . 7.9 pt-20 -54.17 -17.94 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.524 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.55 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -86.67 140.16 30.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 111.467 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -64.91 -176.21 0.25 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.55 179.059 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -165.23 -164.47 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.552 0.692 . . . . 0.0 111.875 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 45.0 t80 -165.27 69.28 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.015 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -70.4 88.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.612 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.7 tp -83.59 92.03 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.653 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.9 m-70 -77.79 145.06 36.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 90.4 mt -144.36 92.77 2.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.269 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.538 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 23.7 t-20 -64.68 85.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 17' ' ' HIS . 4.7 t -62.76 115.01 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.664 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.936 179.702 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.64 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.492 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -33.24 104.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.921 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.98 96.75 10.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.124 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -79.68 100.76 8.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 HD23 ' A' ' 110' ' ' LEU . 27.4 m -146.7 -171.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.0 0.428 . . . . 0.0 112.113 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -107.02 -177.13 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.768 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.56 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.4 t -175.25 -175.81 0.87 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.218 0.533 . . . . 0.0 112.185 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.598 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 7.4 m80 -117.93 -165.35 1.09 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.954 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.44 132.77 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.19 0.519 . . . . 0.0 112.067 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.18 19.63 8.16 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.51 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.2 tptt -63.06 85.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 6.3 m -49.76 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.471 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 78' ' ' VAL . 50.2 m -94.73 99.81 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.489 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HA ' HD23 ' A' ' 77' ' ' LEU . 30.7 tt0 -76.2 132.84 40.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.838 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' CD2' ' A' ' 108' ' ' LEU . 31.1 mt -132.97 99.62 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.105 -179.325 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -84.03 98.25 9.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 38.0 mt -93.37 148.29 22.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.581 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -101.91 162.26 13.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.97 -143.87 7.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.417 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.458 0.17 . . . . 0.0 110.82 179.821 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 54.0 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.3 ttm -152.1 152.46 32.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.019 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 7.8 m95 -107.07 85.27 2.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.742 178.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.2 t -130.35 -163.61 1.33 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.7 mtp85 -91.25 139.58 30.61 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 111.269 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 26.5 t -53.99 133.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.056 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 -39.05 1.85 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.603 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 47' ' ' LEU . 55.2 m-85 -82.15 3.25 27.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.141 0.496 . . . . 0.0 110.62 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -53.29 110.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.223 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 -179.734 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 12.0 mt . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.843 0.354 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.9 t -59.24 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.5 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -147.99 -83.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.07 -28.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.602 -179.123 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.3 mm -76.11 -86.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.69 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.19 106.0 18.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.45 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 1.1 tm-20 -58.08 146.46 33.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 38' ' ' ARG . 46.3 t -145.6 90.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.2 t -77.04 85.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.162 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.21 129.67 37.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.808 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.709 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 50.9 mtpt -130.71 68.48 1.47 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.433 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -65.22 103.86 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.353 178.99 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 m -105.61 114.31 63.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.45 -1.083 0 C-N-CA 123.287 2.658 . . . . 0.0 111.912 179.667 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.3 pt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.6 OUTLIER -134.12 98.43 4.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 87.7 t -85.81 100.0 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.797 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 88' ' ' LEU . 26.5 t -103.54 116.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.039 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 91.3 mt -103.11 108.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.86 108.89 23.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.003 0.43 . . . . 0.0 111.519 -178.924 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 46.7 mtmt -114.11 95.95 40.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.469 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.41 106.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.253 1.969 . . . . 0.0 112.219 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 73.2 mtt180 -69.81 -30.22 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -123.53 -176.98 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -117.4 144.73 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.457 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.91 -129.26 4.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.388 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.453 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.7 m80 -105.92 91.73 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.921 0.391 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.4 OUTLIER -107.75 164.21 12.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.388 179.776 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.524 ' CG2' HG22 ' A' ' 107' ' ' THR . 71.0 m -160.26 157.25 27.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 111.784 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 78' ' ' VAL . 51.7 tp -118.96 87.66 2.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.284 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.686 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.3 mt-10 -69.46 95.89 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.804 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 51.9 mt -108.51 127.28 53.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.188 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.0 p -133.18 157.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.739 -178.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.4 t80 -99.13 88.82 4.05 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.239 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 42' ' ' VAL . 5.9 t -121.41 169.37 10.69 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -101.49 95.94 5.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.951 178.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 93' ' ' THR . 96.0 Cg_exo -44.26 -30.69 3.74 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.662 2.241 . . . . 0.0 112.607 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.65 -40.61 63.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -97.05 -76.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.98 173.11 31.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.195 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.6 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.7 mt -86.03 151.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.847 0.356 . . . . 0.0 111.256 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 40.6 mtmt -145.09 166.22 18.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.42 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 27.1 Cg_exo -62.74 -46.47 11.11 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.029 2.486 . . . . 0.0 112.009 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.16 -29.77 65.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.053 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.5 m-20 -53.78 146.07 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.73 164.32 4.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.4 tpp180 -131.61 163.0 29.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.297 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.651 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.1 t80 -174.26 71.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.177 177.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.01 90.96 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.383 -178.966 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.1 tp -72.18 93.71 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 24.5 m-70 -78.97 145.29 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.569 HD23 HG23 ' A' ' 14' ' ' VAL . 75.0 mt -145.89 110.04 4.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.474 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 41.1 t30 -82.03 69.29 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.457 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.34 117.93 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.64 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.946 179.725 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.008 0.432 . . . . 0.0 111.466 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.57 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 6.1 p-10 -85.94 98.37 10.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.711 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.573 ' HD3' HD13 ' A' ' 108' ' ' LEU . 51.4 tttp -111.41 76.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.748 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 5.5 m0 -86.91 108.9 18.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.679 -178.026 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.94 -171.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.628 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.4 p-10 -97.84 177.46 5.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.08 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.465 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -173.92 -174.66 0.96 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.012 0.434 . . . . 0.0 111.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 60.7 m80 -122.94 -173.98 2.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.919 179.052 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 83' ' ' ARG . 22.5 t -72.49 134.58 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.166 0.508 . . . . 0.0 112.309 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.19 15.87 12.2 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.944 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.0 tptt -58.13 86.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.279 0.539 . . . . 0.0 109.944 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.78 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -57.43 101.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.519 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -98.5 100.8 12.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.637 ' HA ' HD23 ' A' ' 77' ' ' LEU . 32.3 tt0 -72.42 131.83 43.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.71 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 42.6 mt -128.18 87.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.298 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.499 ' NE2' HG22 ' A' ' 75' ' ' VAL . 8.8 m170 -86.99 106.95 18.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 19.1 mt -101.31 174.12 6.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 111.575 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -119.55 160.94 21.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.767 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.62 -163.59 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.954 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.4 t30 . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 179.887 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 2.1 m-85 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 14.5 ttm -114.79 151.02 34.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 66.6 m95 -105.89 99.57 9.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.034 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.731 HG23 HG22 ' A' ' 42' ' ' VAL . 5.9 t -147.78 -176.58 5.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.658 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.674 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.9 mtp85 -82.88 157.12 23.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.024 0.44 . . . . 0.0 111.404 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 91' ' ' VAL . 19.7 t -57.97 130.85 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.595 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -41.75 1.83 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.146 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 57.9 m-85 -70.21 -4.61 22.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 0.0 111.037 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 93' ' ' THR . 21.9 t -49.71 121.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.276 -179.805 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.7 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.098 0.475 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.52 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 83.2 p -52.99 179.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.702 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.07 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -128.89 -42.5 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.126 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.2 mm -62.55 -76.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.7 mt -103.98 118.57 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.495 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -72.65 65.01 0.66 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.124 0.488 . . . . 0.0 109.77 177.646 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 ' HD2' ' A' ' 38' ' ' ARG . 12.0 t -71.08 84.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.58 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.5 t -80.05 85.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 18.6 t -103.82 123.49 47.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.86 -178.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -116.94 106.81 13.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.683 178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.512 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -74.17 103.62 4.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.482 179.853 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 20.2 m -100.35 112.58 64.55 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 3.8 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 123.279 2.652 . . . . 0.0 111.506 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 121.108 0.48 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.6 m-85 50.25 90.17 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.386 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 73' ' ' ILE . 72.8 t -97.94 107.21 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.777 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 11.9 t -112.99 109.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.821 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.78 HD22 HG22 ' A' ' 21' ' ' THR . 72.3 mt -102.64 99.38 9.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.042 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.3 105.69 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 0.0 111.192 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.8 mtmp? -109.19 94.57 15.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.664 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.9 Cg_endo -49.75 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.686 2.258 . . . . 0.0 112.855 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 11.8 mtt180 -74.56 -35.33 63.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.915 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 51' ' ' ILE . 4.2 mptp? -108.03 150.28 27.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.15 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HG2' HG22 ' A' ' 18' ' ' VAL . 49.7 mtm180 -94.28 129.69 40.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 148.53 -116.91 0.84 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -130.77 120.04 23.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -131.57 -178.7 4.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.683 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 88' ' ' LEU . 53.4 m -158.25 156.28 30.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.705 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.508 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.2 tp -133.04 85.7 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.617 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -84.76 88.25 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.089 0.471 . . . . 0.0 111.105 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 76' ' ' VAL . 88.7 mt -83.47 103.05 12.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -84.21 145.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.075 0.464 . . . . 0.0 111.98 -178.719 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' MET . 13.5 t80 -95.18 76.22 3.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.792 HG21 HG21 ' A' ' 42' ' ' VAL . 8.0 t -117.4 155.92 28.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 71.6 mtp180 -92.33 103.56 8.82 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.71 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.1 Cg_endo -51.51 -37.45 62.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.865 2.377 . . . . 0.0 112.776 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -78.91 12.87 1.95 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.477 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -147.26 3.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.259 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.93 179.18 49.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.831 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -105.37 156.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.047 0.451 . . . . 0.0 111.716 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mtmt -139.05 162.84 50.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.0 Cg_endo -72.18 -37.11 4.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.711 2.274 . . . . 0.0 112.212 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.21 -25.94 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.05 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.487 HD21 ' HE3' ' A' ' 100' ' ' LYS . 13.7 m120 -58.48 136.77 57.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -64.45 -175.13 0.15 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.2 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -163.26 -159.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 179.712 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 80.9 t80 -165.59 72.81 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.524 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 1.2 m -69.78 105.81 2.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.366 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.573 HD13 ' HD3' ' A' ' 12' ' ' LYS . 18.2 tp -106.71 94.49 5.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.727 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.5 m-70 -76.65 153.58 35.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.276 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.4 mt -146.92 99.74 3.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.693 -178.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.8 t30 -74.79 68.56 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.3 t -50.19 122.07 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.436 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' THR . 31.9 mmmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.856 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 3.9 p30 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 107' ' ' THR . 22.9 t70 -136.36 -119.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 22.2 tptm -158.02 171.87 19.46 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.416 0.15 . . . . 0.0 110.662 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.62 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 7.3 m0 -124.39 121.7 35.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.657 0.383 . . . . 0.0 110.749 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.9 m -152.5 -171.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 2.6 p-10 -80.49 175.75 10.38 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.397 0.436 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 110' ' ' LEU . 2.5 t -172.01 -173.66 1.16 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 78.5 m80 -108.37 -177.99 3.48 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.485 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.02 136.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.119 0.485 . . . . 0.0 111.765 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.78 10.75 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.388 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.4 tptm -63.96 82.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.735 HG22 HD22 ' A' ' 77' ' ' LEU . 9.6 m -39.49 99.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.678 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.5 m -92.75 96.88 10.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.7 tt0 -80.62 132.17 35.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.38 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD11 HD21 ' A' ' 108' ' ' LEU . 38.9 mt -134.21 104.55 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -86.97 98.73 11.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 12.9 mt -91.69 145.7 24.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.378 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -95.32 161.78 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.93 -139.35 5.28 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.516 0.198 . . . . 0.0 110.54 179.847 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.051 0.453 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 1.5 ttt -149.35 147.93 28.9 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.118 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 2.8 m95 -105.07 86.58 2.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.74 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.418 ' HB ' ' HE2' ' A' ' 35' ' ' MET . 14.6 t -130.46 -171.97 2.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.613 HH11 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -71.58 144.92 49.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.761 0.315 . . . . 0.0 110.807 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 91' ' ' VAL . 77.4 t -60.73 137.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.956 0.407 . . . . 0.0 111.413 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.31 -1.72 8.51 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.058 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.31 40.14 2.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 110.766 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.6 p -82.18 128.27 38.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.099 179.643 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 29.8 mt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.352 0.596 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 78.9 p -51.98 176.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.089 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -153.75 -90.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -131.26 -31.93 1.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.4 mm -71.22 -73.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.389 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 78' ' ' VAL . 28.1 mt -111.58 123.46 50.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.7 73.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.917 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -77.79 92.85 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.5 t -96.96 86.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.382 177.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.7 t -107.08 142.19 37.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -119.37 115.67 24.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.403 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.554 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.78 100.6 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 116.16 65.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.084 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 C-N-CA 123.277 2.651 . . . . 0.0 113.2 -179.141 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.3 pt . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.191 0.52 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.57 106.26 6.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.852 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.77 117.96 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.212 0.53 . . . . 0.0 110.548 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 78' ' ' VAL . 23.5 t -113.39 126.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.874 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.735 HD22 HG22 ' A' ' 21' ' ' THR . 63.1 mt -111.4 90.93 3.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.048 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -93.07 108.86 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.178 0.513 . . . . 0.0 111.645 -178.226 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.2 mtmt -107.25 95.81 14.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 79' ' ' LYS . 2.1 Cg_endo -47.03 108.23 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.591 2.194 . . . . 0.0 112.592 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 21.9 mtt180 -76.14 -33.93 59.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -116.27 171.43 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.033 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 68.5 mtp180 -110.1 146.56 35.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.845 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.58 -170.42 21.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.5 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -70.98 104.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 110.576 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 96.8 m-70 -130.09 142.48 50.6 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.782 0.801 . . . . 0.0 111.676 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 96.2 m -138.24 127.32 24.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.613 HD21 HH11 ' A' ' 38' ' ' ARG . 15.6 tp -93.81 99.72 12.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.113 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 39' ' ' VAL . 35.1 mt-10 -76.69 124.6 27.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.436 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.502 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.0 mt -115.56 165.83 12.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.6 p -156.14 154.38 6.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.2 t80 -103.34 86.88 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.635 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.655 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.8 t -115.83 167.0 11.34 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -103.07 94.36 5.41 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 93' ' ' THR . 90.3 Cg_exo -46.8 -29.91 8.66 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.572 2.181 . . . . 0.0 112.565 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -73.19 -37.04 66.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -106.61 -74.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 111.327 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.91 -174.68 44.73 Favored Glycine 0 CA--C 1.508 -0.345 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.296 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.655 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -96.91 145.56 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.871 0.367 . . . . 0.0 111.153 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 3.6 mttt -130.76 166.74 25.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.14 -44.78 4.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.893 2.395 . . . . 0.0 112.34 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.06 -14.92 27.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.472 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.8 m-20 -58.58 139.96 55.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 174.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.141 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -155.0 158.62 39.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.554 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 24.3 t80 -152.96 108.53 3.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.49 178.031 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.62 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.8 OUTLIER -98.15 130.88 44.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.621 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 24' ' ' ILE . 14.0 mt -89.92 126.43 35.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.337 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.689 ' HB2' HG22 ' A' ' 14' ' ' VAL . 1.7 p80 -72.0 57.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.609 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.42 ' HB3' HG21 ' A' ' 16' ' ' THR . 52.6 mt -103.98 80.31 1.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.108 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.654 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 17.8 t30 -94.35 59.11 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.1 t -33.41 130.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.695 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 14.6 mmmm . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.995 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.778 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.204 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -53.24 99.97 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.841 -178.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -89.61 91.63 8.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.472 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -73.75 99.81 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.512 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.511 HG23 HD23 ' A' ' 110' ' ' LEU . 29.3 m -149.69 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.987 -178.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.2 p-10 -111.88 -175.14 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.508 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.2 t -174.47 -177.22 1.18 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.104 0.478 . . . . 0.0 112.075 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 72.9 m80 -111.96 -159.64 0.69 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.841 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 41.9 t -97.6 128.01 49.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 0.0 111.929 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 71.73 7.51 65.59 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.674 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -56.75 85.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.293 0.547 . . . . 0.0 109.734 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.81 HG22 HD22 ' A' ' 77' ' ' LEU . 3.5 m -58.19 93.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.293 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 78' ' ' VAL . 99.5 m -85.83 99.71 11.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.546 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.3 tt0 -82.72 129.62 34.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 46.0 mt -134.61 107.35 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.926 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -88.76 96.84 10.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.28 178.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.0 mt -91.43 148.22 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.418 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -102.56 161.07 14.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.86 -145.81 7.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.487 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.51 0.195 . . . . 0.0 110.984 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 121.166 0.507 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 5.5 ttm -155.85 152.12 27.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 8.0 m95 -106.92 85.38 2.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.552 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.3 t -129.9 -165.47 1.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.377 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.2 mtp85 -89.2 151.51 22.12 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.861 0.362 . . . . 0.0 110.977 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.8 t -72.14 133.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.497 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.56 3.51 90.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 60.0 m-85 -129.3 -0.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 110.462 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 17.3 t -55.27 109.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.141 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.172 -179.751 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.216 0.531 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.419 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 33.4 t -50.39 175.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.565 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -155.75 -86.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.81 -34.04 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.0 mm -70.33 -76.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.364 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -101.19 112.23 24.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.501 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 3.0 tt0 -66.01 78.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 109.832 178.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG22 HG13 ' A' ' 78' ' ' VAL . 8.5 t -86.51 90.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.325 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.9 t -86.31 86.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.0 t -101.43 124.97 47.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.652 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -115.79 109.45 17.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.553 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -79.77 121.02 24.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.309 -179.784 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 118.96 31.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 123.164 2.576 . . . . 0.0 112.856 -179.312 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.8 pt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.06 0.457 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -136.01 105.81 6.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.979 179.989 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -90.27 104.57 15.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.01 120.16 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.927 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -111.2 99.9 8.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.892 178.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.74 102.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.053 0.454 . . . . 0.0 110.994 -179.085 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 38.2 mtmt -104.18 104.0 41.54 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.2 Cg_exo -51.43 98.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.406 2.071 . . . . 0.0 112.446 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 7.4 mtt180 -69.82 -41.72 74.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -115.54 165.43 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.092 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -100.87 119.22 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.635 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.38 -150.45 21.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.363 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.474 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 55.4 t-80 -86.84 101.74 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.11 0.481 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.497 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 2.0 m-70 -117.12 165.82 12.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 57.6 m -159.84 148.64 17.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 111.945 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 78' ' ' VAL . 11.6 tp -114.52 93.33 4.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.245 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.0 mt-10 -77.12 98.23 4.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.045 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 51.1 mt -107.69 130.33 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.4 p -135.68 156.05 37.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.965 -178.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.3 t80 -99.88 86.73 3.34 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.104 178.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.5 t -120.35 169.34 10.38 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.11 94.85 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.4 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.6 Cg_exo -42.22 -35.61 3.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.839 2.36 . . . . 0.0 112.755 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -68.52 -44.04 75.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.564 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.77 -79.31 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.81 177.18 40.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.105 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.741 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -92.11 151.31 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.934 0.397 . . . . 0.0 111.292 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.596 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 10.0 mttm -141.43 163.15 43.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.125 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 38.8 Cg_endo -67.6 -40.18 10.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.264 . . . . 0.0 112.133 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.05 -28.09 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.553 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.5 m-20 -55.36 148.75 14.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.92 160.7 3.36 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpt180 -130.18 162.9 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.219 -179.025 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.581 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -176.53 69.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.453 0.644 . . . . 0.0 109.677 177.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 12.4 m -91.52 91.33 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.517 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 41.0 tp -71.45 94.36 1.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.524 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -78.22 143.31 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.661 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 14' ' ' VAL . 85.2 mt -145.85 104.64 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.807 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 45.6 t30 -78.42 68.91 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.635 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.5 t -48.75 127.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.65 -178.207 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.976 179.988 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.905 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 111.541 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' THR . 1.2 m-20 -47.65 104.52 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.284 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -97.24 92.72 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.141 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.676 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.09 104.02 12.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 12' ' ' LYS . 4.5 m -150.95 -173.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 112.136 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -101.41 176.7 5.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.819 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.522 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -175.49 -177.1 0.96 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.572 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.9 m-70 -120.82 -166.16 1.3 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.968 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -87.19 136.59 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 112.111 -179.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.59 12.16 32.32 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.628 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tptt -59.79 83.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.182 0.491 . . . . 0.0 109.782 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -54.93 98.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.424 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 100.0 m -96.2 101.18 12.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.6 tt0 -82.44 132.7 35.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.799 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.454 HD11 HD22 ' A' ' 108' ' ' LEU . 45.6 mt -134.97 101.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.961 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -83.67 98.91 9.9 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 14.5 mt -92.61 148.73 21.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -102.9 159.93 15.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.844 0.354 . . . . 0.0 110.399 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 -161.64 34.18 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.715 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.454 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 25.0 ttm -108.53 151.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.306 179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 5.7 m95 -109.88 85.03 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.653 178.391 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -132.65 -166.95 1.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -93.04 122.52 35.5 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.5 p -53.16 138.78 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.178 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.47 -4.59 77.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.743 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.441 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 48.8 m-85 -130.78 3.14 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.286 0.565 . . . . 0.0 110.037 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 93' ' ' THR . 18.2 t -52.12 119.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.095 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.004 -179.447 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.8 mt . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.874 0.369 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 40.8 t -49.28 179.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.142 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -152.55 -88.84 0.06 Allowed 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.59 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -136.11 -31.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.397 -179.038 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.1 mm -73.21 -72.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.438 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.1 mt -105.13 114.37 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.472 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.13 72.1 0.1 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.795 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 38' ' ' ARG . 10.9 t -76.39 84.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.324 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.7 t -80.2 81.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.3 t -94.81 146.84 23.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.315 -178.46 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -138.82 113.18 8.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.36 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.85 104.86 15.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.274 179.373 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.8 m -101.83 109.63 60.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.618 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.079 0 C-N-CA 123.533 2.822 . . . . 0.0 111.652 179.316 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -135.78 95.38 3.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.941 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.6 p -87.97 111.81 22.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.536 0.684 . . . . 0.0 110.602 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 90' ' ' LEU . 38.7 t -108.88 122.91 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.53 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 81.3 mt -108.46 99.23 8.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.808 178.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.49 106.2 17.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.999 0.428 . . . . 0.0 111.145 -178.915 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -108.1 102.15 44.79 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.344 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.649 ' HA ' HD23 ' A' ' 52' ' ' LEU . 70.0 Cg_exo -49.93 98.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.747 2.298 . . . . 0.0 112.81 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -67.57 -37.25 82.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -120.99 -178.81 3.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HE ' HG21 ' A' ' 18' ' ' VAL . 95.7 mtt180 -115.17 124.86 52.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.523 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.78 -142.8 9.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.576 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.495 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 61.9 m80 -87.34 91.65 8.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.495 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.6 OUTLIER -111.65 154.5 24.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.412 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.553 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 62.9 m -158.55 146.23 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.932 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.6 tp -96.72 92.24 6.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.072 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.708 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.2 mt-10 -72.77 94.19 1.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.166 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 40.0 mt -111.53 127.41 55.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.8 p -128.95 158.57 41.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.511 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -99.17 83.33 2.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.429 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 42' ' ' VAL . 10.0 t -117.5 150.83 38.28 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 41.5 mtp180 -91.49 104.49 10.16 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 178.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.9 Cg_exo -39.79 -31.99 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.055 2.503 . . . . 0.0 113.168 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.441 ' HD2' ' HG3' ' A' ' 97' ' ' GLU . 6.7 t80 -77.02 -60.08 2.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG3' ' HD2' ' A' ' 96' ' ' PHE . 36.9 mt-10 -67.91 -64.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.894 0.378 . . . . 0.0 111.301 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.3 -179.78 20.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.813 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.5 mt -93.86 148.07 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.918 0.389 . . . . 0.0 111.472 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 26.2 mtmm -147.82 162.64 30.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.115 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.8 Cg_endo -67.75 -37.1 16.91 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.797 2.331 . . . . 0.0 112.012 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.06 -29.34 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.2 m120 -58.21 154.36 13.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 164.41 4.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.245 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.657 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.7 tpp180 -132.24 165.95 22.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.0 t80 -174.57 74.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.297 177.15 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.93 94.29 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.418 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.3 tp -72.86 93.17 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.016 0.436 . . . . 0.0 110.656 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 40.8 m-70 -75.19 146.02 41.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.668 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.4 mt -145.69 120.21 9.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.568 -178.004 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.7 t30 -86.31 63.07 7.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.523 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -44.74 122.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.729 -178.428 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.093 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.662 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.054 0.455 . . . . 0.0 111.267 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -32.44 108.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.705 179.906 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -87.17 93.7 9.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.622 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.5 m95 -75.74 98.52 4.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 110' ' ' LEU . 28.4 m -149.42 -172.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 112.245 -178.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -112.37 179.0 4.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.455 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.501 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.88 -172.77 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 112.046 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.8 m-70 -117.62 -171.15 2.0 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 10.1 p -83.44 142.51 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.869 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.79 18.67 8.64 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.669 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptm -65.49 80.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 4.6 m -50.5 97.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.422 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.3 m -94.67 104.63 16.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.827 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.2 tt0 -86.91 129.72 34.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.803 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mt -132.48 104.63 7.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.64 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -85.03 96.36 9.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.0 mt -89.27 145.91 25.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.398 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -97.66 161.99 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.847 0.356 . . . . 0.0 110.399 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.16 -137.13 4.11 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.499 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.1 t30 . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.889 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -151.71 151.79 31.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.931 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -108.39 87.08 2.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.347 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 42' ' ' VAL . 15.3 t -130.39 -170.98 2.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.832 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.687 HH21 HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -76.27 137.89 40.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 91' ' ' VAL . 49.0 t -57.1 136.32 20.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.387 -179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.11 -13.81 1.8 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.776 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 39' ' ' VAL . 14.6 m-30 -105.62 22.08 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.341 0.591 . . . . 0.0 110.49 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -76.16 107.13 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.148 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.286 -179.854 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HH21 ' A' ' 38' ' ' ARG . 22.6 mt . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -50.42 173.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.979 178.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -150.46 -95.73 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.618 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.09 -33.11 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.9 mm -73.38 -72.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.19 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.688 ' HB3' HG12 ' A' ' 78' ' ' VAL . 77.2 mt -107.6 117.86 35.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.322 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -70.36 73.03 0.49 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.712 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.651 HG11 ' NH1' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -76.38 91.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.609 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 22.4 t -93.34 87.97 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.328 177.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 76' ' ' VAL . 8.1 t -110.0 144.83 37.98 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.935 -178.46 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -122.9 115.89 22.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.647 178.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.466 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -85.14 105.85 16.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.449 179.466 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 4.3 m -103.0 126.28 32.88 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.45 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 2.6 Cg_endo . . . . . 0 N--CA 1.457 -0.655 0 C-N-CA 123.01 2.473 . . . . 0.0 113.178 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 121.195 0.521 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -136.2 98.68 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.81 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.5 p -90.21 111.34 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.298 0.571 . . . . 0.0 110.625 -179.266 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 56' ' ' CYS . 46.2 t -107.18 124.55 63.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.923 -178.554 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 71.5 mt -111.63 92.95 4.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 177.796 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -91.73 110.72 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.223 -178.775 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.7 mtmp? -107.84 101.96 43.08 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.226 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 71.4 Cg_exo -48.22 99.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.707 2.271 . . . . 0.0 113.066 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.1 mtt180 -69.34 -31.44 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 91.8 mttt -121.25 170.69 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.767 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -115.66 128.45 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 135.65 -152.92 21.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.183 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -65.9 106.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.498 . . . . 0.0 110.639 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 29.7 m-70 -138.04 160.59 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.619 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.506 ' CG2' HG22 ' A' ' 107' ' ' THR . 87.0 m -160.17 148.27 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 111.774 -179.525 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -110.03 101.55 10.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.878 179.194 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 107' ' ' THR . 40.1 mt-10 -79.35 115.75 19.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.444 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.678 HD21 ' NH1' ' A' ' 38' ' ' ARG . 29.4 mt -121.84 151.49 40.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.2 p -154.26 153.6 8.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.094 0.473 . . . . 0.0 111.899 -178.712 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.2 t80 -100.7 91.97 4.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.996 178.459 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 42' ' ' VAL . 8.5 t -126.69 166.1 18.0 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -177.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.7 mtp180 -98.63 97.52 4.92 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.643 178.412 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.5 Cg_exo -46.14 -40.74 21.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.8 2.333 . . . . 0.0 113.415 -179.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.47 17.34 3.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.1 mm-40 -150.57 0.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.29 -178.96 50.69 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.264 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.745 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.8 mt -108.7 151.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.075 0.464 . . . . 0.0 112.031 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -128.39 166.78 22.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.767 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.65 -40.91 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.858 2.372 . . . . 0.0 112.146 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.16 -24.77 67.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.199 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 8.7 m-20 -49.38 148.75 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -61.77 166.11 4.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.433 -179.889 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.702 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.3 tpp180 -134.78 163.73 29.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.386 -178.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.702 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 30.8 t80 -172.31 80.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.223 177.119 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.46 93.68 6.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.654 -178.882 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 47.7 tp -66.77 83.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 25.9 m-70 -69.89 136.16 50.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.6 mt -143.41 109.82 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.474 -178.058 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 60.7 t30 -85.24 54.05 2.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.613 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -35.74 135.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.863 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.9 mmpt? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.894 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 14.8 m-20 -48.49 97.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.126 -178.456 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HD3' HD13 ' A' ' 108' ' ' LEU . 52.9 tttp -100.84 92.04 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.679 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -80.69 104.69 11.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.59 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.8 p -151.29 -179.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.988 0.423 . . . . 0.0 111.694 -179.03 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.776 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -99.45 -179.14 4.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.489 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.54 -173.45 0.75 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.152 0.501 . . . . 0.0 112.111 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 19.4 m80 -115.4 -170.31 1.74 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.09 132.39 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 112.054 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.11 11.97 34.9 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.39 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -64.81 82.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.733 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.16 99.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.568 -178.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' HG23 ' A' ' 78' ' ' VAL . 54.9 m -93.82 96.22 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.8 tt0 -73.99 132.34 42.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.718 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.4 102.0 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.249 -179.211 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -85.64 99.64 11.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 35.5 mt -94.29 147.6 23.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.752 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -99.81 164.75 11.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.73 -134.21 3.14 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.536 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.3 t30 . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 179.925 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.085 0.469 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.4 ttm -147.82 154.09 40.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.816 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.445 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 4.6 m95 -110.42 88.15 2.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.922 178.524 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.4 t -133.54 -163.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.8 mtp85 -90.18 158.38 17.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.812 0.339 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.9 t -77.23 132.03 33.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.656 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.47 9.3 86.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 63.1 m-85 -134.02 -1.75 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.206 0.527 . . . . 0.0 110.538 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -51.71 116.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.115 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.235 -179.743 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 22.8 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 54' ' ' VAL . 55.6 p -62.1 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.572 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -151.73 -82.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.96 -30.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.371 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.1 mm -74.25 -85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.491 -179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.99 108.76 21.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.43 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 10.5 tt0 -61.62 140.89 58.09 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.521 HG21 ' HD2' ' A' ' 38' ' ' ARG . 59.2 t -141.06 89.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.87 0.367 . . . . 0.0 111.753 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.9 t -73.7 94.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -72.16 115.07 10.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.125 -178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 99.4 mttt -121.37 43.92 2.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -66.13 106.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.543 178.726 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -101.37 117.39 62.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.327 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.452 -0.918 0 C-N-CA 123.17 2.58 . . . . 0.0 112.402 -179.499 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 11.8 pt . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -124.97 103.41 8.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.961 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 84.9 t -92.98 100.17 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.063 0.459 . . . . 0.0 110.547 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.76 118.9 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.135 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.733 HD22 HG22 ' A' ' 21' ' ' THR . 81.5 mt -103.82 105.59 15.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.754 178.511 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.72 100.99 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.032 0.444 . . . . 0.0 110.992 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -105.53 102.57 38.53 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.449 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 37.3 Cg_exo -55.96 98.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.241 1.961 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.69 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 70.3 mtt180 -62.26 -34.63 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -124.29 179.69 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -118.28 144.11 46.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.591 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.34 -111.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.556 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -116.25 96.66 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 111.031 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.33 163.26 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.512 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 88' ' ' LEU . 30.1 m -160.08 157.93 29.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 111.712 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.0 tp -126.14 89.09 2.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.2 mt-10 -73.85 93.9 2.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.123 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 56.3 mt -103.38 134.27 47.03 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.247 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 104' ' ' GLU . 8.3 p -139.52 154.86 25.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 111.83 -178.759 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.9 t80 -97.85 90.37 4.92 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.919 HG21 HG21 ' A' ' 42' ' ' VAL . 5.8 t -120.02 173.02 7.33 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.472 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -103.22 95.05 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.861 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 93' ' ' THR . 89.1 Cg_exo -46.8 -30.5 9.44 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.626 2.218 . . . . 0.0 112.682 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.67 -37.24 62.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.22 -79.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.35 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.4 178.48 43.4 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.18 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.1 mt -95.45 154.66 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.454 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.7 mttt -140.72 161.65 53.18 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -71.15 -39.01 4.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.93 -28.07 69.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -54.72 152.27 7.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.215 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.4 tt0 -52.89 156.14 2.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.65 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 15.9 tpp180 -127.71 164.94 21.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.528 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.594 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 54.2 t80 -176.64 64.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 109.52 177.613 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 89' ' ' GLU . 11.1 m -87.12 92.9 9.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.866 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.4 tp -74.75 95.63 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.301 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.3 m-70 -79.72 144.02 34.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.773 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 79.6 mt -144.44 106.55 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.352 -178.344 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -82.79 65.65 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.591 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -42.73 136.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.568 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.928 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.932 0.396 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 7.5 p-10 -54.7 100.02 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -115.09 60.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.718 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 4.9 m0 -78.25 119.24 21.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.401 -177.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.9 -174.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.429 0.633 . . . . 0.0 112.317 -178.553 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -94.07 177.16 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.58 179.771 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -176.31 176.36 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.111 0.481 . . . . 0.0 112.265 179.974 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.583 ' O ' HG13 ' A' ' 112' ' ' VAL . 31.6 m-70 -114.52 -153.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.683 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.3 128.8 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 111.797 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 64.37 13.36 54.3 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.33 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.7 tptm -57.27 86.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.79 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -56.86 97.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.033 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -87.92 104.88 17.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.448 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.1 tt0 -89.26 129.24 35.85 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.181 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 HD12 ' A' ' 26' ' ' LEU . 25.0 mt -141.41 109.85 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -85.38 113.22 21.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.272 179.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mp -104.96 162.28 13.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.4 mptt -119.42 158.6 25.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.92 -141.19 3.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 120.426 0.155 . . . . 0.0 111.052 179.989 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.407 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 58.6 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.019 0.437 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 9.5 ttm -146.53 146.38 30.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.174 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -97.36 80.63 2.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 178.882 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.9 t -121.94 -170.5 2.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 -179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.871 ' NH2' HD12 ' A' ' 47' ' ' LEU . 1.9 ttm-85 -81.84 137.58 35.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 91' ' ' VAL . 71.6 t -54.38 140.18 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.841 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.12 4.47 4.67 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.642 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -123.4 25.65 8.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' HG21 ' A' ' 93' ' ' THR . 6.4 p -67.82 130.68 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.994 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.945 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.871 HD12 ' NH2' ' A' ' 38' ' ' ARG . 12.3 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.59 0.233 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 83.1 p -58.82 -171.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 179.112 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.02 -92.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.439 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.629 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -129.89 -33.32 1.8 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.561 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.8 mm -63.94 -64.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB3' HG12 ' A' ' 78' ' ' VAL . 81.7 mt -122.39 124.21 43.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -71.73 68.89 0.64 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.45 178.482 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -78.86 132.45 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.169 0.509 . . . . 0.0 110.992 -179.661 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.1 t -131.78 85.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.18 179.601 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.632 ' H ' HH22 ' A' ' 38' ' ' ARG . 10.4 t -99.19 111.86 24.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.538 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -95.99 112.66 24.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.423 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.36 108.3 14.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.212 179.392 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 26.5 m -120.69 128.42 25.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 3.0 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 123.428 2.752 . . . . 0.0 111.179 178.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.5 pt . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 4.3 m-85 -141.35 103.14 4.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.639 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 63.4 t -86.25 93.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.3 t -88.58 124.59 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.796 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.79 HD22 HG22 ' A' ' 21' ' ' THR . 77.1 mt -120.12 93.34 4.02 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.18 103.97 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.943 0.402 . . . . 0.0 110.915 -179.148 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.7 mtmt -101.93 98.25 9.65 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -46.42 106.7 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.758 2.305 . . . . 0.0 112.721 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.629 HH11 ' HA ' ' A' ' 50' ' ' GLU . 9.1 mtt180 -79.44 -48.62 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 62.3 mttm -102.91 156.52 17.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -95.32 123.5 38.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.21 -153.72 25.14 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.493 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -90.33 104.13 16.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.471 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 15.6 m-70 -122.28 179.2 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 88' ' ' LEU . 94.8 m -160.12 155.26 24.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.086 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 78' ' ' VAL . 1.5 tm? -131.46 93.4 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -104.61 121.37 43.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.98 -179.799 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 76' ' ' VAL . 39.2 mt -99.0 171.84 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.478 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.1 p -160.34 151.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.107 0.48 . . . . 0.0 112.272 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -94.4 85.19 4.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.146 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.635 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.7 t -107.7 172.1 7.02 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.823 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -104.57 94.04 6.71 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.8 Cg_exo -49.6 -30.89 23.08 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.408 2.072 . . . . 0.0 112.382 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -74.6 -35.35 62.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -107.95 -77.89 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.319 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.95 -173.72 46.52 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.127 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.3 mt -96.68 148.72 5.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -133.75 174.03 5.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.41 -38.16 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.405 2.07 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.51 -10.05 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.762 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 8.5 m-20 -64.45 161.84 16.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.1 tp10 -74.01 167.79 20.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.943 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.669 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.7 tpp180 -142.77 158.83 43.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.6 t80 -158.72 81.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.533 177.027 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 2.6 m -76.59 157.76 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.506 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 78' ' ' VAL . 33.7 tp -156.51 82.69 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.256 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.7 m-70 -67.82 156.28 37.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.398 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.1 mt -147.92 106.4 3.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.034 -178.728 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.476 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 65.9 t30 -79.62 61.88 3.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 17' ' ' HIS . 3.3 t -45.16 121.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.603 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.978 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.904 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 111.967 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.6 p-10 -50.83 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.664 -179.315 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -104.89 93.51 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.45 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -84.39 105.88 15.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.593 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG23 HD23 ' A' ' 110' ' ' LEU . 29.5 m -147.44 -174.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.259 0.552 . . . . 0.0 112.285 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.93 179.69 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.467 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -177.39 -175.76 0.57 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.054 0.454 . . . . 0.0 111.891 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 49.1 m-70 -117.81 -167.11 1.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 179.118 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 33.7 t -86.66 135.84 24.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 111.94 -179.299 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 63.33 11.53 40.69 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.476 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.0 tptt -59.79 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.1 0.45 . . . . 0.0 109.812 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -55.61 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.368 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' VAL . 62.6 m -94.48 98.66 11.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.527 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 31.1 tt0 -75.45 133.51 41.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.604 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.428 HD13 ' HE2' ' A' ' 106' ' ' TYR . 37.2 mt -134.02 101.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -87.19 110.22 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.549 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 33.7 mt -108.18 148.48 29.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.352 -179.229 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -99.5 160.66 14.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.986 0.422 . . . . 0.0 110.605 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.95 -128.63 1.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.374 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.537 0.208 . . . . 0.0 111.146 179.953 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.957 0.408 . . . . 0.0 110.872 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -136.87 154.71 50.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.174 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 8.3 m95 -112.47 98.23 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.94 178.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.611 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.6 t -142.56 -165.79 2.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.822 -179.053 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.8 mtp85 -88.54 156.57 19.0 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' CG2' ' A' ' 91' ' ' VAL . 31.8 t -72.83 131.17 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.935 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 13.96 82.02 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.858 179.468 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -134.88 -4.31 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.725 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -49.52 124.39 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.123 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.17 -179.685 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.5 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.181 0.515 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 24.4 p -50.78 177.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.127 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -153.3 -81.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.19 -33.23 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 22.8 mm -69.28 -81.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.676 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 6.7 mt -97.15 117.59 31.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 23.5 tt0 -68.68 84.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.158 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' H ' ' CB ' ' A' ' 48' ' ' SER . 39.0 t -88.95 91.66 3.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.511 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.6 t -79.68 86.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.4 t -68.95 135.22 50.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.006 -178.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.638 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 8.9 mtpm? -138.25 54.09 1.79 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.84 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -52.52 112.37 0.81 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.511 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.449 ' OG1' HG13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.36 104.16 28.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.537 -179.548 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 27.1 Cg_endo . . . . . 0 N--CA 1.451 -0.976 0 C-N-CA 123.765 2.977 . . . . 0.0 113.039 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.9 pt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -136.44 107.32 6.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.279 -179.482 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -94.36 100.99 12.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.945 0.403 . . . . 0.0 110.737 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 88' ' ' LEU . 32.8 t -105.26 118.2 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.028 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 21' ' ' THR . 89.0 mt -104.1 106.92 17.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.44 104.99 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.272 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 39.3 mtmt -108.75 100.45 39.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.46 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.555 ' HA ' HD23 ' A' ' 52' ' ' LEU . 81.8 Cg_exo -46.41 96.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.586 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.611 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 10.4 mtt180 -69.04 -33.81 74.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.173 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -118.95 -178.45 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -119.52 120.83 37.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.795 179.604 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.7 -121.35 1.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.608 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.36 113.89 26.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 111.102 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.579 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 5.6 m80 -136.14 150.72 49.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.42 ' O ' HD12 ' A' ' 52' ' ' LEU . 91.7 m -161.19 152.6 19.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 112.063 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 76' ' ' VAL . 53.8 tp -121.87 71.79 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.073 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 3.1 pt-20 -70.71 105.38 3.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.624 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 17.6 mt -107.18 154.67 20.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.504 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -145.34 160.22 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.695 -179.748 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -103.88 89.16 3.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.562 178.198 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.92 HG21 HG21 ' A' ' 42' ' ' VAL . 9.1 t -120.25 169.12 10.56 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.2 mtp180 -101.49 95.91 5.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.948 178.563 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 5.6 Cg_endo -47.18 -33.46 15.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -68.46 -35.61 77.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.497 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -103.82 -80.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.359 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.65 46.25 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.095 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -97.21 149.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.027 0.441 . . . . 0.0 111.669 -179.08 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.577 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.8 mttt -135.18 162.91 54.76 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.0 Cg_endo -64.74 -35.23 47.03 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.607 2.205 . . . . 0.0 111.743 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.75 -24.45 66.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.1 m-80 -48.67 136.43 13.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 11.0 tt0 -51.86 155.44 1.76 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 4.3 tpp180 -119.96 159.15 25.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.9 t80 -172.47 69.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 16.5 m -91.43 101.97 14.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.465 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.2 tp -87.97 94.48 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.185 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.692 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 15.3 m-70 -77.55 147.87 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.677 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 HG23 ' A' ' 14' ' ' VAL . 94.9 mt -146.19 108.44 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.547 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 39.4 t30 -84.35 69.68 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 17' ' ' HIS . 2.9 t -45.71 143.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.852 -178.337 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.927 0.394 . . . . 0.0 111.867 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.18 96.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.618 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.8 ptmt -101.06 68.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.554 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.747 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -49.85 104.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.137 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.504 HG23 HD23 ' A' ' 110' ' ' LEU . 35.4 m -146.87 -176.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.3 p-10 -103.38 -171.33 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.466 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -174.41 -174.74 0.89 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.3 0.571 . . . . 0.0 112.379 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 28.7 m80 -113.85 -156.58 0.6 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.647 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 42.3 t -105.26 125.56 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.468 . . . . 0.0 111.585 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.9 12.7 43.95 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.061 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptp -63.64 83.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.135 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.741 HG22 HD22 ' A' ' 77' ' ' LEU . 5.3 m -47.87 103.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.829 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.3 m -97.48 100.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.536 179.223 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 75' ' ' VAL . 35.4 tt0 -83.47 131.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.286 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 108' ' ' LEU . 36.1 mt -136.09 100.0 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.522 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.401 ' HB3' HD12 ' A' ' 73' ' ' ILE . 10.8 m170 -84.08 82.05 8.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 178.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 24' ' ' ILE . 75.0 mt -72.24 158.54 35.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.285 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -116.16 164.76 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.103 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.42 -149.57 11.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.724 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.559 0.219 . . . . 0.0 110.849 -179.95 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' THR . 79.8 m-85 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 121.02 0.438 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 42' ' ' VAL . 8.5 ttp -113.58 154.8 26.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.423 179.388 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -105.22 107.03 17.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.867 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -156.65 -166.27 2.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.485 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 mtp85 -84.25 161.94 20.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.184 -179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 89' ' ' GLU . 48.6 t -76.36 138.69 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.813 -179.418 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.13 79.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.605 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.405 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.4 m-85 -135.03 -2.59 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.672 ' HA ' ' HE3' ' A' ' 35' ' ' MET . 2.3 p -40.29 108.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.287 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.991 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.9 mt . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.488 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.6 p -50.93 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.742 179.038 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.96 -88.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -131.02 -32.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.056 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -71.64 -73.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.324 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.8 mt -107.5 118.97 38.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.442 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.64 69.22 0.42 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.406 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG21 ' HD2' ' A' ' 38' ' ' ARG . 11.8 t -76.56 83.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.316 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 14.9 t -83.61 87.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.033 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 76' ' ' VAL . 39.9 t -95.38 150.57 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.489 -178.503 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' HG13 ' A' ' 75' ' ' VAL . 58.5 mttm -139.02 118.13 12.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.456 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 1.5 t80 -96.57 101.64 13.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.128 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.7 m -107.87 90.23 6.21 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.373 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 96.7 Cg_endo . . . . . 0 N--CA 1.459 -0.543 0 C-N-CA 122.987 2.458 . . . . 0.0 111.818 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm . . . . . 0 CA--C 1.513 -0.457 0 CA-C-O 121.954 0.883 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -129.87 67.57 1.46 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.506 178.463 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.2 p -81.04 107.31 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.476 -178.338 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 88' ' ' LEU . 96.6 t -102.02 125.98 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.46 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD22 HG22 ' A' ' 21' ' ' THR . 76.6 mt -109.3 96.9 6.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.77 178.408 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.61 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -93.73 106.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.04 0.448 . . . . 0.0 111.044 -178.904 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -107.87 105.07 55.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.985 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 Cg_exo -53.05 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.49 2.127 . . . . 0.0 112.45 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.622 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.6 mtt180 -69.87 -49.14 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.459 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -107.62 161.05 15.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.394 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -98.15 113.79 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.733 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.628 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.93 -129.25 1.9 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.578 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.44 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.7 m80 -106.62 99.09 8.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.458 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -111.04 162.69 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.673 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' HD12 ' A' ' 52' ' ' LEU . 99.7 m -159.63 148.87 18.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.044 0.449 . . . . 0.0 112.052 -179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 25.7 tp -121.61 79.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.757 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -77.07 100.19 5.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.178 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.9 mt -98.68 140.75 32.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.116 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -140.98 164.49 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.808 -179.452 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -99.11 84.18 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.78 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.66 HG21 ' HB ' ' A' ' 42' ' ' VAL . 7.6 t -95.5 -175.67 3.54 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.831 -177.233 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 55.7 mtp180 -117.91 101.17 52.08 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.297 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 84.4 Cg_exo -39.92 -34.93 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.054 2.503 . . . . 0.0 113.399 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -88.74 -47.23 8.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.414 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -83.92 -86.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.884 0.374 . . . . 0.0 111.803 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 172.82 -174.06 45.68 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.246 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -93.68 154.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 10.6 mttm -145.44 166.46 17.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.506 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.2 Cg_exo -59.62 -44.88 28.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.857 2.371 . . . . 0.0 111.864 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.51 -26.74 67.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.307 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -49.56 135.47 18.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 9.3 tt0 -49.42 152.53 1.28 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.24 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 7.4 tpp180 -117.63 159.2 23.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.167 0.508 . . . . 0.0 111.71 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.493 ' H ' ' HG3' ' A' ' 105' ' ' ARG . 41.5 t80 -175.55 62.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.532 177.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 9.1 m -84.26 98.12 9.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.726 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 78' ' ' VAL . 18.6 tp -80.57 92.41 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.862 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.747 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -79.59 140.94 36.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.341 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.504 HD23 HG23 ' A' ' 14' ' ' VAL . 89.3 mt -144.01 99.83 3.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.58 -178.322 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.533 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 7.9 t30 -73.16 77.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.628 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 6.1 t -51.5 120.55 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.418 -178.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.887 -179.97 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 9.3 t30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -149.56 -140.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' C ' ' HB3' ' A' ' 109' ' ' HIS . 22.1 ptmt -132.63 -173.94 3.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.451 -179.12 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 16.7 m0 -136.63 117.48 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 179.214 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 109' ' ' HIS . 2.6 p -158.35 158.57 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.547 0.689 . . . . 0.0 112.077 -178.688 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 p30 -44.98 165.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.925 -178.454 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 17' ' ' HIS . 3.1 t -173.02 -167.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.391 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.558 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 57.2 m80 -111.99 179.34 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -94.03 147.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.208 0.528 . . . . 0.0 112.195 -178.567 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.19 21.63 5.96 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.849 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.8 tptt -75.18 73.53 2.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 109.658 179.38 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.738 HG22 HD22 ' A' ' 77' ' ' LEU . 11.6 m -40.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.809 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.6 m -104.52 103.84 13.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.581 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' HG23 ' A' ' 75' ' ' VAL . 28.0 tt0 -82.58 121.7 27.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' HD22 ' A' ' 26' ' ' LEU . 56.7 mt -126.99 99.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.539 ' HB3' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.36 109.61 20.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.61 178.639 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 26' ' ' LEU . 2.6 mm? -91.05 167.56 12.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -107.46 167.66 9.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.965 179.146 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.6 -148.82 18.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.579 -179.469 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.331 0.11 . . . . 0.0 110.871 -179.966 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 87.9 m-85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.19 0.519 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.0 ttm -123.8 150.29 44.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -105.66 81.82 1.72 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 178.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -124.01 -160.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.699 -179.292 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 54' ' ' VAL . 1.8 ttp85 -95.24 114.12 25.87 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG11 HH11 ' A' ' 105' ' ' ARG . 0.9 OUTLIER -48.14 134.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 111.514 -179.283 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.16 3.19 76.29 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.917 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.37 0.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.971 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.3 p -49.48 136.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.195 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.696 179.971 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.0 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.101 0.477 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.455 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 22.7 t -48.69 172.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.472 178.683 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.46 -78.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.74 -34.44 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.469 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -69.97 -78.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 -179.306 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 80' ' ' PRO . 60.2 mt -98.54 117.2 32.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.385 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 25.9 tt0 -67.93 84.26 0.22 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.58 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -92.22 94.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.921 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 43.2 t -91.48 82.13 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.037 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 76' ' ' VAL . 22.2 t -99.61 155.21 17.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.622 -178.367 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -143.41 123.86 13.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -89.36 109.34 20.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.398 179.741 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 m -97.72 105.04 24.11 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.574 -179.356 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 44.1 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 C-N-CA 123.849 3.033 . . . . 0.0 112.464 179.938 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 25' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.6 0.714 . . . . 0.0 111.429 . . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.1 m-85 -144.52 79.79 1.62 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.56 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.512 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.8 p -85.05 106.52 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.268 0.556 . . . . 0.0 110.755 -178.994 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG11 HD21 ' A' ' 88' ' ' LEU . 20.4 t -107.83 116.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.583 -178.968 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.738 HD22 HG22 ' A' ' 21' ' ' THR . 29.1 mt -100.46 100.96 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.858 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.702 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 114.19 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.252 0.549 . . . . 0.0 111.17 -178.947 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.7 mtmm -119.44 92.41 45.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.416 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.4 Cg_endo -47.46 112.87 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.487 2.125 . . . . 0.0 112.905 -178.778 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.1 mtt180 -80.51 -39.82 27.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.861 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.28 176.38 5.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -113.62 149.82 34.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.072 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.528 ' N ' HG23 ' A' ' 112' ' ' VAL . . . 124.01 -160.56 18.56 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.726 179.8 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -71.43 98.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -129.91 154.07 47.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 0.0 111.331 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.548 HG21 ' HE1' ' A' ' 13' ' ' TRP . 37.5 m -159.87 138.9 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.702 ' HB2' HG11 ' A' ' 78' ' ' VAL . 32.0 tp -74.53 111.18 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.292 179.531 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 44.5 mt-10 -87.6 96.75 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.732 -179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 36.3 mt -101.14 170.01 8.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.449 178.796 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 13.3 p -166.56 153.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -104.56 84.27 2.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.769 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.637 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.6 t -124.55 149.23 47.2 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.12 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 74.7 mtp180 -85.81 101.65 2.01 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.965 178.495 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 8.6 Cg_endo -52.28 -38.24 72.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.721 2.281 . . . . 0.0 112.685 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.14 10.89 3.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.74 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 20.7 mm-40 -147.88 1.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.41 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.84 -174.75 54.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.114 -179.515 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.637 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.2 mt -106.45 148.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.002 0.429 . . . . 0.0 111.635 -179.326 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 9.9 mttt -131.63 157.93 76.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.565 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.39 -43.98 50.53 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.75 2.3 . . . . 0.0 112.744 -179.966 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.76 -14.09 49.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.074 -179.365 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.595 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -62.02 137.7 58.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 -179.632 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.9 tt0 -60.37 -179.46 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -162.97 162.35 26.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.214 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.593 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 26.3 t80 -151.53 114.94 4.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.042 0.449 . . . . 0.0 110.177 178.151 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.592 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -104.37 132.12 50.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.043 -178.993 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 110' ' ' LEU . 26.5 tp -101.62 110.45 22.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.527 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 14' ' ' VAL . 8.6 p80 -55.32 71.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.868 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 108' ' ' LEU . 21.1 mt -112.72 70.72 0.72 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.839 0.745 . . . . 0.0 112.937 -178.896 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 31.6 t30 -82.31 60.21 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.757 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -40.71 141.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.615 -178.07 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.044 179.719 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.941 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -36.72 103.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.804 -179.581 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.3 tttt -90.67 100.54 13.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.492 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.672 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.4 m95 -82.86 105.44 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.696 -179.521 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.73 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -153.37 176.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.146 0.498 . . . . 0.0 111.838 -179.118 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -94.39 -176.69 4.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.601 179.67 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.493 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t -174.1 -175.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 112.093 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.0 m-70 -116.68 -163.25 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.005 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.06 126.7 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.795 -179.598 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.44 10.55 29.96 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.09 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.1 tptm -63.27 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.969 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.688 HG22 HD22 ' A' ' 77' ' ' LEU . 5.0 m -46.55 98.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.907 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -90.89 94.8 9.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.031 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.9 tt0 -83.77 128.3 34.44 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.282 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.539 HG22 ' HG ' ' A' ' 26' ' ' LEU . 55.5 mt -133.57 103.42 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.048 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -87.89 119.11 27.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.484 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -118.64 151.66 37.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -178.554 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -125.59 157.9 35.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 163.85 -43.22 0.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.436 -1.364 . . . . 0.0 114.195 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 121.067 0.461 . . . . 0.0 110.009 -177.656 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 60.2 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.75 0.309 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 15.9 ttm -161.31 150.55 16.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.062 0.458 . . . . 0.0 111.053 -179.606 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.537 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -106.49 84.72 2.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.042 178.102 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.628 HG21 ' HA ' ' A' ' 42' ' ' VAL . 6.4 t -136.63 -165.85 1.8 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.329 -178.544 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -86.69 155.68 20.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.906 0.384 . . . . 0.0 111.636 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 91' ' ' VAL . 43.6 t -72.82 132.4 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.84 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.43 85.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.625 179.618 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 60.4 m-85 -132.53 -4.61 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG21 ' A' ' 93' ' ' THR . 21.7 t -53.65 111.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.039 179.314 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.954 -179.471 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 18.8 mt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 76.9 p -67.53 -168.6 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -151.19 -86.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.16 -31.33 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.274 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -72.3 -83.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.475 -179.495 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -99.95 107.03 18.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.65 179.767 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 35.5 tt0 -60.43 142.89 54.44 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.276 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG21 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -144.66 85.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.304 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.2 t -86.06 83.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.425 0.631 . . . . 0.0 109.353 178.12 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 76' ' ' VAL . 9.2 t -102.18 133.51 46.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.447 -178.787 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -116.12 120.84 40.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.303 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.473 ' CZ ' ' HE1' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -90.88 95.37 10.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.245 179.512 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -95.61 108.1 37.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.721 -179.122 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 56.5 Cg_endo . . . . . 0 N--CA 1.447 -1.24 0 C-N-CA 123.582 2.854 . . . . 0.0 111.283 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.08 0.466 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 9.7 m-85 -145.04 95.42 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.892 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.97 126.29 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.257 0.551 . . . . 0.0 110.655 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -123.06 122.76 66.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.18 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.688 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -105.33 94.25 5.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.134 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -92.63 101.57 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.099 0.475 . . . . 0.0 110.756 -179.186 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HE3' ' OG1' ' A' ' 21' ' ' THR . 11.2 mttt -102.11 102.62 25.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.454 -179.326 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 41.5 Cg_exo -56.12 95.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.132 1.888 . . . . 0.0 112.157 179.388 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 68.9 mtt180 -67.43 -28.15 67.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -128.89 173.35 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.436 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -113.46 137.91 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.607 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.56 -136.7 6.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.183 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.496 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 62.0 m80 -99.32 91.68 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 110.742 179.853 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.7 m-70 -111.28 164.48 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.592 -179.899 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 88' ' ' LEU . 32.4 m -158.75 157.99 32.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 0.0 111.823 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.8 tp -124.02 88.49 2.92 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 39.4 mt-10 -74.25 101.28 3.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.246 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 75.9 mt -107.38 139.2 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.323 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.519 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -138.93 166.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.149 0.499 . . . . 0.0 112.087 -179.248 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -106.16 84.26 2.02 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.178 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.848 HG21 HG21 ' A' ' 42' ' ' VAL . 7.5 t -126.66 159.86 32.43 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -176.929 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.0 mtp180 -93.23 100.76 4.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.537 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 42' ' ' VAL . 82.7 Cg_exo -34.14 -42.96 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.485 2.79 . . . . 0.0 113.972 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -80.6 -52.94 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.038 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -70.56 4.98 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.83 -169.26 54.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.931 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.83 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -115.03 155.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.267 0.556 . . . . 0.0 112.256 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 49.5 mtmt -147.0 158.75 44.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.349 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 20.3 Cg_endo -60.86 -34.65 90.97 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.735 2.29 . . . . 0.0 112.684 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.18 -11.88 4.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.838 -179.704 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -71.04 140.51 50.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 111.441 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -55.45 161.99 1.74 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.5 tpp180 -122.94 160.61 25.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.614 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 42.2 t80 -173.63 66.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.887 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 8.7 m -87.01 92.02 8.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.333 -178.881 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 69.6 tp -72.26 94.46 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.185 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.5 m-70 -78.56 142.74 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.076 0.465 . . . . 0.0 110.709 179.443 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 93.6 mt -142.69 109.18 5.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -178.038 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 m-20 -81.73 66.95 7.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.376 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.607 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.41 110.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.357 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.934 -179.89 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 107' ' ' THR . 6.4 m-20 -151.82 -146.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.401 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -133.89 -170.23 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 12.5 m0 -130.86 123.95 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.806 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 109' ' ' HIS . 16.4 m -147.88 154.5 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -178.607 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.4 p-10 -51.02 168.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.83 -179.404 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 t -171.36 -168.96 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.803 -179.5 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.1 m80 -104.03 -175.98 2.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.767 0.318 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -96.89 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.142 0.496 . . . . 0.0 111.897 -179.27 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.25 15.5 5.54 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.416 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -66.39 79.2 0.1 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.023 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.754 HG22 HD22 ' A' ' 77' ' ' LEU . 4.4 m -44.06 101.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.751 -178.9 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -96.25 101.84 13.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.621 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.3 tt0 -80.71 130.06 34.87 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.659 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.558 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.2 mt -132.86 105.61 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.873 -179.716 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -89.23 96.04 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.868 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' HG22 ' A' ' 24' ' ' ILE . 14.7 mt -90.29 146.01 24.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.303 -179.046 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -100.57 161.31 13.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.44 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.56 -145.02 8.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.441 -179.246 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.999 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.154 0.502 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.542 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.0 ttt -147.88 154.03 39.88 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.739 -179.091 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.5 m95 -110.19 93.28 4.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.196 178.921 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -137.25 -168.46 2.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.0 mtp85 -87.62 140.34 29.62 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 91' ' ' VAL . 13.2 t -60.96 130.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.778 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.65 75.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -137.66 0.73 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 110.432 -179.797 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 93' ' ' THR . 21.5 t -54.39 111.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.147 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.04 -179.694 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.4 mt . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.112 0.482 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.482 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.0 p -52.66 175.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.691 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.12 -85.43 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.77 -31.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.299 -179.315 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.5 mm -70.2 -72.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.359 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 80' ' ' PRO . 92.0 mt -111.5 121.47 45.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 68.0 0.37 Allowed 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.82 HG22 HG13 ' A' ' 78' ' ' VAL . 5.8 t -75.62 86.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.42 -178.536 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.0 87.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.85 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.45 ' SG ' HG22 ' A' ' 76' ' ' VAL . 30.5 t -105.44 141.24 37.28 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.992 -178.1 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -130.84 115.81 17.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.744 179.033 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.542 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -83.54 113.96 21.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.736 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.6 m -112.72 111.56 51.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 N--CA 1.451 -0.998 0 C-N-CA 123.522 2.815 . . . . 0.0 112.109 179.563 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.1 pt . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -130.94 100.48 5.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.183 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 110.746 -179.467 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 88' ' ' LEU . 22.0 t -119.38 120.39 63.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.549 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -109.58 97.61 7.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.729 178.203 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.82 HG13 HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -93.98 105.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.987 0.422 . . . . 0.0 111.24 -178.721 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -105.78 103.3 43.23 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.035 -179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 73.1 Cg_exo -48.41 99.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.738 2.292 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -76.85 -33.76 57.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.767 178.986 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.76 161.14 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.421 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 96.3 mtt180 -103.64 124.53 49.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.483 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 146.78 -167.95 28.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -63.49 100.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -135.91 161.01 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.24 0.543 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.555 HG21 ' HE1' ' A' ' 13' ' ' TRP . 47.0 m -165.24 146.27 7.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.52 -179.489 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 76' ' ' VAL . 42.2 tp -78.68 105.28 9.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.949 178.844 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.0 97.33 9.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.418 179.861 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 25.5 mt -104.22 169.93 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.716 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.1 p -165.88 150.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.036 -179.017 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.1 t80 -101.28 91.69 4.62 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.37 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.914 HG21 HG21 ' A' ' 42' ' ' VAL . 1.7 t -126.53 164.93 20.11 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.45 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -101.38 91.85 2.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.536 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 93' ' ' THR . 58.7 Cg_exo -39.69 -35.43 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.0 2.467 . . . . 0.0 113.014 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.77 85.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.97 -88.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -163.95 -179.28 38.13 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.053 -179.681 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 93' ' ' THR . 22.2 mt -93.26 -60.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.499 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 34.7 mtmt 69.15 159.59 0.15 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 83.7 Cg_endo -76.71 -34.77 2.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 123.137 2.558 . . . . 0.0 112.388 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.0 pt-20 -56.63 -35.77 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -54.91 151.7 8.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.96 0.41 . . . . 0.0 111.611 -179.786 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.8 tt0 -65.35 178.23 0.97 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.25 164.36 35.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.097 -179.482 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.587 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 23.4 t80 -147.01 113.93 6.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.992 0.425 . . . . 0.0 109.973 178.318 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HE ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -103.72 128.65 51.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.308 -178.604 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 33.2 tp -98.87 108.27 20.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 14' ' ' VAL . 4.5 p80 -50.4 72.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.747 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 108' ' ' LEU . 94.5 mt -110.22 64.37 0.61 Allowed 'General case' 0 C--N 1.342 0.251 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 42.4 t30 -79.58 51.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.483 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -28.36 136.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.462 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -25.26 105.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.658 -179.251 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.4 tttt -101.39 98.36 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.8 m95 -85.52 103.2 14.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.416 -178.64 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.459 HG23 HD23 ' A' ' 110' ' ' LEU . 26.9 m -149.14 -167.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.671 -179.389 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -108.08 -168.99 1.44 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 179.805 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.508 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.5 t 174.24 -173.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.606 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.7 m80 -120.65 -176.27 3.2 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.099 179.126 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.7 137.67 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.25 0.548 . . . . 0.0 111.999 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.09 16.86 34.91 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.598 179.501 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.2 tptm -57.7 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.091 0.445 . . . . 0.0 110.042 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.815 HG22 HD22 ' A' ' 77' ' ' LEU . 2.9 m -57.2 94.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.25 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -95.57 105.92 17.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.002 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.8 tt0 -85.81 124.98 32.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.851 179.497 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 74' ' ' TYR . 51.7 mt -126.46 101.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.014 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.436 ' ND1' HD12 ' A' ' 73' ' ' ILE . 13.9 m170 -86.57 109.95 19.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.862 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 90' ' ' LEU . 18.8 mt -99.14 176.51 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.98 0.419 . . . . 0.0 111.098 -179.173 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -119.98 169.87 9.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.131 179.26 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.34 -159.07 31.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.717 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 t30 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.402 0.144 . . . . 0.0 110.81 179.824 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 3.1 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.989 0.423 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 14.0 ttm -109.47 149.89 28.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.604 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . 4.2 m95 -108.82 83.78 1.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.708 178.29 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.544 HG23 HG22 ' A' ' 42' ' ' VAL . 14.1 t -125.51 -168.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.19 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.633 ' NE ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -83.61 134.5 34.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.906 0.384 . . . . 0.0 111.512 -178.941 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 91' ' ' VAL . 33.6 t -52.57 136.58 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.8 -23.52 1.06 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.51 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' VAL . 11.7 m-30 -100.19 21.08 13.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 110.159 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HG21 ' A' ' 93' ' ' THR . 20.1 t -76.34 106.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.725 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.032 -179.638 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 56' ' ' CYS . 20.6 mt . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 80.6 p -50.55 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.42 178.485 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.09 -96.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.368 179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -127.24 -32.76 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -73.67 -75.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.6 mt -103.28 115.58 30.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.315 179.498 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -69.44 71.45 0.3 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.768 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.633 HG11 ' NE ' ' A' ' 38' ' ' ARG . 2.1 t -74.3 87.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.324 -178.805 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.2 t -88.33 86.62 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.488 178.127 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.625 ' HB3' HD12 ' A' ' 47' ' ' LEU . 29.6 t -110.41 153.82 24.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.743 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -136.9 118.13 14.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.273 179.34 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -80.34 94.77 6.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -99.58 104.48 27.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.356 -179.369 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 69.0 Cg_endo . . . . . 0 N--CA 1.449 -1.128 0 C-N-CA 123.289 2.659 . . . . 0.0 111.847 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.436 HD12 ' ND1' ' A' ' 25' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.514 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 23.9 m-85 47.31 75.94 0.12 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.326 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.9 p -92.04 101.44 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.179 0.514 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 56' ' ' CYS . 17.3 t -99.67 117.29 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.626 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD22 HG22 ' A' ' 21' ' ' THR . 64.4 mt -107.38 94.58 5.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.105 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.56 HG21 HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -90.98 112.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.023 0.439 . . . . 0.0 111.297 -178.809 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.6 mtmt -113.15 94.25 29.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.2 Cg_endo -47.58 103.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.579 2.186 . . . . 0.0 112.669 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.7 mtt180 -67.46 -33.68 75.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.541 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -119.29 -176.06 3.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.53 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -127.8 121.59 30.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 154.54 -106.98 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -105.58 99.74 9.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.6 m80 -128.67 150.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.503 ' HG1' ' CG ' ' A' ' 109' ' ' HIS . 91.4 m -158.17 147.72 19.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.96 0.409 . . . . 0.0 111.935 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.9 tp -98.31 84.82 3.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.568 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 107' ' ' THR . 46.4 mt-10 -69.64 99.11 1.26 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 21.6 mt -110.57 151.77 27.22 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.937 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -154.79 146.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.632 -178.606 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 35' ' ' MET . 12.4 t80 -95.67 78.04 3.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.4 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.868 HG21 HG21 ' A' ' 42' ' ' VAL . 5.4 t -118.45 159.65 23.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 13.6 mtp180 -98.43 98.17 5.55 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.605 178.879 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.3 Cg_exo -40.78 -34.51 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.079 2.519 . . . . 0.0 113.105 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -68.93 -62.95 1.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.003 -179.416 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.73 4.53 9.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.304 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.03 -164.74 37.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.081 -179.562 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.6 mt -113.04 121.02 64.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.976 -179.198 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -107.76 162.74 18.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.36 -37.47 17.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.663 2.242 . . . . 0.0 112.393 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.4 -17.59 8.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.743 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.75 142.29 56.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 111.473 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.42 173.55 1.18 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.599 179.429 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.8 tpp180 -135.89 163.07 31.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.265 -179.211 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.694 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 13.4 t80 -169.76 74.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 177.152 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -95.94 93.3 6.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.729 -178.851 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.3 tp -76.73 88.65 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 110.24 179.291 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.677 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.0 m-70 -72.38 144.06 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 16' ' ' THR . 64.5 mt -146.37 113.31 6.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.123 -178.35 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.3 t30 -83.34 55.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.491 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.473 HG13 HG23 ' A' ' 16' ' ' THR . 1.8 t -35.64 126.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.743 -178.871 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.928 179.952 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.903 HD21 ' N ' ' A' ' 10' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.132 0.491 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.55 103.52 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.698 -179.284 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 90.48 7.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.889 179.198 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.7 m95 -73.67 99.12 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.715 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 15' ' ' ASP . 10.9 p -156.49 169.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -85.75 -173.25 4.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -175.51 -172.06 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.244 0.545 . . . . 0.0 112.375 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.9 m80 -118.11 -160.12 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.709 178.977 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.1 t -101.16 132.64 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 111.764 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.4 17.85 13.31 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.203 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.1 tptt -63.89 84.07 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.151 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.756 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.84 101.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.674 -178.957 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 78' ' ' VAL . 72.5 m -97.51 100.77 12.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.562 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.4 tt0 -79.82 134.0 36.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.582 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.2 mt -138.34 104.38 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.964 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -84.18 96.58 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.958 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.582 ' HG ' HG22 ' A' ' 24' ' ' ILE . 13.6 mt -95.88 148.01 23.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 -178.583 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -113.54 162.12 16.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.149 179.175 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.29 -23.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.545 -179.022 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.463 0.173 . . . . 0.0 111.016 179.926 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 35.7 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.015 0.436 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.564 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.7 ttt -141.32 148.69 40.15 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.081 -179.814 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.454 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -104.56 83.5 2.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.849 178.916 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -127.43 -168.91 1.95 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.23 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.636 HH11 HG21 ' A' ' 54' ' ' VAL . 1.9 mtp180 -85.63 135.85 33.62 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.31 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' HB ' ' A' ' 91' ' ' VAL . 40.9 t -48.63 150.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.068 -179.254 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.81 1.3 4.83 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.595 179.745 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.91 32.48 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.449 0.642 . . . . 0.0 110.614 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.633 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.1 p -60.26 100.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.994 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.678 179.893 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.9 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.902 0.382 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.5 p -46.66 172.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.255 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -154.19 -84.82 0.07 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.416 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -130.65 -33.33 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.399 -179.202 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -70.5 -78.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.437 -179.53 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -103.16 116.01 31.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.452 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.66 69.83 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.673 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' VAL . 20.6 t -76.62 84.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.0 t -79.41 86.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.284 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 76' ' ' VAL . 43.4 t -99.91 142.14 31.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.434 -178.466 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -133.41 108.96 9.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.072 179.402 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.564 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -78.76 100.63 7.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.259 179.564 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 29.2 m -93.57 108.2 32.33 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.831 -179.056 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 77.5 Cg_endo . . . . . 0 N--CA 1.444 -1.416 0 C-N-CA 124.109 3.206 . . . . 0.0 111.434 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.159 0.504 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -134.56 97.16 3.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.226 -179.779 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.54 102.98 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.501 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 88' ' ' LEU . 40.2 t -105.55 124.06 60.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.756 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -113.17 102.95 10.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.669 178.13 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -95.49 110.4 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.438 . . . . 0.0 111.428 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.6 mtmt -115.32 96.04 44.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.0 Cg_endo -50.99 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.38 2.054 . . . . 0.0 112.403 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 13.6 mtt180 -74.22 -38.11 63.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -111.4 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.142 -179.069 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -112.01 144.2 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.68 -119.74 2.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -110.58 117.42 33.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -132.85 159.06 40.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 107' ' ' THR . 59.3 m -159.39 142.41 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 111.411 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.3 tp -99.36 92.14 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.7 mt-10 -72.51 99.35 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.577 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 33.8 mt -113.72 128.87 56.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.316 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 39' ' ' VAL . 10.7 p -134.55 158.25 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.799 -178.713 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -97.15 82.38 3.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.977 178.605 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.633 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -101.77 177.07 5.01 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.47 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 98' ' ' GLY . 61.4 mtp180 -110.25 94.05 17.37 Favored Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.022 179.544 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.456 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 81.3 Cg_exo -50.81 -29.2 25.59 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.52 2.146 . . . . 0.0 112.441 179.431 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -79.89 -31.14 40.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.459 -179.937 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.26 -77.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.932 0.396 . . . . 0.0 111.361 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 174.22 -173.94 46.2 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.007 -179.331 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.3 mt -93.1 149.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.855 0.359 . . . . 0.0 111.026 -179.471 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.425 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -138.95 168.18 16.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.978 -179.264 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.61 -28.06 4.58 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 112.156 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -78.44 11.62 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.675 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.569 HD21 ' HA ' ' A' ' 93' ' ' THR . 8.9 m-20 -93.4 150.11 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.342 -179.419 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 163.88 8.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.634 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.4 tpp180 -130.96 164.11 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.649 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.634 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.9 t80 -174.4 76.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 109.558 177.595 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.75 88.78 5.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.389 -179.18 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 22.1 tp -67.6 90.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 0.0 110.472 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -73.4 133.91 43.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.662 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.2 mt -141.4 102.86 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.273 -178.191 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.3 t30 -78.64 85.76 4.66 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.071 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 17' ' ' HIS . 18.3 t -55.11 112.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.284 -179.062 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.009 179.877 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.732 . . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 10' ' ' ASN . 7.8 m-20 -30.17 104.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.617 -179.672 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -93.11 89.86 6.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.548 179.489 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.663 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.04 101.22 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 HD23 ' A' ' 110' ' ' LEU . 22.8 m -149.29 -175.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.237 0.541 . . . . 0.0 112.167 -178.849 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.53 -173.71 2.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.295 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.568 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -174.45 -175.75 1.0 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.226 0.536 . . . . 0.0 112.187 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.8 m80 -116.82 -162.24 0.84 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.882 179.23 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.53 122.52 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.069 0.462 . . . . 0.0 111.634 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.2 10.69 35.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.14 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptp -62.81 84.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.061 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 HD22 ' A' ' 77' ' ' LEU . 7.7 m -45.39 100.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.807 -178.7 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 78' ' ' VAL . 69.3 m -91.64 102.96 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.28 179.389 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.6 tt0 -86.43 132.18 34.01 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.339 -179.762 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 108' ' ' LEU . 37.3 mt -139.2 104.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.413 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -79.62 95.76 5.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.777 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 28.8 mt -88.75 143.95 26.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.444 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 166.08 11.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.873 0.368 . . . . 0.0 110.627 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.89 -150.99 13.04 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 -179.947 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 93' ' ' THR . 87.9 m-85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.116 0.484 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 7.1 ttm -147.51 148.89 31.68 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.009 -179.615 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.457 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -93.67 81.48 4.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.218 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 35' ' ' MET . 1.7 t -125.4 146.83 49.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.527 -177.766 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD3' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -53.39 177.34 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.981 0.419 . . . . 0.0 110.623 179.428 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 89' ' ' GLU . 42.8 t -81.78 102.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.522 -179.773 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.5 -12.92 56.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.527 179.236 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.766 ' CG ' HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -73.92 -42.01 61.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 117.45 0.625 . . . . 0.0 110.599 -179.741 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.519 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.0 p -26.7 90.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.138 0.494 . . . . 0.0 111.06 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . . . . . . 0 CA--C 1.522 0.518 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -178.478 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.766 HD22 ' CG ' ' A' ' 41' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.277 0.56 . . . . 0.0 110.125 . . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 54' ' ' VAL . 81.1 p -64.19 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.781 -179.734 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.51 -80.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.71 -31.29 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.513 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.565 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.3 mm -74.35 -86.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.622 -179.465 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.724 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -97.86 109.1 21.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.267 179.803 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.601 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 1.3 tm-20 -62.24 147.46 47.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.052 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 48' ' ' SER . 11.5 t -146.36 133.84 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.594 -179.548 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.6 t -137.87 86.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 178.865 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.577 ' SG ' HG22 ' A' ' 76' ' ' VAL . 42.0 t -93.94 97.58 10.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.784 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 81.7 mttt -72.65 73.71 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.35 178.844 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.536 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -64.24 103.71 0.66 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.473 179.8 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -108.37 125.04 32.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.436 178.658 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.452 -0.936 0 C-N-CA 123.031 2.487 . . . . 0.0 113.047 -178.716 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -136.31 100.71 4.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.094 -179.989 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 62.1 t -79.43 89.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 120.811 0.338 . . . . 0.0 110.893 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 HD21 ' A' ' 88' ' ' LEU . 21.5 t -83.41 121.31 36.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 21' ' ' THR . 77.3 mt -117.02 98.29 6.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.081 178.304 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.724 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.12 110.69 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.827 -179.127 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 42.9 mtmt -110.97 102.58 53.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.959 -178.999 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 45.4 Cg_exo -54.77 100.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.353 2.036 . . . . 0.0 112.315 179.343 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.0 mtt180 -69.77 -42.26 74.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -112.24 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -117.62 142.83 46.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.749 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.1 -135.28 7.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.485 179.906 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.457 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.8 m80 -101.33 91.16 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 -179.989 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.8 OUTLIER -107.43 163.98 12.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.202 179.761 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 88' ' ' LEU . 85.6 m -160.89 155.09 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.14 0.495 . . . . 0.0 112.156 -179.574 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 HG11 ' A' ' 76' ' ' VAL . 14.9 tp -125.64 96.26 4.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.832 178.961 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.5 mt-10 -84.36 99.38 10.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.868 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 33.4 mt -95.88 129.26 43.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.364 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.2 p -130.83 157.19 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.064 0.459 . . . . 0.0 112.097 -178.58 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -100.93 95.02 6.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.595 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.859 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -117.2 167.65 11.01 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.73 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -103.2 93.67 4.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.796 178.507 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -48.91 -29.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.867 2.378 . . . . 0.0 112.961 -179.617 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -77.77 10.37 2.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -150.55 -72.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.09 0.472 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.66 175.34 36.78 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.539 -179.518 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.9 mt -94.24 150.79 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.08 0.467 . . . . 0.0 111.604 -179.123 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -137.53 166.88 23.24 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.3 -48.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.344 2.696 . . . . 0.0 112.498 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.37 -18.15 10.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.683 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.8 m120 -62.56 162.86 9.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.784 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 161.26 5.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.642 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpp180 -135.05 164.28 27.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.57 -178.605 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.642 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.4 t80 -174.29 67.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.248 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 89' ' ' GLU . 12.4 m -87.34 97.81 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.559 -178.828 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 78' ' ' VAL . 63.2 tp -76.56 88.06 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 12.7 m-70 -73.81 142.94 46.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 179.424 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.2 mt -143.71 108.6 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.692 -178.056 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.8 t-20 -81.48 72.23 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.6 t -53.09 122.84 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.667 -178.235 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.071 179.757 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.81 100.42 12.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.148 0.499 . . . . 0.0 111.636 -179.178 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -109.67 61.72 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.497 179.132 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 m0 -78.73 112.55 15.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -178.008 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 34.8 m -150.24 -166.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 -178.819 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -96.05 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.696 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.509 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t 177.82 -174.51 0.15 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.143 0.497 . . . . 0.0 112.059 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 67.7 m-70 -118.55 -160.98 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.761 179.212 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.7 121.86 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 111.34 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 64.45 16.98 61.46 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.062 179.84 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -58.09 91.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.725 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -56.73 101.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.482 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.8 m -100.81 99.21 9.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.663 179.642 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.507 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.1 tt0 -78.66 137.12 37.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.789 179.731 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.92 102.57 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -83.49 112.9 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.695 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 37.4 mt -108.62 154.28 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -178.315 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -110.89 155.68 22.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.98 179.333 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.26 -19.3 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.505 -179.229 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.1 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.517 0.199 . . . . 0.0 110.598 -179.918 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 16.5 ttm -123.88 150.89 44.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.3 m95 -109.24 84.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.769 178.545 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.579 HG21 ' HA ' ' A' ' 42' ' ' VAL . 7.0 t -132.38 -164.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 -179.124 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 19.0 mtp85 -92.75 121.69 34.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 0.0 110.474 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.3 p -51.9 140.07 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.67 -6.76 81.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.714 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 52.0 m-85 -128.31 1.16 5.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.285 0.564 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 93' ' ' THR . 15.4 t -56.08 119.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.064 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.913 -179.482 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.0 mt . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.9 p -52.89 -178.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.765 178.828 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -158.39 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.207 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -129.98 -29.02 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 11.6 mm -74.77 -76.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.283 -179.61 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 78' ' ' VAL . 4.3 mt -102.4 115.27 30.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.299 179.154 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.38 69.52 0.24 Allowed 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.091 0.472 . . . . 0.0 109.94 178.062 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG22 ' CG1' ' A' ' 78' ' ' VAL . 18.4 t -74.32 81.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.018 -179.18 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 31.0 t -78.01 81.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.018 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -97.38 136.21 38.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.478 -178.575 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -126.7 113.75 17.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.858 179.189 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.32 107.19 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.732 179.826 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -99.11 109.33 53.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.702 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.453 -0.896 0 C-N-CA 123.336 2.691 . . . . 0.0 112.183 179.846 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.4 pt . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -140.29 110.99 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.058 -179.619 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -103.48 113.8 41.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.55 . . . . 0.0 110.477 -179.672 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.494 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -109.02 125.77 66.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.499 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.725 HD22 HG22 ' A' ' 21' ' ' THR . 86.3 mt -110.05 101.36 10.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.021 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.61 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.0 111.11 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.976 0.417 . . . . 0.0 111.233 -178.786 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.9 mtmt -115.6 96.81 47.28 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.499 -179.435 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.5 Cg_endo -50.31 104.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.476 2.117 . . . . 0.0 112.656 179.752 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.567 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.4 mtt180 -71.24 -42.16 69.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.298 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -107.77 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -114.67 123.41 49.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.6 -101.78 0.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.488 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -143.72 91.58 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.564 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.3 m-70 -100.0 173.71 6.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.8 m -160.53 150.51 17.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.781 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 36.4 tp -113.93 88.75 2.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 43.8 mt-10 -75.51 93.82 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.071 -179.634 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 62.8 mt -104.16 131.05 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.935 178.654 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.93 153.47 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.722 -178.963 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.3 t80 -96.88 89.66 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.585 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.864 HG21 HG21 ' A' ' 42' ' ' VAL . 7.2 t -130.4 151.7 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.479 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.5 mtp180 -86.99 101.59 2.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.713 178.362 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 1.6 Cg_endo -47.44 -36.63 24.14 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.871 2.381 . . . . 0.0 113.117 -179.734 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -87.72 18.9 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 17.3 mm-40 -149.75 1.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.433 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.69 178.66 51.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.122 -179.523 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.5 mt -105.72 154.29 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.472 . . . . 0.0 111.872 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 42.8 mtmt -137.78 163.04 50.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.885 -179.574 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.1 Cg_endo -70.76 -38.41 5.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.782 2.322 . . . . 0.0 112.347 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.77 -24.59 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.8 m-20 -54.73 148.1 13.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.398 -179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.6 tt0 -56.31 163.28 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.3 tpp180 -132.59 163.59 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 65.1 t80 -174.03 74.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.239 177.525 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -95.09 106.81 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 -178.863 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.1 tp -93.02 91.4 7.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.1 m-70 -74.91 151.48 38.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.423 179.704 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 16' ' ' THR . 95.5 mt -148.58 116.97 6.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -178.538 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 49.4 t30 -86.68 68.07 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.908 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -49.26 119.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.469 -178.684 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.999 179.995 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.51 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 4.2 p-10 -37.63 97.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.894 -179.5 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -107.26 93.53 4.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.436 179.78 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.683 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.2 m95 -88.96 105.03 17.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.12 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 HD23 ' A' ' 110' ' ' LEU . 7.3 m -151.41 -175.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.997 -179.621 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -99.95 -176.33 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.417 179.831 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.494 ' HB ' HD22 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -174.82 -178.06 1.22 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 112.177 -179.807 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.8 m80 -114.14 -167.25 1.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 9.6 p -94.06 135.41 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.261 0.553 . . . . 0.0 112.046 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.1 14.82 11.86 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.546 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptp -65.58 81.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.996 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.726 HG22 HD22 ' A' ' 77' ' ' LEU . 5.5 m -47.34 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.76 -178.785 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 78' ' ' VAL . 60.8 m -94.97 98.13 10.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 179.368 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.4 tt0 -78.74 132.85 37.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.988 179.947 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 108' ' ' LEU . 39.5 mt -137.53 104.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.999 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.23 98.75 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.311 178.214 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 23.9 mt -94.31 145.12 24.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.613 -179.058 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.4 mptt -98.73 162.3 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.543 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.41 -141.72 6.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.267 -179.341 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.403 0.144 . . . . 0.0 110.873 179.855 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 121.103 0.477 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 6.0 ttm -146.7 153.17 39.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.166 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 m95 -105.53 94.92 5.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.843 178.52 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.2 t -140.83 -170.33 3.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.627 -178.938 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.608 HH11 HG21 ' A' ' 54' ' ' VAL . 9.9 mtp85 -86.62 157.07 19.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' A' ' 91' ' ' VAL . 52.6 t -72.7 132.05 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.943 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.07 4.99 79.62 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.481 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.437 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 60.1 m-85 -127.17 -2.04 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.132 0.491 . . . . 0.0 110.45 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 93' ' ' THR . 22.4 t -49.07 112.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.262 179.178 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.217 -179.734 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.3 mt . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 20.9 p -54.98 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.95 179.553 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -156.53 -86.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.329 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.601 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -132.12 -31.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.434 -179.132 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.5 mm -73.0 -78.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 7.1 mt -102.68 114.23 28.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.499 179.375 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -68.55 70.63 0.18 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.066 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG21 HH11 ' A' ' 38' ' ' ARG . 14.0 t -75.1 83.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.911 -179.1 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.0 t -78.42 82.67 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.39 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.0 t -94.56 139.51 31.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.277 -178.605 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -132.45 108.1 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.162 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -79.43 112.64 16.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.368 179.636 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 m -113.15 111.14 50.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.975 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 N--CA 1.446 -1.283 0 C-N-CA 123.735 2.956 . . . . 0.0 111.264 178.828 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.126 0.489 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -134.47 99.94 4.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.078 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.35 102.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.866 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 88' ' ' LEU . 40.8 t -104.74 119.85 54.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.202 -179.385 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.726 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -109.69 98.15 7.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.208 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.33 103.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.038 0.447 . . . . 0.0 111.216 -178.706 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 7.1 mtmp? -106.15 104.41 49.63 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.267 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.1 Cg_exo -54.31 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.475 2.117 . . . . 0.0 112.567 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.601 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -64.5 -41.84 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.407 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -113.15 173.08 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 -179.383 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -113.2 106.92 15.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.604 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 171.19 -123.82 1.07 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.47 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.451 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -103.56 98.32 8.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.571 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.15 158.43 22.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.725 179.998 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 109' ' ' HIS . 33.8 m -159.99 151.9 20.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 111.562 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 45.7 tp -117.05 91.18 3.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 39.1 mt-10 -76.4 97.74 4.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.105 179.948 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.6 mt -108.5 133.54 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.918 178.521 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -137.36 167.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.135 0.493 . . . . 0.0 111.681 -179.379 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.9 t80 -106.4 89.09 2.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.728 178.32 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.917 HG21 HG21 ' A' ' 42' ' ' VAL . 5.7 t -118.29 170.08 9.19 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.59 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -102.56 95.1 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.696 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.0 Cg_exo -42.08 -36.87 4.18 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -40.77 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.963 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.8 -78.55 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.86 178.24 39.19 Favored Glycine 0 CA--C 1.508 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -93.22 153.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.935 0.397 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 39.0 mtmt -145.47 163.44 31.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.067 -179.07 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 19.2 Cg_endo -60.92 -37.84 74.08 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.718 2.279 . . . . 0.0 112.034 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.78 -23.86 67.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.614 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -51.7 136.02 27.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.146 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 91' ' ' VAL . 7.6 tt0 -51.93 156.56 1.47 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 8.8 tpp180 -118.93 158.33 25.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.187 0.518 . . . . 0.0 112.057 -178.54 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.556 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 34.3 t80 -171.74 64.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.772 177.319 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 m -91.08 98.96 12.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.994 -179.278 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 35.0 tp -83.39 94.56 7.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.683 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 26.8 m-70 -79.24 141.41 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.494 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.5 mt -145.17 105.66 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.482 -178.293 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 10.7 m120 -78.13 74.13 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.221 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.604 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -55.4 117.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 34.1 mmtp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.915 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 78.7 p -142.14 110.23 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.64 0.257 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 61.4 m80 59.34 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm -75.52 173.93 10.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.08 -25.91 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.05 88.23 0.13 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.254 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.5 121.22 7.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.492 2.128 . . . . 0.0 112.22 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.631 ' HG ' ' H ' ' A' ' 7' ' ' VAL . 45.5 tp -75.02 147.27 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 m -86.74 12.03 11.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.145 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.631 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 4.9 t -110.67 6.57 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 110.906 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HE3' ' H ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -157.4 127.57 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.525 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -115.03 114.54 25.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.307 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.648 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -127.09 -89.26 0.55 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -26.12 105.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.424 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 89.69 6.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.921 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.656 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -74.15 98.85 3.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.622 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 15' ' ' ASP . 6.6 p -155.34 177.32 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.765 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.4 p-10 -98.21 -175.24 3.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -173.76 -173.0 0.8 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 112.094 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m-70 -114.73 -167.35 1.21 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 30.6 t -94.0 135.23 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.137 0.494 . . . . 0.0 112.153 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.64 16.53 11.49 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.437 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.7 tptm -65.73 81.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.75 HG22 HD22 ' A' ' 77' ' ' LEU . 5.9 m -46.71 99.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.733 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 78' ' ' VAL . 83.5 m -93.79 99.6 11.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.0 tt0 -80.3 131.73 35.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.879 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.59 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.7 mt -134.67 103.97 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.731 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -86.02 95.51 9.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 24' ' ' ILE . 8.2 mt -92.95 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.302 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -101.6 168.52 9.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.47 -130.53 1.93 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.429 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 32' ' ' THR . 59.7 t30 -174.99 90.35 0.3 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.595 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.2 -18.94 2.29 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.695 2.263 . . . . 0.0 113.069 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -97.5 25.36 5.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 29' ' ' ASN . 7.1 t -103.65 -34.03 8.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.55 -43.72 1.19 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.746 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' H ' HG23 ' A' ' 32' ' ' THR . 70.4 m-85 -89.61 -176.78 5.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.118 0.485 . . . . 0.0 111.406 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 2.4 ttt -148.3 151.81 36.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.728 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.8 m95 -109.4 90.33 3.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.081 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.545 ' CG2' HG22 ' A' ' 42' ' ' VAL . 9.6 t -139.72 -166.58 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.375 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.2 mtp85 -92.23 124.21 36.13 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.797 0.332 . . . . 0.0 110.737 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.6 p -52.88 142.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.27 78.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.749 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 50.0 m-85 -128.15 -0.65 5.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.499 . . . . 0.0 110.184 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 93' ' ' THR . 38.1 t -54.78 105.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.036 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.1 -30.04 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.101 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 8.3 mtpm? -66.9 175.08 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.361 . . . . 0.0 110.993 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.88 -40.79 15.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.31 131.66 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.337 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.744 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.5 mt -84.41 -51.94 6.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.012 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 62.4 p -53.23 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.655 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.83 -86.61 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.47 -30.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.161 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.6 mm -74.04 -73.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.278 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.1 mt -104.96 116.02 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.344 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -70.33 68.81 0.36 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 109.902 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 78' ' ' VAL . 14.0 t -74.17 84.67 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.993 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.0 85.41 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' SG ' HG22 ' A' ' 76' ' ' VAL . 34.6 t -102.63 142.69 33.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.69 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -133.01 113.59 12.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.987 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.68 102.66 10.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.451 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.425 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 10.7 m -101.67 110.95 63.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.643 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 70' ' ' VAL . 63.8 Cg_endo -99.88 41.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.539 2.826 . . . . 0.0 111.695 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -41.27 140.67 1.18 Allowed Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.779 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 61' ' ' THR . 23.8 Cg_exo -63.55 -176.59 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 112.386 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -67.61 -172.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -63.26 -71.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.038 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 60.6 m -101.98 -48.36 0.18 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.896 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 12.6 Cg_exo -71.33 -161.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.842 2.361 . . . . 0.0 112.326 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.2 mtt -143.11 15.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.23 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 p -87.23 27.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.979 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.29 84.15 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.545 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 60' ' ' PRO . 14.5 p -82.41 50.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.507 0.67 . . . . 0.0 110.652 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.78 130.17 9.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.95 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -127.63 -119.67 2.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.167 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.4 pt -144.67 -166.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.483 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -131.37 98.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.95 106.64 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 88' ' ' LEU . 29.7 t -110.0 120.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.75 HD22 HG22 ' A' ' 21' ' ' THR . 82.6 mt -110.13 100.97 9.79 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.765 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 105.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.048 0.452 . . . . 0.0 111.18 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -107.18 102.08 41.64 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.239 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 52.5 Cg_exo -51.44 97.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.681 2.254 . . . . 0.0 112.705 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.3 mtt180 -66.24 -43.26 87.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.319 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -114.85 173.74 6.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -108.97 125.07 51.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.798 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.588 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 155.04 -138.42 6.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.4 m80 -97.85 95.16 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.446 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.8 m-70 -112.07 162.18 15.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.498 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 107' ' ' THR . 85.2 m -159.72 144.9 15.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 111.68 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 38.2 tp -101.0 92.66 5.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.026 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.4 mt-10 -75.13 88.51 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.481 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 48.2 mt -103.54 123.42 46.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 92' ' ' TYR . 13.1 p -126.19 158.49 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.5 t80 -102.34 91.85 4.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.327 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.926 HG21 HG21 ' A' ' 42' ' ' VAL . 5.5 t -122.45 167.46 13.3 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -101.07 94.89 4.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.41 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.9 Cg_exo -46.94 -28.77 7.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.252 . . . . 0.0 112.549 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -72.44 -42.62 64.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.312 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.19 -69.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.01 179.04 37.31 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.975 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.844 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.4 mt -98.4 140.84 17.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.959 0.409 . . . . 0.0 111.258 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 46.2 mtmt -140.39 159.44 63.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.194 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 30.6 Cg_endo -63.79 -36.32 51.83 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.917 2.411 . . . . 0.0 112.693 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.68 0.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.518 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.622 HD21 ' HA ' ' A' ' 93' ' ' THR . 6.6 m-20 -85.27 158.07 20.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.185 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 166.37 9.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.7 tpp180 -133.49 164.31 27.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.592 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.656 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 55.4 t80 -171.34 69.66 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.007 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -93.17 90.13 6.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.731 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 28.2 tp -70.59 89.96 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.326 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 36.8 m-70 -72.97 135.93 45.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.963 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.499 HD22 ' HB ' ' A' ' 16' ' ' THR . 86.4 mt -140.1 103.97 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.541 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.485 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.5 t-20 -79.26 65.43 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.588 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -43.49 116.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.521 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.968 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -140.18 145.05 36.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -115.8 115.36 26.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HE1' HD22 ' A' ' 5' ' ' LEU . 68.8 mtm -133.82 -25.25 1.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 2' ' ' ILE . 9.5 mt 58.96 14.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.04 152.06 77.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.003 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.89 144.99 64.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.529 2.153 . . . . 0.0 112.28 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.52 HD22 ' HE1' ' A' ' 1' ' ' MET . 58.6 tp -125.02 -63.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.808 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.3 t -83.13 171.1 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.26 100.3 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' CD ' HD22 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -156.52 127.55 6.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.61 113.16 23.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.463 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -126.94 -86.57 0.59 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -25.15 107.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.776 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.505 ' HD3' HD13 ' A' ' 108' ' ' LEU . 77.0 tttt -106.78 97.24 7.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.766 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 m95 -85.17 106.08 16.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.586 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 15' ' ' ASP . 2.9 p -152.94 -178.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 112.454 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.793 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -103.56 -179.74 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.797 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.503 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.67 -171.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.793 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.6 m-70 -122.25 173.13 7.8 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.041 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.9 p -67.36 138.66 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.282 0.563 . . . . 0.0 112.163 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 62.05 11.65 32.98 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.872 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 18.9 tptt -60.04 83.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.236 0.518 . . . . 0.0 109.828 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 2.5 m -57.41 99.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.447 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -96.99 100.67 12.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.3 tt0 -83.24 133.86 34.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.984 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 HD22 ' A' ' 108' ' ' LEU . 39.3 mt -139.79 105.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.03 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -88.98 113.92 25.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.138 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 14.5 mt -109.48 147.36 33.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.274 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -100.68 161.19 13.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.895 0.379 . . . . 0.0 110.621 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.18 -155.14 25.62 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.456 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.622 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 5.2 t-20 -172.04 118.95 0.43 Allowed Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 37.0 Cg_endo -67.26 -64.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.478 2.118 . . . . 0.0 113.506 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 5.3 t -53.23 -22.91 7.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 29' ' ' ASN . 40.4 m -86.11 -67.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 111.203 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 -117.66 4.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.929 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.446 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 -111.42 -171.45 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.0 ttt -108.98 151.54 26.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.3 m95 -109.54 103.07 11.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.619 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 42' ' ' VAL . 15.1 t -146.9 -174.05 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.717 ' NH1' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -77.38 138.22 39.18 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.219 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 89' ' ' GLU . 98.0 t -54.1 134.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.586 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -33.63 1.52 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.581 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -87.55 25.13 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.873 HG21 HG21 ' A' ' 93' ' ' THR . 25.3 t -79.63 107.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.985 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.62 -19.71 25.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -65.86 170.17 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.976 0.417 . . . . 0.0 111.131 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.15 -24.18 30.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.173 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.02 138.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.2 mt -88.83 -53.43 4.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.681 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -51.04 177.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -154.16 -95.64 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 111.751 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.88 -31.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.119 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.5 mm -72.12 -70.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 80' ' ' PRO . 16.2 mt -105.79 116.27 31.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.222 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -68.32 72.94 0.21 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.554 HG11 ' NE ' ' A' ' 38' ' ' ARG . 3.8 t -76.44 84.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.304 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -81.51 82.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.548 ' HB3' HD12 ' A' ' 47' ' ' LEU . 11.1 t -108.71 147.9 31.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.426 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -138.87 125.4 20.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.485 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.33 97.08 7.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.925 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 25.9 m -90.29 116.05 65.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.443 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HB2' HG11 ' A' ' 70' ' ' VAL . 87.1 Cg_endo -98.93 -160.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.231 2.621 . . . . 0.0 111.586 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.703 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -94.46 141.27 23.25 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.881 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 61' ' ' THR . 38.3 Cg_exo -60.21 120.67 8.58 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -91.99 152.81 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -91.17 -28.86 17.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.619 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 65.8 m -156.94 -50.13 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.752 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 8.4 Cg_exo -73.42 -164.84 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 112.239 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 67' ' ' MET . 24.7 ttt -157.17 19.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.595 . . . . 0.0 110.089 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.46 116.49 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.084 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 31' ' ' THR . . . 94.33 74.32 1.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.387 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.703 ' HB ' ' H ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -101.49 -111.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.274 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 122.35 77.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.634 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -118.72 -130.07 4.1 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.171 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 3.4 pt -131.47 -165.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.05 0.453 . . . . 0.0 110.763 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.515 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -143.38 103.68 4.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.027 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.77 126.53 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 88' ' ' LEU . 18.2 t -122.28 122.37 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.593 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 79.8 mt -109.94 96.4 6.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.851 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.568 ' CG2' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.35 105.38 16.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.239 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.4 mtmt -108.65 100.87 40.95 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.67 ' HA ' HD23 ' A' ' 52' ' ' LEU . 72.2 Cg_exo -48.18 96.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.733 2.289 . . . . 0.0 112.992 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 4.8 mtt180 -63.41 -37.01 85.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.652 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -116.44 -173.85 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.486 HH21 HG11 ' A' ' 18' ' ' VAL . 97.5 mtt180 -132.77 119.22 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.86 -100.59 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.33 100.98 7.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -118.33 161.12 20.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.536 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -160.64 150.66 17.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.886 0.374 . . . . 0.0 111.76 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 76' ' ' VAL . 20.6 tp -132.26 82.52 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.662 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -86.64 105.76 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.717 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.2 mt -89.81 167.09 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.769 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -155.2 147.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.918 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.7 t80 -97.88 82.62 3.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.564 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.873 HG21 HG21 ' A' ' 42' ' ' VAL . 9.9 t -121.99 158.24 29.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 27.1 mtp180 -101.17 101.15 15.31 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.326 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 93' ' ' THR . 78.1 Cg_exo -46.99 -39.45 25.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.752 2.301 . . . . 0.0 113.257 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 9.38 0.99 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.73 4.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 0.0 111.348 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.95 -171.74 51.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.797 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -112.15 150.14 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 111.86 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -135.42 164.17 45.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.81 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -19.79 13.0 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.543 2.162 . . . . 0.0 111.651 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.2 pt-20 -76.75 -0.11 22.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.7 m120 -82.21 149.41 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.44 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.9 171.5 1.19 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.2 tpp180 -136.9 159.5 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 36.0 t80 -162.21 72.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.874 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.745 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 22.7 m -85.51 151.33 24.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.866 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.4 tp -140.7 87.74 2.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.36 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.766 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 13.6 m-70 -74.69 144.11 43.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.503 HD22 ' HB ' ' A' ' 16' ' ' THR . 85.5 mt -144.66 102.75 3.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.296 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -80.6 61.3 4.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -38.64 140.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.86 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.045 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.1 p -145.03 151.74 39.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -90.69 144.64 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -132.69 -177.15 4.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.32 -34.72 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.001 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.02 90.9 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.237 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.9 3.06 5.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.424 2.082 . . . . 0.0 112.376 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.2 mp -62.06 -28.35 69.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.401 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 47.7 t -76.25 171.97 13.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.84 134.1 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.382 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 6' ' ' SER . 13.9 mptt -107.88 26.84 9.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.025 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -38.39 118.38 0.71 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.637 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -114.3 -84.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.913 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' ASN . 8.6 m-20 -25.67 103.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.924 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 55.5 tptt -94.26 90.26 6.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.414 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.19 103.34 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -155.42 177.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.088 0.47 . . . . 0.0 111.83 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.773 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -100.07 -178.17 3.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.765 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.495 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -175.59 -174.75 0.72 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.119 0.485 . . . . 0.0 112.08 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.9 m80 -115.51 -170.02 1.69 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.22 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.56 139.46 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.239 0.542 . . . . 0.0 112.308 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.11 22.29 9.54 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.69 81.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.692 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -51.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.864 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.426 ' HB ' HG23 ' A' ' 78' ' ' VAL . 73.3 m -91.6 101.6 14.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.958 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.3 tt0 -84.81 129.73 34.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.4 mt -139.66 98.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.87 106.32 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 11.3 mt -98.86 143.78 28.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.075 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -94.08 166.57 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.025 0.44 . . . . 0.0 110.806 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.81 -137.01 3.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.078 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 63.3 t30 -176.97 99.23 0.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.424 0.154 . . . . 0.0 110.615 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 17.9 Cg_endo -60.02 -6.22 4.67 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.636 2.224 . . . . 0.0 113.099 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 p -96.89 12.11 33.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.588 0.232 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 29' ' ' ASN . 60.3 p -102.0 -66.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.137 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.97 -55.46 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.95 169.86 10.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 111.06 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 20.9 ttm -143.87 148.81 35.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.175 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 4.6 m95 -106.1 78.47 1.31 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.987 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 42' ' ' VAL . 12.0 t -125.73 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.4 mtp85 -88.61 156.42 19.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 47.4 t -74.39 130.21 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.05 12.23 79.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.525 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 61.8 m-85 -135.25 -1.55 2.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.088 0.471 . . . . 0.0 110.578 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 18.7 t -53.85 117.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.02 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.36 -28.81 13.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.873 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 95.6 mttt -69.16 172.83 6.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -78.24 -62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.87 142.94 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.194 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt -94.64 -51.2 4.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.85 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.6 p -52.32 179.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.745 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.25 -90.98 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.7 pt-20 -130.12 -28.82 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.181 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.1 mm -76.85 -73.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.335 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.0 mt -103.94 115.52 30.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.539 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -71.02 69.38 0.48 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 78' ' ' VAL . 10.8 t -75.92 88.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.091 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 39.4 t -86.27 90.11 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 52.0 t -95.38 144.64 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.94 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 75.7 mttt -130.56 92.63 3.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.887 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.3 t80 -57.7 -17.8 17.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.321 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.441 HG22 HG13 ' A' ' 70' ' ' VAL . 29.9 m 31.57 78.09 0.31 Allowed Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.971 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -102.36 7.03 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 124.182 3.255 . . . . 0.0 113.298 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.518 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.44 136.91 85.63 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 61' ' ' THR . 88.7 Cg_endo -78.22 122.27 5.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.505 2.136 . . . . 0.0 112.464 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 55.9 m -79.57 142.59 35.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.939 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 m -109.68 -39.64 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.702 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 26.6 m -155.3 -53.46 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.601 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 40.1 Cg_endo -99.45 -149.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.86 3.04 . . . . 0.0 112.144 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.9 mtt 59.17 97.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.015 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.82 135.35 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 39.29 11.87 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.441 HG13 HG22 ' A' ' 59' ' ' THR . 72.8 t -140.37 81.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.449 . . . . 0.0 110.818 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.39 13.95 1.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.099 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 30' ' ' PRO . . . 102.31 68.38 0.8 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.249 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.6 pt -114.43 -152.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -150.26 82.14 1.37 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.609 0.242 . . . . 0.0 110.782 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 93.3 t -79.91 91.9 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.062 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 88' ' ' LEU . 40.4 t -90.05 118.67 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 21' ' ' THR . 79.1 mt -110.53 95.12 5.37 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.6 104.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.0 mtmm -110.16 93.9 16.72 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.086 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 4.1 Cg_endo -48.6 100.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.594 2.196 . . . . 0.0 112.549 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.549 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.0 mtt180 -64.63 -32.67 74.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.998 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -120.91 -175.38 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.634 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.51 117.45 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.05 -107.56 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.251 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.491 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.0 m80 -116.48 91.6 3.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER -111.78 157.69 20.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.576 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 109' ' ' HIS . 47.0 m -159.47 146.04 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.1 tp -112.86 92.38 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.7 mt-10 -78.44 94.95 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.197 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 67.7 mt -101.8 135.03 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.7 p -140.11 154.26 23.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 0.0 112.09 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.11 94.13 6.65 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.959 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 7.6 t -129.72 157.13 43.02 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 79.3 mtp180 -91.64 99.93 2.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.859 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.6 Cg_exo -37.93 -56.49 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.261 2.641 . . . . 0.0 113.732 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.466 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 8.2 p90 -78.15 23.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.7 mm-40 -149.9 0.87 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.38 50.44 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.2 mt -104.84 158.65 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.431 . . . . 0.0 111.933 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.406 ' N ' HG22 ' A' ' 99' ' ' ILE . 13.1 mttt -135.26 165.99 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.883 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.11 -41.03 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.886 2.39 . . . . 0.0 111.974 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.47 -26.73 68.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.465 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.6 m-20 -49.27 148.33 2.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.304 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 3.8 tt0 -53.76 160.67 1.3 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.639 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.1 tpp180 -133.54 161.21 35.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.54 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.639 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.5 t80 -171.33 65.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.0 m -87.35 94.66 9.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.39 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 36.2 tp -74.91 92.56 2.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.4 m-70 -77.55 138.48 39.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 16' ' ' THR . 84.3 mt -143.35 103.09 4.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -80.54 66.09 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -44.76 113.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.762 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.924 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.8 p -92.75 -24.13 18.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -126.77 161.58 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm -79.13 -175.52 4.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 pt -76.18 -5.3 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -125.18 145.81 51.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 38.7 Cg_exo -60.86 165.0 12.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.531 2.154 . . . . 0.0 112.142 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 tp -166.88 -43.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -125.8 -155.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.559 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.4 m -55.03 171.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.063 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -164.62 131.26 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.665 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.44 123.56 22.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.674 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -123.87 -93.97 0.5 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.018 0.437 . . . . 0.0 112.041 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 2.2 m-20 -48.82 102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.447 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.425 ' HE2' HG21 ' A' ' 14' ' ' VAL . 75.5 tttt -97.23 93.09 6.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -82.01 99.93 9.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 12' ' ' LYS . 34.1 m -149.82 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 112.271 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.78 -163.71 1.06 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.133 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t 178.24 -175.04 0.17 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 59.0 m80 -120.73 -164.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 83' ' ' ARG . 24.2 t -95.76 115.45 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 111.442 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 67.99 10.7 59.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.108 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.8 tptm -60.11 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.729 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -45.6 103.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.702 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.9 m -91.26 94.75 9.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.571 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HA ' HD23 ' A' ' 77' ' ' LEU . 42.3 tt0 -80.11 128.41 33.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.69 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -136.18 104.55 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.56 96.97 8.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.423 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.523 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 7.8 mt -91.12 140.89 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.196 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 73' ' ' ILE . 54.6 mttm -98.98 165.31 11.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.51 -132.72 2.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 32' ' ' THR . 60.6 t30 -174.24 95.42 0.31 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.32 0.105 . . . . 0.0 110.767 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 12.1 Cg_endo -55.91 -13.66 9.36 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -101.62 21.82 13.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 29' ' ' ASN . 6.2 t -100.13 -31.68 11.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 134.86 -39.27 1.71 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' H ' HG23 ' A' ' 32' ' ' THR . 41.7 m-85 -93.33 -175.43 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 0.0 111.371 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 10.1 ttm -149.09 149.25 30.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.802 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.5 m95 -103.23 85.31 2.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.894 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.538 HG23 HG22 ' A' ' 42' ' ' VAL . 14.5 t -137.23 165.46 26.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.696 HH11 HD11 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -61.37 132.89 54.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.905 0.383 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 89' ' ' GLU . 3.8 p -55.07 147.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.486 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.74 -8.03 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.278 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.715 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 21.8 m-85 -117.7 33.37 5.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 109.943 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 93' ' ' THR . 13.0 t -97.55 87.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.582 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.21 7.37 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -66.77 -160.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.537 -0.831 . . . . 0.0 111.722 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.516 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 5.8 m-20 -106.94 -41.12 5.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.664 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 t -152.8 118.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.963 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 56' ' ' CYS . 14.5 mt -55.0 -59.25 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.331 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 3.2 t -45.55 168.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.961 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 11.4 m-20 -157.53 -159.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.961 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 9.4 pt-20 -74.69 -29.82 61.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.854 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 13.9 mm -80.38 -74.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.325 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 80' ' ' PRO . 19.7 mt -104.42 109.28 21.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.527 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.43 75.59 0.26 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 78' ' ' VAL . 1.7 t -82.58 91.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 23.3 t -92.88 95.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.784 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HB3' HD12 ' A' ' 47' ' ' LEU . 41.0 t -111.9 148.61 33.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.438 0.637 . . . . 0.0 112.151 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -126.17 110.28 13.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.559 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.87 102.81 11.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.566 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 61' ' ' THR . 30.8 m -104.67 116.51 60.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -98.0 12.3 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.042 2.495 . . . . 0.0 112.25 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 59' ' ' THR . 4.4 m -62.19 136.24 95.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.16 152.74 23.69 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.757 2.305 . . . . 0.0 112.368 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.6 m -72.57 -173.59 1.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.5 m -64.07 -42.84 96.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.1 p -85.53 155.04 59.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.302 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.21 -156.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.74 2.293 . . . . 0.0 112.141 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.4 mmm 61.17 17.61 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.73 110.71 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.92 100.87 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.337 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t 47.75 83.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 111.264 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.34 109.55 0.49 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.36 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -115.14 -125.56 4.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.821 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt -149.81 -165.19 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -132.74 98.07 4.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.063 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 80.5 t -84.37 103.42 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.951 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 HH22 ' A' ' 38' ' ' ARG . 33.0 t -102.3 123.28 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.729 HD22 HG22 ' A' ' 21' ' ' THR . 64.9 mt -112.68 93.45 4.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG13 HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.85 107.14 18.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.116 0.484 . . . . 0.0 111.102 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -108.96 95.15 16.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.462 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HA ' HD23 ' A' ' 52' ' ' LEU . 9.7 Cg_endo -53.06 102.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.153 1.902 . . . . 0.0 111.965 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.437 HH11 ' HA ' ' A' ' 50' ' ' GLU . 17.2 mtt180 -64.82 -45.33 86.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.52 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -106.32 173.56 6.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.041 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 18' ' ' VAL . 59.4 mtp180 -109.42 142.64 40.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.03 -150.97 20.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -87.47 92.18 9.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 112' ' ' VAL . 1.7 m-70 -108.77 156.18 19.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 109' ' ' HIS . 90.5 m -160.34 151.33 18.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.116 0.484 . . . . 0.0 111.851 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.678 HD21 ' HD3' ' A' ' 38' ' ' ARG . 13.8 tp -128.71 142.73 50.92 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 6.1 mt-10 -123.56 86.73 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.216 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.696 HD11 HH11 ' A' ' 38' ' ' ARG . 7.0 mp -75.5 125.77 29.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.073 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 92' ' ' TYR . 12.8 p -122.29 156.45 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.76 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -102.51 95.91 6.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.465 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 42' ' ' VAL . 3.5 t -125.35 169.97 11.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -101.6 93.86 3.79 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.118 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -44.29 -27.76 2.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.777 2.318 . . . . 0.0 112.74 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.71 -46.22 59.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.472 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.82 -67.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.93 0.395 . . . . 0.0 111.262 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.41 172.48 27.73 Favored Glycine 0 CA--C 1.507 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.99 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.804 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.2 mt -86.15 139.31 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.932 0.396 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -128.5 164.53 37.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.253 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.65 -35.19 8.14 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.038 2.492 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.81 11.99 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.211 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.9 m-20 -88.1 150.36 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.41 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.2 tt0 -54.43 162.36 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.584 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.674 ' HB3' HD22 ' A' ' 10' ' ' ASN . 15.0 tpp180 -131.93 163.9 27.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.273 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.9 t80 -174.3 71.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.036 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.5 m -84.4 101.67 12.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.504 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 78' ' ' VAL . 59.4 tp -79.05 89.46 4.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 4.6 m-70 -76.77 137.11 39.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.563 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -145.28 104.42 3.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . 32.3 t-20 -80.68 73.74 7.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -51.86 123.98 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.455 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.981 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.8 m -140.46 140.23 35.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.717 0.294 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -118.67 117.22 28.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp 58.29 -171.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.8 mp -87.65 -40.81 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.85 89.37 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.83 126.49 21.91 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.522 2.148 . . . . 0.0 112.336 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.35 -64.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.4 m -152.0 -14.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.43 132.17 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -142.69 -161.5 1.26 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -122.4 108.34 13.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 110.32 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.644 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -129.19 -87.33 0.54 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.127 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER -30.11 106.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.189 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 14' ' ' VAL . 53.5 tttp -95.27 101.08 12.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.987 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.0 m95 -84.18 102.11 12.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.318 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 12' ' ' LYS . 34.6 m -147.47 -168.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.733 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.55 -179.32 3.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.482 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.486 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.22 -172.66 0.6 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.621 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.3 m80 -115.98 -163.74 0.92 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.268 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 38.4 t -93.27 137.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.115 0.483 . . . . 0.0 112.083 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.07 15.03 9.1 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.492 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptm -64.08 82.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.82 98.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.579 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 78' ' ' VAL . 86.5 m -91.63 99.83 12.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.532 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.3 tt0 -81.66 130.28 35.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.7 mt -134.29 104.85 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.873 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -85.94 96.54 9.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.4 mt -91.73 145.18 24.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.442 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.93 163.13 12.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.546 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.16 -141.31 5.03 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.558 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' HG23 ' A' ' 32' ' ' THR . 59.1 t30 -174.6 94.39 0.3 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.557 0.218 . . . . 0.0 110.575 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 50.9 Cg_exo -53.86 -15.84 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 113.28 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.6 HG21 ' HA2' ' A' ' 69' ' ' GLY . 69.4 p -86.41 13.28 8.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 29' ' ' ASN . 47.5 p -95.5 -58.61 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.75 -29.37 0.67 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 42.9 m-85 -97.48 -176.4 3.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 0.0 111.062 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.7 ttm -149.16 151.68 34.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -106.37 86.98 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.113 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -132.02 -167.4 1.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.101 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 24.7 mtp85 -88.54 150.25 23.18 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.0 t -69.57 131.91 33.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.617 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.61 6.33 89.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.576 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.9 m-85 -130.81 -0.76 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.505 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.942 HG21 HG21 ' A' ' 93' ' ' THR . 14.2 t -55.08 103.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.022 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.92 -28.96 10.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.233 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 8.7 mtpm? -63.68 172.11 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 111.108 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.61 -55.87 6.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.66 142.36 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.598 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.1 mt -87.64 -46.46 9.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.811 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 48.3 t -57.0 -179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.208 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.14 -88.6 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.41 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.17 -37.61 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.89 -77.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.38 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 54' ' ' VAL . 69.6 mt -111.23 125.52 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 72.37 0.23 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 3.1 t -75.8 85.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.76 84.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.503 ' HB3' HD12 ' A' ' 47' ' ' LEU . 33.8 t -99.53 148.15 24.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.324 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -138.15 111.18 7.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.304 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.452 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -76.42 102.67 6.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.281 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 22.9 m -100.56 109.44 57.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.076 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 75.5 Cg_endo -100.45 96.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.582 2.854 . . . . 0.0 111.132 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.519 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -75.86 141.06 71.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.36 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 61' ' ' THR . 23.9 Cg_exo -63.88 -178.95 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.742 2.294 . . . . 0.0 112.171 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.9 t -150.54 165.44 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.4 p -55.74 -27.07 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 64.2 p -61.44 161.18 20.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.894 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 47.5 Cg_endo -65.96 -152.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.536 2.158 . . . . 0.0 112.081 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.4 mtm -53.85 -16.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.21 100.1 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.6 ' HA2' HG21 ' A' ' 31' ' ' THR . . . 140.42 106.87 0.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.639 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.3 p -151.22 86.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.288 0.566 . . . . 0.0 110.868 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -96.28 132.78 11.18 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.006 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -142.66 -136.4 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.099 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.3 pt -146.68 -166.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 110.978 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -136.66 100.13 4.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.5 t -85.21 103.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.6 t -106.01 119.29 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.211 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 75.3 mt -109.37 98.98 8.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.824 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.73 104.01 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.953 0.406 . . . . 0.0 111.256 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -102.87 101.67 22.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 77.5 Cg_exo -47.03 98.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.802 2.335 . . . . 0.0 113.299 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -74.47 -36.21 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.354 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.38 172.0 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.641 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.3 121.82 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 139.9 -149.77 21.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.576 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.02 98.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.4 ' HB3' HD21 ' A' ' 52' ' ' LEU . 19.4 m-70 -132.97 156.44 47.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.48 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.544 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 90.6 m -158.92 155.63 28.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.022 0.439 . . . . 0.0 112.111 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 28.8 tp -104.51 94.1 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.888 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.589 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.6 mt-10 -73.43 96.51 2.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.186 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.0 mt -112.15 135.46 52.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.2 p -142.49 154.71 18.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 111.765 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.35 88.89 4.27 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.942 HG21 HG21 ' A' ' 42' ' ' VAL . 3.9 t -117.74 172.6 7.26 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -102.91 93.1 4.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.305 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.8 Cg_exo -43.59 -35.62 6.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.743 2.295 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -71.9 -39.61 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.303 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.73 -72.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.397 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 178.0 36.43 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.973 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.5 mt -90.91 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 13.8 mttt -134.54 162.28 58.63 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.151 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 46.5 Cg_endo -69.22 -40.9 5.52 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.686 2.258 . . . . 0.0 112.16 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.66 -25.76 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.618 HD21 ' HA ' ' A' ' 93' ' ' THR . 9.0 m-20 -53.18 149.58 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.348 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.2 tt0 -56.08 161.12 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.2 tpp180 -132.35 163.54 28.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.992 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.663 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.0 t80 -172.78 71.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 109.424 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.09 90.29 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.156 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.8 tp -70.85 90.59 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 29.2 m-70 -72.0 145.91 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.592 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.7 mt -146.54 115.94 7.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.665 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.517 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.1 t30 -83.96 51.1 1.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.577 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.7 t -36.05 121.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.825 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.036 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.7 p -98.54 122.12 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -146.18 132.36 19.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -131.91 134.33 45.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 pt -93.72 16.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.07 111.98 3.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.22 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.91 130.02 19.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.448 2.099 . . . . 0.0 112.308 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -134.49 -174.1 3.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -61.08 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.33 143.93 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -172.48 133.49 0.63 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.432 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.38 120.67 11.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.604 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -125.06 -94.76 0.47 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.945 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -54.06 100.33 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.5 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -92.65 93.34 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -76.83 102.98 6.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.74 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG23 HD23 ' A' ' 110' ' ' LEU . 17.5 m -150.14 -172.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.067 0.46 . . . . 0.0 112.126 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -107.75 179.43 4.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.591 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.5 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.7 t -175.37 -175.07 0.78 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.018 0.437 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.485 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 62.3 m-70 -118.76 -171.9 2.18 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.271 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.28 125.95 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 111.789 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 66.37 18.5 67.57 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.571 -0.741 . . . . 0.0 113.393 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -59.61 85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.74 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -55.86 98.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.348 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -96.09 103.37 15.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.634 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HA ' HD23 ' A' ' 77' ' ' LEU . 40.1 tt0 -81.93 131.14 35.25 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.803 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 108' ' ' LEU . 46.8 mt -137.21 105.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.953 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.68 99.85 12.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.254 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.1 mt -96.11 149.08 22.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.604 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.27 162.21 13.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.17 -144.11 6.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -174.28 93.74 0.32 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.337 0.113 . . . . 0.0 110.761 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HB3' ' OH ' ' A' ' 58' ' ' TYR . 12.4 Cg_endo -56.58 -21.02 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.738 2.292 . . . . 0.0 112.905 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.2 p -73.64 1.86 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.1 p -90.83 -52.66 4.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.96 -38.64 0.84 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.746 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 78.9 m-85 -85.37 176.74 8.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.31 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.6 ttm -144.02 149.79 37.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.0 m95 -102.77 82.8 2.17 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -128.48 -171.2 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.25 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.704 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.4 mtp85 -86.28 144.05 27.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.013 0.435 . . . . 0.0 111.09 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.83 144.53 12.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.067 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.81 72.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.116 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' A' ' 42' ' ' VAL . 53.8 m-85 -138.24 -37.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.726 0.263 . . . . 0.0 111.43 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.8 p -18.11 118.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.767 0.667 . . . . 0.0 112.439 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.72 61.56 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.018 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.732 ' HD3' ' H ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -89.02 -164.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.237 0.541 . . . . 0.0 111.794 -179.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.69 -32.67 5.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.561 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.91 122.72 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.701 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 1.9 mt -68.92 -56.57 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.373 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.499 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.2 p -49.0 176.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.847 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -77.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.37 -36.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.361 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 24.5 mm -72.22 -79.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.453 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD22 HG12 ' A' ' 78' ' ' VAL . 11.0 mt -99.23 114.52 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.517 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.72 68.9 0.27 Allowed 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 78' ' ' VAL . 16.4 t -74.0 84.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.862 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.95 85.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.8 t -102.26 144.28 30.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.612 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -130.2 107.46 9.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.055 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -80.2 108.73 14.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.412 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 26.3 m -113.05 117.28 46.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.201 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.601 ' HB2' HG12 ' A' ' 70' ' ' VAL . 62.9 Cg_endo -99.88 47.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.381 2.721 . . . . 0.0 111.566 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.455 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -45.76 154.91 0.52 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.698 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.455 ' HD2' HG22 ' A' ' 61' ' ' THR . 57.5 Cg_exo -52.51 123.17 12.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.607 2.205 . . . . 0.0 112.505 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 t -66.98 173.98 3.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -83.15 17.23 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.4 p -57.41 155.49 19.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.67 10.38 2.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.717 2.278 . . . . 0.0 112.794 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.524 ' HG3' HG23 ' A' ' 68' ' ' VAL . 50.8 tpp -172.44 -90.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.403 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 67' ' ' MET . 51.4 t -91.14 126.21 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.68 131.79 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.52 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 60' ' ' PRO . 47.6 t -136.23 77.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.32 114.19 0.94 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.572 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -110.62 -120.97 4.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.501 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.7 pt -145.69 -164.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.005 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.6 m-85 -135.26 99.48 4.26 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 57.9 t -84.99 101.89 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.729 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' SG ' ' A' ' 56' ' ' CYS . 40.0 t -105.9 121.02 57.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 21' ' ' THR . 78.8 mt -111.37 99.54 8.31 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.11 106.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 111.359 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.4 mtmm -111.69 92.85 18.13 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.601 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.1 Cg_endo -51.26 101.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.648 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 18.9 mtt180 -64.17 -29.85 70.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.397 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -127.36 -177.23 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.321 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 21.3 ptt180 -120.31 139.96 51.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.5 -118.82 0.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.691 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -116.65 30.66 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.006 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -46.83 152.06 0.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.568 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 78.2 m -158.24 142.58 15.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.5 tp -93.19 90.53 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.538 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.8 mt-10 -72.57 96.21 1.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.699 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 28.0 mt -111.36 137.97 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -146.47 157.16 11.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.487 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.2 t80 -95.8 91.28 5.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.4 t -121.73 150.87 41.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 77.6 mtp180 -87.42 100.53 1.71 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 5.5 Cg_endo -51.44 -30.33 34.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.384 2.056 . . . . 0.0 112.039 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.36 -32.05 66.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.271 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -108.75 -78.6 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.282 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.48 -178.73 45.28 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.321 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -94.36 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -144.79 154.99 56.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.85 -47.13 4.04 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.897 2.398 . . . . 0.0 112.632 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.89 -14.75 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.759 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.9 m120 -68.56 159.23 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 111.445 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 5.0 tt0 -56.49 157.03 5.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.5 tpp180 -130.93 163.16 28.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.613 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 59.6 t80 -175.32 73.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.534 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.615 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -96.11 88.78 4.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.353 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.5 tp -69.5 90.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.432 . . . . 0.0 110.523 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.0 m-70 -73.03 143.75 47.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.56 HD23 HG23 ' A' ' 14' ' ' VAL . 87.2 mt -144.39 111.83 6.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.6 t30 -83.41 59.53 5.11 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -38.54 133.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.629 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.94 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.5 p -98.08 114.71 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -97.96 118.56 34.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp -132.2 176.64 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.0 mp -96.09 -29.61 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.71 153.74 15.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.7 137.78 67.25 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.539 2.159 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.48 178.19 4.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.1 p -104.97 6.8 33.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.71 16.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.96 -43.08 12.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.264 0.554 . . . . 0.0 110.624 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.53 134.72 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.014 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.895 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 2.1 p30 -102.0 -91.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.841 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -128.21 -112.55 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.877 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG2' HG13 ' A' ' 14' ' ' VAL . 32.7 ttpt -162.03 151.03 15.52 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.886 0.374 . . . . 0.0 111.001 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.773 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.0 m0 -106.07 115.79 30.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 12' ' ' LYS . 19.6 m -148.7 -173.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.586 ' HA ' ' N ' ' A' ' 111' ' ' ASN . 3.3 p-10 -101.85 -171.54 1.99 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.706 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.5 t -175.32 178.89 1.6 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.663 ' O ' HG13 ' A' ' 112' ' ' VAL . 74.9 m80 -109.73 -144.37 0.39 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -106.02 132.23 53.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.163 0.506 . . . . 0.0 111.586 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.76 18.66 46.77 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.328 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tptt -61.35 83.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.648 HG22 HD12 ' A' ' 77' ' ' LEU . 4.6 m -55.48 102.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 78' ' ' VAL . 93.3 m -105.69 97.39 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.346 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 25' ' ' HIS . 28.6 tt0 -72.79 122.09 20.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.299 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.3 mm -117.33 101.0 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 23' ' ' GLU . 2.4 m80 -89.94 115.68 27.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.377 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 51.5 mt -111.83 147.49 35.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.309 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -100.99 162.36 12.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.593 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.75 -132.79 2.46 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.347 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB3' HG23 ' A' ' 32' ' ' THR . 44.5 t30 -176.26 97.85 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.353 0.121 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 54.1 Cg_exo -53.14 -18.11 9.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.443 2.095 . . . . 0.0 112.508 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.1 m -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.479 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 29' ' ' ASN . 75.4 p -53.27 -64.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.428 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.07 -53.06 0.41 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.784 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -80.07 140.99 36.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 111.26 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.5 ttm -99.98 153.22 19.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.5 m95 -101.95 88.76 3.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.152 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -133.04 -169.05 2.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.396 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH2' ' HA ' ' A' ' 48' ' ' SER . 6.6 mtp85 -82.28 142.72 31.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.384 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 89' ' ' GLU . 60.2 t -53.86 145.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.122 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.21 6.89 3.4 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.845 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -127.86 29.22 5.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.527 0.68 . . . . 0.0 110.707 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.641 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.4 p -65.45 133.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.999 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.21 -21.82 26.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HB2' HD23 ' A' ' 47' ' ' LEU . 61.5 mttp -70.74 172.35 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 -54.64 2.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.427 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.49 -35.93 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.6 mt 72.8 -58.26 0.6 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.56 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . 67.2 p -63.67 -162.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.848 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.42 -73.36 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HE2' ' A' ' 82' ' ' LYS . 12.7 pt-20 -142.14 -24.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.937 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -70.19 -66.93 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.113 0.482 . . . . 0.0 111.559 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -116.98 105.86 12.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.964 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -59.06 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.759 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 52' ' ' LEU . 40.7 t -95.3 92.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.828 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.3 t -84.36 77.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.503 0.668 . . . . 0.0 109.2 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 76' ' ' VAL . 13.0 t -92.19 134.81 34.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.283 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 75' ' ' VAL . 43.0 mtmt -129.64 119.47 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 1.1 t80 -84.29 98.78 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.123 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 26.6 m -91.22 108.7 30.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.291 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.659 ' HB2' HG11 ' A' ' 70' ' ' VAL . 61.0 Cg_endo -102.47 93.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.713 2.942 . . . . 0.0 111.465 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -75.24 138.34 71.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 61' ' ' THR . 25.9 Cg_exo -62.05 113.76 2.02 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.679 2.253 . . . . 0.0 112.256 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -103.22 -174.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.3 p -72.82 -6.86 47.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 71.8 p -63.75 156.23 73.28 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 72.5 Cg_endo -73.68 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.546 2.164 . . . . 0.0 112.109 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.71 -14.31 61.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.976 0.417 . . . . 0.0 110.814 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.77 108.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.01 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.4 164.99 38.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.542 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.659 HG11 ' HB2' ' A' ' 60' ' ' PRO . 14.9 t -126.89 -104.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.626 0.251 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 141.76 87.37 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.978 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -146.48 -138.68 3.21 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 5.9 pt -139.74 -164.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 110.934 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -139.93 100.0 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.284 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 57' ' ' LYS . 10.4 p -92.25 133.13 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 109.856 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 56' ' ' CYS . 43.6 t -132.93 99.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 21' ' ' THR . 2.1 mm? -83.09 103.8 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.624 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.33 112.66 28.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.947 0.403 . . . . 0.0 110.797 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.8 mtmm -118.25 101.63 51.17 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.05 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 112' ' ' VAL . 4.6 Cg_endo -49.17 101.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.477 2.118 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 3.8 mtt180 -74.89 -42.47 57.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.498 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 67.2 mttm -113.71 160.03 19.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.013 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -96.19 129.15 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.538 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.53 -119.24 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.456 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -121.14 99.47 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.501 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -111.18 164.79 12.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 m -161.78 152.98 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.668 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.7 tp -119.4 77.79 1.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.959 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -81.53 107.76 14.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.823 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 38' ' ' ARG . 96.2 mt -101.78 154.86 18.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.362 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -146.89 158.92 9.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.23 0.538 . . . . 0.0 112.04 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -94.34 68.9 3.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.702 ' HB ' HG23 ' A' ' 99' ' ' ILE . 1.1 t -84.73 167.27 16.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.82 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -109.35 92.67 11.92 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.718 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.92 -33.71 26.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.635 2.223 . . . . 0.0 112.541 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -69.41 -31.36 69.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.11 -81.28 0.61 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.58 -172.07 40.09 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.32 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.702 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.9 mt -102.99 116.55 46.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.658 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.0 170.54 5.43 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.58 -35.53 16.95 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.514 2.143 . . . . 0.0 112.175 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.45 -19.24 22.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.435 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.77 132.54 52.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 111.325 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -53.55 161.06 1.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.713 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.666 ' HG2' HD22 ' A' ' 10' ' ' ASN . 4.4 tpt180 -126.47 153.12 45.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.242 0.544 . . . . 0.0 112.171 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.895 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 42.5 t80 -165.1 83.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.049 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 89' ' ' GLU . 1.4 m -95.81 111.46 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.7 tp -98.0 94.13 6.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.958 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 37.0 m-70 -77.27 141.16 40.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 0.0 111.033 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 73.7 mt -144.17 77.91 1.56 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.298 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.586 ' N ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 t30 -57.17 89.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 17' ' ' HIS . 5.5 t -57.9 133.49 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.724 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.972 179.692 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -143.8 127.33 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -89.12 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt -135.44 159.31 41.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.74 -30.64 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.93 129.09 36.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -80.76 20.84 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.532 2.155 . . . . 0.0 112.436 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.36 -60.65 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.9 m -63.89 -71.67 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.038 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.32 -176.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -170.49 132.76 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.526 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.1 120.99 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.699 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -127.7 -92.32 0.48 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.131 0.491 . . . . 0.0 112.026 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.486 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -47.75 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.083 -179.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD3' HD13 ' A' ' 108' ' ' LEU . 53.4 tttp -102.47 98.7 8.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.763 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.71 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.3 m95 -87.55 104.32 16.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.265 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 HD23 ' A' ' 110' ' ' LEU . 30.7 m -146.45 -171.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 112.055 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.25 -176.04 2.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.585 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.6 t -175.83 -177.04 0.9 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.138 0.494 . . . . 0.0 112.164 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.8 m80 -115.1 -167.7 1.28 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.805 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -84.55 128.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.169 0.509 . . . . 0.0 111.905 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.63 20.63 59.55 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.483 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.2 tptp -59.03 84.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.026 0.413 . . . . 0.0 109.975 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.758 HG22 HD22 ' A' ' 77' ' ' LEU . 3.9 m -55.72 93.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.353 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 52.2 m -94.59 101.91 13.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.0 tt0 -82.43 133.46 35.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.577 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.572 HD11 HD22 ' A' ' 108' ' ' LEU . 41.4 mt -135.5 101.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.158 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -84.72 107.87 17.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.3 mt -100.89 144.86 29.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.273 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.9 164.01 13.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.93 0.395 . . . . 0.0 110.334 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.61 -139.84 5.78 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.291 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -175.4 88.51 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 67.8 Cg_exo -52.32 -16.99 5.62 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.713 2.275 . . . . 0.0 113.123 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -82.06 11.0 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.471 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.9 p -100.58 -63.27 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.077 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.14 -45.15 0.33 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.769 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 90.2 m-85 -72.32 178.57 3.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.068 0.461 . . . . 0.0 111.212 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.28 151.97 32.56 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.062 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.47 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 3.8 m95 -110.38 88.97 2.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.87 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 42' ' ' VAL . 5.9 t -136.67 -168.7 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.927 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 54' ' ' VAL . 10.2 mtp85 -81.17 140.26 35.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.784 0.326 . . . . 0.0 111.102 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 89' ' ' GLU . 20.3 t -54.39 144.44 5.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.53 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.18 -0.97 5.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.864 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.731 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 26.9 m-85 -128.66 54.12 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.568 0.699 . . . . 0.0 110.504 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 93' ' ' THR . 26.2 t -107.69 121.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.653 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 4.16 85.85 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -67.99 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.308 -0.946 . . . . 0.0 111.555 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 3.9 m-20 -107.95 -47.06 3.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.657 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.5 p -144.38 127.92 12.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.724 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.675 HD23 ' HD3' ' A' ' 44' ' ' LYS . 36.9 mt -68.77 -63.49 1.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.795 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 53' ' ' GLU . 36.9 t -47.23 174.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.02 -83.13 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.91 -31.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.135 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.3 mm -73.97 -79.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.509 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -99.93 115.84 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.678 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.78 70.27 0.19 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.603 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -75.41 83.71 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.251 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.72 84.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HB3' HD12 ' A' ' 47' ' ' LEU . 21.1 t -99.29 127.11 45.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.439 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 75' ' ' VAL . 41.2 mttm -109.37 107.32 17.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.597 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -81.66 103.99 11.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.42 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.499 HG22 HG12 ' A' ' 70' ' ' VAL . 1.2 m -102.45 119.31 56.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.007 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 83.7 Cg_endo -94.78 -168.98 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.163 2.575 . . . . 0.0 113.134 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 158.58 78.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.281 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.619 ' HG3' ' H ' ' A' ' 70' ' ' VAL . 32.5 Cg_exo -58.68 126.54 21.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.673 2.248 . . . . 0.0 112.465 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 55.4 m -88.74 -168.87 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.857 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -62.25 -15.82 49.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.024 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.3 p -60.27 155.77 44.42 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.51 10.08 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.41 65.86 6.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.719 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.82 136.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.346 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.23 65.55 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.418 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.619 ' H ' ' HG3' ' A' ' 62' ' ' PRO . 60.2 t -85.27 -88.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.251 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -144.73 -101.26 0.33 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.092 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.29 18.42 12.07 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt -140.48 -162.45 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 111.156 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.47 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -138.37 109.68 6.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.136 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 57' ' ' LYS . 5.0 p -103.58 111.51 33.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' SG ' ' A' ' 56' ' ' CYS . 28.1 t -104.97 124.04 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.482 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.758 HD22 HG22 ' A' ' 21' ' ' THR . 83.7 mt -109.65 100.96 9.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -94.75 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.1 mtmt -114.27 94.14 34.04 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.354 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.605 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.48 105.43 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.495 2.13 . . . . 0.0 112.577 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 17.5 mtt180 -69.62 -35.85 75.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -117.64 -177.39 3.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.872 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HE ' HG21 ' A' ' 18' ' ' VAL . 85.9 mtt180 -121.3 142.21 50.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.8 -107.37 0.5 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.456 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.8 m80 -125.96 94.68 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -109.96 162.6 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.163 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.2 m -159.92 149.62 18.16 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.582 ' HB2' HG11 ' A' ' 78' ' ' VAL . 27.1 tp -119.47 80.19 1.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -77.71 106.85 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.968 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 38' ' ' ARG . 73.1 mt -102.96 154.0 19.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.099 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.43 152.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.833 0.349 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.3 t80 -102.67 92.09 4.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.849 HG21 HG21 ' A' ' 42' ' ' VAL . 8.1 t -131.42 162.54 29.94 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.5 mtp180 -94.96 95.36 1.53 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.613 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 42' ' ' VAL . 1.3 Cg_endo -45.45 -34.07 10.17 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.094 2.529 . . . . 0.0 112.967 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -72.39 -36.78 68.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.019 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.58 6.32 39.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.675 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.4 -168.35 42.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.923 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.686 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.7 mt -117.14 154.49 18.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.27 0.557 . . . . 0.0 112.343 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.6 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.26 163.55 49.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.549 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.53 -17.47 16.28 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.569 2.179 . . . . 0.0 111.665 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.3 pt-20 -78.79 -6.73 56.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.46 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 100' ' ' LYS . 12.4 m120 -69.65 151.11 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.51 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -60.99 166.31 3.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.699 ' HB3' HD22 ' A' ' 10' ' ' ASN . 16.6 tpp180 -130.46 163.69 26.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.597 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 46.7 t80 -172.97 68.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.5 m -89.64 103.27 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.884 -178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 24' ' ' ILE . 34.7 tp -86.53 90.24 8.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 14.0 m-70 -74.45 145.9 43.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 14' ' ' VAL . 86.4 mt -146.81 104.93 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.176 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 46.7 t30 -79.58 70.62 6.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -47.55 117.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.6 p -88.11 -51.87 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -107.07 -38.41 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.953 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm -141.74 173.3 11.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.0 pt -81.23 -33.03 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.184 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.88 88.12 0.13 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.266 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.34 4.83 4.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.572 2.181 . . . . 0.0 112.438 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.63 119.82 14.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m 59.15 -175.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 9' ' ' ASP . 24.1 t -91.98 148.62 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.653 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -119.9 -7.5 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.557 ' H ' HG12 ' A' ' 7' ' ' VAL . 18.4 t70 -42.02 117.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.341 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.698 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 2.4 p-10 -122.74 -73.47 0.65 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 6.9 p-10 -43.44 103.41 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.488 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB3' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.2 57.13 0.95 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.555 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.5 m0 -78.48 122.83 26.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.921 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 5.7 p -174.76 160.95 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.549 0.69 . . . . 0.0 112.099 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -61.77 176.06 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.059 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 110' ' ' LEU . 4.1 t -174.31 -172.75 0.71 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.04 0.448 . . . . 0.0 111.63 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.0 m80 -117.38 -169.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 83' ' ' ARG . 40.8 t -90.29 129.27 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.687 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 58.34 15.14 22.38 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.26 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.3 tptp -62.96 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.682 HG22 HD22 ' A' ' 77' ' ' LEU . 7.2 m -44.02 103.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.852 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.5 m -94.35 95.12 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.568 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 39.2 tt0 -81.76 131.83 35.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.831 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.451 HD13 ' OH ' ' A' ' 106' ' ' TYR . 41.2 mt -139.3 102.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.5 102.16 11.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 11.5 mt -95.11 145.22 25.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.652 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.5 mptt -99.58 161.45 13.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.335 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.82 -147.01 7.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.559 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -174.56 93.75 0.3 Allowed Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.39 0.138 . . . . 0.0 110.742 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -55.66 -29.43 70.68 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.716 2.277 . . . . 0.0 112.991 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.3 p -59.97 -17.1 35.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.5 p -70.56 -51.29 29.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.834 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.47 1.86 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.798 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.55 -179.01 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.3 ttm -147.14 151.08 36.2 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.3 m95 -104.2 82.79 1.99 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.8 t -127.97 161.6 28.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.364 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.711 ' NH1' HD11 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -54.71 139.88 37.65 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.776 0.322 . . . . 0.0 111.408 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 91' ' ' VAL . 42.3 t -51.14 140.88 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.268 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.38 5.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.729 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 23.2 m-30 -117.25 47.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.207 0.527 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.617 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.3 p -93.44 128.76 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.859 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.29 15.73 46.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.066 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.729 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.06 -164.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.234 0.613 . . . . 0.0 111.686 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.73 -43.7 3.78 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.178 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.2 t -147.0 115.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.171 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD23 ' HD3' ' A' ' 44' ' ' LYS . 15.6 mt -57.76 -61.19 2.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 92.3 p -51.89 175.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.294 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -157.26 -99.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 111.388 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.9 pt-20 -127.28 -32.46 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.8 mm -73.52 -72.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' A' ' 78' ' ' VAL . 85.1 mt -106.15 116.98 32.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.217 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.64 73.32 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG13 HG13 ' A' ' 78' ' ' VAL . 1.3 t -78.9 90.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -92.65 90.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.56 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 9.2 t -114.99 145.88 41.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.287 0.565 . . . . 0.0 111.604 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -126.61 125.2 41.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.143 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -85.59 103.87 14.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.15 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 27.4 m -105.8 128.46 26.4 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.697 ' HB3' ' H ' ' A' ' 70' ' ' VAL . 29.7 Cg_endo -98.68 -152.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.499 2.799 . . . . 0.0 111.737 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -79.23 142.08 58.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.591 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 61' ' ' THR . 36.3 Cg_exo -61.16 96.73 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.48 2.12 . . . . 0.0 112.161 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.56 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 47.5 m -109.43 -167.44 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -116.75 -46.99 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 61.3 m -99.65 -49.55 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 14.4 Cg_exo -70.11 151.32 67.01 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.773 2.316 . . . . 0.0 112.257 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 67' ' ' MET . 47.5 ttp -157.01 19.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.364 0.602 . . . . 0.0 109.982 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -135.7 104.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.051 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.61 84.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.406 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.697 ' H ' ' HB3' ' A' ' 60' ' ' PRO . 1.9 t -125.45 -23.07 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.941 0.4 . . . . 0.0 111.298 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 125.45 84.69 0.57 Allowed Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.885 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 60' ' ' PRO . . . -145.9 -129.27 2.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.285 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 pt -135.08 -167.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.058 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -139.27 98.01 3.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.775 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.3 p -89.12 113.25 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-O 121.343 0.592 . . . . 0.0 110.661 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG22 HH22 ' A' ' 38' ' ' ARG . 20.7 t -107.06 126.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.764 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 HG22 ' A' ' 21' ' ' THR . 70.0 mt -113.62 90.68 3.41 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.648 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -90.85 105.21 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.074 0.464 . . . . 0.0 111.057 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 46.5 mtmt -106.01 96.27 12.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 52' ' ' LEU . 7.4 Cg_endo -50.67 103.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.283 1.989 . . . . 0.0 112.503 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.1 mtt180 -67.69 -35.39 78.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 53.0 mttm -117.43 178.99 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.831 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 18' ' ' VAL . 67.3 mtp180 -117.65 146.55 43.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.45 -149.59 21.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.782 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -91.26 28.3 1.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.752 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.436 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 72.3 m-70 -47.54 157.6 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 109' ' ' HIS . 54.4 m -157.31 148.22 21.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.922 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 38' ' ' ARG . 17.4 tp -107.99 165.78 11.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.75 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' C ' HD12 ' A' ' 90' ' ' LEU . 34.5 mt-10 -151.68 121.24 6.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.711 HD11 ' NH1' ' A' ' 38' ' ' ARG . 9.7 mp -116.81 161.83 18.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.289 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.3 p -158.65 155.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.117 0.484 . . . . 0.0 112.047 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.7 t80 -100.12 86.86 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.706 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.9 t -109.82 171.46 7.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -105.54 93.25 6.84 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 88.9 Cg_exo -49.17 -29.2 16.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.536 2.158 . . . . 0.0 112.339 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.38 -34.69 63.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.213 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -110.24 -76.88 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.249 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.47 -174.76 47.02 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.242 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -96.44 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 0.0 111.013 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 6.8 mttt -136.11 157.01 76.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.65 -47.38 11.43 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.735 2.29 . . . . 0.0 112.739 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.06 -12.71 8.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.85 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.617 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.8 m-20 -64.26 149.94 46.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.927 0.394 . . . . 0.0 111.357 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.71 164.03 2.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.703 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 12.1 tpp180 -137.77 162.13 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.703 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -164.41 83.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.304 0.573 . . . . 0.0 110.08 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 89' ' ' GLU . 25.8 m -88.82 133.76 34.16 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 37.5 tp -118.59 80.98 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.8 m-70 -66.46 145.42 55.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.876 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.7 mt -143.58 108.34 4.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.579 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 60.9 t30 -82.8 50.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.479 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -37.7 112.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.67 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.848 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.2 m -144.91 170.34 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -94.29 -9.49 35.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 68.2 mtm -93.04 -11.19 33.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 1' ' ' MET . 61.4 mt 74.33 -36.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.66 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 1' ' ' MET . . . 57.51 92.48 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.52 111.24 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.0 tp -140.08 -48.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -93.94 164.7 12.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 p -65.21 148.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.097 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -98.51 34.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.0 110.388 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -35.26 120.58 0.54 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.038 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -122.39 -87.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.96 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.25 98.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.804 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.516 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.5 tttt -100.96 94.55 6.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.034 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.685 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m95 -84.64 103.32 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.05 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 110' ' ' LEU . 29.6 m -148.21 -171.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.133 0.492 . . . . 0.0 112.104 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -109.32 178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.819 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.441 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.4 t -176.39 -172.67 0.48 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.95 0.405 . . . . 0.0 111.692 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 66.6 m80 -122.23 179.9 4.39 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.59 136.23 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.339 0.59 . . . . 0.0 112.221 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 58.24 15.16 21.73 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.862 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.4 tptt -58.72 85.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.327 0.563 . . . . 0.0 110.015 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.711 HG22 HD22 ' A' ' 77' ' ' LEU . 3.6 m -56.67 102.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.332 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 m -102.16 101.42 11.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.4 tt0 -81.6 135.02 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 108' ' ' LEU . 42.0 mt -136.41 104.95 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -86.24 97.87 10.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.8 mt -91.02 145.69 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 5.7 mptt -91.4 159.71 15.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.35 -154.39 25.48 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.009 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 23.8 t-20 -172.04 132.19 0.74 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.4 0.143 . . . . 0.0 110.987 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 29' ' ' ASN . 29.9 Cg_exo -62.82 -53.87 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.611 2.207 . . . . 0.0 112.672 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -83.53 51.24 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.676 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -135.01 -64.07 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.202 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.43 -106.67 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.777 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.1 m-85 -88.73 -166.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.007 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.506 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.3 ttt -133.89 149.76 51.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.508 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 23.2 m95 -100.87 110.56 22.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.154 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.663 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -154.99 -172.39 4.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.819 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 mtp85 -89.08 153.66 20.8 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.807 0.337 . . . . 0.0 111.044 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 89' ' ' GLU . 51.6 t -67.11 132.88 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.977 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.46 15.43 81.44 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.851 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.502 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 59.8 m-85 -135.75 -5.56 2.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 37' ' ' THR . 4.3 p -43.47 124.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.74 -38.5 3.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 54.8 mtpt -60.44 170.47 1.36 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.839 0.352 . . . . 0.0 111.245 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -80.33 -61.69 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.784 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.89 143.94 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.87 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt -101.82 -48.75 4.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.248 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.517 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 72.2 p -50.95 177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.016 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -156.43 -89.83 0.04 OUTLIER 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.399 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -127.14 -35.25 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.7 mm -70.53 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.231 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.4 mt -101.35 116.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.451 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -71.16 66.98 0.43 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG21 ' HD2' ' A' ' 38' ' ' ARG . 19.2 t -71.23 81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.822 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.7 t -75.69 78.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -94.63 139.71 30.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.366 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -131.36 107.53 9.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.747 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -72.6 109.58 6.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.289 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -94.18 112.8 58.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.429 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -94.23 -68.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.105 2.537 . . . . 0.0 113.714 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.611 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -131.04 142.02 44.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.831 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HD2' HG22 ' A' ' 61' ' ' THR . 48.3 Cg_exo -56.13 134.96 67.4 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.578 2.185 . . . . 0.0 112.475 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -95.94 -177.3 3.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 t -86.63 10.22 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.5 p -60.52 155.68 47.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.89 14.32 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -127.99 84.79 2.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.29 136.72 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.055 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.06 40.84 1.13 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.36 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.6 83.22 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 110.809 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA3' ' C ' ' A' ' 61' ' ' THR . . . 149.78 97.54 0.17 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.193 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 59' ' ' THR . . . 149.14 2.73 0.32 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.825 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.9 pt -150.92 -162.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 111.112 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -133.02 99.8 4.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.466 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.4 p -94.79 108.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.192 0.52 . . . . 0.0 110.724 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 43.0 t -104.84 126.33 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.825 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.711 HD22 HG22 ' A' ' 21' ' ' THR . 82.1 mt -110.66 98.44 7.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.761 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.584 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.47 107.87 19.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.005 0.431 . . . . 0.0 111.275 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 44.8 mtmt -112.65 95.13 31.37 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.22 101.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.1 . . . . 0.0 112.848 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.528 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -65.77 -31.06 71.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.872 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -119.01 176.97 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.632 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -120.71 126.06 49.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.968 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 149.63 -109.21 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.236 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -111.98 113.55 25.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -135.77 156.48 48.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.591 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.557 ' CG2' HG22 ' A' ' 107' ' ' THR . 28.9 m -158.75 148.68 19.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.534 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 41.2 tp -108.58 90.23 3.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.72 ' HA ' HG23 ' A' ' 107' ' ' THR . 39.3 mt-10 -71.8 97.29 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.104 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -111.46 125.28 53.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.489 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -126.75 172.24 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.488 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 1.7 t80 -109.69 86.36 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.014 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.6 t -117.61 158.01 25.39 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' TYR . 79.8 mtp180 -100.49 98.9 8.72 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.84 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -43.39 -38.02 8.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 112.845 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.88 -40.35 92.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.618 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -102.38 -75.58 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.04 -173.58 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.272 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -99.94 143.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 0.0 111.34 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -135.59 169.49 13.55 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.16 -37.87 17.34 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.643 2.229 . . . . 0.0 112.067 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.57 -17.21 53.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.169 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.623 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.96 135.06 56.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -54.75 158.37 2.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 6.3 tpp180 -119.24 160.16 22.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.433 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 49.7 t80 -173.28 68.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.975 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.72 97.63 10.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.328 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 19.5 tp -78.85 93.28 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.685 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.2 m-70 -76.66 142.71 40.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 14' ' ' VAL . 89.9 mt -146.64 110.94 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.302 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 44.0 t30 -83.44 65.7 8.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -42.4 136.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.991 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.8 m -137.48 -62.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -70.27 113.75 7.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HE3' ' HB3' ' A' ' 5' ' ' LEU . 83.8 mtp -103.1 131.03 50.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.5 pt -85.64 -11.44 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.42 149.49 15.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.23 154.97 31.51 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.581 2.188 . . . . 0.0 112.257 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.435 ' HB3' ' HE3' ' A' ' 1' ' ' MET . 58.3 tp -157.22 -59.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.41 -11.02 1.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.49 125.13 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -143.91 120.77 11.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.021 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.94 121.79 15.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.445 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.7 OUTLIER -124.01 -93.92 0.5 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 111.772 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -59.32 97.71 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.304 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.0 ptmt -93.69 74.69 4.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.701 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -50.22 103.89 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.834 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.617 HG23 HD23 ' A' ' 110' ' ' LEU . 34.7 m -146.82 -174.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 112.436 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -108.95 -178.1 3.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.808 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.556 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.31 -173.39 0.44 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.983 0.421 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.599 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 47.9 m-70 -124.12 -177.22 3.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.979 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.94 137.79 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 112.174 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.33 14.01 11.7 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.659 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.599 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 20.5 tptt -57.82 85.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.193 0.497 . . . . 0.0 109.927 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.77 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -57.27 92.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.291 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -88.36 103.2 15.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.613 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.5 tt0 -85.2 129.66 34.76 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.553 HG22 ' HG ' ' A' ' 26' ' ' LEU . 42.1 mt -133.84 107.69 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.645 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -87.83 91.64 8.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.368 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 24' ' ' ILE . 15.5 mt -86.24 145.13 27.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.488 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -99.53 163.65 12.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.22 -141.24 5.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HB3' HG23 ' A' ' 32' ' ' THR . 62.6 t30 -174.3 92.8 0.32 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.548 0.214 . . . . 0.0 110.564 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 51.0 Cg_exo -53.86 -17.7 11.12 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.742 2.295 . . . . 0.0 113.12 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.5 p -82.84 12.77 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 29' ' ' ASN . 56.8 p -96.55 -64.18 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.208 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.27 -26.38 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.705 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 36.0 m-85 -98.68 -176.0 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.219 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.0 ttm -150.61 151.05 31.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.087 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.485 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.4 m95 -106.62 88.14 2.69 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.5 t -134.56 -168.57 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -74.99 157.5 34.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.67 0.271 . . . . 0.0 110.722 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 98.9 t -79.56 134.81 26.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.749 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 -10.44 5.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.822 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 39' ' ' VAL . 16.8 m-30 -106.08 7.91 32.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.143 0.497 . . . . 0.0 110.284 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.904 HG21 HG21 ' A' ' 93' ' ' THR . 14.4 t -62.16 106.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.08 -19.21 10.18 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.749 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -70.99 178.23 3.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.753 0.311 . . . . 0.0 110.724 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.64 -51.02 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.34 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.56 -30.18 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.77 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.746 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 6.8 mt 70.42 -72.85 0.1 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 40.6 p -49.54 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.779 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.2 -89.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -130.35 -30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.279 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.7 mm -75.32 -79.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.2 mt -102.52 113.42 26.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.572 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -69.81 71.14 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.825 0.345 . . . . 0.0 110.249 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.656 HG11 ' HD3' ' A' ' 38' ' ' ARG . 2.1 t -72.78 87.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG12 ' HE3' ' A' ' 57' ' ' LYS . 20.4 t -86.78 86.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 76' ' ' VAL . 5.6 t -111.82 134.19 53.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.896 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' HG12 ' A' ' 55' ' ' VAL . 32.1 mmtp -113.91 112.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.507 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -70.95 117.5 12.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.847 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -106.2 114.05 62.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.631 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 97.9 Cg_endo -93.29 169.42 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 112.926 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.578 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.67 146.8 73.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD2' HG22 ' A' ' 61' ' ' THR . 32.0 Cg_exo -60.27 136.39 68.07 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.561 2.174 . . . . 0.0 112.413 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.9 t -126.64 -92.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.2 m -70.16 -22.26 62.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.612 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 53.1 p -82.96 159.42 62.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 70.0 Cg_endo -71.31 -155.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.554 2.169 . . . . 0.0 112.039 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -108.14 74.54 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.969 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.51 38.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.65 94.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.367 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 70' ' ' VAL . 5.3 t -115.05 2.09 8.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 111.074 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.4 -140.54 15.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.948 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 59' ' ' THR . . . 115.89 15.32 7.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -151.86 -165.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.141 0.496 . . . . 0.0 111.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -133.73 102.8 5.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.708 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 74.3 t -87.57 107.1 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.777 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.8 t -108.95 119.6 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.77 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -112.2 95.38 5.42 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.587 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -90.8 108.76 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.021 0.439 . . . . 0.0 111.282 -178.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.0 mtmm -110.45 92.27 13.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.63 102.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.524 2.149 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.3 mtt180 -64.1 -34.76 78.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -116.06 -175.81 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.83 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -122.8 146.46 47.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 133.19 -136.79 8.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.492 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.88 95.32 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.963 0.411 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.14 164.37 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.613 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 109' ' ' HIS . 88.3 m -159.8 150.24 18.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.586 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 HH11 ' A' ' 38' ' ' ARG . 34.6 tp -120.28 94.53 4.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.608 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.7 mt-10 -73.88 105.54 5.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.802 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 26.5 mt -111.39 129.64 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.9 p -133.66 158.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.161 0.505 . . . . 0.0 112.092 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -102.37 92.11 4.55 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.979 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.904 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -123.02 170.36 10.23 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -102.11 94.81 4.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.9 Cg_exo -45.21 -38.17 14.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.721 2.28 . . . . 0.0 112.729 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -37.7 88.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -101.57 -80.71 0.49 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.413 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.04 178.39 44.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.732 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.8 mt -94.39 153.08 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 0.0 111.557 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.7 mttt -140.41 162.65 48.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.2 Cg_endo -70.95 -39.77 3.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.712 2.275 . . . . 0.0 111.998 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.5 -27.47 69.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.784 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.5 HD21 ' HA ' ' A' ' 93' ' ' THR . 8.1 m-20 -52.5 153.72 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -59.66 160.35 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.6 tpp180 -129.87 163.9 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.206 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.7 t80 -176.49 71.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 0.0 109.111 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 89' ' ' GLU . 1.9 m -85.83 95.98 9.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.341 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 48.2 tp -72.88 86.28 1.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -75.74 139.6 41.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 14' ' ' VAL . 94.6 mt -145.49 102.52 3.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.621 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 37.5 t30 -79.26 73.0 5.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 HG23 ' A' ' 16' ' ' THR . 1.7 t -48.4 137.82 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.729 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.969 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.6 m -93.45 -34.52 13.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -69.93 -46.22 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.35 157.87 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.7 mt -83.16 -34.94 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.38 88.92 0.11 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.85 115.34 2.45 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.526 2.15 . . . . 0.0 112.304 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -135.78 -64.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -113.6 -36.19 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.17 131.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.037 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -174.27 135.62 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.14 118.52 22.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.521 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -119.36 -87.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.98 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -34.63 100.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.778 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.5 tttt -89.84 100.25 13.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.472 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.674 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -82.05 105.08 12.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.79 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.1 p -154.84 -178.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.077 0.465 . . . . 0.0 111.718 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.79 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -100.67 -176.12 3.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.604 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.496 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.12 -174.4 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.183 0.516 . . . . 0.0 112.195 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.7 m-70 -114.96 -168.93 1.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.113 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.79 128.77 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 111.897 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.65 15.86 27.75 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.505 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.61 84.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.712 HG22 HD22 ' A' ' 77' ' ' LEU . 4.9 m -47.8 101.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.981 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 78' ' ' VAL . 51.9 m -96.03 99.62 11.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.9 tt0 -81.97 131.6 35.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.311 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 108' ' ' LEU . 43.7 mt -138.67 103.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.764 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -85.58 107.02 17.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.346 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.545 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 6.4 mt -104.34 143.93 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.137 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -96.79 162.94 13.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.977 0.418 . . . . 0.0 110.591 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.62 -158.76 29.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.311 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 14.5 t-20 -172.33 135.39 0.82 Allowed Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.694 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.35 -48.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.573 2.182 . . . . 0.0 113.086 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -71.19 2.37 4.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 29' ' ' ASN . 52.8 m -112.11 -54.93 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.11 -108.63 1.29 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.956 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -113.51 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 17.7 ttm -117.7 152.84 34.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.896 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.4 m95 -111.44 89.99 3.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.186 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.0 t -134.24 -165.88 1.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.07 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.8 mtp85 -90.66 155.01 19.15 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.958 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 37.8 t -74.5 133.01 32.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.49 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.75 89.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.51 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 58.7 m-85 -130.68 -1.18 4.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 0.0 110.477 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 93' ' ' THR . 21.0 t -54.13 118.74 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.067 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.02 -28.15 15.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.982 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.0 mttm -69.35 172.44 7.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.53 -62.45 1.62 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -107.22 141.89 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt -92.76 -51.92 4.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 64.4 p -53.47 -179.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.59 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -157.2 -90.81 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.63 -30.37 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -74.99 -79.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.214 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.626 HD22 HG12 ' A' ' 78' ' ' VAL . 7.1 mt -100.21 113.62 26.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.71 68.32 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.068 0.461 . . . . 0.0 109.928 177.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -72.7 84.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.768 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 29.3 t -80.14 80.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.591 0.71 . . . . 0.0 109.19 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' HG22 ' A' ' 76' ' ' VAL . 17.4 t -97.17 124.23 41.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.212 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -114.82 105.96 13.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -70.37 97.95 1.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 m -95.47 125.42 49.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.133 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 22.1 Cg_endo -97.44 -157.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.196 2.597 . . . . 0.0 111.571 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 m -157.26 135.43 7.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.31 103.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.88 2.386 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.7 m -118.89 -171.48 2.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 t -75.15 -4.63 39.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 67.9 p -65.62 156.71 81.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.044 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 72.1 Cg_endo -73.83 -156.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.521 2.147 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.4 mmt -76.78 -6.26 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.77 109.44 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.75 134.41 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.349 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -122.91 -89.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.18 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . 137.55 115.69 1.41 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.231 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 60' ' ' PRO . . . -156.28 -126.47 0.96 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.932 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt -123.68 -165.09 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.9 m-85 -138.99 101.08 4.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.348 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.46 100.2 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 120.876 0.369 . . . . 0.0 110.814 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.3 t -100.96 118.95 48.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.138 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -110.35 97.52 6.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.629 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.626 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.81 106.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.9 mtmm -111.75 92.99 18.66 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.211 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.3 Cg_endo -51.76 102.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.388 2.059 . . . . 0.0 112.606 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.5 mtt180 -63.93 -36.37 83.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.822 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 79.2 mttt -119.45 178.01 4.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -119.82 140.36 50.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.963 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.551 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.45 -113.57 0.71 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.359 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -115.99 93.2 4.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.816 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.1 m-70 -113.63 162.27 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.6 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 109' ' ' HIS . 60.0 m -159.31 149.92 19.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 111.723 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 22.6 tp -115.66 93.47 4.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.388 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.8 mt-10 -78.42 92.62 4.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.191 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 59.3 mt -103.22 123.72 47.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.9 p -126.66 155.59 37.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.946 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.1 t80 -97.89 82.88 3.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.472 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.882 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -118.79 158.75 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 58.5 mtp180 -97.45 98.21 4.78 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.512 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 93' ' ' THR . 93.8 Cg_exo -44.04 -38.44 10.44 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.884 2.39 . . . . 0.0 112.735 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.3 93.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -97.26 -74.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.44 179.7 39.36 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.088 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.651 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.7 mt -94.23 146.25 6.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 43.6 mtmt -140.28 162.9 47.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.215 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 42.4 Cg_endo -68.02 -38.76 12.13 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.777 2.318 . . . . 0.0 112.089 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.7 -28.22 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.826 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.6 HD21 ' HA ' ' A' ' 93' ' ' THR . 6.9 m-20 -55.22 149.37 12.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.05 166.17 2.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.6 tpp180 -132.7 164.11 27.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.44 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.638 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 51.3 t80 -174.47 64.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.635 0.731 . . . . 0.0 109.184 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.3 m -87.61 92.22 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.228 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 27.5 tp -73.46 93.55 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.2 m-70 -77.31 140.71 40.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 16' ' ' THR . 92.3 mt -143.78 104.08 4.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.39 68.33 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.551 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -45.02 118.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.369 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.963 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.4 m -142.71 -3.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -142.52 108.14 5.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.44 151.7 29.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.7 pt -84.03 -1.16 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.12 153.09 53.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.56 -38.09 20.17 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.425 2.083 . . . . 0.0 112.228 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp 59.95 28.37 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.802 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 m 61.66 16.52 7.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.27 119.91 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -174.7 134.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.169 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -55.87 118.96 5.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.069 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.645 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -123.7 -95.1 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.106 0.479 . . . . 0.0 112.137 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.2 99.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.713 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 53.6 tptt -95.09 92.13 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.244 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m95 -75.84 105.68 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.743 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.678 HG22 ' H ' ' A' ' 15' ' ' ASP . 9.9 p -156.93 173.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.239 0.542 . . . . 0.0 111.888 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.678 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -93.64 -173.59 3.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.57 -175.96 0.84 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.153 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 4.5 m-70 -115.24 -163.77 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.715 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.13 132.37 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 111.985 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.55 20.05 22.08 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.507 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptm -63.3 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.782 HG22 HD22 ' A' ' 77' ' ' LEU . 4.1 m -51.43 99.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.517 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HB ' HG23 ' A' ' 78' ' ' VAL . 38.2 m -98.58 101.02 12.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.722 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HG3' HG23 ' A' ' 75' ' ' VAL . 33.4 tt0 -76.79 133.92 39.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.505 HG22 ' HG ' ' A' ' 26' ' ' LEU . 23.2 mt -131.48 94.97 2.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.262 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 6.5 m170 -84.82 78.27 9.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.026 0.441 . . . . 0.0 110.024 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HG ' HG22 ' A' ' 24' ' ' ILE . 89.8 mt -68.98 160.15 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.325 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -113.63 164.24 13.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.07 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.08 -145.95 11.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.771 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.435 HD21 ' HB ' ' A' ' 31' ' ' THR . 42.9 t30 -170.66 105.47 0.42 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.367 0.127 . . . . 0.0 110.782 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.555 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -58.93 -24.03 70.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.478 2.119 . . . . 0.0 112.279 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.435 ' HB ' HD21 ' A' ' 29' ' ' ASN . 22.4 m -60.11 -27.65 67.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.23 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.9 p -59.35 -36.16 75.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.996 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.69 -14.45 6.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.74 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.78 -175.26 2.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.138 0.494 . . . . 0.0 111.315 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 4.6 ttt -147.98 151.9 36.57 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.851 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -107.6 96.7 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.131 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -147.39 -166.42 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.647 HH11 HG21 ' A' ' 54' ' ' VAL . 5.1 mtp180 -84.84 155.7 21.64 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.849 0.357 . . . . 0.0 111.253 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 43.2 t -74.35 132.8 32.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.439 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.44 89.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.261 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 64.9 m-85 -127.6 3.98 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.098 0.475 . . . . 0.0 110.419 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 37' ' ' THR . 3.6 p -45.22 133.1 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.071 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.71 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.302 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.41 -168.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.75 -46.57 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.225 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.407 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 3.4 p -74.86 -46.95 39.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.744 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 7.8 mt 71.83 -60.42 0.52 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 123.401 0.438 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 45.6 p -48.87 -179.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.384 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -156.55 -85.45 0.05 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.89 -30.5 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.585 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -73.74 -76.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.55 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.9 mt -102.85 115.65 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.324 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.18 70.91 0.24 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.21 0.528 . . . . 0.0 109.699 177.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HH11 ' A' ' 38' ' ' ARG . 21.7 t -76.63 83.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.312 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 t -82.01 86.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.488 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.5 t -96.18 150.95 19.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.792 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' HG13 ' A' ' 75' ' ' VAL . 55.1 mttm -139.77 114.4 9.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.973 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.516 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -94.68 105.52 17.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.945 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.6 m -107.39 108.52 61.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -98.62 92.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.47 2.78 . . . . 0.0 111.71 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.6 p -86.4 149.87 50.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.627 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 24.4 Cg_exo -63.56 177.63 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.726 2.284 . . . . 0.0 112.203 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.1 p -106.13 -22.76 12.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.6 t 56.38 12.04 0.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 35.8 p -121.78 163.23 32.37 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 61.0 Cg_endo -69.12 11.89 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.591 2.194 . . . . 0.0 112.337 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 65' ' ' THR . 50.9 ttm -117.97 85.56 2.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.104 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.4 t -38.86 126.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.795 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.58 101.77 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.229 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.99 28.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.555 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -56.96 112.94 3.9 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.219 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.14 -127.39 3.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.747 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm -127.34 154.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.876 0.846 . . . . 0.0 111.706 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 1.9 m-85 -130.27 76.2 1.71 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.564 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.3 p -84.5 110.27 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.001 -177.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 56' ' ' CYS . 90.3 t -106.81 122.06 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.3 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 21' ' ' THR . 81.8 mt -105.36 102.49 11.96 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.905 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.15 108.51 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.951 0.405 . . . . 0.0 111.091 -178.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -113.9 93.78 30.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.9 Cg_endo -47.99 102.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.567 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.9 mtt180 -69.16 -36.72 77.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.293 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -117.15 170.58 8.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -107.22 123.82 48.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.593 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.77 -128.79 2.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.537 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.432 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -106.86 95.58 5.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.377 . . . . 0.0 110.962 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.433 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -109.65 161.53 15.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.402 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.0 m -158.17 148.93 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 111.732 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 24.9 tp -115.77 90.39 3.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.571 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.5 mt-10 -75.57 94.19 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.1 mt -101.91 125.33 48.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.5 p -131.12 158.08 43.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.715 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.6 t80 -97.1 86.44 3.96 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -110.86 167.11 10.49 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 61.5 mtp180 -102.52 97.68 9.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.393 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.0 Cg_exo -51.44 -31.78 40.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.544 2.163 . . . . 0.0 112.635 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.14 10.12 11.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.2 mm-40 -148.41 -79.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.85 40.92 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 mt -94.87 155.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.894 0.378 . . . . 0.0 111.267 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.579 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.3 mtmt -143.76 161.4 46.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.944 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.4 Cg_endo -72.08 -39.7 2.96 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.31 -27.02 69.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.0 m120 -55.97 155.03 6.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -56.25 161.95 2.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.042 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.645 ' HB3' HD22 ' A' ' 10' ' ' ASN . 17.3 tpp180 -131.66 164.28 26.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.746 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 50.0 t80 -177.58 65.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.345 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 10.4 m -87.25 94.12 9.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.7 tp -74.93 93.8 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.703 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.2 m-70 -77.11 138.65 39.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 110.706 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 96.2 mt -142.29 98.06 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -76.08 78.17 2.92 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.593 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.4 t -51.77 123.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.474 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 t -148.37 -43.78 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.777 0.322 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -86.6 118.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.85 174.97 5.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.9 pt -114.05 4.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.96 116.23 12.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.02 110.62 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.456 2.104 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.17 -3.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -147.7 -14.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.5 -10.49 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.145 0.498 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -111.99 0.01 15.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t70 52.64 95.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.051 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.681 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -131.15 -92.2 0.42 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.919 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 4.1 m-20 -55.22 97.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' A' ' 14' ' ' VAL . 54.5 tttp -99.63 95.27 6.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.85 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.54 102.36 12.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.166 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.534 HG21 ' HE3' ' A' ' 12' ' ' LYS . 35.2 m -147.34 -170.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.041 0.448 . . . . 0.0 111.809 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -103.99 -176.19 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.303 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -173.83 -175.65 1.1 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 112.293 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 17.5 m80 -116.56 -163.06 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.017 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 44.4 t -98.56 129.06 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.808 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.67 14.52 36.64 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.287 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -64.08 83.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.2 102.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.809 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 98.3 m -96.16 100.19 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.389 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.0 tt0 -81.34 131.45 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.033 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.9 mt -136.0 104.46 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.78 100.94 12.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.8 mt -95.52 147.72 23.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.466 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -101.94 162.01 13.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.54 -147.49 9.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -174.78 101.87 0.27 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.39 0.138 . . . . 0.0 110.754 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.52 -22.06 49.22 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.491 2.127 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 m -62.61 -30.63 71.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.5 p -62.26 -53.87 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.11 -39.75 0.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.783 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 65.9 m-85 -81.35 -177.46 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.059 0.457 . . . . 0.0 111.375 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ttm -150.94 152.94 34.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.902 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 9.1 m95 -107.25 87.24 2.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -131.85 -166.55 1.74 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.175 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 22.0 mtp85 -90.24 148.14 23.1 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.217 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 17.4 t -68.07 136.29 26.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.544 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.31 1.7 88.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.405 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 61.5 m-85 -128.24 -1.62 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -55.21 107.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.057 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.96 -29.04 8.33 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.959 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 98.0 mttt -68.08 174.92 3.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.982 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.12 -38.93 17.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.14 132.47 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.3 mt -85.62 -51.68 6.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.996 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.6 t -51.43 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.69 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -157.58 -91.34 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -130.88 -32.64 1.63 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.157 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.9 mm -70.46 -76.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.304 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -104.34 114.48 28.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -66.36 72.99 0.08 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 HG13 ' A' ' 78' ' ' VAL . 10.9 t -79.44 85.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.164 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.0 t -81.12 83.3 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.8 t -98.33 139.87 33.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.369 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -133.28 110.0 9.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -76.77 101.44 5.84 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 23.2 m -97.87 109.22 50.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.059 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' HB2' HG12 ' A' ' 70' ' ' VAL . 74.2 Cg_endo -100.8 97.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.593 2.862 . . . . 0.0 111.266 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.461 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -76.26 140.07 68.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.479 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' A' ' 61' ' ' THR . 20.7 Cg_exo -65.73 -179.04 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.753 2.302 . . . . 0.0 112.158 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.4 t -84.81 -177.59 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -80.92 -64.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 62.6 m -103.05 -48.47 0.17 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.916 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 16.1 Cg_exo -69.24 -157.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.845 2.363 . . . . 0.0 112.282 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -154.62 17.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.72 118.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.02 -67.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.408 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 60' ' ' PRO . 98.6 t 53.56 90.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.54 133.37 10.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.528 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -136.03 -128.9 2.78 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -142.96 -165.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.063 0.458 . . . . 0.0 110.991 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -135.32 100.42 4.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.69 104.32 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.926 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HD11 ' A' ' 90' ' ' LEU . 37.2 t -107.09 120.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.289 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 80.0 mt -110.38 100.38 9.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.826 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.13 107.26 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.146 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.0 mtmm -109.5 103.58 53.19 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.392 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.8 Cg_exo -51.59 101.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.204 . . . . 0.0 112.605 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.581 HH11 ' HA ' ' A' ' 50' ' ' GLU . 11.8 mtt180 -71.91 -37.1 70.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.828 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.518 ' H ' ' HE1' ' A' ' 86' ' ' HIS . 57.1 mttm -120.39 173.45 7.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -110.05 137.43 47.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.652 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 141.63 -118.8 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.742 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -110.15 100.38 9.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.0 111.268 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.518 ' HE1' ' H ' ' A' ' 82' ' ' LYS . 11.5 m-70 -119.43 156.45 30.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 107' ' ' THR . 58.1 m -159.63 147.93 17.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.2 tp -104.67 90.12 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.368 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.768 ' HA ' HG23 ' A' ' 107' ' ' THR . 42.9 mt-10 -72.43 95.15 1.73 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.894 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 35.8 mt -109.9 133.96 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.3 p -140.41 153.93 22.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.843 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.5 t80 -97.83 84.57 3.37 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.4 t -116.4 167.83 10.69 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 77.8 mtp180 -100.38 94.53 3.46 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 93' ' ' THR . 77.7 Cg_exo -43.45 -24.63 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.802 2.334 . . . . 0.0 113.371 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -79.47 -62.21 1.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 94' ' ' ARG . 1.6 pp20? -72.23 -39.1 68.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.674 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.8 -165.14 24.64 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -112.98 132.9 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 111.748 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE3' ' CD ' ' A' ' 97' ' ' GLU . 5.8 mttt -120.57 156.26 55.97 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.8 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.53 -47.42 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.918 2.412 . . . . 0.0 112.73 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -53.75 -17.7 2.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.832 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 11.3 m120 -63.76 157.22 24.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -57.51 159.22 5.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.244 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.681 ' HB3' HD22 ' A' ' 10' ' ' ASN . 13.5 tpp180 -129.68 164.34 24.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.029 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.593 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.0 t80 -174.85 72.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.768 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.05 96.02 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.397 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 20.6 tp -76.46 93.3 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.7 m-70 -77.55 144.87 37.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 75.1 mt -145.67 113.37 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.23 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.4 t30 -83.39 65.29 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -46.06 129.01 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.443 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.937 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.8 p -146.41 -9.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -147.36 122.49 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.06 136.52 52.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -81.53 -17.51 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -166.47 -49.94 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.897 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 72.9 Cg_exo -49.55 120.82 6.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.535 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.6 tp -86.61 -67.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.9 t -87.5 174.05 8.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.752 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.665 HG22 ' H ' ' A' ' 9' ' ' ASP . 14.9 p -83.56 138.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 4.5 mptp? -106.23 28.36 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.665 ' H ' HG22 ' A' ' 7' ' ' VAL . 18.4 t70 -35.5 121.78 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.809 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -118.46 -89.13 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -32.36 99.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.207 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' HD13 ' A' ' 108' ' ' LEU . 19.8 ptmt -93.88 73.57 4.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -49.62 104.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG23 HD23 ' A' ' 110' ' ' LEU . 28.2 m -146.62 -175.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 112.503 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -110.83 179.68 3.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.641 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.519 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.8 t -177.08 -173.12 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 112.023 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 64.1 m80 -119.15 -167.47 1.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.038 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 25.9 t -84.46 139.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 112.182 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.4 13.15 10.1 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.731 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.1 tptt -59.92 82.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.737 HG22 HD22 ' A' ' 77' ' ' LEU . 3.7 m -54.39 98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.381 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -94.96 101.24 13.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.4 tt0 -84.18 130.15 34.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.55 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 108' ' ' LEU . 46.9 mt -136.47 101.07 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.205 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -81.69 109.82 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.5 mt -104.63 152.35 22.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -108.48 159.57 16.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.979 0.418 . . . . 0.0 110.443 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.81 -39.14 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.172 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t30 65.38 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.77 -0.215 . . . . 0.0 110.951 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 178.33 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.585 2.19 . . . . 0.0 112.681 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p 47.43 25.11 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.798 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.9 m -117.94 -60.15 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.95 -103.86 0.57 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.671 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -105.83 -166.45 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.526 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 3.3 ttt -118.88 151.21 38.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.966 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -108.39 89.88 3.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.5 t -135.58 -167.05 1.95 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.413 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.715 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.0 mtp85 -89.97 147.23 23.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.703 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 42.5 t -63.92 132.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.697 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.31 14.23 79.12 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.809 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.476 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 63.2 m-85 -136.44 0.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.734 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.3 p -45.28 123.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.175 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -39.19 2.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.536 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 94.1 mttt -60.32 165.96 3.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.02 -45.5 12.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.782 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.36 135.49 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.715 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.8 mt -100.32 -50.19 4.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.14 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 54' ' ' VAL . 88.6 p -52.64 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.495 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.78 -86.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.183 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.64 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.97 -34.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.9 mm -61.52 -62.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.748 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 80' ' ' PRO . 38.6 mt -126.79 134.46 50.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.947 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.434 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -74.07 67.05 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 ' NH1' ' A' ' 38' ' ' ARG . 4.0 t -73.82 82.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.059 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 27.2 t -80.6 81.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.51 0.672 . . . . 0.0 109.215 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' HG22 ' A' ' 76' ' ' VAL . 24.4 t -91.8 135.35 33.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.873 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -127.52 105.14 8.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.526 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -81.62 111.92 18.36 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.514 HG22 HG23 ' A' ' 70' ' ' VAL . 2.6 m -103.27 100.35 17.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.806 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 39.6 Cg_endo -102.15 9.87 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.799 3.0 . . . . 0.0 113.401 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.518 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -85.27 137.31 37.08 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.349 -178.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 61' ' ' THR . 92.6 Cg_endo -86.26 -178.89 2.94 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.793 2.329 . . . . 0.0 112.269 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 66' ' ' PRO . 8.0 t -163.35 -172.41 2.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.802 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -104.07 -58.54 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 58.5 m -106.19 -49.72 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.03 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 15.7 Cg_exo -69.08 122.16 9.01 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.758 2.306 . . . . 0.0 112.298 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 94.6 mmm -145.05 19.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.117 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -107.72 28.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.087 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.52 -29.29 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 59' ' ' THR . 3.5 p -137.67 82.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.305 0.574 . . . . 0.0 110.995 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.77 16.5 0.72 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.083 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 60' ' ' PRO . . . 104.12 29.67 5.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.526 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.4 pt -101.29 -168.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.174 0.511 . . . . 0.0 111.349 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -142.71 97.73 3.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.172 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.67 104.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 110.662 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.461 HG22 ' SG ' ' A' ' 56' ' ' CYS . 23.3 t -99.68 127.16 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.586 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -111.71 98.7 7.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.851 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.95 105.11 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -104.46 98.81 15.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.619 ' HA ' HD22 ' A' ' 52' ' ' LEU . 93.2 Cg_exo -43.05 100.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.066 2.511 . . . . 0.0 113.105 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.64 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.5 mtt180 -76.56 -29.73 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.118 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 79.5 mttt -122.4 154.88 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -96.66 124.62 40.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.031 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.569 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.35 -159.53 24.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.591 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -67.12 117.77 9.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.454 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 88.8 m-70 -145.43 170.04 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 88' ' ' LEU . 51.4 m -161.28 159.65 28.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.119 0.485 . . . . 0.0 112.202 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.666 HD22 HG21 ' A' ' 78' ' ' VAL . 10.1 tp -119.13 93.29 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.467 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.67 95.95 1.94 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 49.7 mt -107.98 115.89 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 92' ' ' TYR . 10.6 p -120.16 157.17 22.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.1 t80 -95.98 79.8 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.22 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.63 ' HA ' HD21 ' A' ' 103' ' ' ASN . 6.3 t -108.45 150.61 27.18 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 17.2 mtp180 -92.03 102.65 6.59 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.821 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 93' ' ' THR . 50.2 Cg_exo -55.25 -30.86 73.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.597 2.198 . . . . 0.0 112.437 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -65.04 -25.14 67.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.464 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -122.65 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.282 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.65 -173.73 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.373 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.597 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.1 mt -97.26 139.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 111.127 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -132.65 166.84 26.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.22 -41.2 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.822 2.348 . . . . 0.0 112.334 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.91 -18.01 41.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.63 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.6 m-20 -60.85 148.19 40.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 168.3 2.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.0 tpp180 -131.75 164.18 26.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.445 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.661 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 45.2 t80 -171.81 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.507 -0.769 . . . . 0.0 108.955 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -86.7 91.98 8.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.574 -179.057 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.2 tp -70.69 90.99 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.075 0.464 . . . . 0.0 110.277 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 31.6 m-70 -77.38 139.96 39.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.693 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -144.06 108.82 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.8 t30 -84.09 61.29 6.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.569 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.8 t -40.55 140.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.942 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.999 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.3 t -103.51 -63.66 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 110.996 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 62.17 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp 58.63 -173.09 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.09 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -114.4 -28.52 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.036 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -59.65 149.96 68.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.163 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 20.5 Cg_exo -66.13 -0.9 4.56 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.677 2.251 . . . . 0.0 112.412 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.16 -31.84 63.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.013 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -89.21 143.48 26.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.49 135.33 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.12 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.666 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -108.09 -3.91 18.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -36.63 120.74 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.367 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.1 p-10 -126.0 -94.1 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 22.1 m-20 -38.45 98.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.539 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -98.38 87.9 3.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.644 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.8 m95 -78.72 98.27 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.752 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 110' ' ' LEU . 30.4 m -147.3 -172.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 111.961 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.76 -178.55 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.798 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -174.74 -174.06 0.78 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.06 0.457 . . . . 0.0 111.927 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 56.6 m80 -116.04 -173.72 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.012 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.81 135.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.249 0.547 . . . . 0.0 112.05 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 60.26 14.18 32.09 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.883 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.0 tptm -58.13 84.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.24 0.52 . . . . 0.0 109.902 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.794 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -56.54 100.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.427 HG21 HD21 ' A' ' 108' ' ' LEU . 88.6 m -96.81 103.72 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.546 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.652 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.2 tt0 -75.9 117.01 17.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.046 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.698 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 67.5 mt -114.15 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.301 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.436 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.2 m170 -100.93 104.29 15.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.415 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 36.3 mt -96.08 163.08 13.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.308 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -101.88 163.56 12.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.096 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.29 -146.31 16.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.516 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.434 ' O ' HG22 ' A' ' 32' ' ' THR . 8.0 p-10 -172.93 142.26 1.04 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.517 0.199 . . . . 0.0 111.2 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.3 -3.3 11.46 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.553 2.169 . . . . 0.0 112.285 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.4 p -82.16 -41.44 20.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.696 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 29' ' ' ASN . 1.7 t -54.65 -43.4 72.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.317 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.55 -63.31 0.48 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.16 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.461 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 81.2 m-85 -60.64 175.85 0.43 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.242 0.544 . . . . 0.0 111.68 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.536 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.2 ttm -146.86 154.26 41.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.661 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.545 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 3.4 m95 -110.92 91.8 3.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -134.73 -163.8 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.083 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.68 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -83.23 150.52 26.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.627 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -73.44 129.7 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.359 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.89 80.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 91.6 m-85 -136.2 4.14 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.2 p -49.17 133.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.253 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.67 -34.8 2.91 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.83 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 57.4 mttp -59.75 164.0 4.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.54 -37.84 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.38 128.47 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.12 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.9 mt -89.41 -50.49 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.113 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 54.1 p -54.18 -171.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.863 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.89 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.87 -34.62 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.486 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.8 mm -70.58 -77.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.502 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.3 mt -101.46 119.49 38.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.404 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.95 70.36 0.35 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.094 0.473 . . . . 0.0 109.887 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -72.58 84.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.896 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.8 t -81.04 91.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 54.0 t -90.25 130.27 36.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.113 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 54.8 mttm -124.98 80.25 1.86 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.842 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.536 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -64.73 119.59 10.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.617 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.5 m -100.43 100.62 12.52 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 40.5 Cg_endo -102.7 -3.99 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.839 3.026 . . . . 0.0 113.753 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.518 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -63.72 140.72 97.86 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.029 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 61' ' ' THR . 31.7 Cg_exo -59.53 177.99 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.517 2.144 . . . . 0.0 112.37 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.8 t -129.1 170.53 13.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -66.95 -39.0 87.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.634 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 72.1 m -156.42 -50.26 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.791 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 8.2 Cg_exo -73.51 -157.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.862 2.375 . . . . 0.0 112.133 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.3 mtt -142.14 19.16 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.64 148.96 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.18 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.61 -44.52 3.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.602 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.6 p -153.44 91.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 111.134 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.35 41.77 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.415 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.2 42.46 0.51 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -87.23 -25.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.089 -0.556 . . . . 0.0 112.456 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 11.6 m-85 41.75 87.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -88.39 131.71 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 38.2 t -137.49 97.61 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.525 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.794 HD22 HG22 ' A' ' 21' ' ' THR . 79.2 mt -92.37 102.52 15.0 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.79 109.14 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 111.3 -178.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -113.21 92.78 23.25 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.08 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.603 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.1 Cg_endo -46.97 102.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 112.619 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 19.9 mtt180 -66.37 -33.49 75.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.792 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -119.08 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -123.13 143.92 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.62 -117.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.587 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.465 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.9 m80 -112.72 94.33 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.103 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.9 OUTLIER -112.51 161.26 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.425 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.9 m -159.22 140.4 12.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.956 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.777 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -112.51 82.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.52 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 13.2 pt-20 -80.43 128.06 33.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.149 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 45.7 mt -122.64 162.51 21.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.917 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -156.08 150.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 111.587 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -93.6 85.91 5.03 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.793 ' HB ' HG23 ' A' ' 99' ' ' ILE . 4.3 t -118.53 161.84 19.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 72.9 mtp180 -99.01 97.95 5.74 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -47.83 -32.62 17.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.767 2.311 . . . . 0.0 113.378 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.06 11.64 17.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -151.38 1.36 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.26 -175.96 49.96 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.305 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -104.17 154.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.909 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -132.47 168.72 16.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.62 -49.77 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.28 2.653 . . . . 0.0 112.702 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.06 -13.51 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.623 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 7.9 m-20 -59.91 144.43 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.414 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 6.2 tt0 -55.5 163.35 1.29 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.625 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.9 tpt180 -130.55 161.29 31.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.646 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 43.3 t80 -171.99 75.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.263 0.554 . . . . 0.0 109.643 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.9 m -97.71 102.38 14.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.833 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.7 tp -84.05 90.22 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 8.8 m-70 -74.33 142.92 45.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 0.0 110.109 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 14' ' ' VAL . 88.8 mt -146.39 99.8 3.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.859 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t30 -75.91 73.27 2.82 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 112' ' ' VAL . 2.6 t -48.4 148.08 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.726 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.1 t -91.71 117.84 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -131.46 12.36 4.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt -64.03 153.92 35.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.14 -18.44 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.83 150.71 17.72 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 57.8 Cg_endo -71.03 148.66 57.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.526 2.151 . . . . 0.0 112.348 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -138.13 -64.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -149.52 -70.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 m -81.33 120.21 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.35 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 4' ' ' PRO . 72.9 mmtt -153.24 129.99 10.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.15 124.14 27.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -121.09 -84.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.964 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ASN . 13.2 m-20 -32.11 101.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.795 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -95.35 90.89 5.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.29 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.694 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -78.26 103.15 8.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.761 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 110' ' ' LEU . 20.9 m -149.93 -172.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 2.9 p-10 -112.88 -177.77 3.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.36 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.557 HG22 HG22 ' A' ' 112' ' ' VAL . 1.5 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.105 0.478 . . . . 0.0 112.255 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.619 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m80 -113.52 -167.77 1.25 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -89.64 138.07 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 112.294 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.28 17.95 19.67 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.738 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.74 81.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.777 HG22 HD22 ' A' ' 77' ' ' LEU . 9.2 m -48.21 97.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 78' ' ' VAL . 53.5 m -93.09 101.43 13.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.722 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HA ' HD23 ' A' ' 77' ' ' LEU . 34.6 tt0 -75.51 119.22 19.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.72 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.29 93.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.3 m170 -86.68 104.17 15.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 52.7 mt -95.53 160.96 14.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.23 163.43 12.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.82 -160.63 27.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.68 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 30' ' ' PRO . 65.6 t30 -168.95 126.53 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HD2' ' OD1' ' A' ' 29' ' ' ASN . 78.4 Cg_exo -50.88 -58.63 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.695 2.263 . . . . 0.0 113.078 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.5 t -82.24 50.91 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.3 m -141.89 -68.47 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.492 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.83 -117.9 2.0 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.246 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 -93.89 -172.66 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.186 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 19.9 ttm -113.66 152.32 30.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.433 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.538 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 8.0 m95 -109.36 87.12 2.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.607 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -134.78 -165.07 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.7 mtp85 -90.34 156.78 18.01 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 39.6 t -76.12 132.02 33.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.521 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.95 88.98 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.407 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 57.6 m-85 -131.92 -0.41 3.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 110.414 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -55.58 119.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.07 -27.05 20.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 65.8 mttm -69.51 172.15 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.66 -62.52 1.5 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.7 141.38 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.143 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt -91.99 -51.99 4.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.927 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.0 p -51.26 179.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.925 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.78 -87.03 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.189 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.599 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -131.81 -30.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.2 mm -72.96 -76.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.509 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 9.6 mt -102.91 116.65 32.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.511 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -69.58 69.87 0.28 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 109.848 178.062 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG22 HG13 ' A' ' 78' ' ' VAL . 24.7 t -73.53 85.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.725 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.5 t -77.34 85.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.395 0.617 . . . . 0.0 109.41 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.24 136.09 52.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.134 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 68.0 mttm -135.72 50.68 2.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.654 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -52.59 116.6 2.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.815 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.426 ' N ' ' HD1' ' A' ' 58' ' ' TYR . 29.4 m -97.32 101.88 11.11 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.405 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 45.5 Cg_endo -106.74 27.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.469 3.446 . . . . 0.0 111.799 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.3 t -107.87 148.18 36.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 23.4 Cg_exo -64.69 146.34 88.47 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.836 2.358 . . . . 0.0 112.426 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.1 t -79.97 -164.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.515 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.9 m -51.69 -65.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 p -104.01 153.91 38.51 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.241 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.72 15.24 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.814 2.342 . . . . 0.0 112.485 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.8 mtp -79.64 -7.16 58.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.4 29.22 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.98 -121.26 10.73 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.626 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 41.7 t -88.07 -104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 70' ' ' VAL . . . -156.67 -68.37 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.89 44.57 88.66 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.604 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -89.77 -22.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 7.9 m-85 39.58 90.41 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.117 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 99.2 t -92.73 95.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.681 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.29 108.86 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.731 0.3 . . . . 0.0 111.773 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.777 HD22 HG22 ' A' ' 21' ' ' THR . 40.3 mt -95.6 110.81 22.86 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.95 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -101.7 104.52 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.888 0.375 . . . . 0.0 110.965 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.1 mtmt -107.79 101.36 40.05 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.339 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 54.0 Cg_exo -51.52 97.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.664 2.243 . . . . 0.0 112.74 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.599 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -62.89 -36.75 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -117.25 -172.62 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.569 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -133.31 125.71 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.831 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.32 -98.61 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.016 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.446 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 49.4 t-80 -122.09 105.57 10.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.74 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.7 m80 -124.41 159.98 29.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.429 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 52' ' ' LEU . 32.4 m -159.59 148.7 18.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.704 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.7 tp -120.46 91.52 3.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.53 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.4 mt-10 -75.86 88.63 2.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.24 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.3 mt -98.45 122.84 42.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.77 154.54 34.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.675 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' MET . 9.7 t80 -96.51 82.41 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.212 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 6.2 t -121.48 151.93 39.7 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 57.5 mtp180 -88.79 102.04 3.55 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.26 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 9.3 Cg_endo -52.99 -33.44 62.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.753 2.302 . . . . 0.0 112.429 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -64.52 -32.72 74.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.19 -72.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.24 38.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.996 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.6 mt -96.44 143.68 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.7 mtmt -137.93 163.06 50.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.146 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.3 Cg_endo -67.92 -38.76 12.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.762 2.308 . . . . 0.0 112.032 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.69 -28.99 69.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.538 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.3 m-20 -54.74 147.49 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.024 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -58.46 165.91 1.95 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.9 tpp180 -131.75 164.1 26.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.071 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 39.1 t80 -176.06 66.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.452 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 89' ' ' GLU . 18.2 m -90.07 97.46 11.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.061 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.3 tp -77.98 93.86 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.266 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.2 m-70 -77.63 144.0 37.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 14' ' ' VAL . 79.1 mt -144.64 104.56 4.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.627 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.9 t30 -81.03 61.53 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 16' ' ' THR . 2.1 t -43.33 131.18 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.569 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.929 179.851 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -87.92 135.37 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -147.85 168.51 22.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt -131.42 -173.32 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.0 tt -129.89 -26.9 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.575 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -63.09 -48.97 83.06 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.687 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 48.4 Cg_exo -56.25 106.59 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.231 1.954 . . . . 0.0 112.326 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.87 -46.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -140.17 -16.61 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.95 -171.7 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -167.46 131.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.59 122.37 18.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.0 OUTLIER -128.12 -93.03 0.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 112.056 -179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 15.4 m-20 -44.89 102.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.752 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.494 ' HE2' HG11 ' A' ' 14' ' ' VAL . 22.7 tptm -98.79 90.95 4.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.301 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.1 m95 -82.13 101.36 10.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.498 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 HD23 ' A' ' 110' ' ' LEU . 11.3 m -152.7 -175.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.407 0.622 . . . . 0.0 112.411 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -97.07 -174.29 2.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.286 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.464 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t -175.6 -175.69 0.8 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.188 0.518 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 38.8 m80 -114.12 -161.51 0.77 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.694 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.88 131.84 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 0.0 111.767 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 14.29 14.44 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.485 -0.779 . . . . 0.0 113.351 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.2 84.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.748 HG22 HD22 ' A' ' 77' ' ' LEU . 6.8 m -46.22 98.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.718 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.2 m -92.94 98.38 11.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.2 tt0 -80.22 133.92 36.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.034 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.538 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.7 mt -135.97 106.63 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.732 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -88.78 91.26 8.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.689 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.538 ' HG ' HG22 ' A' ' 24' ' ' ILE . 16.6 mt -88.27 144.62 26.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.269 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 73' ' ' ILE . 44.8 mttp -101.79 165.66 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.78 -134.15 2.78 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 59.5 t30 -175.72 90.46 0.28 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.505 0.193 . . . . 0.0 110.61 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HB3' ' OH ' ' A' ' 58' ' ' TYR . 11.4 Cg_endo -55.49 -22.78 36.18 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.953 2.435 . . . . 0.0 113.458 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.0 t -78.89 13.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 29' ' ' ASN . 68.5 p -98.96 -60.26 1.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.332 . . . . 0.0 111.039 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 -41.95 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.751 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 70.1 m-85 -82.96 177.75 8.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.727 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 13.3 ttm -146.95 148.95 32.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.408 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.494 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -103.24 80.02 1.79 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.749 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.404 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 12.1 t -124.68 -164.74 1.3 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.344 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 5.9 mtp85 -87.19 135.82 33.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.045 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 91' ' ' VAL . 39.3 t -50.27 152.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.25 1.1 18.98 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HE2' HH21 ' A' ' 38' ' ' ARG . 24.8 m-85 -127.07 43.72 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.473 0.654 . . . . 0.0 110.536 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.4 p -80.0 98.19 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.45 -19.38 22.03 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.061 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -72.87 173.41 9.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.365 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.1 -62.81 1.4 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.03 146.16 7.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.7 mt -105.52 -52.94 2.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.42 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.5 p -50.13 173.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.762 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.65 -87.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.16 -31.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.261 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 mm -73.59 -73.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.417 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 80' ' ' PRO . 53.3 mt -105.5 118.31 36.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.414 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.29 69.57 0.38 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.252 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 78' ' ' VAL . 12.4 t -76.19 86.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.178 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.8 t -82.79 87.4 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.427 ' SG ' HG22 ' A' ' 76' ' ' VAL . 40.2 t -101.63 130.56 47.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.726 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -121.27 110.26 15.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.937 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.48 110.63 17.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.556 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 3.3 m -115.09 110.67 45.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.653 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.754 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 27.1 Cg_endo -100.73 14.06 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.328 2.685 . . . . 0.0 112.21 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 85.2 m -79.49 -50.55 1.29 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 80.2 Cg_exo -40.07 98.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.864 3.043 . . . . 0.0 112.938 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -68.58 127.06 31.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -123.45 -22.91 4.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -60.94 156.0 50.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.72 9.43 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.457 2.105 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.9 mtm -144.14 -98.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.83 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -143.26 142.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.958 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.6 -177.05 46.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 60' ' ' PRO . 21.8 t -127.64 73.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.35 101.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.309 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.754 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -101.03 -123.01 5.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.495 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.0 pt -144.69 -168.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -126.35 102.4 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.088 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -88.97 106.03 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.988 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.6 t -107.89 122.13 61.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.12 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 21' ' ' THR . 82.9 mt -112.03 102.61 10.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.811 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.42 106.82 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -178.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -110.78 94.53 20.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.6 Cg_endo -48.29 107.24 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.16 . . . . 0.0 112.506 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.531 HH11 ' HA ' ' A' ' 50' ' ' GLU . 12.8 mtt180 -73.31 -43.67 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.149 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -108.87 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -110.09 146.91 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.773 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.95 -125.69 4.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.385 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.468 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 56.9 t-80 -110.63 106.06 15.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.468 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.2 m-70 -117.29 164.77 14.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' HD12 ' A' ' 52' ' ' LEU . 67.7 m -159.59 145.32 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.967 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.642 HD22 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -111.81 91.91 3.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.493 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.1 mt-10 -75.57 104.24 6.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 66.2 mt -112.97 132.28 55.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.5 p -138.09 155.48 29.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -93.42 76.39 4.48 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.664 ' HA ' HD22 ' A' ' 103' ' ' ASN . 5.6 t -105.71 155.11 19.58 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 28.1 mtp180 -86.24 104.18 5.12 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.475 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.0 Cg_endo -55.98 -30.08 76.44 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.756 2.304 . . . . 0.0 112.181 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.6 -25.78 61.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.836 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.5 -88.32 0.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.729 0.3 . . . . 0.0 111.655 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.53 -166.12 28.94 Favored Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.562 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.546 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.0 mt -103.17 145.11 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.834 0.35 . . . . 0.0 111.231 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -134.57 168.73 16.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.608 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.12 -38.96 11.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.725 2.283 . . . . 0.0 112.47 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.7 -1.8 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.439 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.664 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.3 m120 -76.18 141.26 41.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.746 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.1 tt0 -58.16 162.04 3.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.599 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.0 tpt180 -130.2 160.01 35.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.251 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.6 t80 -175.24 72.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.461 0.648 . . . . 0.0 109.472 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 89' ' ' GLU . 8.1 m -91.5 96.62 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.15 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.0 tp -75.97 91.73 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.9 m-70 -77.05 137.13 38.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD23 HG23 ' A' ' 14' ' ' VAL . 94.0 mt -143.73 112.7 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.375 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.526 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.1 t30 -86.7 85.51 7.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 17' ' ' HIS . 14.8 t -55.5 124.35 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.324 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 113' ' ' LYS . 3.2 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.0 m -130.39 7.01 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -63.44 -30.2 71.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.85 165.41 25.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.7 pt -101.24 -7.2 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 74.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 152.9 31.07 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.63 2.22 . . . . 0.0 112.215 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.6 mm? -104.26 -68.65 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -81.91 175.07 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 9' ' ' ASP . 16.7 t -79.17 147.99 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 2.9 mppt? -99.42 18.75 17.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.656 ' H ' HG12 ' A' ' 7' ' ' VAL . 17.0 t70 -37.25 133.06 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER -86.6 -86.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.015 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 107' ' ' THR . 25.5 t70 -144.34 -128.82 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.594 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 50.8 tptt -160.24 172.16 17.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 4.5 m0 -120.46 123.99 44.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.746 0.418 . . . . 0.0 110.334 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.3 m -150.68 159.21 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.673 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -50.4 168.2 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.313 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -174.19 -173.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.426 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 26.2 m80 -109.23 -168.58 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.625 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.83 138.45 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.151 0.501 . . . . 0.0 111.891 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.61 17.48 20.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.294 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.2 tptp -66.07 80.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -44.46 101.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.625 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 m -98.97 102.62 14.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.754 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.7 tt0 -80.2 127.56 32.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.584 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.529 HG22 ' HG ' ' A' ' 26' ' ' LEU . 48.1 mt -130.9 105.23 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.907 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -87.19 96.36 10.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.7 mt -91.12 145.6 24.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -100.46 162.99 12.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.68 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.76 -138.95 4.02 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.373 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 32' ' ' THR . 9.5 t-20 -174.93 91.85 0.3 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 69.8 Cg_exo -51.6 -30.76 37.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.4 -30.05 64.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.838 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 29' ' ' ASN . 73.6 p -59.43 -65.9 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.728 0.299 . . . . 0.0 111.243 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.12 -38.23 0.53 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.691 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 88.3 m-85 -77.51 -178.96 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.79 150.05 29.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.7 m95 -103.04 82.9 2.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.673 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 42' ' ' VAL . 10.0 t -124.88 -174.73 3.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.643 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.3 mtp85 -83.12 150.63 26.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' VAL . 41.5 t -64.47 127.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.83 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.95 18.46 67.51 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.064 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 62.4 m-85 -138.02 0.86 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 110.652 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.656 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.6 p -47.05 125.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.257 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.67 -35.69 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.859 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 61.7 mttp -60.48 170.18 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.54 -62.15 1.76 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.848 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.83 144.2 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.7 mt -102.52 -49.18 3.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 35.3 t -51.05 173.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.766 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -159.04 -85.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.256 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.07 -33.98 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.431 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.9 mm -67.42 -78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' O ' HG23 ' A' ' 54' ' ' VAL . 96.4 mt -106.42 119.3 38.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.94 72.29 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 HG13 ' A' ' 78' ' ' VAL . 7.6 t -80.81 86.18 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.498 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.52 85.7 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 76' ' ' VAL . 33.8 t -101.91 149.34 24.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.741 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -139.64 112.99 8.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.879 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.27 107.69 11.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.488 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.6 m -103.05 107.01 53.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.923 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -101.08 92.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 123.647 2.898 . . . . 0.0 111.312 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.506 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -75.62 140.22 71.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.233 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HD2' HG22 ' A' ' 61' ' ' THR . 24.1 Cg_exo -63.65 179.78 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.21 . . . . 0.0 112.276 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -136.12 -17.4 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.763 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t 179.68 -52.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.569 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -120.13 155.21 55.93 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.11 12.41 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 112.44 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.2 mtt -113.61 -79.28 0.58 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.07 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.97 138.12 23.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.45 86.33 1.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.82 81.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 110.777 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -100.3 129.13 9.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.881 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -143.12 -138.51 3.43 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.009 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -145.58 -167.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 111.12 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -133.52 100.86 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.071 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -85.11 107.53 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 110.558 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.573 HG11 HD21 ' A' ' 88' ' ' LEU . 40.3 t -112.71 120.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 73.2 mt -108.58 99.84 9.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.55 108.55 21.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.457 . . . . 0.0 111.698 -178.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 31.7 mtmm -110.16 98.41 35.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.62 109.03 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.368 2.046 . . . . 0.0 112.778 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.4 mtt180 -81.06 -36.4 30.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.086 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -108.68 173.63 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.169 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 63.9 mtp180 -110.76 148.19 32.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.905 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.13 -164.52 13.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -70.5 102.0 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.687 0.28 . . . . 0.0 110.714 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.454 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 99.2 m-70 -128.04 149.95 50.15 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.483 0.659 . . . . 0.0 111.33 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.546 HG21 ' HB ' ' A' ' 107' ' ' THR . 40.3 m -150.95 146.81 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.483 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.604 ' HB2' HG11 ' A' ' 78' ' ' VAL . 20.9 tp -91.16 106.79 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.5 mt-10 -80.82 109.11 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.022 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 55.6 mt -119.03 143.2 47.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.067 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.19 161.57 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.398 0.618 . . . . 0.0 112.411 -179.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.0 t80 -104.23 85.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.48 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.2 t -114.58 165.66 12.54 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 71.3 mtp180 -102.95 93.59 4.56 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 93' ' ' THR . 91.7 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.632 2.221 . . . . 0.0 112.627 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.89 -40.21 63.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.24 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -103.22 -68.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.92 -178.99 37.56 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.035 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.9 mt -90.75 144.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.999 0.428 . . . . 0.0 111.249 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG3' HD21 ' A' ' 103' ' ' ASN . 1.5 mttp -132.61 166.57 28.03 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.39 -40.78 29.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.853 2.369 . . . . 0.0 112.377 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.45 -13.01 35.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.553 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.612 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.82 134.77 56.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 111.45 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.74 164.67 2.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.072 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 2.1 ttp180 -139.79 158.48 44.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 0.0 111.649 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.848 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 47.4 t80 -162.65 103.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.009 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.656 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.7 OUTLIER -102.41 109.42 21.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.51 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 110' ' ' LEU . 25.9 tp -72.5 126.12 29.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.183 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 2.8 p80 -65.66 65.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.387 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.61 HD11 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -102.07 53.93 0.8 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 30.1 t30 -71.09 76.52 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.4 t -53.84 150.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.763 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.1 p -143.77 157.25 44.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -150.95 154.26 36.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -71.76 171.22 12.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 pt -91.99 17.0 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.201 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.2 109.04 1.23 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.93 146.22 25.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 112.476 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.5 mp -95.46 -13.62 24.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.4 m -135.32 -178.93 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 t -107.39 94.99 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 89.91 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.293 0.568 . . . . 0.0 110.649 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.54 27.93 4.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.822 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -52.84 -63.23 1.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.236 0.541 . . . . 0.0 111.08 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HA ' ' N ' ' A' ' 107' ' ' THR . 1.2 p30 -54.86 104.07 0.11 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.286 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 108' ' ' LEU . 22.0 ptmt -101.79 119.69 39.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.028 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.79 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -103.71 111.94 24.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -148.31 -176.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.663 0.744 . . . . 0.0 112.882 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -93.8 -173.0 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.429 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -172.8 -174.54 1.13 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.416 0.627 . . . . 0.0 112.651 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 30.0 m80 -120.44 -148.52 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.382 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.7 t -108.93 128.13 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.589 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.13 20.18 19.62 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.262 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptp -65.95 84.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.672 HG22 HD12 ' A' ' 77' ' ' LEU . 6.4 m -47.17 102.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.851 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.3 m -98.98 93.62 6.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HA ' HD13 ' A' ' 77' ' ' LEU . 38.3 tt0 -78.11 127.95 33.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.156 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 38.2 mt -133.67 105.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.077 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.2 107.36 18.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 34.7 mt -103.16 149.05 25.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -101.14 161.46 13.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.251 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.04 -150.9 13.66 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.564 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.461 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.8 t30 -173.81 106.41 0.3 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.418 0.151 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 19.5 Cg_endo -58.6 -23.38 64.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.46 2.106 . . . . 0.0 112.326 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.408 ' HB ' HD21 ' A' ' 29' ' ' ASN . 18.6 m -63.06 -24.9 68.12 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 29' ' ' ASN . 66.2 p -61.32 -56.05 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.205 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.79 -6.27 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.927 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 44.6 m-85 -123.85 -176.18 3.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 0.0 111.24 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.552 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.4 ttm -150.71 152.32 33.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.543 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 42.7 m95 -100.06 90.7 4.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.693 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.6 t -136.92 -178.49 5.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.325 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HD2' HG21 ' A' ' 54' ' ' VAL . 14.8 mtp85 -83.46 160.1 21.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.972 0.415 . . . . 0.0 111.618 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 89' ' ' GLU . 59.0 t -70.68 141.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.918 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.7 2.99 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.079 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -124.7 -3.11 7.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.597 0.237 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HG21 ' A' ' 37' ' ' THR . 2.1 p -34.81 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 129.45 -46.33 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.409 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -62.55 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 -50.98 1.26 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.434 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 47' ' ' LEU . 2.7 p -63.68 -50.46 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.717 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.0 mt 71.81 -61.01 0.5 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.844 0.457 . . . . 0.0 111.178 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.3 p -46.34 171.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.233 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.41 -85.23 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.3 pt-20 -129.37 -34.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.389 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.574 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -68.89 -76.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.241 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -105.0 118.47 36.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.81 66.31 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.153 0.502 . . . . 0.0 109.753 177.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG22 HG13 ' A' ' 78' ' ' VAL . 18.2 t -76.91 83.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.563 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 25.4 t -77.29 80.69 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.21 139.51 30.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.553 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -133.15 105.46 7.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.961 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.33 115.28 22.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.792 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 m -117.08 119.98 34.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.713 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 63.6 Cg_endo -98.36 41.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.23 2.62 . . . . 0.0 112.03 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.587 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -39.47 139.99 0.82 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.416 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.587 ' HD2' HG22 ' A' ' 61' ' ' THR . 80.9 Cg_exo -47.96 130.27 19.46 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 112.663 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -69.47 172.82 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.983 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -102.16 12.54 36.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 p -57.61 155.0 22.53 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.192 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.23 11.52 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.738 2.292 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -133.38 -118.89 0.19 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.773 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.28 122.61 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.06 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.35 23.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.559 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 60' ' ' PRO . 42.8 t -132.16 75.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.391 . . . . 0.0 110.621 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.08 116.8 1.53 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.661 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.696 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -106.49 -117.73 4.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.273 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -141.72 -164.22 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.948 0.404 . . . . 0.0 110.875 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -138.48 98.65 3.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.405 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 77' ' ' LEU . 90.9 t -87.59 106.12 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.26 110.88 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 21' ' ' THR . 2.4 mm? -95.71 105.59 17.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.855 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -99.37 105.53 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.048 0.452 . . . . 0.0 111.212 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.8 mtmm -110.75 103.23 54.18 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.156 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 10.6 Cg_endo -55.1 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 15.0 mtt180 -81.15 -56.01 4.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.608 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -98.69 161.06 13.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.42 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -94.54 141.34 28.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.577 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.74 -116.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.579 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -129.57 99.98 5.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -108.04 164.78 11.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -157.74 149.91 22.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 78' ' ' VAL . 14.9 tp -123.11 87.35 2.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.252 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -86.98 93.96 9.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.057 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 77.1 mt -91.41 99.22 12.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.028 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -92.94 150.82 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.121 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.3 t80 -90.28 76.96 6.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.0 t -98.48 172.46 7.51 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 69.1 mtp180 -104.42 95.61 8.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.458 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HA ' HG22 ' A' ' 42' ' ' VAL . 66.5 Cg_exo -44.04 -27.58 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 112.651 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -37.19 20.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.391 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 13.9 mm-40 -103.65 -91.64 0.36 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 0.0 111.719 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.42 -178.76 39.84 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.281 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 93' ' ' THR . 11.7 mt -85.24 -77.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER 71.54 156.3 0.16 Allowed Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.966 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 37.8 Cg_endo -66.3 -35.01 33.51 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.795 2.33 . . . . 0.0 112.8 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' HD22 ' A' ' 103' ' ' ASN . 7.9 pt-20 -54.17 -17.94 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.524 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.55 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -86.67 140.16 30.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 111.467 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -64.91 -176.21 0.25 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.55 179.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -165.23 -164.47 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.552 0.692 . . . . 0.0 111.875 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 45.0 t80 -165.27 69.28 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.015 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -70.4 88.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.612 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.7 tp -83.59 92.03 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.653 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.9 m-70 -77.79 145.06 36.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 90.4 mt -144.36 92.77 2.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.269 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.538 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 23.7 t-20 -64.68 85.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 17' ' ' HIS . 4.7 t -62.76 115.01 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.664 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.936 179.702 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -147.89 -32.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -131.17 150.94 51.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp -89.07 -3.69 58.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 2' ' ' ILE . 11.7 mm 60.44 11.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.08 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.05 111.43 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.457 2.104 . . . . 0.0 112.245 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.97 -167.3 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.7 p -58.87 -25.19 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.05 142.67 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 58.6 tptt -176.05 139.08 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.192 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.02 107.04 9.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.64 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -120.19 -83.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.492 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.3 OUTLIER -33.24 104.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.921 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.98 96.75 10.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.124 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -79.68 100.76 8.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 HD23 ' A' ' 110' ' ' LEU . 27.4 m -146.7 -171.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.0 0.428 . . . . 0.0 112.113 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -107.02 -177.13 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.768 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.56 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.4 t -175.25 -175.81 0.87 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.218 0.533 . . . . 0.0 112.185 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.598 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 7.4 m80 -117.93 -165.35 1.09 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.954 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.44 132.77 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.19 0.519 . . . . 0.0 112.067 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.18 19.63 8.16 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.51 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.2 tptt -63.06 85.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 6.3 m -49.76 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.471 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 78' ' ' VAL . 50.2 m -94.73 99.81 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.489 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HA ' HD23 ' A' ' 77' ' ' LEU . 30.7 tt0 -76.2 132.84 40.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.838 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' CD2' ' A' ' 108' ' ' LEU . 31.1 mt -132.97 99.62 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.105 -179.325 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -84.03 98.25 9.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 38.0 mt -93.37 148.29 22.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.581 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -101.91 162.26 13.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.97 -143.87 7.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.417 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -174.16 95.05 0.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.458 0.17 . . . . 0.0 110.82 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 76.1 Cg_exo -49.91 -24.84 11.1 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.586 2.191 . . . . 0.0 112.532 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -62.08 -36.14 80.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.553 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 p -54.92 -60.37 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.326 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.35 -32.23 1.03 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 54.0 m-85 -82.56 -176.29 6.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.3 ttm -152.1 152.46 32.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.019 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 7.8 m95 -107.07 85.27 2.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.742 178.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.2 t -130.35 -163.61 1.33 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.7 mtp85 -91.25 139.58 30.61 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 111.269 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 26.5 t -53.99 133.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.056 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 -39.05 1.85 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.603 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 47' ' ' LEU . 55.2 m-85 -82.15 3.25 27.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.141 0.496 . . . . 0.0 110.62 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -53.29 110.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.223 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.94 -14.96 10.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB2' HD23 ' A' ' 47' ' ' LEU . 92.3 mttt -82.84 -163.28 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.803 0.335 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -114.51 -57.26 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.204 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.36 -36.85 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.598 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 12.0 mt 76.13 -44.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.508 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.9 t -59.24 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.5 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -147.99 -83.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.07 -28.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.602 -179.123 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.3 mm -76.11 -86.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.69 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.19 106.0 18.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.45 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 1.1 tm-20 -58.08 146.46 33.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 38' ' ' ARG . 46.3 t -145.6 90.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.2 t -77.04 85.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.21 129.67 37.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.808 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.709 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 50.9 mtpt -130.71 68.48 1.47 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -65.22 103.86 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.353 178.99 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 m -105.61 114.31 63.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.582 ' HB2' HG12 ' A' ' 70' ' ' VAL . 61.1 Cg_endo -97.84 42.04 0.1 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.287 2.658 . . . . 0.0 111.912 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -37.98 139.79 0.6 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.522 -179.249 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 61' ' ' THR . 76.9 Cg_exo -50.09 143.88 23.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.652 2.234 . . . . 0.0 112.609 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.4 t -91.66 172.67 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 m -94.3 19.21 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.2 p -57.76 154.82 24.82 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.27 11.49 1.5 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.787 2.325 . . . . 0.0 112.523 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 14.4 ptp -147.84 -117.31 0.06 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.815 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.68 123.99 59.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.6 132.84 4.94 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.562 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG12 ' HB2' ' A' ' 60' ' ' PRO . 23.6 t -139.57 77.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 110.611 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . -143.94 125.25 2.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.015 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.533 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -122.91 -113.64 2.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.304 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.3 pt -142.26 -164.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 110.737 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.6 OUTLIER -134.12 98.43 4.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 87.7 t -85.81 100.0 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.797 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 88' ' ' LEU . 26.5 t -103.54 116.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.039 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 91.3 mt -103.11 108.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.86 108.89 23.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.003 0.43 . . . . 0.0 111.519 -178.924 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 46.7 mtmt -114.11 95.95 40.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.469 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.41 106.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.253 1.969 . . . . 0.0 112.219 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 73.2 mtt180 -69.81 -30.22 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -123.53 -176.98 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -117.4 144.73 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.457 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.91 -129.26 4.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.388 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.453 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.7 m80 -105.92 91.73 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.921 0.391 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.4 OUTLIER -107.75 164.21 12.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.388 179.776 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.524 ' CG2' HG22 ' A' ' 107' ' ' THR . 71.0 m -160.26 157.25 27.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 111.784 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 78' ' ' VAL . 51.7 tp -118.96 87.66 2.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.284 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.686 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.3 mt-10 -69.46 95.89 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.804 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 51.9 mt -108.51 127.28 53.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.188 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.0 p -133.18 157.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.739 -178.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.4 t80 -99.13 88.82 4.05 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.239 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 42' ' ' VAL . 5.9 t -121.41 169.37 10.69 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -101.49 95.94 5.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.951 178.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 93' ' ' THR . 96.0 Cg_exo -44.26 -30.69 3.74 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.662 2.241 . . . . 0.0 112.607 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.65 -40.61 63.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -97.05 -76.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.98 173.11 31.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.195 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.6 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.7 mt -86.03 151.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.847 0.356 . . . . 0.0 111.256 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 103' ' ' ASN . 40.6 mtmt -145.09 166.22 18.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.42 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 27.1 Cg_exo -62.74 -46.47 11.11 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.029 2.486 . . . . 0.0 112.009 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.16 -29.77 65.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.053 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.5 m-20 -53.78 146.07 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.73 164.32 4.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.4 tpp180 -131.61 163.0 29.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.297 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.651 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.1 t80 -174.26 71.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.177 177.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.01 90.96 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.383 -178.966 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.1 tp -72.18 93.71 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 24.5 m-70 -78.97 145.29 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.569 HD23 HG23 ' A' ' 14' ' ' VAL . 75.0 mt -145.89 110.04 4.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.474 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 41.1 t30 -82.03 69.29 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.457 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.34 117.93 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.64 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.946 179.725 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.7 p -103.99 118.44 36.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.2 m80 59.5 99.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.39 157.1 18.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt -89.45 -27.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -60.77 129.23 89.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.019 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 34.3 Cg_exo -58.13 133.0 52.54 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.525 2.15 . . . . 0.0 112.265 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.8 tp -146.72 -55.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -122.51 -36.7 2.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.82 131.18 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -174.53 135.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.25 95.74 1.04 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.629 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -122.04 -28.56 4.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.466 -179.547 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.57 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 6.1 p-10 -85.94 98.37 10.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.711 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.573 ' HD3' HD13 ' A' ' 108' ' ' LEU . 51.4 tttp -111.41 76.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.748 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 5.5 m0 -86.91 108.9 18.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.679 -178.026 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.94 -171.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.628 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.4 p-10 -97.84 177.46 5.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.08 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.465 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -173.92 -174.66 0.96 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.012 0.434 . . . . 0.0 111.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 60.7 m80 -122.94 -173.98 2.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.919 179.052 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 83' ' ' ARG . 22.5 t -72.49 134.58 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.166 0.508 . . . . 0.0 112.309 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.19 15.87 12.2 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.944 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.0 tptt -58.13 86.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.279 0.539 . . . . 0.0 109.944 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.78 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -57.43 101.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.519 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -98.5 100.8 12.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.637 ' HA ' HD23 ' A' ' 77' ' ' LEU . 32.3 tt0 -72.42 131.83 43.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.71 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 42.6 mt -128.18 87.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.298 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.499 ' NE2' HG22 ' A' ' 75' ' ' VAL . 8.8 m170 -86.99 106.95 18.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 19.1 mt -101.31 174.12 6.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 111.575 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -119.55 160.94 21.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.767 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.62 -163.59 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.954 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 53.4 t30 -162.74 121.3 1.33 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.68 -30.95 41.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 112.564 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.9 p -83.54 17.36 2.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.6 m -136.04 -67.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.512 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.09 -118.66 4.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.131 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 2.1 m-85 -114.57 -169.25 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 14.5 ttm -114.79 151.02 34.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 66.6 m95 -105.89 99.57 9.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.034 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.731 HG23 HG22 ' A' ' 42' ' ' VAL . 5.9 t -147.78 -176.58 5.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.658 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.674 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.9 mtp85 -82.88 157.12 23.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.024 0.44 . . . . 0.0 111.404 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 91' ' ' VAL . 19.7 t -57.97 130.85 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.595 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -41.75 1.83 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.146 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 57.9 m-85 -70.21 -4.61 22.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 0.0 111.037 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 93' ' ' THR . 21.9 t -49.71 121.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -32.93 5.83 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.276 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 29.0 mtpp -64.72 171.68 3.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.25 -62.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.662 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -104.46 142.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.7 mt -99.07 -50.24 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.52 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 83.2 p -52.99 179.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.702 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.07 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -128.89 -42.5 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.126 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.2 mm -62.55 -76.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.7 mt -103.98 118.57 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.495 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -72.65 65.01 0.66 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.124 0.488 . . . . 0.0 109.77 177.646 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 ' HD2' ' A' ' 38' ' ' ARG . 12.0 t -71.08 84.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.58 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.5 t -80.05 85.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 18.6 t -103.82 123.49 47.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.86 -178.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -116.94 106.81 13.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.683 178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.512 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -74.17 103.62 4.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.482 179.853 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 20.2 m -100.35 112.58 64.55 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 3.8 Cg_exo -82.18 88.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.279 2.652 . . . . 0.0 111.506 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 148.83 72.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.277 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.96 151.05 87.16 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.716 2.277 . . . . 0.0 112.258 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -79.98 179.93 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.781 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -56.4 -58.41 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.4 p -94.06 155.24 40.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.77 -155.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.682 2.255 . . . . 0.0 112.207 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.6 ttp 72.15 -68.54 0.22 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.244 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.0 153.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.36 111.09 2.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.718 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.11 79.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 29' ' ' ASN . . . -63.31 -168.97 1.14 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.987 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -146.11 148.57 20.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.829 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -89.13 -20.36 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.108 0.48 . . . . 0.0 111.38 179.307 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.6 m-85 50.25 90.17 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.386 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 73' ' ' ILE . 72.8 t -97.94 107.21 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.777 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 11.9 t -112.99 109.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.821 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.78 HD22 HG22 ' A' ' 21' ' ' THR . 72.3 mt -102.64 99.38 9.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.042 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.3 105.69 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 0.0 111.192 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.8 mtmp? -109.19 94.57 15.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.664 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.9 Cg_endo -49.75 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.686 2.258 . . . . 0.0 112.855 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 11.8 mtt180 -74.56 -35.33 63.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.915 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 51' ' ' ILE . 4.2 mptp? -108.03 150.28 27.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.15 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HG2' HG22 ' A' ' 18' ' ' VAL . 49.7 mtm180 -94.28 129.69 40.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 148.53 -116.91 0.84 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -130.77 120.04 23.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -131.57 -178.7 4.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.683 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 88' ' ' LEU . 53.4 m -158.25 156.28 30.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.705 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.508 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.2 tp -133.04 85.7 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.617 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -84.76 88.25 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.089 0.471 . . . . 0.0 111.105 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 76' ' ' VAL . 88.7 mt -83.47 103.05 12.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -84.21 145.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.075 0.464 . . . . 0.0 111.98 -178.719 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' MET . 13.5 t80 -95.18 76.22 3.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.792 HG21 HG21 ' A' ' 42' ' ' VAL . 8.0 t -117.4 155.92 28.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 71.6 mtp180 -92.33 103.56 8.82 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.71 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.1 Cg_endo -51.51 -37.45 62.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.865 2.377 . . . . 0.0 112.776 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -78.91 12.87 1.95 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.477 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -147.26 3.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.259 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.93 179.18 49.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.831 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -105.37 156.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.047 0.451 . . . . 0.0 111.716 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mtmt -139.05 162.84 50.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.0 Cg_endo -72.18 -37.11 4.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.711 2.274 . . . . 0.0 112.212 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.21 -25.94 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.05 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.487 HD21 ' HE3' ' A' ' 100' ' ' LYS . 13.7 m120 -58.48 136.77 57.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -64.45 -175.13 0.15 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.2 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -163.26 -159.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 179.712 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 80.9 t80 -165.59 72.81 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 1.2 m -69.78 105.81 2.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.366 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.573 HD13 ' HD3' ' A' ' 12' ' ' LYS . 18.2 tp -106.71 94.49 5.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.727 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.5 m-70 -76.65 153.58 35.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.276 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.4 mt -146.92 99.74 3.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.693 -178.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.8 t30 -74.79 68.56 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.3 t -50.19 122.07 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.436 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' THR . 31.9 mmmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -106.84 124.15 49.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -83.47 -28.43 28.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp -82.45 174.82 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.9 tp -100.17 -31.68 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.63 99.13 4.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.4 3.09 5.01 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.433 2.089 . . . . 0.0 112.459 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.4 mp -67.32 -20.09 65.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.0 p -88.41 170.32 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.14 158.72 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 3.1 mppt? -101.99 9.48 40.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.552 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -42.13 147.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.731 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.856 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 3.9 p30 -89.76 -91.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 111.753 -179.209 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 107' ' ' THR . 22.9 t70 -136.36 -119.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 22.2 tptm -158.02 171.87 19.46 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.416 0.15 . . . . 0.0 110.662 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.62 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 7.3 m0 -124.39 121.7 35.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.657 0.383 . . . . 0.0 110.749 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.9 m -152.5 -171.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 2.6 p-10 -80.49 175.75 10.38 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.397 0.436 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 110' ' ' LEU . 2.5 t -172.01 -173.66 1.16 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 78.5 m80 -108.37 -177.99 3.48 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.485 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.02 136.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.119 0.485 . . . . 0.0 111.765 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.78 10.75 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.388 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.4 tptm -63.96 82.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.735 HG22 HD22 ' A' ' 77' ' ' LEU . 9.6 m -39.49 99.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.678 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.5 m -92.75 96.88 10.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.7 tt0 -80.62 132.17 35.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.38 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD11 HD21 ' A' ' 108' ' ' LEU . 38.9 mt -134.21 104.55 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -86.97 98.73 11.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 12.9 mt -91.69 145.7 24.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.378 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -95.32 161.78 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.93 -139.35 5.28 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -174.99 90.62 0.3 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.516 0.198 . . . . 0.0 110.54 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.64 -16.32 7.89 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.712 2.275 . . . . 0.0 113.106 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.0 p -83.65 12.5 5.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 111.482 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 p -97.1 -63.65 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.256 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.56 -38.71 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.694 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.07 -178.13 6.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 111.24 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 1.5 ttt -149.35 147.93 28.9 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.118 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 2.8 m95 -105.07 86.58 2.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.74 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.418 ' HB ' ' HE2' ' A' ' 35' ' ' MET . 14.6 t -130.46 -171.97 2.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.613 HH11 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -71.58 144.92 49.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.761 0.315 . . . . 0.0 110.807 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 91' ' ' VAL . 77.4 t -60.73 137.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.956 0.407 . . . . 0.0 111.413 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.31 -1.72 8.51 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.058 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 21.5 m-30 -115.31 40.14 2.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 110.766 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.6 p -82.18 128.27 38.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.26 -10.4 6.15 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.099 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 64.0 mttm -64.89 172.51 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.84 -65.22 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.67 133.7 48.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.859 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 29.8 mt -82.83 -62.05 1.71 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.437 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 78.9 p -51.98 176.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.089 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -153.75 -90.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -131.26 -31.93 1.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.4 mm -71.22 -73.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.389 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 78' ' ' VAL . 28.1 mt -111.58 123.46 50.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.7 73.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.917 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -77.79 92.85 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.5 t -96.96 86.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.382 177.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.7 t -107.08 142.19 37.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -119.37 115.67 24.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.403 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.554 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.78 100.6 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.437 HG22 ' HA3' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.22 116.16 65.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.084 179.515 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -95.51 -169.49 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.277 2.651 . . . . 0.0 113.2 -179.141 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -59.18 137.12 88.34 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.05 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 70' ' ' VAL . 7.7 Cg_endo -48.56 155.67 2.18 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.22 2.614 . . . . 0.0 112.65 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -85.19 -167.9 2.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.771 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -73.91 -0.6 16.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -70.28 154.46 94.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.277 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.52 13.77 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.798 2.332 . . . . 0.0 112.634 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.7 mmm -62.08 -24.72 67.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t 50.43 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.876 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 62' ' ' PRO . . . 76.96 94.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.6 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 62' ' ' PRO . 26.2 t -135.37 69.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 111.049 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' HA3' HG22 ' A' ' 59' ' ' THR . . . 112.11 -139.88 15.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.152 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.0 15.01 40.54 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.3 pt -148.07 -165.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.191 0.52 . . . . 0.0 111.167 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.57 106.26 6.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.852 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.77 117.96 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.212 0.53 . . . . 0.0 110.548 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 78' ' ' VAL . 23.5 t -113.39 126.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.874 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.735 HD22 HG22 ' A' ' 21' ' ' THR . 63.1 mt -111.4 90.93 3.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.048 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -93.07 108.86 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.178 0.513 . . . . 0.0 111.645 -178.226 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.2 mtmt -107.25 95.81 14.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 79' ' ' LYS . 2.1 Cg_endo -47.03 108.23 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.591 2.194 . . . . 0.0 112.592 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 21.9 mtt180 -76.14 -33.93 59.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -116.27 171.43 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.033 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 68.5 mtp180 -110.1 146.56 35.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.845 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.58 -170.42 21.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.5 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -70.98 104.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 110.576 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 96.8 m-70 -130.09 142.48 50.6 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.782 0.801 . . . . 0.0 111.676 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 96.2 m -138.24 127.32 24.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.613 HD21 HH11 ' A' ' 38' ' ' ARG . 15.6 tp -93.81 99.72 12.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.113 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 39' ' ' VAL . 35.1 mt-10 -76.69 124.6 27.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.436 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.502 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.0 mt -115.56 165.83 12.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.6 p -156.14 154.38 6.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.2 t80 -103.34 86.88 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.635 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.655 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.8 t -115.83 167.0 11.34 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -103.07 94.36 5.41 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 93' ' ' THR . 90.3 Cg_exo -46.8 -29.91 8.66 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.572 2.181 . . . . 0.0 112.565 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -73.19 -37.04 66.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -106.61 -74.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 111.327 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.91 -174.68 44.73 Favored Glycine 0 CA--C 1.508 -0.345 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.296 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.655 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -96.91 145.56 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.871 0.367 . . . . 0.0 111.153 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' H ' ' ND2' ' A' ' 103' ' ' ASN . 3.6 mttt -130.76 166.74 25.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.633 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.14 -44.78 4.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.893 2.395 . . . . 0.0 112.34 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.06 -14.92 27.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.472 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.8 m-20 -58.58 139.96 55.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 174.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.141 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -155.0 158.62 39.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.554 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 24.3 t80 -152.96 108.53 3.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.49 178.031 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.62 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.8 OUTLIER -98.15 130.88 44.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.621 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 24' ' ' ILE . 14.0 mt -89.92 126.43 35.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.337 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.689 ' HB2' HG22 ' A' ' 14' ' ' VAL . 1.7 p80 -72.0 57.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.609 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.42 ' HB3' HG21 ' A' ' 16' ' ' THR . 52.6 mt -103.98 80.31 1.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.108 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.654 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 17.8 t30 -94.35 59.11 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.1 t -33.41 130.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.695 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 14.6 mmmm . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.995 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -141.71 -13.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 61.94 -83.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.078 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.5 147.18 52.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.6 pt -85.48 2.38 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.59 149.66 0.11 Allowed Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.311 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 -5.22 16.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.452 2.101 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.98 -65.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.5 p -82.93 135.15 35.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.664 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.9 t 65.79 145.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -170.35 132.27 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.49 121.92 16.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.241 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.577 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER -122.03 -94.54 0.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.14 0.495 . . . . 0.0 112.204 -179.178 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -53.24 99.97 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.841 -178.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -89.61 91.63 8.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.472 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -73.75 99.81 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.512 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.511 HG23 HD23 ' A' ' 110' ' ' LEU . 29.3 m -149.69 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.987 -178.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.2 p-10 -111.88 -175.14 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.508 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.2 t -174.47 -177.22 1.18 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.104 0.478 . . . . 0.0 112.075 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 72.9 m80 -111.96 -159.64 0.69 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.841 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 41.9 t -97.6 128.01 49.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 0.0 111.929 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 71.73 7.51 65.59 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.674 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -56.75 85.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.293 0.547 . . . . 0.0 109.734 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.81 HG22 HD22 ' A' ' 77' ' ' LEU . 3.5 m -58.19 93.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.293 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 78' ' ' VAL . 99.5 m -85.83 99.71 11.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.546 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.3 tt0 -82.72 129.62 34.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 46.0 mt -134.61 107.35 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.926 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -88.76 96.84 10.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.28 178.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.0 mt -91.43 148.22 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.418 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -102.56 161.07 14.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.86 -145.81 7.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.487 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -176.35 93.8 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.51 0.195 . . . . 0.0 110.984 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -9.43 12.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.444 2.096 . . . . 0.0 112.308 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -60.9 -22.69 64.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -82.67 -63.37 1.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.156 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.45 -25.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.003 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -80.11 178.19 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.166 0.507 . . . . 0.0 111.399 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 5.5 ttm -155.85 152.12 27.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 8.0 m95 -106.92 85.38 2.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.552 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.3 t -129.9 -165.47 1.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.377 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.2 mtp85 -89.2 151.51 22.12 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.861 0.362 . . . . 0.0 110.977 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.8 t -72.14 133.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.497 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.56 3.51 90.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 60.0 m-85 -129.3 -0.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 110.462 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 17.3 t -55.27 109.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.141 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.08 -28.04 12.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.172 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.67 172.11 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.42 -25.54 31.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.836 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.58 141.76 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.206 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt -93.11 -53.63 4.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.7 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.419 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 33.4 t -50.39 175.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.565 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -155.75 -86.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.81 -34.04 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.0 mm -70.33 -76.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.364 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -101.19 112.23 24.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.501 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 3.0 tt0 -66.01 78.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 109.832 178.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG22 HG13 ' A' ' 78' ' ' VAL . 8.5 t -86.51 90.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.325 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.9 t -86.31 86.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.0 t -101.43 124.97 47.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.652 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -115.79 109.45 17.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.553 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -79.77 121.02 24.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.309 -179.784 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 118.96 31.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.15 158.42 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.164 2.576 . . . . 0.0 112.856 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.571 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -82.17 143.16 48.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 -179.878 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 61' ' ' THR . 39.1 Cg_exo -61.2 157.3 40.57 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.519 2.146 . . . . 0.0 112.224 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.544 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t -111.69 -164.75 0.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -103.09 -62.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.491 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.635 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 63.8 m -67.68 -49.99 37.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.771 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 9.6 Cg_exo -72.75 -160.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.795 2.33 . . . . 0.0 112.102 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.5 mtm -145.68 18.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.2 p -95.44 142.34 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.08 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.37 136.84 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.308 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 70' ' ' VAL . 10.0 p -155.12 14.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.208 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.87 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.918 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.87 6.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.296 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.8 pt -143.45 -164.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.06 0.457 . . . . 0.0 110.953 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -136.01 105.81 6.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.979 179.989 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -90.27 104.57 15.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.01 120.16 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.927 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -111.2 99.9 8.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.892 178.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.74 102.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.053 0.454 . . . . 0.0 110.994 -179.085 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 38.2 mtmt -104.18 104.0 41.54 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.2 Cg_exo -51.43 98.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.406 2.071 . . . . 0.0 112.446 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 7.4 mtt180 -69.82 -41.72 74.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -115.54 165.43 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.092 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -100.87 119.22 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.635 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.38 -150.45 21.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.363 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.474 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 55.4 t-80 -86.84 101.74 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.11 0.481 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.497 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 2.0 m-70 -117.12 165.82 12.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 57.6 m -159.84 148.64 17.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 111.945 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 78' ' ' VAL . 11.6 tp -114.52 93.33 4.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.245 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.0 mt-10 -77.12 98.23 4.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.045 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 51.1 mt -107.69 130.33 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.4 p -135.68 156.05 37.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.965 -178.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.3 t80 -99.88 86.73 3.34 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.104 178.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.5 t -120.35 169.34 10.38 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.11 94.85 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.4 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.6 Cg_exo -42.22 -35.61 3.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.839 2.36 . . . . 0.0 112.755 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -68.52 -44.04 75.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.564 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.77 -79.31 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.81 177.18 40.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.105 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.741 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -92.11 151.31 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.934 0.397 . . . . 0.0 111.292 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.596 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 10.0 mttm -141.43 163.15 43.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.125 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 38.8 Cg_endo -67.6 -40.18 10.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.264 . . . . 0.0 112.133 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.05 -28.09 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.553 HD21 ' HA ' ' A' ' 93' ' ' THR . 7.5 m-20 -55.36 148.75 14.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.92 160.7 3.36 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpt180 -130.18 162.9 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.219 -179.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.581 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -176.53 69.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.453 0.644 . . . . 0.0 109.677 177.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 12.4 m -91.52 91.33 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.517 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 41.0 tp -71.45 94.36 1.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.524 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -78.22 143.31 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.661 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 14' ' ' VAL . 85.2 mt -145.85 104.64 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.807 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 45.6 t30 -78.42 68.91 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.635 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.5 t -48.75 127.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.65 -178.207 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.976 179.988 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.0 p -93.49 -45.69 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -158.17 176.16 12.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.26 154.69 33.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -96.96 14.12 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 4' ' ' PRO . . . -57.2 -50.73 86.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.628 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 3' ' ' ALA . 63.8 Cg_endo -73.45 172.53 15.5 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.149 1.899 . . . . 0.0 112.31 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.75 -65.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.524 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -153.36 -38.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.13 140.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.196 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 2.2 mppt? -103.17 36.53 2.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.145 0.498 . . . . 0.0 110.517 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -35.3 116.78 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.632 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -123.31 -90.74 0.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.541 -179.305 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' THR . 1.2 m-20 -47.65 104.52 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.284 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -97.24 92.72 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.141 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.676 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.09 104.02 12.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 12' ' ' LYS . 4.5 m -150.95 -173.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 112.136 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -101.41 176.7 5.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.819 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.522 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -175.49 -177.1 0.96 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.572 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.9 m-70 -120.82 -166.16 1.3 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.968 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -87.19 136.59 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 112.111 -179.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.59 12.16 32.32 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.628 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tptt -59.79 83.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.182 0.491 . . . . 0.0 109.782 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -54.93 98.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.424 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 100.0 m -96.2 101.18 12.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.6 tt0 -82.44 132.7 35.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.799 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.454 HD11 HD22 ' A' ' 108' ' ' LEU . 45.6 mt -134.97 101.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.961 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -83.67 98.91 9.9 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 14.5 mt -92.61 148.73 21.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -102.9 159.93 15.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.844 0.354 . . . . 0.0 110.399 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 -161.64 34.18 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -169.83 120.02 0.57 Allowed Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.17 -29.9 16.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.428 2.085 . . . . 0.0 112.493 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -82.52 15.69 2.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.319 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.4 m -136.04 -60.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.483 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.58 -119.63 3.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.208 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.454 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -112.24 -168.25 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 -179.203 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 25.0 ttm -108.53 151.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.306 179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 5.7 m95 -109.88 85.03 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.653 178.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -132.65 -166.95 1.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -93.04 122.52 35.5 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.5 p -53.16 138.78 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.178 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.47 -4.59 77.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.743 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.441 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 48.8 m-85 -130.78 3.14 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.286 0.565 . . . . 0.0 110.037 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 93' ' ' THR . 18.2 t -52.12 119.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.095 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.5 -23.09 18.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.004 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HB2' HD23 ' A' ' 47' ' ' LEU . 61.4 mttp -74.59 -159.58 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.643 0.259 . . . . 0.0 110.748 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.24 -55.9 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.448 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 16.6 t -84.45 -40.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.051 -179.103 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.8 mt 75.95 -42.73 0.46 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 40.8 t -49.28 179.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.142 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -152.55 -88.84 0.06 Allowed 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.59 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -136.11 -31.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.397 -179.038 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.1 mm -73.21 -72.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.438 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.1 mt -105.13 114.37 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.472 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.13 72.1 0.1 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.795 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 38' ' ' ARG . 10.9 t -76.39 84.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.324 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.7 t -80.2 81.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.3 t -94.81 146.84 23.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.315 -178.46 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -138.82 113.18 8.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.36 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.85 104.86 15.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.274 179.373 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.8 m -101.83 109.63 60.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.618 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HB2' HG22 ' A' ' 70' ' ' VAL . 60.5 Cg_endo -99.4 99.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.533 2.822 . . . . 0.0 111.652 179.316 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.26 134.76 24.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.695 0.283 . . . . 0.0 111.365 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.51 163.11 37.99 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.825 2.35 . . . . 0.0 112.483 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.575 ' H ' HG11 ' A' ' 68' ' ' VAL . 50.6 m -81.07 -165.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.525 179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -103.05 0.05 31.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.446 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.3 p -100.73 153.81 37.52 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 0.0 111.553 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.99 32.86 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.004 2.469 . . . . 0.0 112.612 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.6 mtt -143.22 35.16 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG11 ' H ' ' A' ' 63' ' ' SER . 13.8 p -130.44 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.39 -179.469 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.95 -94.66 1.68 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 60' ' ' PRO . 7.1 p -157.79 87.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.138 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.71 114.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.867 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -105.6 -113.46 3.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.244 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt -140.27 -167.82 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 111.104 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -135.78 95.38 3.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.941 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.6 p -87.97 111.81 22.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.536 0.684 . . . . 0.0 110.602 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 90' ' ' LEU . 38.7 t -108.88 122.91 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.53 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 81.3 mt -108.46 99.23 8.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.808 178.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.49 106.2 17.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.999 0.428 . . . . 0.0 111.145 -178.915 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -108.1 102.15 44.79 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.344 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.649 ' HA ' HD23 ' A' ' 52' ' ' LEU . 70.0 Cg_exo -49.93 98.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.747 2.298 . . . . 0.0 112.81 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -67.57 -37.25 82.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -120.99 -178.81 3.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HE ' HG21 ' A' ' 18' ' ' VAL . 95.7 mtt180 -115.17 124.86 52.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.523 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.78 -142.8 9.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.576 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.495 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 61.9 m80 -87.34 91.65 8.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.495 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.6 OUTLIER -111.65 154.5 24.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.412 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.553 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 62.9 m -158.55 146.23 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.932 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.6 tp -96.72 92.24 6.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.072 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.708 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.2 mt-10 -72.77 94.19 1.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.166 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 40.0 mt -111.53 127.41 55.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.8 p -128.95 158.57 41.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.511 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -99.17 83.33 2.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.429 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 42' ' ' VAL . 10.0 t -117.5 150.83 38.28 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 41.5 mtp180 -91.49 104.49 10.16 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 178.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.9 Cg_exo -39.79 -31.99 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.055 2.503 . . . . 0.0 113.168 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' HD2' ' HG3' ' A' ' 97' ' ' GLU . 6.7 t80 -77.02 -60.08 2.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG3' ' HD2' ' A' ' 96' ' ' PHE . 36.9 mt-10 -67.91 -64.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.894 0.378 . . . . 0.0 111.301 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.3 -179.78 20.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.813 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.5 mt -93.86 148.07 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.918 0.389 . . . . 0.0 111.472 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 26.2 mtmm -147.82 162.64 30.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.115 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.8 Cg_endo -67.75 -37.1 16.91 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.797 2.331 . . . . 0.0 112.012 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.06 -29.34 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.2 m120 -58.21 154.36 13.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 164.41 4.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.245 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.657 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.7 tpp180 -132.24 165.95 22.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.0 t80 -174.57 74.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.297 177.15 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.93 94.29 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.418 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.3 tp -72.86 93.17 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.016 0.436 . . . . 0.0 110.656 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 40.8 m-70 -75.19 146.02 41.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.668 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.4 mt -145.69 120.21 9.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.568 -178.004 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.7 t30 -86.31 63.07 7.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.523 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -44.74 122.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.729 -178.428 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.093 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -88.22 -28.4 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.52 119.48 38.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' C ' ' H ' ' A' ' 3' ' ' ALA . 1.9 mpt? -85.76 -71.04 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.6 mt 73.12 -29.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.736 ' H ' ' HD2' ' A' ' 4' ' ' PRO . . . -124.76 -54.47 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.736 ' HD2' ' H ' ' A' ' 3' ' ' ALA . 73.1 Cg_endo -76.14 100.8 1.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.005 1.803 . . . . 0.0 112.332 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tt -172.01 -63.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.461 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -142.02 -20.02 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.744 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.5 m -103.51 151.62 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -150.9 136.8 18.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.778 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.99 104.57 11.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.834 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.662 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -115.86 -82.01 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.267 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -32.44 108.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.705 179.906 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -87.17 93.7 9.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.622 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.5 m95 -75.74 98.52 4.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 110' ' ' LEU . 28.4 m -149.42 -172.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 112.245 -178.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -112.37 179.0 4.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.455 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.501 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.88 -172.77 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 112.046 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.8 m-70 -117.62 -171.15 2.0 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 10.1 p -83.44 142.51 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.869 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.79 18.67 8.64 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.669 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptm -65.49 80.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 4.6 m -50.5 97.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.422 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.3 m -94.67 104.63 16.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.827 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.2 tt0 -86.91 129.72 34.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.803 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mt -132.48 104.63 7.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.64 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -85.03 96.36 9.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.0 mt -89.27 145.91 25.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.398 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -97.66 161.99 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.847 0.356 . . . . 0.0 110.399 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.16 -137.13 4.11 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.499 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' HG22 ' A' ' 32' ' ' THR . 61.1 t30 -175.12 101.95 0.26 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 20.5 Cg_endo -60.63 -6.57 5.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.796 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -106.53 15.0 26.42 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.657 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 29' ' ' ASN . 5.9 t -98.28 -31.2 12.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.745 0.307 . . . . 0.0 111.086 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.74 -43.06 1.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.748 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' H ' HG23 ' A' ' 32' ' ' THR . 68.1 m-85 -86.91 -178.88 6.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.082 0.468 . . . . 0.0 111.428 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -151.71 151.79 31.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.931 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -108.39 87.08 2.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.347 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 42' ' ' VAL . 15.3 t -130.39 -170.98 2.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.832 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.687 HH21 HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -76.27 137.89 40.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 91' ' ' VAL . 49.0 t -57.1 136.32 20.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.387 -179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.11 -13.81 1.8 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.776 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 14.6 m-30 -105.62 22.08 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.341 0.591 . . . . 0.0 110.49 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -76.16 107.13 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.148 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.13 -16.28 57.22 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 48.4 mtpt -65.07 172.89 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -75.43 -66.1 0.81 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.494 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.77 131.2 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 0.0 110.823 179.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HH21 ' A' ' 38' ' ' ARG . 22.6 mt -73.7 -65.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.165 179.353 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -50.42 173.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.979 178.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -150.46 -95.73 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.618 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.09 -33.11 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.9 mm -73.38 -72.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.19 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.688 ' HB3' HG12 ' A' ' 78' ' ' VAL . 77.2 mt -107.6 117.86 35.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.322 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -70.36 73.03 0.49 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.712 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.651 HG11 ' NH1' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -76.38 91.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.609 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 22.4 t -93.34 87.97 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.328 177.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 76' ' ' VAL . 8.1 t -110.0 144.83 37.98 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.935 -178.46 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -122.9 115.89 22.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.647 178.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.466 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -85.14 105.85 16.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.449 179.466 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.521 HG22 HG12 ' A' ' 70' ' ' VAL . 4.3 m -103.0 126.28 32.88 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.45 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' A' ' 30' ' ' PRO . 2.6 Cg_endo -84.33 166.17 12.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.01 2.473 . . . . 0.0 113.178 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.6 t -53.42 149.67 14.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.646 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 21.0 Cg_exo -66.75 179.16 2.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.031 2.487 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.0 m -64.81 176.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.06 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -70.92 -34.6 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.7 p -84.75 154.62 61.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.35 14.97 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.832 2.355 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.8 mtp -94.11 -79.35 0.42 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.016 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.59 120.41 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 62' ' ' PRO . . . -113.92 137.99 14.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 59' ' ' THR . 45.0 t -119.43 -95.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.203 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -156.23 -101.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.127 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.75 20.61 8.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt -138.94 -166.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.195 0.521 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -136.2 98.68 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.81 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.5 p -90.21 111.34 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.298 0.571 . . . . 0.0 110.625 -179.266 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 56' ' ' CYS . 46.2 t -107.18 124.55 63.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.923 -178.554 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 71.5 mt -111.63 92.95 4.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 177.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -91.73 110.72 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.223 -178.775 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.7 mtmp? -107.84 101.96 43.08 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.226 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 71.4 Cg_exo -48.22 99.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.707 2.271 . . . . 0.0 113.066 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.1 mtt180 -69.34 -31.44 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 91.8 mttt -121.25 170.69 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.767 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -115.66 128.45 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 135.65 -152.92 21.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.183 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -65.9 106.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.498 . . . . 0.0 110.639 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 29.7 m-70 -138.04 160.59 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.619 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.506 ' CG2' HG22 ' A' ' 107' ' ' THR . 87.0 m -160.17 148.27 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 111.774 -179.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -110.03 101.55 10.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.878 179.194 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 107' ' ' THR . 40.1 mt-10 -79.35 115.75 19.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.444 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.678 HD21 ' NH1' ' A' ' 38' ' ' ARG . 29.4 mt -121.84 151.49 40.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.2 p -154.26 153.6 8.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.094 0.473 . . . . 0.0 111.899 -178.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.2 t80 -100.7 91.97 4.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.996 178.459 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 42' ' ' VAL . 8.5 t -126.69 166.1 18.0 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -177.494 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.7 mtp180 -98.63 97.52 4.92 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.643 178.412 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.5 Cg_exo -46.14 -40.74 21.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.8 2.333 . . . . 0.0 113.415 -179.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.47 17.34 3.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.1 mm-40 -150.57 0.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.29 -178.96 50.69 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.264 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.745 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.8 mt -108.7 151.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.075 0.464 . . . . 0.0 112.031 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -128.39 166.78 22.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.767 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.65 -40.91 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.858 2.372 . . . . 0.0 112.146 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.16 -24.77 67.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.199 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 8.7 m-20 -49.38 148.75 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -61.77 166.11 4.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.433 -179.889 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.702 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.3 tpp180 -134.78 163.73 29.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.386 -178.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.702 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 30.8 t80 -172.31 80.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.223 177.119 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.46 93.68 6.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.654 -178.882 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 47.7 tp -66.77 83.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 25.9 m-70 -69.89 136.16 50.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.6 mt -143.41 109.82 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.474 -178.058 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 60.7 t30 -85.24 54.05 2.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.613 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -35.74 135.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.863 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.9 mmpt? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 t -137.83 124.41 20.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -80.86 158.24 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt -134.29 167.01 21.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.3 mp -98.3 -20.54 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.62 148.6 0.11 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.281 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.88 159.65 17.22 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.55 2.167 . . . . 0.0 112.379 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.9 tp 57.86 93.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.983 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -168.99 -37.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 7' ' ' VAL . 9.9 p -142.13 17.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.22 150.21 19.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.191 0.52 . . . . 0.0 110.057 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.38 117.68 30.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.431 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.677 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.1 p-10 -126.94 -95.84 0.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.316 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 14.8 m-20 -48.49 97.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.126 -178.456 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HD3' HD13 ' A' ' 108' ' ' LEU . 52.9 tttp -100.84 92.04 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.679 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -80.69 104.69 11.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.59 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.8 p -151.29 -179.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.988 0.423 . . . . 0.0 111.694 -179.03 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.776 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -99.45 -179.14 4.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.489 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.54 -173.45 0.75 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.152 0.501 . . . . 0.0 112.111 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 19.4 m80 -115.4 -170.31 1.74 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.09 132.39 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 112.054 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.11 11.97 34.9 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.39 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -64.81 82.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.733 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.16 99.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.568 -178.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' HG23 ' A' ' 78' ' ' VAL . 54.9 m -93.82 96.22 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.8 tt0 -73.99 132.34 42.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.718 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.4 102.0 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.249 -179.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -85.64 99.64 11.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 35.5 mt -94.29 147.6 23.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.752 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -99.81 164.75 11.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.73 -134.21 3.14 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.536 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 32' ' ' THR . 52.3 t30 -173.85 89.33 0.35 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 85.1 Cg_exo -48.41 -18.31 1.34 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.706 2.271 . . . . 0.0 113.181 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.6 p -104.62 30.35 5.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 29' ' ' ASN . 6.1 t -108.87 -35.04 6.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.05 -34.06 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.805 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.437 ' H ' HG23 ' A' ' 32' ' ' THR . 51.3 m-85 -99.71 -179.33 4.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 111.477 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.4 ttm -147.82 154.09 40.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.816 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.445 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 4.6 m95 -110.42 88.15 2.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.922 178.524 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.4 t -133.54 -163.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.8 mtp85 -90.18 158.38 17.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.812 0.339 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.9 t -77.23 132.03 33.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.656 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.47 9.3 86.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.494 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 63.1 m-85 -134.02 -1.75 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.206 0.527 . . . . 0.0 110.538 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -51.71 116.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.115 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.38 -31.15 8.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.235 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.7 mttm -66.13 171.45 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 0.0 111.1 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.29 -63.05 1.41 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.629 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.96 141.03 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.75 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 22.8 mt -92.57 -52.67 4.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.297 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 54' ' ' VAL . 55.6 p -62.1 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.572 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -151.73 -82.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.96 -30.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.371 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.1 mm -74.25 -85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.491 -179.485 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.99 108.76 21.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.43 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 10.5 tt0 -61.62 140.89 58.09 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.521 HG21 ' HD2' ' A' ' 38' ' ' ARG . 59.2 t -141.06 89.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.87 0.367 . . . . 0.0 111.753 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.9 t -73.7 94.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -72.16 115.07 10.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.125 -178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 99.4 mttt -121.37 43.92 2.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -66.13 106.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.543 178.726 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.407 ' HB ' ' HA3' ' A' ' 71' ' ' GLY . 7.5 m -101.37 117.39 62.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.327 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 84.7 Cg_endo -95.07 -159.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.17 2.58 . . . . 0.0 112.402 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.532 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -48.9 141.6 10.16 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HD2' HG22 ' A' ' 61' ' ' THR . 18.0 Cg_exo -66.36 179.85 1.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.819 2.346 . . . . 0.0 112.452 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.4 p -93.28 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.728 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -72.42 -1.61 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -58.17 155.34 26.12 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.74 13.16 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.782 2.321 . . . . 0.0 112.527 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.5 ptm -122.28 81.3 1.82 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.447 HG13 ' HG2' ' A' ' 62' ' ' PRO . 93.8 t -78.59 102.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.097 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.38 42.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.607 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.14 -6.92 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 111.222 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 59' ' ' THR . . . -179.1 -106.28 0.2 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.144 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.44 62.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.12 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 11.8 pt -131.06 -167.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 0.0 111.418 -179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -124.97 103.41 8.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.961 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 84.9 t -92.98 100.17 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.063 0.459 . . . . 0.0 110.547 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.76 118.9 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.135 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.733 HD22 HG22 ' A' ' 21' ' ' THR . 81.5 mt -103.82 105.59 15.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.754 178.511 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.72 100.99 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.032 0.444 . . . . 0.0 110.992 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -105.53 102.57 38.53 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.449 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 37.3 Cg_exo -55.96 98.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.241 1.961 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.69 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 70.3 mtt180 -62.26 -34.63 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -124.29 179.69 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -118.28 144.11 46.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.591 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.34 -111.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.556 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -116.25 96.66 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 111.031 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.33 163.26 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.512 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 88' ' ' LEU . 30.1 m -160.08 157.93 29.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 111.712 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.0 tp -126.14 89.09 2.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.2 mt-10 -73.85 93.9 2.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.123 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 56.3 mt -103.38 134.27 47.03 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.247 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 104' ' ' GLU . 8.3 p -139.52 154.86 25.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 111.83 -178.759 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.9 t80 -97.85 90.37 4.92 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.919 HG21 HG21 ' A' ' 42' ' ' VAL . 5.8 t -120.02 173.02 7.33 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.472 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -103.22 95.05 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.861 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 93' ' ' THR . 89.1 Cg_exo -46.8 -30.5 9.44 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.626 2.218 . . . . 0.0 112.682 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.67 -37.24 62.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.22 -79.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.35 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.4 178.48 43.4 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.18 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.1 mt -95.45 154.66 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.454 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.7 mttt -140.72 161.65 53.18 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -71.15 -39.01 4.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.93 -28.07 69.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -54.72 152.27 7.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.215 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.4 tt0 -52.89 156.14 2.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.677 ' HB3' HD22 ' A' ' 10' ' ' ASN . 15.9 tpp180 -127.71 164.94 21.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.528 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.594 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 54.2 t80 -176.64 64.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 109.52 177.613 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 89' ' ' GLU . 11.1 m -87.12 92.9 9.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.866 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.4 tp -74.75 95.63 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.301 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.3 m-70 -79.72 144.02 34.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.773 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 79.6 mt -144.44 106.55 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.352 -178.344 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -82.79 65.65 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.591 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -42.73 136.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.568 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -147.83 165.14 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -96.12 128.64 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -86.38 124.03 32.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 pt -90.19 6.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.22 83.69 32.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.49 20.31 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.9 tp -56.4 -63.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.015 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -143.66 -27.81 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.046 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.8 101.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -176.7 134.76 0.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.358 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.46 123.58 19.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.649 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -125.69 -59.0 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.859 -179.402 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 7.5 p-10 -54.7 100.02 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -115.09 60.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.718 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 4.9 m0 -78.25 119.24 21.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.401 -177.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.9 -174.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.429 0.633 . . . . 0.0 112.317 -178.553 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -94.07 177.16 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.58 179.771 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -176.31 176.36 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.111 0.481 . . . . 0.0 112.265 179.974 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.583 ' O ' HG13 ' A' ' 112' ' ' VAL . 31.6 m-70 -114.52 -153.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.683 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.3 128.8 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 111.797 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 64.37 13.36 54.3 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.33 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.7 tptm -57.27 86.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.79 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -56.86 97.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.033 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -87.92 104.88 17.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.448 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.1 tt0 -89.26 129.24 35.85 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.181 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 HD12 ' A' ' 26' ' ' LEU . 25.0 mt -141.41 109.85 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -85.38 113.22 21.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.272 179.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mp -104.96 162.28 13.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.4 mptt -119.42 158.6 25.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.92 -141.19 3.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 2.2 t-20 -172.01 104.54 0.36 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.426 0.155 . . . . 0.0 111.052 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.73 -34.33 98.89 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.69 2.26 . . . . 0.0 112.649 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.1 p -76.38 13.15 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.657 -179.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 64.5 m -95.16 -33.36 12.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.23 -32.86 3.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.866 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.407 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 58.6 m-85 -100.18 -176.01 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.019 0.437 . . . . 0.0 111.296 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 9.5 ttm -146.53 146.38 30.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.174 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -97.36 80.63 2.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 178.882 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.9 t -121.94 -170.5 2.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 -179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.871 ' NH2' HD12 ' A' ' 47' ' ' LEU . 1.9 ttm-85 -81.84 137.58 35.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 91' ' ' VAL . 71.6 t -54.38 140.18 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.841 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.12 4.47 4.67 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.642 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -123.4 25.65 8.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' HG21 ' A' ' 93' ' ' THR . 6.4 p -67.82 130.68 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.994 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.57 -29.98 10.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' HD23 ' A' ' 47' ' ' LEU . 63.7 mttp -62.03 170.06 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.44 -59.52 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.866 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.8 -30.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.801 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.871 HD12 ' NH2' ' A' ' 38' ' ' ARG . 12.3 mt 76.11 -48.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.554 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 83.1 p -58.82 -171.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 179.112 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.02 -92.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.439 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.629 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -129.89 -33.32 1.8 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.561 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.8 mm -63.94 -64.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB3' HG12 ' A' ' 78' ' ' VAL . 81.7 mt -122.39 124.21 43.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -71.73 68.89 0.64 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.45 178.482 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -78.86 132.45 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.169 0.509 . . . . 0.0 110.992 -179.661 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.1 t -131.78 85.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.18 179.601 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.632 ' H ' HH22 ' A' ' 38' ' ' ARG . 10.4 t -99.19 111.86 24.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.538 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -95.99 112.66 24.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.423 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.36 108.3 14.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.212 179.392 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.497 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 26.5 m -120.69 128.42 25.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 3.0 Cg_endo -87.71 -149.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.428 2.752 . . . . 0.0 111.179 178.689 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 70' ' ' VAL . 2.7 m -118.95 133.24 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 111.206 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 161.72 9.36 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.052 2.501 . . . . 0.0 112.072 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 t -163.53 160.0 22.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.924 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.9 p -138.9 -1.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.646 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 90.3 m -161.12 -50.9 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 13.4 Cg_exo -70.83 157.99 56.79 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.722 2.282 . . . . 0.0 112.326 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.4 mtt -147.19 15.81 1.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.4 p -110.55 24.62 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.075 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.37 92.22 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.51 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 61' ' ' THR . 3.5 p -139.91 80.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.238 0.542 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.68 108.77 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -93.24 -121.57 3.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.07 -179.7 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.5 pt -147.5 -165.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.347 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 4.3 m-85 -141.35 103.14 4.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.639 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 63.4 t -86.25 93.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.3 t -88.58 124.59 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.796 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.79 HD22 HG22 ' A' ' 21' ' ' THR . 77.1 mt -120.12 93.34 4.02 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.18 103.97 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.943 0.402 . . . . 0.0 110.915 -179.148 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.7 mtmt -101.93 98.25 9.65 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -46.42 106.7 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.758 2.305 . . . . 0.0 112.721 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.629 HH11 ' HA ' ' A' ' 50' ' ' GLU . 9.1 mtt180 -79.44 -48.62 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 62.3 mttm -102.91 156.52 17.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -95.32 123.5 38.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.21 -153.72 25.14 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.493 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -90.33 104.13 16.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.471 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 15.6 m-70 -122.28 179.2 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 88' ' ' LEU . 94.8 m -160.12 155.26 24.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.086 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 78' ' ' VAL . 1.5 tm? -131.46 93.4 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -104.61 121.37 43.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.98 -179.799 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 76' ' ' VAL . 39.2 mt -99.0 171.84 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.478 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.1 p -160.34 151.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.107 0.48 . . . . 0.0 112.272 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -94.4 85.19 4.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.146 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.635 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.7 t -107.7 172.1 7.02 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -104.57 94.04 6.71 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.8 Cg_exo -49.6 -30.89 23.08 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.408 2.072 . . . . 0.0 112.382 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -74.6 -35.35 62.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -107.95 -77.89 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.319 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.95 -173.72 46.52 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.127 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.3 mt -96.68 148.72 5.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -133.75 174.03 5.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.41 -38.16 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.405 2.07 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.51 -10.05 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.762 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 8.5 m-20 -64.45 161.84 16.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.1 tp10 -74.01 167.79 20.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.943 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.669 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.7 tpp180 -142.77 158.83 43.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.6 t80 -158.72 81.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.533 177.027 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 2.6 m -76.59 157.76 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.506 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 78' ' ' VAL . 33.7 tp -156.51 82.69 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.256 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.7 m-70 -67.82 156.28 37.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.398 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.1 mt -147.92 106.4 3.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.034 -178.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.476 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 65.9 t30 -79.62 61.88 3.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 17' ' ' HIS . 3.3 t -45.16 121.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.603 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.978 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.6 m -95.15 119.92 34.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -81.76 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -132.78 -165.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.779 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.75 -30.79 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -69.16 -50.78 19.63 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.757 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 27.2 Cg_exo -62.53 162.93 22.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.204 1.936 . . . . 0.0 112.229 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 5' ' ' LEU . 2.5 pt? -153.6 -38.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.4 m -158.76 -74.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.36 -170.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -137.37 113.6 9.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.91 120.07 8.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.651 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.599 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.2 p-10 -129.46 -92.71 0.44 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.967 -179.312 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.6 p-10 -50.83 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.664 -179.315 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -104.89 93.51 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.45 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -84.39 105.88 15.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.593 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG23 HD23 ' A' ' 110' ' ' LEU . 29.5 m -147.44 -174.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.259 0.552 . . . . 0.0 112.285 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.93 179.69 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.467 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -177.39 -175.76 0.57 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.054 0.454 . . . . 0.0 111.891 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 49.1 m-70 -117.81 -167.11 1.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 179.118 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 33.7 t -86.66 135.84 24.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 111.94 -179.299 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 63.33 11.53 40.69 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.476 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.0 tptt -59.79 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.1 0.45 . . . . 0.0 109.812 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -55.61 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.368 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' VAL . 62.6 m -94.48 98.66 11.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.527 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 31.1 tt0 -75.45 133.51 41.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.604 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.428 HD13 ' HE2' ' A' ' 106' ' ' TYR . 37.2 mt -134.02 101.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -87.19 110.22 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.549 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 33.7 mt -108.18 148.48 29.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.352 -179.229 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -99.5 160.66 14.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.986 0.422 . . . . 0.0 110.605 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.95 -128.63 1.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.374 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -175.77 90.41 0.28 Allowed Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.537 0.208 . . . . 0.0 111.146 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 31.3 Cg_endo -63.5 163.64 23.33 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 p 44.69 28.02 0.3 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.753 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.2 m -134.73 -72.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.5 -112.74 3.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.821 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -96.39 -166.54 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.957 0.408 . . . . 0.0 110.872 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -136.87 154.71 50.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.174 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 8.3 m95 -112.47 98.23 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.94 178.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.611 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.6 t -142.56 -165.79 2.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.822 -179.053 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.8 mtp85 -88.54 156.57 19.0 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' CG2' ' A' ' 91' ' ' VAL . 31.8 t -72.83 131.17 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.935 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 13.96 82.02 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.858 179.468 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 58.0 m-85 -134.88 -4.31 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.725 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -49.52 124.39 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.123 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.36 -32.81 5.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.17 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 93.4 mttt -64.31 169.8 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.02 -61.7 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.602 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.97 142.0 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.5 mt -95.96 -50.46 4.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.119 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 24.4 p -50.78 177.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.127 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -153.3 -81.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.19 -33.23 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.306 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 22.8 mm -69.28 -81.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.676 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 6.7 mt -97.15 117.59 31.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 23.5 tt0 -68.68 84.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.158 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' H ' ' CB ' ' A' ' 48' ' ' SER . 39.0 t -88.95 91.66 3.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.511 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.6 t -79.68 86.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.4 t -68.95 135.22 50.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.006 -178.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.638 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 8.9 mtpm? -138.25 54.09 1.79 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.84 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -52.52 112.37 0.81 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.511 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -100.36 104.16 28.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.537 -179.548 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' ' HG3' ' A' ' 30' ' ' PRO . 27.1 Cg_endo -103.1 4.55 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.765 2.977 . . . . 0.0 113.039 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.547 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -121.68 138.33 28.33 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.413 -178.729 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 61' ' ' THR . 83.9 Cg_endo -79.59 171.33 15.91 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.612 2.208 . . . . 0.0 112.253 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.1 t -165.8 169.2 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.5 p -115.54 9.93 15.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.0 p -62.39 155.49 66.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.88 13.48 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.817 2.345 . . . . 0.0 112.482 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.0 mtt -115.79 80.84 1.5 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -53.85 124.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.21 35.37 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.266 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 59' ' ' THR . 2.6 p -157.31 91.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.155 0.503 . . . . 0.0 110.955 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.07 50.82 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.238 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 30' ' ' PRO . . . 103.76 16.99 18.03 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.324 179.211 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.9 pt -111.28 -168.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 111.369 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -136.44 107.32 6.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.279 -179.482 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -94.36 100.99 12.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.945 0.403 . . . . 0.0 110.737 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 88' ' ' LEU . 32.8 t -105.26 118.2 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.028 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 21' ' ' THR . 89.0 mt -104.1 106.92 17.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.44 104.99 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.272 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 39.3 mtmt -108.75 100.45 39.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.46 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.555 ' HA ' HD23 ' A' ' 52' ' ' LEU . 81.8 Cg_exo -46.41 96.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.586 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.611 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 10.4 mtt180 -69.04 -33.81 74.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.173 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -118.95 -178.45 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -119.52 120.83 37.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.795 179.604 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.7 -121.35 1.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.608 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.36 113.89 26.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 111.102 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.579 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 5.6 m80 -136.14 150.72 49.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.42 ' O ' HD12 ' A' ' 52' ' ' LEU . 91.7 m -161.19 152.6 19.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 112.063 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 76' ' ' VAL . 53.8 tp -121.87 71.79 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.073 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 3.1 pt-20 -70.71 105.38 3.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.624 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 17.6 mt -107.18 154.67 20.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.504 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -145.34 160.22 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.695 -179.748 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -103.88 89.16 3.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.562 178.198 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.92 HG21 HG21 ' A' ' 42' ' ' VAL . 9.1 t -120.25 169.12 10.56 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.2 mtp180 -101.49 95.91 5.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.948 178.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 5.6 Cg_endo -47.18 -33.46 15.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -68.46 -35.61 77.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.497 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -103.82 -80.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.359 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.65 46.25 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.095 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -97.21 149.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.027 0.441 . . . . 0.0 111.669 -179.08 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.577 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.8 mttt -135.18 162.91 54.76 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.0 Cg_endo -64.74 -35.23 47.03 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.607 2.205 . . . . 0.0 111.743 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.75 -24.45 66.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.1 m-80 -48.67 136.43 13.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 11.0 tt0 -51.86 155.44 1.76 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 4.3 tpp180 -119.96 159.15 25.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.9 t80 -172.47 69.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 16.5 m -91.43 101.97 14.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.465 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.2 tp -87.97 94.48 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.185 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.692 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 15.3 m-70 -77.55 147.87 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.677 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 HG23 ' A' ' 14' ' ' VAL . 94.9 mt -146.19 108.44 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.547 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 39.4 t30 -84.35 69.68 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 17' ' ' HIS . 2.9 t -45.71 143.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.852 -178.337 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.1 m -140.32 115.99 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.322 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -96.58 130.23 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm -110.26 164.09 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.8 tt -96.76 -30.72 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.015 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.11 151.11 18.42 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 59.4 Cg_endo -72.23 128.41 13.78 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.476 2.117 . . . . 0.0 112.288 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.2 tp -124.03 -29.71 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.798 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -131.13 -58.32 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 p -164.55 130.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.09 -20.27 17.45 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.684 179.976 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 50.66 104.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -132.21 -80.47 0.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.867 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.18 96.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.618 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.8 ptmt -101.06 68.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.554 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.747 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -49.85 104.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.137 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG23 HD23 ' A' ' 110' ' ' LEU . 35.4 m -146.87 -176.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.3 p-10 -103.38 -171.33 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.466 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -174.41 -174.74 0.89 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.3 0.571 . . . . 0.0 112.379 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 28.7 m80 -113.85 -156.58 0.6 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.647 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 42.3 t -105.26 125.56 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.468 . . . . 0.0 111.585 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.9 12.7 43.95 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.061 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptp -63.64 83.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.135 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.741 HG22 HD22 ' A' ' 77' ' ' LEU . 5.3 m -47.87 103.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.829 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.3 m -97.48 100.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.536 179.223 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 75' ' ' VAL . 35.4 tt0 -83.47 131.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.286 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 108' ' ' LEU . 36.1 mt -136.09 100.0 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.522 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.401 ' HB3' HD12 ' A' ' 73' ' ' ILE . 10.8 m170 -84.08 82.05 8.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 178.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 24' ' ' ILE . 75.0 mt -72.24 158.54 35.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.285 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -116.16 164.76 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.103 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.42 -149.57 11.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.724 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -171.22 84.48 0.5 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.559 0.219 . . . . 0.0 110.849 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.557 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 27.5 Cg_endo -61.84 -10.37 17.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.582 2.188 . . . . 0.0 112.693 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.88 -22.71 5.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.851 0.357 . . . . 0.0 110.889 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.5 p -77.44 -45.13 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.768 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.44 27.09 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.112 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' THR . 79.8 m-85 -140.27 143.86 36.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.02 0.438 . . . . 0.0 111.507 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 42' ' ' VAL . 8.5 ttp -113.58 154.8 26.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.423 179.388 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -105.22 107.03 17.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.867 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -156.65 -166.27 2.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.485 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 mtp85 -84.25 161.94 20.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.184 -179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 89' ' ' GLU . 48.6 t -76.36 138.69 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.813 -179.418 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.13 79.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.605 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.405 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.4 m-85 -135.03 -2.59 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.672 ' HA ' ' HE3' ' A' ' 35' ' ' MET . 2.3 p -40.29 108.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.287 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.68 -44.45 1.47 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -56.4 164.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 0.0 111.053 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.84 -46.77 9.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.07 136.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.9 mt -102.19 -50.55 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.973 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.488 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.6 p -50.93 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.742 179.038 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.96 -88.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -131.02 -32.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.056 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -71.64 -73.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.324 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.8 mt -107.5 118.97 38.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.442 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.64 69.22 0.42 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.406 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG21 ' HD2' ' A' ' 38' ' ' ARG . 11.8 t -76.56 83.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.316 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 14.9 t -83.61 87.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.033 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 76' ' ' VAL . 39.9 t -95.38 150.57 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.489 -178.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' HG13 ' A' ' 75' ' ' VAL . 58.5 mttm -139.02 118.13 12.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.456 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 1.5 t80 -96.57 101.64 13.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.128 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.512 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 27.7 m -107.87 90.23 6.21 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.373 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HA ' ' HA3' ' A' ' 72' ' ' GLY . 96.7 Cg_endo -83.42 -174.75 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.987 2.458 . . . . 0.0 111.818 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.23 140.52 65.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.867 179.539 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 61' ' ' THR . 25.4 Cg_exo -62.81 121.77 9.81 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.505 2.137 . . . . 0.0 112.214 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -113.35 -179.55 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.3 t -70.83 -67.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 58.6 m -99.89 -48.69 0.21 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 14.3 Cg_exo -70.28 156.09 62.74 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.739 2.293 . . . . 0.0 112.443 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.2 mmt -148.71 15.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.045 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.94 134.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.3 50.79 61.64 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -113.36 8.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.962 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 84.79 111.93 0.67 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.217 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 60' ' ' PRO . . . -171.78 -120.8 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.165 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm -114.33 153.43 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.954 0.883 . . . . 0.0 111.784 -179.36 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -129.87 67.57 1.46 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.506 178.463 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.2 p -81.04 107.31 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.476 -178.338 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 88' ' ' LEU . 96.6 t -102.02 125.98 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.46 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD22 HG22 ' A' ' 21' ' ' THR . 76.6 mt -109.3 96.9 6.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.77 178.408 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.61 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -93.73 106.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.04 0.448 . . . . 0.0 111.044 -178.904 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -107.87 105.07 55.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.985 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 Cg_exo -53.05 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.49 2.127 . . . . 0.0 112.45 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.622 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.6 mtt180 -69.87 -49.14 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.459 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -107.62 161.05 15.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -98.15 113.79 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.733 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.628 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.93 -129.25 1.9 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.578 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.44 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.7 m80 -106.62 99.09 8.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.458 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -111.04 162.69 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.673 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' HD12 ' A' ' 52' ' ' LEU . 99.7 m -159.63 148.87 18.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.044 0.449 . . . . 0.0 112.052 -179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 25.7 tp -121.61 79.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.757 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -77.07 100.19 5.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.178 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.9 mt -98.68 140.75 32.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.116 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -140.98 164.49 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.808 -179.452 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -99.11 84.18 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.78 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.66 HG21 ' HB ' ' A' ' 42' ' ' VAL . 7.6 t -95.5 -175.67 3.54 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.831 -177.233 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 55.7 mtp180 -117.91 101.17 52.08 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.297 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 84.4 Cg_exo -39.92 -34.93 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.054 2.503 . . . . 0.0 113.399 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -88.74 -47.23 8.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.414 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -83.92 -86.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.884 0.374 . . . . 0.0 111.803 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 172.82 -174.06 45.68 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.246 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -93.68 154.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 10.6 mttm -145.44 166.46 17.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.506 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.2 Cg_exo -59.62 -44.88 28.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.857 2.371 . . . . 0.0 111.864 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.51 -26.74 67.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.307 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -49.56 135.47 18.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 9.3 tt0 -49.42 152.53 1.28 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.24 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 7.4 tpp180 -117.63 159.2 23.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.167 0.508 . . . . 0.0 111.71 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.493 ' H ' ' HG3' ' A' ' 105' ' ' ARG . 41.5 t80 -175.55 62.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.532 177.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 9.1 m -84.26 98.12 9.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.726 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 78' ' ' VAL . 18.6 tp -80.57 92.41 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.862 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.747 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -79.59 140.94 36.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.341 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.504 HD23 HG23 ' A' ' 14' ' ' VAL . 89.3 mt -144.01 99.83 3.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.58 -178.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.533 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 7.9 t30 -73.16 77.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.628 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 6.1 t -51.5 120.55 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.418 -178.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.887 -179.97 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.4 m -137.46 -38.27 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt -83.48 -172.61 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.773 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -144.21 -22.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.88 111.37 12.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.206 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.15 176.25 10.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.427 2.085 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -154.5 -70.4 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.499 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 78.4 p -165.72 -58.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.8 p -98.56 150.76 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -133.41 110.72 10.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.991 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.72 126.84 29.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.605 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 9.3 t30 -115.96 -16.46 11.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.241 -179.413 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -149.56 -140.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' C ' ' HB3' ' A' ' 109' ' ' HIS . 22.1 ptmt -132.63 -173.94 3.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.451 -179.12 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 16.7 m0 -136.63 117.48 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 179.214 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 109' ' ' HIS . 2.6 p -158.35 158.57 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.547 0.689 . . . . 0.0 112.077 -178.688 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 p30 -44.98 165.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.925 -178.454 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 17' ' ' HIS . 3.1 t -173.02 -167.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.391 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.558 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 57.2 m80 -111.99 179.34 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -94.03 147.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.208 0.528 . . . . 0.0 112.195 -178.567 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.19 21.63 5.96 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.849 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.8 tptt -75.18 73.53 2.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 109.658 179.38 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.738 HG22 HD22 ' A' ' 77' ' ' LEU . 11.6 m -40.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.809 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.6 m -104.52 103.84 13.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.581 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' HG23 ' A' ' 75' ' ' VAL . 28.0 tt0 -82.58 121.7 27.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' HD22 ' A' ' 26' ' ' LEU . 56.7 mt -126.99 99.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.539 ' HB3' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.36 109.61 20.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.61 178.639 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 26' ' ' LEU . 2.6 mm? -91.05 167.56 12.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -107.46 167.66 9.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.965 179.146 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.6 -148.82 18.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.579 -179.469 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.478 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 49.0 t30 -171.64 116.02 0.42 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.331 0.11 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.51 -46.55 26.66 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.39 2.06 . . . . 0.0 112.404 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -57.81 -29.32 64.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.435 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 52.4 m -59.54 -55.25 36.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.19 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.64 -83.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.143 179.752 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 87.9 m-85 -55.46 158.86 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.19 0.519 . . . . 0.0 111.635 -179.256 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.0 ttm -123.8 150.29 44.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -105.66 81.82 1.72 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 178.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -124.01 -160.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.699 -179.292 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 54' ' ' VAL . 1.8 ttp85 -95.24 114.12 25.87 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG11 HH11 ' A' ' 105' ' ' ARG . 0.9 OUTLIER -48.14 134.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 111.514 -179.283 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.16 3.19 76.29 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.917 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 55.7 m-85 -139.37 0.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.971 -179.633 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.3 p -49.48 136.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.195 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.99 -34.69 2.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.0 mttm -62.36 168.46 3.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.35 -61.59 1.77 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.588 179.692 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.44 140.56 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.743 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.0 mt -89.76 -52.08 5.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.924 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.455 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 22.7 t -48.69 172.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.472 178.683 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.46 -78.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.74 -34.44 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.469 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -69.97 -78.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 -179.306 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 80' ' ' PRO . 60.2 mt -98.54 117.2 32.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.385 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 25.9 tt0 -67.93 84.26 0.22 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.58 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -92.22 94.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.921 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 43.2 t -91.48 82.13 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.037 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 76' ' ' VAL . 22.2 t -99.61 155.21 17.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.622 -178.367 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -143.41 123.86 13.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -89.36 109.34 20.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.398 179.741 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 m -97.72 105.04 24.11 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.574 -179.356 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 44.1 Cg_endo -101.5 -162.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.849 3.033 . . . . 0.0 112.464 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.533 HG23 ' HD2' ' A' ' 62' ' ' PRO . 22.8 m 58.12 138.61 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.172 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' A' ' 61' ' ' THR . 20.2 Cg_endo -59.63 178.5 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.144 2.563 . . . . 0.0 112.211 179.59 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.1 p -69.09 114.72 7.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -100.27 -30.32 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.029 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.604 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 62.8 m -155.89 -50.25 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 7.0 Cg_exo -74.56 -171.77 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.802 2.334 . . . . 0.0 112.21 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.3 ptm -160.08 20.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.457 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.67 27.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.943 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.1 84.1 1.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.516 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.53 86.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.062 0.458 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.88 39.51 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.328 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.95 29.94 1.18 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -86.0 162.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.6 0.714 . . . . 0.0 111.429 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.1 m-85 -144.52 79.79 1.62 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.56 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.512 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.8 p -85.05 106.52 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.268 0.556 . . . . 0.0 110.755 -178.994 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG11 HD21 ' A' ' 88' ' ' LEU . 20.4 t -107.83 116.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.583 -178.968 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.738 HD22 HG22 ' A' ' 21' ' ' THR . 29.1 mt -100.46 100.96 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.702 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 114.19 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.252 0.549 . . . . 0.0 111.17 -178.947 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.7 mtmm -119.44 92.41 45.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.416 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.4 Cg_endo -47.46 112.87 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.487 2.125 . . . . 0.0 112.905 -178.778 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.1 mtt180 -80.51 -39.82 27.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.861 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.28 176.38 5.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -113.62 149.82 34.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.072 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.528 ' N ' HG23 ' A' ' 112' ' ' VAL . . . 124.01 -160.56 18.56 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.726 179.8 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -71.43 98.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -129.91 154.07 47.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 0.0 111.331 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.548 HG21 ' HE1' ' A' ' 13' ' ' TRP . 37.5 m -159.87 138.9 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.702 ' HB2' HG11 ' A' ' 78' ' ' VAL . 32.0 tp -74.53 111.18 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.292 179.531 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 44.5 mt-10 -87.6 96.75 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.732 -179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 36.3 mt -101.14 170.01 8.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.449 178.796 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 13.3 p -166.56 153.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -104.56 84.27 2.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.769 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.637 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.6 t -124.55 149.23 47.2 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.12 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 74.7 mtp180 -85.81 101.65 2.01 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.965 178.495 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 8.6 Cg_endo -52.28 -38.24 72.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.721 2.281 . . . . 0.0 112.685 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.14 10.89 3.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.74 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 20.7 mm-40 -147.88 1.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.41 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.84 -174.75 54.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.114 -179.515 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.637 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.2 mt -106.45 148.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.002 0.429 . . . . 0.0 111.635 -179.326 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 9.9 mttt -131.63 157.93 76.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.565 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 52.2 Cg_exo -56.39 -43.98 50.53 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.75 2.3 . . . . 0.0 112.744 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.76 -14.09 49.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.074 -179.365 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.595 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -62.02 137.7 58.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 -179.632 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.9 tt0 -60.37 -179.46 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -162.97 162.35 26.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.214 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.593 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 26.3 t80 -151.53 114.94 4.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.042 0.449 . . . . 0.0 110.177 178.151 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.592 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -104.37 132.12 50.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.043 -178.993 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 110' ' ' LEU . 26.5 tp -101.62 110.45 22.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.527 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 14' ' ' VAL . 8.6 p80 -55.32 71.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.868 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 108' ' ' LEU . 21.1 mt -112.72 70.72 0.72 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.839 0.745 . . . . 0.0 112.937 -178.896 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 31.6 t30 -82.31 60.21 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.757 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -40.71 141.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.615 -178.07 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.044 179.719 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' -1' ' ' SER . . . . . 0.534 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 48.1 t -140.96 3.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 62.9 m80 58.74 26.22 14.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.847 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG3' ' HB3' ' A' ' -1' ' ' SER . 69.3 mtm -60.88 167.97 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.944 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 8' ' ' LYS . 40.1 pt -76.5 -28.42 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.06 90.4 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.214 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.14 110.69 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.558 2.172 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.7 tp -166.9 -33.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 m -136.43 -49.26 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.0 p -130.43 105.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 111.23 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.534 ' HG2' HD22 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -110.37 -12.93 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.701 179.875 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 54.28 106.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.678 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -137.62 -86.71 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.941 -179.667 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -36.72 103.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.804 -179.581 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.3 tttt -90.67 100.54 13.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.492 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.672 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.4 m95 -82.86 105.44 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.696 -179.521 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.73 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -153.37 176.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.146 0.498 . . . . 0.0 111.838 -179.118 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -94.39 -176.69 4.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.601 179.67 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.493 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t -174.1 -175.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 112.093 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.0 m-70 -116.68 -163.25 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.005 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.06 126.7 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.795 -179.598 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.44 10.55 29.96 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.09 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.1 tptm -63.27 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.688 HG22 HD22 ' A' ' 77' ' ' LEU . 5.0 m -46.55 98.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.907 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -90.89 94.8 9.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.031 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.9 tt0 -83.77 128.3 34.44 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.282 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.539 HG22 ' HG ' ' A' ' 26' ' ' LEU . 55.5 mt -133.57 103.42 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.048 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -87.89 119.11 27.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.484 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -118.64 151.66 37.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -178.554 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -125.59 157.9 35.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 163.85 -43.22 0.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.436 -1.364 . . . . 0.0 114.195 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER 48.86 103.91 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 121.067 0.461 . . . . 0.0 110.009 -177.656 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.612 ' C ' ' H ' ' A' ' 32' ' ' THR . 56.2 Cg_endo -68.1 -151.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.654 1.569 . . . . 0.0 111.277 -179.45 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -74.02 23.4 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.785 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.612 ' H ' ' C ' ' A' ' 30' ' ' PRO . 12.0 p 63.19 23.84 14.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.152 -179.372 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.26 -34.12 0.33 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.711 179.329 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' HB2' ' CB ' ' A' ' 30' ' ' PRO . 60.2 m-85 -75.23 -166.78 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.75 0.309 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 15.9 ttm -161.31 150.55 16.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.062 0.458 . . . . 0.0 111.053 -179.606 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.537 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -106.49 84.72 2.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.042 178.102 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.628 HG21 ' HA ' ' A' ' 42' ' ' VAL . 6.4 t -136.63 -165.85 1.8 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.329 -178.544 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -86.69 155.68 20.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.906 0.384 . . . . 0.0 111.636 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 91' ' ' VAL . 43.6 t -72.82 132.4 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.84 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.43 85.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.625 179.618 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 60.4 m-85 -132.53 -4.61 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG21 ' A' ' 93' ' ' THR . 21.7 t -53.65 111.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.039 179.314 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.09 -28.86 13.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.954 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 98.0 mttt -68.69 174.24 4.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.09 -64.14 1.2 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.769 179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.6 p -99.25 142.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.809 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 18.8 mt -92.21 -51.71 5.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.282 -179.958 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 76.9 p -67.53 -168.6 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -151.19 -86.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.16 -31.33 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.274 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -72.3 -83.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.475 -179.495 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -99.95 107.03 18.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.65 179.767 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 35.5 tt0 -60.43 142.89 54.44 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.276 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG21 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -144.66 85.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.304 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.2 t -86.06 83.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.425 0.631 . . . . 0.0 109.353 178.12 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 76' ' ' VAL . 9.2 t -102.18 133.51 46.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.447 -178.787 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -116.12 120.84 40.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.303 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.473 ' CZ ' ' HE1' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -90.88 95.37 10.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.245 179.512 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 32.4 m -95.61 108.1 37.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.721 -179.122 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.619 ' HB2' HG22 ' A' ' 70' ' ' VAL . 56.5 Cg_endo -101.24 82.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.582 2.854 . . . . 0.0 111.283 179.154 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.552 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -53.87 139.15 52.96 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.596 -179.039 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.552 ' HD2' HG22 ' A' ' 61' ' ' THR . 87.5 Cg_endo -90.44 154.05 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.204 2.603 . . . . 0.0 112.458 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 p -100.82 -169.91 1.78 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -112.4 -73.04 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.637 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 68.0 m -156.94 -51.58 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.595 179.795 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 1.7 Cg_endo -86.25 36.39 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.089 2.526 . . . . 0.0 111.85 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 45.0 ttp -177.06 31.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.269 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -41.03 137.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.03 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.18 124.77 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.151 -179.692 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.619 HG22 ' HB2' ' A' ' 60' ' ' PRO . 8.7 p -81.4 24.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.228 0.537 . . . . 0.0 110.979 -179.766 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.96 130.38 44.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.991 -179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -134.08 -130.65 3.04 Favored Glycine 0 N--CA 1.453 -0.18 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.54 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.29 -169.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.08 0.466 . . . . 0.0 110.789 179.033 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 9.7 m-85 -145.04 95.42 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.892 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.97 126.29 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.257 0.551 . . . . 0.0 110.655 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -123.06 122.76 66.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.18 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.688 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -105.33 94.25 5.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.134 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -92.63 101.57 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.099 0.475 . . . . 0.0 110.756 -179.186 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HE3' ' OG1' ' A' ' 21' ' ' THR . 11.2 mttt -102.11 102.62 25.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.454 -179.326 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 41.5 Cg_exo -56.12 95.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.132 1.888 . . . . 0.0 112.157 179.388 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 68.9 mtt180 -67.43 -28.15 67.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -128.89 173.35 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.436 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -113.46 137.91 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.607 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.56 -136.7 6.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.183 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.496 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 62.0 m80 -99.32 91.68 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 110.742 179.853 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.7 m-70 -111.28 164.48 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.592 -179.899 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 88' ' ' LEU . 32.4 m -158.75 157.99 32.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 0.0 111.823 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.8 tp -124.02 88.49 2.92 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 39.4 mt-10 -74.25 101.28 3.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.246 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 75.9 mt -107.38 139.2 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.323 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.519 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -138.93 166.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.149 0.499 . . . . 0.0 112.087 -179.248 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -106.16 84.26 2.02 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.178 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.848 HG21 HG21 ' A' ' 42' ' ' VAL . 7.5 t -126.66 159.86 32.43 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -176.929 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.0 mtp180 -93.23 100.76 4.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.537 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 42' ' ' VAL . 82.7 Cg_exo -34.14 -42.96 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.485 2.79 . . . . 0.0 113.972 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -80.6 -52.94 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.038 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -70.56 4.98 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.83 -169.26 54.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.931 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.83 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -115.03 155.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.267 0.556 . . . . 0.0 112.256 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 49.5 mtmt -147.0 158.75 44.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.349 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 20.3 Cg_endo -60.86 -34.65 90.97 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.735 2.29 . . . . 0.0 112.684 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.18 -11.88 4.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.838 -179.704 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -71.04 140.51 50.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 111.441 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -55.45 161.99 1.74 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.5 tpp180 -122.94 160.61 25.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.614 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 42.2 t80 -173.63 66.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.887 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 8.7 m -87.01 92.02 8.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.333 -178.881 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 69.6 tp -72.26 94.46 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.185 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.5 m-70 -78.56 142.74 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.076 0.465 . . . . 0.0 110.709 179.443 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 93.6 mt -142.69 109.18 5.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -178.038 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 m-20 -81.73 66.95 7.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.376 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.607 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.41 110.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.357 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.934 -179.89 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.417 -0.273 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.2 m -95.34 146.31 24.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -98.37 21.02 11.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt 61.41 -179.89 0.11 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.1 pt -138.1 26.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.151 -179.904 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -53.17 -49.32 88.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.678 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 49.6 Cg_exo -56.01 152.52 36.43 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.153 1.902 . . . . 0.0 112.167 179.799 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 tp -149.04 -68.13 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.087 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.3 t -127.09 5.1 6.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.7 152.84 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.041 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -129.82 107.8 9.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 109.96 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.81 130.14 42.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -104.68 -21.55 13.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.892 -179.833 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 107' ' ' THR . 6.4 m-20 -151.82 -146.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.401 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -133.89 -170.23 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 12.5 m0 -130.86 123.95 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.806 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 109' ' ' HIS . 16.4 m -147.88 154.5 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -178.607 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.4 p-10 -51.02 168.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.83 -179.404 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 t -171.36 -168.96 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.803 -179.5 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.1 m80 -104.03 -175.98 2.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.767 0.318 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -96.89 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.142 0.496 . . . . 0.0 111.897 -179.27 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.25 15.5 5.54 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.416 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -66.39 79.2 0.1 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.023 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.754 HG22 HD22 ' A' ' 77' ' ' LEU . 4.4 m -44.06 101.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.751 -178.9 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -96.25 101.84 13.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.621 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.3 tt0 -80.71 130.06 34.87 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.659 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.558 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.2 mt -132.86 105.61 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.873 -179.716 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -89.23 96.04 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.868 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' HG22 ' A' ' 24' ' ' ILE . 14.7 mt -90.29 146.01 24.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.303 -179.046 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -100.57 161.31 13.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.44 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.56 -145.02 8.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.441 -179.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 10.6 t-20 -175.02 96.94 0.28 Allowed Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 11.4 Cg_endo -55.03 -31.13 73.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.68 2.253 . . . . 0.0 112.847 -179.552 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.8 -21.74 20.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.544 -179.818 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.5 p -66.0 -59.86 3.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.933 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.79 -33.31 0.52 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.849 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.99 -179.13 5.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.154 0.502 . . . . 0.0 111.493 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.542 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.0 ttt -147.88 154.03 39.88 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.739 -179.091 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.5 m95 -110.19 93.28 4.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.196 178.921 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -137.25 -168.46 2.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.0 mtp85 -87.62 140.34 29.62 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 91' ' ' VAL . 13.2 t -60.96 130.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.778 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.65 75.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -137.66 0.73 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 110.432 -179.797 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 93' ' ' THR . 21.5 t -54.39 111.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.147 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.32 -31.77 7.58 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.04 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -68.89 173.98 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.121 179.791 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.42 -63.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.679 179.678 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.01 142.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.4 mt -96.03 -51.05 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.482 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.0 p -52.66 175.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.691 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.12 -85.43 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.77 -31.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.299 -179.315 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.5 mm -70.2 -72.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.359 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 80' ' ' PRO . 92.0 mt -111.5 121.47 45.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 68.0 0.37 Allowed 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.82 HG22 HG13 ' A' ' 78' ' ' VAL . 5.8 t -75.62 86.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.42 -178.536 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.0 87.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.45 ' SG ' HG22 ' A' ' 76' ' ' VAL . 30.5 t -105.44 141.24 37.28 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.992 -178.1 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -130.84 115.81 17.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.744 179.033 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.542 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -83.54 113.96 21.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.736 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.6 m -112.72 111.56 51.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HB2' HG12 ' A' ' 70' ' ' VAL . 66.8 Cg_endo -99.52 40.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.522 2.815 . . . . 0.0 112.109 179.563 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -42.01 140.37 1.53 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.557 -179.192 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.548 ' HD2' HG22 ' A' ' 61' ' ' THR . 26.7 Cg_exo -62.25 -177.36 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.69 2.26 . . . . 0.0 112.368 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -70.69 -170.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 179.908 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -73.83 -67.87 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 61.5 m -92.87 -48.47 0.3 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.883 -179.782 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 12.4 Cg_exo -71.3 -173.97 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.786 2.324 . . . . 0.0 112.303 -179.661 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -138.08 15.16 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.52 150.28 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.274 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.21 -52.25 1.09 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.578 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 60' ' ' PRO . 89.2 t 52.04 86.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.985 0.421 . . . . 0.0 111.027 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.06 124.77 1.76 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.868 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.544 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -120.78 -117.37 2.55 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.378 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.1 pt -139.03 -166.38 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.104 0.478 . . . . 0.0 110.984 179.749 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -130.94 100.48 5.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.183 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 110.746 -179.467 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 88' ' ' LEU . 22.0 t -119.38 120.39 63.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.549 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -109.58 97.61 7.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.729 178.203 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.82 HG13 HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -93.98 105.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.987 0.422 . . . . 0.0 111.24 -178.721 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -105.78 103.3 43.23 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.035 -179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 73.1 Cg_exo -48.41 99.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.738 2.292 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -76.85 -33.76 57.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.767 178.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.76 161.14 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.421 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 96.3 mtt180 -103.64 124.53 49.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.483 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 146.78 -167.95 28.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -63.49 100.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -135.91 161.01 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.24 0.543 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.555 HG21 ' HE1' ' A' ' 13' ' ' TRP . 47.0 m -165.24 146.27 7.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.52 -179.489 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 76' ' ' VAL . 42.2 tp -78.68 105.28 9.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.949 178.844 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.0 97.33 9.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.418 179.861 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 25.5 mt -104.22 169.93 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.716 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.1 p -165.88 150.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.036 -179.017 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.1 t80 -101.28 91.69 4.62 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.37 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.914 HG21 HG21 ' A' ' 42' ' ' VAL . 1.7 t -126.53 164.93 20.11 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.45 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -101.38 91.85 2.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.536 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 93' ' ' THR . 58.7 Cg_exo -39.69 -35.43 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.0 2.467 . . . . 0.0 113.014 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.77 85.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.97 -88.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -163.95 -179.28 38.13 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.053 -179.681 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 93' ' ' THR . 22.2 mt -93.26 -60.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.499 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 34.7 mtmt 69.15 159.59 0.15 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 83.7 Cg_endo -76.71 -34.77 2.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 123.137 2.558 . . . . 0.0 112.388 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.0 pt-20 -56.63 -35.77 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -54.91 151.7 8.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.96 0.41 . . . . 0.0 111.611 -179.786 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.8 tt0 -65.35 178.23 0.97 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.25 164.36 35.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.097 -179.482 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.587 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 23.4 t80 -147.01 113.93 6.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.992 0.425 . . . . 0.0 109.973 178.318 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HE ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -103.72 128.65 51.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.308 -178.604 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 33.2 tp -98.87 108.27 20.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 14' ' ' VAL . 4.5 p80 -50.4 72.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.747 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 108' ' ' LEU . 94.5 mt -110.22 64.37 0.61 Allowed 'General case' 0 C--N 1.342 0.251 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 42.4 t30 -79.58 51.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.483 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -28.36 136.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.462 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -145.84 147.36 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.949 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -131.6 167.61 19.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -96.23 -178.51 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 tp -69.81 -36.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -169.31 -50.49 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.826 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 32.4 Cg_exo -58.45 148.2 81.84 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.18 1.92 . . . . 0.0 112.315 179.975 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.4 mp -102.07 -52.84 3.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.863 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.7 m -143.33 -77.55 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.44 116.81 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.09 126.82 4.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.565 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.88 115.8 24.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -179.995 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -130.39 -88.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.316 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.599 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.4 OUTLIER -25.26 105.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.658 -179.251 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.4 tttt -101.39 98.36 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.8 m95 -85.52 103.2 14.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.416 -178.64 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.459 HG23 HD23 ' A' ' 110' ' ' LEU . 26.9 m -149.14 -167.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.671 -179.389 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -108.08 -168.99 1.44 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 179.805 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.508 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.5 t 174.24 -173.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.606 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.7 m80 -120.65 -176.27 3.2 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.099 179.126 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.7 137.67 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.25 0.548 . . . . 0.0 111.999 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.09 16.86 34.91 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.598 179.501 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.2 tptm -57.7 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.091 0.445 . . . . 0.0 110.042 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.815 HG22 HD22 ' A' ' 77' ' ' LEU . 2.9 m -57.2 94.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.25 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -95.57 105.92 17.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.002 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.8 tt0 -85.81 124.98 32.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.851 179.497 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 74' ' ' TYR . 51.7 mt -126.46 101.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.014 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.436 ' ND1' HD12 ' A' ' 73' ' ' ILE . 13.9 m170 -86.57 109.95 19.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.862 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 90' ' ' LEU . 18.8 mt -99.14 176.51 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.98 0.419 . . . . 0.0 111.098 -179.173 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -119.98 169.87 9.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.131 179.26 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.34 -159.07 31.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.717 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.598 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 18.0 t-20 -171.64 102.53 0.38 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.402 0.144 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.09 177.66 2.35 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.423 2.082 . . . . 0.0 112.206 -179.995 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.8 p 50.42 20.14 0.64 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.431 -179.693 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.2 m -144.4 -69.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.22 -118.49 3.89 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.515 -179.883 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 3.1 m-85 -122.46 -175.74 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.915 -179.583 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 14.0 ttm -109.47 149.89 28.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.604 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . 4.2 m95 -108.82 83.78 1.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.708 178.29 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.544 HG23 HG22 ' A' ' 42' ' ' VAL . 14.1 t -125.51 -168.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.19 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.633 ' NE ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -83.61 134.5 34.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.906 0.384 . . . . 0.0 111.512 -178.941 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 91' ' ' VAL . 33.6 t -52.57 136.58 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.8 -23.52 1.06 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.51 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' VAL . 11.7 m-30 -100.19 21.08 13.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 110.159 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HG21 ' A' ' 93' ' ' THR . 20.1 t -76.34 106.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.725 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.01 -20.26 26.61 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.032 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -66.15 170.41 5.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.372 . . . . 0.0 111.144 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.5 -31.13 18.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.43 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.52 121.76 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 56' ' ' CYS . 20.6 mt -74.35 -59.47 2.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.699 179.474 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 80.6 p -50.55 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.42 178.485 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.09 -96.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.368 179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -127.24 -32.76 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -73.67 -75.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.6 mt -103.28 115.58 30.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.315 179.498 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -69.44 71.45 0.3 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.768 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.633 HG11 ' NE ' ' A' ' 38' ' ' ARG . 2.1 t -74.3 87.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.324 -178.805 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.2 t -88.33 86.62 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.488 178.127 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.625 ' HB3' HD12 ' A' ' 47' ' ' LEU . 29.6 t -110.41 153.82 24.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.743 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -136.9 118.13 14.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.273 179.34 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -80.34 94.77 6.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.541 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 21.5 m -99.58 104.48 27.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.356 -179.369 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.733 ' HB2' HG13 ' A' ' 70' ' ' VAL . 69.0 Cg_endo -97.17 30.99 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.289 2.659 . . . . 0.0 111.847 -179.559 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.6 p -65.64 145.38 99.05 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.303 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HA ' ' H ' ' A' ' 70' ' ' VAL . 92.3 Cg_endo -80.14 155.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.605 2.203 . . . . 0.0 112.492 -179.946 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.5 p -96.55 -174.54 3.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -136.9 -0.01 2.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 60.3 m -99.14 -49.94 0.21 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.771 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 3.1 Cg_exo -77.75 -151.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.028 2.486 . . . . 0.0 112.085 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 mtt -129.52 17.66 5.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.962 179.859 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -108.63 153.83 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.081 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.3 128.03 5.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 60' ' ' PRO . 70.4 t 59.26 96.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-O 120.984 0.421 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 29' ' ' ASN . . . -122.43 -42.32 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.36 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . 107.01 120.82 4.64 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.718 179.627 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.436 HD12 ' ND1' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -89.2 -24.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 0.0 112.056 179.786 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 23.9 m-85 47.31 75.94 0.12 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.326 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.9 p -92.04 101.44 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.179 0.514 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 56' ' ' CYS . 17.3 t -99.67 117.29 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.626 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD22 HG22 ' A' ' 21' ' ' THR . 64.4 mt -107.38 94.58 5.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.105 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.56 HG21 HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -90.98 112.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.023 0.439 . . . . 0.0 111.297 -178.809 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.6 mtmt -113.15 94.25 29.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.2 Cg_endo -47.58 103.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.579 2.186 . . . . 0.0 112.669 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.7 mtt180 -67.46 -33.68 75.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.541 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -119.29 -176.06 3.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.53 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -127.8 121.59 30.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 154.54 -106.98 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -105.58 99.74 9.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.6 m80 -128.67 150.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.503 ' HG1' ' CG ' ' A' ' 109' ' ' HIS . 91.4 m -158.17 147.72 19.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.96 0.409 . . . . 0.0 111.935 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.9 tp -98.31 84.82 3.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.568 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 107' ' ' THR . 46.4 mt-10 -69.64 99.11 1.26 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 21.6 mt -110.57 151.77 27.22 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.937 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -154.79 146.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.632 -178.606 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 35' ' ' MET . 12.4 t80 -95.67 78.04 3.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.4 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.868 HG21 HG21 ' A' ' 42' ' ' VAL . 5.4 t -118.45 159.65 23.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 13.6 mtp180 -98.43 98.17 5.55 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.605 178.879 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.3 Cg_exo -40.78 -34.51 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.079 2.519 . . . . 0.0 113.105 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -68.93 -62.95 1.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.003 -179.416 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.73 4.53 9.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.304 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.03 -164.74 37.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.081 -179.562 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.6 mt -113.04 121.02 64.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.976 -179.198 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -107.76 162.74 18.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.36 -37.47 17.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.663 2.242 . . . . 0.0 112.393 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.4 -17.59 8.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.743 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.75 142.29 56.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 111.473 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.42 173.55 1.18 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.599 179.429 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.8 tpp180 -135.89 163.07 31.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.265 -179.211 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.694 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 13.4 t80 -169.76 74.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 177.152 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -95.94 93.3 6.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.729 -178.851 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.3 tp -76.73 88.65 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 110.24 179.291 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.677 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.0 m-70 -72.38 144.06 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 16' ' ' THR . 64.5 mt -146.37 113.31 6.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.123 -178.35 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.3 t30 -83.34 55.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.491 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.473 HG13 HG23 ' A' ' 16' ' ' THR . 1.8 t -35.64 126.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.743 -178.871 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.928 179.952 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 51.2 m -137.57 -14.57 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -132.51 132.65 42.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm 57.88 -168.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.68 -61.83 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.616 ' H ' ' HD2' ' A' ' 4' ' ' PRO . . . -168.71 -52.1 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.75 -179.9 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' A' ' 3' ' ' ALA . 49.0 Cg_endo -68.53 100.13 0.66 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.105 1.87 . . . . 0.0 112.332 -179.748 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -171.45 91.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.789 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.8 t 59.57 13.61 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.176 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.99 94.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.057 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -179.99 152.35 0.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.796 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 112.56 19.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.531 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -132.09 -94.0 0.36 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.132 0.491 . . . . 0.0 111.952 -179.45 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.55 103.52 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.698 -179.284 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 90.48 7.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.889 179.198 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.7 m95 -73.67 99.12 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.715 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 15' ' ' ASP . 10.9 p -156.49 169.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -85.75 -173.25 4.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -175.51 -172.06 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.244 0.545 . . . . 0.0 112.375 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.9 m80 -118.11 -160.12 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.709 178.977 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.401 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.1 t -101.16 132.64 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 111.764 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.4 17.85 13.31 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.203 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.1 tptt -63.89 84.07 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.151 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.756 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.84 101.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.674 -178.957 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 78' ' ' VAL . 72.5 m -97.51 100.77 12.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.562 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.4 tt0 -79.82 134.0 36.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.582 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.2 mt -138.34 104.38 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.964 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -84.18 96.58 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.958 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.582 ' HG ' HG22 ' A' ' 24' ' ' ILE . 13.6 mt -95.88 148.01 23.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 -178.583 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -113.54 162.12 16.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.149 179.175 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.29 -23.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.545 -179.022 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 31' ' ' THR . 41.1 t30 64.34 104.62 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.463 0.173 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HG2' ' HB ' ' A' ' 70' ' ' VAL . 11.2 Cg_endo -55.24 -27.09 55.09 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.527 2.151 . . . . 0.0 112.478 179.757 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.481 ' HB ' HD21 ' A' ' 29' ' ' ASN . 6.7 m -57.69 -24.52 57.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.489 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.2 p -60.46 -62.56 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 156.88 -50.7 0.43 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.75 179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 35.7 m-85 -77.23 -176.31 4.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.564 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.7 ttt -141.32 148.69 40.15 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.081 -179.814 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.454 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -104.56 83.5 2.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.849 178.916 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -127.43 -168.91 1.95 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.23 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.636 HH11 HG21 ' A' ' 54' ' ' VAL . 1.9 mtp180 -85.63 135.85 33.62 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.31 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' HB ' ' A' ' 91' ' ' VAL . 40.9 t -48.63 150.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.068 -179.254 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.81 1.3 4.83 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.595 179.745 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.91 32.48 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.449 0.642 . . . . 0.0 110.614 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.633 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.1 p -60.26 100.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.994 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.36 -26.56 6.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.678 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.53 -179.75 1.45 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.865 0.364 . . . . 0.0 111.229 -179.863 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.59 -51.74 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.842 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 47' ' ' LEU . 3.6 p -68.94 -45.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.268 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.9 mt 71.09 -63.0 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.029 179.601 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.5 p -46.66 172.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.255 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -154.19 -84.82 0.07 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.416 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -130.65 -33.33 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.399 -179.202 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -70.5 -78.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.437 -179.53 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -103.16 116.01 31.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.452 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.66 69.83 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.673 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' VAL . 20.6 t -76.62 84.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.0 t -79.41 86.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.284 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 76' ' ' VAL . 43.4 t -99.91 142.14 31.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.434 -178.466 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -133.41 108.96 9.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.072 179.402 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.564 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -78.76 100.63 7.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.259 179.564 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 29.2 m -93.57 108.2 32.33 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.831 -179.056 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HB2' HG11 ' A' ' 70' ' ' VAL . 77.5 Cg_endo -104.18 85.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.109 3.206 . . . . 0.0 111.434 179.285 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -49.12 132.44 15.96 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.53 -179.191 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.28 153.89 15.84 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.062 2.508 . . . . 0.0 112.343 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -68.75 116.89 9.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.032 -179.947 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.0 p -79.76 -20.14 46.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 74.7 p -81.65 156.52 70.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 93.0 Cg_endo -75.39 12.31 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.681 2.254 . . . . 0.0 112.533 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 64.6 mtt -124.27 -105.17 0.36 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.6 t -143.5 142.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.42 87.73 0.06 OUTLIER Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 179.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.527 ' HB ' ' HG2' ' A' ' 30' ' ' PRO . 57.3 t -58.85 -89.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.959 179.854 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.81 99.46 0.42 Allowed Glycine 0 C--N 1.322 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.057 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.435 ' H ' ' HD2' ' A' ' 30' ' ' PRO . . . -147.74 -150.36 5.18 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.921 179.506 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt -141.52 -167.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.159 0.504 . . . . 0.0 111.338 179.405 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -134.56 97.16 3.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.226 -179.779 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.54 102.98 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.501 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 88' ' ' LEU . 40.2 t -105.55 124.06 60.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.756 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -113.17 102.95 10.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.669 178.13 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -95.49 110.4 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.438 . . . . 0.0 111.428 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.6 mtmt -115.32 96.04 44.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.0 Cg_endo -50.99 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.38 2.054 . . . . 0.0 112.403 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 13.6 mtt180 -74.22 -38.11 63.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -111.4 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.142 -179.069 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -112.01 144.2 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.68 -119.74 2.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -110.58 117.42 33.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -132.85 159.06 40.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 107' ' ' THR . 59.3 m -159.39 142.41 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 111.411 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.3 tp -99.36 92.14 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.7 mt-10 -72.51 99.35 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.577 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 33.8 mt -113.72 128.87 56.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.316 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 39' ' ' VAL . 10.7 p -134.55 158.25 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.799 -178.713 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -97.15 82.38 3.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.977 178.605 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.633 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -101.77 177.07 5.01 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.47 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 98' ' ' GLY . 61.4 mtp180 -110.25 94.05 17.37 Favored Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.022 179.544 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.456 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 81.3 Cg_exo -50.81 -29.2 25.59 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.52 2.146 . . . . 0.0 112.441 179.431 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -79.89 -31.14 40.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.459 -179.937 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.26 -77.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.932 0.396 . . . . 0.0 111.361 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 174.22 -173.94 46.2 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.007 -179.331 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.3 mt -93.1 149.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.855 0.359 . . . . 0.0 111.026 -179.471 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.425 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -138.95 168.18 16.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.978 -179.264 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.61 -28.06 4.58 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 112.156 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -78.44 11.62 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.675 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.569 HD21 ' HA ' ' A' ' 93' ' ' THR . 8.9 m-20 -93.4 150.11 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.342 -179.419 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 163.88 8.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.634 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.4 tpp180 -130.96 164.11 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.649 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.634 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.9 t80 -174.4 76.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 109.558 177.595 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.75 88.78 5.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.389 -179.18 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 22.1 tp -67.6 90.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 0.0 110.472 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -73.4 133.91 43.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.662 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.2 mt -141.4 102.86 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.273 -178.191 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.3 t30 -78.64 85.76 4.66 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.071 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 17' ' ' HIS . 18.3 t -55.11 112.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.284 -179.062 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.009 179.877 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -143.47 124.82 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -152.64 -55.86 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -89.97 -29.97 18.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 2' ' ' ILE . 15.5 tt 42.35 28.08 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.588 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 4' ' ' PRO . . . -82.41 -50.3 0.8 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.624 -179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 3' ' ' ALA . 59.0 Cg_endo -71.82 -10.5 26.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.061 1.841 . . . . 0.0 112.322 -179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.9 tp -88.34 -48.37 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.785 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.0 p -141.25 156.31 45.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.806 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.1 t 65.77 138.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.304 179.941 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -172.4 135.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.325 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.83 115.27 22.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -123.21 -81.06 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 10' ' ' ASN . 7.8 m-20 -30.17 104.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.617 -179.672 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -93.11 89.86 6.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.548 179.489 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.663 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.04 101.22 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 HD23 ' A' ' 110' ' ' LEU . 22.8 m -149.29 -175.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.237 0.541 . . . . 0.0 112.167 -178.849 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.53 -173.71 2.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.295 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.568 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -174.45 -175.75 1.0 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.226 0.536 . . . . 0.0 112.187 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.8 m80 -116.82 -162.24 0.84 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.882 179.23 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.53 122.52 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.069 0.462 . . . . 0.0 111.634 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.2 10.69 35.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.14 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptp -62.81 84.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.061 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 HD22 ' A' ' 77' ' ' LEU . 7.7 m -45.39 100.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.807 -178.7 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 78' ' ' VAL . 69.3 m -91.64 102.96 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.28 179.389 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.6 tt0 -86.43 132.18 34.01 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.339 -179.762 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 108' ' ' LEU . 37.3 mt -139.2 104.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.413 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -79.62 95.76 5.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.777 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 28.8 mt -88.75 143.95 26.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.444 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 166.08 11.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.873 0.368 . . . . 0.0 110.627 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.89 -150.99 13.04 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 62.4 t30 -175.86 96.16 0.26 Allowed Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 13.6 Cg_endo -56.23 -16.52 17.64 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.764 2.31 . . . . 0.0 113.132 -179.599 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.2 p -82.96 9.15 10.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.675 0.274 . . . . 0.0 111.433 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 29' ' ' ASN . 70.5 p -97.84 -60.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.052 179.754 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.48 -27.55 0.32 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.92 179.879 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 93' ' ' THR . 87.9 m-85 -102.61 175.0 5.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.633 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 7.1 ttm -147.51 148.89 31.68 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.009 -179.615 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.457 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -93.67 81.48 4.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.218 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 35' ' ' MET . 1.7 t -125.4 146.83 49.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.527 -177.766 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD3' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -53.39 177.34 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.981 0.419 . . . . 0.0 110.623 179.428 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 89' ' ' GLU . 42.8 t -81.78 102.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.522 -179.773 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.5 -12.92 56.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.527 179.236 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.766 ' CG ' HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -73.92 -42.01 61.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 117.45 0.625 . . . . 0.0 110.599 -179.741 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.519 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.0 p -26.7 90.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.138 0.494 . . . . 0.0 111.06 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . 89.75 49.92 3.25 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -178.478 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.795 ' HD3' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -112.07 -163.33 0.84 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.594 0.712 . . . . 0.0 112.299 -178.548 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.674 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 6.1 m-20 -115.67 -32.82 5.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.995 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.505 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.1 t -155.31 118.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.737 178.7 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.795 HD23 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -51.31 -62.7 1.46 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.125 -179.847 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 54' ' ' VAL . 81.1 p -64.19 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.781 -179.734 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.51 -80.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.71 -31.29 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.513 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.565 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.3 mm -74.35 -86.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.622 -179.465 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.724 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -97.86 109.1 21.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.267 179.803 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.601 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 1.3 tm-20 -62.24 147.46 47.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.052 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 48' ' ' SER . 11.5 t -146.36 133.84 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.594 -179.548 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.6 t -137.87 86.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 178.865 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.577 ' SG ' HG22 ' A' ' 76' ' ' VAL . 42.0 t -93.94 97.58 10.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.784 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 81.7 mttt -72.65 73.71 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.35 178.844 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.536 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -64.24 103.71 0.66 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.473 179.8 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.51 HG22 ' HA3' ' A' ' 71' ' ' GLY . 1.4 m -108.37 125.04 32.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.436 178.658 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -94.0 -167.02 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.031 2.487 . . . . 0.0 113.047 -178.716 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -59.48 135.17 88.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.221 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.491 ' HG3' ' H ' ' A' ' 69' ' ' GLY . 10.9 Cg_endo -53.34 163.27 2.55 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.068 2.512 . . . . 0.0 112.427 179.638 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.5 m -85.17 -166.12 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.2 p -77.16 11.49 1.83 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 72.4 p -56.72 156.54 12.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 92.3 Cg_endo -75.25 12.89 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.723 2.282 . . . . 0.0 112.426 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.2 ttp -131.83 86.14 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.731 179.879 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.95 122.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.491 ' H ' ' HG3' ' A' ' 62' ' ' PRO . . . 123.3 68.31 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.449 179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 62' ' ' PRO . 86.3 t -108.5 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.065 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' HA3' HG22 ' A' ' 59' ' ' THR . . . -164.15 -131.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.993 -179.712 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.36 15.47 29.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.508 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt -147.1 -168.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.548 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -136.31 100.71 4.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.094 -179.989 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 62.1 t -79.43 89.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 120.811 0.338 . . . . 0.0 110.893 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 HD21 ' A' ' 88' ' ' LEU . 21.5 t -83.41 121.31 36.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 21' ' ' THR . 77.3 mt -117.02 98.29 6.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.081 178.304 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.724 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.12 110.69 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.827 -179.127 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 42.9 mtmt -110.97 102.58 53.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.959 -178.999 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 45.4 Cg_exo -54.77 100.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.353 2.036 . . . . 0.0 112.315 179.343 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.0 mtt180 -69.77 -42.26 74.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -112.24 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -117.62 142.83 46.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.749 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.1 -135.28 7.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.485 179.906 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.457 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.8 m80 -101.33 91.16 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 -179.989 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.8 OUTLIER -107.43 163.98 12.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.202 179.761 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 88' ' ' LEU . 85.6 m -160.89 155.09 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.14 0.495 . . . . 0.0 112.156 -179.574 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 HG11 ' A' ' 76' ' ' VAL . 14.9 tp -125.64 96.26 4.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.832 178.961 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.5 mt-10 -84.36 99.38 10.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.868 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 33.4 mt -95.88 129.26 43.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.364 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.2 p -130.83 157.19 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.064 0.459 . . . . 0.0 112.097 -178.58 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -100.93 95.02 6.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.595 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.859 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -117.2 167.65 11.01 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.73 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -103.2 93.67 4.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.796 178.507 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -48.91 -29.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.867 2.378 . . . . 0.0 112.961 -179.617 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -77.77 10.37 2.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -150.55 -72.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.09 0.472 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.66 175.34 36.78 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.539 -179.518 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.9 mt -94.24 150.79 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.08 0.467 . . . . 0.0 111.604 -179.123 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -137.53 166.88 23.24 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.3 -48.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.344 2.696 . . . . 0.0 112.498 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.37 -18.15 10.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.683 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.8 m120 -62.56 162.86 9.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.784 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 161.26 5.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.642 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpp180 -135.05 164.28 27.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.57 -178.605 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.642 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.4 t80 -174.29 67.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.248 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 89' ' ' GLU . 12.4 m -87.34 97.81 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.559 -178.828 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 78' ' ' VAL . 63.2 tp -76.56 88.06 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 12.7 m-70 -73.81 142.94 46.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 179.424 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.2 mt -143.71 108.6 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.692 -178.056 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.455 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.8 t-20 -81.48 72.23 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.6 t -53.09 122.84 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.667 -178.235 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.071 179.757 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.7 m -77.31 124.93 28.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -90.44 -32.03 16.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtm -121.53 144.66 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.022 179.929 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -114.69 12.0 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -60.39 -49.35 90.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.657 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 51.6 Cg_exo -54.76 149.37 41.34 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.126 1.884 . . . . 0.0 112.25 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.7 mm? 59.11 17.1 5.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -142.07 -26.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 p -160.27 148.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -171.26 134.59 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.571 -179.873 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.24 122.38 24.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.375 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -125.56 -14.73 6.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.991 -179.303 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.81 100.42 12.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.148 0.499 . . . . 0.0 111.636 -179.178 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -109.67 61.72 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.497 179.132 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 m0 -78.73 112.55 15.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -178.008 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 34.8 m -150.24 -166.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 -178.819 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -96.05 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.696 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.509 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t 177.82 -174.51 0.15 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.143 0.497 . . . . 0.0 112.059 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 67.7 m-70 -118.55 -160.98 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.761 179.212 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.7 121.86 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 111.34 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 64.45 16.98 61.46 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.062 179.84 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -58.09 91.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.725 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -56.73 101.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.482 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.8 m -100.81 99.21 9.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.663 179.642 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.507 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.1 tt0 -78.66 137.12 37.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.789 179.731 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.92 102.57 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -83.49 112.9 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.695 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 37.4 mt -108.62 154.28 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -178.315 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -110.89 155.68 22.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.98 179.333 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.26 -19.3 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.505 -179.229 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 32' ' ' THR . 61.1 t30 62.46 91.52 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.517 0.199 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 73.4 Cg_exo -49.45 -19.98 3.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.939 2.426 . . . . 0.0 113.277 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.1 p -85.19 22.89 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.543 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 29' ' ' ASN . 10.7 t -110.7 -37.12 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.699 0.285 . . . . 0.0 111.222 179.915 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.3 -72.37 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.943 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -59.48 160.34 7.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.151 0.5 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 16.5 ttm -123.88 150.89 44.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.3 m95 -109.24 84.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.769 178.545 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.579 HG21 ' HA ' ' A' ' 42' ' ' VAL . 7.0 t -132.38 -164.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 -179.124 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 19.0 mtp85 -92.75 121.69 34.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 0.0 110.474 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.3 p -51.9 140.07 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.67 -6.76 81.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.714 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 52.0 m-85 -128.31 1.16 5.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.285 0.564 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 93' ' ' THR . 15.4 t -56.08 119.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.064 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.24 -25.84 25.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.913 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 28.3 mtpp -71.28 173.09 8.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 179.77 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 -61.86 1.81 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.755 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.68 141.19 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.0 mt -90.03 -53.22 4.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.757 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.9 p -52.89 -178.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.765 178.828 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -158.39 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.207 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -129.98 -29.02 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 11.6 mm -74.77 -76.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.283 -179.61 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 78' ' ' VAL . 4.3 mt -102.4 115.27 30.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.299 179.154 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.38 69.52 0.24 Allowed 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.091 0.472 . . . . 0.0 109.94 178.062 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG22 ' CG1' ' A' ' 78' ' ' VAL . 18.4 t -74.32 81.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.018 -179.18 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 31.0 t -78.01 81.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.018 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -97.38 136.21 38.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.478 -178.575 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -126.7 113.75 17.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.858 179.189 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.32 107.19 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.732 179.826 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.63 HG22 ' HA3' ' A' ' 71' ' ' GLY . 6.4 m -99.11 109.33 53.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 61.1 Cg_endo -98.34 -166.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.336 2.691 . . . . 0.0 112.183 179.846 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 HG12 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -150.68 135.07 9.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.913 179.26 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.58 52.74 1.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.038 2.492 . . . . 0.0 111.904 179.548 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 t -164.32 176.63 8.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.041 -179.228 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.8 m -96.59 -1.51 46.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.54 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 74.4 p -63.66 158.44 59.79 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.113 179.912 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 65.0 Cg_endo -70.98 -154.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.547 2.165 . . . . 0.0 112.06 179.966 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.4 mtm -60.26 -13.0 10.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 -179.873 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.87 105.91 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.34 -122.35 1.02 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.598 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.607 HG12 HG23 ' A' ' 61' ' ' THR . 7.9 p -113.06 21.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.515 . . . . 0.0 110.835 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 59' ' ' THR . . . 146.38 -139.96 8.44 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.635 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.24 15.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.868 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.4 pt -136.37 -164.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 179.811 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -140.29 110.99 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.058 -179.619 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -103.48 113.8 41.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.55 . . . . 0.0 110.477 -179.672 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.494 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -109.02 125.77 66.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.499 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.725 HD22 HG22 ' A' ' 21' ' ' THR . 86.3 mt -110.05 101.36 10.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.021 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.61 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.0 111.11 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.976 0.417 . . . . 0.0 111.233 -178.786 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.9 mtmt -115.6 96.81 47.28 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.499 -179.435 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.5 Cg_endo -50.31 104.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.476 2.117 . . . . 0.0 112.656 179.752 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.567 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.4 mtt180 -71.24 -42.16 69.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.298 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -107.77 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -114.67 123.41 49.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.6 -101.78 0.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.488 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -143.72 91.58 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.564 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.3 m-70 -100.0 173.71 6.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.8 m -160.53 150.51 17.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.781 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 36.4 tp -113.93 88.75 2.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 43.8 mt-10 -75.51 93.82 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.071 -179.634 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 62.8 mt -104.16 131.05 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.935 178.654 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.93 153.47 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.722 -178.963 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.3 t80 -96.88 89.66 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.585 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.864 HG21 HG21 ' A' ' 42' ' ' VAL . 7.2 t -130.4 151.7 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.479 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.5 mtp180 -86.99 101.59 2.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.713 178.362 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 1.6 Cg_endo -47.44 -36.63 24.14 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.871 2.381 . . . . 0.0 113.117 -179.734 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -87.72 18.9 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 17.3 mm-40 -149.75 1.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.433 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.69 178.66 51.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.122 -179.523 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.5 mt -105.72 154.29 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.472 . . . . 0.0 111.872 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 42.8 mtmt -137.78 163.04 50.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.885 -179.574 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.1 Cg_endo -70.76 -38.41 5.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.782 2.322 . . . . 0.0 112.347 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.77 -24.59 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 93' ' ' THR . 6.8 m-20 -54.73 148.1 13.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.398 -179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.6 tt0 -56.31 163.28 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.3 tpp180 -132.59 163.59 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 65.1 t80 -174.03 74.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.239 177.525 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -95.09 106.81 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 -178.863 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.1 tp -93.02 91.4 7.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.1 m-70 -74.91 151.48 38.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.423 179.704 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 16' ' ' THR . 95.5 mt -148.58 116.97 6.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -178.538 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 49.4 t30 -86.68 68.07 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.908 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -49.26 119.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.469 -178.684 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.999 179.995 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.9 p -144.44 168.86 19.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -94.28 -2.37 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mmm 58.23 -171.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.3 pt -74.01 -32.64 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.12 151.0 7.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.009 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.85 152.22 63.49 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.255 179.992 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.2 mt -70.53 159.33 34.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.6 m -100.64 0.71 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -89.44 13.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 9' ' ' ASP . 5.6 ptmm? -124.16 -62.7 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 8' ' ' LYS . 6.3 t70 50.96 99.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.274 -179.822 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -129.58 -74.09 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.855 -179.308 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 4.2 p-10 -37.63 97.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.894 -179.5 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -107.26 93.53 4.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.436 179.78 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.683 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.2 m95 -88.96 105.03 17.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.12 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 HD23 ' A' ' 110' ' ' LEU . 7.3 m -151.41 -175.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.997 -179.621 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -99.95 -176.33 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.417 179.831 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.494 ' HB ' HD22 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -174.82 -178.06 1.22 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 112.177 -179.807 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.8 m80 -114.14 -167.25 1.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 9.6 p -94.06 135.41 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.261 0.553 . . . . 0.0 112.046 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.1 14.82 11.86 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.546 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptp -65.58 81.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.996 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.726 HG22 HD22 ' A' ' 77' ' ' LEU . 5.5 m -47.34 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.76 -178.785 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 78' ' ' VAL . 60.8 m -94.97 98.13 10.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 179.368 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.4 tt0 -78.74 132.85 37.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.988 179.947 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 108' ' ' LEU . 39.5 mt -137.53 104.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.999 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.23 98.75 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.311 178.214 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 23.9 mt -94.31 145.12 24.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.613 -179.058 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.4 mptt -98.73 162.3 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.543 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.41 -141.72 6.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.267 -179.341 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 62.3 t30 -172.46 101.11 0.35 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.403 0.144 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.608 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 47.6 Cg_exo -56.85 -36.83 99.05 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.614 2.209 . . . . 0.0 112.416 179.93 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.7 p -65.61 -21.9 66.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 39.6 m -63.99 -49.65 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.43 -70.25 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.904 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -62.52 -179.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.477 . . . . 0.0 111.46 -179.539 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 6.0 ttm -146.7 153.17 39.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.166 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 m95 -105.53 94.92 5.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.843 178.52 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.2 t -140.83 -170.33 3.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.627 -178.938 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.608 HH11 HG21 ' A' ' 54' ' ' VAL . 9.9 mtp85 -86.62 157.07 19.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' A' ' 91' ' ' VAL . 52.6 t -72.7 132.05 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.943 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.07 4.99 79.62 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.481 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.437 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 60.1 m-85 -127.17 -2.04 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.132 0.491 . . . . 0.0 110.45 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 93' ' ' THR . 22.4 t -49.07 112.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.262 179.178 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.87 -17.71 13.02 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.217 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HB2' HD23 ' A' ' 47' ' ' LEU . 28.7 mtpp -79.92 -159.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -120.11 -56.03 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 16.9 t -86.35 -39.18 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.799 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.3 mt 76.01 -43.66 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.298 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 20.9 p -54.98 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.95 179.553 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -156.53 -86.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.329 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.601 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -132.12 -31.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.434 -179.132 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.5 mm -73.0 -78.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 7.1 mt -102.68 114.23 28.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.499 179.375 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -68.55 70.63 0.18 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.066 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG21 HH11 ' A' ' 38' ' ' ARG . 14.0 t -75.1 83.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.911 -179.1 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.0 t -78.42 82.67 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.39 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.0 t -94.56 139.51 31.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.277 -178.605 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -132.45 108.1 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.162 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -79.43 112.64 16.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.368 179.636 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.1 m -113.15 111.14 50.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.975 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -101.42 99.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.735 2.956 . . . . 0.0 111.264 178.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -123.31 136.93 27.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.347 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 9.0 Cg_endo -50.13 132.6 33.74 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.973 2.448 . . . . 0.0 112.298 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.561 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 26.1 t -69.35 -177.3 1.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.747 179.841 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.0 p -94.9 -9.08 35.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.194 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 p -98.3 151.64 37.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.656 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.78 33.17 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.103 2.535 . . . . 0.0 112.653 179.716 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.6 ttp -130.0 -2.25 4.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.692 -179.575 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 74.7 t -127.83 131.57 69.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.16 -179.719 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.82 -56.81 2.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 54.3 t -143.34 82.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.924 0.392 . . . . 0.0 110.625 179.868 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -116.37 102.93 1.1 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.867 -179.844 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -105.83 -131.12 6.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.034 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt -147.36 -166.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.126 0.489 . . . . 0.0 111.095 179.597 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -134.47 99.94 4.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.078 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.35 102.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.866 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 88' ' ' LEU . 40.8 t -104.74 119.85 54.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.202 -179.385 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.726 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -109.69 98.15 7.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.208 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.33 103.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.038 0.447 . . . . 0.0 111.216 -178.706 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 7.1 mtmp? -106.15 104.41 49.63 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.267 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.1 Cg_exo -54.31 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.475 2.117 . . . . 0.0 112.567 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.601 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -64.5 -41.84 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.407 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -113.15 173.08 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 -179.383 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -113.2 106.92 15.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.604 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 171.19 -123.82 1.07 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.47 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.451 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -103.56 98.32 8.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.571 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.15 158.43 22.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.725 179.998 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 109' ' ' HIS . 33.8 m -159.99 151.9 20.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 111.562 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 45.7 tp -117.05 91.18 3.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 39.1 mt-10 -76.4 97.74 4.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.105 179.948 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.6 mt -108.5 133.54 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.918 178.521 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -137.36 167.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.135 0.493 . . . . 0.0 111.681 -179.379 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.9 t80 -106.4 89.09 2.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.728 178.32 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.917 HG21 HG21 ' A' ' 42' ' ' VAL . 5.7 t -118.29 170.08 9.19 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.59 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -102.56 95.1 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.696 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.0 Cg_exo -42.08 -36.87 4.18 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -40.77 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.963 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.8 -78.55 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.86 178.24 39.19 Favored Glycine 0 CA--C 1.508 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -93.22 153.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.935 0.397 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 39.0 mtmt -145.47 163.44 31.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.067 -179.07 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 19.2 Cg_endo -60.92 -37.84 74.08 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.718 2.279 . . . . 0.0 112.034 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.78 -23.86 67.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.614 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -51.7 136.02 27.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.146 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 91' ' ' VAL . 7.6 tt0 -51.93 156.56 1.47 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 8.8 tpp180 -118.93 158.33 25.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.187 0.518 . . . . 0.0 112.057 -178.54 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.556 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 34.3 t80 -171.74 64.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.772 177.319 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 m -91.08 98.96 12.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.994 -179.278 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 35.0 tp -83.39 94.56 7.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.683 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 26.8 m-70 -79.24 141.41 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.494 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.5 mt -145.17 105.66 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.482 -178.293 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 10.7 m120 -78.13 74.13 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.221 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.604 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -55.4 117.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 34.1 mmtp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.915 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.648 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.636 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -26.12 105.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.424 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 89.69 6.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.921 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.656 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -74.15 98.85 3.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.622 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 15' ' ' ASP . 6.6 p -155.34 177.32 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.765 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.4 p-10 -98.21 -175.24 3.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -173.76 -173.0 0.8 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 112.094 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m-70 -114.73 -167.35 1.21 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 30.6 t -94.0 135.23 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.137 0.494 . . . . 0.0 112.153 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.64 16.53 11.49 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.437 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.7 tptm -65.73 81.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.75 HG22 HD22 ' A' ' 77' ' ' LEU . 5.9 m -46.71 99.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.733 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 78' ' ' VAL . 83.5 m -93.79 99.6 11.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.0 tt0 -80.3 131.73 35.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.879 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.59 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.7 mt -134.67 103.97 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.731 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -86.02 95.51 9.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 24' ' ' ILE . 8.2 mt -92.95 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.302 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -101.6 168.52 9.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.47 -130.53 1.93 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.429 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.595 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 2.4 ttt -148.3 151.81 36.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.728 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.8 m95 -109.4 90.33 3.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.081 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.545 ' CG2' HG22 ' A' ' 42' ' ' VAL . 9.6 t -139.72 -166.58 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.375 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.2 mtp85 -92.23 124.21 36.13 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.797 0.332 . . . . 0.0 110.737 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.6 p -52.88 142.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.27 78.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.749 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 50.0 m-85 -128.15 -0.65 5.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.499 . . . . 0.0 110.184 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 93' ' ' THR . 38.1 t -54.78 105.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.036 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.101 -179.566 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.744 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.5 mt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 62.4 p -53.23 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.655 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.83 -86.61 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.47 -30.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.161 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.6 mm -74.04 -73.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.278 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.1 mt -104.96 116.02 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.344 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -70.33 68.81 0.36 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 109.902 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 78' ' ' VAL . 14.0 t -74.17 84.67 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.993 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.0 85.41 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' SG ' HG22 ' A' ' 76' ' ' VAL . 34.6 t -102.63 142.69 33.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.69 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -133.01 113.59 12.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.987 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.68 102.66 10.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.451 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -101.67 110.95 63.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.643 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.45 -1.043 0 C-N-CA 123.539 2.826 . . . . 0.0 111.695 179.163 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.4 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.113 0.483 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -131.37 98.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.95 106.64 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 88' ' ' LEU . 29.7 t -110.0 120.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.75 HD22 HG22 ' A' ' 21' ' ' THR . 82.6 mt -110.13 100.97 9.79 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.765 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 105.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.048 0.452 . . . . 0.0 111.18 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -107.18 102.08 41.64 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.239 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 52.5 Cg_exo -51.44 97.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.681 2.254 . . . . 0.0 112.705 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.3 mtt180 -66.24 -43.26 87.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.319 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -114.85 173.74 6.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -108.97 125.07 51.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.798 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.588 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 155.04 -138.42 6.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.4 m80 -97.85 95.16 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.446 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.8 m-70 -112.07 162.18 15.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.498 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 107' ' ' THR . 85.2 m -159.72 144.9 15.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 111.68 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 38.2 tp -101.0 92.66 5.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.026 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.4 mt-10 -75.13 88.51 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.481 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 48.2 mt -103.54 123.42 46.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 92' ' ' TYR . 13.1 p -126.19 158.49 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.5 t80 -102.34 91.85 4.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.327 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.926 HG21 HG21 ' A' ' 42' ' ' VAL . 5.5 t -122.45 167.46 13.3 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -101.07 94.89 4.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.41 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.9 Cg_exo -46.94 -28.77 7.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.252 . . . . 0.0 112.549 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -72.44 -42.62 64.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.312 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.19 -69.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.01 179.04 37.31 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.975 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.844 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.4 mt -98.4 140.84 17.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.959 0.409 . . . . 0.0 111.258 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 46.2 mtmt -140.39 159.44 63.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.194 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 30.6 Cg_endo -63.79 -36.32 51.83 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.917 2.411 . . . . 0.0 112.693 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.68 0.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.518 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.561 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -85.27 158.07 20.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.185 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 166.37 9.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.7 tpp180 -133.49 164.31 27.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.592 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.656 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 55.4 t80 -171.34 69.66 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.007 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -93.17 90.13 6.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.731 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 28.2 tp -70.59 89.96 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.326 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 36.8 m-70 -72.97 135.93 45.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.963 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.499 HD22 ' HB ' ' A' ' 16' ' ' THR . 86.4 mt -140.1 103.97 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.541 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.485 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.5 t-20 -79.26 65.43 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.588 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -43.49 116.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.521 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.968 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 112.01 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.573 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -25.15 107.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.776 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.505 ' HD3' HD13 ' A' ' 108' ' ' LEU . 77.0 tttt -106.78 97.24 7.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.766 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 m95 -85.17 106.08 16.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.586 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 15' ' ' ASP . 2.9 p -152.94 -178.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 112.454 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.793 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -103.56 -179.74 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.797 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.503 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.67 -171.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.793 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.6 m-70 -122.25 173.13 7.8 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.041 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.9 p -67.36 138.66 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.282 0.563 . . . . 0.0 112.163 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 62.05 11.65 32.98 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.872 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 18.9 tptt -60.04 83.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.236 0.518 . . . . 0.0 109.828 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 2.5 m -57.41 99.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.447 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -96.99 100.67 12.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.3 tt0 -83.24 133.86 34.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.984 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 HD22 ' A' ' 108' ' ' LEU . 39.3 mt -139.79 105.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.03 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -88.98 113.92 25.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.138 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 14.5 mt -109.48 147.36 33.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.274 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -100.68 161.19 13.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.895 0.379 . . . . 0.0 110.621 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.18 -155.14 25.62 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.456 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.446 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.0 ttt -108.98 151.54 26.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.3 m95 -109.54 103.07 11.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.619 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 42' ' ' VAL . 15.1 t -146.9 -174.05 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.717 ' NH1' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -77.38 138.22 39.18 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.219 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 89' ' ' GLU . 98.0 t -54.1 134.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.586 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -33.63 1.52 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.581 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -87.55 25.13 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.873 HG21 HG21 ' A' ' 93' ' ' THR . 25.3 t -79.63 107.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.985 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.684 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.2 mt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -51.04 177.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -154.16 -95.64 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 111.751 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.88 -31.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.119 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.5 mm -72.12 -70.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 80' ' ' PRO . 16.2 mt -105.79 116.27 31.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.222 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -68.32 72.94 0.21 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.554 HG11 ' NE ' ' A' ' 38' ' ' ARG . 3.8 t -76.44 84.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.304 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -81.51 82.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.548 ' HB3' HD12 ' A' ' 47' ' ' LEU . 11.1 t -108.71 147.9 31.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.426 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -138.87 125.4 20.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.485 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.33 97.08 7.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.925 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 25.9 m -90.29 116.05 65.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.443 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 87.1 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 C-N-CA 123.231 2.621 . . . . 0.0 111.586 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 3.4 pt . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.05 0.453 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.515 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -143.38 103.68 4.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.027 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.77 126.53 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 88' ' ' LEU . 18.2 t -122.28 122.37 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.593 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 79.8 mt -109.94 96.4 6.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.851 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.568 ' CG2' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.35 105.38 16.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.239 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.4 mtmt -108.65 100.87 40.95 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.67 ' HA ' HD23 ' A' ' 52' ' ' LEU . 72.2 Cg_exo -48.18 96.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.733 2.289 . . . . 0.0 112.992 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 4.8 mtt180 -63.41 -37.01 85.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.652 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -116.44 -173.85 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.486 HH21 HG11 ' A' ' 18' ' ' VAL . 97.5 mtt180 -132.77 119.22 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.86 -100.59 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.33 100.98 7.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -118.33 161.12 20.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.536 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -160.64 150.66 17.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.886 0.374 . . . . 0.0 111.76 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 76' ' ' VAL . 20.6 tp -132.26 82.52 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.662 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -86.64 105.76 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.717 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.2 mt -89.81 167.09 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.769 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -155.2 147.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.918 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.7 t80 -97.88 82.62 3.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.564 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.873 HG21 HG21 ' A' ' 42' ' ' VAL . 9.9 t -121.99 158.24 29.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 27.1 mtp180 -101.17 101.15 15.31 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.326 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 93' ' ' THR . 78.1 Cg_exo -46.99 -39.45 25.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.752 2.301 . . . . 0.0 113.257 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 9.38 0.99 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.73 4.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 0.0 111.348 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.95 -171.74 51.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.797 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -112.15 150.14 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 111.86 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -135.42 164.17 45.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.81 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -19.79 13.0 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.543 2.162 . . . . 0.0 111.651 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.2 pt-20 -76.75 -0.11 22.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.7 m120 -82.21 149.41 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.44 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.9 171.5 1.19 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.2 tpp180 -136.9 159.5 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 36.0 t80 -162.21 72.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.874 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.745 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 22.7 m -85.51 151.33 24.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.866 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.4 tp -140.7 87.74 2.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.36 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.766 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 13.6 m-70 -74.69 144.11 43.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.503 HD22 ' HB ' ' A' ' 16' ' ' THR . 85.5 mt -144.66 102.75 3.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.296 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -80.6 61.3 4.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -38.64 140.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.86 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.045 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.637 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.877 0.37 . . . . 0.0 111.913 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.592 ' H ' HD22 ' A' ' 10' ' ' ASN . 8.6 m-20 -25.67 103.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.924 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 55.5 tptt -94.26 90.26 6.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.414 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.19 103.34 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -155.42 177.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.088 0.47 . . . . 0.0 111.83 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.773 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -100.07 -178.17 3.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.765 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.495 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -175.59 -174.75 0.72 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.119 0.485 . . . . 0.0 112.08 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.9 m80 -115.51 -170.02 1.69 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.22 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.56 139.46 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.239 0.542 . . . . 0.0 112.308 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.11 22.29 9.54 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.69 81.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.692 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -51.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.864 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.426 ' HB ' HG23 ' A' ' 78' ' ' VAL . 73.3 m -91.6 101.6 14.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.958 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.3 tt0 -84.81 129.73 34.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.4 mt -139.66 98.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.87 106.32 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 11.3 mt -98.86 143.78 28.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.075 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -94.08 166.57 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.025 0.44 . . . . 0.0 110.806 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.81 -137.01 3.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.078 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 t30 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.424 0.154 . . . . 0.0 110.615 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.019 0.437 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 20.9 ttm -143.87 148.81 35.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.175 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 4.6 m95 -106.1 78.47 1.31 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.987 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 42' ' ' VAL . 12.0 t -125.73 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.4 mtp85 -88.61 156.42 19.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 47.4 t -74.39 130.21 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.05 12.23 79.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.525 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 61.8 m-85 -135.25 -1.55 2.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.088 0.471 . . . . 0.0 110.578 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 18.7 t -53.85 117.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.02 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.873 -179.609 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.211 0.529 . . . . 0.0 109.85 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.6 p -52.32 179.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.745 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.25 -90.98 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.7 pt-20 -130.12 -28.82 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.181 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.1 mm -76.85 -73.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.335 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.0 mt -103.94 115.52 30.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.539 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -71.02 69.38 0.48 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 78' ' ' VAL . 10.8 t -75.92 88.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.091 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 39.4 t -86.27 90.11 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 52.0 t -95.38 144.64 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.94 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 75.7 mttt -130.56 92.63 3.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.887 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.3 t80 -57.7 -17.8 17.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.321 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.9 m 31.57 78.09 0.31 Allowed Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.971 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 124.182 3.255 . . . . 0.0 113.298 -179.162 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.6 pt . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -150.26 82.14 1.37 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.609 0.242 . . . . 0.0 110.782 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 93.3 t -79.91 91.9 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.062 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 88' ' ' LEU . 40.4 t -90.05 118.67 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 21' ' ' THR . 79.1 mt -110.53 95.12 5.37 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.6 104.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.0 mtmm -110.16 93.9 16.72 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.086 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 4.1 Cg_endo -48.6 100.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.594 2.196 . . . . 0.0 112.549 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.549 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.0 mtt180 -64.63 -32.67 74.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.998 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -120.91 -175.38 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.634 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.51 117.45 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.05 -107.56 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.251 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.491 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.0 m80 -116.48 91.6 3.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER -111.78 157.69 20.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.576 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 109' ' ' HIS . 47.0 m -159.47 146.04 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.1 tp -112.86 92.38 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.7 mt-10 -78.44 94.95 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.197 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 67.7 mt -101.8 135.03 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.7 p -140.11 154.26 23.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 0.0 112.09 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.11 94.13 6.65 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.959 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 7.6 t -129.72 157.13 43.02 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 79.3 mtp180 -91.64 99.93 2.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.859 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.6 Cg_exo -37.93 -56.49 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.261 2.641 . . . . 0.0 113.732 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.466 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 8.2 p90 -78.15 23.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.7 mm-40 -149.9 0.87 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.38 50.44 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.2 mt -104.84 158.65 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.431 . . . . 0.0 111.933 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 13.1 mttt -135.26 165.99 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.883 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.11 -41.03 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.886 2.39 . . . . 0.0 111.974 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.47 -26.73 68.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -49.27 148.33 2.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.304 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 3.8 tt0 -53.76 160.67 1.3 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.639 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.1 tpp180 -133.54 161.21 35.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.54 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.639 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.5 t80 -171.33 65.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.0 m -87.35 94.66 9.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.39 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 36.2 tp -74.91 92.56 2.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.4 m-70 -77.55 138.48 39.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 16' ' ' THR . 84.3 mt -143.35 103.09 4.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.436 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.54 66.09 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -44.76 113.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.762 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.924 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.674 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 121.018 0.437 . . . . 0.0 112.041 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 2.2 m-20 -48.82 102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.447 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.425 ' HE2' HG21 ' A' ' 14' ' ' VAL . 75.5 tttt -97.23 93.09 6.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -82.01 99.93 9.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 12' ' ' LYS . 34.1 m -149.82 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 112.271 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.78 -163.71 1.06 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.133 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t 178.24 -175.04 0.17 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 59.0 m80 -120.73 -164.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 83' ' ' ARG . 24.2 t -95.76 115.45 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 111.442 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 67.99 10.7 59.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.108 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.8 tptm -60.11 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.729 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -45.6 103.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.702 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.9 m -91.26 94.75 9.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.571 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HA ' HD23 ' A' ' 77' ' ' LEU . 42.3 tt0 -80.11 128.41 33.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.69 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -136.18 104.55 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.56 96.97 8.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.423 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.523 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 7.8 mt -91.12 140.89 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.196 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 73' ' ' ILE . 54.6 mttm -98.98 165.31 11.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.51 -132.72 2.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.32 0.105 . . . . 0.0 110.767 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 121.047 0.451 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 10.1 ttm -149.09 149.25 30.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.802 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.5 m95 -103.23 85.31 2.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.894 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.538 HG23 HG22 ' A' ' 42' ' ' VAL . 14.5 t -137.23 165.46 26.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.696 HH11 HD11 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -61.37 132.89 54.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.905 0.383 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 89' ' ' GLU . 3.8 p -55.07 147.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.486 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.74 -8.03 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.278 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 39' ' ' VAL . 21.8 m-85 -117.7 33.37 5.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 109.943 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 93' ' ' THR . 13.0 t -97.55 87.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.582 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 56' ' ' CYS . 14.5 mt . . . . . 0 N--CA 1.454 -0.225 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 3.2 t -45.55 168.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.961 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 11.4 m-20 -157.53 -159.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.961 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 9.4 pt-20 -74.69 -29.82 61.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.854 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 13.9 mm -80.38 -74.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.325 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 80' ' ' PRO . 19.7 mt -104.42 109.28 21.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.527 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.43 75.59 0.26 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 78' ' ' VAL . 1.7 t -82.58 91.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 23.3 t -92.88 95.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.784 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HB3' HD12 ' A' ' 47' ' ' LEU . 41.0 t -111.9 148.61 33.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.438 0.637 . . . . 0.0 112.151 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -126.17 110.28 13.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.559 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.87 102.81 11.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.566 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.8 m -104.67 116.51 60.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.449 -1.129 0 C-N-CA 123.042 2.495 . . . . 0.0 112.25 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -132.74 98.07 4.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.063 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 80.5 t -84.37 103.42 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.951 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 HH22 ' A' ' 38' ' ' ARG . 33.0 t -102.3 123.28 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.729 HD22 HG22 ' A' ' 21' ' ' THR . 64.9 mt -112.68 93.45 4.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG13 HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.85 107.14 18.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.116 0.484 . . . . 0.0 111.102 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -108.96 95.15 16.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.462 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HA ' HD23 ' A' ' 52' ' ' LEU . 9.7 Cg_endo -53.06 102.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.153 1.902 . . . . 0.0 111.965 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.437 HH11 ' HA ' ' A' ' 50' ' ' GLU . 17.2 mtt180 -64.82 -45.33 86.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.52 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -106.32 173.56 6.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.041 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 18' ' ' VAL . 59.4 mtp180 -109.42 142.64 40.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.03 -150.97 20.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -87.47 92.18 9.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 112' ' ' VAL . 1.7 m-70 -108.77 156.18 19.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 109' ' ' HIS . 90.5 m -160.34 151.33 18.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.116 0.484 . . . . 0.0 111.851 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.678 HD21 ' HD3' ' A' ' 38' ' ' ARG . 13.8 tp -128.71 142.73 50.92 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 6.1 mt-10 -123.56 86.73 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.216 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.696 HD11 HH11 ' A' ' 38' ' ' ARG . 7.0 mp -75.5 125.77 29.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.073 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 92' ' ' TYR . 12.8 p -122.29 156.45 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.76 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -102.51 95.91 6.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.465 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 42' ' ' VAL . 3.5 t -125.35 169.97 11.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -101.6 93.86 3.79 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.118 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -44.29 -27.76 2.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.777 2.318 . . . . 0.0 112.74 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.71 -46.22 59.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.472 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.82 -67.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.93 0.395 . . . . 0.0 111.262 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.41 172.48 27.73 Favored Glycine 0 CA--C 1.507 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.99 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.804 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.2 mt -86.15 139.31 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.932 0.396 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -128.5 164.53 37.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.253 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.65 -35.19 8.14 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.038 2.492 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.81 11.99 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.211 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.507 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -88.1 150.36 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.41 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.2 tt0 -54.43 162.36 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.584 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.674 ' HB3' HD22 ' A' ' 10' ' ' ASN . 15.0 tpp180 -131.93 163.9 27.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.273 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.9 t80 -174.3 71.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.036 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.5 m -84.4 101.67 12.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.504 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 78' ' ' VAL . 59.4 tp -79.05 89.46 4.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 4.6 m-70 -76.77 137.11 39.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.563 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -145.28 104.42 3.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.68 73.74 7.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -51.86 123.98 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.455 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.981 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.644 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.603 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -30.11 106.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.189 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 14' ' ' VAL . 53.5 tttp -95.27 101.08 12.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.987 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.0 m95 -84.18 102.11 12.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.318 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 12' ' ' LYS . 34.6 m -147.47 -168.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.733 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.55 -179.32 3.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.482 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.486 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.22 -172.66 0.6 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.621 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.3 m80 -115.98 -163.74 0.92 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.268 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 38.4 t -93.27 137.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.115 0.483 . . . . 0.0 112.083 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.07 15.03 9.1 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.492 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptm -64.08 82.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.82 98.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.579 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 78' ' ' VAL . 86.5 m -91.63 99.83 12.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.532 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.3 tt0 -81.66 130.28 35.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.7 mt -134.29 104.85 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.873 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -85.94 96.54 9.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.4 mt -91.73 145.18 24.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.442 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.93 163.13 12.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.546 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.16 -141.31 5.03 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.558 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.1 t30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.557 0.218 . . . . 0.0 110.575 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 42.9 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.035 0.445 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.7 ttm -149.16 151.68 34.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -106.37 86.98 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.113 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -132.02 -167.4 1.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.101 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 24.7 mtp85 -88.54 150.25 23.18 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.0 t -69.57 131.91 33.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.617 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.61 6.33 89.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.576 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.9 m-85 -130.81 -0.76 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.505 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.942 HG21 HG21 ' A' ' 93' ' ' THR . 14.2 t -55.08 103.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.022 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.228 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.233 -179.645 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.1 mt . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.191 0.519 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 48.3 t -57.0 -179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.208 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.14 -88.6 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.41 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.17 -37.61 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.89 -77.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.38 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 54' ' ' VAL . 69.6 mt -111.23 125.52 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 72.37 0.23 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 3.1 t -75.8 85.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.76 84.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.503 ' HB3' HD12 ' A' ' 47' ' ' LEU . 33.8 t -99.53 148.15 24.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.324 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -138.15 111.18 7.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.304 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.452 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -76.42 102.67 6.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.281 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 22.9 m -100.56 109.44 57.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.076 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 75.5 Cg_endo . . . . . 0 N--CA 1.446 -1.299 0 C-N-CA 123.582 2.854 . . . . 0.0 111.132 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.3 pt . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -136.66 100.13 4.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.5 t -85.21 103.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.6 t -106.01 119.29 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.211 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 75.3 mt -109.37 98.98 8.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.824 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.73 104.01 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.953 0.406 . . . . 0.0 111.256 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -102.87 101.67 22.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 77.5 Cg_exo -47.03 98.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.802 2.335 . . . . 0.0 113.299 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -74.47 -36.21 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.354 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.38 172.0 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.641 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.3 121.82 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 139.9 -149.77 21.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.576 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.02 98.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.4 ' HB3' HD21 ' A' ' 52' ' ' LEU . 19.4 m-70 -132.97 156.44 47.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.48 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.544 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 90.6 m -158.92 155.63 28.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.022 0.439 . . . . 0.0 112.111 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 28.8 tp -104.51 94.1 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.888 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.589 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.6 mt-10 -73.43 96.51 2.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.186 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.0 mt -112.15 135.46 52.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.2 p -142.49 154.71 18.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 111.765 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.35 88.89 4.27 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.942 HG21 HG21 ' A' ' 42' ' ' VAL . 3.9 t -117.74 172.6 7.26 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -102.91 93.1 4.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.305 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.8 Cg_exo -43.59 -35.62 6.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.743 2.295 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -71.9 -39.61 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.303 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.73 -72.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.397 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 178.0 36.43 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.973 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.5 mt -90.91 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 13.8 mttt -134.54 162.28 58.63 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.151 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 46.5 Cg_endo -69.22 -40.9 5.52 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.686 2.258 . . . . 0.0 112.16 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.66 -25.76 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.566 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -53.18 149.58 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.348 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.2 tt0 -56.08 161.12 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.2 tpp180 -132.35 163.54 28.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.992 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.663 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.0 t80 -172.78 71.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 109.424 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.09 90.29 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.156 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.8 tp -70.85 90.59 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 29.2 m-70 -72.0 145.91 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.592 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.7 mt -146.54 115.94 7.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.665 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.517 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.1 t30 -83.96 51.1 1.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.577 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.7 t -36.05 121.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.825 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.036 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.604 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.945 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -54.06 100.33 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.5 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -92.65 93.34 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -76.83 102.98 6.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.74 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG23 HD23 ' A' ' 110' ' ' LEU . 17.5 m -150.14 -172.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.067 0.46 . . . . 0.0 112.126 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -107.75 179.43 4.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.591 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.5 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.7 t -175.37 -175.07 0.78 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.018 0.437 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.485 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 62.3 m-70 -118.76 -171.9 2.18 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.271 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.28 125.95 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 111.789 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 66.37 18.5 67.57 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.571 -0.741 . . . . 0.0 113.393 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -59.61 85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.74 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -55.86 98.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.348 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -96.09 103.37 15.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.634 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HA ' HD23 ' A' ' 77' ' ' LEU . 40.1 tt0 -81.93 131.14 35.25 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.803 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 108' ' ' LEU . 46.8 mt -137.21 105.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.953 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.68 99.85 12.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.254 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.1 mt -96.11 149.08 22.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.604 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.27 162.21 13.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.17 -144.11 6.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.337 0.113 . . . . 0.0 110.761 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 78.9 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.155 0.502 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.6 ttm -144.02 149.79 37.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.0 m95 -102.77 82.8 2.17 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -128.48 -171.2 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.25 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.704 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.4 mtp85 -86.28 144.05 27.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.013 0.435 . . . . 0.0 111.09 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.83 144.53 12.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.067 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.81 72.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.116 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' A' ' 42' ' ' VAL . 53.8 m-85 -138.24 -37.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.726 0.263 . . . . 0.0 111.43 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.8 p -18.11 118.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.767 0.667 . . . . 0.0 112.439 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.359 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.018 -179.432 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 1.9 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.008 0.432 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.499 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.2 p -49.0 176.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.847 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -77.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.37 -36.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.361 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 24.5 mm -72.22 -79.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.453 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD22 HG12 ' A' ' 78' ' ' VAL . 11.0 mt -99.23 114.52 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.517 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.72 68.9 0.27 Allowed 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 78' ' ' VAL . 16.4 t -74.0 84.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.862 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.95 85.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.8 t -102.26 144.28 30.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.612 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -130.2 107.46 9.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.055 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -80.2 108.73 14.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 26.3 m -113.05 117.28 46.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.201 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 62.9 Cg_endo . . . . . 0 N--CA 1.447 -1.213 0 C-N-CA 123.381 2.721 . . . . 0.0 111.566 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.7 pt . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.6 m-85 -135.26 99.48 4.26 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 57.9 t -84.99 101.89 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.729 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' SG ' ' A' ' 56' ' ' CYS . 40.0 t -105.9 121.02 57.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 21' ' ' THR . 78.8 mt -111.37 99.54 8.31 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.11 106.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 111.359 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.4 mtmm -111.69 92.85 18.13 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.601 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.1 Cg_endo -51.26 101.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.648 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 18.9 mtt180 -64.17 -29.85 70.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.397 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -127.36 -177.23 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.321 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 21.3 ptt180 -120.31 139.96 51.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.5 -118.82 0.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.691 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -116.65 30.66 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.006 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -46.83 152.06 0.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.568 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 78.2 m -158.24 142.58 15.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.5 tp -93.19 90.53 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.538 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.8 mt-10 -72.57 96.21 1.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.699 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 28.0 mt -111.36 137.97 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -146.47 157.16 11.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.487 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.2 t80 -95.8 91.28 5.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.4 t -121.73 150.87 41.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 77.6 mtp180 -87.42 100.53 1.71 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 5.5 Cg_endo -51.44 -30.33 34.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.384 2.056 . . . . 0.0 112.039 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.36 -32.05 66.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.271 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -108.75 -78.6 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.282 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.48 -178.73 45.28 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.321 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -94.36 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -144.79 154.99 56.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.85 -47.13 4.04 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.897 2.398 . . . . 0.0 112.632 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.89 -14.75 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.759 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.9 m120 -68.56 159.23 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 111.445 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 5.0 tt0 -56.49 157.03 5.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.5 tpp180 -130.93 163.16 28.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.613 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 59.6 t80 -175.32 73.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.534 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.615 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -96.11 88.78 4.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.353 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.5 tp -69.5 90.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.432 . . . . 0.0 110.523 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.0 m-70 -73.03 143.75 47.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.56 HD23 HG23 ' A' ' 14' ' ' VAL . 87.2 mt -144.39 111.83 6.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.6 t30 -83.41 59.53 5.11 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -38.54 133.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.629 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.94 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.895 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 2.1 p30 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -128.21 -112.55 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.877 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG2' HG13 ' A' ' 14' ' ' VAL . 32.7 ttpt -162.03 151.03 15.52 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.886 0.374 . . . . 0.0 111.001 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.773 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.0 m0 -106.07 115.79 30.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 12' ' ' LYS . 19.6 m -148.7 -173.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.586 ' HA ' ' N ' ' A' ' 111' ' ' ASN . 3.3 p-10 -101.85 -171.54 1.99 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.706 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.5 t -175.32 178.89 1.6 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.663 ' O ' HG13 ' A' ' 112' ' ' VAL . 74.9 m80 -109.73 -144.37 0.39 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -106.02 132.23 53.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.163 0.506 . . . . 0.0 111.586 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.76 18.66 46.77 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.328 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tptt -61.35 83.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.648 HG22 HD12 ' A' ' 77' ' ' LEU . 4.6 m -55.48 102.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 78' ' ' VAL . 93.3 m -105.69 97.39 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.346 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 25' ' ' HIS . 28.6 tt0 -72.79 122.09 20.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.299 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.3 mm -117.33 101.0 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 23' ' ' GLU . 2.4 m80 -89.94 115.68 27.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.377 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 51.5 mt -111.83 147.49 35.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.309 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -100.99 162.36 12.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.593 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.75 -132.79 2.46 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.347 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.353 0.121 . . . . 0.0 110.783 179.869 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 121.066 0.46 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.5 ttm -99.98 153.22 19.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.5 m95 -101.95 88.76 3.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.152 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -133.04 -169.05 2.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.396 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH2' ' HA ' ' A' ' 48' ' ' SER . 6.6 mtp85 -82.28 142.72 31.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.384 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 89' ' ' GLU . 60.2 t -53.86 145.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.122 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.21 6.89 3.4 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.845 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -127.86 29.22 5.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.527 0.68 . . . . 0.0 110.707 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.641 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.4 p -65.45 133.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.999 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.923 0.392 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.56 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . 67.2 p -63.67 -162.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.848 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.42 -73.36 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HE2' ' A' ' 82' ' ' LYS . 12.7 pt-20 -142.14 -24.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.937 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -70.19 -66.93 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.113 0.482 . . . . 0.0 111.559 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -116.98 105.86 12.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.964 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -59.06 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.759 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 52' ' ' LEU . 40.7 t -95.3 92.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.828 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.3 t -84.36 77.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.503 0.668 . . . . 0.0 109.2 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 76' ' ' VAL . 13.0 t -92.19 134.81 34.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.283 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 75' ' ' VAL . 43.0 mtmt -129.64 119.47 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 1.1 t80 -84.29 98.78 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.123 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.6 m -91.22 108.7 30.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.291 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 61.0 Cg_endo . . . . . 0 N--CA 1.447 -1.256 0 C-N-CA 123.713 2.942 . . . . 0.0 111.465 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 5.9 pt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -139.93 100.0 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.284 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 57' ' ' LYS . 10.4 p -92.25 133.13 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 109.856 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 56' ' ' CYS . 43.6 t -132.93 99.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 21' ' ' THR . 2.1 mm? -83.09 103.8 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.624 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.33 112.66 28.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.947 0.403 . . . . 0.0 110.797 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.8 mtmm -118.25 101.63 51.17 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.05 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 112' ' ' VAL . 4.6 Cg_endo -49.17 101.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.477 2.118 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 3.8 mtt180 -74.89 -42.47 57.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.498 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 67.2 mttm -113.71 160.03 19.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.013 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -96.19 129.15 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.538 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.53 -119.24 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.456 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -121.14 99.47 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.501 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -111.18 164.79 12.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 m -161.78 152.98 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.668 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.7 tp -119.4 77.79 1.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.959 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -81.53 107.76 14.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.823 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 38' ' ' ARG . 96.2 mt -101.78 154.86 18.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.362 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -146.89 158.92 9.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.23 0.538 . . . . 0.0 112.04 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -94.34 68.9 3.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.702 ' HB ' HG23 ' A' ' 99' ' ' ILE . 1.1 t -84.73 167.27 16.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.82 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -109.35 92.67 11.92 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.718 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.92 -33.71 26.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.635 2.223 . . . . 0.0 112.541 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -69.41 -31.36 69.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.11 -81.28 0.61 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.58 -172.07 40.09 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.32 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.702 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.9 mt -102.99 116.55 46.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.658 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.0 170.54 5.43 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.58 -35.53 16.95 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.514 2.143 . . . . 0.0 112.175 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.45 -19.24 22.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.435 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.77 132.54 52.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 111.325 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -53.55 161.06 1.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.713 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.666 ' HG2' HD22 ' A' ' 10' ' ' ASN . 4.4 tpt180 -126.47 153.12 45.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.242 0.544 . . . . 0.0 112.171 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.895 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 42.5 t80 -165.1 83.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.049 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 89' ' ' GLU . 1.4 m -95.81 111.46 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.7 tp -98.0 94.13 6.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.958 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 37.0 m-70 -77.27 141.16 40.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 0.0 111.033 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 73.7 mt -144.17 77.91 1.56 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.298 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.586 ' N ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 t30 -57.17 89.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 17' ' ' HIS . 5.5 t -57.9 133.49 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.724 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.972 179.692 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.699 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.131 0.491 . . . . 0.0 112.026 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.486 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -47.75 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.083 -179.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD3' HD13 ' A' ' 108' ' ' LEU . 53.4 tttp -102.47 98.7 8.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.763 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.71 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.3 m95 -87.55 104.32 16.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.265 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 HD23 ' A' ' 110' ' ' LEU . 30.7 m -146.45 -171.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 112.055 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.25 -176.04 2.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.585 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.6 t -175.83 -177.04 0.9 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.138 0.494 . . . . 0.0 112.164 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.8 m80 -115.1 -167.7 1.28 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.805 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -84.55 128.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.169 0.509 . . . . 0.0 111.905 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.63 20.63 59.55 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.483 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.2 tptp -59.03 84.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.026 0.413 . . . . 0.0 109.975 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.758 HG22 HD22 ' A' ' 77' ' ' LEU . 3.9 m -55.72 93.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.353 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 52.2 m -94.59 101.91 13.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.0 tt0 -82.43 133.46 35.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.577 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.572 HD11 HD22 ' A' ' 108' ' ' LEU . 41.4 mt -135.5 101.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.158 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -84.72 107.87 17.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.3 mt -100.89 144.86 29.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.273 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.9 164.01 13.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.93 0.395 . . . . 0.0 110.334 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.61 -139.84 5.78 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.291 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.0 t30 . . . . . 0 C--N 1.329 -0.319 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.84 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 90.2 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.28 151.97 32.56 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.062 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.47 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 3.8 m95 -110.38 88.97 2.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.87 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 42' ' ' VAL . 5.9 t -136.67 -168.7 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.927 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 54' ' ' VAL . 10.2 mtp85 -81.17 140.26 35.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.784 0.326 . . . . 0.0 111.102 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 89' ' ' GLU . 20.3 t -54.39 144.44 5.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.53 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.18 -0.97 5.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.864 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -128.66 54.12 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.568 0.699 . . . . 0.0 110.504 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 93' ' ' THR . 26.2 t -107.69 121.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.653 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -177.631 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 56' ' ' CYS . 36.9 mt . . . . . 0 CA--C 1.519 -0.245 0 CA-C-O 121.449 0.642 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 53' ' ' GLU . 36.9 t -47.23 174.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.02 -83.13 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.91 -31.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.135 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.3 mm -73.97 -79.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.509 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -99.93 115.84 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.678 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.78 70.27 0.19 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.603 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -75.41 83.71 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.251 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.72 84.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HB3' HD12 ' A' ' 47' ' ' LEU . 21.1 t -99.29 127.11 45.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.439 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 75' ' ' VAL . 41.2 mttm -109.37 107.32 17.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.597 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -81.66 103.99 11.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.42 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 1.2 m -102.45 119.31 56.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.007 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 83.7 Cg_endo . . . . . 0 N--CA 1.452 -0.942 0 C-N-CA 123.163 2.575 . . . . 0.0 113.134 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.47 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -138.37 109.68 6.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.136 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 57' ' ' LYS . 5.0 p -103.58 111.51 33.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' SG ' ' A' ' 56' ' ' CYS . 28.1 t -104.97 124.04 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.482 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.758 HD22 HG22 ' A' ' 21' ' ' THR . 83.7 mt -109.65 100.96 9.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -94.75 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.1 mtmt -114.27 94.14 34.04 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.354 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.605 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.48 105.43 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.495 2.13 . . . . 0.0 112.577 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 17.5 mtt180 -69.62 -35.85 75.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -117.64 -177.39 3.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.872 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HE ' HG21 ' A' ' 18' ' ' VAL . 85.9 mtt180 -121.3 142.21 50.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.8 -107.37 0.5 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.456 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.8 m80 -125.96 94.68 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -109.96 162.6 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.163 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.2 m -159.92 149.62 18.16 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.582 ' HB2' HG11 ' A' ' 78' ' ' VAL . 27.1 tp -119.47 80.19 1.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -77.71 106.85 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.968 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 38' ' ' ARG . 73.1 mt -102.96 154.0 19.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.099 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.43 152.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.833 0.349 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.3 t80 -102.67 92.09 4.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.849 HG21 HG21 ' A' ' 42' ' ' VAL . 8.1 t -131.42 162.54 29.94 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.5 mtp180 -94.96 95.36 1.53 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.613 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 42' ' ' VAL . 1.3 Cg_endo -45.45 -34.07 10.17 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.094 2.529 . . . . 0.0 112.967 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -72.39 -36.78 68.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.019 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.58 6.32 39.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.675 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.4 -168.35 42.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.923 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.686 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.7 mt -117.14 154.49 18.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.27 0.557 . . . . 0.0 112.343 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.6 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.26 163.55 49.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.549 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.53 -17.47 16.28 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.569 2.179 . . . . 0.0 111.665 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.3 pt-20 -78.79 -6.73 56.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.46 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 100' ' ' LYS . 12.4 m120 -69.65 151.11 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.51 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -60.99 166.31 3.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.699 ' HB3' HD22 ' A' ' 10' ' ' ASN . 16.6 tpp180 -130.46 163.69 26.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.597 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 46.7 t80 -172.97 68.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.5 m -89.64 103.27 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.884 -178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 24' ' ' ILE . 34.7 tp -86.53 90.24 8.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 14.0 m-70 -74.45 145.9 43.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 14' ' ' VAL . 86.4 mt -146.81 104.93 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.176 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 46.7 t30 -79.58 70.62 6.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -47.55 117.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.698 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 2.4 p-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.401 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 6.9 p-10 -43.44 103.41 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.488 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB3' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.2 57.13 0.95 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.555 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.5 m0 -78.48 122.83 26.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.921 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 5.7 p -174.76 160.95 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.549 0.69 . . . . 0.0 112.099 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -61.77 176.06 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.059 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 110' ' ' LEU . 4.1 t -174.31 -172.75 0.71 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.04 0.448 . . . . 0.0 111.63 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.0 m80 -117.38 -169.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 83' ' ' ARG . 40.8 t -90.29 129.27 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.687 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 58.34 15.14 22.38 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.26 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.3 tptp -62.96 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.682 HG22 HD22 ' A' ' 77' ' ' LEU . 7.2 m -44.02 103.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.852 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.5 m -94.35 95.12 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.568 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 39.2 tt0 -81.76 131.83 35.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.831 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.451 HD13 ' OH ' ' A' ' 106' ' ' TYR . 41.2 mt -139.3 102.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.5 102.16 11.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 11.5 mt -95.11 145.22 25.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.652 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.5 mptt -99.58 161.45 13.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.335 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.82 -147.01 7.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.559 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.0 t30 . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 120.39 0.138 . . . . 0.0 110.742 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.3 ttm -147.14 151.08 36.2 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.3 m95 -104.2 82.79 1.99 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.8 t -127.97 161.6 28.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.364 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.711 ' NH1' HD11 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -54.71 139.88 37.65 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.776 0.322 . . . . 0.0 111.408 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 91' ' ' VAL . 42.3 t -51.14 140.88 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.268 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.38 5.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 47' ' ' LEU . 23.2 m-30 -117.25 47.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.207 0.527 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.617 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.3 p -93.44 128.76 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.859 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.281 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.066 -178.746 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.6 HD13 HH21 ' A' ' 38' ' ' ARG . 15.6 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 92.3 p -51.89 175.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.294 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -157.26 -99.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 111.388 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.9 pt-20 -127.28 -32.46 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.8 mm -73.52 -72.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' A' ' 78' ' ' VAL . 85.1 mt -106.15 116.98 32.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.217 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.64 73.32 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG13 HG13 ' A' ' 78' ' ' VAL . 1.3 t -78.9 90.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -92.65 90.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.56 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 9.2 t -114.99 145.88 41.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.287 0.565 . . . . 0.0 111.604 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -126.61 125.2 41.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.143 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -85.59 103.87 14.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.15 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 27.4 m -105.8 128.46 26.4 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 29.7 Cg_endo . . . . . 0 N--CA 1.449 -1.147 0 C-N-CA 123.499 2.799 . . . . 0.0 111.737 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 pt . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -139.27 98.01 3.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.775 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.3 p -89.12 113.25 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-O 121.343 0.592 . . . . 0.0 110.661 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG22 HH22 ' A' ' 38' ' ' ARG . 20.7 t -107.06 126.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.764 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 HG22 ' A' ' 21' ' ' THR . 70.0 mt -113.62 90.68 3.41 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.648 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -90.85 105.21 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.074 0.464 . . . . 0.0 111.057 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 46.5 mtmt -106.01 96.27 12.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 52' ' ' LEU . 7.4 Cg_endo -50.67 103.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.283 1.989 . . . . 0.0 112.503 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.1 mtt180 -67.69 -35.39 78.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 53.0 mttm -117.43 178.99 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.831 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 18' ' ' VAL . 67.3 mtp180 -117.65 146.55 43.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.45 -149.59 21.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.782 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -91.26 28.3 1.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.752 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.436 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 72.3 m-70 -47.54 157.6 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 109' ' ' HIS . 54.4 m -157.31 148.22 21.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.922 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 38' ' ' ARG . 17.4 tp -107.99 165.78 11.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.75 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.558 ' C ' HD12 ' A' ' 90' ' ' LEU . 34.5 mt-10 -151.68 121.24 6.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.711 HD11 ' NH1' ' A' ' 38' ' ' ARG . 9.7 mp -116.81 161.83 18.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.289 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.3 p -158.65 155.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.117 0.484 . . . . 0.0 112.047 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.7 t80 -100.12 86.86 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.706 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.9 t -109.82 171.46 7.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -105.54 93.25 6.84 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 88.9 Cg_exo -49.17 -29.2 16.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.536 2.158 . . . . 0.0 112.339 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.38 -34.69 63.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.213 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -110.24 -76.88 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.249 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.47 -174.76 47.02 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.242 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -96.44 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 0.0 111.013 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.8 mttt -136.11 157.01 76.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.65 -47.38 11.43 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.735 2.29 . . . . 0.0 112.739 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.06 -12.71 8.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.85 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -64.26 149.94 46.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.927 0.394 . . . . 0.0 111.357 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.71 164.03 2.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.703 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 12.1 tpp180 -137.77 162.13 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.703 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -164.41 83.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.304 0.573 . . . . 0.0 110.08 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 89' ' ' GLU . 25.8 m -88.82 133.76 34.16 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 37.5 tp -118.59 80.98 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.8 m-70 -66.46 145.42 55.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.876 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.7 mt -143.58 108.34 4.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.579 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 60.9 t30 -82.8 50.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.479 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -37.7 112.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.67 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.848 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.96 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.25 98.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.804 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.516 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.5 tttt -100.96 94.55 6.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.034 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.685 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m95 -84.64 103.32 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.05 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 110' ' ' LEU . 29.6 m -148.21 -171.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.133 0.492 . . . . 0.0 112.104 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -109.32 178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.819 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.441 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.4 t -176.39 -172.67 0.48 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.95 0.405 . . . . 0.0 111.692 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 66.6 m80 -122.23 179.9 4.39 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.59 136.23 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.339 0.59 . . . . 0.0 112.221 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 58.24 15.16 21.73 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.862 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.4 tptt -58.72 85.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.327 0.563 . . . . 0.0 110.015 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.711 HG22 HD22 ' A' ' 77' ' ' LEU . 3.6 m -56.67 102.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.332 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 m -102.16 101.42 11.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.4 tt0 -81.6 135.02 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 108' ' ' LEU . 42.0 mt -136.41 104.95 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -86.24 97.87 10.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.8 mt -91.02 145.69 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 5.7 mptt -91.4 159.71 15.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.35 -154.39 25.48 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.009 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.4 0.143 . . . . 0.0 110.987 179.72 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.1 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.937 0.399 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.506 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.3 ttt -133.89 149.76 51.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.508 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 23.2 m95 -100.87 110.56 22.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.154 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.663 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -154.99 -172.39 4.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.819 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 mtp85 -89.08 153.66 20.8 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.807 0.337 . . . . 0.0 111.044 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 89' ' ' GLU . 51.6 t -67.11 132.88 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.977 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.46 15.43 81.44 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.851 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.422 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 59.8 m-85 -135.75 -5.56 2.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 37' ' ' THR . 4.3 p -43.47 124.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.517 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 72.2 p -50.95 177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.016 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -156.43 -89.83 0.04 OUTLIER 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.399 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -127.14 -35.25 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.7 mm -70.53 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.231 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.4 mt -101.35 116.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.451 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -71.16 66.98 0.43 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG21 ' HD2' ' A' ' 38' ' ' ARG . 19.2 t -71.23 81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.822 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.7 t -75.69 78.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -94.63 139.71 30.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.366 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -131.36 107.53 9.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.747 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -72.6 109.58 6.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.289 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.419 ' OG1' HG13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -94.18 112.8 58.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.429 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 N--CA 1.456 -0.696 0 C-N-CA 123.105 2.537 . . . . 0.0 113.714 -179.344 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.9 pt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -133.02 99.8 4.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.466 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.4 p -94.79 108.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.192 0.52 . . . . 0.0 110.724 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 43.0 t -104.84 126.33 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.825 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.711 HD22 HG22 ' A' ' 21' ' ' THR . 82.1 mt -110.66 98.44 7.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.761 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.584 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.47 107.87 19.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.005 0.431 . . . . 0.0 111.275 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 44.8 mtmt -112.65 95.13 31.37 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.22 101.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.1 . . . . 0.0 112.848 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.528 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -65.77 -31.06 71.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.872 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -119.01 176.97 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.632 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -120.71 126.06 49.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.968 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 149.63 -109.21 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.236 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -111.98 113.55 25.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -135.77 156.48 48.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.591 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.557 ' CG2' HG22 ' A' ' 107' ' ' THR . 28.9 m -158.75 148.68 19.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.534 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 41.2 tp -108.58 90.23 3.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.72 ' HA ' HG23 ' A' ' 107' ' ' THR . 39.3 mt-10 -71.8 97.29 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.104 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -111.46 125.28 53.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.489 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -126.75 172.24 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.488 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 1.7 t80 -109.69 86.36 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.014 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.6 t -117.61 158.01 25.39 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' TYR . 79.8 mtp180 -100.49 98.9 8.72 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.84 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -43.39 -38.02 8.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 112.845 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.88 -40.35 92.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.618 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -102.38 -75.58 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.04 -173.58 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.272 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -99.94 143.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 0.0 111.34 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -135.59 169.49 13.55 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.16 -37.87 17.34 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.643 2.229 . . . . 0.0 112.067 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.57 -17.21 53.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.169 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.623 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.96 135.06 56.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -54.75 158.37 2.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 6.3 tpp180 -119.24 160.16 22.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.433 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 49.7 t80 -173.28 68.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.975 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.72 97.63 10.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.328 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 19.5 tp -78.85 93.28 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.685 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.2 m-70 -76.66 142.71 40.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 14' ' ' VAL . 89.9 mt -146.64 110.94 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.302 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 44.0 t30 -83.44 65.7 8.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -42.4 136.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.991 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 111.772 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -59.32 97.71 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.304 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.0 ptmt -93.69 74.69 4.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.701 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -50.22 103.89 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.834 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.617 HG23 HD23 ' A' ' 110' ' ' LEU . 34.7 m -146.82 -174.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 112.436 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -108.95 -178.1 3.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.808 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.556 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.31 -173.39 0.44 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.983 0.421 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.599 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 47.9 m-70 -124.12 -177.22 3.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.979 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.94 137.79 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 112.174 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.33 14.01 11.7 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.659 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.599 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 20.5 tptt -57.82 85.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.193 0.497 . . . . 0.0 109.927 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.77 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -57.27 92.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.291 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -88.36 103.2 15.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.613 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.5 tt0 -85.2 129.66 34.76 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.553 HG22 ' HG ' ' A' ' 26' ' ' LEU . 42.1 mt -133.84 107.69 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.645 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -87.83 91.64 8.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.368 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 24' ' ' ILE . 15.5 mt -86.24 145.13 27.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.488 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -99.53 163.65 12.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.22 -141.24 5.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.6 t30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.548 0.214 . . . . 0.0 110.564 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 36.0 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.097 0.475 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.0 ttm -150.61 151.05 31.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.087 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.485 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.4 m95 -106.62 88.14 2.69 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.5 t -134.56 -168.57 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -74.99 157.5 34.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.67 0.271 . . . . 0.0 110.722 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 98.9 t -79.56 134.81 26.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.749 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 -10.44 5.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.822 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 39' ' ' VAL . 16.8 m-30 -106.08 7.91 32.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.143 0.497 . . . . 0.0 110.284 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.904 HG21 HG21 ' A' ' 93' ' ' THR . 14.4 t -62.16 106.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.749 -179.412 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.746 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 6.8 mt . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 40.6 p -49.54 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.779 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.2 -89.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -130.35 -30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.279 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.7 mm -75.32 -79.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.2 mt -102.52 113.42 26.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.572 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -69.81 71.14 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.825 0.345 . . . . 0.0 110.249 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.656 HG11 ' HD3' ' A' ' 38' ' ' ARG . 2.1 t -72.78 87.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG12 ' HE3' ' A' ' 57' ' ' LYS . 20.4 t -86.78 86.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 76' ' ' VAL . 5.6 t -111.82 134.19 53.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.896 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' HG12 ' A' ' 55' ' ' VAL . 32.1 mmtp -113.91 112.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.507 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -70.95 117.5 12.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.847 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.2 114.05 62.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.631 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 112.926 -179.435 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.141 0.496 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -133.73 102.8 5.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.708 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 74.3 t -87.57 107.1 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.777 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.547 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.8 t -108.95 119.6 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.77 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -112.2 95.38 5.42 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.587 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -90.8 108.76 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.021 0.439 . . . . 0.0 111.282 -178.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.0 mtmm -110.45 92.27 13.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.63 102.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.524 2.149 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.3 mtt180 -64.1 -34.76 78.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -116.06 -175.81 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.83 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -122.8 146.46 47.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.461 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 133.19 -136.79 8.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.492 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.88 95.32 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.963 0.411 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.14 164.37 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.613 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 109' ' ' HIS . 88.3 m -159.8 150.24 18.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.586 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 HH11 ' A' ' 38' ' ' ARG . 34.6 tp -120.28 94.53 4.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.608 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.7 mt-10 -73.88 105.54 5.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.802 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 26.5 mt -111.39 129.64 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.9 p -133.66 158.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.161 0.505 . . . . 0.0 112.092 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -102.37 92.11 4.55 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.979 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.904 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -123.02 170.36 10.23 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -102.11 94.81 4.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.9 Cg_exo -45.21 -38.17 14.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.721 2.28 . . . . 0.0 112.729 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -37.7 88.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -101.57 -80.71 0.49 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.413 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.04 178.39 44.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.732 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.8 mt -94.39 153.08 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 0.0 111.557 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.7 mttt -140.41 162.65 48.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.2 Cg_endo -70.95 -39.77 3.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.712 2.275 . . . . 0.0 111.998 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.5 -27.47 69.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.784 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -52.5 153.72 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -59.66 160.35 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.6 tpp180 -129.87 163.9 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.206 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.7 t80 -176.49 71.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 0.0 109.111 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 89' ' ' GLU . 1.9 m -85.83 95.98 9.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.341 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 48.2 tp -72.88 86.28 1.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -75.74 139.6 41.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 14' ' ' VAL . 94.6 mt -145.49 102.52 3.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.621 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 37.5 t30 -79.26 73.0 5.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 HG23 ' A' ' 16' ' ' THR . 1.7 t -48.4 137.82 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.729 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.969 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.599 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -34.63 100.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.778 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.5 tttt -89.84 100.25 13.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.472 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.674 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -82.05 105.08 12.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.79 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.1 p -154.84 -178.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.077 0.465 . . . . 0.0 111.718 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.79 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -100.67 -176.12 3.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.604 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.496 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.12 -174.4 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.183 0.516 . . . . 0.0 112.195 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.7 m-70 -114.96 -168.93 1.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.113 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.79 128.77 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 111.897 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.65 15.86 27.75 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.505 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.61 84.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.712 HG22 HD22 ' A' ' 77' ' ' LEU . 4.9 m -47.8 101.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.981 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 78' ' ' VAL . 51.9 m -96.03 99.62 11.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.9 tt0 -81.97 131.6 35.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.311 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 108' ' ' LEU . 43.7 mt -138.67 103.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.764 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -85.58 107.02 17.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.346 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.545 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 6.4 mt -104.34 143.93 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.137 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -96.79 162.94 13.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.977 0.418 . . . . 0.0 110.591 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.62 -158.76 29.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.311 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.694 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 17.7 ttm -117.7 152.84 34.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.896 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.4 m95 -111.44 89.99 3.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.186 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.0 t -134.24 -165.88 1.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.07 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.8 mtp85 -90.66 155.01 19.15 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.958 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 37.8 t -74.5 133.01 32.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.49 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.75 89.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.7 m-85 -130.68 -1.18 4.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 0.0 110.477 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 93' ' ' THR . 21.0 t -54.13 118.74 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.067 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.982 -179.49 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.15 0.5 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 64.4 p -53.47 -179.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.59 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -157.2 -90.81 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.63 -30.37 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -74.99 -79.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.214 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.626 HD22 HG12 ' A' ' 78' ' ' VAL . 7.1 mt -100.21 113.62 26.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.71 68.32 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.068 0.461 . . . . 0.0 109.928 177.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -72.7 84.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.768 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 29.3 t -80.14 80.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.591 0.71 . . . . 0.0 109.19 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' HG22 ' A' ' 76' ' ' VAL . 17.4 t -97.17 124.23 41.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.212 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -114.82 105.96 13.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -70.37 97.95 1.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 m -95.47 125.42 49.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.133 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 22.1 Cg_endo . . . . . 0 N--CA 1.448 -1.201 0 C-N-CA 123.196 2.597 . . . . 0.0 111.571 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.9 m-85 -138.99 101.08 4.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.348 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.46 100.2 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 120.876 0.369 . . . . 0.0 110.814 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.3 t -100.96 118.95 48.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.138 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -110.35 97.52 6.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.629 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.626 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.81 106.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.9 mtmm -111.75 92.99 18.66 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.211 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.3 Cg_endo -51.76 102.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.388 2.059 . . . . 0.0 112.606 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.5 mtt180 -63.93 -36.37 83.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.822 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 79.2 mttt -119.45 178.01 4.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -119.82 140.36 50.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.963 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.551 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.45 -113.57 0.71 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.359 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -115.99 93.2 4.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.816 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.1 m-70 -113.63 162.27 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.6 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 109' ' ' HIS . 60.0 m -159.31 149.92 19.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 111.723 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 22.6 tp -115.66 93.47 4.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.388 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.8 mt-10 -78.42 92.62 4.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.191 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 59.3 mt -103.22 123.72 47.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.9 p -126.66 155.59 37.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.946 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.1 t80 -97.89 82.88 3.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.472 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.882 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -118.79 158.75 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 58.5 mtp180 -97.45 98.21 4.78 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.512 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 93' ' ' THR . 93.8 Cg_exo -44.04 -38.44 10.44 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.884 2.39 . . . . 0.0 112.735 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.3 93.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -97.26 -74.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.44 179.7 39.36 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.088 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.651 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.7 mt -94.23 146.25 6.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.597 ' HE3' HD21 ' A' ' 103' ' ' ASN . 43.6 mtmt -140.28 162.9 47.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.215 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 42.4 Cg_endo -68.02 -38.76 12.13 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.777 2.318 . . . . 0.0 112.089 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.429 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.6 pt-20 -61.7 -28.22 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.826 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.597 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -55.22 149.37 12.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.05 166.17 2.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.6 tpp180 -132.7 164.11 27.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.44 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.638 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 51.3 t80 -174.47 64.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.635 0.731 . . . . 0.0 109.184 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.3 m -87.61 92.22 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.228 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 27.5 tp -73.46 93.55 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.2 m-70 -77.31 140.71 40.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 16' ' ' THR . 92.3 mt -143.78 104.08 4.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.39 68.33 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.551 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -45.02 118.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.369 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.963 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.645 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.106 0.479 . . . . 0.0 112.137 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.2 99.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.713 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 53.6 tptt -95.09 92.13 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.244 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m95 -75.84 105.68 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.743 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.678 HG22 ' H ' ' A' ' 15' ' ' ASP . 9.9 p -156.93 173.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.239 0.542 . . . . 0.0 111.888 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.678 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -93.64 -173.59 3.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.57 -175.96 0.84 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.153 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 4.5 m-70 -115.24 -163.77 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.715 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.13 132.37 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 111.985 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.55 20.05 22.08 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.507 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptm -63.3 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.782 HG22 HD22 ' A' ' 77' ' ' LEU . 4.1 m -51.43 99.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.517 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HB ' HG23 ' A' ' 78' ' ' VAL . 38.2 m -98.58 101.02 12.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.722 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HG3' HG23 ' A' ' 75' ' ' VAL . 33.4 tt0 -76.79 133.92 39.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.505 HG22 ' HG ' ' A' ' 26' ' ' LEU . 23.2 mt -131.48 94.97 2.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.262 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 6.5 m170 -84.82 78.27 9.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.026 0.441 . . . . 0.0 110.024 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HG ' HG22 ' A' ' 24' ' ' ILE . 89.8 mt -68.98 160.15 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.325 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -113.63 164.24 13.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.07 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.08 -145.95 11.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.771 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.9 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.367 0.127 . . . . 0.0 110.782 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.138 0.494 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 4.6 ttt -147.98 151.9 36.57 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.851 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -107.6 96.7 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.131 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -147.39 -166.42 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.647 HH11 HG21 ' A' ' 54' ' ' VAL . 5.1 mtp180 -84.84 155.7 21.64 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.849 0.357 . . . . 0.0 111.253 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 43.2 t -74.35 132.8 32.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.439 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.44 89.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.261 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 64.9 m-85 -127.6 3.98 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.098 0.475 . . . . 0.0 110.419 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 37' ' ' THR . 3.6 p -45.22 133.1 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.071 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.302 -179.771 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.925 0.393 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 45.6 p -48.87 -179.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.384 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -156.55 -85.45 0.05 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.89 -30.5 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.585 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -73.74 -76.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.55 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.9 mt -102.85 115.65 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.324 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.18 70.91 0.24 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.21 0.528 . . . . 0.0 109.699 177.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HH11 ' A' ' 38' ' ' ARG . 21.7 t -76.63 83.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.312 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 t -82.01 86.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.488 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.5 t -96.18 150.95 19.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.792 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' HG13 ' A' ' 75' ' ' VAL . 55.1 mttm -139.77 114.4 9.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.973 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.516 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -94.68 105.52 17.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.945 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.6 m -107.39 108.52 61.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.446 -1.265 0 C-N-CA 123.47 2.78 . . . . 0.0 111.71 179.76 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 121.876 0.846 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 1.9 m-85 -130.27 76.2 1.71 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.564 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.3 p -84.5 110.27 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.001 -177.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 56' ' ' CYS . 90.3 t -106.81 122.06 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.3 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 21' ' ' THR . 81.8 mt -105.36 102.49 11.96 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.905 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.15 108.51 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.951 0.405 . . . . 0.0 111.091 -178.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -113.9 93.78 30.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.9 Cg_endo -47.99 102.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.567 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.9 mtt180 -69.16 -36.72 77.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.293 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -117.15 170.58 8.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -107.22 123.82 48.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.593 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.77 -128.79 2.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.537 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.432 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -106.86 95.58 5.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.377 . . . . 0.0 110.962 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.433 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -109.65 161.53 15.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.402 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.0 m -158.17 148.93 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 111.732 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 24.9 tp -115.77 90.39 3.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.571 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.5 mt-10 -75.57 94.19 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.1 mt -101.91 125.33 48.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.5 p -131.12 158.08 43.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.715 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.6 t80 -97.1 86.44 3.96 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -110.86 167.11 10.49 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 61.5 mtp180 -102.52 97.68 9.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.393 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.0 Cg_exo -51.44 -31.78 40.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.544 2.163 . . . . 0.0 112.635 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.14 10.12 11.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.2 mm-40 -148.41 -79.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.85 40.92 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 mt -94.87 155.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.894 0.378 . . . . 0.0 111.267 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.579 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.3 mtmt -143.76 161.4 46.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.944 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.4 Cg_endo -72.08 -39.7 2.96 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.31 -27.02 69.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.0 m120 -55.97 155.03 6.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -56.25 161.95 2.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.042 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.645 ' HB3' HD22 ' A' ' 10' ' ' ASN . 17.3 tpp180 -131.66 164.28 26.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.746 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 50.0 t80 -177.58 65.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.345 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 10.4 m -87.25 94.12 9.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.7 tp -74.93 93.8 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.703 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.2 m-70 -77.11 138.65 39.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 110.706 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 96.2 mt -142.29 98.06 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -76.08 78.17 2.92 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.593 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.4 t -51.77 123.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.474 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.681 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.009 0.433 . . . . 0.0 111.919 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 4.1 m-20 -55.22 97.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' A' ' 14' ' ' VAL . 54.5 tttp -99.63 95.27 6.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.85 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.54 102.36 12.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.166 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.534 HG21 ' HE3' ' A' ' 12' ' ' LYS . 35.2 m -147.34 -170.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.041 0.448 . . . . 0.0 111.809 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -103.99 -176.19 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.303 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -173.83 -175.65 1.1 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 112.293 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 17.5 m80 -116.56 -163.06 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.017 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 44.4 t -98.56 129.06 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.808 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.67 14.52 36.64 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.287 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -64.08 83.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.2 102.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.809 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 98.3 m -96.16 100.19 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.389 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.0 tt0 -81.34 131.45 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.033 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.9 mt -136.0 104.46 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.78 100.94 12.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.8 mt -95.52 147.72 23.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.466 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -101.94 162.01 13.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.54 -147.49 9.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 t30 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.39 0.138 . . . . 0.0 110.754 179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 65.9 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.059 0.457 . . . . 0.0 111.375 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ttm -150.94 152.94 34.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.902 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 9.1 m95 -107.25 87.24 2.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -131.85 -166.55 1.74 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.175 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 22.0 mtp85 -90.24 148.14 23.1 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.217 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 17.4 t -68.07 136.29 26.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.544 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.31 1.7 88.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.405 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.418 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 61.5 m-85 -128.24 -1.62 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -55.21 107.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.057 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.959 -179.551 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.3 mt . . . . . 0 N--CA 1.452 -0.339 0 CA-C-O 121.135 0.493 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.6 t -51.43 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.69 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -157.58 -91.34 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -130.88 -32.64 1.63 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.157 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.9 mm -70.46 -76.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.304 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -104.34 114.48 28.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -66.36 72.99 0.08 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 HG13 ' A' ' 78' ' ' VAL . 10.9 t -79.44 85.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.164 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.0 t -81.12 83.3 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.8 t -98.33 139.87 33.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.369 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -133.28 110.0 9.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -76.77 101.44 5.84 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 23.2 m -97.87 109.22 50.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.059 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 74.2 Cg_endo . . . . . 0 N--CA 1.446 -1.282 0 C-N-CA 123.593 2.862 . . . . 0.0 111.266 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 121.063 0.458 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -135.32 100.42 4.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.69 104.32 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.926 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HD11 ' A' ' 90' ' ' LEU . 37.2 t -107.09 120.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.289 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 80.0 mt -110.38 100.38 9.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.826 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.13 107.26 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.146 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.0 mtmm -109.5 103.58 53.19 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.392 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.8 Cg_exo -51.59 101.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.204 . . . . 0.0 112.605 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.581 HH11 ' HA ' ' A' ' 50' ' ' GLU . 11.8 mtt180 -71.91 -37.1 70.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.828 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.518 ' H ' ' HE1' ' A' ' 86' ' ' HIS . 57.1 mttm -120.39 173.45 7.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -110.05 137.43 47.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.652 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 141.63 -118.8 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.742 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -110.15 100.38 9.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.0 111.268 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.518 ' HE1' ' H ' ' A' ' 82' ' ' LYS . 11.5 m-70 -119.43 156.45 30.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 107' ' ' THR . 58.1 m -159.63 147.93 17.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.2 tp -104.67 90.12 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.368 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.768 ' HA ' HG23 ' A' ' 107' ' ' THR . 42.9 mt-10 -72.43 95.15 1.73 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.894 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 35.8 mt -109.9 133.96 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.3 p -140.41 153.93 22.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.843 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.5 t80 -97.83 84.57 3.37 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.4 t -116.4 167.83 10.69 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 77.8 mtp180 -100.38 94.53 3.46 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 93' ' ' THR . 77.7 Cg_exo -43.45 -24.63 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.802 2.334 . . . . 0.0 113.371 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -79.47 -62.21 1.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 94' ' ' ARG . 1.6 pp20? -72.23 -39.1 68.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.674 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.8 -165.14 24.64 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -112.98 132.9 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 111.748 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE3' ' CD ' ' A' ' 97' ' ' GLU . 5.8 mttt -120.57 156.26 55.97 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.8 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.53 -47.42 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.918 2.412 . . . . 0.0 112.73 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -53.75 -17.7 2.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.832 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 11.3 m120 -63.76 157.22 24.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -57.51 159.22 5.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.244 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.681 ' HB3' HD22 ' A' ' 10' ' ' ASN . 13.5 tpp180 -129.68 164.34 24.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.029 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.593 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.0 t80 -174.85 72.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.768 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.05 96.02 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.397 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 20.6 tp -76.46 93.3 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.7 m-70 -77.55 144.87 37.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 75.1 mt -145.67 113.37 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.23 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.4 t30 -83.39 65.29 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -46.06 129.01 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.443 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.937 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.624 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.6 OUTLIER -32.36 99.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.207 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' HD13 ' A' ' 108' ' ' LEU . 19.8 ptmt -93.88 73.57 4.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -49.62 104.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG23 HD23 ' A' ' 110' ' ' LEU . 28.2 m -146.62 -175.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 112.503 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -110.83 179.68 3.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.641 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.519 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.8 t -177.08 -173.12 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 112.023 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 64.1 m80 -119.15 -167.47 1.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.038 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 25.9 t -84.46 139.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 112.182 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.4 13.15 10.1 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.731 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.1 tptt -59.92 82.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.737 HG22 HD22 ' A' ' 77' ' ' LEU . 3.7 m -54.39 98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.381 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -94.96 101.24 13.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.4 tt0 -84.18 130.15 34.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.55 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 108' ' ' LEU . 46.9 mt -136.47 101.07 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.205 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -81.69 109.82 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.5 mt -104.63 152.35 22.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -108.48 159.57 16.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.979 0.418 . . . . 0.0 110.443 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.81 -39.14 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.172 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 115.77 -0.215 . . . . 0.0 110.951 179.79 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 121.114 0.483 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.526 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 3.3 ttt -118.88 151.21 38.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.966 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -108.39 89.88 3.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.5 t -135.58 -167.05 1.95 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.413 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.715 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.0 mtp85 -89.97 147.23 23.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.703 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 42.5 t -63.92 132.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.697 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.31 14.23 79.12 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.809 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.423 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 63.2 m-85 -136.44 0.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.734 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.605 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.3 p -45.28 123.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.175 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.536 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.715 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.8 mt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 54' ' ' VAL . 88.6 p -52.64 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.495 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.78 -86.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.183 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.64 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.97 -34.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.9 mm -61.52 -62.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.748 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 80' ' ' PRO . 38.6 mt -126.79 134.46 50.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.947 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.434 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -74.07 67.05 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 ' NH1' ' A' ' 38' ' ' ARG . 4.0 t -73.82 82.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.059 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 27.2 t -80.6 81.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.51 0.672 . . . . 0.0 109.215 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' HG22 ' A' ' 76' ' ' VAL . 24.4 t -91.8 135.35 33.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.873 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -127.52 105.14 8.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.526 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -81.62 111.92 18.36 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -103.27 100.35 17.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.806 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 39.6 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 C-N-CA 123.799 3.0 . . . . 0.0 113.401 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.4 pt . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.174 0.511 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -142.71 97.73 3.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.172 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.67 104.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 110.662 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.461 HG22 ' SG ' ' A' ' 56' ' ' CYS . 23.3 t -99.68 127.16 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.586 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -111.71 98.7 7.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.851 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.95 105.11 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -104.46 98.81 15.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.619 ' HA ' HD22 ' A' ' 52' ' ' LEU . 93.2 Cg_exo -43.05 100.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.066 2.511 . . . . 0.0 113.105 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.64 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.5 mtt180 -76.56 -29.73 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.118 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 79.5 mttt -122.4 154.88 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -96.66 124.62 40.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.031 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.569 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.35 -159.53 24.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.591 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -67.12 117.77 9.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.454 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 88.8 m-70 -145.43 170.04 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 88' ' ' LEU . 51.4 m -161.28 159.65 28.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.119 0.485 . . . . 0.0 112.202 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.666 HD22 HG21 ' A' ' 78' ' ' VAL . 10.1 tp -119.13 93.29 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.467 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.67 95.95 1.94 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 49.7 mt -107.98 115.89 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 92' ' ' TYR . 10.6 p -120.16 157.17 22.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.1 t80 -95.98 79.8 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.22 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.625 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 6.3 t -108.45 150.61 27.18 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 17.2 mtp180 -92.03 102.65 6.59 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.821 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 93' ' ' THR . 50.2 Cg_exo -55.25 -30.86 73.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.597 2.198 . . . . 0.0 112.437 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -65.04 -25.14 67.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.464 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -122.65 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.282 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.65 -173.73 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.373 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.597 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.1 mt -97.26 139.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 111.127 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -132.65 166.84 26.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.22 -41.2 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.822 2.348 . . . . 0.0 112.334 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.91 -18.01 41.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -60.85 148.19 40.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 168.3 2.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.0 tpp180 -131.75 164.18 26.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.445 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.661 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 45.2 t80 -171.81 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.507 -0.769 . . . . 0.0 108.955 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -86.7 91.98 8.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.574 -179.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.2 tp -70.69 90.99 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.075 0.464 . . . . 0.0 110.277 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 31.6 m-70 -77.38 139.96 39.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.693 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -144.06 108.82 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.8 t30 -84.09 61.29 6.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.569 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.8 t -40.55 140.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.942 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.999 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.1 p-10 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.483 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 22.1 m-20 -38.45 98.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.539 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -98.38 87.9 3.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.644 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.8 m95 -78.72 98.27 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.752 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 110' ' ' LEU . 30.4 m -147.3 -172.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 111.961 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.76 -178.55 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.798 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -174.74 -174.06 0.78 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.06 0.457 . . . . 0.0 111.927 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.597 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 56.6 m80 -116.04 -173.72 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.012 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.81 135.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.249 0.547 . . . . 0.0 112.05 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 60.26 14.18 32.09 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.883 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.0 tptm -58.13 84.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.24 0.52 . . . . 0.0 109.902 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.794 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -56.54 100.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.427 HG21 HD21 ' A' ' 108' ' ' LEU . 88.6 m -96.81 103.72 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.546 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.652 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.2 tt0 -75.9 117.01 17.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.046 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.698 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 67.5 mt -114.15 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.301 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.436 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.2 m170 -100.93 104.29 15.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.415 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 36.3 mt -96.08 163.08 13.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.308 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -101.88 163.56 12.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.096 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.29 -146.31 16.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.516 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.517 0.199 . . . . 0.0 111.2 179.992 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.461 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 81.2 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.242 0.544 . . . . 0.0 111.68 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.536 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.2 ttm -146.86 154.26 41.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.661 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.545 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 3.4 m95 -110.92 91.8 3.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -134.73 -163.8 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.083 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.68 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -83.23 150.52 26.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.627 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -73.44 129.7 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.359 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.89 80.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -136.2 4.14 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.2 p -49.17 133.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.253 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.83 179.748 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.9 mt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 54.1 p -54.18 -171.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.863 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.89 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.87 -34.62 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.486 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.8 mm -70.58 -77.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.502 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.3 mt -101.46 119.49 38.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.404 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.95 70.36 0.35 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.094 0.473 . . . . 0.0 109.887 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -72.58 84.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.896 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.8 t -81.04 91.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 54.0 t -90.25 130.27 36.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.113 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 54.8 mttm -124.98 80.25 1.86 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.842 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.536 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -64.73 119.59 10.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.617 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.5 m -100.43 100.62 12.52 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 40.5 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 C-N-CA 123.839 3.026 . . . . 0.0 113.753 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.278 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 11.6 m-85 41.75 87.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -88.39 131.71 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 38.2 t -137.49 97.61 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.525 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.794 HD22 HG22 ' A' ' 21' ' ' THR . 79.2 mt -92.37 102.52 15.0 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.79 109.14 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 111.3 -178.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -113.21 92.78 23.25 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.08 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.603 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.1 Cg_endo -46.97 102.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 112.619 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 19.9 mtt180 -66.37 -33.49 75.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.792 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -119.08 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -123.13 143.92 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.62 -117.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.587 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.465 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.9 m80 -112.72 94.33 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.103 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.9 OUTLIER -112.51 161.26 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.425 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.9 m -159.22 140.4 12.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.956 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.777 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -112.51 82.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.52 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 13.2 pt-20 -80.43 128.06 33.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.149 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 45.7 mt -122.64 162.51 21.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.917 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -156.08 150.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 111.587 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -93.6 85.91 5.03 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.793 ' HB ' HG23 ' A' ' 99' ' ' ILE . 4.3 t -118.53 161.84 19.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 72.9 mtp180 -99.01 97.95 5.74 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -47.83 -32.62 17.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.767 2.311 . . . . 0.0 113.378 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.06 11.64 17.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -151.38 1.36 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.26 -175.96 49.96 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.305 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -104.17 154.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.909 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.6 mmtt -132.47 168.72 16.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.62 -49.77 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.28 2.653 . . . . 0.0 112.702 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.06 -13.51 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.623 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.537 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -59.91 144.43 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.414 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 6.2 tt0 -55.5 163.35 1.29 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.625 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.9 tpt180 -130.55 161.29 31.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.646 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 43.3 t80 -171.99 75.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.263 0.554 . . . . 0.0 109.643 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.9 m -97.71 102.38 14.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.833 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.7 tp -84.05 90.22 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 8.8 m-70 -74.33 142.92 45.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 0.0 110.109 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 14' ' ' VAL . 88.8 mt -146.39 99.8 3.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.859 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t30 -75.91 73.27 2.82 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 112' ' ' VAL . 2.6 t -48.4 148.08 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.726 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.577 ' H ' HD22 ' A' ' 10' ' ' ASN . 13.2 m-20 -32.11 101.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.795 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -95.35 90.89 5.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.29 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.694 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -78.26 103.15 8.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.761 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 110' ' ' LEU . 20.9 m -149.93 -172.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 2.9 p-10 -112.88 -177.77 3.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.36 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.557 HG22 HG22 ' A' ' 112' ' ' VAL . 1.5 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.105 0.478 . . . . 0.0 112.255 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.619 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m80 -113.52 -167.77 1.25 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -89.64 138.07 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 112.294 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.28 17.95 19.67 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.738 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.74 81.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.777 HG22 HD22 ' A' ' 77' ' ' LEU . 9.2 m -48.21 97.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 78' ' ' VAL . 53.5 m -93.09 101.43 13.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.722 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HA ' HD23 ' A' ' 77' ' ' LEU . 34.6 tt0 -75.51 119.22 19.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.72 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.29 93.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.3 m170 -86.68 104.17 15.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 52.7 mt -95.53 160.96 14.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.23 163.43 12.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.82 -160.63 27.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.68 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 C--N 1.33 -0.264 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.93 0.395 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 19.9 ttm -113.66 152.32 30.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.433 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.538 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 8.0 m95 -109.36 87.12 2.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.607 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -134.78 -165.07 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.7 mtp85 -90.34 156.78 18.01 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 39.6 t -76.12 132.02 33.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.521 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.95 88.98 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.407 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 57.6 m-85 -131.92 -0.41 3.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 110.414 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -55.58 119.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.002 -179.557 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.287 0.565 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.0 p -51.26 179.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.925 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.78 -87.03 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.189 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.599 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -131.81 -30.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.2 mm -72.96 -76.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.509 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 9.6 mt -102.91 116.65 32.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.511 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -69.58 69.87 0.28 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 109.848 178.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG22 HG13 ' A' ' 78' ' ' VAL . 24.7 t -73.53 85.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.725 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.5 t -77.34 85.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.395 0.617 . . . . 0.0 109.41 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.24 136.09 52.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.134 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 68.0 mttm -135.72 50.68 2.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.654 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -52.59 116.6 2.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.815 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.426 ' N ' ' HD1' ' A' ' 58' ' ' TYR . 29.4 m -97.32 101.88 11.11 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.405 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 45.5 Cg_endo . . . . . 0 N--CA 1.445 -1.378 0 C-N-CA 124.469 3.446 . . . . 0.0 111.799 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 7.9 m-85 39.58 90.41 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.117 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 99.2 t -92.73 95.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.681 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.29 108.86 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.731 0.3 . . . . 0.0 111.773 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.777 HD22 HG22 ' A' ' 21' ' ' THR . 40.3 mt -95.6 110.81 22.86 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.95 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -101.7 104.52 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.888 0.375 . . . . 0.0 110.965 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.1 mtmt -107.79 101.36 40.05 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.339 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 54.0 Cg_exo -51.52 97.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.664 2.243 . . . . 0.0 112.74 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.599 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -62.89 -36.75 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -117.25 -172.62 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.569 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -133.31 125.71 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.831 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.32 -98.61 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.016 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.446 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 49.4 t-80 -122.09 105.57 10.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.74 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.7 m80 -124.41 159.98 29.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.429 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 52' ' ' LEU . 32.4 m -159.59 148.7 18.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.704 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.7 tp -120.46 91.52 3.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.53 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.4 mt-10 -75.86 88.63 2.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.24 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.3 mt -98.45 122.84 42.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.77 154.54 34.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.675 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' MET . 9.7 t80 -96.51 82.41 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.212 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 6.2 t -121.48 151.93 39.7 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 57.5 mtp180 -88.79 102.04 3.55 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.26 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 9.3 Cg_endo -52.99 -33.44 62.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.753 2.302 . . . . 0.0 112.429 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -64.52 -32.72 74.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.19 -72.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.24 38.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.996 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.6 mt -96.44 143.68 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.7 mtmt -137.93 163.06 50.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.146 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.3 Cg_endo -67.92 -38.76 12.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.762 2.308 . . . . 0.0 112.032 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.7 pt-20 -60.69 -28.99 69.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.566 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -54.74 147.49 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.024 179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -58.46 165.91 1.95 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.9 tpp180 -131.75 164.1 26.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.071 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 39.1 t80 -176.06 66.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.452 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 89' ' ' GLU . 18.2 m -90.07 97.46 11.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.061 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.3 tp -77.98 93.86 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.266 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.2 m-70 -77.63 144.0 37.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 14' ' ' VAL . 79.1 mt -144.64 104.56 4.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.627 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.9 t30 -81.03 61.53 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 16' ' ' THR . 2.1 t -43.33 131.18 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.569 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.929 179.851 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 15.4 m-20 -44.89 102.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.752 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.494 ' HE2' HG11 ' A' ' 14' ' ' VAL . 22.7 tptm -98.79 90.95 4.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.301 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.1 m95 -82.13 101.36 10.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.498 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 HD23 ' A' ' 110' ' ' LEU . 11.3 m -152.7 -175.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.407 0.622 . . . . 0.0 112.411 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -97.07 -174.29 2.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.286 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.464 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t -175.6 -175.69 0.8 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.188 0.518 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 38.8 m80 -114.12 -161.51 0.77 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.694 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.88 131.84 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 0.0 111.767 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 14.29 14.44 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.485 -0.779 . . . . 0.0 113.351 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.2 84.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.748 HG22 HD22 ' A' ' 77' ' ' LEU . 6.8 m -46.22 98.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.718 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.2 m -92.94 98.38 11.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.2 tt0 -80.22 133.92 36.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.034 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.538 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.7 mt -135.97 106.63 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.732 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -88.78 91.26 8.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.689 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.538 ' HG ' HG22 ' A' ' 24' ' ' ILE . 16.6 mt -88.27 144.62 26.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.269 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 73' ' ' ILE . 44.8 mttp -101.79 165.66 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.78 -134.15 2.78 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.505 0.193 . . . . 0.0 110.61 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 70.1 m-85 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.004 0.431 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.727 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 13.3 ttm -146.95 148.95 32.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.408 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.494 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -103.24 80.02 1.79 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.749 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.404 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 12.1 t -124.68 -164.74 1.3 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.344 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 5.9 mtp85 -87.19 135.82 33.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.045 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 91' ' ' VAL . 39.3 t -50.27 152.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.25 1.1 18.98 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HE2' HH21 ' A' ' 38' ' ' ARG . 24.8 m-85 -127.07 43.72 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.473 0.654 . . . . 0.0 110.536 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.4 p -80.0 98.19 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.061 179.593 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.7 mt . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.19 0.519 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.42 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.5 p -50.13 173.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.762 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.65 -87.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.16 -31.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.261 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 mm -73.59 -73.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.417 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 80' ' ' PRO . 53.3 mt -105.5 118.31 36.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.414 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.29 69.57 0.38 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.252 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 78' ' ' VAL . 12.4 t -76.19 86.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.178 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.8 t -82.79 87.4 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.427 ' SG ' HG22 ' A' ' 76' ' ' VAL . 40.2 t -101.63 130.56 47.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.726 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -121.27 110.26 15.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.937 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.48 110.63 17.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.556 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -115.09 110.67 45.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.653 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 N--CA 1.451 -1.029 0 C-N-CA 123.328 2.685 . . . . 0.0 112.21 179.181 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.0 pt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -126.35 102.4 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.088 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -88.97 106.03 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.988 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.6 t -107.89 122.13 61.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.12 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 21' ' ' THR . 82.9 mt -112.03 102.61 10.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.811 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.42 106.82 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -178.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -110.78 94.53 20.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.6 Cg_endo -48.29 107.24 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.16 . . . . 0.0 112.506 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.531 HH11 ' HA ' ' A' ' 50' ' ' GLU . 12.8 mtt180 -73.31 -43.67 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.149 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -108.87 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -110.09 146.91 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.773 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.95 -125.69 4.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.385 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.468 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 56.9 t-80 -110.63 106.06 15.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.468 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.2 m-70 -117.29 164.77 14.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' HD12 ' A' ' 52' ' ' LEU . 67.7 m -159.59 145.32 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.967 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.642 HD22 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -111.81 91.91 3.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.493 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.1 mt-10 -75.57 104.24 6.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 66.2 mt -112.97 132.28 55.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.5 p -138.09 155.48 29.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -93.42 76.39 4.48 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.664 ' HA ' HD22 ' A' ' 103' ' ' ASN . 5.6 t -105.71 155.11 19.58 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 28.1 mtp180 -86.24 104.18 5.12 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.475 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.0 Cg_endo -55.98 -30.08 76.44 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.756 2.304 . . . . 0.0 112.181 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.6 -25.78 61.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.836 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.5 -88.32 0.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.729 0.3 . . . . 0.0 111.655 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.53 -166.12 28.94 Favored Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.562 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.546 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.0 mt -103.17 145.11 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.834 0.35 . . . . 0.0 111.231 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -134.57 168.73 16.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.608 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.12 -38.96 11.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.725 2.283 . . . . 0.0 112.47 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.7 -1.8 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.439 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.664 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.3 m120 -76.18 141.26 41.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.746 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.1 tt0 -58.16 162.04 3.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.599 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.0 tpt180 -130.2 160.01 35.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.251 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.6 t80 -175.24 72.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.461 0.648 . . . . 0.0 109.472 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 89' ' ' GLU . 8.1 m -91.5 96.62 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.15 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.0 tp -75.97 91.73 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.9 m-70 -77.05 137.13 38.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.507 HD23 HG23 ' A' ' 14' ' ' VAL . 94.0 mt -143.73 112.7 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.375 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.526 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.1 t30 -86.7 85.51 7.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 17' ' ' HIS . 14.8 t -55.5 124.35 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.324 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 113' ' ' LYS . 3.2 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 107' ' ' THR . 25.5 t70 -144.34 -128.82 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.594 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 50.8 tptt -160.24 172.16 17.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 4.5 m0 -120.46 123.99 44.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.746 0.418 . . . . 0.0 110.334 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.3 m -150.68 159.21 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.673 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -50.4 168.2 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.313 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -174.19 -173.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.426 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 26.2 m80 -109.23 -168.58 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.625 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.83 138.45 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.151 0.501 . . . . 0.0 111.891 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.61 17.48 20.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.294 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.2 tptp -66.07 80.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -44.46 101.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.625 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 m -98.97 102.62 14.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.754 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.7 tt0 -80.2 127.56 32.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.584 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.529 HG22 ' HG ' ' A' ' 26' ' ' LEU . 48.1 mt -130.9 105.23 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.907 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -87.19 96.36 10.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.7 mt -91.12 145.6 24.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -100.46 162.99 12.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.68 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.76 -138.95 4.02 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.373 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t30 . . . . . 0 C--N 1.33 -0.282 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.815 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 88.3 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.79 150.05 29.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.7 m95 -103.04 82.9 2.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.673 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 42' ' ' VAL . 10.0 t -124.88 -174.73 3.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.643 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.3 mtp85 -83.12 150.63 26.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' VAL . 41.5 t -64.47 127.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.83 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.95 18.46 67.51 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.064 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.426 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 62.4 m-85 -138.02 0.86 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 110.652 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.656 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.6 p -47.05 125.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.257 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.859 179.778 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.7 mt . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.16 0.505 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 35.3 t -51.05 173.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.766 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -159.04 -85.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.256 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.07 -33.98 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.431 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.9 mm -67.42 -78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.607 ' O ' HG23 ' A' ' 54' ' ' VAL . 96.4 mt -106.42 119.3 38.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.94 72.29 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 HG13 ' A' ' 78' ' ' VAL . 7.6 t -80.81 86.18 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.498 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.52 85.7 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 76' ' ' VAL . 33.8 t -101.91 149.34 24.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.741 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -139.64 112.99 8.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.879 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.27 107.69 11.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.488 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.6 m -103.05 107.01 53.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.923 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 N--CA 1.445 -1.343 0 C-N-CA 123.647 2.898 . . . . 0.0 111.312 179.079 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -133.52 100.86 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.071 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -85.11 107.53 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 110.558 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.573 HG11 HD21 ' A' ' 88' ' ' LEU . 40.3 t -112.71 120.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 73.2 mt -108.58 99.84 9.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.55 108.55 21.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.457 . . . . 0.0 111.698 -178.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 31.7 mtmm -110.16 98.41 35.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.62 109.03 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.368 2.046 . . . . 0.0 112.778 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.4 mtt180 -81.06 -36.4 30.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.086 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -108.68 173.63 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.169 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 63.9 mtp180 -110.76 148.19 32.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.905 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.13 -164.52 13.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -70.5 102.0 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.687 0.28 . . . . 0.0 110.714 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.454 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 99.2 m-70 -128.04 149.95 50.15 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.483 0.659 . . . . 0.0 111.33 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.546 HG21 ' HB ' ' A' ' 107' ' ' THR . 40.3 m -150.95 146.81 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.483 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.604 ' HB2' HG11 ' A' ' 78' ' ' VAL . 20.9 tp -91.16 106.79 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.5 mt-10 -80.82 109.11 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.022 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 55.6 mt -119.03 143.2 47.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.067 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.19 161.57 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.398 0.618 . . . . 0.0 112.411 -179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.0 t80 -104.23 85.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.48 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.2 t -114.58 165.66 12.54 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 71.3 mtp180 -102.95 93.59 4.56 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 93' ' ' THR . 91.7 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.632 2.221 . . . . 0.0 112.627 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.89 -40.21 63.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.24 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -103.22 -68.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.92 -178.99 37.56 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.035 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.9 mt -90.75 144.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.999 0.428 . . . . 0.0 111.249 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG3' HD21 ' A' ' 103' ' ' ASN . 1.5 mttp -132.61 166.57 28.03 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.39 -40.78 29.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.853 2.369 . . . . 0.0 112.377 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.45 -13.01 35.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.553 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.612 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.82 134.77 56.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 111.45 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.74 164.67 2.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.072 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 2.1 ttp180 -139.79 158.48 44.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 0.0 111.649 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.848 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 47.4 t80 -162.65 103.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.009 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.656 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.7 OUTLIER -102.41 109.42 21.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.51 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 110' ' ' LEU . 25.9 tp -72.5 126.12 29.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.183 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 2.8 p80 -65.66 65.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.387 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.61 HD11 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -102.07 53.93 0.8 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 30.1 t30 -71.09 76.52 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.4 t -53.84 150.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.763 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 121.236 0.541 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HA ' ' N ' ' A' ' 107' ' ' THR . 1.2 p30 -54.86 104.07 0.11 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.286 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 108' ' ' LEU . 22.0 ptmt -101.79 119.69 39.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.028 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.79 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -103.71 111.94 24.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -148.31 -176.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.663 0.744 . . . . 0.0 112.882 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -93.8 -173.0 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.429 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -172.8 -174.54 1.13 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.416 0.627 . . . . 0.0 112.651 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 30.0 m80 -120.44 -148.52 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.382 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.7 t -108.93 128.13 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.589 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.13 20.18 19.62 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.262 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptp -65.95 84.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.672 HG22 HD12 ' A' ' 77' ' ' LEU . 6.4 m -47.17 102.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.851 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.3 m -98.98 93.62 6.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HA ' HD13 ' A' ' 77' ' ' LEU . 38.3 tt0 -78.11 127.95 33.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.156 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 38.2 mt -133.67 105.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.077 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.2 107.36 18.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 34.7 mt -103.16 149.05 25.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -101.14 161.46 13.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.251 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.04 -150.9 13.66 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.564 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.418 0.151 . . . . 0.0 110.63 179.945 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 44.6 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.086 0.47 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.552 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.4 ttm -150.71 152.32 33.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.543 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 42.7 m95 -100.06 90.7 4.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.693 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.6 t -136.92 -178.49 5.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.325 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HD2' HG21 ' A' ' 54' ' ' VAL . 14.8 mtp85 -83.46 160.1 21.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.972 0.415 . . . . 0.0 111.618 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 89' ' ' GLU . 59.0 t -70.68 141.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.918 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.7 2.99 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.079 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -124.7 -3.11 7.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.597 0.237 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HG21 ' A' ' 37' ' ' THR . 2.1 p -34.81 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.282 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.409 -179.677 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.0 mt . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.846 0.355 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.3 p -46.34 171.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.233 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.41 -85.23 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.3 pt-20 -129.37 -34.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.389 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.574 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -68.89 -76.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.241 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -105.0 118.47 36.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.81 66.31 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.153 0.502 . . . . 0.0 109.753 177.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.559 HG22 HG13 ' A' ' 78' ' ' VAL . 18.2 t -76.91 83.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.563 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 25.4 t -77.29 80.69 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.21 139.51 30.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.553 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -133.15 105.46 7.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.961 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.33 115.28 22.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.792 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 m -117.08 119.98 34.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.713 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 N--CA 1.45 -1.05 0 C-N-CA 123.23 2.62 . . . . 0.0 112.03 -179.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.948 0.404 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -138.48 98.65 3.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.405 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 77' ' ' LEU . 90.9 t -87.59 106.12 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.26 110.88 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 21' ' ' THR . 2.4 mm? -95.71 105.59 17.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.855 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -99.37 105.53 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.048 0.452 . . . . 0.0 111.212 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.8 mtmm -110.75 103.23 54.18 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.156 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 10.6 Cg_endo -55.1 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 15.0 mtt180 -81.15 -56.01 4.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.608 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -98.69 161.06 13.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.42 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -94.54 141.34 28.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.577 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.74 -116.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.579 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -129.57 99.98 5.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -108.04 164.78 11.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -157.74 149.91 22.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 78' ' ' VAL . 14.9 tp -123.11 87.35 2.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.252 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -86.98 93.96 9.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.057 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 77.1 mt -91.41 99.22 12.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.028 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -92.94 150.82 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.121 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.3 t80 -90.28 76.96 6.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.0 t -98.48 172.46 7.51 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 69.1 mtp180 -104.42 95.61 8.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.458 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HA ' HG22 ' A' ' 42' ' ' VAL . 66.5 Cg_exo -44.04 -27.58 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 112.651 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -37.19 20.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.391 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 13.9 mm-40 -103.65 -91.64 0.36 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 0.0 111.719 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.42 -178.76 39.84 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.281 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 93' ' ' THR . 11.7 mt -85.24 -77.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER 71.54 156.3 0.16 Allowed Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.966 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 37.8 Cg_endo -66.3 -35.01 33.51 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.795 2.33 . . . . 0.0 112.8 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' HD22 ' A' ' 103' ' ' ASN . 7.9 pt-20 -54.17 -17.94 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.524 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.55 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -86.67 140.16 30.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 111.467 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -64.91 -176.21 0.25 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.55 179.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -165.23 -164.47 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.552 0.692 . . . . 0.0 111.875 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 45.0 t80 -165.27 69.28 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.015 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -70.4 88.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.612 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.7 tp -83.59 92.03 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.653 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.9 m-70 -77.79 145.06 36.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 90.4 mt -144.36 92.77 2.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.269 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.538 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -64.68 85.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 17' ' ' HIS . 4.7 t -62.76 115.01 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.664 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.936 179.702 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.64 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 120.957 0.408 . . . . 0.0 111.492 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.594 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -33.24 104.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.921 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.98 96.75 10.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.124 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -79.68 100.76 8.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 HD23 ' A' ' 110' ' ' LEU . 27.4 m -146.7 -171.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.0 0.428 . . . . 0.0 112.113 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -107.02 -177.13 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.768 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.56 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.4 t -175.25 -175.81 0.87 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.218 0.533 . . . . 0.0 112.185 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.598 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 7.4 m80 -117.93 -165.35 1.09 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.954 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.44 132.77 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.19 0.519 . . . . 0.0 112.067 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.18 19.63 8.16 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.51 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.2 tptt -63.06 85.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 6.3 m -49.76 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.471 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 78' ' ' VAL . 50.2 m -94.73 99.81 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.489 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HA ' HD23 ' A' ' 77' ' ' LEU . 30.7 tt0 -76.2 132.84 40.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.838 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' CD2' ' A' ' 108' ' ' LEU . 31.1 mt -132.97 99.62 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.105 -179.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -84.03 98.25 9.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 38.0 mt -93.37 148.29 22.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.581 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -101.91 162.26 13.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.97 -143.87 7.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.417 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.458 0.17 . . . . 0.0 110.82 179.821 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 54.0 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.3 ttm -152.1 152.46 32.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.019 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 7.8 m95 -107.07 85.27 2.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.742 178.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.2 t -130.35 -163.61 1.33 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.7 mtp85 -91.25 139.58 30.61 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 111.269 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 26.5 t -53.99 133.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.056 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 -39.05 1.85 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.603 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 47' ' ' LEU . 55.2 m-85 -82.15 3.25 27.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.141 0.496 . . . . 0.0 110.62 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -53.29 110.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.223 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 -179.734 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 12.0 mt . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.843 0.354 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.9 t -59.24 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.5 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -147.99 -83.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.07 -28.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.602 -179.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.3 mm -76.11 -86.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.69 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.19 106.0 18.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.45 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 1.1 tm-20 -58.08 146.46 33.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 38' ' ' ARG . 46.3 t -145.6 90.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.2 t -77.04 85.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.21 129.67 37.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.808 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.709 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 50.9 mtpt -130.71 68.48 1.47 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.433 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -65.22 103.86 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.353 178.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 m -105.61 114.31 63.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.45 -1.083 0 C-N-CA 123.287 2.658 . . . . 0.0 111.912 179.667 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.3 pt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.6 OUTLIER -134.12 98.43 4.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 87.7 t -85.81 100.0 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.797 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 88' ' ' LEU . 26.5 t -103.54 116.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.039 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 91.3 mt -103.11 108.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.86 108.89 23.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.003 0.43 . . . . 0.0 111.519 -178.924 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 46.7 mtmt -114.11 95.95 40.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.469 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.41 106.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.253 1.969 . . . . 0.0 112.219 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 73.2 mtt180 -69.81 -30.22 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -123.53 -176.98 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -117.4 144.73 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.457 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.91 -129.26 4.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.388 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.453 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.7 m80 -105.92 91.73 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.921 0.391 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.4 OUTLIER -107.75 164.21 12.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.388 179.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.524 ' CG2' HG22 ' A' ' 107' ' ' THR . 71.0 m -160.26 157.25 27.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 111.784 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 78' ' ' VAL . 51.7 tp -118.96 87.66 2.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.284 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.686 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.3 mt-10 -69.46 95.89 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.804 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.655 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 51.9 mt -108.51 127.28 53.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.0 p -133.18 157.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.739 -178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.4 t80 -99.13 88.82 4.05 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.239 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 42' ' ' VAL . 5.9 t -121.41 169.37 10.69 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -101.49 95.94 5.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.951 178.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 93' ' ' THR . 96.0 Cg_exo -44.26 -30.69 3.74 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.662 2.241 . . . . 0.0 112.607 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.65 -40.61 63.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -97.05 -76.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.98 173.11 31.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.195 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.6 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.7 mt -86.03 151.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.847 0.356 . . . . 0.0 111.256 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.581 ' HE3' HD21 ' A' ' 103' ' ' ASN . 40.6 mtmt -145.09 166.22 18.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.42 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 27.1 Cg_exo -62.74 -46.47 11.11 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.029 2.486 . . . . 0.0 112.009 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.431 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.6 pt-20 -58.16 -29.77 65.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.053 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.581 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -53.78 146.07 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.73 164.32 4.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.4 tpp180 -131.61 163.0 29.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.297 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.651 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.1 t80 -174.26 71.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.177 177.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.01 90.96 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.383 -178.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.1 tp -72.18 93.71 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 24.5 m-70 -78.97 145.29 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.569 HD23 HG23 ' A' ' 14' ' ' VAL . 75.0 mt -145.89 110.04 4.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.474 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 2.5 t-20 -82.03 69.29 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.457 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.34 117.93 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.64 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.946 179.725 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.008 0.432 . . . . 0.0 111.466 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.57 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 6.1 p-10 -85.94 98.37 10.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.711 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.573 ' HD3' HD13 ' A' ' 108' ' ' LEU . 51.4 tttp -111.41 76.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.748 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 5.5 m0 -86.91 108.9 18.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.679 -178.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.94 -171.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.628 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.4 p-10 -97.84 177.46 5.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.08 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.465 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -173.92 -174.66 0.96 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.012 0.434 . . . . 0.0 111.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 60.7 m80 -122.94 -173.98 2.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.919 179.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 83' ' ' ARG . 22.5 t -72.49 134.58 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.166 0.508 . . . . 0.0 112.309 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.19 15.87 12.2 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.944 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.0 tptt -58.13 86.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.279 0.539 . . . . 0.0 109.944 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.78 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -57.43 101.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.519 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -98.5 100.8 12.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.637 ' HA ' HD23 ' A' ' 77' ' ' LEU . 32.3 tt0 -72.42 131.83 43.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.71 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 42.6 mt -128.18 87.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.298 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.499 ' NE2' HG22 ' A' ' 75' ' ' VAL . 8.8 m170 -86.99 106.95 18.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 19.1 mt -101.31 174.12 6.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 111.575 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -119.55 160.94 21.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.767 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.62 -163.59 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.954 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.4 t30 . . . . . 0 C--N 1.331 -0.226 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 179.887 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 2.1 m-85 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 14.5 ttm -114.79 151.02 34.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 66.6 m95 -105.89 99.57 9.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.034 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.731 HG23 HG22 ' A' ' 42' ' ' VAL . 5.9 t -147.78 -176.58 5.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.658 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.674 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.9 mtp85 -82.88 157.12 23.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.024 0.44 . . . . 0.0 111.404 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 91' ' ' VAL . 19.7 t -57.97 130.85 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.595 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -41.75 1.83 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.146 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 57.9 m-85 -70.21 -4.61 22.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 0.0 111.037 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 93' ' ' THR . 21.9 t -49.71 121.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.276 -179.805 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.7 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 121.098 0.475 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.52 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 83.2 p -52.99 179.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.702 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.07 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -128.89 -42.5 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.126 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.2 mm -62.55 -76.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.7 mt -103.98 118.57 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.495 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -72.65 65.01 0.66 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.124 0.488 . . . . 0.0 109.77 177.646 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 ' HD2' ' A' ' 38' ' ' ARG . 12.0 t -71.08 84.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.58 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.5 t -80.05 85.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 18.6 t -103.82 123.49 47.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.86 -178.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -116.94 106.81 13.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.683 178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.512 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -74.17 103.62 4.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.482 179.853 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 20.2 m -100.35 112.58 64.55 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 3.8 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 123.279 2.652 . . . . 0.0 111.506 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 121.108 0.48 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.6 m-85 50.25 90.17 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.386 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 73' ' ' ILE . 72.8 t -97.94 107.21 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.777 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 11.9 t -112.99 109.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.821 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.78 HD22 HG22 ' A' ' 21' ' ' THR . 72.3 mt -102.64 99.38 9.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.042 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.3 105.69 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 0.0 111.192 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.8 mtmp? -109.19 94.57 15.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.664 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.9 Cg_endo -49.75 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.686 2.258 . . . . 0.0 112.855 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 11.8 mtt180 -74.56 -35.33 63.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.915 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 51' ' ' ILE . 4.2 mptp? -108.03 150.28 27.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.15 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HG2' HG22 ' A' ' 18' ' ' VAL . 49.7 mtm180 -94.28 129.69 40.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 148.53 -116.91 0.84 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -130.77 120.04 23.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -131.57 -178.7 4.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.683 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 88' ' ' LEU . 53.4 m -158.25 156.28 30.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.705 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.508 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.2 tp -133.04 85.7 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.617 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -84.76 88.25 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.089 0.471 . . . . 0.0 111.105 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 76' ' ' VAL . 88.7 mt -83.47 103.05 12.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -84.21 145.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.075 0.464 . . . . 0.0 111.98 -178.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' MET . 13.5 t80 -95.18 76.22 3.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.792 HG21 HG21 ' A' ' 42' ' ' VAL . 8.0 t -117.4 155.92 28.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 71.6 mtp180 -92.33 103.56 8.82 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.71 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.1 Cg_endo -51.51 -37.45 62.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.865 2.377 . . . . 0.0 112.776 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -78.91 12.87 1.95 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.477 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -147.26 3.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.259 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.93 179.18 49.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.831 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -105.37 156.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.047 0.451 . . . . 0.0 111.716 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mtmt -139.05 162.84 50.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.0 Cg_endo -72.18 -37.11 4.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.711 2.274 . . . . 0.0 112.212 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.21 -25.94 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.05 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.487 HD21 ' HE3' ' A' ' 100' ' ' LYS . 13.7 m120 -58.48 136.77 57.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -64.45 -175.13 0.15 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.2 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -163.26 -159.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 179.712 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 80.9 t80 -165.59 72.81 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 1.2 m -69.78 105.81 2.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.366 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.573 HD13 ' HD3' ' A' ' 12' ' ' LYS . 18.2 tp -106.71 94.49 5.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.727 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.5 m-70 -76.65 153.58 35.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.276 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.4 mt -146.92 99.74 3.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.693 -178.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.8 t30 -74.79 68.56 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.3 t -50.19 122.07 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.436 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' THR . 31.9 mmmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.856 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 3.9 p30 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 111.753 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 107' ' ' THR . 22.9 t70 -136.36 -119.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 22.2 tptm -158.02 171.87 19.46 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.416 0.15 . . . . 0.0 110.662 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.62 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 7.3 m0 -124.39 121.7 35.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.657 0.383 . . . . 0.0 110.749 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.9 m -152.5 -171.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 2.6 p-10 -80.49 175.75 10.38 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.397 0.436 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 110' ' ' LEU . 2.5 t -172.01 -173.66 1.16 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 78.5 m80 -108.37 -177.99 3.48 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.485 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.02 136.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.119 0.485 . . . . 0.0 111.765 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.78 10.75 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.388 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.4 tptm -63.96 82.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.735 HG22 HD22 ' A' ' 77' ' ' LEU . 9.6 m -39.49 99.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.678 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.5 m -92.75 96.88 10.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.7 tt0 -80.62 132.17 35.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.38 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.575 HD11 HD21 ' A' ' 108' ' ' LEU . 38.9 mt -134.21 104.55 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -86.97 98.73 11.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 12.9 mt -91.69 145.7 24.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.378 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -95.32 161.78 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.93 -139.35 5.28 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 120.516 0.198 . . . . 0.0 110.54 179.847 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.051 0.453 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 1.5 ttt -149.35 147.93 28.9 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.118 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 2.8 m95 -105.07 86.58 2.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.74 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.418 ' HB ' ' HE2' ' A' ' 35' ' ' MET . 14.6 t -130.46 -171.97 2.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.613 HH11 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -71.58 144.92 49.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.761 0.315 . . . . 0.0 110.807 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 91' ' ' VAL . 77.4 t -60.73 137.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.956 0.407 . . . . 0.0 111.413 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.31 -1.72 8.51 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.058 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.31 40.14 2.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 110.766 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.6 p -82.18 128.27 38.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.099 179.643 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 29.8 mt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.352 0.596 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 78.9 p -51.98 176.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.089 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -153.75 -90.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -131.26 -31.93 1.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.4 mm -71.22 -73.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.389 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 78' ' ' VAL . 28.1 mt -111.58 123.46 50.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.7 73.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -77.79 92.85 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.5 t -96.96 86.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.382 177.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.7 t -107.08 142.19 37.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -119.37 115.67 24.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.403 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.554 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.78 100.6 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 116.16 65.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.084 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 C-N-CA 123.277 2.651 . . . . 0.0 113.2 -179.141 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.3 pt . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.191 0.52 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.57 106.26 6.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.852 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.77 117.96 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.212 0.53 . . . . 0.0 110.548 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 78' ' ' VAL . 23.5 t -113.39 126.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.874 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.735 HD22 HG22 ' A' ' 21' ' ' THR . 63.1 mt -111.4 90.93 3.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -93.07 108.86 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.178 0.513 . . . . 0.0 111.645 -178.226 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.2 mtmt -107.25 95.81 14.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 79' ' ' LYS . 2.1 Cg_endo -47.03 108.23 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.591 2.194 . . . . 0.0 112.592 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 21.9 mtt180 -76.14 -33.93 59.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -116.27 171.43 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.033 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 68.5 mtp180 -110.1 146.56 35.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.845 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.58 -170.42 21.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.5 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -70.98 104.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 110.576 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 96.8 m-70 -130.09 142.48 50.6 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.782 0.801 . . . . 0.0 111.676 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 96.2 m -138.24 127.32 24.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.613 HD21 HH11 ' A' ' 38' ' ' ARG . 15.6 tp -93.81 99.72 12.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.113 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 39' ' ' VAL . 35.1 mt-10 -76.69 124.6 27.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.436 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.502 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.0 mt -115.56 165.83 12.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.6 p -156.14 154.38 6.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.2 t80 -103.34 86.88 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.635 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.655 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.8 t -115.83 167.0 11.34 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -103.07 94.36 5.41 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 93' ' ' THR . 90.3 Cg_exo -46.8 -29.91 8.66 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.572 2.181 . . . . 0.0 112.565 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -73.19 -37.04 66.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -106.61 -74.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 111.327 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.91 -174.68 44.73 Favored Glycine 0 CA--C 1.508 -0.345 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.296 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.655 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -96.91 145.56 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.871 0.367 . . . . 0.0 111.153 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -130.76 166.74 25.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.633 -179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.14 -44.78 4.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.893 2.395 . . . . 0.0 112.34 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.06 -14.92 27.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.472 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.571 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -58.58 139.96 55.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -179.786 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 174.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.141 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -155.0 158.62 39.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.554 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 24.3 t80 -152.96 108.53 3.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.49 178.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.62 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.8 OUTLIER -98.15 130.88 44.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.621 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 24' ' ' ILE . 14.0 mt -89.92 126.43 35.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.337 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.689 ' HB2' HG22 ' A' ' 14' ' ' VAL . 1.7 p80 -72.0 57.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.609 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.42 ' HB3' HG21 ' A' ' 16' ' ' THR . 52.6 mt -103.98 80.31 1.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.654 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 17.8 t30 -94.35 59.11 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.1 t -33.41 130.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.695 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 14.6 mmmm . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.995 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.577 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 112.204 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -53.24 99.97 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.841 -178.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -89.61 91.63 8.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.472 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -73.75 99.81 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.512 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.511 HG23 HD23 ' A' ' 110' ' ' LEU . 29.3 m -149.69 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.987 -178.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.2 p-10 -111.88 -175.14 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.508 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.2 t -174.47 -177.22 1.18 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.104 0.478 . . . . 0.0 112.075 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 72.9 m80 -111.96 -159.64 0.69 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.841 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 41.9 t -97.6 128.01 49.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 0.0 111.929 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 71.73 7.51 65.59 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.674 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -56.75 85.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.293 0.547 . . . . 0.0 109.734 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.81 HG22 HD22 ' A' ' 77' ' ' LEU . 3.5 m -58.19 93.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.293 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 78' ' ' VAL . 99.5 m -85.83 99.71 11.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.546 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.3 tt0 -82.72 129.62 34.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 46.0 mt -134.61 107.35 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.926 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -88.76 96.84 10.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.28 178.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.0 mt -91.43 148.22 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.418 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -102.56 161.07 14.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.86 -145.81 7.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.487 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.51 0.195 . . . . 0.0 110.984 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 121.166 0.507 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 5.5 ttm -155.85 152.12 27.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 8.0 m95 -106.92 85.38 2.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.552 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.3 t -129.9 -165.47 1.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.377 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.2 mtp85 -89.2 151.51 22.12 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.861 0.362 . . . . 0.0 110.977 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.8 t -72.14 133.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.497 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.56 3.51 90.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 60.0 m-85 -129.3 -0.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 110.462 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 17.3 t -55.27 109.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.141 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.172 -179.751 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.216 0.531 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.419 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 33.4 t -50.39 175.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.565 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -155.75 -86.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.81 -34.04 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.0 mm -70.33 -76.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.364 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -101.19 112.23 24.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.501 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 3.0 tt0 -66.01 78.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 109.832 178.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG22 HG13 ' A' ' 78' ' ' VAL . 8.5 t -86.51 90.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.325 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.9 t -86.31 86.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.0 t -101.43 124.97 47.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.652 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -115.79 109.45 17.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.553 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -79.77 121.02 24.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.309 -179.784 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 118.96 31.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 C-N-CA 123.164 2.576 . . . . 0.0 112.856 -179.312 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.8 pt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.06 0.457 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -136.01 105.81 6.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.979 179.989 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -90.27 104.57 15.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.01 120.16 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.927 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -111.2 99.9 8.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.892 178.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.74 102.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.053 0.454 . . . . 0.0 110.994 -179.085 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 38.2 mtmt -104.18 104.0 41.54 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.2 Cg_exo -51.43 98.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.406 2.071 . . . . 0.0 112.446 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 7.4 mtt180 -69.82 -41.72 74.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -115.54 165.43 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.092 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -100.87 119.22 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.635 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.38 -150.45 21.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.363 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.474 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 55.4 t-80 -86.84 101.74 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.11 0.481 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.497 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 2.0 m-70 -117.12 165.82 12.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 57.6 m -159.84 148.64 17.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 111.945 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 78' ' ' VAL . 11.6 tp -114.52 93.33 4.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.245 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.0 mt-10 -77.12 98.23 4.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.045 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 51.1 mt -107.69 130.33 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.4 p -135.68 156.05 37.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.965 -178.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.3 t80 -99.88 86.73 3.34 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.104 178.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.5 t -120.35 169.34 10.38 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.11 94.85 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.4 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.6 Cg_exo -42.22 -35.61 3.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.839 2.36 . . . . 0.0 112.755 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -68.52 -44.04 75.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.564 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.77 -79.31 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.81 177.18 40.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.105 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.741 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -92.11 151.31 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.934 0.397 . . . . 0.0 111.292 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.596 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 10.0 mttm -141.43 163.15 43.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.125 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 38.8 Cg_endo -67.6 -40.18 10.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.264 . . . . 0.0 112.133 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.401 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.2 pt-20 -62.05 -28.09 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.543 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -55.36 148.75 14.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.003 179.704 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.92 160.7 3.36 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpt180 -130.18 162.9 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.219 -179.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.581 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -176.53 69.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.453 0.644 . . . . 0.0 109.677 177.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 12.4 m -91.52 91.33 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.517 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 41.0 tp -71.45 94.36 1.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.524 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -78.22 143.31 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.661 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 14' ' ' VAL . 85.2 mt -145.85 104.64 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.807 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 45.6 t30 -78.42 68.91 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.635 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.5 t -48.75 127.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.65 -178.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.976 179.988 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.632 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 121.063 0.459 . . . . 0.0 111.541 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' THR . 1.2 m-20 -47.65 104.52 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.284 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -97.24 92.72 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.141 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.676 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.09 104.02 12.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 12' ' ' LYS . 4.5 m -150.95 -173.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 112.136 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -101.41 176.7 5.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.819 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.522 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -175.49 -177.1 0.96 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.572 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.9 m-70 -120.82 -166.16 1.3 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.968 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -87.19 136.59 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 112.111 -179.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.59 12.16 32.32 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.628 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tptt -59.79 83.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.182 0.491 . . . . 0.0 109.782 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -54.93 98.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.424 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 100.0 m -96.2 101.18 12.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.6 tt0 -82.44 132.7 35.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.799 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.454 HD11 HD22 ' A' ' 108' ' ' LEU . 45.6 mt -134.97 101.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.961 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -83.67 98.91 9.9 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 14.5 mt -92.61 148.73 21.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -102.9 159.93 15.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.844 0.354 . . . . 0.0 110.399 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 -161.64 34.18 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 C--N 1.33 -0.271 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.715 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.454 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 25.0 ttm -108.53 151.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.306 179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 5.7 m95 -109.88 85.03 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.653 178.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -132.65 -166.95 1.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -93.04 122.52 35.5 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.5 p -53.16 138.78 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.178 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.47 -4.59 77.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.743 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.441 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 48.8 m-85 -130.78 3.14 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.286 0.565 . . . . 0.0 110.037 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 93' ' ' THR . 18.2 t -52.12 119.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.095 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.004 -179.447 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.8 mt . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.874 0.369 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 40.8 t -49.28 179.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.142 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -152.55 -88.84 0.06 Allowed 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.59 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -136.11 -31.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.397 -179.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.1 mm -73.21 -72.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.438 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.1 mt -105.13 114.37 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.472 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.13 72.1 0.1 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 38' ' ' ARG . 10.9 t -76.39 84.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.324 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.7 t -80.2 81.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.3 t -94.81 146.84 23.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.315 -178.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -138.82 113.18 8.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.36 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.85 104.86 15.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.274 179.373 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.8 m -101.83 109.63 60.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.618 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.079 0 C-N-CA 123.533 2.822 . . . . 0.0 111.652 179.316 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -135.78 95.38 3.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.941 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.6 p -87.97 111.81 22.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.536 0.684 . . . . 0.0 110.602 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 90' ' ' LEU . 38.7 t -108.88 122.91 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.53 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 81.3 mt -108.46 99.23 8.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.808 178.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.49 106.2 17.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.999 0.428 . . . . 0.0 111.145 -178.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -108.1 102.15 44.79 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.344 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.649 ' HA ' HD23 ' A' ' 52' ' ' LEU . 70.0 Cg_exo -49.93 98.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.747 2.298 . . . . 0.0 112.81 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -67.57 -37.25 82.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -120.99 -178.81 3.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HE ' HG21 ' A' ' 18' ' ' VAL . 95.7 mtt180 -115.17 124.86 52.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.523 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.78 -142.8 9.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.576 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.495 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 61.9 m80 -87.34 91.65 8.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.495 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.6 OUTLIER -111.65 154.5 24.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.412 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.553 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 62.9 m -158.55 146.23 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.932 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.6 tp -96.72 92.24 6.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.072 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.708 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.2 mt-10 -72.77 94.19 1.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.166 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 40.0 mt -111.53 127.41 55.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.8 p -128.95 158.57 41.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.511 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -99.17 83.33 2.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.429 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 42' ' ' VAL . 10.0 t -117.5 150.83 38.28 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 41.5 mtp180 -91.49 104.49 10.16 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 178.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.9 Cg_exo -39.79 -31.99 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.055 2.503 . . . . 0.0 113.168 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.441 ' HD2' ' HG3' ' A' ' 97' ' ' GLU . 6.7 t80 -77.02 -60.08 2.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG3' ' HD2' ' A' ' 96' ' ' PHE . 36.9 mt-10 -67.91 -64.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.894 0.378 . . . . 0.0 111.301 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.3 -179.78 20.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.813 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.5 mt -93.86 148.07 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.918 0.389 . . . . 0.0 111.472 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 26.2 mtmm -147.82 162.64 30.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.115 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.8 Cg_endo -67.75 -37.1 16.91 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.797 2.331 . . . . 0.0 112.012 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.06 -29.34 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.2 m120 -58.21 154.36 13.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 164.41 4.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.245 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.657 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.7 tpp180 -132.24 165.95 22.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.0 t80 -174.57 74.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.297 177.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.93 94.29 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.418 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.3 tp -72.86 93.17 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.016 0.436 . . . . 0.0 110.656 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 40.8 m-70 -75.19 146.02 41.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.668 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.4 mt -145.69 120.21 9.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.568 -178.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.7 t30 -86.31 63.07 7.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.523 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -44.74 122.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.729 -178.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.093 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.662 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.054 0.455 . . . . 0.0 111.267 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.469 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -32.44 108.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.705 179.906 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -87.17 93.7 9.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.622 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.5 m95 -75.74 98.52 4.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 110' ' ' LEU . 28.4 m -149.42 -172.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 112.245 -178.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -112.37 179.0 4.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.455 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.501 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.88 -172.77 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 112.046 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.8 m-70 -117.62 -171.15 2.0 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 10.1 p -83.44 142.51 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.79 18.67 8.64 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.669 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptm -65.49 80.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 4.6 m -50.5 97.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.422 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.3 m -94.67 104.63 16.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.827 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.2 tt0 -86.91 129.72 34.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.803 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mt -132.48 104.63 7.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.64 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -85.03 96.36 9.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.0 mt -89.27 145.91 25.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.398 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -97.66 161.99 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.847 0.356 . . . . 0.0 110.399 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.16 -137.13 4.11 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.499 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.1 t30 . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.889 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 121.082 0.468 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -151.71 151.79 31.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.931 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -108.39 87.08 2.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.347 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 42' ' ' VAL . 15.3 t -130.39 -170.98 2.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.832 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.687 HH21 HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -76.27 137.89 40.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 91' ' ' VAL . 49.0 t -57.1 136.32 20.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.387 -179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.11 -13.81 1.8 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.776 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 39' ' ' VAL . 14.6 m-30 -105.62 22.08 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.341 0.591 . . . . 0.0 110.49 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -76.16 107.13 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.148 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.286 -179.854 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HH21 ' A' ' 38' ' ' ARG . 22.6 mt . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -50.42 173.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.979 178.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -150.46 -95.73 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.618 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.09 -33.11 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.9 mm -73.38 -72.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.19 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.688 ' HB3' HG12 ' A' ' 78' ' ' VAL . 77.2 mt -107.6 117.86 35.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.322 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -70.36 73.03 0.49 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.651 HG11 ' NH1' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -76.38 91.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 22.4 t -93.34 87.97 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.328 177.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 76' ' ' VAL . 8.1 t -110.0 144.83 37.98 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.935 -178.46 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -122.9 115.89 22.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.647 178.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.466 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -85.14 105.85 16.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.449 179.466 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 4.3 m -103.0 126.28 32.88 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.45 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 2.6 Cg_endo . . . . . 0 N--CA 1.457 -0.655 0 C-N-CA 123.01 2.473 . . . . 0.0 113.178 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 121.195 0.521 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -136.2 98.68 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.81 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.5 p -90.21 111.34 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.298 0.571 . . . . 0.0 110.625 -179.266 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 56' ' ' CYS . 46.2 t -107.18 124.55 63.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.923 -178.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 71.5 mt -111.63 92.95 4.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 177.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -91.73 110.72 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.223 -178.775 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.7 mtmp? -107.84 101.96 43.08 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.226 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 71.4 Cg_exo -48.22 99.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.707 2.271 . . . . 0.0 113.066 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.1 mtt180 -69.34 -31.44 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 91.8 mttt -121.25 170.69 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.767 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -115.66 128.45 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 135.65 -152.92 21.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.183 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -65.9 106.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.498 . . . . 0.0 110.639 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 29.7 m-70 -138.04 160.59 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.619 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.506 ' CG2' HG22 ' A' ' 107' ' ' THR . 87.0 m -160.17 148.27 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 111.774 -179.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -110.03 101.55 10.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.878 179.194 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 107' ' ' THR . 40.1 mt-10 -79.35 115.75 19.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.678 HD21 ' NH1' ' A' ' 38' ' ' ARG . 29.4 mt -121.84 151.49 40.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.2 p -154.26 153.6 8.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.094 0.473 . . . . 0.0 111.899 -178.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.2 t80 -100.7 91.97 4.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.996 178.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 42' ' ' VAL . 8.5 t -126.69 166.1 18.0 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -177.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.7 mtp180 -98.63 97.52 4.92 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.643 178.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.5 Cg_exo -46.14 -40.74 21.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.8 2.333 . . . . 0.0 113.415 -179.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.47 17.34 3.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.1 mm-40 -150.57 0.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.29 -178.96 50.69 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.264 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.745 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.8 mt -108.7 151.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.075 0.464 . . . . 0.0 112.031 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.554 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 16.2 mttt -128.39 166.78 22.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.767 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.65 -40.91 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.858 2.372 . . . . 0.0 112.146 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.16 -24.77 67.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.199 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.554 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -49.38 148.75 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 179.859 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -61.77 166.11 4.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.433 -179.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.702 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.3 tpp180 -134.78 163.73 29.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.386 -178.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.702 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 30.8 t80 -172.31 80.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.223 177.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.46 93.68 6.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.654 -178.882 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 47.7 tp -66.77 83.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 25.9 m-70 -69.89 136.16 50.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.6 mt -143.41 109.82 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.474 -178.058 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 60.7 t30 -85.24 54.05 2.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.613 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -35.74 135.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.863 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.9 mmpt? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.677 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.1 p-10 . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 14.8 m-20 -48.49 97.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.126 -178.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HD3' HD13 ' A' ' 108' ' ' LEU . 52.9 tttp -100.84 92.04 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.679 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -80.69 104.69 11.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.59 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.8 p -151.29 -179.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.988 0.423 . . . . 0.0 111.694 -179.03 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.776 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -99.45 -179.14 4.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.489 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.54 -173.45 0.75 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.152 0.501 . . . . 0.0 112.111 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 19.4 m80 -115.4 -170.31 1.74 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.09 132.39 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 112.054 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.11 11.97 34.9 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.39 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -64.81 82.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.733 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.16 99.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.568 -178.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' HG23 ' A' ' 78' ' ' VAL . 54.9 m -93.82 96.22 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.8 tt0 -73.99 132.34 42.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.718 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.4 102.0 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.249 -179.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -85.64 99.64 11.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 35.5 mt -94.29 147.6 23.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.752 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -99.81 164.75 11.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.73 -134.21 3.14 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.536 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.3 t30 . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 179.925 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.085 0.469 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.4 ttm -147.82 154.09 40.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.816 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.445 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 4.6 m95 -110.42 88.15 2.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.922 178.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.4 t -133.54 -163.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.8 mtp85 -90.18 158.38 17.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.812 0.339 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.9 t -77.23 132.03 33.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.656 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.47 9.3 86.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 63.1 m-85 -134.02 -1.75 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.206 0.527 . . . . 0.0 110.538 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -51.71 116.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.115 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.235 -179.743 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 22.8 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.059 0.457 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 54' ' ' VAL . 55.6 p -62.1 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.572 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -151.73 -82.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.96 -30.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.371 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.1 mm -74.25 -85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.491 -179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.99 108.76 21.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.43 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 10.5 tt0 -61.62 140.89 58.09 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.521 HG21 ' HD2' ' A' ' 38' ' ' ARG . 59.2 t -141.06 89.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.87 0.367 . . . . 0.0 111.753 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.9 t -73.7 94.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -72.16 115.07 10.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.125 -178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 99.4 mttt -121.37 43.92 2.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -66.13 106.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.543 178.726 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -101.37 117.39 62.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.327 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.452 -0.918 0 C-N-CA 123.17 2.58 . . . . 0.0 112.402 -179.499 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 11.8 pt . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.234 0.54 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -124.97 103.41 8.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.961 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 84.9 t -92.98 100.17 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.063 0.459 . . . . 0.0 110.547 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.76 118.9 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.135 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.733 HD22 HG22 ' A' ' 21' ' ' THR . 81.5 mt -103.82 105.59 15.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.754 178.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.72 100.99 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.032 0.444 . . . . 0.0 110.992 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -105.53 102.57 38.53 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.449 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 37.3 Cg_exo -55.96 98.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.241 1.961 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.69 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 70.3 mtt180 -62.26 -34.63 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -124.29 179.69 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -118.28 144.11 46.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.591 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.34 -111.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.556 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -116.25 96.66 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 111.031 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.33 163.26 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.512 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 88' ' ' LEU . 30.1 m -160.08 157.93 29.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 111.712 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.0 tp -126.14 89.09 2.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.2 mt-10 -73.85 93.9 2.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.123 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 56.3 mt -103.38 134.27 47.03 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 104' ' ' GLU . 8.3 p -139.52 154.86 25.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 111.83 -178.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.9 t80 -97.85 90.37 4.92 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.919 HG21 HG21 ' A' ' 42' ' ' VAL . 5.8 t -120.02 173.02 7.33 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -103.22 95.05 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.861 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 93' ' ' THR . 89.1 Cg_exo -46.8 -30.5 9.44 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.626 2.218 . . . . 0.0 112.682 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.67 -37.24 62.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.22 -79.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.35 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.4 178.48 43.4 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.18 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.1 mt -95.45 154.66 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.454 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.7 mttt -140.72 161.65 53.18 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -71.15 -39.01 4.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.93 -28.07 69.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -54.72 152.27 7.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.215 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.4 tt0 -52.89 156.14 2.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.677 ' HB3' HD22 ' A' ' 10' ' ' ASN . 15.9 tpp180 -127.71 164.94 21.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.528 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.594 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 54.2 t80 -176.64 64.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 109.52 177.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 89' ' ' GLU . 11.1 m -87.12 92.9 9.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.866 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.4 tp -74.75 95.63 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.301 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.3 m-70 -79.72 144.02 34.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.773 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 79.6 mt -144.44 106.55 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.352 -178.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -82.79 65.65 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.591 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -42.73 136.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.568 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.649 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.932 0.396 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 7.5 p-10 -54.7 100.02 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -115.09 60.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.718 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 4.9 m0 -78.25 119.24 21.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.401 -177.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.9 -174.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.429 0.633 . . . . 0.0 112.317 -178.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -94.07 177.16 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.58 179.771 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -176.31 176.36 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.111 0.481 . . . . 0.0 112.265 179.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.583 ' O ' HG13 ' A' ' 112' ' ' VAL . 31.6 m-70 -114.52 -153.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.683 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.3 128.8 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 111.797 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 64.37 13.36 54.3 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.33 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.7 tptm -57.27 86.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.79 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -56.86 97.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.033 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -87.92 104.88 17.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.448 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.1 tt0 -89.26 129.24 35.85 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.181 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 HD12 ' A' ' 26' ' ' LEU . 25.0 mt -141.41 109.85 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -85.38 113.22 21.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.272 179.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mp -104.96 162.28 13.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.4 mptt -119.42 158.6 25.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.92 -141.19 3.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 120.426 0.155 . . . . 0.0 111.052 179.989 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.407 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 58.6 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.019 0.437 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 9.5 ttm -146.53 146.38 30.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.174 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -97.36 80.63 2.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 178.882 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.9 t -121.94 -170.5 2.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 -179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.871 ' NH2' HD12 ' A' ' 47' ' ' LEU . 1.9 ttm-85 -81.84 137.58 35.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 91' ' ' VAL . 71.6 t -54.38 140.18 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.841 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.12 4.47 4.67 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.642 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -123.4 25.65 8.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' HG21 ' A' ' 93' ' ' THR . 6.4 p -67.82 130.68 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.994 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.945 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.871 HD12 ' NH2' ' A' ' 38' ' ' ARG . 12.3 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.59 0.233 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 83.1 p -58.82 -171.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 179.112 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.02 -92.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.439 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.629 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -129.89 -33.32 1.8 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.561 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.8 mm -63.94 -64.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB3' HG12 ' A' ' 78' ' ' VAL . 81.7 mt -122.39 124.21 43.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -71.73 68.89 0.64 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.45 178.482 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -78.86 132.45 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.169 0.509 . . . . 0.0 110.992 -179.661 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.1 t -131.78 85.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.18 179.601 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.632 ' H ' HH22 ' A' ' 38' ' ' ARG . 10.4 t -99.19 111.86 24.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.538 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -95.99 112.66 24.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.423 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.36 108.3 14.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.212 179.392 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 26.5 m -120.69 128.42 25.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 3.0 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 123.428 2.752 . . . . 0.0 111.179 178.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.5 pt . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.347 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 4.3 m-85 -141.35 103.14 4.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.639 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 63.4 t -86.25 93.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.3 t -88.58 124.59 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.796 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.79 HD22 HG22 ' A' ' 21' ' ' THR . 77.1 mt -120.12 93.34 4.02 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.18 103.97 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.943 0.402 . . . . 0.0 110.915 -179.148 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.7 mtmt -101.93 98.25 9.65 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -46.42 106.7 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.758 2.305 . . . . 0.0 112.721 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.629 HH11 ' HA ' ' A' ' 50' ' ' GLU . 9.1 mtt180 -79.44 -48.62 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 62.3 mttm -102.91 156.52 17.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -95.32 123.5 38.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.21 -153.72 25.14 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.493 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -90.33 104.13 16.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.471 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 15.6 m-70 -122.28 179.2 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 88' ' ' LEU . 94.8 m -160.12 155.26 24.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.086 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 78' ' ' VAL . 1.5 tm? -131.46 93.4 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -104.61 121.37 43.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.98 -179.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 76' ' ' VAL . 39.2 mt -99.0 171.84 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.478 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.1 p -160.34 151.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.107 0.48 . . . . 0.0 112.272 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -94.4 85.19 4.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.146 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.635 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.7 t -107.7 172.1 7.02 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -104.57 94.04 6.71 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.8 Cg_exo -49.6 -30.89 23.08 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.408 2.072 . . . . 0.0 112.382 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -74.6 -35.35 62.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -107.95 -77.89 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.319 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.95 -173.72 46.52 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.127 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.3 mt -96.68 148.72 5.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 4.4 mttt -133.75 174.03 5.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.41 -38.16 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.405 2.07 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.51 -10.05 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.762 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -64.45 161.84 16.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -179.927 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.1 tp10 -74.01 167.79 20.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.943 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.669 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.7 tpp180 -142.77 158.83 43.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.6 t80 -158.72 81.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.533 177.027 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 2.6 m -76.59 157.76 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.506 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 78' ' ' VAL . 33.7 tp -156.51 82.69 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.256 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.7 m-70 -67.82 156.28 37.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.398 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.1 mt -147.92 106.4 3.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.034 -178.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.476 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 65.9 t30 -79.62 61.88 3.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 17' ' ' HIS . 3.3 t -45.16 121.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.603 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.978 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.599 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.2 p-10 . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.6 p-10 -50.83 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.664 -179.315 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -104.89 93.51 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.45 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -84.39 105.88 15.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.593 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG23 HD23 ' A' ' 110' ' ' LEU . 29.5 m -147.44 -174.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.259 0.552 . . . . 0.0 112.285 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.93 179.69 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.467 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -177.39 -175.76 0.57 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.054 0.454 . . . . 0.0 111.891 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 49.1 m-70 -117.81 -167.11 1.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 179.118 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 33.7 t -86.66 135.84 24.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 111.94 -179.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 63.33 11.53 40.69 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.476 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.0 tptt -59.79 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.1 0.45 . . . . 0.0 109.812 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -55.61 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.368 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' VAL . 62.6 m -94.48 98.66 11.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.527 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 31.1 tt0 -75.45 133.51 41.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.604 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.428 HD13 ' HE2' ' A' ' 106' ' ' TYR . 37.2 mt -134.02 101.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -87.19 110.22 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.549 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 33.7 mt -108.18 148.48 29.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.352 -179.229 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -99.5 160.66 14.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.986 0.422 . . . . 0.0 110.605 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.95 -128.63 1.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.374 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.537 0.208 . . . . 0.0 111.146 179.953 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.957 0.408 . . . . 0.0 110.872 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -136.87 154.71 50.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.174 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 8.3 m95 -112.47 98.23 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.94 178.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.611 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.6 t -142.56 -165.79 2.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.822 -179.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.8 mtp85 -88.54 156.57 19.0 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' CG2' ' A' ' 91' ' ' VAL . 31.8 t -72.83 131.17 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.935 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 13.96 82.02 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.858 179.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.413 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -134.88 -4.31 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.725 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -49.52 124.39 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.123 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.17 -179.685 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.5 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.181 0.515 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 24.4 p -50.78 177.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.127 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -153.3 -81.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.19 -33.23 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 22.8 mm -69.28 -81.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.676 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 6.7 mt -97.15 117.59 31.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 23.5 tt0 -68.68 84.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.56 ' H ' ' CB ' ' A' ' 48' ' ' SER . 39.0 t -88.95 91.66 3.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.511 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.6 t -79.68 86.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.4 t -68.95 135.22 50.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.006 -178.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.638 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 8.9 mtpm? -138.25 54.09 1.79 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.84 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -52.52 112.37 0.81 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.511 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.449 ' OG1' HG13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.36 104.16 28.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.537 -179.548 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 27.1 Cg_endo . . . . . 0 N--CA 1.451 -0.976 0 C-N-CA 123.765 2.977 . . . . 0.0 113.039 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.9 pt . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.152 0.501 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -136.44 107.32 6.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.279 -179.482 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -94.36 100.99 12.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.945 0.403 . . . . 0.0 110.737 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 88' ' ' LEU . 32.8 t -105.26 118.2 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.028 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 21' ' ' THR . 89.0 mt -104.1 106.92 17.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.44 104.99 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.272 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 39.3 mtmt -108.75 100.45 39.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.46 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.555 ' HA ' HD23 ' A' ' 52' ' ' LEU . 81.8 Cg_exo -46.41 96.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.586 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.611 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 10.4 mtt180 -69.04 -33.81 74.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.173 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -118.95 -178.45 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -119.52 120.83 37.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.795 179.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.7 -121.35 1.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.608 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.36 113.89 26.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 111.102 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.579 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 5.6 m80 -136.14 150.72 49.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.42 ' O ' HD12 ' A' ' 52' ' ' LEU . 91.7 m -161.19 152.6 19.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 112.063 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 76' ' ' VAL . 53.8 tp -121.87 71.79 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.073 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 3.1 pt-20 -70.71 105.38 3.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.624 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 17.6 mt -107.18 154.67 20.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.504 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -145.34 160.22 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.695 -179.748 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -103.88 89.16 3.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.562 178.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.92 HG21 HG21 ' A' ' 42' ' ' VAL . 9.1 t -120.25 169.12 10.56 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.2 mtp180 -101.49 95.91 5.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.948 178.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 5.6 Cg_endo -47.18 -33.46 15.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -68.46 -35.61 77.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.497 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -103.82 -80.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.359 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.65 46.25 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.095 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -97.21 149.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.027 0.441 . . . . 0.0 111.669 -179.08 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.577 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.8 mttt -135.18 162.91 54.76 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.0 Cg_endo -64.74 -35.23 47.03 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.607 2.205 . . . . 0.0 111.743 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.75 -24.45 66.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.1 m-80 -48.67 136.43 13.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 11.0 tt0 -51.86 155.44 1.76 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 4.3 tpp180 -119.96 159.15 25.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.9 t80 -172.47 69.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 16.5 m -91.43 101.97 14.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.465 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.2 tp -87.97 94.48 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.185 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.692 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 15.3 m-70 -77.55 147.87 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.677 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 HG23 ' A' ' 14' ' ' VAL . 94.9 mt -146.19 108.44 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.547 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 39.4 t30 -84.35 69.68 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 17' ' ' HIS . 2.9 t -45.71 143.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.852 -178.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.927 0.394 . . . . 0.0 111.867 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.524 ' H ' HD22 ' A' ' 10' ' ' ASN . 8.8 m-20 -48.18 96.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.618 -179.297 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.8 ptmt -101.06 68.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.554 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.747 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -49.85 104.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.137 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.504 HG23 HD23 ' A' ' 110' ' ' LEU . 35.4 m -146.87 -176.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.3 p-10 -103.38 -171.33 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.466 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -174.41 -174.74 0.89 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.3 0.571 . . . . 0.0 112.379 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 28.7 m80 -113.85 -156.58 0.6 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.647 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 42.3 t -105.26 125.56 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.468 . . . . 0.0 111.585 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.9 12.7 43.95 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.061 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptp -63.64 83.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.741 HG22 HD22 ' A' ' 77' ' ' LEU . 5.3 m -47.87 103.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.829 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.3 m -97.48 100.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.536 179.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 75' ' ' VAL . 35.4 tt0 -83.47 131.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.286 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 108' ' ' LEU . 36.1 mt -136.09 100.0 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.522 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.401 ' HB3' HD12 ' A' ' 73' ' ' ILE . 10.8 m170 -84.08 82.05 8.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 178.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 24' ' ' ILE . 75.0 mt -72.24 158.54 35.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.285 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -116.16 164.76 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.103 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.42 -149.57 11.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.724 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.559 0.219 . . . . 0.0 110.849 -179.95 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' THR . 79.8 m-85 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 121.02 0.438 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 42' ' ' VAL . 8.5 ttp -113.58 154.8 26.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.423 179.388 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -105.22 107.03 17.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.867 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -156.65 -166.27 2.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.485 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 mtp85 -84.25 161.94 20.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.184 -179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 89' ' ' GLU . 48.6 t -76.36 138.69 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.813 -179.418 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.13 79.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.605 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.405 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.4 m-85 -135.03 -2.59 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.672 ' HA ' ' HE3' ' A' ' 35' ' ' MET . 2.3 p -40.29 108.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.287 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.991 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.9 mt . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.175 0.512 . . . . 0.0 109.973 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.488 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.6 p -50.93 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.742 179.038 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.96 -88.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -131.02 -32.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.056 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -71.64 -73.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.324 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.8 mt -107.5 118.97 38.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.442 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.64 69.22 0.42 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG21 ' HD2' ' A' ' 38' ' ' ARG . 11.8 t -76.56 83.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.316 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 14.9 t -83.61 87.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.033 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 76' ' ' VAL . 39.9 t -95.38 150.57 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.489 -178.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' HG13 ' A' ' 75' ' ' VAL . 58.5 mttm -139.02 118.13 12.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.456 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 1.5 t80 -96.57 101.64 13.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.128 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.7 m -107.87 90.23 6.21 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 96.7 Cg_endo . . . . . 0 N--CA 1.459 -0.543 0 C-N-CA 122.987 2.458 . . . . 0.0 111.818 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm . . . . . 0 CA--C 1.513 -0.457 0 CA-C-O 121.954 0.883 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -129.87 67.57 1.46 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.506 178.463 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.2 p -81.04 107.31 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.476 -178.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 88' ' ' LEU . 96.6 t -102.02 125.98 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.46 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD22 HG22 ' A' ' 21' ' ' THR . 76.6 mt -109.3 96.9 6.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.77 178.408 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.61 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -93.73 106.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.04 0.448 . . . . 0.0 111.044 -178.904 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -107.87 105.07 55.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.985 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 Cg_exo -53.05 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.49 2.127 . . . . 0.0 112.45 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.622 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.6 mtt180 -69.87 -49.14 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.459 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -107.62 161.05 15.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -98.15 113.79 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.733 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.628 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.93 -129.25 1.9 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.578 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.44 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.7 m80 -106.62 99.09 8.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.458 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -111.04 162.69 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.673 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' HD12 ' A' ' 52' ' ' LEU . 99.7 m -159.63 148.87 18.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.044 0.449 . . . . 0.0 112.052 -179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 25.7 tp -121.61 79.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.757 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -77.07 100.19 5.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.178 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.9 mt -98.68 140.75 32.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.116 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -140.98 164.49 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.808 -179.452 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -99.11 84.18 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.66 HG21 ' HB ' ' A' ' 42' ' ' VAL . 7.6 t -95.5 -175.67 3.54 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.831 -177.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 55.7 mtp180 -117.91 101.17 52.08 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.297 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 84.4 Cg_exo -39.92 -34.93 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.054 2.503 . . . . 0.0 113.399 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -88.74 -47.23 8.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.414 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -83.92 -86.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.884 0.374 . . . . 0.0 111.803 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 172.82 -174.06 45.68 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.246 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -93.68 154.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 10.6 mttm -145.44 166.46 17.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.506 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.2 Cg_exo -59.62 -44.88 28.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.857 2.371 . . . . 0.0 111.864 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.51 -26.74 67.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.307 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -49.56 135.47 18.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 9.3 tt0 -49.42 152.53 1.28 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.24 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 7.4 tpp180 -117.63 159.2 23.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.167 0.508 . . . . 0.0 111.71 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.493 ' H ' ' HG3' ' A' ' 105' ' ' ARG . 41.5 t80 -175.55 62.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.532 177.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 9.1 m -84.26 98.12 9.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.726 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 78' ' ' VAL . 18.6 tp -80.57 92.41 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.862 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.747 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -79.59 140.94 36.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.341 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.504 HD23 HG23 ' A' ' 14' ' ' VAL . 89.3 mt -144.01 99.83 3.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.58 -178.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.533 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 7.9 t30 -73.16 77.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.628 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 6.1 t -51.5 120.55 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.418 -178.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.887 -179.97 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.75 0.31 . . . . 0.0 111.241 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -149.56 -140.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' C ' ' HB3' ' A' ' 109' ' ' HIS . 22.1 ptmt -132.63 -173.94 3.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.451 -179.12 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 16.7 m0 -136.63 117.48 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 179.214 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 109' ' ' HIS . 2.6 p -158.35 158.57 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.547 0.689 . . . . 0.0 112.077 -178.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 p30 -44.98 165.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.925 -178.454 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 17' ' ' HIS . 3.1 t -173.02 -167.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.391 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.558 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 57.2 m80 -111.99 179.34 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -94.03 147.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.208 0.528 . . . . 0.0 112.195 -178.567 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.19 21.63 5.96 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.849 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.8 tptt -75.18 73.53 2.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 109.658 179.38 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.738 HG22 HD22 ' A' ' 77' ' ' LEU . 11.6 m -40.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.809 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.6 m -104.52 103.84 13.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.581 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' HG23 ' A' ' 75' ' ' VAL . 28.0 tt0 -82.58 121.7 27.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' HD22 ' A' ' 26' ' ' LEU . 56.7 mt -126.99 99.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.539 ' HB3' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.36 109.61 20.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.61 178.639 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 26' ' ' LEU . 2.6 mm? -91.05 167.56 12.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -107.46 167.66 9.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.965 179.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.6 -148.82 18.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.579 -179.469 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 t30 . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.331 0.11 . . . . 0.0 110.871 -179.966 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 87.9 m-85 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.19 0.519 . . . . 0.0 111.635 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.0 ttm -123.8 150.29 44.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -105.66 81.82 1.72 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 178.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -124.01 -160.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.699 -179.292 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 54' ' ' VAL . 1.8 ttp85 -95.24 114.12 25.87 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG11 HH11 ' A' ' 105' ' ' ARG . 0.9 OUTLIER -48.14 134.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 111.514 -179.283 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.16 3.19 76.29 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.917 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -139.37 0.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.971 -179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.3 p -49.48 136.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.195 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.696 179.971 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.0 mt . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.101 0.477 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.455 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 22.7 t -48.69 172.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.472 178.683 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.46 -78.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.74 -34.44 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.469 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -69.97 -78.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 -179.306 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 80' ' ' PRO . 60.2 mt -98.54 117.2 32.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.385 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 25.9 tt0 -67.93 84.26 0.22 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.58 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -92.22 94.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 43.2 t -91.48 82.13 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.037 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 76' ' ' VAL . 22.2 t -99.61 155.21 17.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.622 -178.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -143.41 123.86 13.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -89.36 109.34 20.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.398 179.741 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 m -97.72 105.04 24.11 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.574 -179.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 44.1 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 C-N-CA 123.849 3.033 . . . . 0.0 112.464 179.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 25' ' ' HIS . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 121.6 0.714 . . . . 0.0 111.429 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.1 m-85 -144.52 79.79 1.62 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.56 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.512 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.8 p -85.05 106.52 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.268 0.556 . . . . 0.0 110.755 -178.994 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG11 HD21 ' A' ' 88' ' ' LEU . 20.4 t -107.83 116.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.583 -178.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.738 HD22 HG22 ' A' ' 21' ' ' THR . 29.1 mt -100.46 100.96 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.702 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 114.19 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.252 0.549 . . . . 0.0 111.17 -178.947 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.7 mtmm -119.44 92.41 45.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.416 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.4 Cg_endo -47.46 112.87 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.487 2.125 . . . . 0.0 112.905 -178.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.1 mtt180 -80.51 -39.82 27.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.861 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.28 176.38 5.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -113.62 149.82 34.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.072 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.528 ' N ' HG23 ' A' ' 112' ' ' VAL . . . 124.01 -160.56 18.56 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.726 179.8 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.496 ' HA ' HD22 ' A' ' 111' ' ' ASN . 65.7 m80 -71.43 98.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 110.752 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -129.91 154.07 47.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 0.0 111.331 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.548 HG21 ' HE1' ' A' ' 13' ' ' TRP . 37.5 m -159.87 138.9 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.702 ' HB2' HG11 ' A' ' 78' ' ' VAL . 32.0 tp -74.53 111.18 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.292 179.531 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 44.5 mt-10 -87.6 96.75 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.732 -179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 36.3 mt -101.14 170.01 8.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.449 178.796 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 13.3 p -166.56 153.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -104.56 84.27 2.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.637 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.6 t -124.55 149.23 47.2 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.12 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 74.7 mtp180 -85.81 101.65 2.01 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.965 178.495 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 8.6 Cg_endo -52.28 -38.24 72.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.721 2.281 . . . . 0.0 112.685 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.14 10.89 3.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.74 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 20.7 mm-40 -147.88 1.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.41 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.84 -174.75 54.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.114 -179.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.637 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.2 mt -106.45 148.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.002 0.429 . . . . 0.0 111.635 -179.326 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 9.9 mttt -131.63 157.93 76.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.565 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.39 -43.98 50.53 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.75 2.3 . . . . 0.0 112.744 -179.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.76 -14.09 49.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.074 -179.365 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.595 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -62.02 137.7 58.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 -179.632 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.9 tt0 -60.37 -179.46 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -162.97 162.35 26.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.214 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.593 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 26.3 t80 -151.53 114.94 4.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.042 0.449 . . . . 0.0 110.177 178.151 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.592 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -104.37 132.12 50.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.043 -178.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 110' ' ' LEU . 26.5 tp -101.62 110.45 22.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.527 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 14' ' ' VAL . 8.6 p80 -55.32 71.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.868 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 108' ' ' LEU . 21.1 mt -112.72 70.72 0.72 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.839 0.745 . . . . 0.0 112.937 -178.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 2.2 t-20 -82.31 60.21 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.757 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -40.71 141.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.615 -178.07 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.044 179.719 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.941 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.606 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -36.72 103.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.804 -179.581 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.3 tttt -90.67 100.54 13.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.492 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.672 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.4 m95 -82.86 105.44 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.696 -179.521 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.73 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -153.37 176.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.146 0.498 . . . . 0.0 111.838 -179.118 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -94.39 -176.69 4.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.601 179.67 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.493 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t -174.1 -175.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 112.093 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.0 m-70 -116.68 -163.25 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.005 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.06 126.7 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.795 -179.598 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.44 10.55 29.96 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.09 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.1 tptm -63.27 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.688 HG22 HD22 ' A' ' 77' ' ' LEU . 5.0 m -46.55 98.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.907 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -90.89 94.8 9.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.031 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.9 tt0 -83.77 128.3 34.44 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.282 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.539 HG22 ' HG ' ' A' ' 26' ' ' LEU . 55.5 mt -133.57 103.42 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.048 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -87.89 119.11 27.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -118.64 151.66 37.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -178.554 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -125.59 157.9 35.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 163.85 -43.22 0.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.436 -1.364 . . . . 0.0 114.195 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 121.067 0.461 . . . . 0.0 110.009 -177.656 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 60.2 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.75 0.309 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 15.9 ttm -161.31 150.55 16.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.062 0.458 . . . . 0.0 111.053 -179.606 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.537 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -106.49 84.72 2.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.042 178.102 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.628 HG21 ' HA ' ' A' ' 42' ' ' VAL . 6.4 t -136.63 -165.85 1.8 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.329 -178.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -86.69 155.68 20.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.906 0.384 . . . . 0.0 111.636 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 91' ' ' VAL . 43.6 t -72.82 132.4 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.84 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.43 85.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.625 179.618 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.406 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 60.4 m-85 -132.53 -4.61 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG21 ' A' ' 93' ' ' THR . 21.7 t -53.65 111.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.039 179.314 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.954 -179.471 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 18.8 mt . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 76.9 p -67.53 -168.6 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -151.19 -86.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.16 -31.33 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.274 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -72.3 -83.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.475 -179.495 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -99.95 107.03 18.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.65 179.767 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 35.5 tt0 -60.43 142.89 54.44 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.276 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.611 HG21 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -144.66 85.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.304 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.2 t -86.06 83.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.425 0.631 . . . . 0.0 109.353 178.12 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 76' ' ' VAL . 9.2 t -102.18 133.51 46.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.447 -178.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -116.12 120.84 40.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.303 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.473 ' CZ ' ' HE1' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -90.88 95.37 10.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.245 179.512 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.4 m -95.61 108.1 37.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.721 -179.122 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 56.5 Cg_endo . . . . . 0 N--CA 1.447 -1.24 0 C-N-CA 123.582 2.854 . . . . 0.0 111.283 179.154 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.08 0.466 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 9.7 m-85 -145.04 95.42 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.892 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.97 126.29 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.257 0.551 . . . . 0.0 110.655 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -123.06 122.76 66.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.18 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.688 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -105.33 94.25 5.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.134 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -92.63 101.57 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.099 0.475 . . . . 0.0 110.756 -179.186 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HE3' ' OG1' ' A' ' 21' ' ' THR . 11.2 mttt -102.11 102.62 25.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.454 -179.326 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 41.5 Cg_exo -56.12 95.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.132 1.888 . . . . 0.0 112.157 179.388 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 68.9 mtt180 -67.43 -28.15 67.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -128.89 173.35 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.436 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -113.46 137.91 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.607 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.56 -136.7 6.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.183 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.496 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 62.0 m80 -99.32 91.68 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 110.742 179.853 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.7 m-70 -111.28 164.48 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.592 -179.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 88' ' ' LEU . 32.4 m -158.75 157.99 32.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 0.0 111.823 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.8 tp -124.02 88.49 2.92 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 39.4 mt-10 -74.25 101.28 3.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.246 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 75.9 mt -107.38 139.2 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.323 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.519 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -138.93 166.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.149 0.499 . . . . 0.0 112.087 -179.248 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -106.16 84.26 2.02 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.178 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.848 HG21 HG21 ' A' ' 42' ' ' VAL . 7.5 t -126.66 159.86 32.43 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -176.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.0 mtp180 -93.23 100.76 4.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.537 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 42' ' ' VAL . 82.7 Cg_exo -34.14 -42.96 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.485 2.79 . . . . 0.0 113.972 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -80.6 -52.94 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.038 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -70.56 4.98 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.83 -169.26 54.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.931 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.83 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -115.03 155.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.267 0.556 . . . . 0.0 112.256 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 49.5 mtmt -147.0 158.75 44.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.349 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 20.3 Cg_endo -60.86 -34.65 90.97 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.735 2.29 . . . . 0.0 112.684 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.18 -11.88 4.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.838 -179.704 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -71.04 140.51 50.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 111.441 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -55.45 161.99 1.74 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.5 tpp180 -122.94 160.61 25.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.614 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 42.2 t80 -173.63 66.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.887 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 8.7 m -87.01 92.02 8.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.333 -178.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 69.6 tp -72.26 94.46 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.185 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.5 m-70 -78.56 142.74 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.076 0.465 . . . . 0.0 110.709 179.443 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 93.6 mt -142.69 109.18 5.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -178.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 m-20 -81.73 66.95 7.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.376 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.607 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.41 110.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.357 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.934 -179.89 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 107' ' ' THR . 6.4 m-20 -151.82 -146.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.401 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -133.89 -170.23 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 12.5 m0 -130.86 123.95 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.806 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 109' ' ' HIS . 16.4 m -147.88 154.5 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -178.607 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.4 p-10 -51.02 168.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.83 -179.404 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 t -171.36 -168.96 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.803 -179.5 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.1 m80 -104.03 -175.98 2.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.767 0.318 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -96.89 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.142 0.496 . . . . 0.0 111.897 -179.27 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.25 15.5 5.54 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.416 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -66.39 79.2 0.1 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.023 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.754 HG22 HD22 ' A' ' 77' ' ' LEU . 4.4 m -44.06 101.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.751 -178.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -96.25 101.84 13.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.621 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.3 tt0 -80.71 130.06 34.87 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.659 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.558 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.2 mt -132.86 105.61 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.873 -179.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -89.23 96.04 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' HG22 ' A' ' 24' ' ' ILE . 14.7 mt -90.29 146.01 24.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.303 -179.046 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -100.57 161.31 13.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.44 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.56 -145.02 8.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.441 -179.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--N 1.329 -0.3 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.999 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.154 0.502 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.542 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.0 ttt -147.88 154.03 39.88 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.739 -179.091 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.5 m95 -110.19 93.28 4.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.196 178.921 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -137.25 -168.46 2.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.0 mtp85 -87.62 140.34 29.62 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 91' ' ' VAL . 13.2 t -60.96 130.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.778 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.65 75.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -137.66 0.73 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 110.432 -179.797 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 93' ' ' THR . 21.5 t -54.39 111.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.147 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.04 -179.694 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.4 mt . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.112 0.482 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.482 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.0 p -52.66 175.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.691 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.12 -85.43 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.77 -31.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.299 -179.315 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.5 mm -70.2 -72.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.359 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 80' ' ' PRO . 92.0 mt -111.5 121.47 45.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 68.0 0.37 Allowed 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.82 HG22 HG13 ' A' ' 78' ' ' VAL . 5.8 t -75.62 86.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.42 -178.536 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.0 87.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.45 ' SG ' HG22 ' A' ' 76' ' ' VAL . 30.5 t -105.44 141.24 37.28 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.992 -178.1 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -130.84 115.81 17.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.744 179.033 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.542 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -83.54 113.96 21.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.736 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.6 m -112.72 111.56 51.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 N--CA 1.451 -0.998 0 C-N-CA 123.522 2.815 . . . . 0.0 112.109 179.563 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.1 pt . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.104 0.478 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -130.94 100.48 5.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.183 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 110.746 -179.467 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 88' ' ' LEU . 22.0 t -119.38 120.39 63.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.549 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -109.58 97.61 7.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.729 178.203 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.82 HG13 HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -93.98 105.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.987 0.422 . . . . 0.0 111.24 -178.721 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -105.78 103.3 43.23 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.035 -179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 73.1 Cg_exo -48.41 99.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.738 2.292 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -76.85 -33.76 57.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.767 178.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.76 161.14 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.421 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 96.3 mtt180 -103.64 124.53 49.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.483 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 146.78 -167.95 28.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -63.49 100.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -135.91 161.01 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.24 0.543 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.555 HG21 ' HE1' ' A' ' 13' ' ' TRP . 47.0 m -165.24 146.27 7.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.52 -179.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 76' ' ' VAL . 42.2 tp -78.68 105.28 9.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.949 178.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.0 97.33 9.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.418 179.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 25.5 mt -104.22 169.93 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.1 p -165.88 150.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.036 -179.017 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.1 t80 -101.28 91.69 4.62 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.37 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.914 HG21 HG21 ' A' ' 42' ' ' VAL . 1.7 t -126.53 164.93 20.11 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.45 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -101.38 91.85 2.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.536 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 93' ' ' THR . 58.7 Cg_exo -39.69 -35.43 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.0 2.467 . . . . 0.0 113.014 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.77 85.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.97 -88.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -163.95 -179.28 38.13 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.053 -179.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 93' ' ' THR . 22.2 mt -93.26 -60.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 34.7 mtmt 69.15 159.59 0.15 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 83.7 Cg_endo -76.71 -34.77 2.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 123.137 2.558 . . . . 0.0 112.388 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.0 pt-20 -56.63 -35.77 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -54.91 151.7 8.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.96 0.41 . . . . 0.0 111.611 -179.786 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.8 tt0 -65.35 178.23 0.97 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.25 164.36 35.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.097 -179.482 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.587 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 23.4 t80 -147.01 113.93 6.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.992 0.425 . . . . 0.0 109.973 178.318 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HE ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -103.72 128.65 51.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.308 -178.604 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 33.2 tp -98.87 108.27 20.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 14' ' ' VAL . 4.5 p80 -50.4 72.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.747 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 108' ' ' LEU . 94.5 mt -110.22 64.37 0.61 Allowed 'General case' 0 C--N 1.342 0.251 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 42.4 t30 -79.58 51.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.483 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -28.36 136.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.462 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.599 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.4 OUTLIER -25.26 105.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.658 -179.251 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.4 tttt -101.39 98.36 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.8 m95 -85.52 103.2 14.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.416 -178.64 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.459 HG23 HD23 ' A' ' 110' ' ' LEU . 26.9 m -149.14 -167.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.671 -179.389 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -108.08 -168.99 1.44 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 179.805 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.508 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.5 t 174.24 -173.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.606 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.7 m80 -120.65 -176.27 3.2 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.099 179.126 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.7 137.67 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.25 0.548 . . . . 0.0 111.999 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.09 16.86 34.91 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.598 179.501 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.2 tptm -57.7 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.091 0.445 . . . . 0.0 110.042 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.815 HG22 HD22 ' A' ' 77' ' ' LEU . 2.9 m -57.2 94.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.25 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -95.57 105.92 17.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.002 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.8 tt0 -85.81 124.98 32.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.851 179.497 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 74' ' ' TYR . 51.7 mt -126.46 101.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.014 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.436 ' ND1' HD12 ' A' ' 73' ' ' ILE . 13.9 m170 -86.57 109.95 19.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 90' ' ' LEU . 18.8 mt -99.14 176.51 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.98 0.419 . . . . 0.0 111.098 -179.173 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -119.98 169.87 9.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.131 179.26 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.34 -159.07 31.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.717 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.4 t30 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.402 0.144 . . . . 0.0 110.81 179.824 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 3.1 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.989 0.423 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 14.0 ttm -109.47 149.89 28.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.604 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . 4.2 m95 -108.82 83.78 1.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.708 178.29 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.544 HG23 HG22 ' A' ' 42' ' ' VAL . 14.1 t -125.51 -168.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.633 ' NE ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -83.61 134.5 34.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.906 0.384 . . . . 0.0 111.512 -178.941 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 91' ' ' VAL . 33.6 t -52.57 136.58 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.8 -23.52 1.06 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.51 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' VAL . 11.7 m-30 -100.19 21.08 13.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 110.159 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HG21 ' A' ' 93' ' ' THR . 20.1 t -76.34 106.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.725 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.032 -179.638 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 56' ' ' CYS . 20.6 mt . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 80.6 p -50.55 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.42 178.485 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.09 -96.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.368 179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -127.24 -32.76 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -73.67 -75.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.6 mt -103.28 115.58 30.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.315 179.498 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -69.44 71.45 0.3 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.768 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.633 HG11 ' NE ' ' A' ' 38' ' ' ARG . 2.1 t -74.3 87.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.324 -178.805 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.2 t -88.33 86.62 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.488 178.127 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.625 ' HB3' HD12 ' A' ' 47' ' ' LEU . 29.6 t -110.41 153.82 24.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.743 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -136.9 118.13 14.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.273 179.34 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -80.34 94.77 6.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.5 m -99.58 104.48 27.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.356 -179.369 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 69.0 Cg_endo . . . . . 0 N--CA 1.449 -1.128 0 C-N-CA 123.289 2.659 . . . . 0.0 111.847 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.436 HD12 ' ND1' ' A' ' 25' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.514 -0.416 0 CA-C-O 120.968 0.413 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 23.9 m-85 47.31 75.94 0.12 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.326 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.9 p -92.04 101.44 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.179 0.514 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 56' ' ' CYS . 17.3 t -99.67 117.29 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.815 HD22 HG22 ' A' ' 21' ' ' THR . 64.4 mt -107.38 94.58 5.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.105 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.56 HG21 HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -90.98 112.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.023 0.439 . . . . 0.0 111.297 -178.809 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.6 mtmt -113.15 94.25 29.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.2 Cg_endo -47.58 103.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.579 2.186 . . . . 0.0 112.669 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.7 mtt180 -67.46 -33.68 75.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.541 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -119.29 -176.06 3.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.53 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -127.8 121.59 30.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 154.54 -106.98 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -105.58 99.74 9.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.6 m80 -128.67 150.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.503 ' HG1' ' CG ' ' A' ' 109' ' ' HIS . 91.4 m -158.17 147.72 19.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.96 0.409 . . . . 0.0 111.935 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.9 tp -98.31 84.82 3.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.568 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 107' ' ' THR . 46.4 mt-10 -69.64 99.11 1.26 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 21.6 mt -110.57 151.77 27.22 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -154.79 146.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.632 -178.606 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 35' ' ' MET . 12.4 t80 -95.67 78.04 3.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.4 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.868 HG21 HG21 ' A' ' 42' ' ' VAL . 5.4 t -118.45 159.65 23.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 13.6 mtp180 -98.43 98.17 5.55 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.605 178.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.3 Cg_exo -40.78 -34.51 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.079 2.519 . . . . 0.0 113.105 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -68.93 -62.95 1.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.003 -179.416 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.73 4.53 9.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.304 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.03 -164.74 37.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.081 -179.562 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.6 mt -113.04 121.02 64.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.976 -179.198 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -107.76 162.74 18.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.36 -37.47 17.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.663 2.242 . . . . 0.0 112.393 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.4 -17.59 8.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.743 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.75 142.29 56.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 111.473 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.42 173.55 1.18 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.599 179.429 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.8 tpp180 -135.89 163.07 31.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.265 -179.211 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.694 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 13.4 t80 -169.76 74.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 177.152 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -95.94 93.3 6.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.729 -178.851 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.3 tp -76.73 88.65 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 110.24 179.291 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.677 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.0 m-70 -72.38 144.06 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 16' ' ' THR . 64.5 mt -146.37 113.31 6.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.123 -178.35 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.3 t30 -83.34 55.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.491 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.473 HG13 HG23 ' A' ' 16' ' ' THR . 1.8 t -35.64 126.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.743 -178.871 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.928 179.952 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 121.132 0.491 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.55 103.52 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.698 -179.284 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 90.48 7.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.889 179.198 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.7 m95 -73.67 99.12 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.715 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 15' ' ' ASP . 10.9 p -156.49 169.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -85.75 -173.25 4.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -175.51 -172.06 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.244 0.545 . . . . 0.0 112.375 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.9 m80 -118.11 -160.12 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.709 178.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.1 t -101.16 132.64 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 111.764 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.4 17.85 13.31 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.203 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.1 tptt -63.89 84.07 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.151 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.756 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.84 101.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.674 -178.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 78' ' ' VAL . 72.5 m -97.51 100.77 12.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.562 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.4 tt0 -79.82 134.0 36.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.582 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.2 mt -138.34 104.38 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.964 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -84.18 96.58 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.582 ' HG ' HG22 ' A' ' 24' ' ' ILE . 13.6 mt -95.88 148.01 23.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 -178.583 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -113.54 162.12 16.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.149 179.175 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.29 -23.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.545 -179.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.1 t30 . . . . . 0 C--N 1.332 -0.187 0 CA-C-O 120.463 0.173 . . . . 0.0 111.016 179.926 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 35.7 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.015 0.436 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.564 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.7 ttt -141.32 148.69 40.15 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.081 -179.814 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.454 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -104.56 83.5 2.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.849 178.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -127.43 -168.91 1.95 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.23 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.636 HH11 HG21 ' A' ' 54' ' ' VAL . 1.9 mtp180 -85.63 135.85 33.62 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.31 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' HB ' ' A' ' 91' ' ' VAL . 40.9 t -48.63 150.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.068 -179.254 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.81 1.3 4.83 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.595 179.745 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.91 32.48 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.449 0.642 . . . . 0.0 110.614 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.633 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.1 p -60.26 100.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.994 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.678 179.893 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.9 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.902 0.382 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.5 p -46.66 172.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.255 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -154.19 -84.82 0.07 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.416 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -130.65 -33.33 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.399 -179.202 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -70.5 -78.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.437 -179.53 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -103.16 116.01 31.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.452 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.66 69.83 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.673 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' VAL . 20.6 t -76.62 84.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.0 t -79.41 86.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.284 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 76' ' ' VAL . 43.4 t -99.91 142.14 31.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.434 -178.466 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -133.41 108.96 9.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.072 179.402 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.564 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -78.76 100.63 7.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.259 179.564 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 29.2 m -93.57 108.2 32.33 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.831 -179.056 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 77.5 Cg_endo . . . . . 0 N--CA 1.444 -1.416 0 C-N-CA 124.109 3.206 . . . . 0.0 111.434 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.159 0.504 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -134.56 97.16 3.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.226 -179.779 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.54 102.98 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.501 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 88' ' ' LEU . 40.2 t -105.55 124.06 60.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.756 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -113.17 102.95 10.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.669 178.13 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -95.49 110.4 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.438 . . . . 0.0 111.428 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.6 mtmt -115.32 96.04 44.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.0 Cg_endo -50.99 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.38 2.054 . . . . 0.0 112.403 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 13.6 mtt180 -74.22 -38.11 63.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -111.4 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.142 -179.069 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -112.01 144.2 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.68 -119.74 2.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -110.58 117.42 33.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -132.85 159.06 40.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 107' ' ' THR . 59.3 m -159.39 142.41 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 111.411 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.3 tp -99.36 92.14 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.7 mt-10 -72.51 99.35 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.577 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 33.8 mt -113.72 128.87 56.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.316 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 39' ' ' VAL . 10.7 p -134.55 158.25 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.799 -178.713 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -97.15 82.38 3.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.977 178.605 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.633 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -101.77 177.07 5.01 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 98' ' ' GLY . 61.4 mtp180 -110.25 94.05 17.37 Favored Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.022 179.544 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.456 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 81.3 Cg_exo -50.81 -29.2 25.59 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.52 2.146 . . . . 0.0 112.441 179.431 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -79.89 -31.14 40.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.459 -179.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.26 -77.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.932 0.396 . . . . 0.0 111.361 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 174.22 -173.94 46.2 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.007 -179.331 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.3 mt -93.1 149.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.855 0.359 . . . . 0.0 111.026 -179.471 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -138.95 168.18 16.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.978 -179.264 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.61 -28.06 4.58 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 112.156 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -78.44 11.62 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.675 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.546 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -93.4 150.11 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.342 -179.419 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 163.88 8.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.634 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.4 tpp180 -130.96 164.11 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.649 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.634 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.9 t80 -174.4 76.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 109.558 177.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.75 88.78 5.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.389 -179.18 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 22.1 tp -67.6 90.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 0.0 110.472 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -73.4 133.91 43.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.662 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.2 mt -141.4 102.86 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.273 -178.191 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.3 t30 -78.64 85.76 4.66 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.071 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 17' ' ' HIS . 18.3 t -55.11 112.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.284 -179.062 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.009 179.877 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.732 . . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.571 ' H ' HD22 ' A' ' 10' ' ' ASN . 7.8 m-20 -30.17 104.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.617 -179.672 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -93.11 89.86 6.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.548 179.489 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.663 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.04 101.22 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 HD23 ' A' ' 110' ' ' LEU . 22.8 m -149.29 -175.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.237 0.541 . . . . 0.0 112.167 -178.849 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.53 -173.71 2.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.295 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.568 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -174.45 -175.75 1.0 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.226 0.536 . . . . 0.0 112.187 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.8 m80 -116.82 -162.24 0.84 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.882 179.23 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.53 122.52 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.069 0.462 . . . . 0.0 111.634 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.2 10.69 35.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.14 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptp -62.81 84.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.061 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 HD22 ' A' ' 77' ' ' LEU . 7.7 m -45.39 100.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.807 -178.7 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 78' ' ' VAL . 69.3 m -91.64 102.96 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.28 179.389 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.6 tt0 -86.43 132.18 34.01 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.339 -179.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 108' ' ' LEU . 37.3 mt -139.2 104.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.413 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -79.62 95.76 5.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.777 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 28.8 mt -88.75 143.95 26.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.444 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 166.08 11.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.873 0.368 . . . . 0.0 110.627 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.89 -150.99 13.04 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 -179.947 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 93' ' ' THR . 87.9 m-85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.116 0.484 . . . . 0.0 111.633 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 7.1 ttm -147.51 148.89 31.68 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.009 -179.615 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.457 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -93.67 81.48 4.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.218 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 35' ' ' MET . 1.7 t -125.4 146.83 49.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.527 -177.766 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD3' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -53.39 177.34 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.981 0.419 . . . . 0.0 110.623 179.428 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 89' ' ' GLU . 42.8 t -81.78 102.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.522 -179.773 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.5 -12.92 56.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.527 179.236 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.766 ' CG ' HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -73.92 -42.01 61.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 117.45 0.625 . . . . 0.0 110.599 -179.741 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.519 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.0 p -26.7 90.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.138 0.494 . . . . 0.0 111.06 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . . . . . . 0 CA--C 1.522 0.518 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -178.478 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.766 HD22 ' CG ' ' A' ' 41' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.277 0.56 . . . . 0.0 110.125 . . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 54' ' ' VAL . 81.1 p -64.19 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.781 -179.734 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.51 -80.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.71 -31.29 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.513 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.565 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.3 mm -74.35 -86.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.622 -179.465 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.724 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -97.86 109.1 21.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.267 179.803 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.601 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 1.3 tm-20 -62.24 147.46 47.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.052 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 48' ' ' SER . 11.5 t -146.36 133.84 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.594 -179.548 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.6 t -137.87 86.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 178.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.577 ' SG ' HG22 ' A' ' 76' ' ' VAL . 42.0 t -93.94 97.58 10.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.784 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 81.7 mttt -72.65 73.71 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.35 178.844 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.536 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -64.24 103.71 0.66 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.473 179.8 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.4 m -108.37 125.04 32.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.436 178.658 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo . . . . . 0 N--CA 1.452 -0.936 0 C-N-CA 123.031 2.487 . . . . 0.0 113.047 -178.716 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -136.31 100.71 4.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.094 -179.989 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 62.1 t -79.43 89.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 120.811 0.338 . . . . 0.0 110.893 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 HD21 ' A' ' 88' ' ' LEU . 21.5 t -83.41 121.31 36.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 21' ' ' THR . 77.3 mt -117.02 98.29 6.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.081 178.304 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.724 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.12 110.69 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.827 -179.127 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 42.9 mtmt -110.97 102.58 53.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.959 -178.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 45.4 Cg_exo -54.77 100.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.353 2.036 . . . . 0.0 112.315 179.343 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.0 mtt180 -69.77 -42.26 74.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -112.24 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -117.62 142.83 46.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.749 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.1 -135.28 7.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.485 179.906 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.457 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.8 m80 -101.33 91.16 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 -179.989 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.8 OUTLIER -107.43 163.98 12.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.202 179.761 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 88' ' ' LEU . 85.6 m -160.89 155.09 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.14 0.495 . . . . 0.0 112.156 -179.574 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 HG11 ' A' ' 76' ' ' VAL . 14.9 tp -125.64 96.26 4.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.832 178.961 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.5 mt-10 -84.36 99.38 10.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.868 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 33.4 mt -95.88 129.26 43.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.364 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.2 p -130.83 157.19 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.064 0.459 . . . . 0.0 112.097 -178.58 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -100.93 95.02 6.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.595 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.859 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -117.2 167.65 11.01 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.73 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -103.2 93.67 4.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.796 178.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -48.91 -29.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.867 2.378 . . . . 0.0 112.961 -179.617 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -77.77 10.37 2.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -150.55 -72.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.09 0.472 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.66 175.34 36.78 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.539 -179.518 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.9 mt -94.24 150.79 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.08 0.467 . . . . 0.0 111.604 -179.123 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -137.53 166.88 23.24 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.3 -48.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.344 2.696 . . . . 0.0 112.498 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.37 -18.15 10.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.683 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.8 m120 -62.56 162.86 9.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.784 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 161.26 5.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.642 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpp180 -135.05 164.28 27.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.57 -178.605 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.642 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.4 t80 -174.29 67.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.248 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 89' ' ' GLU . 12.4 m -87.34 97.81 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.559 -178.828 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 78' ' ' VAL . 63.2 tp -76.56 88.06 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 12.7 m-70 -73.81 142.94 46.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 179.424 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.2 mt -143.71 108.6 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.692 -178.056 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.8 t-20 -81.48 72.23 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.6 t -53.09 122.84 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.667 -178.235 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.071 179.757 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.81 100.42 12.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.148 0.499 . . . . 0.0 111.636 -179.178 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -109.67 61.72 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.497 179.132 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 m0 -78.73 112.55 15.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -178.008 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 34.8 m -150.24 -166.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 -178.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -96.05 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.696 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.509 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t 177.82 -174.51 0.15 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.143 0.497 . . . . 0.0 112.059 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 67.7 m-70 -118.55 -160.98 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.761 179.212 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.7 121.86 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 111.34 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 64.45 16.98 61.46 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.062 179.84 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -58.09 91.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.725 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -56.73 101.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.482 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.8 m -100.81 99.21 9.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.663 179.642 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.507 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.1 tt0 -78.66 137.12 37.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.789 179.731 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.92 102.57 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -83.49 112.9 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.695 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 37.4 mt -108.62 154.28 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -178.315 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -110.89 155.68 22.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.98 179.333 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.26 -19.3 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.505 -179.229 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.1 t30 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.517 0.199 . . . . 0.0 110.598 -179.918 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.151 0.5 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 16.5 ttm -123.88 150.89 44.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.3 m95 -109.24 84.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.769 178.545 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.579 HG21 ' HA ' ' A' ' 42' ' ' VAL . 7.0 t -132.38 -164.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 -179.124 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 19.0 mtp85 -92.75 121.69 34.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 0.0 110.474 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.3 p -51.9 140.07 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.67 -6.76 81.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.714 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 52.0 m-85 -128.31 1.16 5.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.285 0.564 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 93' ' ' THR . 15.4 t -56.08 119.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.064 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.913 -179.482 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.0 mt . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.22 0.533 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.9 p -52.89 -178.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.765 178.828 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -158.39 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.207 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -129.98 -29.02 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 11.6 mm -74.77 -76.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.283 -179.61 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 78' ' ' VAL . 4.3 mt -102.4 115.27 30.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.299 179.154 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.38 69.52 0.24 Allowed 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.091 0.472 . . . . 0.0 109.94 178.062 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG22 ' CG1' ' A' ' 78' ' ' VAL . 18.4 t -74.32 81.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.018 -179.18 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 31.0 t -78.01 81.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.018 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -97.38 136.21 38.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.478 -178.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -126.7 113.75 17.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.858 179.189 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.32 107.19 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.732 179.826 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.4 m -99.11 109.33 53.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.702 179.816 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.453 -0.896 0 C-N-CA 123.336 2.691 . . . . 0.0 112.183 179.846 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.4 pt . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -140.29 110.99 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.058 -179.619 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -103.48 113.8 41.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.55 . . . . 0.0 110.477 -179.672 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.494 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -109.02 125.77 66.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.499 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.725 HD22 HG22 ' A' ' 21' ' ' THR . 86.3 mt -110.05 101.36 10.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.021 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.61 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.0 111.11 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.976 0.417 . . . . 0.0 111.233 -178.786 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.9 mtmt -115.6 96.81 47.28 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.499 -179.435 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.5 Cg_endo -50.31 104.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.476 2.117 . . . . 0.0 112.656 179.752 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.567 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.4 mtt180 -71.24 -42.16 69.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.298 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -107.77 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -114.67 123.41 49.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.6 -101.78 0.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.488 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -143.72 91.58 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.564 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.3 m-70 -100.0 173.71 6.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.8 m -160.53 150.51 17.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.781 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 36.4 tp -113.93 88.75 2.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 43.8 mt-10 -75.51 93.82 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.071 -179.634 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 62.8 mt -104.16 131.05 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.935 178.654 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.93 153.47 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.722 -178.963 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.3 t80 -96.88 89.66 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.864 HG21 HG21 ' A' ' 42' ' ' VAL . 7.2 t -130.4 151.7 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.479 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.5 mtp180 -86.99 101.59 2.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.713 178.362 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 1.6 Cg_endo -47.44 -36.63 24.14 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.871 2.381 . . . . 0.0 113.117 -179.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -87.72 18.9 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 17.3 mm-40 -149.75 1.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.433 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.69 178.66 51.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.122 -179.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.5 mt -105.72 154.29 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.472 . . . . 0.0 111.872 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.647 ' HE3' HD21 ' A' ' 103' ' ' ASN . 42.8 mtmt -137.78 163.04 50.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.885 -179.574 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.1 Cg_endo -70.76 -38.41 5.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.782 2.322 . . . . 0.0 112.347 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.77 -24.59 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.647 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -54.73 148.1 13.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.398 -179.999 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.6 tt0 -56.31 163.28 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.3 tpp180 -132.59 163.59 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 65.1 t80 -174.03 74.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.239 177.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -95.09 106.81 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 -178.863 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.1 tp -93.02 91.4 7.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.1 m-70 -74.91 151.48 38.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.423 179.704 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 16' ' ' THR . 95.5 mt -148.58 116.97 6.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -178.538 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 49.4 t30 -86.68 68.07 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -49.26 119.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.469 -178.684 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.999 179.995 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 111.855 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.531 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 4.2 p-10 -37.63 97.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.894 -179.5 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -107.26 93.53 4.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.436 179.78 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.683 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.2 m95 -88.96 105.03 17.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.12 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 HD23 ' A' ' 110' ' ' LEU . 7.3 m -151.41 -175.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.997 -179.621 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -99.95 -176.33 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.417 179.831 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.494 ' HB ' HD22 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -174.82 -178.06 1.22 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 112.177 -179.807 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.8 m80 -114.14 -167.25 1.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 9.6 p -94.06 135.41 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.261 0.553 . . . . 0.0 112.046 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.1 14.82 11.86 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.546 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptp -65.58 81.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.726 HG22 HD22 ' A' ' 77' ' ' LEU . 5.5 m -47.34 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.76 -178.785 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 78' ' ' VAL . 60.8 m -94.97 98.13 10.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 179.368 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.4 tt0 -78.74 132.85 37.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.988 179.947 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 108' ' ' LEU . 39.5 mt -137.53 104.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.999 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.23 98.75 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.311 178.214 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 23.9 mt -94.31 145.12 24.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.613 -179.058 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.4 mptt -98.73 162.3 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.543 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.41 -141.72 6.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.267 -179.341 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.403 0.144 . . . . 0.0 110.873 179.855 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 121.103 0.477 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 6.0 ttm -146.7 153.17 39.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.166 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 m95 -105.53 94.92 5.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.843 178.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.2 t -140.83 -170.33 3.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.627 -178.938 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.608 HH11 HG21 ' A' ' 54' ' ' VAL . 9.9 mtp85 -86.62 157.07 19.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' A' ' 91' ' ' VAL . 52.6 t -72.7 132.05 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.943 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.07 4.99 79.62 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.481 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.437 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 60.1 m-85 -127.17 -2.04 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.132 0.491 . . . . 0.0 110.45 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 93' ' ' THR . 22.4 t -49.07 112.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.262 179.178 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.217 -179.734 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.3 mt . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.737 0.303 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 20.9 p -54.98 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.95 179.553 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -156.53 -86.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.329 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.601 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -132.12 -31.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.434 -179.132 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.5 mm -73.0 -78.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 7.1 mt -102.68 114.23 28.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.499 179.375 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -68.55 70.63 0.18 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.066 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.608 HG21 HH11 ' A' ' 38' ' ' ARG . 14.0 t -75.1 83.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.911 -179.1 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.0 t -78.42 82.67 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.39 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.0 t -94.56 139.51 31.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.277 -178.605 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -132.45 108.1 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.162 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -79.43 112.64 16.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.368 179.636 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 m -113.15 111.14 50.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.975 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo . . . . . 0 N--CA 1.446 -1.283 0 C-N-CA 123.735 2.956 . . . . 0.0 111.264 178.828 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.126 0.489 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -134.47 99.94 4.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.078 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.35 102.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.866 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 88' ' ' LEU . 40.8 t -104.74 119.85 54.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.202 -179.385 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.726 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -109.69 98.15 7.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.208 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.33 103.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.038 0.447 . . . . 0.0 111.216 -178.706 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 7.1 mtmp? -106.15 104.41 49.63 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.267 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.1 Cg_exo -54.31 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.475 2.117 . . . . 0.0 112.567 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.601 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -64.5 -41.84 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.407 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -113.15 173.08 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 -179.383 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -113.2 106.92 15.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.604 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 171.19 -123.82 1.07 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.47 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.451 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -103.56 98.32 8.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.571 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.15 158.43 22.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.725 179.998 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 109' ' ' HIS . 33.8 m -159.99 151.9 20.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 111.562 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 45.7 tp -117.05 91.18 3.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 39.1 mt-10 -76.4 97.74 4.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.105 179.948 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.6 mt -108.5 133.54 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.918 178.521 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -137.36 167.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.135 0.493 . . . . 0.0 111.681 -179.379 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.9 t80 -106.4 89.09 2.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.728 178.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.917 HG21 HG21 ' A' ' 42' ' ' VAL . 5.7 t -118.29 170.08 9.19 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.59 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -102.56 95.1 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.0 Cg_exo -42.08 -36.87 4.18 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -40.77 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.963 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.8 -78.55 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.86 178.24 39.19 Favored Glycine 0 CA--C 1.508 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -93.22 153.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.935 0.397 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 39.0 mtmt -145.47 163.44 31.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.067 -179.07 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 19.2 Cg_endo -60.92 -37.84 74.08 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.718 2.279 . . . . 0.0 112.034 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.78 -23.86 67.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.614 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -51.7 136.02 27.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.146 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 91' ' ' VAL . 7.6 tt0 -51.93 156.56 1.47 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 8.8 tpp180 -118.93 158.33 25.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.187 0.518 . . . . 0.0 112.057 -178.54 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.556 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 34.3 t80 -171.74 64.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.772 177.319 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 m -91.08 98.96 12.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.994 -179.278 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 35.0 tp -83.39 94.56 7.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.683 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 26.8 m-70 -79.24 141.41 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.494 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.5 mt -145.17 105.66 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.482 -178.293 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 10.7 m120 -78.13 74.13 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.221 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.604 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -55.4 117.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 34.1 mmtp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.915 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 78.7 p -142.14 110.23 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.64 0.257 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 61.4 m80 59.34 99.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm -75.52 173.93 10.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -73.08 -25.91 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.113 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.05 88.23 0.13 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.254 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.5 121.22 7.53 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.492 2.128 . . . . 0.0 112.22 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.631 ' HG ' ' H ' ' A' ' 7' ' ' VAL . 45.5 tp -75.02 147.27 40.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.9 m -86.74 12.03 11.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.145 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.631 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 4.9 t -110.67 6.57 8.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.167 0.508 . . . . 0.0 110.906 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HE3' ' H ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -157.4 127.57 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.525 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -115.03 114.54 25.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.307 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.648 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -127.09 -89.26 0.55 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.636 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -26.12 105.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.424 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 89.69 6.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.921 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.656 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -74.15 98.85 3.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.622 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' H ' ' A' ' 15' ' ' ASP . 6.6 p -155.34 177.32 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.502 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.765 ' H ' HG22 ' A' ' 14' ' ' VAL . 3.4 p-10 -98.21 -175.24 3.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -173.76 -173.0 0.8 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 112.094 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m-70 -114.73 -167.35 1.21 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 30.6 t -94.0 135.23 29.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.137 0.494 . . . . 0.0 112.153 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.64 16.53 11.49 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.437 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.7 tptm -65.73 81.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.75 HG22 HD22 ' A' ' 77' ' ' LEU . 5.9 m -46.71 99.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.733 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 78' ' ' VAL . 83.5 m -93.79 99.6 11.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.0 tt0 -80.3 131.73 35.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.879 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.59 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.7 mt -134.67 103.97 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.731 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -86.02 95.51 9.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.59 ' HG ' HG22 ' A' ' 24' ' ' ILE . 8.2 mt -92.95 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.302 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -101.6 168.52 9.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.47 -130.53 1.93 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.429 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 32' ' ' THR . 59.7 t30 -174.99 90.35 0.3 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.444 0.164 . . . . 0.0 110.595 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.2 -18.94 2.29 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.695 2.263 . . . . 0.0 113.069 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.7 p -97.5 25.36 5.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 29' ' ' ASN . 7.1 t -103.65 -34.03 8.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.206 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.55 -43.72 1.19 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.746 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' H ' HG23 ' A' ' 32' ' ' THR . 70.4 m-85 -89.61 -176.78 5.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.118 0.485 . . . . 0.0 111.406 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 2.4 ttt -148.3 151.81 36.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.728 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.8 m95 -109.4 90.33 3.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.081 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.545 ' CG2' HG22 ' A' ' 42' ' ' VAL . 9.6 t -139.72 -166.58 2.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.375 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.2 mtp85 -92.23 124.21 36.13 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.797 0.332 . . . . 0.0 110.737 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.6 p -52.88 142.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.27 78.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.749 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 50.0 m-85 -128.15 -0.65 5.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.149 0.499 . . . . 0.0 110.184 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.926 HG21 HG21 ' A' ' 93' ' ' THR . 38.1 t -54.78 105.63 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.036 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.1 -30.04 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.101 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 8.3 mtpm? -66.9 175.08 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.361 . . . . 0.0 110.993 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.88 -40.79 15.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.31 131.66 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.337 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.744 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.5 mt -84.41 -51.94 6.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.012 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.481 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 62.4 p -53.23 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.655 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.83 -86.61 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.253 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.47 -30.67 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.161 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.6 mm -74.04 -73.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.278 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.1 mt -104.96 116.02 31.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.344 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -70.33 68.81 0.36 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 109.902 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 78' ' ' VAL . 14.0 t -74.17 84.67 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.993 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -82.0 85.41 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' SG ' HG22 ' A' ' 76' ' ' VAL . 34.6 t -102.63 142.69 33.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.69 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -133.01 113.59 12.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.987 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.68 102.66 10.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.451 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.425 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 10.7 m -101.67 110.95 63.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.643 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 70' ' ' VAL . 63.8 Cg_endo -99.88 41.66 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.539 2.826 . . . . 0.0 111.695 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -41.27 140.67 1.18 Allowed Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.779 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 61' ' ' THR . 23.8 Cg_exo -63.55 -176.59 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 112.386 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -67.61 -172.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -63.26 -71.35 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.038 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 60.6 m -101.98 -48.36 0.18 Allowed Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.896 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 12.6 Cg_exo -71.33 -161.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.842 2.361 . . . . 0.0 112.326 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.2 mtt -143.11 15.68 1.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.23 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 p -87.23 27.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.979 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.29 84.15 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.545 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' A' ' 60' ' ' PRO . 14.5 p -82.41 50.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.507 0.67 . . . . 0.0 110.652 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.78 130.17 9.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.95 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -127.63 -119.67 2.25 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.167 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.4 pt -144.67 -166.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.113 0.483 . . . . 0.0 110.976 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -131.37 98.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.17 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.95 106.64 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 120.906 0.384 . . . . 0.0 110.963 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG11 HD21 ' A' ' 88' ' ' LEU . 29.7 t -110.0 120.55 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.75 HD22 HG22 ' A' ' 21' ' ' THR . 82.6 mt -110.13 100.97 9.79 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.765 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.598 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 105.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.048 0.452 . . . . 0.0 111.18 -178.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -107.18 102.08 41.64 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.239 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 52.5 Cg_exo -51.44 97.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.681 2.254 . . . . 0.0 112.705 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.3 mtt180 -66.24 -43.26 87.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.319 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -114.85 173.74 6.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -108.97 125.07 51.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.798 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.588 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 155.04 -138.42 6.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.427 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.4 m80 -97.85 95.16 7.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.95 0.405 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.446 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.8 m-70 -112.07 162.18 15.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.498 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.413 HG22 HG22 ' A' ' 107' ' ' THR . 85.2 m -159.72 144.9 15.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.0 0.428 . . . . 0.0 111.68 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 38.2 tp -101.0 92.66 5.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.026 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.4 mt-10 -75.13 88.51 2.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.481 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.599 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 48.2 mt -103.54 123.42 46.89 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 92' ' ' TYR . 13.1 p -126.19 158.49 35.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.5 t80 -102.34 91.85 4.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.327 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.926 HG21 HG21 ' A' ' 42' ' ' VAL . 5.5 t -122.45 167.46 13.3 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -101.07 94.89 4.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.41 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.9 Cg_exo -46.94 -28.77 7.47 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.679 2.252 . . . . 0.0 112.549 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -72.44 -42.62 64.83 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.312 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -95.19 -69.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.15 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.01 179.04 37.31 Favored Glycine 0 CA--C 1.508 -0.38 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.975 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.844 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.4 mt -98.4 140.84 17.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.959 0.409 . . . . 0.0 111.258 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 46.2 mtmt -140.39 159.44 63.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.194 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 30.6 Cg_endo -63.79 -36.32 51.83 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.917 2.411 . . . . 0.0 112.693 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.68 0.51 1.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.518 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.561 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -85.27 158.07 20.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.185 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.83 166.37 9.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.7 tpp180 -133.49 164.31 27.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.592 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.656 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 55.4 t80 -171.34 69.66 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.007 177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.624 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -93.17 90.13 6.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.731 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 28.2 tp -70.59 89.96 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.043 0.449 . . . . 0.0 110.326 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 36.8 m-70 -72.97 135.93 45.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.963 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.499 HD22 ' HB ' ' A' ' 16' ' ' THR . 86.4 mt -140.1 103.97 4.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.541 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.485 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.5 t-20 -79.26 65.43 4.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.588 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.8 t -43.49 116.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.521 -178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.968 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -140.18 145.05 36.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -115.8 115.36 26.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HE1' HD22 ' A' ' 5' ' ' LEU . 68.8 mtm -133.82 -25.25 1.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 2' ' ' ILE . 9.5 mt 58.96 14.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.04 152.06 77.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.003 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.89 144.99 64.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.529 2.153 . . . . 0.0 112.28 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.52 HD22 ' HE1' ' A' ' 1' ' ' MET . 58.6 tp -125.02 -63.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.808 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.3 t -83.13 171.1 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.814 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.26 100.3 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -156.52 127.55 6.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -115.61 113.16 23.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.463 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -126.94 -86.57 0.59 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.573 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -25.15 107.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.776 -179.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.505 ' HD3' HD13 ' A' ' 108' ' ' LEU . 77.0 tttt -106.78 97.24 7.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.942 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.766 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.6 m95 -85.17 106.08 16.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.586 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.793 HG22 ' H ' ' A' ' 15' ' ' ASP . 2.9 p -152.94 -178.58 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 112.454 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.793 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -103.56 -179.74 4.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.797 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.503 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.67 -171.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.99 0.424 . . . . 0.0 111.793 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.6 m-70 -122.25 173.13 7.8 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.041 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.9 p -67.36 138.66 22.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.282 0.563 . . . . 0.0 112.163 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 62.05 11.65 32.98 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.276 -0.874 . . . . 0.0 113.872 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 18.9 tptt -60.04 83.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.236 0.518 . . . . 0.0 109.828 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 2.5 m -57.41 99.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.447 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 m -96.99 100.67 12.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.572 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.3 tt0 -83.24 133.86 34.98 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.984 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 HD22 ' A' ' 108' ' ' LEU . 39.3 mt -139.79 105.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.03 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -88.98 113.92 25.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.138 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.515 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 14.5 mt -109.48 147.36 33.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.274 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -100.68 161.19 13.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.895 0.379 . . . . 0.0 110.621 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.18 -155.14 25.62 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.456 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.622 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.6 t30 -172.04 118.95 0.43 Allowed Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 37.0 Cg_endo -67.26 -64.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.478 2.118 . . . . 0.0 113.506 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 69' ' ' GLY . 5.3 t -53.23 -22.91 7.53 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 29' ' ' ASN . 40.4 m -86.11 -67.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.77 0.319 . . . . 0.0 111.203 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.38 -117.66 4.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.929 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.446 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 -111.42 -171.45 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.919 0.39 . . . . 0.0 111.179 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.485 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.0 ttt -108.98 151.54 26.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.452 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 7.3 m95 -109.54 103.07 11.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.619 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.49 HG23 HG22 ' A' ' 42' ' ' VAL . 15.1 t -146.9 -174.05 4.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.573 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.717 ' NH1' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -77.38 138.22 39.18 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.846 0.355 . . . . 0.0 111.219 -178.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 89' ' ' GLU . 98.0 t -54.1 134.81 16.84 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.586 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -33.63 1.52 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.581 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -87.55 25.13 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.873 HG21 HG21 ' A' ' 93' ' ' THR . 25.3 t -79.63 107.17 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.985 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.62 -19.71 25.81 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -65.86 170.17 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.976 0.417 . . . . 0.0 111.131 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -84.15 -24.18 30.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.173 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.02 138.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.637 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 2.2 mt -88.83 -53.43 4.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.681 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -51.04 177.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -154.16 -95.64 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 111.751 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.88 -31.92 1.48 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.119 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.5 mm -72.12 -70.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.977 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 80' ' ' PRO . 16.2 mt -105.79 116.27 31.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.222 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -68.32 72.94 0.21 Allowed 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.554 HG11 ' NE ' ' A' ' 38' ' ' ARG . 3.8 t -76.44 84.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.304 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -81.51 82.74 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.548 ' HB3' HD12 ' A' ' 47' ' ' LEU . 11.1 t -108.71 147.9 31.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.426 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -138.87 125.4 20.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.485 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.33 97.08 7.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.925 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 25.9 m -90.29 116.05 65.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.443 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HB2' HG11 ' A' ' 70' ' ' VAL . 87.1 Cg_endo -98.93 -160.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.231 2.621 . . . . 0.0 111.586 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.703 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -94.46 141.27 23.25 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 110.881 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 61' ' ' THR . 38.3 Cg_exo -60.21 120.67 8.58 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.622 2.215 . . . . 0.0 112.257 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -91.99 152.81 19.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.7 m -91.17 -28.86 17.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.619 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 65.8 m -156.94 -50.13 0.01 OUTLIER Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.752 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 8.4 Cg_exo -73.42 -164.84 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 112.239 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 67' ' ' MET . 24.7 ttt -157.17 19.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.348 0.595 . . . . 0.0 110.089 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.46 116.49 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.084 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 31' ' ' THR . . . 94.33 74.32 1.24 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.387 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.703 ' HB ' ' H ' ' A' ' 61' ' ' THR . 0.0 OUTLIER -101.49 -111.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.274 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.468 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 122.35 77.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.634 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -118.72 -130.07 4.1 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.171 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 3.4 pt -131.47 -165.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 121.05 0.453 . . . . 0.0 110.763 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.515 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -143.38 103.68 4.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.027 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.3 p -95.77 126.53 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.285 0.564 . . . . 0.0 110.565 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.785 HG11 HD21 ' A' ' 88' ' ' LEU . 18.2 t -122.28 122.37 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.593 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 79.8 mt -109.94 96.4 6.22 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.851 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.568 ' CG2' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.35 105.38 16.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.239 -178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.4 mtmt -108.65 100.87 40.95 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.67 ' HA ' HD23 ' A' ' 52' ' ' LEU . 72.2 Cg_exo -48.18 96.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.733 2.289 . . . . 0.0 112.992 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 4.8 mtt180 -63.41 -37.01 85.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.652 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -116.44 -173.85 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.49 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.486 HH21 HG11 ' A' ' 18' ' ' VAL . 97.5 mtt180 -132.77 119.22 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.763 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.86 -100.59 0.19 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.33 100.98 7.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 1.0 OUTLIER -118.33 161.12 20.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.536 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.6 m -160.64 150.66 17.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.886 0.374 . . . . 0.0 111.76 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.785 HD21 HG11 ' A' ' 76' ' ' VAL . 20.6 tp -132.26 82.52 2.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.662 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -86.64 105.76 17.12 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.717 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.2 mt -89.81 167.09 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.769 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -155.2 147.18 12.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.934 0.397 . . . . 0.0 111.918 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.7 t80 -97.88 82.62 3.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.564 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.873 HG21 HG21 ' A' ' 42' ' ' VAL . 9.9 t -121.99 158.24 29.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 27.1 mtp180 -101.17 101.15 15.31 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.326 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 93' ' ' THR . 78.1 Cg_exo -46.99 -39.45 25.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.752 2.301 . . . . 0.0 113.257 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -72.14 9.38 0.99 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.73 4.56 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 0.0 111.348 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.95 -171.74 51.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.797 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -112.15 150.14 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 111.86 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.567 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -135.42 164.17 45.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.81 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.37 -19.79 13.0 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.543 2.162 . . . . 0.0 111.651 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.2 pt-20 -76.75 -0.11 22.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.7 m120 -82.21 149.41 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.44 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -60.9 171.5 1.19 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.805 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.662 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.2 tpp180 -136.9 159.5 41.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.662 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 36.0 t80 -162.21 72.62 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.874 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.745 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 22.7 m -85.51 151.33 24.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.866 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.4 tp -140.7 87.74 2.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.36 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.766 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 13.6 m-70 -74.69 144.11 43.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.503 HD22 ' HB ' ' A' ' 16' ' ' THR . 85.5 mt -144.66 102.75 3.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.296 -178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 8.8 t30 -80.6 61.3 4.26 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 80' ' ' PRO . 2.0 t -38.64 140.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.871 -1.058 . . . . 0.0 111.86 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.045 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.1 p -145.03 151.74 39.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -90.69 144.64 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -132.69 -177.15 4.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.32 -34.72 68.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.001 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 58.02 90.9 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.237 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.9 3.06 5.33 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.424 2.082 . . . . 0.0 112.376 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.2 mp -62.06 -28.35 69.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.831 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.401 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 47.7 t -76.25 171.97 13.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.84 134.1 57.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.382 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 6' ' ' SER . 13.9 mptt -107.88 26.84 9.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.025 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -38.39 118.38 0.71 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.199 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.637 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -114.3 -84.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.913 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.592 ' H ' HD22 ' A' ' 10' ' ' ASN . 8.6 m-20 -25.67 103.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.924 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 55.5 tptt -94.26 90.26 6.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.414 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.19 103.34 8.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.571 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -155.42 177.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.088 0.47 . . . . 0.0 111.83 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.773 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.9 OUTLIER -100.07 -178.17 3.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.765 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.495 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -175.59 -174.75 0.72 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.119 0.485 . . . . 0.0 112.08 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.648 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.9 m80 -115.51 -170.02 1.69 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.22 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 p -83.56 139.46 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.239 0.542 . . . . 0.0 112.308 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.11 22.29 9.54 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.289 -0.868 . . . . 0.0 113.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.69 81.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.692 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -51.63 96.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.864 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.426 ' HB ' HG23 ' A' ' 78' ' ' VAL . 73.3 m -91.6 101.6 14.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.958 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.3 tt0 -84.81 129.73 34.77 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.4 mt -139.66 98.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.031 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.87 106.32 11.8 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 11.3 mt -98.86 143.78 28.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.075 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' H ' ' HD3' ' A' ' 27' ' ' LYS . 1.4 mppt? -94.08 166.57 12.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.025 0.44 . . . . 0.0 110.806 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.81 -137.01 3.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.078 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 63.3 t30 -176.97 99.23 0.23 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.424 0.154 . . . . 0.0 110.615 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 17.9 Cg_endo -60.02 -6.22 4.67 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.636 2.224 . . . . 0.0 113.099 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.5 p -96.89 12.11 33.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.588 0.232 . . . . 0.0 111.611 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 29' ' ' ASN . 60.3 p -102.0 -66.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.137 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.97 -55.46 0.28 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.604 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.95 169.86 10.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 111.06 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 20.9 ttm -143.87 148.81 35.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.175 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 4.6 m95 -106.1 78.47 1.31 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.987 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 42' ' ' VAL . 12.0 t -125.73 -164.04 1.27 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.4 mtp85 -88.61 156.42 19.06 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 47.4 t -74.39 130.21 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.621 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.05 12.23 79.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.525 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 61.8 m-85 -135.25 -1.55 2.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.088 0.471 . . . . 0.0 110.578 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 18.7 t -53.85 117.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.02 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.36 -28.81 13.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.873 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 95.6 mttt -69.16 172.83 6.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -78.24 -62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.89 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.87 142.94 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.194 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt -94.64 -51.2 4.83 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.85 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.6 p -52.32 179.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.745 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -156.25 -90.98 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.7 pt-20 -130.12 -28.82 2.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.181 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.1 mm -76.85 -73.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.335 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 12.0 mt -103.94 115.52 30.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.539 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -71.02 69.38 0.48 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 78' ' ' VAL . 10.8 t -75.92 88.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.091 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 39.4 t -86.27 90.11 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 52.0 t -95.38 144.64 25.75 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.94 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 75.7 mttt -130.56 92.63 3.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.887 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.3 t80 -57.7 -17.8 17.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.321 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.441 HG22 HG13 ' A' ' 70' ' ' VAL . 29.9 m 31.57 78.09 0.31 Allowed Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.971 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -102.36 7.03 0.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 124.182 3.255 . . . . 0.0 113.298 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.518 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -58.44 136.91 85.63 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.021 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 61' ' ' THR . 88.7 Cg_endo -78.22 122.27 5.62 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.505 2.136 . . . . 0.0 112.464 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 55.9 m -79.57 142.59 35.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.939 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 m -109.68 -39.64 5.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.702 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 26.6 m -155.3 -53.46 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.601 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.702 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 40.1 Cg_endo -99.45 -149.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.86 3.04 . . . . 0.0 112.144 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.9 mtt 59.17 97.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.015 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.82 135.35 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.95 39.29 11.87 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.552 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.441 HG13 HG22 ' A' ' 59' ' ' THR . 72.8 t -140.37 81.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.044 0.449 . . . . 0.0 110.818 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.39 13.95 1.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.099 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 30' ' ' PRO . . . 102.31 68.38 0.8 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.249 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.6 pt -114.43 -152.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 1.5 m-85 -150.26 82.14 1.37 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.609 0.242 . . . . 0.0 110.782 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 93.3 t -79.91 91.9 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.062 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.535 HG11 HD21 ' A' ' 88' ' ' LEU . 40.4 t -90.05 118.67 35.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 21' ' ' THR . 79.1 mt -110.53 95.12 5.37 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.6 104.93 15.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.018 0.437 . . . . 0.0 111.31 -178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.0 mtmm -110.16 93.9 16.72 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.086 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 4.1 Cg_endo -48.6 100.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.594 2.196 . . . . 0.0 112.549 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.549 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.0 mtt180 -64.63 -32.67 74.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.998 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -120.91 -175.38 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.634 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -129.51 117.45 20.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.009 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.05 -107.56 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.251 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.491 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.0 m80 -116.48 91.6 3.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.896 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER -111.78 157.69 20.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.576 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 109' ' ' HIS . 47.0 m -159.47 146.04 16.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.643 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.1 tp -112.86 92.38 3.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.413 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.7 mt-10 -78.44 94.95 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.197 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 67.7 mt -101.8 135.03 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.7 p -140.11 154.26 23.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.007 0.432 . . . . 0.0 112.09 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.11 94.13 6.65 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.482 -0.781 . . . . 0.0 108.959 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 7.6 t -129.72 157.13 43.02 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 79.3 mtp180 -91.64 99.93 2.87 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.859 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.6 Cg_exo -37.93 -56.49 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.261 2.641 . . . . 0.0 113.732 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.466 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 8.2 p90 -78.15 23.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.7 mm-40 -149.9 0.87 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.82 178.38 50.44 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.483 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.2 mt -104.84 158.65 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.431 . . . . 0.0 111.933 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.517 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 13.1 mttt -135.26 165.99 32.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.883 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.11 -41.03 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.886 2.39 . . . . 0.0 111.974 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.47 -26.73 68.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -49.27 148.33 2.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.304 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 3.8 tt0 -53.76 160.67 1.3 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.639 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.1 tpp180 -133.54 161.21 35.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.54 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.639 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.5 t80 -171.33 65.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.0 m -87.35 94.66 9.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.39 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 36.2 tp -74.91 92.56 2.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.643 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.4 m-70 -77.55 138.48 39.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 16' ' ' THR . 84.3 mt -143.35 103.09 4.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.187 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.54 66.09 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.8 t -44.76 113.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.762 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.924 179.733 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.8 p -92.75 -24.13 18.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -126.77 161.58 27.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm -79.13 -175.52 4.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.9 pt -76.18 -5.3 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -125.18 145.81 51.82 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.123 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 38.7 Cg_exo -60.86 165.0 12.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.531 2.154 . . . . 0.0 112.142 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.0 tp -166.88 -43.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.733 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.0 m -125.8 -155.15 0.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.559 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.4 m -55.03 171.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.063 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -164.62 131.26 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.665 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.44 123.56 22.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.167 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.674 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -123.87 -93.97 0.5 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.018 0.437 . . . . 0.0 112.041 -179.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 2.2 m-20 -48.82 102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.447 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.425 ' HE2' HG21 ' A' ' 14' ' ' VAL . 75.5 tttt -97.23 93.09 6.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.107 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -82.01 99.93 9.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.425 HG21 ' HE2' ' A' ' 12' ' ' LYS . 34.1 m -149.82 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.132 0.491 . . . . 0.0 112.271 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.78 -163.71 1.06 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.133 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t 178.24 -175.04 0.17 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 59.0 m80 -120.73 -164.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 83' ' ' ARG . 24.2 t -95.76 115.45 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.062 0.458 . . . . 0.0 111.442 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 67.99 10.7 59.54 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.108 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.8 tptm -60.11 88.3 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.729 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -45.6 103.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.702 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.9 m -91.26 94.75 9.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.571 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HA ' HD23 ' A' ' 77' ' ' LEU . 42.3 tt0 -80.11 128.41 33.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.69 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -136.18 104.55 4.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.56 96.97 8.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.423 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.523 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 7.8 mt -91.12 140.89 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.196 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' HG22 ' A' ' 73' ' ' ILE . 54.6 mttm -98.98 165.31 11.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.944 0.402 . . . . 0.0 110.603 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.51 -132.72 2.52 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 32' ' ' THR . 60.6 t30 -174.24 95.42 0.31 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.32 0.105 . . . . 0.0 110.767 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 12.1 Cg_endo -55.91 -13.66 9.36 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.662 2.241 . . . . 0.0 112.971 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -101.62 21.82 13.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 29' ' ' ASN . 6.2 t -100.13 -31.68 11.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 134.86 -39.27 1.71 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.691 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' H ' HG23 ' A' ' 32' ' ' THR . 41.7 m-85 -93.33 -175.43 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.047 0.451 . . . . 0.0 111.371 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.537 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 10.1 ttm -149.09 149.25 30.77 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.802 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.5 m95 -103.23 85.31 2.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.894 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.538 HG23 HG22 ' A' ' 42' ' ' VAL . 14.5 t -137.23 165.46 26.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.652 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.696 HH11 HD11 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -61.37 132.89 54.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.905 0.383 . . . . 0.0 111.085 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 89' ' ' GLU . 3.8 p -55.07 147.67 3.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.486 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.74 -8.03 3.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.278 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.715 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 21.8 m-85 -117.7 33.37 5.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 109.943 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 93' ' ' THR . 13.0 t -97.55 87.82 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.582 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.21 7.37 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -66.77 -160.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.537 -0.831 . . . . 0.0 111.722 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.516 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 5.8 m-20 -106.94 -41.12 5.28 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.664 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.3 t -152.8 118.21 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.963 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 56' ' ' CYS . 14.5 mt -55.0 -59.25 5.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.331 179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.588 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 3.2 t -45.55 168.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.961 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 50' ' ' GLU . 11.4 m-20 -157.53 -159.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.961 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 49' ' ' ASP . 9.4 pt-20 -74.69 -29.82 61.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.854 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 13.9 mm -80.38 -74.77 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.325 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 80' ' ' PRO . 19.7 mt -104.42 109.28 21.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.527 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.43 75.59 0.26 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 HG13 ' A' ' 78' ' ' VAL . 1.7 t -82.58 91.61 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 23.3 t -92.88 95.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.784 178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HB3' HD12 ' A' ' 47' ' ' LEU . 41.0 t -111.9 148.61 33.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.438 0.637 . . . . 0.0 112.151 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -126.17 110.28 13.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.559 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.87 102.81 11.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.566 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 61' ' ' THR . 30.8 m -104.67 116.51 60.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -98.0 12.3 0.87 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.042 2.495 . . . . 0.0 112.25 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 59' ' ' THR . 4.4 m -62.19 136.24 95.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.16 152.74 23.69 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.757 2.305 . . . . 0.0 112.368 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.6 m -72.57 -173.59 1.19 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.5 m -64.07 -42.84 96.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.924 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.1 p -85.53 155.04 59.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.302 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.21 -156.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.74 2.293 . . . . 0.0 112.141 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.4 mmm 61.17 17.61 8.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.6 t -129.73 110.71 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.92 100.87 2.45 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.337 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t 47.75 83.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.008 0.432 . . . . 0.0 111.264 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -146.34 109.55 0.49 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.36 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -115.14 -125.56 4.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.821 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt -149.81 -165.19 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.947 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.5 OUTLIER -132.74 98.07 4.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.063 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 80.5 t -84.37 103.42 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.951 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.577 HG22 HH22 ' A' ' 38' ' ' ARG . 33.0 t -102.3 123.28 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.729 HD22 HG22 ' A' ' 21' ' ' THR . 64.9 mt -112.68 93.45 4.44 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG13 HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.85 107.14 18.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.116 0.484 . . . . 0.0 111.102 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -108.96 95.15 16.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.462 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HA ' HD23 ' A' ' 52' ' ' LEU . 9.7 Cg_endo -53.06 102.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.153 1.902 . . . . 0.0 111.965 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.437 HH11 ' HA ' ' A' ' 50' ' ' GLU . 17.2 mtt180 -64.82 -45.33 86.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.52 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -106.32 173.56 6.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.041 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.48 ' HG2' HG22 ' A' ' 18' ' ' VAL . 59.4 mtp180 -109.42 142.64 40.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.03 -150.97 20.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.336 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -87.47 92.18 9.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.873 0.368 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CD2' HG21 ' A' ' 112' ' ' VAL . 1.7 m-70 -108.77 156.18 19.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.464 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 109' ' ' HIS . 90.5 m -160.34 151.33 18.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.116 0.484 . . . . 0.0 111.851 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.678 HD21 ' HD3' ' A' ' 38' ' ' ARG . 13.8 tp -128.71 142.73 50.92 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 6.1 mt-10 -123.56 86.73 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.216 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.696 HD11 HH11 ' A' ' 38' ' ' ARG . 7.0 mp -75.5 125.77 29.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.073 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 92' ' ' TYR . 12.8 p -122.29 156.45 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.76 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -102.51 95.91 6.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.465 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 42' ' ' VAL . 3.5 t -125.35 169.97 11.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -101.6 93.86 3.79 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.118 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -44.29 -27.76 2.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.777 2.318 . . . . 0.0 112.74 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -71.71 -46.22 59.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.472 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -92.82 -67.96 0.83 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.93 0.395 . . . . 0.0 111.262 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.41 172.48 27.73 Favored Glycine 0 CA--C 1.507 -0.459 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.99 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.804 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.2 mt -86.15 139.31 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.932 0.396 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -128.5 164.53 37.41 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.253 -178.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.65 -35.19 8.14 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.038 2.492 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.81 11.99 0.94 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.211 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.507 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -88.1 150.36 23.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.41 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.2 tt0 -54.43 162.36 1.14 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.584 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.674 ' HB3' HD22 ' A' ' 10' ' ' ASN . 15.0 tpp180 -131.93 163.9 27.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.273 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.9 t80 -174.3 71.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.036 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 27.5 m -84.4 101.67 12.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.504 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 78' ' ' VAL . 59.4 tp -79.05 89.46 4.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 4.6 m-70 -76.77 137.11 39.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.563 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -145.28 104.42 3.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.39 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -80.68 73.74 7.64 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -51.86 123.98 3.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.455 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.981 179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.8 m -140.46 140.23 35.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.717 0.294 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -118.67 117.22 28.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp 58.29 -171.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.8 mp -87.65 -40.81 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.85 89.37 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.147 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.83 126.49 21.91 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.522 2.148 . . . . 0.0 112.336 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.35 -64.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.4 m -152.0 -14.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.1 t -94.43 132.17 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -142.69 -161.5 1.26 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -122.4 108.34 13.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 110.32 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.644 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -129.19 -87.33 0.54 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.127 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.603 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -30.11 106.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.189 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 14' ' ' VAL . 53.5 tttp -95.27 101.08 12.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.987 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.65 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.0 m95 -84.18 102.11 12.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.318 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 12' ' ' LYS . 34.6 m -147.47 -168.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.923 0.392 . . . . 0.0 111.733 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.55 -179.32 3.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.482 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.486 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.22 -172.66 0.6 Allowed 'General case' 0 C--O 1.232 0.133 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.621 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.3 m80 -115.98 -163.74 0.92 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.268 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 38.4 t -93.27 137.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.115 0.483 . . . . 0.0 112.083 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.07 15.03 9.1 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.492 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptm -64.08 82.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.82 98.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.579 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 78' ' ' VAL . 86.5 m -91.63 99.83 12.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.532 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.3 tt0 -81.66 130.28 35.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.7 mt -134.29 104.85 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.873 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -85.94 96.54 9.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.493 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.4 mt -91.73 145.18 24.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.442 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.93 163.13 12.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.546 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.16 -141.31 5.03 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.558 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB3' HG23 ' A' ' 32' ' ' THR . 59.1 t30 -174.6 94.39 0.3 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.557 0.218 . . . . 0.0 110.575 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 50.9 Cg_exo -53.86 -15.84 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.786 2.324 . . . . 0.0 113.28 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.6 HG21 ' HA2' ' A' ' 69' ' ' GLY . 69.4 p -86.41 13.28 8.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 29' ' ' ASN . 47.5 p -95.5 -58.61 2.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.795 0.331 . . . . 0.0 111.092 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.75 -29.37 0.67 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 42.9 m-85 -97.48 -176.4 3.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 0.0 111.062 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.7 ttm -149.16 151.68 34.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -106.37 86.98 2.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.113 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -132.02 -167.4 1.87 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.101 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 24.7 mtp85 -88.54 150.25 23.18 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.877 0.37 . . . . 0.0 111.144 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.0 t -69.57 131.91 33.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.617 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.61 6.33 89.21 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.576 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.9 m-85 -130.81 -0.76 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.505 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.942 HG21 HG21 ' A' ' 93' ' ' THR . 14.2 t -55.08 103.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.022 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.92 -28.96 10.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.233 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' A' ' 44' ' ' LYS . 8.7 mtpm? -63.68 172.11 2.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 111.108 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -71.61 -55.87 6.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.0 t -117.66 142.36 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.598 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.1 mt -87.64 -46.46 9.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.811 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 48.3 t -57.0 -179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.208 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.14 -88.6 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.41 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.17 -37.61 1.45 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.89 -77.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.38 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 54' ' ' VAL . 69.6 mt -111.23 125.52 53.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 72.37 0.23 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 52' ' ' LEU . 3.1 t -75.8 85.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.8 t -84.76 84.52 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.503 ' HB3' HD12 ' A' ' 47' ' ' LEU . 33.8 t -99.53 148.15 24.58 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.324 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -138.15 111.18 7.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.304 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.452 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -76.42 102.67 6.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.281 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 22.9 m -100.56 109.44 57.31 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.076 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 75.5 Cg_endo -100.45 96.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.582 2.854 . . . . 0.0 111.132 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.519 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -75.86 141.06 71.26 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.36 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 61' ' ' THR . 23.9 Cg_exo -63.88 -178.95 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.742 2.294 . . . . 0.0 112.171 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.9 t -150.54 165.44 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.824 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.4 p -55.74 -27.07 48.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.694 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 64.2 p -61.44 161.18 20.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.894 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 47.5 Cg_endo -65.96 -152.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.536 2.158 . . . . 0.0 112.081 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.4 mtm -53.85 -16.22 1.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.359 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.21 100.1 9.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.022 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.6 ' HA2' HG21 ' A' ' 31' ' ' THR . . . 140.42 106.87 0.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.639 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.3 p -151.22 86.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.288 0.566 . . . . 0.0 110.868 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -96.28 132.78 11.18 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.006 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -142.66 -136.4 3.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.099 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.3 pt -146.68 -166.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 110.978 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -136.66 100.13 4.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.5 t -85.21 103.42 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.6 t -106.01 119.29 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.211 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 75.3 mt -109.37 98.98 8.29 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.824 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.73 104.01 15.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.953 0.406 . . . . 0.0 111.256 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -102.87 101.67 22.43 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.021 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 77.5 Cg_exo -47.03 98.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.802 2.335 . . . . 0.0 113.299 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -74.47 -36.21 63.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.354 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.38 172.0 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.641 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.3 121.82 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.577 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 139.9 -149.77 21.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.576 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.02 98.17 0.41 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.4 ' HB3' HD21 ' A' ' 52' ' ' LEU . 19.4 m-70 -132.97 156.44 47.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.48 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.544 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 90.6 m -158.92 155.63 28.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.022 0.439 . . . . 0.0 112.111 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 28.8 tp -104.51 94.1 5.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.888 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.589 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.6 mt-10 -73.43 96.51 2.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.186 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.0 mt -112.15 135.46 52.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.2 p -142.49 154.71 18.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 120.939 0.399 . . . . 0.0 111.765 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.6 t80 -98.35 88.89 4.27 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.942 HG21 HG21 ' A' ' 42' ' ' VAL . 3.9 t -117.74 172.6 7.26 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -102.91 93.1 4.07 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.305 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.8 Cg_exo -43.59 -35.62 6.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.743 2.295 . . . . 0.0 112.729 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -71.9 -39.61 69.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.303 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -96.73 -72.83 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.397 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 178.0 36.43 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.973 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.665 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.5 mt -90.91 147.89 4.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.035 0.445 . . . . 0.0 111.436 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 13.8 mttt -134.54 162.28 58.63 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.151 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 46.5 Cg_endo -69.22 -40.9 5.52 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.686 2.258 . . . . 0.0 112.16 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.66 -25.76 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.566 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -53.18 149.58 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.348 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.2 tt0 -56.08 161.12 2.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.9 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.663 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.2 tpp180 -132.35 163.54 28.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.992 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.663 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 51.0 t80 -172.78 71.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.466 0.65 . . . . 0.0 109.424 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.09 90.29 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.156 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.8 tp -70.85 90.59 0.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 29.2 m-70 -72.0 145.91 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.592 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.7 mt -146.54 115.94 7.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.665 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.517 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.1 t30 -83.96 51.1 1.97 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.577 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.7 t -36.05 121.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.825 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.351 -0.833 . . . . 0.0 111.036 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.7 p -98.54 122.12 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -146.18 132.36 19.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -131.91 134.33 45.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 pt -93.72 16.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.07 111.98 3.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.22 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.91 130.02 19.62 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.448 2.099 . . . . 0.0 112.308 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -134.49 -174.1 3.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -61.08 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -79.33 143.93 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -172.48 133.49 0.63 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.432 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.38 120.67 11.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.604 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -125.06 -94.76 0.47 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 111.945 -179.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -54.06 100.33 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.5 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.595 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -92.65 93.34 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -76.83 102.98 6.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.74 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG23 HD23 ' A' ' 110' ' ' LEU . 17.5 m -150.14 -172.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.067 0.46 . . . . 0.0 112.126 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -107.75 179.43 4.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.591 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.5 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.7 t -175.37 -175.07 0.78 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.018 0.437 . . . . 0.0 111.978 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.485 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 62.3 m-70 -118.76 -171.9 2.18 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.271 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.28 125.95 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 111.789 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 66.37 18.5 67.57 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.571 -0.741 . . . . 0.0 113.393 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -59.61 85.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.74 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -55.86 98.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.348 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.1 m -96.09 103.37 15.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.634 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HA ' HD23 ' A' ' 77' ' ' LEU . 40.1 tt0 -81.93 131.14 35.25 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.803 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.477 HD11 HD22 ' A' ' 108' ' ' LEU . 46.8 mt -137.21 105.43 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.953 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.68 99.85 12.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.254 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.1 mt -96.11 149.08 22.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.604 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.27 162.21 13.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.17 -144.11 6.04 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.578 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -174.28 93.74 0.32 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.337 0.113 . . . . 0.0 110.761 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HB3' ' OH ' ' A' ' 58' ' ' TYR . 12.4 Cg_endo -56.58 -21.02 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.738 2.292 . . . . 0.0 112.905 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.2 p -73.64 1.86 9.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.682 0.277 . . . . 0.0 111.443 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.1 p -90.83 -52.66 4.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.029 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.96 -38.64 0.84 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.746 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 78.9 m-85 -85.37 176.74 8.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.31 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.556 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.6 ttm -144.02 149.79 37.24 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.197 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.0 m95 -102.77 82.8 2.17 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -128.48 -171.2 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.25 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.704 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.4 mtp85 -86.28 144.05 27.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.013 0.435 . . . . 0.0 111.09 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.83 144.53 12.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.067 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.81 72.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.116 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.503 ' O ' ' C ' ' A' ' 42' ' ' VAL . 53.8 m-85 -138.24 -37.95 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.726 0.263 . . . . 0.0 111.43 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.558 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.8 p -18.11 118.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 123.767 0.667 . . . . 0.0 112.439 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.53 7.72 61.56 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.018 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.732 ' HD3' ' H ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -89.02 -164.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.237 0.541 . . . . 0.0 111.794 -179.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.69 -32.67 5.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.561 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.2 t -144.91 122.72 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.701 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 1.9 mt -68.92 -56.57 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.373 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.499 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.2 p -49.0 176.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.847 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.62 -77.14 0.05 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.37 -36.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.361 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 24.5 mm -72.22 -79.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.453 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD22 HG12 ' A' ' 78' ' ' VAL . 11.0 mt -99.23 114.52 27.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.517 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.72 68.9 0.27 Allowed 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 78' ' ' VAL . 16.4 t -74.0 84.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.862 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 t -80.95 85.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.8 t -102.26 144.28 30.97 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.612 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -130.2 107.46 9.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.055 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -80.2 108.73 14.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.412 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 26.3 m -113.05 117.28 46.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.201 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.601 ' HB2' HG12 ' A' ' 70' ' ' VAL . 62.9 Cg_endo -99.88 47.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.381 2.721 . . . . 0.0 111.566 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.455 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -45.76 154.91 0.52 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.698 -179.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.455 ' HD2' HG22 ' A' ' 61' ' ' THR . 57.5 Cg_exo -52.51 123.17 12.22 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.607 2.205 . . . . 0.0 112.505 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 t -66.98 173.98 3.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.9 m -83.15 17.23 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.971 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.4 p -57.41 155.49 19.08 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.67 10.38 2.27 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.717 2.278 . . . . 0.0 112.794 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.524 ' HG3' HG23 ' A' ' 68' ' ' VAL . 50.8 tpp -172.44 -90.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.403 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 67' ' ' MET . 51.4 t -91.14 126.21 43.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.296 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.68 131.79 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.52 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 60' ' ' PRO . 47.6 t -136.23 77.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.964 0.411 . . . . 0.0 110.76 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.32 114.19 0.94 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.572 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -110.62 -120.97 4.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.501 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.7 pt -145.69 -164.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.005 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.6 m-85 -135.26 99.48 4.26 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 57.9 t -84.99 101.89 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.729 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.492 HG22 ' SG ' ' A' ' 56' ' ' CYS . 40.0 t -105.9 121.02 57.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 21' ' ' THR . 78.8 mt -111.37 99.54 8.31 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.493 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.11 106.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.0 0.428 . . . . 0.0 111.359 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.4 mtmm -111.69 92.85 18.13 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.084 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.601 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.1 Cg_endo -51.26 101.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.437 2.091 . . . . 0.0 112.648 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 18.9 mtt180 -64.17 -29.85 70.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.397 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -127.36 -177.23 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.321 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 21.3 ptt180 -120.31 139.96 51.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.841 0.353 . . . . 0.0 111.061 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.58 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.5 -118.82 0.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.691 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -116.65 30.66 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.879 0.371 . . . . 0.0 111.006 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.439 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -46.83 152.06 0.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.568 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 78.2 m -158.24 142.58 15.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.5 tp -93.19 90.53 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.538 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.8 mt-10 -72.57 96.21 1.93 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.699 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.579 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 28.0 mt -111.36 137.97 48.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.7 p -146.47 157.16 11.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.487 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.2 t80 -95.8 91.28 5.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.748 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.4 t -121.73 150.87 41.2 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 77.6 mtp180 -87.42 100.53 1.71 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.872 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 5.5 Cg_endo -51.44 -30.33 34.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.384 2.056 . . . . 0.0 112.039 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -72.36 -32.05 66.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.271 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -108.75 -78.6 0.59 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.282 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.48 -178.73 45.28 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.321 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.748 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -94.36 152.16 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -144.79 154.99 56.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.85 -47.13 4.04 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.897 2.398 . . . . 0.0 112.632 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.89 -14.75 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.759 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.9 m120 -68.56 159.23 32.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.887 0.375 . . . . 0.0 111.445 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 5.0 tt0 -56.49 157.03 5.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.5 tpp180 -130.93 163.16 28.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.918 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.613 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 59.6 t80 -175.32 73.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.534 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.615 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -96.11 88.78 4.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.353 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.5 tp -69.5 90.86 0.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.008 0.432 . . . . 0.0 110.523 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.0 m-70 -73.03 143.75 47.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.602 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.56 HD23 HG23 ' A' ' 14' ' ' VAL . 87.2 mt -144.39 111.83 6.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.6 t30 -83.41 59.53 5.11 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -38.54 133.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.629 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.94 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.5 p -98.08 114.71 26.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -97.96 118.56 34.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp -132.2 176.64 8.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.0 mp -96.09 -29.61 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.71 153.74 15.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.7 137.78 67.25 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.539 2.159 . . . . 0.0 112.354 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.48 178.19 4.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.1 p -104.97 6.8 33.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.71 16.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -86.96 -43.08 12.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.264 0.554 . . . . 0.0 110.624 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.53 134.72 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.014 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.895 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 2.1 p30 -102.0 -91.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.841 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -128.21 -112.55 0.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.877 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG2' HG13 ' A' ' 14' ' ' VAL . 32.7 ttpt -162.03 151.03 15.52 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.886 0.374 . . . . 0.0 111.001 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.773 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.0 m0 -106.07 115.79 30.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.13 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 12' ' ' LYS . 19.6 m -148.7 -173.79 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.586 ' HA ' ' N ' ' A' ' 111' ' ' ASN . 3.3 p-10 -101.85 -171.54 1.99 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.706 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.5 t -175.32 178.89 1.6 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.073 0.463 . . . . 0.0 112.059 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.663 ' O ' HG13 ' A' ' 112' ' ' VAL . 74.9 m80 -109.73 -144.37 0.39 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -106.02 132.23 53.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.163 0.506 . . . . 0.0 111.586 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.76 18.66 46.77 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.328 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tptt -61.35 83.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.648 HG22 HD12 ' A' ' 77' ' ' LEU . 4.6 m -55.48 102.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.631 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 78' ' ' VAL . 93.3 m -105.69 97.39 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.346 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 25' ' ' HIS . 28.6 tt0 -72.79 122.09 20.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.299 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.3 mm -117.33 101.0 11.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 23' ' ' GLU . 2.4 m80 -89.94 115.68 27.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.377 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 51.5 mt -111.83 147.49 35.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.309 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -100.99 162.36 12.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.593 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.75 -132.79 2.46 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.347 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB3' HG23 ' A' ' 32' ' ' THR . 44.5 t30 -176.26 97.85 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.353 0.121 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 54.1 Cg_exo -53.14 -18.11 9.46 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.443 2.095 . . . . 0.0 112.508 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.1 m -70.65 -32.5 69.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.479 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 29' ' ' ASN . 75.4 p -53.27 -64.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.428 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.07 -53.06 0.41 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.784 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -80.07 140.99 36.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 111.26 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.5 ttm -99.98 153.22 19.36 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.5 m95 -101.95 88.76 3.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.152 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -133.04 -169.05 2.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.396 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' NH2' ' HA ' ' A' ' 48' ' ' SER . 6.6 mtp85 -82.28 142.72 31.86 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.384 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 89' ' ' GLU . 60.2 t -53.86 145.09 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.122 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 58.21 6.89 3.4 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.845 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -127.86 29.22 5.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.527 0.68 . . . . 0.0 110.707 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.641 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.4 p -65.45 133.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.999 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.21 -21.82 26.22 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HB2' HD23 ' A' ' 47' ' ' LEU . 61.5 mttp -70.74 172.35 8.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 0.0 111.051 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 -54.64 2.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.427 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -80.49 -35.93 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.486 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.6 mt 72.8 -58.26 0.6 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.56 ' HA ' ' NH2' ' A' ' 38' ' ' ARG . 67.2 p -63.67 -162.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.848 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -162.42 -73.36 0.05 OUTLIER 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG3' ' HE2' ' A' ' 82' ' ' LYS . 12.7 pt-20 -142.14 -24.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.937 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -70.19 -66.93 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.113 0.482 . . . . 0.0 111.559 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -116.98 105.86 12.78 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.964 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -59.06 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.003 0.43 . . . . 0.0 110.759 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 52' ' ' LEU . 40.7 t -95.3 92.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.828 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.3 t -84.36 77.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.503 0.668 . . . . 0.0 109.2 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 76' ' ' VAL . 13.0 t -92.19 134.81 34.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.283 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 75' ' ' VAL . 43.0 mtmt -129.64 119.47 23.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.317 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 1.1 t80 -84.29 98.78 10.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.123 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 26.6 m -91.22 108.7 30.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.291 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.659 ' HB2' HG11 ' A' ' 70' ' ' VAL . 61.0 Cg_endo -102.47 93.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.713 2.942 . . . . 0.0 111.465 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.53 ' O ' HG12 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -75.24 138.34 71.88 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 61' ' ' THR . 25.9 Cg_exo -62.05 113.76 2.02 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.679 2.253 . . . . 0.0 112.256 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.6 m -103.22 -174.1 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.3 p -72.82 -6.86 47.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 71.8 p -63.75 156.23 73.28 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 72.5 Cg_endo -73.68 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.546 2.164 . . . . 0.0 112.109 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 56.3 ttp -65.71 -14.31 61.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.976 0.417 . . . . 0.0 110.814 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.77 108.58 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.01 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.4 164.99 38.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.542 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.659 HG11 ' HB2' ' A' ' 60' ' ' PRO . 14.9 t -126.89 -104.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.626 0.251 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 141.76 87.37 0.11 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.978 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -146.48 -138.68 3.21 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 5.9 pt -139.74 -164.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.014 0.435 . . . . 0.0 110.934 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -139.93 100.0 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.284 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 57' ' ' LYS . 10.4 p -92.25 133.13 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 109.856 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 56' ' ' CYS . 43.6 t -132.93 99.89 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.648 HD12 HG22 ' A' ' 21' ' ' THR . 2.1 mm? -83.09 103.8 12.8 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.624 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.33 112.66 28.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.947 0.403 . . . . 0.0 110.797 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.8 mtmm -118.25 101.63 51.17 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.05 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 112' ' ' VAL . 4.6 Cg_endo -49.17 101.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.477 2.118 . . . . 0.0 112.278 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 3.8 mtt180 -74.89 -42.47 57.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.498 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 67.2 mttm -113.71 160.03 19.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.013 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -96.19 129.15 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.538 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.53 -119.24 0.95 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.456 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -121.14 99.47 6.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.501 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 0.3 OUTLIER -111.18 164.79 12.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.833 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 m -161.78 152.98 18.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.668 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.7 tp -119.4 77.79 1.24 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.959 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -81.53 107.76 14.55 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.823 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 38' ' ' ARG . 96.2 mt -101.78 154.86 18.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.362 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -146.89 158.92 9.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.23 0.538 . . . . 0.0 112.04 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -94.34 68.9 3.62 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.702 ' HB ' HG23 ' A' ' 99' ' ' ILE . 1.1 t -84.73 167.27 16.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.82 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -109.35 92.67 11.92 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.718 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.92 -33.71 26.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.635 2.223 . . . . 0.0 112.541 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -69.41 -31.36 69.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.395 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -116.11 -81.28 0.61 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.445 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.58 -172.07 40.09 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.32 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.702 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.9 mt -102.99 116.55 46.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.658 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -108.0 170.54 5.43 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.58 -35.53 16.95 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.514 2.143 . . . . 0.0 112.175 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.45 -19.24 22.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.435 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.77 132.54 52.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.858 0.361 . . . . 0.0 111.325 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -53.55 161.06 1.11 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.713 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.666 ' HG2' HD22 ' A' ' 10' ' ' ASN . 4.4 tpt180 -126.47 153.12 45.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.242 0.544 . . . . 0.0 112.171 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.895 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 42.5 t80 -165.1 83.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.049 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 89' ' ' GLU . 1.4 m -95.81 111.46 23.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.483 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 21.7 tp -98.0 94.13 6.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.958 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 37.0 m-70 -77.27 141.16 40.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.116 0.484 . . . . 0.0 111.033 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 73.7 mt -144.17 77.91 1.56 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.298 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.586 ' N ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 t30 -57.17 89.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 17' ' ' HIS . 5.5 t -57.9 133.49 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.724 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.146 -0.93 . . . . 0.0 110.972 179.692 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -143.8 127.33 16.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -89.12 -66.83 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt -135.44 159.31 41.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.74 -30.64 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.93 129.09 36.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -80.76 20.84 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.532 2.155 . . . . 0.0 112.436 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.36 -60.65 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.9 m -63.89 -71.67 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.038 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.32 -176.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -170.49 132.76 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.526 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.1 120.99 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.391 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.699 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -127.7 -92.32 0.48 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.131 0.491 . . . . 0.0 112.026 -179.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.486 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -47.75 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.083 -179.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HD3' HD13 ' A' ' 108' ' ' LEU . 53.4 tttp -102.47 98.7 8.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.763 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.71 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.3 m95 -87.55 104.32 16.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.265 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG23 HD23 ' A' ' 110' ' ' LEU . 30.7 m -146.45 -171.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.012 0.434 . . . . 0.0 112.055 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.25 -176.04 2.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.585 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.6 t -175.83 -177.04 0.9 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.138 0.494 . . . . 0.0 112.164 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.8 m80 -115.1 -167.7 1.28 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.805 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -84.55 128.94 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.169 0.509 . . . . 0.0 111.905 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.63 20.63 59.55 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.483 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.582 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.2 tptp -59.03 84.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.026 0.413 . . . . 0.0 109.975 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.758 HG22 HD22 ' A' ' 77' ' ' LEU . 3.9 m -55.72 93.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.353 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 52.2 m -94.59 101.91 13.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.69 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.0 tt0 -82.43 133.46 35.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.577 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.572 HD11 HD22 ' A' ' 108' ' ' LEU . 41.4 mt -135.5 101.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.158 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -84.72 107.87 17.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.3 mt -100.89 144.86 29.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.273 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.9 164.01 13.81 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.93 0.395 . . . . 0.0 110.334 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.61 -139.84 5.78 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.636 -0.793 . . . . 0.0 112.291 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -175.4 88.51 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 67.8 Cg_exo -52.32 -16.99 5.62 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.713 2.275 . . . . 0.0 113.123 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.1 p -82.06 11.0 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.471 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.9 p -100.58 -63.27 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.077 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 163.14 -45.15 0.33 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.769 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 90.2 m-85 -72.32 178.57 3.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.068 0.461 . . . . 0.0 111.212 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.28 151.97 32.56 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.062 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.47 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 3.8 m95 -110.38 88.97 2.89 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.87 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 42' ' ' VAL . 5.9 t -136.67 -168.7 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.927 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.603 ' HD2' HG21 ' A' ' 54' ' ' VAL . 10.2 mtp85 -81.17 140.26 35.08 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.784 0.326 . . . . 0.0 111.102 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 89' ' ' GLU . 20.3 t -54.39 144.44 5.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.53 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.18 -0.97 5.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.864 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.731 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 26.9 m-85 -128.66 54.12 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.568 0.699 . . . . 0.0 110.504 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.849 HG21 HG21 ' A' ' 93' ' ' THR . 26.2 t -107.69 121.94 61.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.653 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 4.16 85.85 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -67.99 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.308 -0.946 . . . . 0.0 111.555 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 3.9 m-20 -107.95 -47.06 3.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.657 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.5 p -144.38 127.92 12.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.724 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.675 HD23 ' HD3' ' A' ' 44' ' ' LYS . 36.9 mt -68.77 -63.49 1.05 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.795 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 53' ' ' GLU . 36.9 t -47.23 174.14 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.961 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -157.02 -83.13 0.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.91 -31.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.135 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.3 mm -73.97 -79.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.509 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -99.93 115.84 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.678 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -68.78 70.27 0.19 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.603 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -75.41 83.71 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.251 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -83.72 84.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HB3' HD12 ' A' ' 47' ' ' LEU . 21.1 t -99.29 127.11 45.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.439 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' O ' HG12 ' A' ' 75' ' ' VAL . 41.2 mttm -109.37 107.32 17.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.597 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -81.66 103.99 11.75 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.42 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.499 HG22 HG12 ' A' ' 70' ' ' VAL . 1.2 m -102.45 119.31 56.55 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.007 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 83.7 Cg_endo -94.78 -168.98 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.163 2.575 . . . . 0.0 113.134 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.52 158.58 78.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.281 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.619 ' HG3' ' H ' ' A' ' 70' ' ' VAL . 32.5 Cg_exo -58.68 126.54 21.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.673 2.248 . . . . 0.0 112.465 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 55.4 m -88.74 -168.87 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.857 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -62.25 -15.82 49.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.024 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.3 p -60.27 155.77 44.42 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.51 10.08 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.41 65.86 6.28 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.719 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.82 136.08 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.346 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.23 65.55 1.79 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.418 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.619 ' H ' ' HG3' ' A' ' 62' ' ' PRO . 60.2 t -85.27 -88.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 0.0 111.251 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.421 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -144.73 -101.26 0.33 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.092 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.29 18.42 12.07 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.126 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.2 pt -140.48 -162.45 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.153 0.502 . . . . 0.0 111.156 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.47 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -138.37 109.68 6.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.136 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 57' ' ' LYS . 5.0 p -103.58 111.51 33.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' SG ' ' A' ' 56' ' ' CYS . 28.1 t -104.97 124.04 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.482 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.758 HD22 HG22 ' A' ' 21' ' ' THR . 83.7 mt -109.65 100.96 9.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -94.75 108.89 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.1 mtmt -114.27 94.14 34.04 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.354 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.605 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.48 105.43 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.495 2.13 . . . . 0.0 112.577 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 17.5 mtt180 -69.62 -35.85 75.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -117.64 -177.39 3.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.872 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HE ' HG21 ' A' ' 18' ' ' VAL . 85.9 mtt180 -121.3 142.21 50.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 141.8 -107.37 0.5 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.456 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 66.8 m80 -125.96 94.68 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 111.14 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -109.96 162.6 14.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.163 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.2 m -159.92 149.62 18.16 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.582 ' HB2' HG11 ' A' ' 78' ' ' VAL . 27.1 tp -119.47 80.19 1.53 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.977 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -77.71 106.85 9.79 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.968 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 38' ' ' ARG . 73.1 mt -102.96 154.0 19.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.099 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.43 152.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.833 0.349 . . . . 0.0 111.578 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.3 t80 -102.67 92.09 4.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.849 HG21 HG21 ' A' ' 42' ' ' VAL . 8.1 t -131.42 162.54 29.94 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.5 mtp180 -94.96 95.36 1.53 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.613 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.54 ' HB3' HG12 ' A' ' 42' ' ' VAL . 1.3 Cg_endo -45.45 -34.07 10.17 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.094 2.529 . . . . 0.0 112.967 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -72.39 -36.78 68.78 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.019 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -102.58 6.32 39.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.675 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.4 -168.35 42.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.923 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.686 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.7 mt -117.14 154.49 18.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.27 0.557 . . . . 0.0 112.343 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.6 ' HB2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -136.26 163.55 49.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.549 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.53 -17.47 16.28 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.569 2.179 . . . . 0.0 111.665 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HG2' ' HB2' ' A' ' 100' ' ' LYS . 11.3 pt-20 -78.79 -6.73 56.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.46 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 100' ' ' LYS . 12.4 m120 -69.65 151.11 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.51 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -60.99 166.31 3.57 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.584 179.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.699 ' HB3' HD22 ' A' ' 10' ' ' ASN . 16.6 tpp180 -130.46 163.69 26.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.597 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 46.7 t80 -172.97 68.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.5 m -89.64 103.27 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.884 -178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.572 HD22 HD11 ' A' ' 24' ' ' ILE . 34.7 tp -86.53 90.24 8.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.215 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 14.0 m-70 -74.45 145.9 43.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.436 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.516 HD23 HG23 ' A' ' 14' ' ' VAL . 86.4 mt -146.81 104.93 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.176 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 46.7 t30 -79.58 70.62 6.09 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.9 t -47.55 117.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.316 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.6 p -88.11 -51.87 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -107.07 -38.41 6.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.953 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm -141.74 173.3 11.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.0 pt -81.23 -33.03 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.184 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.88 88.12 0.13 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.266 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.34 4.83 4.57 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.572 2.181 . . . . 0.0 112.438 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.63 119.82 14.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m 59.15 -175.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.196 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 9' ' ' ASP . 24.1 t -91.98 148.62 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.653 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -119.9 -7.5 9.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.998 0.427 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.557 ' H ' HG12 ' A' ' 7' ' ' VAL . 18.4 t70 -42.02 117.9 1.04 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.341 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.698 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 2.4 p-10 -122.74 -73.47 0.65 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 6.9 p-10 -43.44 103.41 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.488 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' HB3' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -120.2 57.13 0.95 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.555 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.629 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 6.5 m0 -78.48 122.83 26.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.921 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 5.7 p -174.76 160.95 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.549 0.69 . . . . 0.0 112.099 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -61.77 176.06 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.059 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 110' ' ' LEU . 4.1 t -174.31 -172.75 0.71 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.04 0.448 . . . . 0.0 111.63 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.0 m80 -117.38 -169.88 1.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 83' ' ' ARG . 40.8 t -90.29 129.27 41.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.078 0.466 . . . . 0.0 111.687 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 58.34 15.14 22.38 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.26 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.609 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.3 tptp -62.96 85.1 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.682 HG22 HD22 ' A' ' 77' ' ' LEU . 7.2 m -44.02 103.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.852 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.5 m -94.35 95.12 8.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.568 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 39.2 tt0 -81.76 131.83 35.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.831 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.451 HD13 ' OH ' ' A' ' 106' ' ' TYR . 41.2 mt -139.3 102.82 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.914 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -82.5 102.16 11.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HB2' ' HD1' ' A' ' 74' ' ' TYR . 11.5 mt -95.11 145.22 25.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.652 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.5 mptt -99.58 161.45 13.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.335 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.82 -147.01 7.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.559 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -174.56 93.75 0.3 Allowed Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.39 0.138 . . . . 0.0 110.742 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.56 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 11.4 Cg_endo -55.66 -29.43 70.68 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.716 2.277 . . . . 0.0 112.991 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.3 p -59.97 -17.1 35.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.444 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.5 p -70.56 -51.29 29.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.834 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.12 -12.47 1.86 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.798 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -109.55 -179.01 3.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.3 ttm -147.14 151.08 36.2 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.717 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 1.3 m95 -104.2 82.79 1.99 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.8 t -127.97 161.6 28.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.364 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.711 ' NH1' HD11 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -54.71 139.88 37.65 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.776 0.322 . . . . 0.0 111.408 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 91' ' ' VAL . 42.3 t -51.14 140.88 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.268 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.84 -0.38 5.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.729 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . 23.2 m-30 -117.25 47.0 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.207 0.527 . . . . 0.0 110.916 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.617 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.3 p -93.44 128.76 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.859 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.29 15.73 46.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.066 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.729 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -70.06 -164.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.234 0.613 . . . . 0.0 111.686 -179.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.73 -43.7 3.78 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.178 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.2 t -147.0 115.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.171 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD23 ' HD3' ' A' ' 44' ' ' LYS . 15.6 mt -57.76 -61.19 2.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.651 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 92.3 p -51.89 175.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.294 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -157.26 -99.19 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.908 0.385 . . . . 0.0 111.388 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.9 pt-20 -127.28 -32.46 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.8 mm -73.52 -72.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' A' ' 78' ' ' VAL . 85.1 mt -106.15 116.98 32.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.217 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.64 73.32 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG13 HG13 ' A' ' 78' ' ' VAL . 1.3 t -78.9 90.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 38.6 t -92.65 90.72 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.56 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.558 ' HB2' ' HA ' ' A' ' 76' ' ' VAL . 9.2 t -114.99 145.88 41.8 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.287 0.565 . . . . 0.0 111.604 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -126.61 125.2 41.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.143 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -85.59 103.87 14.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.15 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 27.4 m -105.8 128.46 26.4 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.812 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.697 ' HB3' ' H ' ' A' ' 70' ' ' VAL . 29.7 Cg_endo -98.68 -152.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 123.499 2.799 . . . . 0.0 111.737 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -79.23 142.08 58.55 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.591 179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 61' ' ' THR . 36.3 Cg_exo -61.16 96.73 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.48 2.12 . . . . 0.0 112.161 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.56 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 47.5 m -109.43 -167.44 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -116.75 -46.99 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 61.3 m -99.65 -49.55 0.2 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 14.4 Cg_exo -70.11 151.32 67.01 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.773 2.316 . . . . 0.0 112.257 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 67' ' ' MET . 47.5 ttp -157.01 19.3 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.364 0.602 . . . . 0.0 109.982 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.1 t -135.7 104.54 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.051 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.61 84.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.406 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.697 ' H ' ' HB3' ' A' ' 60' ' ' PRO . 1.9 t -125.45 -23.07 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.941 0.4 . . . . 0.0 111.298 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 125.45 84.69 0.57 Allowed Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.885 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 60' ' ' PRO . . . -145.9 -129.27 2.05 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.285 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.3 pt -135.08 -167.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 121.129 0.49 . . . . 0.0 111.058 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -139.27 98.01 3.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.775 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 75' ' ' VAL . 11.3 p -89.12 113.25 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 CA-C-O 121.343 0.592 . . . . 0.0 110.661 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG22 HH22 ' A' ' 38' ' ' ARG . 20.7 t -107.06 126.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.764 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 HG22 ' A' ' 21' ' ' THR . 70.0 mt -113.62 90.68 3.41 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.648 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -90.85 105.21 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.074 0.464 . . . . 0.0 111.057 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 46.5 mtmt -106.01 96.27 12.64 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 52' ' ' LEU . 7.4 Cg_endo -50.67 103.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.283 1.989 . . . . 0.0 112.503 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.1 mtt180 -67.69 -35.39 78.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 53.0 mttm -117.43 178.99 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.831 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 18' ' ' VAL . 67.3 mtp180 -117.65 146.55 43.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.45 -149.59 21.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.782 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -91.26 28.3 1.69 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.752 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.436 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 72.3 m-70 -47.54 157.6 0.22 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 109' ' ' HIS . 54.4 m -157.31 148.22 21.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.922 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 38' ' ' ARG . 17.4 tp -107.99 165.78 11.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.75 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' C ' HD12 ' A' ' 90' ' ' LEU . 34.5 mt-10 -151.68 121.24 6.91 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.711 HD11 ' NH1' ' A' ' 38' ' ' ARG . 9.7 mp -116.81 161.83 18.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.289 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.3 p -158.65 155.2 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 121.117 0.484 . . . . 0.0 112.047 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.7 t80 -100.12 86.86 3.32 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.706 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.9 t -109.82 171.46 7.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -105.54 93.25 6.84 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.529 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 88.9 Cg_exo -49.17 -29.2 16.03 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.536 2.158 . . . . 0.0 112.339 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -74.38 -34.69 63.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.213 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -110.24 -76.88 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.249 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.47 -174.76 47.02 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.242 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -96.44 147.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 0.0 111.013 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.8 mttt -136.11 157.01 76.57 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.65 -47.38 11.43 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.735 2.29 . . . . 0.0 112.739 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.06 -12.71 8.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.85 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -64.26 149.94 46.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.927 0.394 . . . . 0.0 111.357 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.71 164.03 2.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.703 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 12.1 tpp180 -137.77 162.13 34.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.703 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -164.41 83.82 0.42 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.304 0.573 . . . . 0.0 110.08 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 89' ' ' GLU . 25.8 m -88.82 133.76 34.16 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 37.5 tp -118.59 80.98 1.61 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.8 m-70 -66.46 145.42 55.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.876 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.7 mt -143.58 108.34 4.9 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.579 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 60.9 t30 -82.8 50.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.479 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -37.7 112.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.67 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.848 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.2 m -144.91 170.34 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -94.29 -9.49 35.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 68.2 mtm -93.04 -11.19 33.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 1' ' ' MET . 61.4 mt 74.33 -36.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.66 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' H ' ' C ' ' A' ' 1' ' ' MET . . . 57.51 92.48 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.213 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.52 111.24 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.522 2.148 . . . . 0.0 112.306 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.0 tp -140.08 -48.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.756 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 t -93.94 164.7 12.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.833 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 p -65.21 148.74 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.097 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -98.51 34.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.0 110.388 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -35.26 120.58 0.54 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.038 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.587 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -122.39 -87.14 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.96 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.25 98.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.804 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.516 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.5 tttt -100.96 94.55 6.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.034 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.685 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m95 -84.64 103.32 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.05 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 110' ' ' LEU . 29.6 m -148.21 -171.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.133 0.492 . . . . 0.0 112.104 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -109.32 178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.819 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.441 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.4 t -176.39 -172.67 0.48 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.95 0.405 . . . . 0.0 111.692 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 66.6 m80 -122.23 179.9 4.39 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.065 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.59 136.23 26.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.339 0.59 . . . . 0.0 112.221 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 58.24 15.16 21.73 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.862 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.4 tptt -58.72 85.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.327 0.563 . . . . 0.0 110.015 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.711 HG22 HD22 ' A' ' 77' ' ' LEU . 3.6 m -56.67 102.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.332 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.8 m -102.16 101.42 11.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.778 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.4 tt0 -81.6 135.02 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.749 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 108' ' ' LEU . 42.0 mt -136.41 104.95 4.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.754 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -86.24 97.87 10.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 16.8 mt -91.02 145.69 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.148 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 5.7 mptt -91.4 159.71 15.84 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.009 0.433 . . . . 0.0 110.571 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.35 -154.39 25.48 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.009 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 5.9 t30 -172.04 132.19 0.74 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.4 0.143 . . . . 0.0 110.987 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 29' ' ' ASN . 29.9 Cg_exo -62.82 -53.87 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.611 2.207 . . . . 0.0 112.672 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -83.53 51.24 1.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.676 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -135.01 -64.07 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.202 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.43 -106.67 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.777 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 2.1 m-85 -88.73 -166.52 1.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 0.0 111.007 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.506 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.3 ttt -133.89 149.76 51.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.39 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.508 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 23.2 m95 -100.87 110.56 22.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.154 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.663 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -154.99 -172.39 4.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.819 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 mtp85 -89.08 153.66 20.8 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.807 0.337 . . . . 0.0 111.044 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 89' ' ' GLU . 51.6 t -67.11 132.88 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.977 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.46 15.43 81.44 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.851 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.502 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 59.8 m-85 -135.75 -5.56 2.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 37' ' ' THR . 4.3 p -43.47 124.72 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.74 -38.5 3.16 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 54.8 mtpt -60.44 170.47 1.36 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.839 0.352 . . . . 0.0 111.245 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -80.33 -61.69 1.9 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.784 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 p -100.89 143.94 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.87 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.8 mt -101.82 -48.75 4.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.248 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.517 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 72.2 p -50.95 177.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.016 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -156.43 -89.83 0.04 OUTLIER 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.399 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -127.14 -35.25 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.288 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.7 mm -70.53 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.231 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.4 mt -101.35 116.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.451 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -71.16 66.98 0.43 Allowed 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG21 ' HD2' ' A' ' 38' ' ' ARG . 19.2 t -71.23 81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.822 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.7 t -75.69 78.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -94.63 139.71 30.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.366 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -131.36 107.53 9.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.747 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -72.6 109.58 6.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.289 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -94.18 112.8 58.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.429 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -94.23 -68.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.105 2.537 . . . . 0.0 113.714 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.611 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -131.04 142.02 44.08 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.831 -179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.611 ' HD2' HG22 ' A' ' 61' ' ' THR . 48.3 Cg_exo -56.13 134.96 67.4 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.578 2.185 . . . . 0.0 112.475 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.8 m -95.94 -177.3 3.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.2 t -86.63 10.22 16.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.5 p -60.52 155.68 47.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -75.89 14.32 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.5 mmt -127.99 84.79 2.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.29 136.72 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.055 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.06 40.84 1.13 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.36 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.6 83.22 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 0.0 110.809 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.439 ' HA3' ' C ' ' A' ' 61' ' ' THR . . . 149.78 97.54 0.17 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.193 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 59' ' ' THR . . . 149.14 2.73 0.32 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.825 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.9 pt -150.92 -162.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.129 0.49 . . . . 0.0 111.112 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.4 OUTLIER -133.02 99.8 4.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.466 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.4 p -94.79 108.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.192 0.52 . . . . 0.0 110.724 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 43.0 t -104.84 126.33 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.825 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.711 HD22 HG22 ' A' ' 21' ' ' THR . 82.1 mt -110.66 98.44 7.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.761 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.584 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.47 107.87 19.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.005 0.431 . . . . 0.0 111.275 -178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 44.8 mtmt -112.65 95.13 31.37 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.252 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.62 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.4 Cg_endo -50.22 101.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.1 . . . . 0.0 112.848 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.528 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -65.77 -31.06 71.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.872 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -119.01 176.97 5.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.632 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -120.71 126.06 49.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.968 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 149.63 -109.21 0.43 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.236 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -111.98 113.55 25.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 110.805 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -135.77 156.48 48.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.591 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.557 ' CG2' HG22 ' A' ' 107' ' ' THR . 28.9 m -158.75 148.68 19.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.534 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 41.2 tp -108.58 90.23 3.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.817 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.72 ' HA ' HG23 ' A' ' 107' ' ' THR . 39.3 mt-10 -71.8 97.29 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.104 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.646 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 38.2 mt -111.46 125.28 53.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.218 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.489 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -126.75 172.24 14.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.488 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 1.7 t80 -109.69 86.36 2.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.014 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.624 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.6 t -117.61 158.01 25.39 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' TYR . 79.8 mtp180 -100.49 98.9 8.72 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.84 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 93' ' ' THR . 84.4 Cg_exo -43.39 -38.02 8.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 112.845 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -60.88 -40.35 92.68 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.618 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -102.38 -75.58 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.879 0.371 . . . . 0.0 111.419 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.04 -173.58 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.272 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.624 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -99.94 143.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 0.0 111.34 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -135.59 169.49 13.55 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.16 -37.87 17.34 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.643 2.229 . . . . 0.0 112.067 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.57 -17.21 53.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.169 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.623 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.96 135.06 56.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.909 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -54.75 158.37 2.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.228 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 6.3 tpp180 -119.24 160.16 22.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.433 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.584 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 49.7 t80 -173.28 68.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.975 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.72 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.72 97.63 10.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.328 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 19.5 tp -78.85 93.28 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.013 0.435 . . . . 0.0 110.713 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.685 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.2 m-70 -76.66 142.71 40.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.373 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 14' ' ' VAL . 89.9 mt -146.64 110.94 5.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.302 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 44.0 t30 -83.44 65.7 8.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.2 t -42.4 136.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.991 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.8 m -137.48 -62.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -70.27 113.75 7.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HE3' ' HB3' ' A' ' 5' ' ' LEU . 83.8 mtp -103.1 131.03 50.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.5 pt -85.64 -11.44 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.148 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.42 149.49 15.17 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.23 154.97 31.51 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.581 2.188 . . . . 0.0 112.257 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.435 ' HB3' ' HE3' ' A' ' 1' ' ' MET . 58.3 tp -157.22 -59.63 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.41 -11.02 1.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.874 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.49 125.13 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -143.91 120.77 11.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.021 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -64.94 121.79 15.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.445 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.7 OUTLIER -124.01 -93.92 0.5 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 111.772 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -59.32 97.71 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.304 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.0 ptmt -93.69 74.69 4.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.701 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -50.22 103.89 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.834 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.617 HG23 HD23 ' A' ' 110' ' ' LEU . 34.7 m -146.82 -174.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.239 0.542 . . . . 0.0 112.436 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -108.95 -178.1 3.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.808 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.556 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.31 -173.39 0.44 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.983 0.421 . . . . 0.0 111.676 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.599 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 47.9 m-70 -124.12 -177.22 3.71 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.979 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -71.94 137.79 22.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 112.174 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.33 14.01 11.7 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.659 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.599 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 20.5 tptt -57.82 85.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.193 0.497 . . . . 0.0 109.927 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.77 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -57.27 92.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.291 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.9 m -88.36 103.2 15.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.613 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.5 tt0 -85.2 129.66 34.76 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.553 HG22 ' HG ' ' A' ' 26' ' ' LEU . 42.1 mt -133.84 107.69 10.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.645 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -87.83 91.64 8.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.368 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.553 ' HG ' HG22 ' A' ' 24' ' ' ILE . 15.5 mt -86.24 145.13 27.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.488 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -99.53 163.65 12.42 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.942 0.401 . . . . 0.0 110.522 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.22 -141.24 5.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.492 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HB3' HG23 ' A' ' 32' ' ' THR . 62.6 t30 -174.3 92.8 0.32 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.548 0.214 . . . . 0.0 110.564 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 51.0 Cg_exo -53.86 -17.7 11.12 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.742 2.295 . . . . 0.0 113.12 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.5 p -82.84 12.77 4.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.649 0.261 . . . . 0.0 111.566 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.408 HG23 ' HB3' ' A' ' 29' ' ' ASN . 56.8 p -96.55 -64.18 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 111.208 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.27 -26.38 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.705 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 36.0 m-85 -98.68 -176.0 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.097 0.475 . . . . 0.0 111.219 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.0 ttm -150.61 151.05 31.97 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.087 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.485 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 5.4 m95 -106.62 88.14 2.69 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.5 t -134.56 -168.57 2.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.856 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.746 ' HE ' ' HB3' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -74.99 157.5 34.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.67 0.271 . . . . 0.0 110.722 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 98.9 t -79.56 134.81 26.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.749 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 -10.44 5.09 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.822 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 39' ' ' VAL . 16.8 m-30 -106.08 7.91 32.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.143 0.497 . . . . 0.0 110.284 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.904 HG21 HG21 ' A' ' 93' ' ' THR . 14.4 t -62.16 106.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.08 -19.21 10.18 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.749 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -70.99 178.23 3.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.753 0.311 . . . . 0.0 110.724 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.64 -51.02 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.34 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.56 -30.18 12.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.77 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.746 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 6.8 mt 70.42 -72.85 0.1 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 40.6 p -49.54 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.779 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.2 -89.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.445 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -130.35 -30.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.279 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.7 mm -75.32 -79.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.34 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.2 mt -102.52 113.42 26.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.572 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -69.81 71.14 0.35 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.825 0.345 . . . . 0.0 110.249 178.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.656 HG11 ' HD3' ' A' ' 38' ' ' ARG . 2.1 t -72.78 87.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.933 0.397 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG12 ' HE3' ' A' ' 57' ' ' LYS . 20.4 t -86.78 86.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 76' ' ' VAL . 5.6 t -111.82 134.19 53.54 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.896 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' HE3' HG12 ' A' ' 55' ' ' VAL . 32.1 mmtp -113.91 112.43 23.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.273 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.507 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -70.95 117.5 12.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.847 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -106.2 114.05 62.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.631 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 97.9 Cg_endo -93.29 169.42 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.123 2.549 . . . . 0.0 112.926 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.578 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.67 146.8 73.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HD2' HG22 ' A' ' 61' ' ' THR . 32.0 Cg_exo -60.27 136.39 68.07 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.561 2.174 . . . . 0.0 112.413 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.9 t -126.64 -92.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.2 m -70.16 -22.26 62.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.612 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 53.1 p -82.96 159.42 62.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.96 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 70.0 Cg_endo -71.31 -155.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.554 2.169 . . . . 0.0 112.039 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -108.14 74.54 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.969 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.51 38.55 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.553 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.65 94.71 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.367 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 70' ' ' VAL . 5.3 t -115.05 2.09 8.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.054 0.454 . . . . 0.0 111.074 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.4 -140.54 15.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.948 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 59' ' ' THR . . . 115.89 15.32 7.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.509 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -151.86 -165.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.141 0.496 . . . . 0.0 111.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -133.73 102.8 5.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.708 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 74.3 t -87.57 107.1 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.777 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.8 t -108.95 119.6 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.77 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -112.2 95.38 5.42 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.587 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -90.8 108.76 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.021 0.439 . . . . 0.0 111.282 -178.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.0 mtmm -110.45 92.27 13.54 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.63 102.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.524 2.149 . . . . 0.0 112.553 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 14.3 mtt180 -64.1 -34.76 78.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.022 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -116.06 -175.81 2.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.83 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -122.8 146.46 47.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 133.19 -136.79 8.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.492 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.88 95.32 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.963 0.411 . . . . 0.0 110.997 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -113.14 164.37 13.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.613 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.419 HG23 ' HA ' ' A' ' 109' ' ' HIS . 88.3 m -159.8 150.24 18.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.586 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 HH11 ' A' ' 38' ' ' ARG . 34.6 tp -120.28 94.53 4.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.608 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HA ' HG23 ' A' ' 107' ' ' THR . 41.7 mt-10 -73.88 105.54 5.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.802 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 26.5 mt -111.39 129.64 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.9 p -133.66 158.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.161 0.505 . . . . 0.0 112.092 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -102.37 92.11 4.55 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.979 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.904 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -123.02 170.36 10.23 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -102.11 94.81 4.99 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.9 Cg_exo -45.21 -38.17 14.31 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.721 2.28 . . . . 0.0 112.729 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -37.7 88.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -101.57 -80.71 0.49 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.413 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.04 178.39 44.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.259 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.732 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.8 mt -94.39 153.08 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 0.0 111.557 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.7 mttt -140.41 162.65 48.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.595 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.2 Cg_endo -70.95 -39.77 3.97 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.712 2.275 . . . . 0.0 111.998 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.5 -27.47 69.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.784 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -52.5 153.72 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -59.66 160.35 7.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.6 tpp180 -129.87 163.9 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.206 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.7 t80 -176.49 71.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 0.0 109.111 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.511 HG23 ' HA ' ' A' ' 89' ' ' GLU . 1.9 m -85.83 95.98 9.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.341 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 48.2 tp -72.88 86.28 1.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -75.74 139.6 41.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.617 HD23 HG23 ' A' ' 14' ' ' VAL . 94.6 mt -145.49 102.52 3.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.621 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.441 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 37.5 t30 -79.26 73.0 5.88 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 HG23 ' A' ' 16' ' ' THR . 1.7 t -48.4 137.82 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.729 -178.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.969 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.6 m -93.45 -34.52 13.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.759 0.314 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -69.93 -46.22 65.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt -97.35 157.87 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.7 mt -83.16 -34.94 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.38 88.92 0.11 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.85 115.34 2.45 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.526 2.15 . . . . 0.0 112.304 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -135.78 -64.39 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.0 t -113.6 -36.19 4.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.17 131.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.037 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -174.27 135.62 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.392 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.14 118.52 22.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.521 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -119.36 -87.37 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.98 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.599 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -34.63 100.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.778 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.5 tttt -89.84 100.25 13.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.472 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.674 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -82.05 105.08 12.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.676 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.79 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.1 p -154.84 -178.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.077 0.465 . . . . 0.0 111.718 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.79 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -100.67 -176.12 3.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.604 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.496 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.12 -174.4 0.9 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.183 0.516 . . . . 0.0 112.195 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 9.7 m-70 -114.96 -168.93 1.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.113 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.79 128.77 41.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.095 0.474 . . . . 0.0 111.897 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.65 15.86 27.75 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.507 -0.769 . . . . 0.0 113.505 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.61 84.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.712 HG22 HD22 ' A' ' 77' ' ' LEU . 4.9 m -47.8 101.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.981 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 78' ' ' VAL . 51.9 m -96.03 99.62 11.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.9 tt0 -81.97 131.6 35.25 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.311 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 108' ' ' LEU . 43.7 mt -138.67 103.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.764 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -85.58 107.02 17.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.346 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.545 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 6.4 mt -104.34 143.93 32.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.137 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -96.79 162.94 13.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.977 0.418 . . . . 0.0 110.591 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.62 -158.76 29.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.311 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.565 HD22 ' N ' ' A' ' 32' ' ' THR . 3.9 t30 -172.33 135.39 0.82 Allowed Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 120.492 0.187 . . . . 0.0 110.694 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.35 -48.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.573 2.182 . . . . 0.0 113.086 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.0 p -71.19 2.37 4.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.565 ' N ' HD22 ' A' ' 29' ' ' ASN . 52.8 m -112.11 -54.93 2.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.162 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.11 -108.63 1.29 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.956 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -113.51 -169.35 1.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 17.7 ttm -117.7 152.84 34.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.896 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 11.4 m95 -111.44 89.99 3.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.186 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.0 t -134.24 -165.88 1.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.07 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.8 mtp85 -90.66 155.01 19.15 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.958 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 37.8 t -74.5 133.01 32.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.49 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.73 4.75 89.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.51 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 58.7 m-85 -130.68 -1.18 4.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 0.0 110.477 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 93' ' ' THR . 21.0 t -54.13 118.74 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.067 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.02 -28.15 15.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.982 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.0 mttm -69.35 172.44 7.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.53 -62.45 1.62 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -107.22 141.89 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.4 mt -92.76 -51.92 4.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.981 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 64.4 p -53.47 -179.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.59 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -157.2 -90.81 0.03 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.275 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.63 -30.37 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.512 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -74.99 -79.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.214 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.626 HD22 HG12 ' A' ' 78' ' ' VAL . 7.1 mt -100.21 113.62 26.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.71 68.32 0.26 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.068 0.461 . . . . 0.0 109.928 177.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG21 ' HD2' ' A' ' 38' ' ' ARG . 13.8 t -72.7 84.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.768 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 29.3 t -80.14 80.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.591 0.71 . . . . 0.0 109.19 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.446 ' SG ' HG22 ' A' ' 76' ' ' VAL . 17.4 t -97.17 124.23 41.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.212 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -114.82 105.96 13.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.182 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -70.37 97.95 1.34 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.9 m -95.47 125.42 49.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.133 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 22.1 Cg_endo -97.44 -157.91 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 123.196 2.597 . . . . 0.0 111.571 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 m -157.26 135.43 7.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.31 103.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.88 2.386 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.7 m -118.89 -171.48 2.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 t -75.15 -4.63 39.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 67.9 p -65.62 156.71 81.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.044 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 72.1 Cg_endo -73.83 -156.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.521 2.147 . . . . 0.0 112.154 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.4 mmt -76.78 -6.26 51.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.931 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.77 109.44 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.75 134.41 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.349 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -122.91 -89.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 111.18 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.55 115.69 1.41 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.231 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 60' ' ' PRO . . . -156.28 -126.47 0.96 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.932 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt -123.68 -165.09 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.9 m-85 -138.99 101.08 4.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.348 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.46 100.2 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 120.876 0.369 . . . . 0.0 110.814 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG22 ' SG ' ' A' ' 56' ' ' CYS . 26.3 t -100.96 118.95 48.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.138 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.712 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -110.35 97.52 6.96 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.629 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.626 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.81 106.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -178.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 28.9 mtmm -111.75 92.99 18.66 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.211 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HA ' HD23 ' A' ' 52' ' ' LEU . 8.3 Cg_endo -51.76 102.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.388 2.059 . . . . 0.0 112.606 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.5 mtt180 -63.93 -36.37 83.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.822 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 86' ' ' HIS . 79.2 mttt -119.45 178.01 4.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -119.82 140.36 50.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.963 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.551 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.45 -113.57 0.71 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.359 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -115.99 93.2 4.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.909 0.385 . . . . 0.0 110.816 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 82' ' ' LYS . 1.1 m-70 -113.63 162.27 16.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.6 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.44 HG23 ' HA ' ' A' ' 109' ' ' HIS . 60.0 m -159.31 149.92 19.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 111.723 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 22.6 tp -115.66 93.47 4.28 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.388 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.8 mt-10 -78.42 92.62 4.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.191 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 59.3 mt -103.22 123.72 47.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.9 p -126.66 155.59 37.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.946 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 8.1 t80 -97.89 82.88 3.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.472 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.882 HG21 HG21 ' A' ' 42' ' ' VAL . 5.6 t -118.79 158.75 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 58.5 mtp180 -97.45 98.21 4.78 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.512 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 93' ' ' THR . 93.8 Cg_exo -44.04 -38.44 10.44 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.884 2.39 . . . . 0.0 112.735 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -42.3 93.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.311 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -97.26 -74.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.265 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.44 179.7 39.36 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.088 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.651 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.7 mt -94.23 146.25 6.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.597 ' HE3' HD21 ' A' ' 103' ' ' ASN . 43.6 mtmt -140.28 162.9 47.26 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.215 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 42.4 Cg_endo -68.02 -38.76 12.13 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.777 2.318 . . . . 0.0 112.089 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.429 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.6 pt-20 -61.7 -28.22 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.826 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.597 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -55.22 149.37 12.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.023 179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.05 166.17 2.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.6 tpp180 -132.7 164.11 27.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.44 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.638 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 51.3 t80 -174.47 64.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.635 0.731 . . . . 0.0 109.184 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 89' ' ' GLU . 9.3 m -87.61 92.22 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.228 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 27.5 tp -73.46 93.55 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.38 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.674 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.2 m-70 -77.31 140.71 40.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.637 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 16' ' ' THR . 92.3 mt -143.78 104.08 4.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.252 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.39 68.33 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.551 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -45.02 118.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.369 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.963 -179.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.4 m -142.71 -3.09 1.02 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -142.52 108.14 5.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.44 151.7 29.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.7 pt -84.03 -1.16 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.132 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.12 153.09 53.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.56 -38.09 20.17 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.425 2.083 . . . . 0.0 112.228 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.4 tp 59.95 28.37 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.802 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.1 m 61.66 16.52 7.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.27 119.91 56.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -174.7 134.85 0.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.169 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -55.87 118.96 5.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.069 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.645 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -123.7 -95.1 0.48 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.106 0.479 . . . . 0.0 112.137 -178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.2 99.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.713 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HE3' ' HB ' ' A' ' 14' ' ' VAL . 53.6 tptt -95.09 92.13 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.244 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.8 m95 -75.84 105.68 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.743 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.678 HG22 ' H ' ' A' ' 15' ' ' ASP . 9.9 p -156.93 173.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.239 0.542 . . . . 0.0 111.888 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.678 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -93.64 -173.59 3.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.668 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 110' ' ' LEU . 3.1 t -175.57 -175.96 0.84 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.193 0.52 . . . . 0.0 112.153 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 4.5 m-70 -115.24 -163.77 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.715 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -91.13 132.37 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.223 0.535 . . . . 0.0 111.985 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.55 20.05 22.08 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.418 -0.81 . . . . 0.0 113.507 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.603 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptm -63.3 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.782 HG22 HD22 ' A' ' 77' ' ' LEU . 4.1 m -51.43 99.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.517 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HB ' HG23 ' A' ' 78' ' ' VAL . 38.2 m -98.58 101.02 12.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.722 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.587 ' HG3' HG23 ' A' ' 75' ' ' VAL . 33.4 tt0 -76.79 133.92 39.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.719 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.505 HG22 ' HG ' ' A' ' 26' ' ' LEU . 23.2 mt -131.48 94.97 2.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.262 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.402 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 6.5 m170 -84.82 78.27 9.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.026 0.441 . . . . 0.0 110.024 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.505 ' HG ' HG22 ' A' ' 24' ' ' ILE . 89.8 mt -68.98 160.15 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.325 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -113.63 164.24 13.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.07 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.08 -145.95 11.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.771 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.435 HD21 ' HB ' ' A' ' 31' ' ' THR . 42.9 t30 -170.66 105.47 0.42 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.367 0.127 . . . . 0.0 110.782 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.555 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 19.1 Cg_endo -58.93 -24.03 70.8 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.478 2.119 . . . . 0.0 112.279 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.435 ' HB ' HD21 ' A' ' 29' ' ' ASN . 22.4 m -60.11 -27.65 67.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.23 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.9 p -59.35 -36.16 75.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.996 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.69 -14.45 6.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.74 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.78 -175.26 2.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.138 0.494 . . . . 0.0 111.315 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.516 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 4.6 ttt -147.98 151.9 36.57 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.851 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -107.6 96.7 6.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.131 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.639 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -147.39 -166.42 2.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.647 HH11 HG21 ' A' ' 54' ' ' VAL . 5.1 mtp180 -84.84 155.7 21.64 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.849 0.357 . . . . 0.0 111.253 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 43.2 t -74.35 132.8 32.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.439 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.44 89.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.261 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 64.9 m-85 -127.6 3.98 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.098 0.475 . . . . 0.0 110.419 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.639 ' HA ' HG21 ' A' ' 37' ' ' THR . 3.6 p -45.22 133.1 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.071 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.71 -33.71 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.302 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -67.41 -168.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.75 -46.57 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.225 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.407 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 3.4 p -74.86 -46.95 39.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.744 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' C ' ' A' ' 46' ' ' VAL . 7.8 mt 71.83 -60.42 0.52 Allowed 'General case' 0 C--O 1.232 0.156 0 O-C-N 123.401 0.438 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 45.6 p -48.87 -179.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.384 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -156.55 -85.45 0.05 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.89 -30.5 1.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.585 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -73.74 -76.8 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.55 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.624 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.9 mt -102.85 115.65 31.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.324 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -69.18 70.91 0.24 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.21 0.528 . . . . 0.0 109.699 177.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.647 HG21 HH11 ' A' ' 38' ' ' ARG . 21.7 t -76.63 83.74 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.312 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 18.1 t -82.01 86.55 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.488 ' SG ' HG22 ' A' ' 76' ' ' VAL . 31.5 t -96.18 150.95 19.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.792 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HB2' HG13 ' A' ' 75' ' ' VAL . 55.1 mttm -139.77 114.4 9.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.973 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.516 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -94.68 105.52 17.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.945 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 86.6 m -107.39 108.52 61.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.341 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -98.62 92.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.47 2.78 . . . . 0.0 111.71 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 1.6 p -86.4 149.87 50.28 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.627 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 24.4 Cg_exo -63.56 177.63 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.726 2.284 . . . . 0.0 112.203 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.1 p -106.13 -22.76 12.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.022 0.439 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.6 t 56.38 12.04 0.95 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.841 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 35.8 p -121.78 163.23 32.37 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.942 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 61.0 Cg_endo -69.12 11.89 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.591 2.194 . . . . 0.0 112.337 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 65' ' ' THR . 50.9 ttm -117.97 85.56 2.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.104 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.4 t -38.86 126.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.795 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.58 101.77 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.229 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.99 28.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.555 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -56.96 112.94 3.9 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.219 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.14 -127.39 3.25 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.747 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm -127.34 154.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.876 0.846 . . . . 0.0 111.706 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 1.9 m-85 -130.27 76.2 1.71 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.564 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.3 p -84.5 110.27 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.001 -177.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 56' ' ' CYS . 90.3 t -106.81 122.06 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.3 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 21' ' ' THR . 81.8 mt -105.36 102.49 11.96 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.905 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.15 108.51 21.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.951 0.405 . . . . 0.0 111.091 -178.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -113.9 93.78 30.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.9 Cg_endo -47.99 102.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.638 2.226 . . . . 0.0 112.567 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 6.9 mtt180 -69.16 -36.72 77.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.293 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -117.15 170.58 8.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.132 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -107.22 123.82 48.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.593 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.77 -128.79 2.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.537 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.432 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -106.86 95.58 5.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.377 . . . . 0.0 110.962 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.433 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -109.65 161.53 15.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.402 179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.0 m -158.17 148.93 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 111.732 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 24.9 tp -115.77 90.39 3.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.571 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.5 mt-10 -75.57 94.19 3.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.1 mt -101.91 125.33 48.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 92' ' ' TYR . 9.5 p -131.12 158.08 43.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.715 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 1.6 t80 -97.1 86.44 3.96 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.707 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -110.86 167.11 10.49 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 61.5 mtp180 -102.52 97.68 9.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.393 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 93' ' ' THR . 74.0 Cg_exo -51.44 -31.78 40.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.544 2.163 . . . . 0.0 112.635 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.14 10.12 11.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.2 mm-40 -148.41 -79.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.141 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.59 177.85 40.92 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.19 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.707 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.6 mt -94.87 155.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.894 0.378 . . . . 0.0 111.267 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.579 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 16.3 mtmt -143.76 161.4 46.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.944 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.4 Cg_endo -72.08 -39.7 2.96 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.31 -27.02 69.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 10.0 m120 -55.97 155.03 6.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -56.25 161.95 2.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.042 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.645 ' HB3' HD22 ' A' ' 10' ' ' ASN . 17.3 tpp180 -131.66 164.28 26.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.746 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.58 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 50.0 t80 -177.58 65.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.345 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 10.4 m -87.25 94.12 9.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.41 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.7 tp -74.93 93.8 2.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.229 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.703 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.2 m-70 -77.11 138.65 39.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.126 0.488 . . . . 0.0 110.706 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 96.2 mt -142.29 98.06 3.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -76.08 78.17 2.92 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.593 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.4 t -51.77 123.91 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.474 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.916 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 t -148.37 -43.78 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.777 0.322 . . . . 0.0 110.93 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -86.6 118.8 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -110.85 174.97 5.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.9 pt -114.05 4.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.96 116.23 12.72 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.02 110.62 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.456 2.104 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 pp -151.17 -3.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -147.7 -14.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.5 -10.49 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.145 0.498 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -111.99 0.01 15.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.362 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 t70 52.64 95.22 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.051 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.681 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -131.15 -92.2 0.42 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.919 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 4.1 m-20 -55.22 97.59 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HE3' HG21 ' A' ' 14' ' ' VAL . 54.5 tttp -99.63 95.27 6.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.85 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.54 102.36 12.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.166 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.534 HG21 ' HE3' ' A' ' 12' ' ' LYS . 35.2 m -147.34 -170.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.041 0.448 . . . . 0.0 111.809 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -103.99 -176.19 3.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.303 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -173.83 -175.65 1.1 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 112.293 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.602 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 17.5 m80 -116.56 -163.06 0.88 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.017 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 44.4 t -98.56 129.06 49.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.109 0.481 . . . . 0.0 111.808 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.67 14.52 36.64 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.287 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -64.08 83.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.744 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -47.2 102.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.809 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 98.3 m -96.16 100.19 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.389 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.0 tt0 -81.34 131.45 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.033 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 26' ' ' LEU . 43.9 mt -136.0 104.46 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -86.78 100.94 12.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.8 mt -95.52 147.72 23.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.466 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -101.94 162.01 13.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.825 0.345 . . . . 0.0 110.478 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.54 -147.49 9.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.484 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -174.78 101.87 0.27 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.39 0.138 . . . . 0.0 110.754 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.52 -22.06 49.22 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.491 2.127 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.0 m -62.61 -30.63 71.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.5 p -62.26 -53.87 48.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.032 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.11 -39.75 0.92 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.783 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 65.9 m-85 -81.35 -177.46 6.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.059 0.457 . . . . 0.0 111.375 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.6 ttm -150.94 152.94 34.32 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.902 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 9.1 m95 -107.25 87.24 2.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -131.85 -166.55 1.74 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.175 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 22.0 mtp85 -90.24 148.14 23.1 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.217 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 17.4 t -68.07 136.29 26.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.544 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.31 1.7 88.54 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.405 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 61.5 m-85 -128.24 -1.62 5.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.342 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -55.21 107.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.057 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.96 -29.04 8.33 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.959 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 98.0 mttt -68.08 174.92 3.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.76 0.314 . . . . 0.0 110.982 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.12 -38.93 17.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.14 132.47 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.277 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.3 mt -85.62 -51.68 6.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.996 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.432 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.6 t -51.43 176.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.69 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -157.58 -91.34 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.403 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -130.88 -32.64 1.63 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.157 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 23.9 mm -70.46 -76.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.304 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -104.34 114.48 28.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.429 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -66.36 72.99 0.08 Allowed 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.583 HG22 HG13 ' A' ' 78' ' ' VAL . 10.9 t -79.44 85.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.164 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.0 t -81.12 83.3 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.8 t -98.33 139.87 33.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.369 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.7 mttp -133.28 110.0 9.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.191 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -76.77 101.44 5.84 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 23.2 m -97.87 109.22 50.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.059 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' HB2' HG12 ' A' ' 70' ' ' VAL . 74.2 Cg_endo -100.8 97.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.593 2.862 . . . . 0.0 111.266 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.461 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -76.26 140.07 68.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.479 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' A' ' 61' ' ' THR . 20.7 Cg_exo -65.73 -179.04 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.753 2.302 . . . . 0.0 112.158 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.4 t -84.81 -177.59 6.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.712 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -80.92 -64.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.958 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 62.6 m -103.05 -48.47 0.17 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.916 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 16.1 Cg_exo -69.24 -157.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.845 2.363 . . . . 0.0 112.282 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -154.62 17.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.72 118.61 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.02 -67.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.408 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 60' ' ' PRO . 98.6 t 53.56 90.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.938 0.399 . . . . 0.0 111.323 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.54 133.37 10.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.528 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -136.03 -128.9 2.78 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.306 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -142.96 -165.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 121.063 0.458 . . . . 0.0 110.991 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -135.32 100.42 4.52 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.088 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -86.69 104.32 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 120.919 0.39 . . . . 0.0 110.926 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG21 HD11 ' A' ' 90' ' ' LEU . 37.2 t -107.09 120.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.289 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD22 HG22 ' A' ' 21' ' ' THR . 80.0 mt -110.38 100.38 9.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.826 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.13 107.26 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.975 0.417 . . . . 0.0 111.146 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 29.0 mtmm -109.5 103.58 53.19 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.392 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.8 Cg_exo -51.59 101.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.204 . . . . 0.0 112.605 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.581 HH11 ' HA ' ' A' ' 50' ' ' GLU . 11.8 mtt180 -71.91 -37.1 70.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.828 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.518 ' H ' ' HE1' ' A' ' 86' ' ' HIS . 57.1 mttm -120.39 173.45 7.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -110.05 137.43 47.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.652 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 141.63 -118.8 1.38 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.742 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -110.15 100.38 9.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.793 0.33 . . . . 0.0 111.268 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.518 ' HE1' ' H ' ' A' ' 82' ' ' LYS . 11.5 m-70 -119.43 156.45 30.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.35 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.582 ' CG2' HG22 ' A' ' 107' ' ' THR . 58.1 m -159.63 147.93 17.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 33.2 tp -104.67 90.12 3.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.368 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.768 ' HA ' HG23 ' A' ' 107' ' ' THR . 42.9 mt-10 -72.43 95.15 1.73 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.894 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 35.8 mt -109.9 133.96 52.59 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 104' ' ' GLU . 7.3 p -140.41 153.93 22.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.843 -178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.5 t80 -97.83 84.57 3.37 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.4 t -116.4 167.83 10.69 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 97' ' ' GLU . 77.8 mtp180 -100.38 94.53 3.46 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 93' ' ' THR . 77.7 Cg_exo -43.45 -24.63 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.802 2.334 . . . . 0.0 113.371 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -79.47 -62.21 1.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 94' ' ' ARG . 1.6 pp20? -72.23 -39.1 68.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 111.674 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.8 -165.14 24.64 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -112.98 132.9 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 111.748 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE3' ' CD ' ' A' ' 97' ' ' GLU . 5.8 mttt -120.57 156.26 55.97 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.8 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.53 -47.42 1.46 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.918 2.412 . . . . 0.0 112.73 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -53.75 -17.7 2.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.832 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 11.3 m120 -63.76 157.22 24.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.336 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -57.51 159.22 5.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.244 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.681 ' HB3' HD22 ' A' ' 10' ' ' ASN . 13.5 tpp180 -129.68 164.34 24.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.029 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.593 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 61.0 t80 -174.85 72.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.768 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.05 96.02 8.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.397 -178.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 20.6 tp -76.46 93.3 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 39.7 m-70 -77.55 144.87 37.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 16' ' ' THR . 75.1 mt -145.67 113.37 6.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.23 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.4 t30 -83.39 65.29 8.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.6 t -46.06 129.01 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.443 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.937 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.8 p -146.41 -9.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -147.36 122.49 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -69.06 136.52 52.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.5 tt -81.53 -17.51 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -166.47 -49.94 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.897 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 72.9 Cg_exo -49.55 120.82 6.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.27 1.98 . . . . 0.0 112.535 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.6 tp -86.61 -67.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.9 t -87.5 174.05 8.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.752 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.665 HG22 ' H ' ' A' ' 9' ' ' ASP . 14.9 p -83.56 138.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 4.5 mptp? -106.23 28.36 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.871 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.665 ' H ' HG22 ' A' ' 7' ' ' VAL . 18.4 t70 -35.5 121.78 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.809 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -118.46 -89.13 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.624 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.6 OUTLIER -32.36 99.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.207 -179.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' HD13 ' A' ' 108' ' ' LEU . 19.8 ptmt -93.88 73.57 4.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.673 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.7 m95 -49.62 104.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG23 HD23 ' A' ' 110' ' ' LEU . 28.2 m -146.62 -175.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 112.503 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -110.83 179.68 3.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.641 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.519 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.8 t -177.08 -173.12 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.976 0.417 . . . . 0.0 112.023 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 64.1 m80 -119.15 -167.47 1.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.038 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 25.9 t -84.46 139.91 16.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.183 0.516 . . . . 0.0 112.182 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 57.4 13.15 10.1 Favored Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.731 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.1 tptt -59.92 82.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.737 HG22 HD22 ' A' ' 77' ' ' LEU . 3.7 m -54.39 98.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.381 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -94.96 101.24 13.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.4 tt0 -84.18 130.15 34.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.55 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD11 HD22 ' A' ' 108' ' ' LEU . 46.9 mt -136.47 101.07 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.205 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -81.69 109.82 16.46 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 18.5 mt -104.63 152.35 22.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.469 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -108.48 159.57 16.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.979 0.418 . . . . 0.0 110.443 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.81 -39.14 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.172 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.9 t30 65.38 109.43 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.77 -0.215 . . . . 0.0 110.951 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.44 178.33 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.585 2.19 . . . . 0.0 112.681 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p 47.43 25.11 0.56 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.798 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 98.9 m -117.94 -60.15 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.95 -103.86 0.57 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.671 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -105.83 -166.45 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 0.0 111.002 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.526 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 3.3 ttt -118.88 151.21 38.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.966 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.471 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -108.39 89.88 3.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.5 t -135.58 -167.05 1.95 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.413 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.715 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.0 mtp85 -89.97 147.23 23.83 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.703 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 42.5 t -63.92 132.37 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.697 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.31 14.23 79.12 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.809 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.476 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 63.2 m-85 -136.44 0.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.047 0.451 . . . . 0.0 110.734 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.605 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.3 p -45.28 123.19 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.175 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.22 -39.19 2.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.536 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 94.1 mttt -60.32 165.96 3.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 111.119 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -85.02 -45.5 12.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.782 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -108.36 135.49 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.269 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.715 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.8 mt -100.32 -50.19 4.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.14 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 54' ' ' VAL . 88.6 p -52.64 174.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.495 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -154.78 -86.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.183 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.64 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.97 -34.23 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.9 mm -61.52 -62.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.748 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 80' ' ' PRO . 38.6 mt -126.79 134.46 50.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.947 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.434 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 0.3 OUTLIER -74.07 67.05 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG21 ' NH1' ' A' ' 38' ' ' ARG . 4.0 t -73.82 82.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.059 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 27.2 t -80.6 81.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.51 0.672 . . . . 0.0 109.215 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.461 ' SG ' HG22 ' A' ' 76' ' ' VAL . 24.4 t -91.8 135.35 33.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.873 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -127.52 105.14 8.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.526 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -81.62 111.92 18.36 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.514 HG22 HG23 ' A' ' 70' ' ' VAL . 2.6 m -103.27 100.35 17.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.806 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HA ' ' HA2' ' A' ' 72' ' ' GLY . 39.6 Cg_endo -102.15 9.87 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.799 3.0 . . . . 0.0 113.401 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.518 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -85.27 137.31 37.08 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.349 -178.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 61' ' ' THR . 92.6 Cg_endo -86.26 -178.89 2.94 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.793 2.329 . . . . 0.0 112.269 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 66' ' ' PRO . 8.0 t -163.35 -172.41 2.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.802 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -104.07 -58.54 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.119 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.624 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 58.5 m -106.19 -49.72 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.03 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 15.7 Cg_exo -69.08 122.16 9.01 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.758 2.306 . . . . 0.0 112.298 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 94.6 mmm -145.05 19.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.117 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -107.72 28.12 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.087 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.52 -29.29 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.653 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.514 HG23 HG22 ' A' ' 59' ' ' THR . 3.5 p -137.67 82.84 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.305 0.574 . . . . 0.0 110.995 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -152.77 16.5 0.72 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.083 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 60' ' ' PRO . . . 104.12 29.67 5.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.526 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.4 pt -101.29 -168.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.174 0.511 . . . . 0.0 111.349 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -142.71 97.73 3.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.172 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 p -92.67 104.67 15.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 110.662 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.461 HG22 ' SG ' ' A' ' 56' ' ' CYS . 23.3 t -99.68 127.16 52.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.586 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -111.71 98.7 7.6 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.851 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.95 105.11 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -104.46 98.81 15.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.619 ' HA ' HD22 ' A' ' 52' ' ' LEU . 93.2 Cg_exo -43.05 100.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.066 2.511 . . . . 0.0 113.105 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.64 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.5 mtt180 -76.56 -29.73 56.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.118 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 79.5 mttt -122.4 154.88 37.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.962 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -96.66 124.62 40.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.031 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.569 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.35 -159.53 24.81 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.591 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -67.12 117.77 9.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.454 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 88.8 m-70 -145.43 170.04 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.649 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 88' ' ' LEU . 51.4 m -161.28 159.65 28.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.119 0.485 . . . . 0.0 112.202 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.666 HD22 HG21 ' A' ' 78' ' ' VAL . 10.1 tp -119.13 93.29 4.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.467 178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.2 mt-10 -72.67 95.95 1.94 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 49.7 mt -107.98 115.89 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 92' ' ' TYR . 10.6 p -120.16 157.17 22.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.1 t80 -95.98 79.8 3.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.22 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.625 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 6.3 t -108.45 150.61 27.18 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 17.2 mtp180 -92.03 102.65 6.59 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.821 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 93' ' ' THR . 50.2 Cg_exo -55.25 -30.86 73.86 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.597 2.198 . . . . 0.0 112.437 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -65.04 -25.14 67.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.464 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -122.65 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.867 0.365 . . . . 0.0 111.282 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 174.65 -173.73 46.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.373 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.597 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.1 mt -97.26 139.49 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 111.127 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -132.65 166.84 26.05 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.22 -41.2 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.822 2.348 . . . . 0.0 112.334 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.91 -18.01 41.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -60.85 148.19 40.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.11 168.3 2.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.0 tpp180 -131.75 164.18 26.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.445 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.661 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 45.2 t80 -171.81 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.507 -0.769 . . . . 0.0 108.955 177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.507 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -86.7 91.98 8.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.574 -179.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.2 tp -70.69 90.99 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.075 0.464 . . . . 0.0 110.277 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 31.6 m-70 -77.38 139.96 39.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.693 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.6 mt -144.06 108.82 4.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.767 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.8 t30 -84.09 61.29 6.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.569 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.8 t -40.55 140.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.942 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.999 179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.3 t -103.51 -63.66 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.721 0.296 . . . . 0.0 110.996 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 62.17 -82.69 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp 58.63 -173.09 0.1 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.09 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -114.4 -28.52 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.036 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -59.65 149.96 68.94 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.163 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 20.5 Cg_exo -66.13 -0.9 4.56 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.677 2.251 . . . . 0.0 112.412 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.16 -31.84 63.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.013 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -89.21 143.48 26.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.849 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.49 135.33 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.12 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.666 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -108.09 -3.91 18.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -36.63 120.74 0.71 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.367 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.1 p-10 -126.0 -94.1 0.47 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 22.1 m-20 -38.45 98.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.539 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -98.38 87.9 3.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.644 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.8 m95 -78.72 98.27 6.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.752 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 110' ' ' LEU . 30.4 m -147.3 -172.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 111.961 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.1 p-10 -113.76 -178.55 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.798 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.521 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.0 t -174.74 -174.06 0.78 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.06 0.457 . . . . 0.0 111.927 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.597 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 56.6 m80 -116.04 -173.72 2.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.012 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -77.81 135.56 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.249 0.547 . . . . 0.0 112.05 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 60.26 14.18 32.09 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.883 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 8.0 tptm -58.13 84.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.24 0.52 . . . . 0.0 109.902 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.794 HG22 HD22 ' A' ' 77' ' ' LEU . 3.0 m -56.54 100.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.497 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.427 HG21 HD21 ' A' ' 108' ' ' LEU . 88.6 m -96.81 103.72 15.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.546 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.652 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.2 tt0 -75.9 117.01 17.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.046 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.698 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 67.5 mt -114.15 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.301 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.436 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.2 m170 -100.93 104.29 15.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.415 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 36.3 mt -96.08 163.08 13.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.308 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -101.88 163.56 12.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.096 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.29 -146.31 16.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.516 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.434 ' O ' HG22 ' A' ' 32' ' ' THR . 8.0 p-10 -172.93 142.26 1.04 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.517 0.199 . . . . 0.0 111.2 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.3 -3.3 11.46 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.553 2.169 . . . . 0.0 112.285 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.4 p -82.16 -41.44 20.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.696 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.434 HG22 ' O ' ' A' ' 29' ' ' ASN . 1.7 t -54.65 -43.4 72.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.317 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.55 -63.31 0.48 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.16 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.461 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 81.2 m-85 -60.64 175.85 0.43 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.242 0.544 . . . . 0.0 111.68 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.536 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 8.2 ttm -146.86 154.26 41.11 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.661 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.545 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 3.4 m95 -110.92 91.8 3.8 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.9 t -134.73 -163.8 1.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.083 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.68 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -83.23 150.52 26.14 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.81 0.338 . . . . 0.0 110.627 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 t -73.44 129.7 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.359 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.21 12.89 80.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.506 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 91.6 m-85 -136.2 4.14 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.537 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.574 ' HA ' HG21 ' A' ' 37' ' ' THR . 7.2 p -49.17 133.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.253 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.67 -34.8 2.91 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.83 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.498 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 57.4 mttp -59.75 164.0 4.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.54 -37.84 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.676 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.38 128.47 75.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.12 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.9 mt -89.41 -50.49 6.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.113 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.446 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 54.1 p -54.18 -171.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.863 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.89 -79.35 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.176 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.87 -34.62 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.486 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.8 mm -70.58 -77.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.502 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.3 mt -101.46 119.49 38.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.404 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.95 70.36 0.35 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.094 0.473 . . . . 0.0 109.887 177.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -72.58 84.4 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.896 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 38.8 t -81.04 91.2 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 54.0 t -90.25 130.27 36.39 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.113 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 54.8 mttm -124.98 80.25 1.86 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.842 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.536 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -64.73 119.59 10.86 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.617 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.5 m -100.43 100.62 12.52 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.631 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 40.5 Cg_endo -102.7 -3.99 0.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 123.839 3.026 . . . . 0.0 113.753 -178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.518 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -63.72 140.72 97.86 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.029 -178.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' HG22 ' A' ' 61' ' ' THR . 31.7 Cg_exo -59.53 177.99 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.517 2.144 . . . . 0.0 112.37 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.8 t -129.1 170.53 13.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.0 m -66.95 -39.0 87.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.634 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 72.1 m -156.42 -50.26 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.791 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 8.2 Cg_exo -73.51 -157.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.862 2.375 . . . . 0.0 112.133 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.3 mtt -142.14 19.16 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.64 148.96 15.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.18 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.61 -44.52 3.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.602 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.6 p -153.44 91.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 111.134 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.35 41.77 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.415 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.2 42.46 0.51 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -87.23 -25.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.089 -0.556 . . . . 0.0 112.456 -179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 11.6 m-85 41.75 87.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -88.39 131.71 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.025 0.44 . . . . 0.0 110.426 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 38.2 t -137.49 97.61 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.525 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.794 HD22 HG22 ' A' ' 21' ' ' THR . 79.2 mt -92.37 102.52 15.0 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.79 109.14 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 111.3 -178.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.9 mtmt -113.21 92.78 23.25 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.08 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.603 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.1 Cg_endo -46.97 102.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 112.619 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 19.9 mtt180 -66.37 -33.49 75.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.792 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -119.08 -176.01 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.712 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -123.13 143.92 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.719 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.62 -117.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.587 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.465 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.9 m80 -112.72 94.33 4.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 111.103 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.9 OUTLIER -112.51 161.26 16.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.425 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.9 m -159.22 140.4 12.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.956 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.777 ' HB2' HG11 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -112.51 82.01 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.52 179.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 13.2 pt-20 -80.43 128.06 33.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.224 0.535 . . . . 0.0 111.149 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 45.7 mt -122.64 162.51 21.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.917 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -156.08 150.79 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.931 0.396 . . . . 0.0 111.587 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.3 t80 -93.6 85.91 5.03 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.793 ' HB ' HG23 ' A' ' 99' ' ' ILE . 4.3 t -118.53 161.84 19.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 72.9 mtp180 -99.01 97.95 5.74 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.181 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -47.83 -32.62 17.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.767 2.311 . . . . 0.0 113.378 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.06 11.64 17.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -151.38 1.36 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.26 -175.96 49.96 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.305 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.793 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -104.17 154.42 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 111.909 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.537 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 6.6 mmtt -132.47 168.72 16.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.62 -49.77 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.28 2.653 . . . . 0.0 112.702 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.06 -13.51 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.623 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.537 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -59.91 144.43 48.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.414 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 6.2 tt0 -55.5 163.35 1.29 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.969 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.625 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 13.9 tpt180 -130.55 161.29 31.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.907 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.646 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 43.3 t80 -171.99 75.95 0.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.263 0.554 . . . . 0.0 109.643 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 20.9 m -97.71 102.38 14.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.833 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.7 tp -84.05 90.22 7.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 8.8 m-70 -74.33 142.92 45.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.907 0.384 . . . . 0.0 110.109 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 14' ' ' VAL . 88.8 mt -146.39 99.8 3.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.859 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.3 t30 -75.91 73.27 2.82 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 112' ' ' VAL . 2.6 t -48.4 148.08 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.726 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 11.1 mmpt? . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.343 -0.837 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.1 t -91.71 117.84 30.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -131.46 12.36 4.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt -64.03 153.92 35.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.14 -18.44 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.83 150.71 17.72 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 57.8 Cg_endo -71.03 148.66 57.36 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.526 2.151 . . . . 0.0 112.348 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -138.13 -64.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -149.52 -70.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 m -81.33 120.21 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.35 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 4' ' ' PRO . 72.9 mmtt -153.24 129.99 10.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.18 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.15 124.14 27.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.557 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -121.09 -84.28 0.66 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.964 -179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.577 ' H ' HD22 ' A' ' 10' ' ' ASN . 13.2 m-20 -32.11 101.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.795 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.6 OUTLIER -95.35 90.89 5.98 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.29 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.694 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -78.26 103.15 8.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.761 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG23 HD23 ' A' ' 110' ' ' LEU . 20.9 m -149.93 -172.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.788 0.328 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 2.9 p-10 -112.88 -177.77 3.22 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.36 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.557 HG22 HG22 ' A' ' 112' ' ' VAL . 1.5 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.105 0.478 . . . . 0.0 112.255 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.619 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.9 m80 -113.52 -167.77 1.25 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.28 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -89.64 138.07 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 112.294 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.28 17.95 19.67 Favored Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.738 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.619 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.8 tptp -66.74 81.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.777 HG22 HD22 ' A' ' 77' ' ' LEU . 9.2 m -48.21 97.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.42 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' HG23 ' A' ' 78' ' ' VAL . 53.5 m -93.09 101.43 13.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.722 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.592 ' HA ' HD23 ' A' ' 77' ' ' LEU . 34.6 tt0 -75.51 119.22 19.27 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.72 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -118.29 93.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.463 ' CD2' HG22 ' A' ' 75' ' ' VAL . 10.3 m170 -86.68 104.17 15.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.556 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 52.7 mt -95.53 160.96 14.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 -178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -99.23 163.43 12.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.82 -160.63 27.47 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.68 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 30' ' ' PRO . 65.6 t30 -168.95 126.53 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HD2' ' OD1' ' A' ' 29' ' ' ASN . 78.4 Cg_exo -50.88 -58.63 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.695 2.263 . . . . 0.0 113.078 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.5 t -82.24 50.91 1.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.945 0.402 . . . . 0.0 111.593 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 50.3 m -141.89 -68.47 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.492 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.83 -117.9 2.0 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.397 -0.906 . . . . 0.0 113.246 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 1.4 m-85 -93.89 -172.66 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 111.186 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 19.9 ttm -113.66 152.32 30.58 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.433 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.538 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 8.0 m95 -109.36 87.12 2.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.134 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.607 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.2 t -134.78 -165.07 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.436 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.642 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.7 mtp85 -90.34 156.78 18.01 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 39.6 t -76.12 132.02 33.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.521 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.95 88.98 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.407 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 57.6 m-85 -131.92 -0.41 3.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 110.414 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.898 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -55.58 119.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.07 -27.05 20.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.002 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 65.8 mttm -69.51 172.15 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.867 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.66 -62.52 1.5 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 p -110.7 141.38 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.143 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt -91.99 -51.99 4.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.927 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.0 p -51.26 179.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.925 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.78 -87.03 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.189 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.599 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -131.81 -30.91 1.57 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.2 mm -72.96 -76.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.509 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 80' ' ' PRO . 9.6 mt -102.91 116.65 32.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.511 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -69.58 69.87 0.28 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.14 0.495 . . . . 0.0 109.848 178.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG22 HG13 ' A' ' 78' ' ' VAL . 24.7 t -73.53 85.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.725 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.5 t -77.34 85.56 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.395 0.617 . . . . 0.0 109.41 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 t -68.24 136.09 52.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.134 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.692 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 68.0 mttm -135.72 50.68 2.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.654 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.3 OUTLIER -52.59 116.6 2.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.815 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.426 ' N ' ' HD1' ' A' ' 58' ' ' TYR . 29.4 m -97.32 101.88 11.11 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.405 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 45.5 Cg_endo -106.74 27.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 124.469 3.446 . . . . 0.0 111.799 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.3 t -107.87 148.18 36.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 23.4 Cg_exo -64.69 146.34 88.47 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.836 2.358 . . . . 0.0 112.426 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.1 t -79.97 -164.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.515 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.9 m -51.69 -65.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.3 p -104.01 153.91 38.51 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.241 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.72 15.24 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.814 2.342 . . . . 0.0 112.485 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.8 mtp -79.64 -7.16 58.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 t -132.4 29.22 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.853 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.98 -121.26 10.73 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.626 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 41.7 t -88.07 -104.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.823 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 70' ' ' VAL . . . -156.67 -68.37 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.764 -0.535 . . . . 0.0 111.764 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.89 44.57 88.66 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.604 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -89.77 -22.92 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 7.9 m-85 39.58 90.41 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.117 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 99.2 t -92.73 95.59 5.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.681 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 t -100.29 108.86 23.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.731 0.3 . . . . 0.0 111.773 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.777 HD22 HG22 ' A' ' 21' ' ' THR . 40.3 mt -95.6 110.81 22.86 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.95 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.614 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -101.7 104.52 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.888 0.375 . . . . 0.0 110.965 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 42.1 mtmt -107.79 101.36 40.05 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.339 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HA ' HD23 ' A' ' 52' ' ' LEU . 54.0 Cg_exo -51.52 97.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.664 2.243 . . . . 0.0 112.74 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.599 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -62.89 -36.75 84.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.869 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -117.25 -172.62 2.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.569 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -133.31 125.71 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.831 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.32 -98.61 0.19 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.016 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.446 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 49.4 t-80 -122.09 105.57 10.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.74 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.7 m80 -124.41 159.98 29.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.429 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' HD12 ' A' ' 52' ' ' LEU . 32.4 m -159.59 148.7 18.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.704 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.7 tp -120.46 91.52 3.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.53 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.485 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.4 mt-10 -75.86 88.63 2.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.24 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.629 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 42.3 mt -98.45 122.84 42.14 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.77 154.54 34.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.675 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 35' ' ' MET . 9.7 t80 -96.51 82.41 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.212 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.898 HG21 HG21 ' A' ' 42' ' ' VAL . 6.2 t -121.48 151.93 39.7 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 57.5 mtp180 -88.79 102.04 3.55 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.26 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 9.3 Cg_endo -52.99 -33.44 62.59 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.753 2.302 . . . . 0.0 112.429 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -64.52 -32.72 74.48 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.441 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -105.19 -72.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.953 0.406 . . . . 0.0 111.21 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.24 38.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.996 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.63 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.6 mt -96.44 143.68 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 41.7 mtmt -137.93 163.06 50.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.146 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.3 Cg_endo -67.92 -38.76 12.48 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.762 2.308 . . . . 0.0 112.032 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.7 pt-20 -60.69 -28.99 69.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.566 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -54.74 147.49 14.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.024 179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -58.46 165.91 1.95 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.64 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.9 tpp180 -131.75 164.1 26.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.071 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 39.1 t80 -176.06 66.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.452 177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 89' ' ' GLU . 18.2 m -90.07 97.46 11.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.061 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.3 tp -77.98 93.86 4.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.266 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 16.2 m-70 -77.63 144.0 37.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.346 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.502 HD23 HG23 ' A' ' 14' ' ' VAL . 79.1 mt -144.64 104.56 4.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.627 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.9 t30 -81.03 61.53 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.557 HG22 HG22 ' A' ' 16' ' ' THR . 2.1 t -43.33 131.18 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.569 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.929 179.851 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -87.92 135.37 33.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -147.85 168.51 22.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt -131.42 -173.32 3.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.0 tt -129.89 -26.9 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.575 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -63.09 -48.97 83.06 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.687 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 48.4 Cg_exo -56.25 106.59 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.231 1.954 . . . . 0.0 112.326 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -140.87 -46.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.782 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -140.17 -16.61 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.95 -171.7 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -167.46 131.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.59 122.37 18.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 1.0 OUTLIER -128.12 -93.03 0.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.068 0.461 . . . . 0.0 112.056 -179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 107' ' ' THR . 15.4 m-20 -44.89 102.14 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.752 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.494 ' HE2' HG11 ' A' ' 14' ' ' VAL . 22.7 tptm -98.79 90.95 4.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.301 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.1 m95 -82.13 101.36 10.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.498 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 HD23 ' A' ' 110' ' ' LEU . 11.3 m -152.7 -175.25 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.407 0.622 . . . . 0.0 112.411 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -97.07 -174.29 2.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.286 179.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.464 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.9 t -175.6 -175.69 0.8 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.188 0.518 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 38.8 m80 -114.12 -161.51 0.77 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.694 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -101.88 131.84 49.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.09 0.471 . . . . 0.0 111.767 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.64 14.29 14.44 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.485 -0.779 . . . . 0.0 113.351 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptm -63.2 84.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.748 HG22 HD22 ' A' ' 77' ' ' LEU . 6.8 m -46.22 98.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.718 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.2 m -92.94 98.38 11.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.411 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HA ' HD23 ' A' ' 77' ' ' LEU . 37.2 tt0 -80.22 133.92 36.06 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.034 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.538 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.7 mt -135.97 106.63 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.732 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -88.78 91.26 8.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.689 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.538 ' HG ' HG22 ' A' ' 24' ' ' ILE . 16.6 mt -88.27 144.62 26.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.269 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 73' ' ' ILE . 44.8 mttp -101.79 165.66 11.08 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.925 0.393 . . . . 0.0 110.527 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.78 -134.15 2.78 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.518 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 59.5 t30 -175.72 90.46 0.28 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.505 0.193 . . . . 0.0 110.61 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HB3' ' OH ' ' A' ' 58' ' ' TYR . 11.4 Cg_endo -55.49 -22.78 36.18 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.953 2.435 . . . . 0.0 113.458 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.0 t -78.89 13.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 29' ' ' ASN . 68.5 p -98.96 -60.26 1.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.798 0.332 . . . . 0.0 111.039 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 -41.95 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.751 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 70.1 m-85 -82.96 177.75 8.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.004 0.431 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.727 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 13.3 ttm -146.95 148.95 32.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.408 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.494 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -103.24 80.02 1.79 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.749 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.404 ' HB ' ' SD ' ' A' ' 35' ' ' MET . 12.1 t -124.68 -164.74 1.3 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.344 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 5.9 mtp85 -87.19 135.82 33.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.966 0.412 . . . . 0.0 111.045 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 91' ' ' VAL . 39.3 t -50.27 152.21 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.722 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.25 1.1 18.98 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.4 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HE2' HH21 ' A' ' 38' ' ' ARG . 24.8 m-85 -127.07 43.72 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.473 0.654 . . . . 0.0 110.536 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.583 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.4 p -80.0 98.19 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.395 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.45 -19.38 22.03 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.061 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -72.87 173.41 9.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.365 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.1 -62.81 1.4 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.03 146.16 7.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.7 mt -105.52 -52.94 2.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.171 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.42 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.5 p -50.13 173.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.762 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.65 -87.68 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -131.16 -31.16 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.261 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 mm -73.59 -73.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.417 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.704 HD23 ' HA ' ' A' ' 80' ' ' PRO . 53.3 mt -105.5 118.31 36.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.414 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -70.29 69.57 0.38 Allowed 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.252 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG22 HG13 ' A' ' 78' ' ' VAL . 12.4 t -76.19 86.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.178 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.8 t -82.79 87.4 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.427 ' SG ' HG22 ' A' ' 76' ' ' VAL . 40.2 t -101.63 130.56 47.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.726 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -121.27 110.26 15.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.937 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.48 110.63 17.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.556 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 3.3 m -115.09 110.67 45.53 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.653 -179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.754 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 27.1 Cg_endo -100.73 14.06 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.328 2.685 . . . . 0.0 112.21 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 62' ' ' PRO . 85.2 m -79.49 -50.55 1.29 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 61' ' ' THR . 80.2 Cg_exo -40.07 98.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.864 3.043 . . . . 0.0 112.938 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -68.58 127.06 31.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.084 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -123.45 -22.91 4.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -60.94 156.0 50.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.0 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.72 9.43 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.457 2.105 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 69.9 mtm -144.14 -98.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.83 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -143.26 142.78 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.958 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.6 -177.05 46.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.466 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 60' ' ' PRO . 21.8 t -127.64 73.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.35 101.11 0.3 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.309 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.754 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -101.03 -123.01 5.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.495 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 10.0 pt -144.69 -168.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.119 0.485 . . . . 0.0 111.462 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.494 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -126.35 102.4 7.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.088 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -88.97 106.03 16.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 110.988 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.427 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.6 t -107.89 122.13 61.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.12 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.748 HD22 HG22 ' A' ' 21' ' ' THR . 82.9 mt -112.03 102.61 10.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.811 178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.679 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.42 106.82 18.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -178.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 47.7 mtmt -110.78 94.53 20.21 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.051 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.6 Cg_endo -48.29 107.24 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.16 . . . . 0.0 112.506 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.531 HH11 ' HA ' ' A' ' 50' ' ' GLU . 12.8 mtt180 -73.31 -43.67 60.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.149 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -108.87 175.25 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.18 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -110.09 146.91 34.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.773 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.95 -125.69 4.59 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.385 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.468 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 56.9 t-80 -110.63 106.06 15.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.09 0.471 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.468 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.2 m-70 -117.29 164.77 14.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.419 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' HD12 ' A' ' 52' ' ' LEU . 67.7 m -159.59 145.32 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.967 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.642 HD22 HG21 ' A' ' 78' ' ' VAL . 13.5 tp -111.81 91.91 3.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.493 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.1 mt-10 -75.57 104.24 6.04 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.606 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 66.2 mt -112.97 132.28 55.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.5 p -138.09 155.48 29.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -93.42 76.39 4.48 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.664 ' HA ' HD22 ' A' ' 103' ' ' ASN . 5.6 t -105.71 155.11 19.58 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 28.1 mtp180 -86.24 104.18 5.12 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.475 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.0 Cg_endo -55.98 -30.08 76.44 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.756 2.304 . . . . 0.0 112.181 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.6 -25.78 61.45 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.836 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -123.5 -88.32 0.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.729 0.3 . . . . 0.0 111.655 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.53 -166.12 28.94 Favored Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.562 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.546 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.0 mt -103.17 145.11 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.834 0.35 . . . . 0.0 111.231 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -134.57 168.73 16.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.608 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.12 -38.96 11.38 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.725 2.283 . . . . 0.0 112.47 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.7 -1.8 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.439 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.664 HD22 ' HA ' ' A' ' 93' ' ' THR . 3.3 m120 -76.18 141.26 41.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.746 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.1 tt0 -58.16 162.04 3.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.819 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.599 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.0 tpt180 -130.2 160.01 35.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.251 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.599 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.6 t80 -175.24 72.01 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.461 0.648 . . . . 0.0 109.472 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 89' ' ' GLU . 8.1 m -91.5 96.62 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.15 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.0 tp -75.97 91.73 3.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.28 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.9 m-70 -77.05 137.13 38.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.567 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD23 HG23 ' A' ' 14' ' ' VAL . 94.0 mt -143.73 112.7 6.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.375 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.526 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.1 t30 -86.7 85.51 7.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 17' ' ' HIS . 14.8 t -55.5 124.35 8.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.324 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 113' ' ' LYS . 3.2 mmmp? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.0 m -130.39 7.01 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -63.44 -30.2 71.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -73.85 165.41 25.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.7 pt -101.24 -7.2 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.16 150.5 74.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.49 152.9 31.07 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.63 2.22 . . . . 0.0 112.215 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.6 mm? -104.26 -68.65 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -81.91 175.07 10.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 9' ' ' ASP . 16.7 t -79.17 147.99 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.927 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 2.9 mppt? -99.42 18.75 17.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.692 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.656 ' H ' HG12 ' A' ' 7' ' ' VAL . 17.0 t70 -37.25 133.06 0.71 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.879 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER -86.6 -86.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.015 -179.136 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 107' ' ' THR . 25.5 t70 -144.34 -128.82 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.594 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 50.8 tptt -160.24 172.16 17.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 4.5 m0 -120.46 123.99 44.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.746 0.418 . . . . 0.0 110.334 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.3 m -150.68 159.21 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.673 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -50.4 168.2 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.313 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -174.19 -173.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.426 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 26.2 m80 -109.23 -168.58 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.625 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.83 138.45 26.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.151 0.501 . . . . 0.0 111.891 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.61 17.48 20.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.294 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.2 tptp -66.07 80.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 5.1 m -44.46 101.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.625 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.5 m -98.97 102.62 14.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.754 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.7 tt0 -80.2 127.56 32.48 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.584 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.529 HG22 ' HG ' ' A' ' 26' ' ' LEU . 48.1 mt -130.9 105.23 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.907 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -87.19 96.36 10.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' HG ' HG22 ' A' ' 24' ' ' ILE . 20.7 mt -91.12 145.6 24.54 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.319 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -100.46 162.99 12.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.68 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.76 -138.95 4.02 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.373 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.476 HD21 ' HB ' ' A' ' 31' ' ' THR . 4.2 t30 -174.93 91.85 0.3 Allowed Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 69.8 Cg_exo -51.6 -30.76 37.52 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.476 ' HB ' HD21 ' A' ' 29' ' ' ASN . 0.5 OUTLIER -57.4 -30.05 64.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.838 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 29' ' ' ASN . 73.6 p -59.43 -65.9 0.6 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.728 0.299 . . . . 0.0 111.243 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.12 -38.23 0.53 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.691 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 88.3 m-85 -77.51 -178.96 5.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 111.154 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.546 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 7.5 ttm -151.79 150.05 29.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.7 m95 -103.04 82.9 2.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.673 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 42' ' ' VAL . 10.0 t -124.88 -174.73 3.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.643 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.717 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.3 mtp85 -83.12 150.63 26.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.849 0.357 . . . . 0.0 111.076 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 91' ' ' VAL . 41.5 t -64.47 127.73 25.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.83 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.95 18.46 67.51 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.064 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 62.4 m-85 -138.02 0.86 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 110.652 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.656 ' HA ' HG21 ' A' ' 37' ' ' THR . 5.6 p -47.05 125.42 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.257 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.67 -35.69 3.58 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.859 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 61.7 mttp -60.48 170.18 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.54 -62.15 1.76 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.848 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.83 144.2 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.717 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.7 mt -102.52 -49.18 3.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.306 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 35.3 t -51.05 173.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.766 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -159.04 -85.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.256 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.07 -33.98 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.431 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.9 mm -67.42 -78.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.455 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.607 ' O ' HG23 ' A' ' 54' ' ' VAL . 96.4 mt -106.42 119.3 38.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.94 72.29 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.709 HG22 HG13 ' A' ' 78' ' ' VAL . 7.6 t -80.81 86.18 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.498 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.2 t -83.52 85.7 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 76' ' ' VAL . 33.8 t -101.91 149.34 24.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.741 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -139.64 112.99 8.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.879 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.27 107.69 11.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.488 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.6 m -103.05 107.01 53.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.923 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -101.08 92.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 123.647 2.898 . . . . 0.0 111.312 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.506 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -75.62 140.22 71.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.233 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HD2' HG22 ' A' ' 61' ' ' THR . 24.1 Cg_exo -63.65 179.78 0.9 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.614 2.21 . . . . 0.0 112.276 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.0 t -136.12 -17.4 1.61 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.763 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.1 t 179.68 -52.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.569 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 37.5 p -120.13 155.21 55.93 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.216 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.11 12.41 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.721 2.281 . . . . 0.0 112.44 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.2 mtt -113.61 -79.28 0.58 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.07 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.97 138.12 23.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.45 86.33 1.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.592 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.82 81.91 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.953 0.406 . . . . 0.0 110.777 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -100.3 129.13 9.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.881 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -143.12 -138.51 3.43 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.009 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -145.58 -167.54 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.148 0.499 . . . . 0.0 111.12 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.2 m-85 -133.52 100.86 4.93 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.071 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.6 t -85.11 107.53 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 110.558 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.573 HG11 HD21 ' A' ' 88' ' ' LEU . 40.3 t -112.71 120.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 73.2 mt -108.58 99.84 9.16 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -96.55 108.55 21.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.457 . . . . 0.0 111.698 -178.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 31.7 mtmm -110.16 98.41 35.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.568 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.8 Cg_endo -49.62 109.03 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.368 2.046 . . . . 0.0 112.778 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 16.4 mtt180 -81.06 -36.4 30.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.086 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -108.68 173.63 6.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.169 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 63.9 mtp180 -110.76 148.19 32.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.905 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.13 -164.52 13.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -70.5 102.0 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.687 0.28 . . . . 0.0 110.714 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.454 ' H ' ' HA ' ' A' ' 111' ' ' ASN . 99.2 m-70 -128.04 149.95 50.15 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.483 0.659 . . . . 0.0 111.33 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.546 HG21 ' HB ' ' A' ' 107' ' ' THR . 40.3 m -150.95 146.81 26.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.483 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.604 ' HB2' HG11 ' A' ' 78' ' ' VAL . 20.9 tp -91.16 106.79 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 44.5 mt-10 -80.82 109.11 15.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.022 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 55.6 mt -119.03 143.2 47.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.067 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.19 161.57 19.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.398 0.618 . . . . 0.0 112.411 -179.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.0 t80 -104.23 85.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.48 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.666 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.2 t -114.58 165.66 12.54 Favored 'General case' 0 C--O 1.223 -0.306 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 71.3 mtp180 -102.95 93.59 4.56 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.845 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 93' ' ' THR . 91.7 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.632 2.221 . . . . 0.0 112.627 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.89 -40.21 63.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.24 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -103.22 -68.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.975 0.417 . . . . 0.0 111.307 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.92 -178.99 37.56 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.035 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.666 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.9 mt -90.75 144.16 9.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.999 0.428 . . . . 0.0 111.249 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.539 ' HG3' HD21 ' A' ' 103' ' ' ASN . 1.5 mttp -132.61 166.57 28.03 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.87 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.39 -40.78 29.72 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.853 2.369 . . . . 0.0 112.377 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.45 -13.01 35.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.553 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.612 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -57.82 134.77 56.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.013 0.435 . . . . 0.0 111.45 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.74 164.67 2.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.072 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 2.1 ttp180 -139.79 158.48 44.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 0.0 111.649 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.848 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 47.4 t80 -162.65 103.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.009 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.656 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.7 OUTLIER -102.41 109.42 21.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.51 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 110' ' ' LEU . 25.9 tp -72.5 126.12 29.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.095 0.474 . . . . 0.0 111.183 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 13' ' ' TRP . 2.8 p80 -65.66 65.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 114.556 -1.202 . . . . 0.0 113.387 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.61 HD11 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -102.07 53.93 0.8 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 30.1 t30 -71.09 76.52 0.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.4 t -53.84 150.13 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.763 -178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.046 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.1 p -143.77 157.25 44.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.839 0.352 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -150.95 154.26 36.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -71.76 171.22 12.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.946 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.0 pt -91.99 17.0 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.201 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.2 109.04 1.23 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.93 146.22 25.81 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 112.476 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.5 mp -95.46 -13.62 24.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.671 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.4 m -135.32 -178.93 5.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 t -107.39 94.99 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 89.91 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.293 0.568 . . . . 0.0 110.649 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -98.54 27.93 4.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.822 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.84 -63.23 1.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.236 0.541 . . . . 0.0 111.08 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' HA ' ' N ' ' A' ' 107' ' ' THR . 1.2 p30 -54.86 104.07 0.11 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.286 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' CD ' HD13 ' A' ' 108' ' ' LEU . 22.0 ptmt -101.79 119.69 39.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.028 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.79 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -103.71 111.94 24.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -148.31 -176.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.663 0.744 . . . . 0.0 112.882 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.538 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -93.8 -173.0 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.429 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 1.3 t -172.8 -174.54 1.13 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.416 0.627 . . . . 0.0 112.651 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.614 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 30.0 m80 -120.44 -148.52 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.382 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.7 t -108.93 128.13 65.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.029 0.442 . . . . 0.0 111.589 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 80' ' ' PRO . . . 55.13 20.18 19.62 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.648 -0.705 . . . . 0.0 113.262 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptp -65.95 84.4 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.672 HG22 HD12 ' A' ' 77' ' ' LEU . 6.4 m -47.17 102.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.851 -178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 78' ' ' VAL . 77.3 m -98.98 93.62 6.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' HA ' HD13 ' A' ' 77' ' ' LEU . 38.3 tt0 -78.11 127.95 33.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.156 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 38.2 mt -133.67 105.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.077 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.2 107.36 18.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.207 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 34.7 mt -103.16 149.05 25.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -101.14 161.46 13.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.251 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.04 -150.9 13.66 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.564 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.461 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.8 t30 -173.81 106.41 0.3 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.418 0.151 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 19.5 Cg_endo -58.6 -23.38 64.98 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.46 2.106 . . . . 0.0 112.326 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.408 ' HB ' HD21 ' A' ' 29' ' ' ASN . 18.6 m -63.06 -24.9 68.12 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.235 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 29' ' ' ASN . 66.2 p -61.32 -56.05 24.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.205 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.79 -6.27 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.927 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 44.6 m-85 -123.85 -176.18 3.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.086 0.47 . . . . 0.0 111.24 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.552 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 7.4 ttm -150.71 152.32 33.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.062 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.543 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 42.7 m95 -100.06 90.7 4.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.693 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.6 t -136.92 -178.49 5.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.325 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HD2' HG21 ' A' ' 54' ' ' VAL . 14.8 mtp85 -83.46 160.1 21.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.972 0.415 . . . . 0.0 111.618 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 89' ' ' GLU . 59.0 t -70.68 141.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.918 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.7 2.99 61.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.079 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -124.7 -3.11 7.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.597 0.237 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.585 ' HA ' HG21 ' A' ' 37' ' ' THR . 2.1 p -34.81 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.366 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 129.45 -46.33 1.08 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.409 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -62.55 -167.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.344 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.57 -50.98 1.26 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.434 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 47' ' ' LEU . 2.7 p -63.68 -50.46 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.717 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 7.0 mt 71.81 -61.01 0.5 Allowed 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.844 0.457 . . . . 0.0 111.178 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 60.3 p -46.34 171.68 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.233 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -156.41 -85.23 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.3 pt-20 -129.37 -34.25 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.389 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.574 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.7 mm -68.89 -76.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.241 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.0 mt -105.0 118.47 36.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -69.81 66.31 0.24 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.153 0.502 . . . . 0.0 109.753 177.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.559 HG22 HG13 ' A' ' 78' ' ' VAL . 18.2 t -76.91 83.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.563 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 25.4 t -77.29 80.69 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.21 139.51 30.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.553 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -133.15 105.46 7.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.961 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.33 115.28 22.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.792 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 m -117.08 119.98 34.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.713 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.696 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 63.6 Cg_endo -98.36 41.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.23 2.62 . . . . 0.0 112.03 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.587 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -39.47 139.99 0.82 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.416 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.587 ' HD2' HG22 ' A' ' 61' ' ' THR . 80.9 Cg_exo -47.96 130.27 19.46 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.675 2.25 . . . . 0.0 112.663 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -69.47 172.82 6.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.983 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -102.16 12.54 36.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 p -57.61 155.0 22.53 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.192 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.23 11.52 1.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.738 2.292 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -133.38 -118.89 0.19 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.773 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -129.28 122.61 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 111.06 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.03 151.35 23.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.559 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 60' ' ' PRO . 42.8 t -132.16 75.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.92 0.391 . . . . 0.0 110.621 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.08 116.8 1.53 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.661 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.696 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -106.49 -117.73 4.3 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.273 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.7 pt -141.72 -164.22 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.948 0.404 . . . . 0.0 110.875 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -138.48 98.65 3.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.405 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 77' ' ' LEU . 90.9 t -87.59 106.12 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.26 110.88 33.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 21' ' ' THR . 2.4 mm? -95.71 105.59 17.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.855 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -99.37 105.53 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.048 0.452 . . . . 0.0 111.212 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 30.8 mtmm -110.75 103.23 54.18 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.156 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 10.6 Cg_endo -55.1 111.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.345 2.03 . . . . 0.0 112.278 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.579 HH11 ' HA ' ' A' ' 50' ' ' GLU . 15.0 mtt180 -81.15 -56.01 4.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.608 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -98.69 161.06 13.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.42 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -94.54 141.34 28.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.577 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.74 -116.67 1.05 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.579 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -129.57 99.98 5.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 0.0 111.017 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -108.04 164.78 11.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.8 m -157.74 149.91 22.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.546 HD22 HG21 ' A' ' 78' ' ' VAL . 14.9 tp -123.11 87.35 2.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.252 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -86.98 93.96 9.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.929 0.395 . . . . 0.0 111.057 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 77.1 mt -91.41 99.22 12.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.028 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -92.94 150.82 3.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.121 -178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.3 t80 -90.28 76.96 6.73 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.0 t -98.48 172.46 7.51 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -176.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 69.1 mtp180 -104.42 95.61 8.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.458 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HA ' HG22 ' A' ' 42' ' ' VAL . 66.5 Cg_exo -44.04 -27.58 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 112.651 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -37.19 20.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.391 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 13.9 mm-40 -103.65 -91.64 0.36 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 0.0 111.719 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -167.42 -178.76 39.84 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.281 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.533 HG23 ' HB ' ' A' ' 93' ' ' THR . 11.7 mt -85.24 -77.18 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.0 OUTLIER 71.54 156.3 0.16 Allowed Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.966 -179.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 37.8 Cg_endo -66.3 -35.01 33.51 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.795 2.33 . . . . 0.0 112.8 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HG3' HD22 ' A' ' 103' ' ' ASN . 7.9 pt-20 -54.17 -17.94 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.524 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.55 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -86.67 140.16 30.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 111.467 -179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.574 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -64.91 -176.21 0.25 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.55 179.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -165.23 -164.47 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.552 0.692 . . . . 0.0 111.875 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 45.0 t80 -165.27 69.28 0.14 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.015 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -70.4 88.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.612 -178.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.7 tp -83.59 92.03 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.653 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.9 m-70 -77.79 145.06 36.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.16 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 90.4 mt -144.36 92.77 2.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.269 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.538 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -64.68 85.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 17' ' ' HIS . 4.7 t -62.76 115.01 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.664 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.287 -0.864 . . . . 0.0 110.936 179.702 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -147.89 -32.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.86 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -131.17 150.94 51.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.966 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp -89.07 -3.69 58.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 2' ' ' ILE . 11.7 mm 60.44 11.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.58 145.08 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.05 111.43 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.457 2.104 . . . . 0.0 112.245 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.97 -167.3 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.7 p -58.87 -25.19 63.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.912 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 m -84.05 142.67 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -176.05 139.08 0.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.192 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.02 107.04 9.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.64 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -120.19 -83.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.492 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.594 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.3 OUTLIER -33.24 104.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.921 -179.728 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.98 96.75 10.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.124 179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -79.68 100.76 8.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.449 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.569 HG23 HD23 ' A' ' 110' ' ' LEU . 27.4 m -146.7 -171.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.0 0.428 . . . . 0.0 112.113 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -107.02 -177.13 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.768 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.56 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.4 t -175.25 -175.81 0.87 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.218 0.533 . . . . 0.0 112.185 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.598 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 7.4 m80 -117.93 -165.35 1.09 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.954 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.44 132.77 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.19 0.519 . . . . 0.0 112.067 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.18 19.63 8.16 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.51 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.598 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.2 tptt -63.06 85.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 6.3 m -49.76 96.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.471 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HB ' HG23 ' A' ' 78' ' ' VAL . 50.2 m -94.73 99.81 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.489 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HA ' HD23 ' A' ' 77' ' ' LEU . 30.7 tt0 -76.2 132.84 40.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.838 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' CD2' ' A' ' 108' ' ' LEU . 31.1 mt -132.97 99.62 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.105 -179.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -84.03 98.25 9.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 38.0 mt -93.37 148.29 22.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.581 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -101.91 162.26 13.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.439 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.97 -143.87 7.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.417 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -174.16 95.05 0.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.458 0.17 . . . . 0.0 110.82 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 76.1 Cg_exo -49.91 -24.84 11.1 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.586 2.191 . . . . 0.0 112.532 179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -62.08 -36.14 80.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.553 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.0 p -54.92 -60.37 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.326 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.35 -32.23 1.03 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.547 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 54.0 m-85 -82.56 -176.29 6.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 0.0 111.139 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.3 ttm -152.1 152.46 32.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.019 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 7.8 m95 -107.07 85.27 2.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.742 178.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.2 t -130.35 -163.61 1.33 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.7 mtp85 -91.25 139.58 30.61 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 111.269 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 26.5 t -53.99 133.42 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.056 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.28 -39.05 1.85 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.603 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 47' ' ' LEU . 55.2 m-85 -82.15 3.25 27.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.141 0.496 . . . . 0.0 110.62 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -53.29 110.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.223 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.94 -14.96 10.38 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB2' HD23 ' A' ' 47' ' ' LEU . 92.3 mttt -82.84 -163.28 0.69 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.803 0.335 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -114.51 -57.26 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.204 -179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.36 -36.85 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.598 -179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 12.0 mt 76.13 -44.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.508 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 41.9 t -59.24 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.5 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -147.99 -83.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.386 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.07 -28.82 0.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.602 -179.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.3 mm -76.11 -86.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.69 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.776 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.19 106.0 18.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.45 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG2' ' NE ' ' A' ' 81' ' ' ARG . 1.1 tm-20 -58.08 146.46 33.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.536 HG21 ' HD2' ' A' ' 38' ' ' ARG . 46.3 t -145.6 90.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.667 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 26.2 t -77.04 85.3 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -75.21 129.67 37.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.808 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.709 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 50.9 mtpt -130.71 68.48 1.47 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.691 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.46 ' OH ' ' HG3' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -65.22 103.86 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.353 178.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 m -105.61 114.31 63.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.582 ' HB2' HG12 ' A' ' 70' ' ' VAL . 61.1 Cg_endo -97.84 42.04 0.1 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.287 2.658 . . . . 0.0 111.912 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -37.98 139.79 0.6 Allowed Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.522 -179.249 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.598 ' HD2' HG22 ' A' ' 61' ' ' THR . 76.9 Cg_exo -50.09 143.88 23.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.652 2.234 . . . . 0.0 112.609 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.4 t -91.66 172.67 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.0 m -94.3 19.21 9.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.2 p -57.76 154.82 24.82 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.229 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.27 11.49 1.5 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.787 2.325 . . . . 0.0 112.523 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 14.4 ptp -147.84 -117.31 0.06 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.815 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.68 123.99 59.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.802 0.334 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.6 132.84 4.94 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.562 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG12 ' HB2' ' A' ' 60' ' ' PRO . 23.6 t -139.57 77.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.823 0.344 . . . . 0.0 110.611 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 30' ' ' PRO . . . -143.94 125.25 2.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.015 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.533 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -122.91 -113.64 2.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.304 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.3 pt -142.26 -164.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 110.737 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.6 OUTLIER -134.12 98.43 4.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.13 179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 87.7 t -85.81 100.0 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.797 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 88' ' ' LEU . 26.5 t -103.54 116.42 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.039 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 91.3 mt -103.11 108.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -99.86 108.89 23.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.003 0.43 . . . . 0.0 111.519 -178.924 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 46.7 mtmt -114.11 95.95 40.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.469 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.41 106.39 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.253 1.969 . . . . 0.0 112.219 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 73.2 mtt180 -69.81 -30.22 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -123.53 -176.98 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -117.4 144.73 44.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.457 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 137.91 -129.26 4.55 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.388 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.453 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.7 m80 -105.92 91.73 3.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.921 0.391 . . . . 0.0 110.96 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.4 OUTLIER -107.75 164.21 12.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.388 179.776 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.524 ' CG2' HG22 ' A' ' 107' ' ' THR . 71.0 m -160.26 157.25 27.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 111.784 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 78' ' ' VAL . 51.7 tp -118.96 87.66 2.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.284 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.686 ' HA ' HG23 ' A' ' 107' ' ' THR . 43.3 mt-10 -69.46 95.89 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.804 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.655 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 51.9 mt -108.51 127.28 53.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.0 p -133.18 157.06 42.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.739 -178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' MET . 4.4 t80 -99.13 88.82 4.05 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.239 178.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 42' ' ' VAL . 5.9 t -121.41 169.37 10.69 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -101.49 95.94 5.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.951 178.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 93' ' ' THR . 96.0 Cg_exo -44.26 -30.69 3.74 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.662 2.241 . . . . 0.0 112.607 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -73.65 -40.61 63.6 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -97.05 -76.13 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.321 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.98 173.11 31.3 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.195 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.6 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.7 mt -86.03 151.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.847 0.356 . . . . 0.0 111.256 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.581 ' HE3' HD21 ' A' ' 103' ' ' ASN . 40.6 mtmt -145.09 166.22 18.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.42 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 27.1 Cg_exo -62.74 -46.47 11.11 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.029 2.486 . . . . 0.0 112.009 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.6 pt-20 -58.16 -29.77 65.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.053 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.581 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -53.78 146.07 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.075 179.884 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -60.73 164.32 4.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.651 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.4 tpp180 -131.61 163.0 29.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.297 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.651 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.1 t80 -174.26 71.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.177 177.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -92.01 90.96 7.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.383 -178.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.1 tp -72.18 93.71 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.868 0.366 . . . . 0.0 110.882 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.666 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 24.5 m-70 -78.97 145.29 34.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.569 HD23 HG23 ' A' ' 14' ' ' VAL . 75.0 mt -145.89 110.04 4.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.474 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 2.5 t-20 -82.03 69.29 8.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.457 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.34 117.93 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.64 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.946 179.725 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.7 p -103.99 118.44 36.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 110.846 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.2 m80 59.5 99.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -108.39 157.1 18.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.5 tt -89.45 -27.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . . . -60.77 129.23 89.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.019 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 3' ' ' ALA . 34.3 Cg_exo -58.13 133.0 52.54 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.525 2.15 . . . . 0.0 112.265 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.8 tp -146.72 -55.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.4 t -122.51 -36.7 2.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.836 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.82 131.18 41.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -174.53 135.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.25 95.74 1.04 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.629 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -122.04 -28.56 4.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.466 -179.547 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.57 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 6.1 p-10 -85.94 98.37 10.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.711 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.573 ' HD3' HD13 ' A' ' 108' ' ' LEU . 51.4 tttp -111.41 76.66 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.748 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 5.5 m0 -86.91 108.9 18.99 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.679 -178.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 m -147.94 -171.45 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.628 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.4 p-10 -97.84 177.46 5.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.08 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.465 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -173.92 -174.66 0.96 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 121.012 0.434 . . . . 0.0 111.834 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 60.7 m80 -122.94 -173.98 2.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.919 179.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 83' ' ' ARG . 22.5 t -72.49 134.58 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.166 0.508 . . . . 0.0 112.309 -179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.19 15.87 12.2 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.944 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.585 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 21.0 tptt -58.13 86.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.279 0.539 . . . . 0.0 109.944 178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.78 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -57.43 101.63 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.519 -179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -98.5 100.8 12.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.637 ' HA ' HD23 ' A' ' 77' ' ' LEU . 32.3 tt0 -72.42 131.83 43.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.71 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 42.6 mt -128.18 87.71 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.298 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.499 ' NE2' HG22 ' A' ' 75' ' ' VAL . 8.8 m170 -86.99 106.95 18.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 74' ' ' TYR . 19.1 mt -101.31 174.12 6.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 111.575 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -119.55 160.94 21.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.767 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 147.62 -163.59 28.78 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.954 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.527 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 53.4 t30 -162.74 121.3 1.33 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.68 -30.95 41.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.472 2.115 . . . . 0.0 112.564 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.9 p -83.54 17.36 2.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.295 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.6 m -136.04 -67.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.512 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.09 -118.66 4.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.131 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 93' ' ' THR . 2.1 m-85 -114.57 -169.25 1.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 14.5 ttm -114.79 151.02 34.52 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.669 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 66.6 m95 -105.89 99.57 9.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.034 178.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.731 HG23 HG22 ' A' ' 42' ' ' VAL . 5.9 t -147.78 -176.58 5.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.658 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.674 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.9 mtp85 -82.88 157.12 23.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.024 0.44 . . . . 0.0 111.404 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 91' ' ' VAL . 19.7 t -57.97 130.85 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.595 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 -41.75 1.83 Allowed Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.146 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 57.9 m-85 -70.21 -4.61 22.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.765 0.317 . . . . 0.0 111.037 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.792 HG21 HG21 ' A' ' 93' ' ' THR . 21.9 t -49.71 121.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.55 -32.93 5.83 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.276 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 29.0 mtpp -64.72 171.68 3.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.352 . . . . 0.0 111.048 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.25 -62.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.662 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.6 p -104.46 142.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.7 mt -99.07 -50.24 4.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.52 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 83.2 p -52.99 179.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.702 179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -159.07 -87.08 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.994 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -128.89 -42.5 1.4 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.126 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.544 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . 16.2 mm -62.55 -76.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 80' ' ' PRO . 8.7 mt -103.98 118.57 36.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.495 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -72.65 65.01 0.66 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.124 0.488 . . . . 0.0 109.77 177.646 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG21 ' HD2' ' A' ' 38' ' ' ARG . 12.0 t -71.08 84.1 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.58 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.5 t -80.05 85.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 18.6 t -103.82 123.49 47.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.86 -178.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -116.94 106.81 13.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.683 178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.512 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -74.17 103.62 4.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.482 179.853 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 20.2 m -100.35 112.58 64.55 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.705 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 59' ' ' THR . 3.8 Cg_exo -82.18 88.34 1.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.279 2.652 . . . . 0.0 111.506 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 148.83 72.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.277 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.96 151.05 87.16 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.716 2.277 . . . . 0.0 112.258 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 t -79.98 179.93 7.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.781 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -56.4 -58.41 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.4 p -94.06 155.24 40.32 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.77 -155.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.682 2.255 . . . . 0.0 112.207 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.6 ttp 72.15 -68.54 0.22 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.244 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.0 153.52 15.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.308 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.36 111.09 2.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.718 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.11 79.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.89 0.376 . . . . 0.0 110.807 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 29' ' ' ASN . . . -63.31 -168.97 1.14 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.763 . . . . 0.0 111.987 179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . -146.11 148.57 20.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.829 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -89.13 -20.36 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.108 0.48 . . . . 0.0 111.38 179.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.669 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.6 m-85 50.25 90.17 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.386 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 73' ' ' ILE . 72.8 t -97.94 107.21 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.777 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HB ' ' HB ' ' A' ' 24' ' ' ILE . 11.9 t -112.99 109.42 28.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.821 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.78 HD22 HG22 ' A' ' 21' ' ' THR . 72.3 mt -102.64 99.38 9.37 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.042 178.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.547 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.3 105.69 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 0.0 111.192 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.8 mtmp? -109.19 94.57 15.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.664 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.9 Cg_endo -49.75 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.686 2.258 . . . . 0.0 112.855 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 11.8 mtt180 -74.56 -35.33 63.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.915 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 51' ' ' ILE . 4.2 mptp? -108.03 150.28 27.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.15 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HG2' HG22 ' A' ' 18' ' ' VAL . 49.7 mtm180 -94.28 129.69 40.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 148.53 -116.91 0.84 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -130.77 120.04 23.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.859 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -131.57 -178.7 4.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.683 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 88' ' ' LEU . 53.4 m -158.25 156.28 30.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 111.705 -179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.508 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 23.2 tp -133.04 85.7 2.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.617 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -84.76 88.25 7.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.089 0.471 . . . . 0.0 111.105 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 76' ' ' VAL . 88.7 mt -83.47 103.05 12.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -84.21 145.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.075 0.464 . . . . 0.0 111.98 -178.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' MET . 13.5 t80 -95.18 76.22 3.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.792 HG21 HG21 ' A' ' 42' ' ' VAL . 8.0 t -117.4 155.92 28.8 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 71.6 mtp180 -92.33 103.56 8.82 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.71 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 10.1 Cg_endo -51.51 -37.45 62.49 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.865 2.377 . . . . 0.0 112.776 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -78.91 12.87 1.95 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.477 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -147.26 3.0 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.259 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.93 179.18 49.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.831 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.2 mt -105.37 156.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.047 0.451 . . . . 0.0 111.716 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mtmt -139.05 162.84 50.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.69 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 59.0 Cg_endo -72.18 -37.11 4.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.711 2.274 . . . . 0.0 112.212 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.21 -25.94 67.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.05 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.487 HD21 ' HE3' ' A' ' 100' ' ' LYS . 13.7 m120 -58.48 136.77 57.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -64.45 -175.13 0.15 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.2 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -163.26 -159.28 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 111.098 179.712 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 80.9 t80 -165.59 72.81 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.615 178.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.649 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 1.2 m -69.78 105.81 2.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.366 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.573 HD13 ' HD3' ' A' ' 12' ' ' LYS . 18.2 tp -106.71 94.49 5.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.727 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.748 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 23.5 m-70 -76.65 153.58 35.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.276 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.4 mt -146.92 99.74 3.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.693 -178.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 55.8 t30 -74.79 68.56 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.564 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.3 t -50.19 122.07 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.436 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 16' ' ' THR . 31.9 mmmt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.994 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -106.84 124.15 49.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -83.47 -28.43 28.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp -82.45 174.82 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.9 tp -100.17 -31.68 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.63 99.13 4.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.4 3.09 5.01 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.433 2.089 . . . . 0.0 112.459 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.4 mp -67.32 -20.09 65.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.0 p -88.41 170.32 11.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.14 158.72 5.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 3.1 mppt? -101.99 9.48 40.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.552 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -42.13 147.55 0.23 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.731 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.856 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 3.9 p30 -89.76 -91.74 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 111.753 -179.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 107' ' ' THR . 22.9 t70 -136.36 -119.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.593 ' HG3' ' N ' ' A' ' 13' ' ' TRP . 22.2 tptm -158.02 171.87 19.46 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.416 0.15 . . . . 0.0 110.662 -178.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.62 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 7.3 m0 -124.39 121.7 35.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.657 0.383 . . . . 0.0 110.749 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' HIS . 2.9 m -152.5 -171.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.654 ' HA ' ' HB3' ' A' ' 111' ' ' ASN . 2.6 p-10 -80.49 175.75 10.38 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.397 0.436 . . . . 0.0 111.515 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 110' ' ' LEU . 2.5 t -172.01 -173.66 1.16 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 78.5 m80 -108.37 -177.99 3.48 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.485 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.02 136.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.119 0.485 . . . . 0.0 111.765 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 56.78 10.75 4.92 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.388 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.4 tptm -63.96 82.36 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.735 HG22 HD22 ' A' ' 77' ' ' LEU . 9.6 m -39.49 99.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.678 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.5 m -92.75 96.88 10.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.7 tt0 -80.62 132.17 35.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.38 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.575 HD11 HD21 ' A' ' 108' ' ' LEU . 38.9 mt -134.21 104.55 5.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -86.97 98.73 11.41 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 12.9 mt -91.69 145.7 24.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.378 -178.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -95.32 161.78 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.443 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 171.93 -139.35 5.28 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -174.99 90.62 0.3 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.516 0.198 . . . . 0.0 110.54 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.64 -16.32 7.89 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.712 2.275 . . . . 0.0 113.106 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.0 p -83.65 12.5 5.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.636 0.255 . . . . 0.0 111.482 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 p -97.1 -63.65 1.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.256 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.56 -38.71 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.694 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.07 -178.13 6.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.051 0.453 . . . . 0.0 111.24 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 1.5 ttt -149.35 147.93 28.9 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.118 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 2.8 m95 -105.07 86.58 2.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.74 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.418 ' HB ' ' HE2' ' A' ' 35' ' ' MET . 14.6 t -130.46 -171.97 2.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.613 HH11 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -71.58 144.92 49.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.761 0.315 . . . . 0.0 110.807 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.629 HG22 ' HB ' ' A' ' 91' ' ' VAL . 77.4 t -60.73 137.42 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.956 0.407 . . . . 0.0 111.413 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.31 -1.72 8.51 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.058 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 21.5 m-30 -115.31 40.14 2.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.984 0.421 . . . . 0.0 110.766 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 93' ' ' THR . 7.6 p -82.18 128.27 38.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.368 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.26 -10.4 6.15 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.099 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 64.0 mttm -64.89 172.51 2.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.84 -65.22 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.636 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.67 133.7 48.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.859 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.572 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 29.8 mt -82.83 -62.05 1.71 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.437 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 78.9 p -51.98 176.0 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.089 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -153.75 -90.92 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -131.26 -31.93 1.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.4 mm -71.22 -73.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.389 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.644 ' HB3' HG12 ' A' ' 78' ' ' VAL . 28.1 mt -111.58 123.46 50.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.227 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.7 73.05 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -77.79 92.85 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.5 t -96.96 86.76 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.382 177.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 2.7 t -107.08 142.19 37.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -119.37 115.67 24.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.403 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.554 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -81.78 100.6 9.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.437 HG22 ' HA3' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.22 116.16 65.62 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.084 179.515 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -95.51 -169.49 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.277 2.651 . . . . 0.0 113.2 -179.141 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -59.18 137.12 88.34 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.05 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 70' ' ' VAL . 7.7 Cg_endo -48.56 155.67 2.18 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.22 2.614 . . . . 0.0 112.65 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -85.19 -167.9 2.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.771 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -73.91 -0.6 16.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.2 p -70.28 154.46 94.5 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.277 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.52 13.77 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.798 2.332 . . . . 0.0 112.634 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 95.7 mmm -62.08 -24.72 67.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.3 t 50.43 102.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.876 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 62' ' ' PRO . . . 76.96 94.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.6 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 62' ' ' PRO . 26.2 t -135.37 69.22 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.372 . . . . 0.0 111.049 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' HA3' HG22 ' A' ' 59' ' ' THR . . . 112.11 -139.88 15.87 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.152 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.0 15.01 40.54 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.095 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.3 pt -148.07 -165.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-O 121.191 0.52 . . . . 0.0 111.167 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -134.57 106.26 6.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.852 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.77 117.96 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.212 0.53 . . . . 0.0 110.548 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 78' ' ' VAL . 23.5 t -113.39 126.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.874 -178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.735 HD22 HG22 ' A' ' 21' ' ' THR . 63.1 mt -111.4 90.93 3.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -93.07 108.86 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.178 0.513 . . . . 0.0 111.645 -178.226 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.2 mtmt -107.25 95.81 14.16 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.887 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 79' ' ' LYS . 2.1 Cg_endo -47.03 108.23 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.591 2.194 . . . . 0.0 112.592 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 21.9 mtt180 -76.14 -33.93 59.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.157 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -116.27 171.43 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.033 -179.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.572 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 68.5 mtp180 -110.1 146.56 35.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.845 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.58 -170.42 21.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.5 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -70.98 104.96 3.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.708 0.29 . . . . 0.0 110.576 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 96.8 m-70 -130.09 142.48 50.6 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.782 0.801 . . . . 0.0 111.676 -179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 96.2 m -138.24 127.32 24.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.307 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.613 HD21 HH11 ' A' ' 38' ' ' ARG . 15.6 tp -93.81 99.72 12.04 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.113 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' C ' HG23 ' A' ' 39' ' ' VAL . 35.1 mt-10 -76.69 124.6 27.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.436 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.502 HD21 ' NH1' ' A' ' 38' ' ' ARG . 28.0 mt -115.56 165.83 12.58 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.629 ' HB ' HG22 ' A' ' 39' ' ' VAL . 13.6 p -156.14 154.38 6.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.2 t80 -103.34 86.88 2.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.635 178.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.655 ' HB ' HG23 ' A' ' 99' ' ' ILE . 2.8 t -115.83 167.0 11.34 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -103.07 94.36 5.41 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 179.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 93' ' ' THR . 90.3 Cg_exo -46.8 -29.91 8.66 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.572 2.181 . . . . 0.0 112.565 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -73.19 -37.04 66.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -106.61 -74.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 111.327 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.91 -174.68 44.73 Favored Glycine 0 CA--C 1.508 -0.345 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.296 -179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.655 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.1 mt -96.91 145.56 8.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.871 0.367 . . . . 0.0 111.153 -179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -130.76 166.74 25.09 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.633 -179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.14 -44.78 4.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.893 2.395 . . . . 0.0 112.34 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.06 -14.92 27.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.472 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.571 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -58.58 139.96 55.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -179.786 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 174.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.141 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.733 ' HG2' HD22 ' A' ' 10' ' ' ASN . 0.1 OUTLIER -155.0 158.62 39.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.794 -179.554 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 24.3 t80 -152.96 108.53 3.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.342 0.591 . . . . 0.0 110.49 178.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.62 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.8 OUTLIER -98.15 130.88 44.9 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.621 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 24' ' ' ILE . 14.0 mt -89.92 126.43 35.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.337 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.689 ' HB2' HG22 ' A' ' 14' ' ' VAL . 1.7 p80 -72.0 57.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.609 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.42 ' HB3' HG21 ' A' ' 16' ' ' THR . 52.6 mt -103.98 80.31 1.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.654 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . 17.8 t30 -94.35 59.11 2.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 83' ' ' ARG . 2.1 t -33.41 130.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.695 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 15' ' ' ASP . 14.6 mmmm . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.995 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.559 -0.217 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -141.71 -13.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 61.94 -83.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.078 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.5 147.18 52.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.6 pt -85.48 2.38 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.59 149.66 0.11 Allowed Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.311 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.54 -5.22 16.29 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.452 2.101 . . . . 0.0 112.432 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.5 tp -72.98 -65.89 0.74 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.5 p -82.93 135.15 35.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.664 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.9 t 65.79 145.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -170.35 132.27 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.49 121.92 16.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.241 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.577 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.9 OUTLIER -122.03 -94.54 0.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.14 0.495 . . . . 0.0 112.204 -179.178 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -53.24 99.97 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.841 -178.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -89.61 91.63 8.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.472 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.678 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.4 m95 -73.75 99.81 3.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.512 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.511 HG23 HD23 ' A' ' 110' ' ' LEU . 29.3 m -149.69 -172.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.987 -178.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.2 p-10 -111.88 -175.14 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.508 179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.2 t -174.47 -177.22 1.18 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.104 0.478 . . . . 0.0 112.075 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 72.9 m80 -111.96 -159.64 0.69 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.841 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 41.9 t -97.6 128.01 49.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.154 0.502 . . . . 0.0 111.929 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 71.73 7.51 65.59 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.674 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -56.75 85.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.293 0.547 . . . . 0.0 109.734 178.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.81 HG22 HD22 ' A' ' 77' ' ' LEU . 3.5 m -58.19 93.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.293 -178.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.406 ' HB ' HG23 ' A' ' 78' ' ' VAL . 99.5 m -85.83 99.71 11.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.546 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.3 tt0 -82.72 129.62 34.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.735 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.515 HD11 HD22 ' A' ' 108' ' ' LEU . 46.0 mt -134.61 107.35 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.926 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -88.76 96.84 10.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.28 178.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 22.0 mt -91.43 148.22 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.418 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -102.56 161.07 14.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.86 -145.81 7.54 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.487 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -176.35 93.8 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.51 0.195 . . . . 0.0 110.984 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -9.43 12.37 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.444 2.096 . . . . 0.0 112.308 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.9 p -60.9 -22.69 64.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.17 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -82.67 -63.37 1.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.156 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.45 -25.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.003 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -80.11 178.19 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.166 0.507 . . . . 0.0 111.399 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 5.5 ttm -155.85 152.12 27.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 8.0 m95 -106.92 85.38 2.13 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.552 HG21 ' HA ' ' A' ' 42' ' ' VAL . 11.3 t -129.9 -165.47 1.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.377 -179.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.668 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 13.2 mtp85 -89.2 151.51 22.12 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.861 0.362 . . . . 0.0 110.977 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.8 t -72.14 133.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.497 -179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.56 3.51 90.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.453 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 60.0 m-85 -129.3 -0.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.104 0.478 . . . . 0.0 110.462 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.894 HG21 HG21 ' A' ' 93' ' ' THR . 17.3 t -55.27 109.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.141 179.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.08 -28.04 12.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.172 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -64.67 172.11 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.94 0.4 . . . . 0.0 111.01 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.42 -25.54 31.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.836 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.58 141.76 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.206 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.4 mt -93.11 -53.63 4.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.7 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.419 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 33.4 t -50.39 175.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.565 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -155.75 -86.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.81 -34.04 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.0 mm -70.33 -76.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.364 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -101.19 112.23 24.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.501 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 3.0 tt0 -66.01 78.2 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.077 0.465 . . . . 0.0 109.832 178.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG22 HG13 ' A' ' 78' ' ' VAL . 8.5 t -86.51 90.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.325 -178.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.9 t -86.31 86.56 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.0 t -101.43 124.97 47.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.652 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -115.79 109.45 17.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.553 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -79.77 121.02 24.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.309 -179.784 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 118.96 31.63 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.912 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -92.15 158.42 3.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.164 2.576 . . . . 0.0 112.856 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.571 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -82.17 143.16 48.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.072 -179.878 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 61' ' ' THR . 39.1 Cg_exo -61.2 157.3 40.57 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.519 2.146 . . . . 0.0 112.224 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.544 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t -111.69 -164.75 0.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.721 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -103.09 -62.71 1.25 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.491 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.635 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 63.8 m -67.68 -49.99 37.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.771 -179.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 9.6 Cg_exo -72.75 -160.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.795 2.33 . . . . 0.0 112.102 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 71.5 mtm -145.68 18.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.083 0.468 . . . . 0.0 110.295 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 62' ' ' PRO . 7.2 p -95.44 142.34 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.08 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.37 136.84 4.86 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.308 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 70' ' ' VAL . 10.0 p -155.12 14.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.208 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -153.87 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.918 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.87 6.18 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.296 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.8 pt -143.45 -164.23 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.06 0.457 . . . . 0.0 110.953 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 1.0 OUTLIER -136.01 105.81 6.21 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.979 179.989 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -90.27 104.57 15.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.86 0.362 . . . . 0.0 110.974 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.01 120.16 57.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.927 -179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -111.2 99.9 8.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.892 178.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.74 102.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.053 0.454 . . . . 0.0 110.994 -179.085 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 38.2 mtmt -104.18 104.0 41.54 Favored Pre-proline 0 N--CA 1.454 -0.27 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.194 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.645 ' HA ' HD23 ' A' ' 52' ' ' LEU . 50.2 Cg_exo -51.43 98.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.406 2.071 . . . . 0.0 112.446 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 7.4 mtt180 -69.82 -41.72 74.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -115.54 165.43 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.092 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.1 mtm180 -100.87 119.22 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.635 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 156.38 -150.45 21.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.363 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.474 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 55.4 t-80 -86.84 101.74 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.11 0.481 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.497 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 2.0 m-70 -117.12 165.82 12.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.314 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.438 HG23 ' HA ' ' A' ' 109' ' ' HIS . 57.6 m -159.84 148.64 17.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.973 0.416 . . . . 0.0 111.945 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 78' ' ' VAL . 11.6 tp -114.52 93.33 4.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.245 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 44.0 mt-10 -77.12 98.23 4.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.045 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 51.1 mt -107.69 130.33 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.4 p -135.68 156.05 37.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.965 -178.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 7.3 t80 -99.88 86.73 3.34 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.104 178.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.894 HG21 HG21 ' A' ' 42' ' ' VAL . 4.5 t -120.35 169.34 10.38 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -177.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -100.11 94.85 3.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.4 178.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.6 Cg_exo -42.22 -35.61 3.59 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.839 2.36 . . . . 0.0 112.755 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -68.52 -44.04 75.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.564 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.77 -79.31 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.377 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.81 177.18 40.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.105 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.741 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.4 mt -92.11 151.31 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.934 0.397 . . . . 0.0 111.292 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.596 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 10.0 mttm -141.43 163.15 43.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.125 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 38.8 Cg_endo -67.6 -40.18 10.71 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.264 . . . . 0.0 112.133 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.401 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.2 pt-20 -62.05 -28.09 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.749 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.543 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER -55.36 148.75 14.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.003 179.704 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.92 160.7 3.36 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpt180 -130.18 162.9 27.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.219 -179.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.581 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 57.6 t80 -176.53 69.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.453 0.644 . . . . 0.0 109.677 177.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' ASP . 12.4 m -91.52 91.33 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.517 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 41.0 tp -71.45 94.36 1.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.524 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -78.22 143.31 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.661 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 14' ' ' VAL . 85.2 mt -145.85 104.64 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.807 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 45.6 t30 -78.42 68.91 4.53 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.635 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.5 t -48.75 127.43 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.65 -178.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.976 179.988 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.0 p -93.49 -45.69 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 -158.17 176.16 12.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -119.26 154.69 33.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -96.96 14.12 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 4' ' ' PRO . . . -57.2 -50.73 86.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.628 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 3' ' ' ALA . 63.8 Cg_endo -73.45 172.53 15.5 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.149 1.899 . . . . 0.0 112.31 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.9 tt -140.75 -65.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.524 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -153.36 -38.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.13 140.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.196 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HD3' ' N ' ' A' ' 8' ' ' LYS . 2.2 mppt? -103.17 36.53 2.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.145 0.498 . . . . 0.0 110.517 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -35.3 116.78 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.632 HD22 ' HB3' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -123.31 -90.74 0.56 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.541 -179.305 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' THR . 1.2 m-20 -47.65 104.52 0.06 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.284 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -97.24 92.72 6.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.141 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.676 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -83.09 104.02 12.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.602 -178.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 12' ' ' LYS . 4.5 m -150.95 -173.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 121.089 0.471 . . . . 0.0 112.136 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -101.41 176.7 5.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.819 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.522 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.2 t -175.49 -177.1 0.96 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 111.592 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.572 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 42.9 m-70 -120.82 -166.16 1.3 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.968 179.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG21 ' HE ' ' A' ' 83' ' ' ARG . 38.4 t -87.19 136.59 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.264 0.554 . . . . 0.0 112.111 -179.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 61.59 12.16 32.32 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.628 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tptt -59.79 83.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.182 0.491 . . . . 0.0 109.782 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.739 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -54.93 98.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.424 -179.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 100.0 m -96.2 101.18 12.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.709 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.6 tt0 -82.44 132.7 35.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.799 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.454 HD11 HD22 ' A' ' 108' ' ' LEU . 45.6 mt -134.97 101.89 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.961 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -83.67 98.91 9.9 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 14.5 mt -92.61 148.73 21.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.37 -179.206 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -102.9 159.93 15.06 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.844 0.354 . . . . 0.0 110.399 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 -161.64 34.18 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -169.83 120.02 0.57 Allowed Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.17 -29.9 16.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.428 2.085 . . . . 0.0 112.493 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.7 p -82.52 15.69 2.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.319 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.4 m -136.04 -60.68 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.483 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.58 -119.63 3.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.208 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.454 ' CG ' ' HG3' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -112.24 -168.25 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 -179.203 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 25.0 ttm -108.53 151.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.306 179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 5.7 m95 -109.88 85.03 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.653 178.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.606 HG21 ' HA ' ' A' ' 42' ' ' VAL . 13.6 t -132.65 -166.95 1.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.528 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -93.04 122.52 35.5 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.783 0.325 . . . . 0.0 110.615 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.5 p -53.16 138.78 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.178 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.47 -4.59 77.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.743 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.441 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 48.8 m-85 -130.78 3.14 4.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.286 0.565 . . . . 0.0 110.037 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 93' ' ' THR . 18.2 t -52.12 119.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.095 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.5 -23.09 18.71 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.004 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HB2' HD23 ' A' ' 47' ' ' LEU . 61.4 mttp -74.59 -159.58 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.643 0.259 . . . . 0.0 110.748 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.24 -55.9 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 111.502 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.448 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 16.6 t -84.45 -40.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.051 -179.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 8.8 mt 75.95 -42.73 0.46 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.423 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.46 ' HB2' ' N ' ' A' ' 54' ' ' VAL . 40.8 t -49.28 179.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.142 178.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -152.55 -88.84 0.06 Allowed 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.59 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -136.11 -31.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.397 -179.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 17.1 mm -73.21 -72.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.438 -179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 80' ' ' PRO . 11.1 mt -105.13 114.37 28.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.472 179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -67.13 72.1 0.1 Allowed 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.588 HG21 ' NH1' ' A' ' 38' ' ' ARG . 10.9 t -76.39 84.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.324 -178.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.7 t -80.2 81.96 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 76' ' ' VAL . 36.3 t -94.81 146.84 23.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.315 -178.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -138.82 113.18 8.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.36 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.85 104.86 15.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.274 179.373 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.8 m -101.83 109.63 60.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.618 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.689 ' HB2' HG22 ' A' ' 70' ' ' VAL . 60.5 Cg_endo -99.4 99.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.533 2.822 . . . . 0.0 111.652 179.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.26 134.76 24.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.695 0.283 . . . . 0.0 111.365 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.51 163.11 37.99 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.825 2.35 . . . . 0.0 112.483 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.575 ' H ' HG11 ' A' ' 68' ' ' VAL . 50.6 m -81.07 -165.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.525 179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -103.05 0.05 31.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.446 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.3 p -100.73 153.81 37.52 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.738 0.304 . . . . 0.0 111.553 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.99 32.86 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.004 2.469 . . . . 0.0 112.612 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.6 mtt -143.22 35.16 1.34 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.585 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG11 ' H ' ' A' ' 63' ' ' SER . 13.8 p -130.44 150.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.39 -179.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.95 -94.66 1.68 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.689 HG22 ' HB2' ' A' ' 60' ' ' PRO . 7.1 p -157.79 87.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.299 0.571 . . . . 0.0 111.138 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -140.71 114.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.867 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -105.6 -113.46 3.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.244 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.8 pt -140.27 -167.82 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.136 0.493 . . . . 0.0 111.104 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -135.78 95.38 3.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.941 179.872 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.6 p -87.97 111.81 22.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.536 0.684 . . . . 0.0 110.602 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG21 HD11 ' A' ' 90' ' ' LEU . 38.7 t -108.88 122.91 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.53 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 21' ' ' THR . 81.3 mt -108.46 99.23 8.64 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.808 178.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -94.49 106.2 17.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.999 0.428 . . . . 0.0 111.145 -178.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.1 mtmt -108.1 102.15 44.79 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.344 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.649 ' HA ' HD23 ' A' ' 52' ' ' LEU . 70.0 Cg_exo -49.93 98.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.747 2.298 . . . . 0.0 112.81 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.8 mtt180 -67.57 -37.25 82.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.085 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -120.99 -178.81 3.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.842 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HE ' HG21 ' A' ' 18' ' ' VAL . 95.7 mtt180 -115.17 124.86 52.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.523 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 152.78 -142.8 9.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.576 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.495 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 61.9 m80 -87.34 91.65 8.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.924 0.392 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.495 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.6 OUTLIER -111.65 154.5 24.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.412 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.553 ' HG1' ' CE1' ' A' ' 109' ' ' HIS . 62.9 m -158.55 146.23 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.932 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.6 tp -96.72 92.24 6.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.072 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.708 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.2 mt-10 -72.77 94.19 1.75 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.166 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.628 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 40.0 mt -111.53 127.41 55.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.063 178.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.8 p -128.95 158.57 41.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.511 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.586 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.5 t80 -99.17 83.33 2.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.429 178.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 42' ' ' VAL . 10.0 t -117.5 150.83 38.28 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' HG3' ' CG ' ' A' ' 34' ' ' TYR . 41.5 mtp180 -91.49 104.49 10.16 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 178.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.9 Cg_exo -39.79 -31.99 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.055 2.503 . . . . 0.0 113.168 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' HD2' ' HG3' ' A' ' 97' ' ' GLU . 6.7 t80 -77.02 -60.08 2.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.311 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG3' ' HD2' ' A' ' 96' ' ' PHE . 36.9 mt-10 -67.91 -64.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.894 0.378 . . . . 0.0 111.301 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.3 -179.78 20.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.813 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.623 HG23 ' HB ' ' A' ' 93' ' ' THR . 2.5 mt -93.86 148.07 5.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.918 0.389 . . . . 0.0 111.472 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 26.2 mtmm -147.82 162.64 30.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.115 -179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 41.8 Cg_endo -67.75 -37.1 16.91 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.797 2.331 . . . . 0.0 112.012 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.06 -29.34 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.836 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.2 m120 -58.21 154.36 13.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.072 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 164.41 4.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.245 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.657 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 16.7 tpp180 -132.24 165.95 22.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.955 -179.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.0 t80 -174.57 74.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.297 177.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.93 94.29 6.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.418 -179.102 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 16.3 tp -72.86 93.17 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.016 0.436 . . . . 0.0 110.656 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.676 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 40.8 m-70 -75.19 146.02 41.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.668 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 16' ' ' THR . 97.4 mt -145.69 120.21 9.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.568 -178.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.477 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 8.7 t30 -86.31 63.07 7.8 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.523 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -44.74 122.99 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.729 -178.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.093 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 t -88.22 -28.4 21.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.769 0.319 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -103.52 119.48 38.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' C ' ' H ' ' A' ' 3' ' ' ALA . 1.9 mpt? -85.76 -71.04 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.771 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.6 mt 73.12 -29.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.736 ' H ' ' HD2' ' A' ' 4' ' ' PRO . . . -124.76 -54.47 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.736 ' HD2' ' H ' ' A' ' 3' ' ' ALA . 73.1 Cg_endo -76.14 100.8 1.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.005 1.803 . . . . 0.0 112.332 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tt -172.01 -63.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.461 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.8 p -142.02 -20.02 0.72 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.744 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.5 m -103.51 151.62 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -150.9 136.8 18.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.778 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.99 104.57 11.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.834 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.662 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -115.86 -82.01 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.267 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.469 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.0 OUTLIER -32.44 108.11 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.705 179.906 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -87.17 93.7 9.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.852 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.622 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.5 m95 -75.74 98.52 4.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.528 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 110' ' ' LEU . 28.4 m -149.42 -172.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.169 0.509 . . . . 0.0 112.245 -178.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -112.37 179.0 4.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.455 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.501 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -177.88 -172.77 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 112.046 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.639 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 18.8 m-70 -117.62 -171.15 2.0 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.44 179.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 10.1 p -83.44 142.51 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 53.79 18.67 8.64 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.669 179.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.639 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.4 tptm -65.49 80.59 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 178.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.757 HG22 HD22 ' A' ' 77' ' ' LEU . 4.6 m -50.5 97.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.422 -179.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.3 m -94.67 104.63 16.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.827 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 36.2 tt0 -86.91 129.72 34.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.803 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.1 mt -132.48 104.63 7.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.64 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -85.03 96.36 9.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 17.0 mt -89.27 145.91 25.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.398 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -97.66 161.99 13.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.847 0.356 . . . . 0.0 110.399 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.16 -137.13 4.11 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.499 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' O ' HG22 ' A' ' 32' ' ' THR . 61.1 t30 -175.12 101.95 0.26 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 20.5 Cg_endo -60.63 -6.57 5.9 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.479 2.119 . . . . 0.0 112.796 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.3 p -106.53 15.0 26.42 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.657 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 29' ' ' ASN . 5.9 t -98.28 -31.2 12.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.745 0.307 . . . . 0.0 111.086 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.74 -43.06 1.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.748 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' H ' HG23 ' A' ' 32' ' ' THR . 68.1 m-85 -86.91 -178.88 6.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.082 0.468 . . . . 0.0 111.428 -179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -151.71 151.79 31.9 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.931 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.2 m95 -108.39 87.08 2.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.347 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 42' ' ' VAL . 15.3 t -130.39 -170.98 2.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.832 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.687 HH21 HD13 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -76.27 137.89 40.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.794 0.33 . . . . 0.0 110.903 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 91' ' ' VAL . 49.0 t -57.1 136.32 20.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.387 -179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.11 -13.81 1.8 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.776 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 14.6 m-30 -105.62 22.08 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.341 0.591 . . . . 0.0 110.49 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 93' ' ' THR . 12.7 t -76.16 107.13 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.148 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.13 -16.28 57.22 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 48.4 mtpt -65.07 172.89 2.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -75.43 -66.1 0.81 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.494 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 p -106.77 131.2 57.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.561 0.696 . . . . 0.0 110.823 179.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.687 HD13 HH21 ' A' ' 38' ' ' ARG . 22.6 mt -73.7 -65.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.165 179.353 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 p -50.42 173.72 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.979 178.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -150.46 -95.73 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.618 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.473 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -128.09 -33.11 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 15.9 mm -73.38 -72.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.19 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.688 ' HB3' HG12 ' A' ' 78' ' ' VAL . 77.2 mt -107.6 117.86 35.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.322 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -70.36 73.03 0.49 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.651 HG11 ' NH1' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -76.38 91.93 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 22.4 t -93.34 87.97 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.328 177.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 76' ' ' VAL . 8.1 t -110.0 144.83 37.98 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.935 -178.46 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -122.9 115.89 22.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.647 178.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.466 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -85.14 105.85 16.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.449 179.466 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.521 HG22 HG12 ' A' ' 70' ' ' VAL . 4.3 m -103.0 126.28 32.88 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.057 179.45 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' A' ' 30' ' ' PRO . 2.6 Cg_endo -84.33 166.17 12.48 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.01 2.473 . . . . 0.0 113.178 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 3.6 t -53.42 149.67 14.01 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.646 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 21.0 Cg_exo -66.75 179.16 2.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.031 2.487 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.0 m -64.81 176.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.06 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -70.92 -34.6 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 73.7 p -84.75 154.62 61.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.223 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.35 14.97 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.832 2.355 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 86.8 mtp -94.11 -79.35 0.42 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.016 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.59 120.41 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 62' ' ' PRO . . . -113.92 137.99 14.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 59' ' ' THR . 45.0 t -119.43 -95.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 0.0 111.203 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' HA3' ' CG2' ' A' ' 59' ' ' THR . . . -156.23 -101.72 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.127 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 107.75 20.61 8.36 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt -138.94 -166.31 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.195 0.521 . . . . 0.0 111.327 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.3 OUTLIER -136.2 98.68 3.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.81 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' VAL . 5.5 p -90.21 111.34 23.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.298 0.571 . . . . 0.0 110.625 -179.266 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG22 ' SG ' ' A' ' 56' ' ' CYS . 46.2 t -107.18 124.55 63.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.923 -178.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.757 HD22 HG22 ' A' ' 21' ' ' THR . 71.5 mt -111.63 92.95 4.23 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 177.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.688 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -91.73 110.72 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.223 -178.775 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.7 mtmp? -107.84 101.96 43.08 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.226 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 20' ' ' LYS . 71.4 Cg_exo -48.22 99.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.707 2.271 . . . . 0.0 113.066 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' A' ' 50' ' ' GLU . 5.1 mtt180 -69.34 -31.44 69.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 91.8 mttt -121.25 170.69 9.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.767 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -115.66 128.45 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 135.65 -152.92 21.12 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.183 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -65.9 106.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.498 . . . . 0.0 110.639 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 29.7 m-70 -138.04 160.59 38.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.619 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.506 ' CG2' HG22 ' A' ' 107' ' ' THR . 87.0 m -160.17 148.27 16.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.945 0.402 . . . . 0.0 111.774 -179.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.657 HD21 HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -110.03 101.55 10.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.878 179.194 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' HG23 ' A' ' 107' ' ' THR . 40.1 mt-10 -79.35 115.75 19.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.678 HD21 ' NH1' ' A' ' 38' ' ' ARG . 29.4 mt -121.84 151.49 40.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.2 p -154.26 153.6 8.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.094 0.473 . . . . 0.0 111.899 -178.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' MET . 5.2 t80 -100.7 91.97 4.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.996 178.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 42' ' ' VAL . 8.5 t -126.69 166.1 18.0 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -177.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.7 mtp180 -98.63 97.52 4.92 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.643 178.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' A' ' 93' ' ' THR . 80.5 Cg_exo -46.14 -40.74 21.52 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.8 2.333 . . . . 0.0 113.415 -179.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.47 17.34 3.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.1 mm-40 -150.57 0.08 0.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.29 -178.96 50.69 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.264 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.745 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.8 mt -108.7 151.74 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.075 0.464 . . . . 0.0 112.031 -179.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.554 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 16.2 mttt -128.39 166.78 22.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.767 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.65 -40.91 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.858 2.372 . . . . 0.0 112.146 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.16 -24.77 67.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.199 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.554 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -49.38 148.75 2.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.302 179.859 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -61.77 166.11 4.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.433 -179.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.702 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.3 tpp180 -134.78 163.73 29.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.386 -178.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.702 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 30.8 t80 -172.31 80.89 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.223 177.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -97.46 93.68 6.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.654 -178.882 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 47.7 tp -66.77 83.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 25.9 m-70 -69.89 136.16 50.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.172 0.511 . . . . 0.0 110.697 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' A' ' 16' ' ' THR . 94.6 mt -143.41 109.82 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.474 -178.058 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . 60.7 t30 -85.24 54.05 2.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.613 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -35.74 135.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.863 -178.681 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.9 mmpt? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.948 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 t -137.83 124.41 20.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -80.86 158.24 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt -134.29 167.01 21.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 2' ' ' ILE . 4.3 mp -98.3 -20.54 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.62 148.6 0.11 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.281 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.88 159.65 17.22 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.55 2.167 . . . . 0.0 112.379 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.9 tp 57.86 93.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.983 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -168.99 -37.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 7' ' ' VAL . 9.9 p -142.13 17.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.22 150.21 19.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.191 0.52 . . . . 0.0 110.057 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -94.38 117.68 30.48 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.431 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.677 HD22 ' HB3' ' A' ' 105' ' ' ARG . 1.1 p-10 -126.94 -95.84 0.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 13' ' ' TRP . 14.8 m-20 -48.49 97.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.126 -178.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HD3' HD13 ' A' ' 108' ' ' LEU . 52.9 tttp -100.84 92.04 4.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.679 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.66 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.9 m95 -80.69 104.69 11.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.59 -179.252 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' H ' ' A' ' 15' ' ' ASP . 3.8 p -151.29 -179.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.988 0.423 . . . . 0.0 111.694 -179.03 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.776 ' H ' HG22 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -99.45 -179.14 4.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.606 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.489 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -174.54 -173.45 0.75 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.152 0.501 . . . . 0.0 112.111 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 19.4 m80 -115.4 -170.31 1.74 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.09 132.39 36.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.233 0.539 . . . . 0.0 112.054 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.11 11.97 34.9 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.39 179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.1 tptp -64.81 82.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.733 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.16 99.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.568 -178.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' HG23 ' A' ' 78' ' ' VAL . 54.9 m -93.82 96.22 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.601 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HD23 ' A' ' 77' ' ' LEU . 33.8 tt0 -73.99 132.34 42.29 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.718 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.4 102.0 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.249 -179.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -85.64 99.64 11.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 35.5 mt -94.29 147.6 23.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.752 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -99.81 164.75 11.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.73 -134.21 3.14 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.536 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 32' ' ' THR . 52.3 t30 -173.85 89.33 0.35 Allowed Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.572 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 85.1 Cg_exo -48.41 -18.31 1.34 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.706 2.271 . . . . 0.0 113.181 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.6 p -104.62 30.35 5.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 29' ' ' ASN . 6.1 t -108.87 -35.04 6.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 111.2 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.05 -34.06 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.805 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.437 ' H ' HG23 ' A' ' 32' ' ' THR . 51.3 m-85 -99.71 -179.33 4.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 111.477 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.4 ttm -147.82 154.09 40.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.816 -179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.445 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 4.6 m95 -110.42 88.15 2.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.922 178.524 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.4 t -133.54 -163.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.513 -179.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.639 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 7.8 mtp85 -90.18 158.38 17.27 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.812 0.339 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 89' ' ' GLU . 21.9 t -77.23 132.03 33.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.656 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.47 9.3 86.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.494 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 63.1 m-85 -134.02 -1.75 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.206 0.527 . . . . 0.0 110.538 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.919 HG21 HG21 ' A' ' 93' ' ' THR . 21.3 t -51.71 116.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.115 179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.38 -31.15 8.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.235 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.7 mttm -66.13 171.45 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 0.0 111.1 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.29 -63.05 1.41 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.629 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -100.96 141.03 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.75 179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 22.8 mt -92.57 -52.67 4.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.297 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 54' ' ' VAL . 55.6 p -62.1 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.572 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -151.73 -82.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.094 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -135.96 -30.31 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.371 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 20.1 mm -74.25 -85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.491 -179.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.73 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -96.99 108.76 21.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.43 179.595 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.69 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 10.5 tt0 -61.62 140.89 58.09 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.521 HG21 ' HD2' ' A' ' 38' ' ' ARG . 59.2 t -141.06 89.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.87 0.367 . . . . 0.0 111.753 -179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.9 t -73.7 94.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 28.1 p -72.16 115.07 10.96 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.125 -178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 99.4 mttt -121.37 43.92 2.68 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.042 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -66.13 106.81 1.73 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.543 178.726 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.407 ' HB ' ' HA3' ' A' ' 71' ' ' GLY . 7.5 m -101.37 117.39 62.16 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.327 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 84.7 Cg_endo -95.07 -159.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.17 2.58 . . . . 0.0 112.402 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.532 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -48.9 141.6 10.16 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HD2' HG22 ' A' ' 61' ' ' THR . 18.0 Cg_exo -66.36 179.85 1.83 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.819 2.346 . . . . 0.0 112.452 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 88.4 p -93.28 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.728 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -72.42 -1.61 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.1 p -58.17 155.34 26.12 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.25 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.74 13.16 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.782 2.321 . . . . 0.0 112.527 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.5 ptm -122.28 81.3 1.82 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.447 HG13 ' HG2' ' A' ' 62' ' ' PRO . 93.8 t -78.59 102.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.097 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.38 42.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.607 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.14 -6.92 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.963 0.411 . . . . 0.0 111.222 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 59' ' ' THR . . . -179.1 -106.28 0.2 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.144 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.44 62.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.12 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 11.8 pt -131.06 -167.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.234 0.54 . . . . 0.0 111.418 -179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -124.97 103.41 8.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.961 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 84.9 t -92.98 100.17 10.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.063 0.459 . . . . 0.0 110.547 -179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.76 118.9 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.135 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.733 HD22 HG22 ' A' ' 21' ' ' THR . 81.5 mt -103.82 105.59 15.85 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.754 178.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.73 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.72 100.99 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.032 0.444 . . . . 0.0 110.992 -179.108 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -105.53 102.57 38.53 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.449 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 37.3 Cg_exo -55.96 98.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.241 1.961 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.69 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 70.3 mtt180 -62.26 -34.63 76.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.736 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -124.29 179.69 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.628 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -118.28 144.11 46.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.855 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.591 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.34 -111.75 0.83 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.556 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -116.25 96.66 5.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 111.031 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.513 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.33 163.26 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.512 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 88' ' ' LEU . 30.1 m -160.08 157.93 29.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 111.712 -179.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 24.0 tp -126.14 89.09 2.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.412 179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 43.2 mt-10 -73.85 93.9 2.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.123 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.627 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 56.3 mt -103.38 134.27 47.03 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 104' ' ' GLU . 8.3 p -139.52 154.86 25.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 120.888 0.375 . . . . 0.0 111.83 -178.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.561 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.9 t80 -97.85 90.37 4.92 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.919 HG21 HG21 ' A' ' 42' ' ' VAL . 5.8 t -120.02 173.02 7.33 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -177.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -103.22 95.05 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.861 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 93' ' ' THR . 89.1 Cg_exo -46.8 -30.5 9.44 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.626 2.218 . . . . 0.0 112.682 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.67 -37.24 62.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -100.22 -79.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.35 -179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.4 178.48 43.4 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.18 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG23 ' HB ' ' A' ' 93' ' ' THR . 4.1 mt -95.45 154.66 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.454 -179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.7 mttt -140.72 161.65 53.18 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.9 Cg_endo -71.15 -39.01 4.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.93 -28.07 69.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.4 m120 -54.72 152.27 7.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.215 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.4 tt0 -52.89 156.14 2.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.903 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.677 ' HB3' HD22 ' A' ' 10' ' ' ASN . 15.9 tpp180 -127.71 164.94 21.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.528 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.594 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 54.2 t80 -176.64 64.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.554 0.692 . . . . 0.0 109.52 177.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 89' ' ' GLU . 11.1 m -87.12 92.9 9.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.866 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 24.4 tp -74.75 95.63 2.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.301 -179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 18.3 m-70 -79.72 144.02 34.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.773 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 79.6 mt -144.44 106.55 4.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.352 -178.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -82.79 65.65 8.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.591 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.1 t -42.73 136.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.568 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.899 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -147.83 165.14 31.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -96.12 128.64 43.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -86.38 124.03 32.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.1 pt -90.19 6.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.233 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.22 83.69 32.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.49 20.31 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.9 tp -56.4 -63.82 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.015 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -143.66 -27.81 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.046 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.8 101.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -176.7 134.76 0.22 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.358 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.46 123.58 19.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.649 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -125.69 -59.0 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.859 -179.402 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 7.5 p-10 -54.7 100.02 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.796 -179.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -115.09 60.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.718 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.666 ' HE1' ' HB ' ' A' ' 107' ' ' THR . 4.9 m0 -78.25 119.24 21.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.401 -177.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.9 -174.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.429 0.633 . . . . 0.0 112.317 -178.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.476 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -94.07 177.16 6.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.58 179.771 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -176.31 176.36 1.67 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.111 0.481 . . . . 0.0 112.265 179.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.583 ' O ' HG13 ' A' ' 112' ' ' VAL . 31.6 m-70 -114.52 -153.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.683 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.3 128.8 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.128 0.49 . . . . 0.0 111.797 -179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 64.37 13.36 54.3 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.33 179.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 6.7 tptm -57.27 86.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.79 HG22 HD22 ' A' ' 77' ' ' LEU . 3.3 m -56.86 97.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.509 -179.033 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.0 m -87.92 104.88 17.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.448 179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.1 tt0 -89.26 129.24 35.85 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.181 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HG22 HD12 ' A' ' 26' ' ' LEU . 25.0 mt -141.41 109.85 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -85.38 113.22 21.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.272 179.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mp -104.96 162.28 13.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 2.4 mptt -119.42 158.6 25.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.648 179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -174.92 -141.19 3.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.506 -179.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 60.1 t30 -172.01 104.54 0.36 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.426 0.155 . . . . 0.0 111.052 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.73 -34.33 98.89 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.69 2.26 . . . . 0.0 112.649 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.1 p -76.38 13.15 1.0 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.657 -179.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 64.5 m -95.16 -33.36 12.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.23 -32.86 3.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.866 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.407 ' HB2' ' CE2' ' A' ' 92' ' ' TYR . 58.6 m-85 -100.18 -176.01 3.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.019 0.437 . . . . 0.0 111.296 -179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 9.5 ttm -146.53 146.38 30.48 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.174 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -97.36 80.63 2.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.496 178.882 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.9 t -121.94 -170.5 2.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.724 -179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.871 ' NH2' HD12 ' A' ' 47' ' ' LEU . 1.9 ttm-85 -81.84 137.58 35.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.804 0.335 . . . . 0.0 111.194 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' A' ' 91' ' ' VAL . 71.6 t -54.38 140.18 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.841 -179.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.12 4.47 4.67 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.642 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -123.4 25.65 8.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.11 0.481 . . . . 0.0 110.847 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' HG21 ' A' ' 93' ' ' THR . 6.4 p -67.82 130.68 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.994 179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.57 -29.98 10.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' HD23 ' A' ' 47' ' ' LEU . 63.7 mttp -62.03 170.06 2.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.44 -59.52 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.866 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.8 -30.0 6.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.801 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.871 HD12 ' NH2' ' A' ' 38' ' ' ARG . 12.3 mt 76.11 -48.22 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.554 -179.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 83.1 p -58.82 -171.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.774 0.321 . . . . 0.0 111.304 179.112 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.02 -92.08 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.439 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.629 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -129.89 -33.32 1.8 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.561 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.418 HG22 ' HG ' ' A' ' 52' ' ' LEU . 37.8 mm -63.94 -64.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.625 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB3' HG12 ' A' ' 78' ' ' VAL . 81.7 mt -122.39 124.21 43.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -71.73 68.89 0.64 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.871 0.367 . . . . 0.0 110.45 178.482 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -78.86 132.45 32.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.169 0.509 . . . . 0.0 110.992 -179.661 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.1 t -131.78 85.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.18 179.601 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.632 ' H ' HH22 ' A' ' 38' ' ' ARG . 10.4 t -99.19 111.86 24.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.538 -179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -95.99 112.66 24.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.423 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.36 108.3 14.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.212 179.392 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.497 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 26.5 m -120.69 128.42 25.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.346 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HA ' ' H ' ' A' ' 72' ' ' GLY . 3.0 Cg_endo -87.71 -149.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.428 2.752 . . . . 0.0 111.179 178.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 70' ' ' VAL . 2.7 m -118.95 133.24 23.69 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.882 0.372 . . . . 0.0 111.206 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.57 161.72 9.36 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.052 2.501 . . . . 0.0 112.072 179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.6 t -163.53 160.0 22.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.924 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.9 p -138.9 -1.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.646 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 90.3 m -161.12 -50.9 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 13.4 Cg_exo -70.83 157.99 56.79 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.722 2.282 . . . . 0.0 112.326 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.4 mtt -147.19 15.81 1.17 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.061 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.4 p -110.55 24.62 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.075 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.37 92.22 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.51 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 61' ' ' THR . 3.5 p -139.91 80.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.238 0.542 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -128.68 108.77 0.93 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -93.24 -121.57 3.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.07 -179.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 4.5 pt -147.5 -165.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.347 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 36' ' ' TRP . 4.3 m-85 -141.35 103.14 4.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.639 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 63.4 t -86.25 93.51 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 56' ' ' CYS . 21.3 t -88.58 124.59 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.796 -179.373 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.79 HD22 HG22 ' A' ' 21' ' ' THR . 77.1 mt -120.12 93.34 4.02 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.707 HG13 HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -91.18 103.97 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.943 0.402 . . . . 0.0 110.915 -179.148 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 43.7 mtmt -101.93 98.25 9.65 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.827 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 2.7 Cg_endo -46.42 106.7 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.758 2.305 . . . . 0.0 112.721 -179.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.629 HH11 ' HA ' ' A' ' 50' ' ' GLU . 9.1 mtt180 -79.44 -48.62 13.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.268 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 86' ' ' HIS . 62.3 mttm -102.91 156.52 17.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -95.32 123.5 38.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.564 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 151.21 -153.72 25.14 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.493 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -90.33 104.13 16.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.471 ' NE2' ' HB2' ' A' ' 82' ' ' LYS . 15.6 m-70 -122.28 179.2 4.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 88' ' ' LEU . 94.8 m -160.12 155.26 24.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.134 0.492 . . . . 0.0 112.086 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HB2' HG11 ' A' ' 78' ' ' VAL . 1.5 tm? -131.46 93.4 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.655 178.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -104.61 121.37 43.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.98 -179.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 76' ' ' VAL . 39.2 mt -99.0 171.84 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.478 179.25 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HB ' HG22 ' A' ' 39' ' ' VAL . 7.1 p -160.34 151.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.107 0.48 . . . . 0.0 112.272 -178.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -94.4 85.19 4.51 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.146 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.635 ' HB ' HG23 ' A' ' 99' ' ' ILE . 3.7 t -107.7 172.1 7.02 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -104.57 94.04 6.71 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.8 Cg_exo -49.6 -30.89 23.08 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.408 2.072 . . . . 0.0 112.382 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -74.6 -35.35 62.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.423 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -107.95 -77.89 0.59 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.319 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.95 -173.72 46.52 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.127 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 93' ' ' THR . 5.3 mt -96.68 148.72 5.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 0.0 111.238 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 4.4 mttt -133.75 174.03 5.15 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.388 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.41 -38.16 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.405 2.07 . . . . 0.0 112.573 -179.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.51 -10.05 31.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.762 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -64.45 161.84 16.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.12 -179.927 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 7.1 tp10 -74.01 167.79 20.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.943 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.669 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.7 tpp180 -142.77 158.83 43.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.921 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 63.6 t80 -158.72 81.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.533 177.027 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 2.6 m -76.59 157.76 31.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.506 -179.053 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 78' ' ' VAL . 33.7 tp -156.51 82.69 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.256 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.7 m-70 -67.82 156.28 37.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.398 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.442 HD22 ' HB ' ' A' ' 16' ' ' THR . 96.1 mt -147.92 106.4 3.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.034 -178.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.476 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 65.9 t30 -79.62 61.88 3.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 17' ' ' HIS . 3.3 t -45.16 121.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.603 -178.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.978 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 52.6 m -95.15 119.92 34.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -81.76 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 mmt -132.78 -165.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.779 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.75 -30.79 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.385 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.617 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -69.16 -50.78 19.63 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.757 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 27.2 Cg_exo -62.53 162.93 22.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.204 1.936 . . . . 0.0 112.229 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 5' ' ' LEU . 2.5 pt? -153.6 -38.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.832 179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.4 m -158.76 -74.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.36 -170.28 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -137.37 113.6 9.99 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.91 120.07 8.37 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.651 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.599 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.2 p-10 -129.46 -92.71 0.44 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.967 -179.312 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 1.6 p-10 -50.83 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.664 -179.315 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.7 OUTLIER -104.89 93.51 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.196 179.45 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.3 m95 -84.39 105.88 15.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.593 -179.332 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG23 HD23 ' A' ' 110' ' ' LEU . 29.5 m -147.44 -174.01 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 121.259 0.552 . . . . 0.0 112.285 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -107.93 179.69 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.467 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.1 t -177.39 -175.76 0.57 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.054 0.454 . . . . 0.0 111.891 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 49.1 m-70 -117.81 -167.11 1.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.787 179.118 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 33.7 t -86.66 135.84 24.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.169 0.509 . . . . 0.0 111.94 -179.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 63.33 11.53 40.69 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.335 -0.848 . . . . 0.0 113.476 179.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 17.0 tptt -59.79 83.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.1 0.45 . . . . 0.0 109.812 178.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.749 HG22 HD22 ' A' ' 77' ' ' LEU . 3.8 m -55.61 97.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.368 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' VAL . 62.6 m -94.48 98.66 11.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.527 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HA ' HD23 ' A' ' 77' ' ' LEU . 31.1 tt0 -75.45 133.51 41.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.604 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.428 HD13 ' HE2' ' A' ' 106' ' ' TYR . 37.2 mt -134.02 101.04 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.303 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -87.19 110.22 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.549 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 33.7 mt -108.18 148.48 29.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.352 -179.229 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -99.5 160.66 14.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.986 0.422 . . . . 0.0 110.605 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 177.95 -128.63 1.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.374 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.596 HD22 ' HB ' ' A' ' 32' ' ' THR . 1.9 p-10 -175.77 90.41 0.28 Allowed Pre-proline 0 CA--C 1.53 0.206 0 CA-C-O 120.537 0.208 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HG3' ' HA ' ' A' ' 60' ' ' PRO . 31.3 Cg_endo -63.5 163.64 23.33 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.474 2.116 . . . . 0.0 112.233 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 p 44.69 28.02 0.3 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.753 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.596 ' HB ' HD22 ' A' ' 29' ' ' ASN . 53.2 m -134.73 -72.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' H ' HD22 ' A' ' 29' ' ' ASN . . . -108.5 -112.74 3.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.821 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -96.39 -166.54 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.957 0.408 . . . . 0.0 110.872 -179.613 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 8.4 ttm -136.87 154.71 50.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.174 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.427 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 8.3 m95 -112.47 98.23 7.13 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.94 178.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.611 HG21 ' HA ' ' A' ' 42' ' ' VAL . 14.6 t -142.56 -165.79 2.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.822 -179.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 8.8 mtp85 -88.54 156.57 19.0 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.776 0.322 . . . . 0.0 110.887 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG22 ' CG2' ' A' ' 91' ' ' VAL . 31.8 t -72.83 131.17 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.935 -179.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.43 13.96 82.02 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.858 179.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 58.0 m-85 -134.88 -4.31 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.078 0.466 . . . . 0.0 110.725 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.92 HG21 HG21 ' A' ' 93' ' ' THR . 21.6 t -49.52 124.39 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.123 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.36 -32.81 5.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.17 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 93.4 mttt -64.31 169.8 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.846 0.355 . . . . 0.0 110.974 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.02 -61.7 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.602 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 p -106.97 142.0 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.845 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 5.5 mt -95.96 -50.46 4.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.119 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.56 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 24.4 p -50.78 177.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.127 179.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -153.3 -81.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -137.19 -33.23 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.479 -179.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 22.8 mm -69.28 -81.75 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.676 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 6.7 mt -97.15 117.59 31.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 79' ' ' LYS . 23.5 tt0 -68.68 84.33 0.29 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.56 ' H ' ' CB ' ' A' ' 48' ' ' SER . 39.0 t -88.95 91.66 3.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.511 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 22.6 t -79.68 86.5 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.4 t -68.95 135.22 50.62 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.006 -178.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.638 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 8.9 mtpm? -138.25 54.09 1.79 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.84 -179.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -52.52 112.37 0.81 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.511 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -100.36 104.16 28.2 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.537 -179.548 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' ' HG3' ' A' ' 30' ' ' PRO . 27.1 Cg_endo -103.1 4.55 0.39 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.765 2.977 . . . . 0.0 113.039 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.547 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -121.68 138.33 28.33 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.413 -178.729 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 61' ' ' THR . 83.9 Cg_endo -79.59 171.33 15.91 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.612 2.208 . . . . 0.0 112.253 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.1 t -165.8 169.2 15.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.5 p -115.54 9.93 15.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.0 p -62.39 155.49 66.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.258 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.88 13.48 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.817 2.345 . . . . 0.0 112.482 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.0 mtt -115.79 80.84 1.5 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.725 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -53.85 124.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.134 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.21 35.37 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.266 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 59' ' ' THR . 2.6 p -157.31 91.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.155 0.503 . . . . 0.0 110.955 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.07 50.82 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.238 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 30' ' ' PRO . . . 103.76 16.99 18.03 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.324 179.211 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 6.9 pt -111.28 -168.14 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.152 0.501 . . . . 0.0 111.369 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HD1' ' HB2' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -136.44 107.32 6.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.279 -179.482 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 85.6 t -94.36 100.99 12.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.945 0.403 . . . . 0.0 110.737 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 88' ' ' LEU . 32.8 t -105.26 118.2 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.028 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.749 HD22 HG22 ' A' ' 21' ' ' THR . 89.0 mt -104.1 106.92 17.59 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.44 104.99 16.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.272 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 39.3 mtmt -108.75 100.45 39.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.46 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.555 ' HA ' HD23 ' A' ' 52' ' ' LEU . 81.8 Cg_exo -46.41 96.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.59 2.194 . . . . 0.0 112.586 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.611 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 10.4 mtt180 -69.04 -33.81 74.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.173 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -118.95 -178.45 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -119.52 120.83 37.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.795 179.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 144.7 -121.35 1.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.608 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.36 113.89 26.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.081 0.467 . . . . 0.0 111.102 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.579 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 5.6 m80 -136.14 150.72 49.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.42 ' O ' HD12 ' A' ' 52' ' ' LEU . 91.7 m -161.19 152.6 19.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 112.063 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 76' ' ' VAL . 53.8 tp -121.87 71.79 1.0 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.073 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 3.1 pt-20 -70.71 105.38 3.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.624 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 17.6 mt -107.18 154.67 20.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.504 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -145.34 160.22 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.695 -179.748 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -103.88 89.16 3.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.562 178.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.92 HG21 HG21 ' A' ' 42' ' ' VAL . 9.1 t -120.25 169.12 10.56 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 95' ' ' PRO . 77.2 mtp180 -101.49 95.91 5.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.948 178.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 94' ' ' ARG . 5.6 Cg_endo -47.18 -33.46 15.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.982 2.455 . . . . 0.0 112.538 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -68.46 -35.61 77.82 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.497 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -103.82 -80.13 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.359 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.65 46.25 Favored Glycine 0 CA--C 1.51 -0.253 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.095 -179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.672 HG23 ' HB ' ' A' ' 93' ' ' THR . 8.0 mt -97.21 149.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.027 0.441 . . . . 0.0 111.669 -179.08 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.577 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 15.8 mttt -135.18 162.91 54.76 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.922 -179.325 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.0 Cg_endo -64.74 -35.23 47.03 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.607 2.205 . . . . 0.0 111.743 179.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.75 -24.45 66.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.016 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 100' ' ' LYS . 1.1 m-80 -48.67 136.43 13.41 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.237 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 11.0 tt0 -51.86 155.44 1.76 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.599 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 4.3 tpp180 -119.96 159.15 25.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.254 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 68.9 t80 -172.47 69.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 16.5 m -91.43 101.97 14.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.465 -178.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 29.2 tp -87.97 94.48 9.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.185 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.692 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 15.3 m-70 -77.55 147.87 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.677 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 HG23 ' A' ' 14' ' ' VAL . 94.9 mt -146.19 108.44 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.547 -178.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.44 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 39.4 t30 -84.35 69.68 10.53 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 17' ' ' HIS . 2.9 t -45.71 143.59 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.852 -178.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.882 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.1 m -140.32 115.99 10.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.322 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -96.58 130.23 43.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm -110.26 164.09 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.8 tt -96.76 -30.72 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.015 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.11 151.11 18.42 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 59.4 Cg_endo -72.23 128.41 13.78 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.476 2.117 . . . . 0.0 112.288 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 57.2 tp -124.03 -29.71 3.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.798 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -131.13 -58.32 1.01 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 p -164.55 130.92 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.09 -20.27 17.45 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.684 179.976 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 50.66 104.04 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.713 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.564 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -132.21 -80.47 0.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.867 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.524 ' H ' HD22 ' A' ' 10' ' ' ASN . 8.8 m-20 -48.18 96.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.618 -179.297 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.571 ' HD3' HD13 ' A' ' 108' ' ' LEU . 20.8 ptmt -101.06 68.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.554 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.747 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 3.0 m95 -49.85 104.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.137 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG23 HD23 ' A' ' 110' ' ' LEU . 35.4 m -146.87 -176.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 3.3 p-10 -103.38 -171.33 1.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.466 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.487 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.8 t -174.41 -174.74 0.89 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.3 0.571 . . . . 0.0 112.379 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.588 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 28.7 m80 -113.85 -156.58 0.6 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.647 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 42.3 t -105.26 125.56 60.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.082 0.468 . . . . 0.0 111.585 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.9 12.7 43.95 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.061 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.3 tptp -63.64 83.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.741 HG22 HD22 ' A' ' 77' ' ' LEU . 5.3 m -47.87 103.03 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.829 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.3 m -97.48 100.82 12.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.536 179.223 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 75' ' ' VAL . 35.4 tt0 -83.47 131.32 35.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.286 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 108' ' ' LEU . 36.1 mt -136.09 100.0 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.522 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.401 ' HB3' HD12 ' A' ' 73' ' ' ILE . 10.8 m170 -84.08 82.05 8.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.969 178.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.522 ' HG ' HG22 ' A' ' 24' ' ' ILE . 75.0 mt -72.24 158.54 35.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.285 -179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -116.16 164.76 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.103 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.42 -149.57 11.78 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.724 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.64 HD21 ' HB ' ' A' ' 31' ' ' THR . 8.5 t30 -171.22 84.48 0.5 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.559 0.219 . . . . 0.0 110.849 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.557 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 27.5 Cg_endo -61.84 -10.37 17.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.582 2.188 . . . . 0.0 112.693 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.64 ' HB ' HD21 ' A' ' 29' ' ' ASN . 0.8 OUTLIER -52.88 -22.71 5.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.851 0.357 . . . . 0.0 110.889 179.709 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.407 HG23 HD22 ' A' ' 29' ' ' ASN . 42.5 p -77.44 -45.13 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.768 179.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.44 27.09 0.19 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.112 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' THR . 79.8 m-85 -140.27 143.86 36.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.02 0.438 . . . . 0.0 111.507 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.672 ' HE3' ' HA ' ' A' ' 42' ' ' VAL . 8.5 ttp -113.58 154.8 26.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.423 179.388 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -105.22 107.03 17.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.867 178.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -156.65 -166.27 2.08 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.485 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 mtp85 -84.25 161.94 20.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.184 -179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 89' ' ' GLU . 48.6 t -76.36 138.69 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.813 -179.418 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.13 79.54 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.605 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.405 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 66.4 m-85 -135.03 -2.59 2.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.672 ' HA ' ' HE3' ' A' ' 35' ' ' MET . 2.3 p -40.29 108.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.287 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.68 -44.45 1.47 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -56.4 164.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.893 0.378 . . . . 0.0 111.053 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -86.84 -46.77 9.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.07 136.14 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.339 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 4.9 mt -102.19 -50.55 3.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.973 179.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.488 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.6 p -50.93 175.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.742 179.038 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -155.96 -88.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.5 pt-20 -131.02 -32.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.056 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -71.64 -73.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.324 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.8 mt -107.5 118.97 38.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.442 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.64 69.22 0.42 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG21 ' HD2' ' A' ' 38' ' ' ARG . 11.8 t -76.56 83.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.316 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 14.9 t -83.61 87.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.033 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 76' ' ' VAL . 39.9 t -95.38 150.57 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.489 -178.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.471 ' HB2' HG13 ' A' ' 75' ' ' VAL . 58.5 mttm -139.02 118.13 12.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.456 179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 1.5 t80 -96.57 101.64 13.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.128 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.512 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 27.7 m -107.87 90.23 6.21 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.373 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HA ' ' HA3' ' A' ' 72' ' ' GLY . 96.7 Cg_endo -83.42 -174.75 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.987 2.458 . . . . 0.0 111.818 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.51 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.23 140.52 65.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.867 179.539 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.51 ' HD2' HG22 ' A' ' 61' ' ' THR . 25.4 Cg_exo -62.81 121.77 9.81 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.505 2.137 . . . . 0.0 112.214 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -113.35 -179.55 3.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.713 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.3 t -70.83 -67.13 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.057 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 58.6 m -99.89 -48.69 0.21 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.033 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 14.3 Cg_exo -70.28 156.09 62.74 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.739 2.293 . . . . 0.0 112.443 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 26.2 mmt -148.71 15.27 0.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.045 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.94 134.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.3 50.79 61.64 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.547 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -113.36 8.36 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.962 -179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . 84.79 111.93 0.67 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.217 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 60' ' ' PRO . . . -171.78 -120.8 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.165 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 74' ' ' TYR . 1.9 mm -114.33 153.43 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 121.954 0.883 . . . . 0.0 111.784 -179.36 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -129.87 67.57 1.46 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.506 178.463 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.2 p -81.04 107.31 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.476 -178.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG11 HD21 ' A' ' 88' ' ' LEU . 96.6 t -102.02 125.98 56.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.46 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD22 HG22 ' A' ' 21' ' ' THR . 76.6 mt -109.3 96.9 6.6 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.77 178.408 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.61 HG21 HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -93.73 106.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.04 0.448 . . . . 0.0 111.044 -178.904 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -107.87 105.07 55.43 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.985 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 Cg_exo -53.05 98.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.49 2.127 . . . . 0.0 112.45 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.622 HH11 ' HA ' ' A' ' 50' ' ' GLU . 4.6 mtt180 -69.87 -49.14 55.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.459 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -107.62 161.05 15.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.176 -179.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -98.15 113.79 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.733 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.628 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 165.93 -129.25 1.9 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.578 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.44 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 68.7 m80 -106.62 99.09 8.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.458 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -111.04 162.69 14.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.673 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.4 ' O ' HD12 ' A' ' 52' ' ' LEU . 99.7 m -159.63 148.87 18.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.044 0.449 . . . . 0.0 112.052 -179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 25.7 tp -121.61 79.53 1.57 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.757 179.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.617 ' HA ' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -77.07 100.19 5.6 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.178 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 71.9 mt -98.68 140.75 32.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.116 179.162 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -140.98 164.49 20.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.808 -179.452 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 104' ' ' GLU . 0.4 OUTLIER -99.11 84.18 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.66 HG21 ' HB ' ' A' ' 42' ' ' VAL . 7.6 t -95.5 -175.67 3.54 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.831 -177.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 55.7 mtp180 -117.91 101.17 52.08 Favored Pre-proline 0 CA--C 1.529 0.165 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.297 179.099 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 84.4 Cg_exo -39.92 -34.93 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.054 2.503 . . . . 0.0 113.399 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.446 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -88.74 -47.23 8.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.414 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -83.92 -86.87 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.884 0.374 . . . . 0.0 111.803 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 172.82 -174.06 45.68 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.246 -179.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -93.68 154.11 3.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.722 0.296 . . . . 0.0 111.001 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 10.6 mttm -145.44 166.46 17.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 -179.506 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 31.2 Cg_exo -59.62 -44.88 28.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.857 2.371 . . . . 0.0 111.864 179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -60.51 -26.74 67.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.307 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.569 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -49.56 135.47 18.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.107 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 9.3 tt0 -49.42 152.53 1.28 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.24 179.593 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 10' ' ' ASN . 7.4 tpp180 -117.63 159.2 23.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.167 0.508 . . . . 0.0 111.71 -178.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.493 ' H ' ' HG3' ' A' ' 105' ' ' ARG . 41.5 t80 -175.55 62.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.532 177.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 89' ' ' GLU . 9.1 m -84.26 98.12 9.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.726 -178.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 78' ' ' VAL . 18.6 tp -80.57 92.41 5.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.862 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.747 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 21.5 m-70 -79.59 140.94 36.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.341 179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.504 HD23 HG23 ' A' ' 14' ' ' VAL . 89.3 mt -144.01 99.83 3.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.58 -178.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.533 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 7.9 t30 -73.16 77.26 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.628 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 6.1 t -51.5 120.55 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.418 -178.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.887 -179.97 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.4 m -137.46 -38.27 0.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -91.92 149.29 21.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 mtt -83.48 -172.61 4.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.773 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -144.21 -22.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.88 111.37 12.06 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.206 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.15 176.25 10.18 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.427 2.085 . . . . 0.0 112.357 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -154.5 -70.4 0.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.499 ' HA ' ' HB3' ' A' ' 101' ' ' PRO . 78.4 p -165.72 -58.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.8 p -98.56 150.76 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -133.41 110.72 10.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 109.991 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.72 126.84 29.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.605 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -115.96 -16.46 11.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.241 -179.413 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -149.56 -140.32 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' C ' ' HB3' ' A' ' 109' ' ' HIS . 22.1 ptmt -132.63 -173.94 3.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 111.451 -179.12 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 16.7 m0 -136.63 117.48 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.796 179.214 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 109' ' ' HIS . 2.6 p -158.35 158.57 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 121.547 0.689 . . . . 0.0 112.077 -178.688 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.0 p30 -44.98 165.74 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.925 -178.454 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 17' ' ' HIS . 3.1 t -173.02 -167.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.391 -179.558 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.558 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 57.2 m80 -111.99 179.34 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.865 0.364 . . . . 0.0 110.945 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 t -94.03 147.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.208 0.528 . . . . 0.0 112.195 -178.567 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.19 21.63 5.96 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.849 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.558 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.8 tptt -75.18 73.53 2.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.152 0.501 . . . . 0.0 109.658 179.38 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.738 HG22 HD22 ' A' ' 77' ' ' LEU . 11.6 m -40.27 102.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.809 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.6 m -104.52 103.84 13.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.686 179.581 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HG3' HG23 ' A' ' 75' ' ' VAL . 28.0 tt0 -82.58 121.7 27.14 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' HD22 ' A' ' 26' ' ' LEU . 56.7 mt -126.99 99.19 5.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.539 ' HB3' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -88.36 109.61 20.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.61 178.639 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 26' ' ' LEU . 2.6 mm? -91.05 167.56 12.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.504 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -107.46 167.66 9.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.965 179.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.6 -148.82 18.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.579 -179.469 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.478 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 49.0 t30 -171.64 116.02 0.42 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.331 0.11 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.51 -46.55 26.66 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.39 2.06 . . . . 0.0 112.404 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 m -57.81 -29.32 64.81 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.435 -179.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 52.4 m -59.54 -55.25 36.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.19 -179.901 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.64 -83.25 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.143 179.752 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' CD2' ' HG3' ' A' ' 94' ' ' ARG . 87.9 m-85 -55.46 158.86 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.19 0.519 . . . . 0.0 111.635 -179.256 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 13.0 ttm -123.8 150.29 44.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.276 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -105.66 81.82 1.72 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 178.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.3 t -124.01 -160.98 0.96 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.699 -179.292 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 54' ' ' VAL . 1.8 ttp85 -95.24 114.12 25.87 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG11 HH11 ' A' ' 105' ' ' ARG . 0.9 OUTLIER -48.14 134.7 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.032 0.444 . . . . 0.0 111.514 -179.283 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.16 3.19 76.29 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.917 -179.364 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 55.7 m-85 -139.37 0.9 1.92 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.766 0.317 . . . . 0.0 110.971 -179.633 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' THR . 9.3 p -49.48 136.17 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.195 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.99 -34.69 2.98 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.696 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 66.0 mttm -62.36 168.46 3.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.861 0.362 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.35 -61.59 1.77 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.588 179.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.3 p -104.44 140.56 22.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.743 179.633 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 10.0 mt -89.76 -52.08 5.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.924 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.455 ' CB ' ' H ' ' A' ' 54' ' ' VAL . 22.7 t -48.69 172.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.472 178.683 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.46 -78.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.74 -34.44 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.469 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.4 mm -69.97 -78.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 -179.306 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 80' ' ' PRO . 60.2 mt -98.54 117.2 32.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.385 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 25.9 tt0 -67.93 84.26 0.22 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.58 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.683 HG22 HG13 ' A' ' 78' ' ' VAL . 19.8 t -92.22 94.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -176.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 43.2 t -91.48 82.13 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.037 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.512 ' SG ' HG22 ' A' ' 76' ' ' VAL . 22.2 t -99.61 155.21 17.72 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.622 -178.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -143.41 123.86 13.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.594 179.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -89.36 109.34 20.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.398 179.741 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.3 m -97.72 105.04 24.11 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.574 -179.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 58' ' ' TYR . 44.1 Cg_endo -101.5 -162.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.849 3.033 . . . . 0.0 112.464 179.938 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.533 HG23 ' HD2' ' A' ' 62' ' ' PRO . 22.8 m 58.12 138.61 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.172 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' A' ' 61' ' ' THR . 20.2 Cg_endo -59.63 178.5 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.144 2.563 . . . . 0.0 112.211 179.59 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.1 p -69.09 114.72 7.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -100.27 -30.32 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.029 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.604 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 62.8 m -155.89 -50.25 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 7.0 Cg_exo -74.56 -171.77 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.802 2.334 . . . . 0.0 112.21 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 25.3 ptm -160.08 20.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.457 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.3 p -98.67 27.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.943 -179.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.1 84.1 1.75 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.516 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -144.53 86.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.062 0.458 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.88 39.51 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.328 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.95 29.94 1.18 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -86.0 162.94 2.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.6 0.714 . . . . 0.0 111.429 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.1 m-85 -144.52 79.79 1.62 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.56 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.512 HG23 ' HG3' ' A' ' 23' ' ' GLU . 2.8 p -85.05 106.52 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.268 0.556 . . . . 0.0 110.755 -178.994 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG11 HD21 ' A' ' 88' ' ' LEU . 20.4 t -107.83 116.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.583 -178.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.738 HD22 HG22 ' A' ' 21' ' ' THR . 29.1 mt -100.46 100.96 11.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.702 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -95.19 114.19 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.252 0.549 . . . . 0.0 111.17 -178.947 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 29.7 mtmm -119.44 92.41 45.85 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.416 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.64 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.4 Cg_endo -47.46 112.87 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.487 2.125 . . . . 0.0 112.905 -178.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.1 mtt180 -80.51 -39.82 27.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.861 179.578 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -108.28 176.38 5.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -113.62 149.82 34.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.072 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.528 ' N ' HG23 ' A' ' 112' ' ' VAL . . . 124.01 -160.56 18.56 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.726 179.8 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.496 ' HA ' HD22 ' A' ' 111' ' ' ASN . 65.7 m80 -71.43 98.84 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.681 0.277 . . . . 0.0 110.752 179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -129.91 154.07 47.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.389 0.614 . . . . 0.0 111.331 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.548 HG21 ' HE1' ' A' ' 13' ' ' TRP . 37.5 m -159.87 138.9 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.218 -179.796 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.702 ' HB2' HG11 ' A' ' 78' ' ' VAL . 32.0 tp -74.53 111.18 9.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.292 179.531 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 44.5 mt-10 -87.6 96.75 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.732 -179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 36.3 mt -101.14 170.01 8.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.449 178.796 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 13.3 p -166.56 153.15 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.696 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.0 t80 -104.56 84.27 2.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.637 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.6 t -124.55 149.23 47.2 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.12 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 74.7 mtp180 -85.81 101.65 2.01 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.965 178.495 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 8.6 Cg_endo -52.28 -38.24 72.08 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.721 2.281 . . . . 0.0 112.685 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.14 10.89 3.87 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.74 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 20.7 mm-40 -147.88 1.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.41 -179.702 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.84 -174.75 54.89 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.445 -0.884 . . . . 0.0 112.114 -179.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.637 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.2 mt -106.45 148.59 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.002 0.429 . . . . 0.0 111.635 -179.326 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' ND2' ' A' ' 103' ' ' ASN . 9.9 mttt -131.63 157.93 76.79 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.565 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 52.2 Cg_exo -56.39 -43.98 50.53 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.75 2.3 . . . . 0.0 112.744 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.76 -14.09 49.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.074 -179.365 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.595 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -62.02 137.7 58.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 -179.632 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 91' ' ' VAL . 5.9 tt0 -60.37 -179.46 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.618 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -162.97 162.35 26.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.214 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.593 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 26.3 t80 -151.53 114.94 4.81 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.042 0.449 . . . . 0.0 110.177 178.151 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.592 ' HB ' ' HE1' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -104.37 132.12 50.97 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.043 -178.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 110' ' ' LEU . 26.5 tp -101.62 110.45 22.44 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.09 0.471 . . . . 0.0 110.527 178.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 14' ' ' VAL . 8.6 p80 -55.32 71.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.868 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 108' ' ' LEU . 21.1 mt -112.72 70.72 0.72 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.839 0.745 . . . . 0.0 112.937 -178.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 2.2 t-20 -82.31 60.21 4.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.757 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -40.71 141.65 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.615 -178.07 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.044 179.719 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . 0.534 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 48.1 t -140.96 3.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 62.9 m80 58.74 26.22 14.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.162 179.847 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG3' ' HB3' ' A' ' -1' ' ' SER . 69.3 mtm -60.88 167.97 2.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.944 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 8' ' ' LYS . 40.1 pt -76.5 -28.42 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.233 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.06 90.4 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.214 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.14 110.69 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.558 2.172 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.7 tp -166.9 -33.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.893 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.2 m -136.43 -49.26 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.0 p -130.43 105.86 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 111.23 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HA ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -110.37 -12.93 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.701 179.875 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 54.28 106.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.678 179.864 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -137.62 -86.71 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.941 -179.667 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.606 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.5 OUTLIER -36.72 103.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.804 -179.581 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE2' HG11 ' A' ' 14' ' ' VAL . 75.3 tttt -90.67 100.54 13.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.492 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.672 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.4 m95 -82.86 105.44 13.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.696 -179.521 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.73 HG22 ' H ' ' A' ' 15' ' ' ASP . 4.7 p -153.37 176.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.146 0.498 . . . . 0.0 111.838 -179.118 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.73 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -94.39 -176.69 4.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.601 179.67 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.493 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t -174.1 -175.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.175 0.512 . . . . 0.0 112.093 -179.915 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.0 m-70 -116.68 -163.25 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.005 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.06 126.7 49.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.165 0.507 . . . . 0.0 111.795 -179.598 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.44 10.55 29.96 Favored Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.09 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.586 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.1 tptm -63.27 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.688 HG22 HD22 ' A' ' 77' ' ' LEU . 5.0 m -46.55 98.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.907 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -90.89 94.8 9.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.031 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 35.9 tt0 -83.77 128.3 34.44 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.282 -179.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.539 HG22 ' HG ' ' A' ' 26' ' ' LEU . 55.5 mt -133.57 103.42 5.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.048 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -87.89 119.11 27.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' HG ' HG22 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -118.64 151.66 37.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.556 -178.554 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -125.59 157.9 35.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 163.85 -43.22 0.32 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.436 -1.364 . . . . 0.0 114.195 -179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER 48.86 103.91 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 121.067 0.461 . . . . 0.0 110.009 -177.656 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.612 ' C ' ' H ' ' A' ' 32' ' ' THR . 56.2 Cg_endo -68.1 -151.95 0.03 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 121.654 1.569 . . . . 0.0 111.277 -179.45 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -74.02 23.4 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 177.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.612 ' H ' ' C ' ' A' ' 30' ' ' PRO . 12.0 p 63.19 23.84 14.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.152 -179.372 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.26 -34.12 0.33 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.711 179.329 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' HB2' ' CB ' ' A' ' 30' ' ' PRO . 60.2 m-85 -75.23 -166.78 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.75 0.309 . . . . 0.0 110.414 179.458 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 15.9 ttm -161.31 150.55 16.46 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.062 0.458 . . . . 0.0 111.053 -179.606 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.537 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -106.49 84.72 2.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.042 178.102 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.628 HG21 ' HA ' ' A' ' 42' ' ' VAL . 6.4 t -136.63 -165.85 1.8 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.329 -178.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 12.5 mtp85 -86.69 155.68 20.28 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.906 0.384 . . . . 0.0 111.636 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.519 HG22 ' CG2' ' A' ' 91' ' ' VAL . 43.6 t -72.82 132.4 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.84 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.5 10.43 85.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.625 179.618 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . 60.4 m-85 -132.53 -4.61 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG21 HG21 ' A' ' 93' ' ' THR . 21.7 t -53.65 111.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.039 179.314 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.09 -28.86 13.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.954 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.525 ' HD2' ' HA ' ' A' ' 41' ' ' PHE . 98.0 mttt -68.69 174.24 4.45 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.09 -64.14 1.2 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.769 179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.6 p -99.25 142.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.809 179.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 18.8 mt -92.21 -51.71 5.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.282 -179.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.5 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 76.9 p -67.53 -168.6 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.168 179.202 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -151.19 -86.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.293 179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.16 -31.33 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.274 -179.357 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.6 mm -72.3 -83.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.475 -179.495 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -99.95 107.03 18.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.65 179.767 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 35.5 tt0 -60.43 142.89 54.44 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.276 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.611 HG21 ' HD2' ' A' ' 38' ' ' ARG . 21.7 t -144.66 85.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.304 -179.365 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 34.2 t -86.06 83.5 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.425 0.631 . . . . 0.0 109.353 178.12 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 76' ' ' VAL . 9.2 t -102.18 133.51 46.94 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.447 -178.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -116.12 120.84 40.32 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.303 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.473 ' CZ ' ' HE1' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -90.88 95.37 10.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.245 179.512 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 32.4 m -95.61 108.1 37.66 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.721 -179.122 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.619 ' HB2' HG22 ' A' ' 70' ' ' VAL . 56.5 Cg_endo -101.24 82.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.582 2.854 . . . . 0.0 111.283 179.154 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.552 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -53.87 139.15 52.96 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.596 -179.039 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.552 ' HD2' HG22 ' A' ' 61' ' ' THR . 87.5 Cg_endo -90.44 154.05 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.204 2.603 . . . . 0.0 112.458 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 p -100.82 -169.91 1.78 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -112.4 -73.04 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.637 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 68.0 m -156.94 -51.58 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.595 179.795 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 1.7 Cg_endo -86.25 36.39 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.089 2.526 . . . . 0.0 111.85 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 45.0 ttp -177.06 31.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.269 -179.402 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -41.03 137.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.03 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.18 124.77 1.97 Allowed Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.151 -179.692 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.619 HG22 ' HB2' ' A' ' 60' ' ' PRO . 8.7 p -81.4 24.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.228 0.537 . . . . 0.0 110.979 -179.766 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.96 130.38 44.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.991 -179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -134.08 -130.65 3.04 Favored Glycine 0 N--CA 1.453 -0.18 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.54 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.29 -169.63 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.08 0.466 . . . . 0.0 110.789 179.033 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 9.7 m-85 -145.04 95.42 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.892 -179.644 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.8 p -97.97 126.29 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.257 0.551 . . . . 0.0 110.655 -179.415 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.552 HG22 ' SG ' ' A' ' 56' ' ' CYS . 39.7 t -123.06 122.76 66.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.18 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.688 HD22 HG22 ' A' ' 21' ' ' THR . 79.4 mt -105.33 94.25 5.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.134 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -92.63 101.57 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.099 0.475 . . . . 0.0 110.756 -179.186 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' HE3' ' OG1' ' A' ' 21' ' ' THR . 11.2 mttt -102.11 102.62 25.23 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.454 -179.326 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.466 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 41.5 Cg_exo -56.12 95.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.132 1.888 . . . . 0.0 112.157 179.388 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.549 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 68.9 mtt180 -67.43 -28.15 67.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 0.0 110.796 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -128.89 173.35 10.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.436 179.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -113.46 137.91 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 111.008 179.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.607 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 145.56 -136.7 6.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.183 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.496 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 62.0 m80 -99.32 91.68 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 110.742 179.853 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 1.7 m-70 -111.28 164.48 12.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.592 -179.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 88' ' ' LEU . 32.4 m -158.75 157.99 32.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 0.0 111.823 -179.361 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 14.8 tp -124.02 88.49 2.92 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.588 179.601 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' ARG . 39.4 mt-10 -74.25 101.28 3.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.246 -179.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 75.9 mt -107.38 139.2 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.323 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.519 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -138.93 166.01 23.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.149 0.499 . . . . 0.0 112.087 -179.248 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -106.16 84.26 2.02 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.178 178.705 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.848 HG21 HG21 ' A' ' 42' ' ' VAL . 7.5 t -126.66 159.86 32.43 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -176.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 73.0 mtp180 -93.23 100.76 4.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.537 178.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 42' ' ' VAL . 82.7 Cg_exo -34.14 -42.96 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.485 2.79 . . . . 0.0 113.972 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HD1' ' HG2' ' A' ' 97' ' ' GLU . 0.2 OUTLIER -80.6 -52.94 7.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.038 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -70.56 4.98 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.83 -169.26 54.54 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.931 -179.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.83 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -115.03 155.65 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.267 0.556 . . . . 0.0 112.256 -179.05 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 49.5 mtmt -147.0 158.75 44.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.349 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 20.3 Cg_endo -60.86 -34.65 90.97 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.735 2.29 . . . . 0.0 112.684 -179.689 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.18 -11.88 4.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.838 -179.704 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -71.04 140.51 50.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 111.441 -179.842 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -55.45 161.99 1.74 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 5.5 tpp180 -122.94 160.61 25.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.162 0.506 . . . . 0.0 111.808 -178.753 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.614 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 42.2 t80 -173.63 66.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.887 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 8.7 m -87.01 92.02 8.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.333 -178.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 69.6 tp -72.26 94.46 1.58 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.185 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 19.5 m-70 -78.56 142.74 37.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.076 0.465 . . . . 0.0 110.709 179.443 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 93.6 mt -142.69 109.18 5.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -178.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.45 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 m-20 -81.73 66.95 7.52 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.376 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.607 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.9 t -48.41 110.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.357 -178.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.934 -179.89 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 112.417 -0.273 . . . . 0.0 112.417 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 53.2 m -95.34 146.31 24.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -98.37 21.02 11.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt 61.41 -179.89 0.11 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.064 -179.99 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.1 pt -138.1 26.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.151 -179.904 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -53.17 -49.32 88.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.678 -179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 49.6 Cg_exo -56.01 152.52 36.43 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.153 1.902 . . . . 0.0 112.167 179.799 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.5 tp -149.04 -68.13 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.087 -179.901 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.3 t -127.09 5.1 6.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -148.7 152.84 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.041 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -129.82 107.8 9.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.935 0.398 . . . . 0.0 109.96 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.81 130.14 42.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.953 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -104.68 -21.55 13.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.892 -179.833 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 107' ' ' THR . 6.4 m-20 -151.82 -146.73 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.401 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 0.2 OUTLIER -133.89 -170.23 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 -179.934 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 109' ' ' HIS . 12.5 m0 -130.86 123.95 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.806 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 109' ' ' HIS . 16.4 m -147.88 154.5 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.049 0.452 . . . . 0.0 111.698 -178.607 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.4 p-10 -51.02 168.83 0.05 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.83 -179.404 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.8 t -171.36 -168.96 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.803 -179.5 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.1 m80 -104.03 -175.98 2.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.767 0.318 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.55 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 8.4 p -96.89 140.56 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.142 0.496 . . . . 0.0 111.897 -179.27 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.25 15.5 5.54 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.416 179.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 14.4 tptt -66.39 79.2 0.1 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.023 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.754 HG22 HD22 ' A' ' 77' ' ' LEU . 4.4 m -44.06 101.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.751 -178.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 m -96.25 101.84 13.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.621 179.578 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' HA ' HD23 ' A' ' 77' ' ' LEU . 36.3 tt0 -80.71 130.06 34.87 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.659 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.558 HG22 ' HG ' ' A' ' 26' ' ' LEU . 46.2 mt -132.86 105.61 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.873 -179.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -89.23 96.04 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' HG22 ' A' ' 24' ' ' ILE . 14.7 mt -90.29 146.01 24.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.303 -179.046 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -100.57 161.31 13.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.44 -179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.56 -145.02 8.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.441 -179.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.517 HD21 ' HB ' ' A' ' 31' ' ' THR . 5.5 t30 -175.02 96.94 0.28 Allowed Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 -179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 11.4 Cg_endo -55.03 -31.13 73.31 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.68 2.253 . . . . 0.0 112.847 -179.552 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.517 ' HB ' HD21 ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.8 -21.74 20.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.544 -179.818 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.5 p -66.0 -59.86 3.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.933 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.79 -33.31 0.52 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.849 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.99 -179.13 5.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.154 0.502 . . . . 0.0 111.493 -179.658 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.542 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.0 ttt -147.88 154.03 39.88 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.739 -179.091 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 4.5 m95 -110.19 93.28 4.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.196 178.921 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 42' ' ' VAL . 15.1 t -137.25 -168.46 2.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.526 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.706 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 16.0 mtp85 -87.62 140.34 29.62 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.903 0.382 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 91' ' ' VAL . 13.2 t -60.96 130.78 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.778 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.18 12.65 75.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HD2' ' HB3' ' A' ' 38' ' ' ARG . 58.0 m-85 -137.66 0.73 2.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.265 0.555 . . . . 0.0 110.432 -179.797 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.914 HG21 HG21 ' A' ' 93' ' ' THR . 21.5 t -54.39 111.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.147 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.32 -31.77 7.58 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.04 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -68.89 173.98 4.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.121 179.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.42 -63.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.679 179.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 p -100.01 142.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.706 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 11.4 mt -96.03 -51.05 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.482 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 73.0 p -52.66 175.01 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.691 179.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -155.12 -85.43 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.77 -31.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.299 -179.315 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.5 mm -70.2 -72.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.359 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 80' ' ' PRO . 92.0 mt -111.5 121.47 45.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.191 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 68.0 0.37 Allowed 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.82 HG22 HG13 ' A' ' 78' ' ' VAL . 5.8 t -75.62 86.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.42 -178.536 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.0 87.91 2.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.45 ' SG ' HG22 ' A' ' 76' ' ' VAL . 30.5 t -105.44 141.24 37.28 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.992 -178.1 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -130.84 115.81 17.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.744 179.033 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.542 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -83.54 113.96 21.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.736 179.744 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.6 m -112.72 111.56 51.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.336 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HB2' HG12 ' A' ' 70' ' ' VAL . 66.8 Cg_endo -99.52 40.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.522 2.815 . . . . 0.0 112.109 179.563 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -42.01 140.37 1.53 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.557 -179.192 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.548 ' HD2' HG22 ' A' ' 61' ' ' THR . 26.7 Cg_exo -62.25 -177.36 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.69 2.26 . . . . 0.0 112.368 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.4 m -70.69 -170.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 179.908 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -73.83 -67.87 0.56 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 61.5 m -92.87 -48.47 0.3 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.883 -179.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 12.4 Cg_exo -71.3 -173.97 1.08 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.786 2.324 . . . . 0.0 112.303 -179.661 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -138.08 15.16 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.017 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.52 150.28 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.274 -179.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.21 -52.25 1.09 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.578 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 60' ' ' PRO . 89.2 t 52.04 86.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.985 0.421 . . . . 0.0 111.027 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -151.06 124.77 1.76 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.868 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.544 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . -120.78 -117.37 2.55 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.378 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 8.1 pt -139.03 -166.38 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.104 0.478 . . . . 0.0 110.984 179.749 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -130.94 100.48 5.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.183 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.852 0.358 . . . . 0.0 110.746 -179.467 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 88' ' ' LEU . 22.0 t -119.38 120.39 63.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.549 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.754 HD22 HG22 ' A' ' 21' ' ' THR . 72.4 mt -109.58 97.61 7.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.729 178.203 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.82 HG13 HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -93.98 105.73 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.987 0.422 . . . . 0.0 111.24 -178.721 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -105.78 103.3 43.23 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.035 -179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.55 ' HB2' ' HA ' ' A' ' 18' ' ' VAL . 73.1 Cg_exo -48.41 99.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.738 2.292 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -76.85 -33.76 57.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.767 178.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.76 161.14 21.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.935 -179.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.421 ' HA ' ' HB ' ' A' ' 112' ' ' VAL . 96.3 mtt180 -103.64 124.53 49.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.972 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.483 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 146.78 -167.95 28.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -63.49 100.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 0.0 110.811 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -135.91 161.01 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.24 0.543 . . . . 0.0 110.976 -179.884 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.555 HG21 ' HE1' ' A' ' 13' ' ' TRP . 47.0 m -165.24 146.27 7.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.52 -179.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 76' ' ' VAL . 42.2 tp -78.68 105.28 9.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.949 178.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.0 97.33 9.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.418 179.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 25.5 mt -104.22 169.93 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 104' ' ' GLU . 9.1 p -165.88 150.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.036 -179.017 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 35' ' ' MET . 3.1 t80 -101.28 91.69 4.62 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.37 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.914 HG21 HG21 ' A' ' 42' ' ' VAL . 1.7 t -126.53 164.93 20.11 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.45 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -101.38 91.85 2.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.536 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 93' ' ' THR . 58.7 Cg_exo -39.69 -35.43 0.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.0 2.467 . . . . 0.0 113.014 -179.86 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.65 -45.77 85.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.295 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.97 -88.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -163.95 -179.28 38.13 Favored Glycine 0 CA--C 1.507 -0.431 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.053 -179.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.75 HG23 ' HB ' ' A' ' 93' ' ' THR . 22.2 mt -93.26 -60.8 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -178.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 34.7 mtmt 69.15 159.59 0.15 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 83.7 Cg_endo -76.71 -34.77 2.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 123.137 2.558 . . . . 0.0 112.388 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 103' ' ' ASN . 9.0 pt-20 -56.63 -35.77 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.461 ' OD1' ' HA ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -54.91 151.7 8.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.96 0.41 . . . . 0.0 111.611 -179.786 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.631 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.8 tt0 -65.35 178.23 0.97 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.686 -179.728 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.608 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -159.25 164.36 35.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.097 -179.482 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.587 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 23.4 t80 -147.01 113.93 6.13 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.992 0.425 . . . . 0.0 109.973 178.318 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.579 HG23 ' HE ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -103.72 128.65 51.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.308 -178.604 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 110' ' ' LEU . 33.2 tp -98.87 108.27 20.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.742 ' HB2' HG22 ' A' ' 14' ' ' VAL . 4.5 p80 -50.4 72.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.747 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.565 ' HG ' ' HG ' ' A' ' 108' ' ' LEU . 94.5 mt -110.22 64.37 0.61 Allowed 'General case' 0 C--N 1.342 0.251 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 42.4 t30 -79.58 51.94 1.34 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.483 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -28.36 136.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.462 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 79.9 p -145.84 147.36 31.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.949 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -131.6 167.61 19.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -96.23 -178.51 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.2 tp -69.81 -36.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.154 -179.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -169.31 -50.49 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.826 179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 32.4 Cg_exo -58.45 148.2 81.84 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.18 1.92 . . . . 0.0 112.315 179.975 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.4 mp -102.07 -52.84 3.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.792 179.863 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.7 m -143.33 -77.55 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.44 116.81 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 179.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.09 126.82 4.36 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.565 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.88 115.8 24.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.398 -179.995 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -130.39 -88.01 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.316 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.599 ' H ' HD22 ' A' ' 10' ' ' ASN . 0.4 OUTLIER -25.26 105.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.658 -179.251 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HD3' HD13 ' A' ' 108' ' ' LEU . 75.4 tttt -101.39 98.36 8.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.985 179.123 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.677 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.8 m95 -85.52 103.2 14.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.416 -178.64 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.459 HG23 HD23 ' A' ' 110' ' ' LEU . 26.9 m -149.14 -167.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.671 -179.389 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' A' ' 16' ' ' THR . 0.6 OUTLIER -108.08 -168.99 1.44 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.651 179.805 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.508 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.5 t 174.24 -173.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.606 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 77.7 m80 -120.65 -176.27 3.2 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.099 179.126 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.7 137.67 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.25 0.548 . . . . 0.0 111.999 -179.419 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' THR . . . 59.09 16.86 34.91 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.598 179.501 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 4.2 tptm -57.7 84.18 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.091 0.445 . . . . 0.0 110.042 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.815 HG22 HD22 ' A' ' 77' ' ' LEU . 2.9 m -57.2 94.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.043 -179.25 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.5 m -95.57 105.92 17.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.002 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 34.8 tt0 -85.81 124.98 32.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.851 179.497 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 74' ' ' TYR . 51.7 mt -126.46 101.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.014 179.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.436 ' ND1' HD12 ' A' ' 73' ' ' ILE . 13.9 m170 -86.57 109.95 19.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.715 178.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.506 HD11 HD13 ' A' ' 90' ' ' LEU . 18.8 mt -99.14 176.51 5.52 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.98 0.419 . . . . 0.0 111.098 -179.173 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -119.98 169.87 9.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.131 179.26 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.34 -159.07 31.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.717 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.608 HD22 ' HB ' ' A' ' 32' ' ' THR . 5.4 t30 -171.64 102.53 0.38 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.402 0.144 . . . . 0.0 110.81 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.09 177.66 2.35 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.423 2.082 . . . . 0.0 112.206 -179.995 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.8 p 50.42 20.14 0.64 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.431 -179.693 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.608 ' HB ' HD22 ' A' ' 29' ' ' ASN . 34.2 m -144.4 -69.86 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.22 -118.49 3.89 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.515 -179.883 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 3.1 m-85 -122.46 -175.74 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.989 0.423 . . . . 0.0 110.915 -179.583 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 14.0 ttm -109.47 149.89 28.92 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.604 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . 4.2 m95 -108.82 83.78 1.82 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.708 178.29 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.544 HG23 HG22 ' A' ' 42' ' ' VAL . 14.1 t -125.51 -168.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 -179.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.633 ' NE ' HG11 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -83.61 134.5 34.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.906 0.384 . . . . 0.0 111.512 -178.941 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 91' ' ' VAL . 33.6 t -52.57 136.58 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.378 -179.853 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.8 -23.52 1.06 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.51 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 39' ' ' VAL . 11.7 m-30 -100.19 21.08 13.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.29 0.567 . . . . 0.0 110.159 -179.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.868 HG21 HG21 ' A' ' 93' ' ' THR . 20.1 t -76.34 106.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.07 -179.725 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.01 -20.26 26.61 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.032 -179.638 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -66.15 170.41 5.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.372 . . . . 0.0 111.144 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.5 -31.13 18.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.43 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.52 121.76 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 56' ' ' CYS . 20.6 mt -74.35 -59.47 2.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.699 179.474 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.471 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 80.6 p -50.55 175.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.42 178.485 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.09 -96.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.368 179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' HH11 ' A' ' 81' ' ' ARG . 13.0 pt-20 -127.24 -32.76 2.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -73.67 -75.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.032 179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 80' ' ' PRO . 14.6 mt -103.28 115.58 30.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.315 179.498 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -69.44 71.45 0.3 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.768 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.633 HG11 ' NE ' ' A' ' 38' ' ' ARG . 2.1 t -74.3 87.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.324 -178.805 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 21.2 t -88.33 86.62 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.488 178.127 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.625 ' HB3' HD12 ' A' ' 47' ' ' LEU . 29.6 t -110.41 153.82 24.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.743 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -136.9 118.13 14.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.273 179.34 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.419 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.2 OUTLIER -80.34 94.77 6.2 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.541 ' O ' ' HA2' ' A' ' 72' ' ' GLY . 21.5 m -99.58 104.48 27.84 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.356 -179.369 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.733 ' HB2' HG13 ' A' ' 70' ' ' VAL . 69.0 Cg_endo -97.17 30.99 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 123.289 2.659 . . . . 0.0 111.847 -179.559 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.6 p -65.64 145.38 99.05 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.303 -179.621 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HA ' ' H ' ' A' ' 70' ' ' VAL . 92.3 Cg_endo -80.14 155.43 22.6 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.605 2.203 . . . . 0.0 112.492 -179.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.5 p -96.55 -174.54 3.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.6 p -136.9 -0.01 2.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' A' ' 66' ' ' PRO . 60.3 m -99.14 -49.94 0.21 Allowed Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.771 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 65' ' ' THR . 3.1 Cg_exo -77.75 -151.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.028 2.486 . . . . 0.0 112.085 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.8 mtt -129.52 17.66 5.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.962 179.859 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -108.63 153.83 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.081 -179.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -129.3 128.03 5.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 60' ' ' PRO . 70.4 t 59.26 96.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-O 120.984 0.421 . . . . 0.0 111.017 -179.958 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 29' ' ' ASN . . . -122.43 -42.32 0.43 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.36 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 59' ' ' THR . . . 107.01 120.82 4.64 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.718 179.627 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.436 HD12 ' ND1' ' A' ' 25' ' ' HIS . 0.3 OUTLIER -89.2 -24.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.968 0.413 . . . . 0.0 112.056 179.786 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 26' ' ' LEU . 23.9 m-85 47.31 75.94 0.12 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.326 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.9 p -92.04 101.44 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.179 0.514 . . . . 0.0 110.248 179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.539 HG22 ' SG ' ' A' ' 56' ' ' CYS . 17.3 t -99.67 117.29 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.815 HD22 HG22 ' A' ' 21' ' ' THR . 64.4 mt -107.38 94.58 5.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.105 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.56 HG21 HD22 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -90.98 112.11 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.023 0.439 . . . . 0.0 111.297 -178.809 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 45.6 mtmt -113.15 94.25 29.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.114 -179.684 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HA ' HD23 ' A' ' 52' ' ' LEU . 2.2 Cg_endo -47.58 103.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.579 2.186 . . . . 0.0 112.669 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.7 mtt180 -67.46 -33.68 75.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.541 179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -119.29 -176.06 3.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.53 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -127.8 121.59 30.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.892 179.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 154.54 -106.98 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -105.58 99.74 9.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.6 m80 -128.67 150.23 50.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.503 ' HG1' ' CG ' ' A' ' 109' ' ' HIS . 91.4 m -158.17 147.72 19.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.96 0.409 . . . . 0.0 111.935 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 39.9 tp -98.31 84.82 3.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.647 179.568 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.583 ' HA ' HG23 ' A' ' 107' ' ' THR . 46.4 mt-10 -69.64 99.11 1.26 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' TYR . 21.6 mt -110.57 151.77 27.22 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 39' ' ' VAL . 3.6 p -154.79 146.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.92 0.391 . . . . 0.0 111.632 -178.606 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' A' ' 35' ' ' MET . 12.4 t80 -95.67 78.04 3.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.4 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.868 HG21 HG21 ' A' ' 42' ' ' VAL . 5.4 t -118.45 159.65 23.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 34' ' ' TYR . 13.6 mtp180 -98.43 98.17 5.55 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.605 178.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 93' ' ' THR . 86.3 Cg_exo -40.78 -34.51 1.33 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.079 2.519 . . . . 0.0 113.105 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -68.93 -62.95 1.16 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.003 -179.416 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.73 4.53 9.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.304 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.03 -164.74 37.3 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.081 -179.562 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.616 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.6 mt -113.04 121.02 64.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.976 -179.198 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -107.76 162.74 18.79 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.36 -37.47 17.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.663 2.242 . . . . 0.0 112.393 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.4 -17.59 8.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.743 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -60.75 142.29 56.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.361 . . . . 0.0 111.473 -179.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.42 173.55 1.18 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.599 179.429 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.694 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 14.8 tpp180 -135.89 163.07 31.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.265 -179.211 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.694 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 13.4 t80 -169.76 74.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 177.152 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -95.94 93.3 6.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.729 -178.851 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 17.3 tp -76.73 88.65 3.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.106 0.479 . . . . 0.0 110.24 179.291 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.677 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 46.0 m-70 -72.38 144.06 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.652 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 16' ' ' THR . 64.5 mt -146.37 113.31 6.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.123 -178.35 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 9.3 t30 -83.34 55.98 3.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.491 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.473 HG13 HG23 ' A' ' 16' ' ' THR . 1.8 t -35.64 126.15 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.743 -178.871 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.928 179.952 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 51.2 m -137.57 -14.57 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -132.51 132.65 42.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm 57.88 -168.45 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm -61.68 -61.83 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.616 ' H ' ' HD2' ' A' ' 4' ' ' PRO . . . -168.71 -52.1 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.75 -179.9 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.616 ' HD2' ' H ' ' A' ' 3' ' ' ALA . 49.0 Cg_endo -68.53 100.13 0.66 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.105 1.87 . . . . 0.0 112.332 -179.748 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 55.9 tp -171.45 91.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.789 179.878 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.8 t 59.57 13.61 3.45 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.176 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.99 94.12 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.057 179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -179.99 152.35 0.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.796 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.11 112.56 19.27 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.531 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -132.09 -94.0 0.36 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.132 0.491 . . . . 0.0 111.952 -179.45 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -52.55 103.52 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.698 -179.284 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.75 90.48 7.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.889 179.198 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.668 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.7 m95 -73.67 99.12 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.715 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 15' ' ' ASP . 10.9 p -156.49 169.93 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.249 0.547 . . . . 0.0 111.931 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 14' ' ' VAL . 1.1 m-20 -85.75 -173.25 4.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.728 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 110' ' ' LEU . 2.0 t -175.51 -172.06 0.53 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.244 0.545 . . . . 0.0 112.375 -179.723 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 12.9 m80 -118.11 -160.12 0.77 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.709 178.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.401 ' H ' ' HB3' ' A' ' 17' ' ' HIS . 39.1 t -101.16 132.64 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 111.764 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.4 17.85 13.31 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.203 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.592 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 15.1 tptt -63.89 84.07 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.151 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.756 HG22 HD22 ' A' ' 77' ' ' LEU . 6.1 m -47.84 101.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.674 -178.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 78' ' ' VAL . 72.5 m -97.51 100.77 12.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.562 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HA ' HD23 ' A' ' 77' ' ' LEU . 39.4 tt0 -79.82 134.0 36.31 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.582 HG22 ' HG ' ' A' ' 26' ' ' LEU . 40.2 mt -138.34 104.38 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.964 -179.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -84.18 96.58 9.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.582 ' HG ' HG22 ' A' ' 24' ' ' ILE . 13.6 mt -95.88 148.01 23.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.727 -178.583 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -113.54 162.12 16.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.149 179.175 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.29 -23.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.545 -179.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 31' ' ' THR . 41.1 t30 64.34 104.62 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.463 0.173 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HG2' ' HB ' ' A' ' 70' ' ' VAL . 11.2 Cg_endo -55.24 -27.09 55.09 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.527 2.151 . . . . 0.0 112.478 179.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.481 ' HB ' HD21 ' A' ' 29' ' ' ASN . 6.7 m -57.69 -24.52 57.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.489 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 73.2 p -60.46 -62.56 1.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 156.88 -50.7 0.43 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.75 179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 92' ' ' TYR . 35.7 m-85 -77.23 -176.31 4.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.015 0.436 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.564 ' HG3' ' HE2' ' A' ' 58' ' ' TYR . 2.7 ttt -141.32 148.69 40.15 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.081 -179.814 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.454 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 6.6 m95 -104.56 83.5 2.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.849 178.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -127.43 -168.91 1.95 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.23 -179.261 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.636 HH11 HG21 ' A' ' 54' ' ' VAL . 1.9 mtp180 -85.63 135.85 33.62 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.31 -179.544 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.576 HG22 ' HB ' ' A' ' 91' ' ' VAL . 40.9 t -48.63 150.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.068 -179.254 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.81 1.3 4.83 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.595 179.745 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -125.91 32.48 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.449 0.642 . . . . 0.0 110.614 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.633 ' HB ' HG21 ' A' ' 93' ' ' THR . 2.1 p -60.26 100.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.994 179.657 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.36 -26.56 6.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.678 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -68.53 -179.75 1.45 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.865 0.364 . . . . 0.0 111.229 -179.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.59 -51.74 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.842 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 47' ' ' LEU . 3.6 p -68.94 -45.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.268 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.9 mt 71.09 -63.0 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.029 179.601 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 53.5 p -46.66 172.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.255 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -154.19 -84.82 0.07 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.416 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.4 pt-20 -130.65 -33.33 1.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.399 -179.202 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.545 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 21.6 mm -70.5 -78.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.437 -179.53 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 80' ' ' PRO . 10.6 mt -103.16 116.01 31.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.452 179.549 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.3 OUTLIER -68.66 69.83 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.673 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 78' ' ' VAL . 20.6 t -76.62 84.34 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 21.0 t -79.41 86.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.284 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 76' ' ' VAL . 43.4 t -99.91 142.14 31.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.434 -178.466 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -133.41 108.96 9.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.072 179.402 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.564 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.5 OUTLIER -78.76 100.63 7.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.259 179.564 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 29.2 m -93.57 108.2 32.33 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.831 -179.056 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HB2' HG11 ' A' ' 70' ' ' VAL . 77.5 Cg_endo -104.18 85.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.109 3.206 . . . . 0.0 111.434 179.285 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -49.12 132.44 15.96 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.53 -179.191 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.28 153.89 15.84 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.062 2.508 . . . . 0.0 112.343 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -68.75 116.89 9.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.032 -179.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.0 p -79.76 -20.14 46.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.689 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 74.7 p -81.65 156.52 70.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.973 179.876 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 93.0 Cg_endo -75.39 12.31 1.35 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.681 2.254 . . . . 0.0 112.533 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 64.6 mtt -124.27 -105.17 0.36 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.6 t -143.5 142.65 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.42 87.73 0.06 OUTLIER Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 179.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.527 ' HB ' ' HG2' ' A' ' 30' ' ' PRO . 57.3 t -58.85 -89.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.009 0.433 . . . . 0.0 110.959 179.854 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.81 99.46 0.42 Allowed Glycine 0 C--N 1.322 -0.224 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.057 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.435 ' H ' ' HD2' ' A' ' 30' ' ' PRO . . . -147.74 -150.36 5.18 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.082 -0.58 . . . . 0.0 111.921 179.506 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 9.5 pt -141.52 -167.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.159 0.504 . . . . 0.0 111.338 179.405 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.3 m-85 -134.56 97.16 3.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.226 -179.779 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 68.9 t -83.54 102.98 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.823 -179.501 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.588 HG11 HD21 ' A' ' 88' ' ' LEU . 40.2 t -105.55 124.06 60.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.342 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.756 HD22 HG22 ' A' ' 21' ' ' THR . 85.9 mt -113.17 102.95 10.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.669 178.13 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -95.49 110.4 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.438 . . . . 0.0 111.428 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.6 mtmt -115.32 96.04 44.49 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.064 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HA ' HD23 ' A' ' 52' ' ' LEU . 6.0 Cg_endo -50.99 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.38 2.054 . . . . 0.0 112.403 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 13.6 mtt180 -74.22 -38.11 63.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.257 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -111.4 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.142 -179.069 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -112.01 144.2 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.68 -119.74 2.8 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.448 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -110.58 117.42 33.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.061 0.458 . . . . 0.0 110.964 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -132.85 159.06 40.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.474 179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.457 HG22 HG22 ' A' ' 107' ' ' THR . 59.3 m -159.39 142.41 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 111.411 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 35.3 tp -99.36 92.14 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.421 179.58 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.593 ' HA ' HG23 ' A' ' 107' ' ' THR . 44.7 mt-10 -72.51 99.35 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.606 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.577 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 33.8 mt -113.72 128.87 56.59 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.316 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HB ' HG22 ' A' ' 39' ' ' VAL . 10.7 p -134.55 158.25 41.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 0.0 111.799 -178.713 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 35' ' ' MET . 0.8 OUTLIER -97.15 82.38 3.17 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.977 178.605 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.633 HG21 ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -101.77 177.07 5.01 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' HB2' ' H ' ' A' ' 98' ' ' GLY . 61.4 mtp180 -110.25 94.05 17.37 Favored Pre-proline 0 CA--C 1.528 0.103 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.022 179.544 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.456 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 81.3 Cg_exo -50.81 -29.2 25.59 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.52 2.146 . . . . 0.0 112.441 179.431 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -79.89 -31.14 40.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.459 -179.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -114.26 -77.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.932 0.396 . . . . 0.0 111.361 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.533 ' H ' ' HB2' ' A' ' 94' ' ' ARG . . . 174.22 -173.94 46.2 Favored Glycine 0 CA--C 1.507 -0.419 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.007 -179.331 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 93' ' ' THR . 3.3 mt -93.1 149.84 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.855 0.359 . . . . 0.0 111.026 -179.471 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' HG3' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -138.95 168.18 16.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.978 -179.264 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.61 -28.06 4.58 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.667 2.245 . . . . 0.0 112.156 -179.637 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -78.44 11.62 2.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.69 179.675 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.546 ' N ' HD22 ' A' ' 103' ' ' ASN . 1.0 OUTLIER -93.4 150.11 20.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.342 -179.419 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.69 163.88 8.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.634 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 15.4 tpp180 -130.96 164.11 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.649 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.634 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 70.9 t80 -174.4 76.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.405 0.621 . . . . 0.0 109.558 177.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.593 HG23 ' HA ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -95.75 88.78 5.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.389 -179.18 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 22.1 tp -67.6 90.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 0.0 110.472 179.807 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.668 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 34.5 m-70 -73.4 133.91 43.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.662 179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 94.2 mt -141.4 102.86 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.273 -178.191 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.46 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 6.3 t30 -78.64 85.76 4.66 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.071 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 17' ' ' HIS . 18.3 t -55.11 112.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.284 -179.062 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.009 179.877 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.3 p -143.47 124.82 14.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -152.64 -55.86 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt -89.97 -29.97 18.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 2' ' ' ILE . 15.5 tt 42.35 28.08 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.588 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 4' ' ' PRO . . . -82.41 -50.3 0.8 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.624 -179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 3' ' ' ALA . 59.0 Cg_endo -71.82 -10.5 26.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.061 1.841 . . . . 0.0 112.322 -179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.9 tp -88.34 -48.37 7.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.785 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.0 p -141.25 156.31 45.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.806 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.1 t 65.77 138.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.304 179.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -172.4 135.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.325 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.83 115.27 22.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.714 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -123.21 -81.06 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.732 -179.707 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.571 ' H ' HD22 ' A' ' 10' ' ' ASN . 7.8 m-20 -30.17 104.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.617 -179.672 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -93.11 89.86 6.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.548 179.489 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.663 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 4.3 m95 -78.04 101.22 6.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.443 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 HD23 ' A' ' 110' ' ' LEU . 22.8 m -149.29 -175.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.237 0.541 . . . . 0.0 112.167 -178.849 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.455 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -99.53 -173.71 2.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.295 179.784 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.568 ' HB ' HD22 ' A' ' 110' ' ' LEU . 1.3 t -174.45 -175.75 1.0 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.226 0.536 . . . . 0.0 112.187 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 52.8 m80 -116.82 -162.24 0.84 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.882 179.23 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.53 122.52 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.069 0.462 . . . . 0.0 111.634 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.2 10.69 35.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.14 179.755 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 5.1 tptp -62.81 84.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.061 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 HD22 ' A' ' 77' ' ' LEU . 7.7 m -45.39 100.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.807 -178.7 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 78' ' ' VAL . 69.3 m -91.64 102.96 15.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.28 179.389 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . 41.6 tt0 -86.43 132.18 34.01 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.339 -179.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.415 HD11 HD22 ' A' ' 108' ' ' LEU . 37.3 mt -139.2 104.84 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.413 179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -79.62 95.76 5.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.777 178.713 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 28.8 mt -88.75 143.95 26.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.444 -179.284 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -97.01 166.08 11.77 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.873 0.368 . . . . 0.0 110.627 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.89 -150.99 13.04 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 62.4 t30 -175.86 96.16 0.26 Allowed Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 29' ' ' ASN . 13.6 Cg_endo -56.23 -16.52 17.64 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.764 2.31 . . . . 0.0 113.132 -179.599 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.2 p -82.96 9.15 10.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.675 0.274 . . . . 0.0 111.433 -179.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.401 HG23 ' HB3' ' A' ' 29' ' ' ASN . 70.5 p -97.84 -60.83 1.48 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.052 179.754 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.48 -27.55 0.32 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.92 179.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 93' ' ' THR . 87.9 m-85 -102.61 175.0 5.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.116 0.484 . . . . 0.0 111.633 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 7.1 ttm -147.51 148.89 31.68 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.009 -179.615 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.457 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 15.6 m95 -93.67 81.48 4.29 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.218 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.51 HG22 ' HG2' ' A' ' 35' ' ' MET . 1.7 t -125.4 146.83 49.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.527 -177.766 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HD3' HG11 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -53.39 177.34 0.02 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.981 0.419 . . . . 0.0 110.623 179.428 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 89' ' ' GLU . 42.8 t -81.78 102.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.522 -179.773 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.5 -12.92 56.85 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.527 179.236 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.766 ' CG ' HD22 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -73.92 -42.01 61.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 117.45 0.625 . . . . 0.0 110.599 -179.741 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.519 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.0 p -26.7 90.39 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.138 0.494 . . . . 0.0 111.06 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . 89.75 49.92 3.25 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -178.478 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.795 ' HD3' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -112.07 -163.33 0.84 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.594 0.712 . . . . 0.0 112.299 -178.548 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.674 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 6.1 m-20 -115.67 -32.82 5.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.637 -1.165 . . . . 0.0 107.995 176.309 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.505 ' N ' ' HD2' ' A' ' 44' ' ' LYS . 2.1 t -155.31 118.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.737 178.7 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.795 HD23 ' HD3' ' A' ' 44' ' ' LYS . 0.7 OUTLIER -51.31 -62.7 1.46 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.125 -179.847 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.595 ' HB3' HG23 ' A' ' 54' ' ' VAL . 81.1 p -64.19 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.781 -179.734 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -152.51 -80.47 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.71 -31.29 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.513 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.565 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 19.3 mm -74.35 -86.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.622 -179.465 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.724 HD22 HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -97.86 109.1 21.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.267 179.803 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.601 ' HB2' ' HG3' ' A' ' 81' ' ' ARG . 1.3 tm-20 -62.24 147.46 47.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.052 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 48' ' ' SER . 11.5 t -146.36 133.84 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 0.0 111.594 -179.548 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 40.6 t -137.87 86.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.782 178.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.577 ' SG ' HG22 ' A' ' 76' ' ' VAL . 42.0 t -93.94 97.58 10.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.784 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 81.7 mttt -72.65 73.71 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.35 178.844 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.536 ' C ' ' HD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -64.24 103.71 0.66 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.473 179.8 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.51 HG22 ' HA3' ' A' ' 71' ' ' GLY . 1.4 m -108.37 125.04 32.8 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.436 178.658 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -94.0 -167.02 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.031 2.487 . . . . 0.0 113.047 -178.716 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -59.48 135.17 88.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.221 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.491 ' HG3' ' H ' ' A' ' 69' ' ' GLY . 10.9 Cg_endo -53.34 163.27 2.55 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.068 2.512 . . . . 0.0 112.427 179.638 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.5 m -85.17 -166.12 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.2 p -77.16 11.49 1.83 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 72.4 p -56.72 156.54 12.17 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -179.969 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 92.3 Cg_endo -75.25 12.89 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.723 2.282 . . . . 0.0 112.426 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.2 ttp -131.83 86.14 2.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.731 179.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.95 122.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.105 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.491 ' H ' ' HG3' ' A' ' 62' ' ' PRO . . . 123.3 68.31 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.449 179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 62' ' ' PRO . 86.3 t -108.5 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.065 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' HA3' HG22 ' A' ' 59' ' ' THR . . . -164.15 -131.57 1.25 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.993 -179.712 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.36 15.47 29.95 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.508 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt -147.1 -168.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.188 0.518 . . . . 0.0 111.548 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -136.31 100.71 4.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.094 -179.989 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 62.1 t -79.43 89.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-O 120.811 0.338 . . . . 0.0 110.893 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.688 HG11 HD21 ' A' ' 88' ' ' LEU . 21.5 t -83.41 121.31 36.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 21' ' ' THR . 77.3 mt -117.02 98.29 6.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.081 178.304 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.724 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -96.12 110.69 24.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.827 -179.127 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 42.9 mtmt -110.97 102.58 53.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.959 -178.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 17' ' ' HIS . 45.4 Cg_exo -54.77 100.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.353 2.036 . . . . 0.0 112.315 179.343 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 53' ' ' GLU . 71.0 mtt180 -69.77 -42.26 74.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -112.24 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.647 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -117.62 142.83 46.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.749 179.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 138.1 -135.28 7.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.485 179.906 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.457 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 64.8 m80 -101.33 91.16 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 -179.989 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.457 ' HD1' ' C ' ' A' ' 85' ' ' HIS . 0.8 OUTLIER -107.43 163.98 12.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.202 179.761 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 88' ' ' LEU . 85.6 m -160.89 155.09 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.14 0.495 . . . . 0.0 112.156 -179.574 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 HG11 ' A' ' 76' ' ' VAL . 14.9 tp -125.64 96.26 4.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.832 178.961 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.624 ' HB2' HG23 ' A' ' 39' ' ' VAL . 5.5 mt-10 -84.36 99.38 10.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.782 0.325 . . . . 0.0 111.868 -178.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 106' ' ' TYR . 33.4 mt -95.88 129.26 43.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.364 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 92' ' ' TYR . 11.2 p -130.83 157.19 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.064 0.459 . . . . 0.0 112.097 -178.58 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -100.93 95.02 6.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.595 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.859 ' HB ' HG23 ' A' ' 99' ' ' ILE . 5.0 t -117.2 167.65 11.01 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.73 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -103.2 93.67 4.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.796 178.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 93' ' ' THR . 83.6 Cg_exo -48.91 -29.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.867 2.378 . . . . 0.0 112.961 -179.617 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -77.77 10.37 2.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -150.55 -72.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.09 0.472 . . . . 0.0 110.983 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.66 175.34 36.78 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.539 -179.518 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.9 mt -94.24 150.79 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.08 0.467 . . . . 0.0 111.604 -179.123 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -137.53 166.88 23.24 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.98 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.3 -48.31 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.344 2.696 . . . . 0.0 112.498 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -56.37 -18.15 10.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.683 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 92' ' ' TYR . 12.8 m120 -62.56 162.86 9.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.784 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 161.26 5.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.642 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 17.0 tpp180 -135.05 164.28 27.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.57 -178.605 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.642 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 40.4 t80 -174.29 67.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.248 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 89' ' ' GLU . 12.4 m -87.34 97.81 11.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.559 -178.828 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 78' ' ' VAL . 63.2 tp -76.56 88.06 3.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.099 179.946 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.663 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 12.7 m-70 -73.81 142.94 46.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 179.424 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.568 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.2 mt -143.71 108.6 4.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.692 -178.056 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.455 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 51.8 t-20 -81.48 72.23 8.52 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.235 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 17' ' ' HIS . 1.6 t -53.09 122.84 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.667 -178.235 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.071 179.757 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.7 m -77.31 124.93 28.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.871 0.367 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -90.44 -32.03 16.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtm -121.53 144.66 48.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.022 179.929 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.2 pt -114.69 12.0 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . . . -60.39 -49.35 90.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.657 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 3' ' ' ALA . 51.6 Cg_exo -54.76 149.37 41.34 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.126 1.884 . . . . 0.0 112.25 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.443 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.7 mm? 59.11 17.1 5.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -142.07 -26.91 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.858 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 p -160.27 148.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -171.26 134.59 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.571 -179.873 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.24 122.38 24.3 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.375 179.787 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.647 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 0.7 OUTLIER -125.56 -14.73 6.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.991 -179.303 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -87.81 100.42 12.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.148 0.499 . . . . 0.0 111.636 -179.178 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -109.67 61.72 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.497 179.132 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.69 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 7.6 m0 -78.73 112.55 15.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.46 -178.008 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' LEU . 34.8 m -150.24 -166.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.105 -178.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -96.05 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.696 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.509 ' HB ' HD22 ' A' ' 110' ' ' LEU . 2.7 t 177.82 -174.51 0.15 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.143 0.497 . . . . 0.0 112.059 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 67.7 m-70 -118.55 -160.98 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.761 179.212 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.0 t -95.7 121.86 46.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 111.34 179.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 79' ' ' LYS . . . 64.45 16.98 61.46 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.062 179.84 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 11.4 tptt -58.09 91.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.725 HG22 HD22 ' A' ' 77' ' ' LEU . 6.9 m -56.73 101.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.482 -178.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 78' ' ' VAL . 40.8 m -100.81 99.21 9.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.663 179.642 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.507 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.1 tt0 -78.66 137.12 37.66 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.789 179.731 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.92 102.57 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.576 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -83.49 112.9 20.39 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.695 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 37.4 mt -108.62 154.28 22.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.155 -178.315 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -110.89 155.68 22.28 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.98 179.333 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.26 -19.3 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.505 -179.229 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 32' ' ' THR . 61.1 t30 62.46 91.52 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.517 0.199 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HG2' ' HA ' ' A' ' 60' ' ' PRO . 73.4 Cg_exo -49.45 -19.98 3.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.939 2.426 . . . . 0.0 113.277 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.1 p -85.19 22.89 1.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.543 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 29' ' ' ASN . 10.7 t -110.7 -37.12 5.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.699 0.285 . . . . 0.0 111.222 179.915 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 141.3 -72.37 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.943 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -59.48 160.34 7.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.151 0.5 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 16.5 ttm -123.88 150.89 44.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.501 -179.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 3.3 m95 -109.24 84.19 1.88 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.769 178.545 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.579 HG21 ' HA ' ' A' ' 42' ' ' VAL . 7.0 t -132.38 -164.02 1.41 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.5 -179.124 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.643 ' HB2' ' HB3' ' A' ' 47' ' ' LEU . 19.0 mtp85 -92.75 121.69 34.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.731 0.3 . . . . 0.0 110.474 179.792 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 89' ' ' GLU . 2.3 p -51.9 140.07 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.67 -6.76 81.9 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.714 -179.32 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 52.0 m-85 -128.31 1.16 5.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.285 0.564 . . . . 0.0 110.187 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.864 HG21 HG21 ' A' ' 93' ' ' THR . 15.4 t -56.08 119.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.064 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.24 -25.84 25.34 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.913 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' A' ' 41' ' ' PHE . 28.3 mtpp -71.28 173.09 8.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 179.77 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.42 -61.86 1.81 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.755 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.68 141.19 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 6.0 mt -90.03 -53.22 4.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.757 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.463 ' HB3' ' N ' ' A' ' 54' ' ' VAL . 59.9 p -52.89 -178.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.765 178.828 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -158.39 -90.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.207 -179.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.6 pt-20 -129.98 -29.02 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 11.6 mm -74.77 -76.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.283 -179.61 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 78' ' ' VAL . 4.3 mt -102.4 115.27 30.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.299 179.154 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -69.38 69.52 0.24 Allowed 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 121.091 0.472 . . . . 0.0 109.94 178.062 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG22 ' CG1' ' A' ' 78' ' ' VAL . 18.4 t -74.32 81.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.018 -179.18 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 31.0 t -78.01 81.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.018 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' SG ' HG22 ' A' ' 76' ' ' VAL . 15.2 t -97.38 136.21 38.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.478 -178.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -126.7 113.75 17.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.858 179.189 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -82.32 107.19 14.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.732 179.826 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.63 HG22 ' HA3' ' A' ' 71' ' ' GLY . 6.4 m -99.11 109.33 53.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.509 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 61.1 Cg_endo -98.34 -166.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.336 2.691 . . . . 0.0 112.183 179.846 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 HG12 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -150.68 135.07 9.51 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.913 179.26 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.58 52.74 1.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.038 2.492 . . . . 0.0 111.904 179.548 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.5 t -164.32 176.63 8.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.041 -179.228 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 54.8 m -96.59 -1.51 46.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.54 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 74.4 p -63.66 158.44 59.79 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.113 179.912 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 65.0 Cg_endo -70.98 -154.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.547 2.165 . . . . 0.0 112.06 179.966 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.4 mtm -60.26 -13.0 10.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.219 -179.873 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.87 105.91 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.974 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.34 -122.35 1.02 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.598 179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.607 HG12 HG23 ' A' ' 61' ' ' THR . 7.9 p -113.06 21.25 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.515 . . . . 0.0 110.835 -179.887 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 59' ' ' THR . . . 146.38 -139.96 8.44 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.635 179.925 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.24 15.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.868 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.4 pt -136.37 -164.17 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 111.474 179.811 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -140.29 110.99 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.058 -179.619 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -103.48 113.8 41.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.254 0.55 . . . . 0.0 110.477 -179.672 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.494 HG22 ' SG ' ' A' ' 56' ' ' CYS . 41.8 t -109.02 125.77 66.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.499 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.725 HD22 HG22 ' A' ' 21' ' ' THR . 86.3 mt -110.05 101.36 10.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.021 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.61 HG12 HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -95.0 111.11 25.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.976 0.417 . . . . 0.0 111.233 -178.786 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 48.9 mtmt -115.6 96.81 47.28 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.499 -179.435 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HA ' HD23 ' A' ' 52' ' ' LEU . 5.5 Cg_endo -50.31 104.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.476 2.117 . . . . 0.0 112.656 179.752 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.567 HH11 ' HA ' ' A' ' 50' ' ' GLU . 8.4 mtt180 -71.24 -42.16 69.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.298 179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -107.77 175.05 5.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -114.67 123.41 49.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 179.84 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.597 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 162.6 -101.78 0.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.488 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -143.72 91.58 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.564 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 1.3 m-70 -100.0 173.71 6.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.671 -179.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 109' ' ' HIS . 53.8 m -160.53 150.51 17.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.781 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 90' ' ' LEU . 36.4 tp -113.93 88.75 2.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 39' ' ' VAL . 43.8 mt-10 -75.51 93.82 3.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.071 -179.634 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 62.8 mt -104.16 131.05 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.935 178.654 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.93 153.47 36.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.722 -178.963 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 35' ' ' MET . 2.3 t80 -96.88 89.66 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.864 HG21 HG21 ' A' ' 42' ' ' VAL . 7.2 t -130.4 151.7 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.479 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 97' ' ' GLU . 78.5 mtp180 -86.99 101.59 2.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.713 178.362 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 35' ' ' MET . 1.6 Cg_endo -47.44 -36.63 24.14 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.871 2.381 . . . . 0.0 113.117 -179.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -87.72 18.9 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.482 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' A' ' 94' ' ' ARG . 17.3 mm-40 -149.75 1.49 0.5 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.433 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.69 178.66 51.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.122 -179.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 93' ' ' THR . 7.5 mt -105.72 154.29 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.472 . . . . 0.0 111.872 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.647 ' HE3' HD21 ' A' ' 103' ' ' ASN . 42.8 mtmt -137.78 163.04 50.96 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.885 -179.574 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 56.1 Cg_endo -70.76 -38.41 5.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.782 2.322 . . . . 0.0 112.347 -179.927 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.77 -24.59 67.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.647 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -54.73 148.1 13.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.398 -179.999 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 92' ' ' TYR . 4.6 tt0 -56.31 163.28 1.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.856 179.768 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 18.3 tpp180 -132.59 163.59 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.647 ' HA ' ' HB2' ' A' ' 10' ' ' ASN . 65.1 t80 -174.03 74.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.239 177.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -95.09 106.81 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 -178.863 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 26.1 tp -93.02 91.4 7.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 20.1 m-70 -74.91 151.48 38.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.423 179.704 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' HB ' ' A' ' 16' ' ' THR . 95.5 mt -148.58 116.97 6.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.264 -178.538 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' H ' ' HA ' ' A' ' 15' ' ' ASP . 49.4 t30 -86.68 68.07 10.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.908 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 2.0 t -49.26 119.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.469 -178.684 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.999 179.995 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 80.9 p -144.44 168.86 19.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.749 0.309 . . . . 0.0 110.97 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -94.28 -2.37 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.5 mmm 58.23 -171.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.041 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.3 pt -74.01 -32.64 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.184 179.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.12 151.0 7.51 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.009 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.85 152.22 63.49 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.446 2.097 . . . . 0.0 112.255 179.992 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.2 mt -70.53 159.33 34.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.6 m -100.64 0.71 39.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.9 m -89.44 13.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.452 ' HG3' ' H ' ' A' ' 9' ' ' ASP . 5.6 ptmm? -124.16 -62.7 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 8' ' ' LYS . 6.3 t70 50.96 99.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.274 -179.822 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -129.58 -74.09 0.56 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.855 -179.308 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 4.2 p-10 -37.63 97.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.894 -179.5 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HE3' HG11 ' A' ' 14' ' ' VAL . 55.3 tptt -107.26 93.53 4.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.436 179.78 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.683 ' HA ' ' HB2' ' A' ' 109' ' ' HIS . 2.2 m95 -88.96 105.03 17.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.34 -179.12 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.468 HG23 HD23 ' A' ' 110' ' ' LEU . 7.3 m -151.41 -175.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.997 -179.621 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HA ' ' H ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER -99.95 -176.33 3.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.417 179.831 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.494 ' HB ' HD22 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -174.82 -178.06 1.22 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.176 0.512 . . . . 0.0 112.177 -179.807 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.589 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 13.8 m80 -114.14 -167.25 1.19 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.04 179.212 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 80' ' ' PRO . 9.6 p -94.06 135.41 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.261 0.553 . . . . 0.0 112.046 -179.299 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.1 14.82 11.86 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.546 179.579 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.589 ' HD3' ' HB2' ' A' ' 17' ' ' HIS . 3.6 tptp -65.58 81.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.726 HG22 HD22 ' A' ' 77' ' ' LEU . 5.5 m -47.34 101.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.76 -178.785 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 78' ' ' VAL . 60.8 m -94.97 98.13 10.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.431 179.368 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HA ' HD23 ' A' ' 77' ' ' LEU . 38.4 tt0 -78.74 132.85 37.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.988 179.947 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 108' ' ' LEU . 39.5 mt -137.53 104.66 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.999 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -86.23 98.75 11.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.311 178.214 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 23.9 mt -94.31 145.12 24.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.613 -179.058 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.595 ' HD2' ' H ' ' A' ' 27' ' ' LYS . 4.4 mptt -98.73 162.3 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.543 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.41 -141.72 6.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.267 -179.341 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 62.3 t30 -172.46 101.11 0.35 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.403 0.144 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.608 ' HD2' ' HA2' ' A' ' 71' ' ' GLY . 47.6 Cg_exo -56.85 -36.83 99.05 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.614 2.209 . . . . 0.0 112.416 179.93 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.7 p -65.61 -21.9 66.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.425 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 29' ' ' ASN . 39.6 m -63.99 -49.65 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.157 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.43 -70.25 0.3 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.904 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -62.52 -179.46 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.477 . . . . 0.0 111.46 -179.539 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 6.0 ttm -146.7 153.17 39.95 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.166 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 10.0 m95 -105.53 94.92 5.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.843 178.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 42' ' ' VAL . 9.2 t -140.83 -170.33 3.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.627 -178.938 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.608 HH11 HG21 ' A' ' 54' ' ' VAL . 9.9 mtp85 -86.62 157.07 19.78 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 111.454 -179.327 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' A' ' 91' ' ' VAL . 52.6 t -72.7 132.05 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.943 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.07 4.99 79.62 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.481 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.437 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 60.1 m-85 -127.17 -2.04 6.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.132 0.491 . . . . 0.0 110.45 179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 HG21 ' A' ' 93' ' ' THR . 22.4 t -49.07 112.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.262 179.178 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.87 -17.71 13.02 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.217 -179.734 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HB2' HD23 ' A' ' 47' ' ' LEU . 28.7 mtpp -79.92 -159.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.705 0.288 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -120.11 -56.03 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.282 -179.678 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' C ' ' HG ' ' A' ' 47' ' ' LEU . 16.9 t -86.35 -39.18 13.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.799 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 38' ' ' ARG . 9.3 mt 76.01 -43.66 0.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.751 -179.298 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 20.9 p -54.98 -175.48 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.95 179.553 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -156.53 -86.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.329 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.601 ' HA ' HH11 ' A' ' 81' ' ' ARG . 12.8 pt-20 -132.12 -31.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.434 -179.132 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 18.5 mm -73.0 -78.5 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.571 ' HG ' ' HB3' ' A' ' 86' ' ' HIS . 7.1 mt -102.68 114.23 28.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.499 179.375 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -68.55 70.63 0.18 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.066 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.608 HG21 HH11 ' A' ' 38' ' ' ARG . 14.0 t -75.1 83.71 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.911 -179.1 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 77' ' ' LEU . 24.0 t -78.42 82.67 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.39 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 43.0 t -94.56 139.51 31.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.277 -178.605 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -132.45 108.1 8.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.162 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HE2' ' HG3' ' A' ' 35' ' ' MET . 0.4 OUTLIER -79.43 112.64 16.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.368 179.636 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.1 m -113.15 111.14 50.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.975 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -101.42 99.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 123.735 2.956 . . . . 0.0 111.264 178.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.6 m -123.31 136.93 27.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.347 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 9.0 Cg_endo -50.13 132.6 33.74 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.973 2.448 . . . . 0.0 112.298 179.646 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.561 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 26.1 t -69.35 -177.3 1.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.747 179.841 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.0 p -94.9 -9.08 35.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.194 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.1 p -98.3 151.64 37.59 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.656 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.78 33.17 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.103 2.535 . . . . 0.0 112.653 179.716 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.6 ttp -130.0 -2.25 4.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.019 0.438 . . . . 0.0 110.692 -179.575 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 74.7 t -127.83 131.57 69.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.16 -179.719 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.82 -56.81 2.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.376 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 54.3 t -143.34 82.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.924 0.392 . . . . 0.0 110.625 179.868 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' HD2' ' A' ' 30' ' ' PRO . . . -116.37 102.93 1.1 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.867 -179.844 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 59' ' ' THR . . . -105.83 -131.12 6.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.034 179.925 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 26' ' ' LEU . 7.9 pt -147.36 -166.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.126 0.489 . . . . 0.0 111.095 179.597 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' CE2' ' HB2' ' A' ' 36' ' ' TRP . 1.1 m-85 -134.47 99.94 4.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.078 -179.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -85.35 102.32 11.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.978 0.418 . . . . 0.0 110.866 -179.52 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 88' ' ' LEU . 40.8 t -104.74 119.85 54.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.202 -179.385 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.726 HD22 HG22 ' A' ' 21' ' ' THR . 78.3 mt -109.69 98.15 7.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.208 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -92.33 103.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.038 0.447 . . . . 0.0 111.216 -178.706 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 79' ' ' LYS . 7.1 mtmp? -106.15 104.41 49.63 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.267 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.1 Cg_exo -54.31 96.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.475 2.117 . . . . 0.0 112.567 179.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.601 HH11 ' HA ' ' A' ' 50' ' ' GLU . 3.9 mtt180 -64.5 -41.84 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.407 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -113.15 173.08 6.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 -179.383 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -113.2 106.92 15.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.604 ' H ' ' HB ' ' A' ' 112' ' ' VAL . . . 171.19 -123.82 1.07 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.47 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.451 ' C ' ' HD1' ' A' ' 86' ' ' HIS . 63.3 m80 -103.56 98.32 8.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.571 ' HB3' ' HG ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -115.15 158.43 22.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.725 179.998 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 109' ' ' HIS . 33.8 m -159.99 151.9 20.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.852 0.358 . . . . 0.0 111.562 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 108' ' ' LEU . 45.7 tp -117.05 91.18 3.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . 39.1 mt-10 -76.4 97.74 4.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.105 179.948 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 88' ' ' LEU . 59.6 mt -108.5 133.54 52.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.918 178.521 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CG2' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -137.36 167.07 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.135 0.493 . . . . 0.0 111.681 -179.379 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' MET . 1.9 t80 -106.4 89.09 2.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.728 178.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.917 HG21 HG21 ' A' ' 42' ' ' VAL . 5.7 t -118.29 170.08 9.19 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.59 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -102.56 95.1 5.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 93' ' ' THR . 71.0 Cg_exo -42.08 -36.87 4.18 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -40.77 70.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.288 -179.963 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.8 -78.55 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.924 0.393 . . . . 0.0 111.388 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.86 178.24 39.19 Favored Glycine 0 CA--C 1.508 -0.348 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.945 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.658 HG23 ' HB ' ' A' ' 93' ' ' THR . 6.0 mt -93.22 153.62 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.935 0.397 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 39.0 mtmt -145.47 163.44 31.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.067 -179.07 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 100' ' ' LYS . 19.2 Cg_endo -60.92 -37.84 74.08 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.718 2.279 . . . . 0.0 112.034 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.78 -23.86 67.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.046 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.614 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.8 OUTLIER -51.7 136.02 27.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.146 179.907 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 91' ' ' VAL . 7.6 tt0 -51.93 156.56 1.47 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.556 ' HG3' ' N ' ' A' ' 106' ' ' TYR . 8.8 tpp180 -118.93 158.33 25.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.187 0.518 . . . . 0.0 112.057 -178.54 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.556 ' N ' ' HG3' ' A' ' 105' ' ' ARG . 34.3 t80 -171.74 64.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.772 177.319 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 m -91.08 98.96 12.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.994 -179.278 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 35.0 tp -83.39 94.56 7.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.683 ' HB2' ' HA ' ' A' ' 13' ' ' TRP . 26.8 m-70 -79.24 141.41 37.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.494 HD22 ' HB ' ' A' ' 16' ' ' THR . 91.5 mt -145.17 105.66 4.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.482 -178.293 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 10.7 m120 -78.13 74.13 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.221 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.604 ' HB ' ' H ' ' A' ' 84' ' ' GLY . 1.7 t -55.4 117.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 -178.594 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 111' ' ' ASN . 34.1 mmtp . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.915 179.854 . . . . . . . . 1 1 . 1 stop_ save_